data_2kxi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.617 ' HB2' ' HD2' ' A' ' 97' ' ' ARG . 5.9 m120 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -99.01 114.19 26.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.359 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.5 143.31 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.473 ' HE1' ' HB ' ' A' ' 92' ' ' ILE . 1.3 t80 -138.18 134.01 33.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.05 141.98 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -127.57 157.78 21.03 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 tt -138.42 136.91 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.002 0.43 . . . . 0.0 110.701 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.2 m -100.05 -16.61 17.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.24 0.543 . . . . 0.0 109.976 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -86.89 51.19 2.17 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -21.89 42.95 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.643 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -63.3 -55.72 22.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.717 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.383 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' HG3' HD22 ' A' ' 21' ' ' LEU . 6.3 tm-20 -55.83 -57.29 12.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.813 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -70.17 -29.81 66.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.355 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.06 -43.8 64.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -78.77 -23.91 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.993 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.99 24.39 73.1 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.186 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 5.7 mt-30 -161.54 27.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.126 0.171 . . . . 0.0 110.751 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.48 HD22 ' HG3' ' A' ' 15' ' ' GLU . 15.5 mt 73.57 -43.43 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -164.76 141.97 5.11 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -171.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.63 138.3 79.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.41 2.074 . . . . 0.0 112.071 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.397 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt . . . . . 0 C--O 1.242 0.661 0 CA-C-O 121.582 0.706 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -58.63 -24.61 61.44 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.346 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.83 1.0 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.555 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.421 HG11 ' OH ' ' A' ' 68' ' ' TYR . 2.3 p -69.42 -38.68 77.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.236 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.402 ' CZ ' ' HG3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -62.1 -57.02 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.073 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.05 85.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -58.23 -49.98 75.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -70.72 -35.93 72.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.0 -42.39 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 111.03 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -92.22 -60.25 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.821 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -90.8 -73.25 0.54 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.795 0.331 . . . . 0.0 111.727 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 66.29 3.85 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.254 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 13.6 tp -62.46 90.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.079 0.466 . . . . 0.0 110.907 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 64.1 47.5 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.739 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -15.44 63.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.81 5.56 Favored Glycine 0 C--N 1.329 0.14 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.432 ' SG ' ' CE1' ' A' ' 68' ' ' TYR . 13.9 t -59.01 -50.44 74.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.432 ' CE1' ' SG ' ' A' ' 67' ' ' CYS . 12.1 m-85 -106.33 160.35 15.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.072 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.21 99.49 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -78.82 126.43 30.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.698 179.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 121' ' ' VAL . 15.4 t -140.21 152.25 45.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.596 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.512 ' H ' HD11 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -89.46 169.11 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.85 10.17 3.59 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -116.79 127.44 54.34 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -69.8 -19.23 63.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.053 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.62 0.47 26.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.512 HD11 ' H ' ' A' ' 72' ' ' THR . 1.2 tt -52.27 -27.08 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.854 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.65 68.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.221 0.534 . . . . 0.0 110.839 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -49.22 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 -177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -62.92 -41.78 99.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.492 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -69.4 -43.52 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.259 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.73 99.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.071 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -69.92 -52.99 19.95 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -65.89 -21.97 66.48 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.509 ' HB2' HG13 ' A' ' 87' ' ' ILE . 12.3 m -97.77 0.06 46.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.45 29.25 74.5 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.505 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 85' ' ' SER . 4.4 mt -80.3 -8.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 122.811 -0.229 . . . . 0.0 111.06 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 3.8 tt0 -45.17 -27.52 0.62 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.908 0.385 . . . . 0.0 111.306 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.8 89.98 3.24 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.66 -148.14 12.1 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.233 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -116.68 146.21 42.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.839 0.456 . . . . 0.0 110.306 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.496 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 pt -144.69 141.86 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 6.8 p90 -131.63 152.88 50.48 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.017 0.437 . . . . 0.0 111.2 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 138' ' ' ALA . 1.5 m -118.83 142.59 33.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.274 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.634 HD21 HG11 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -134.22 142.69 47.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.672 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -98.15 142.18 30.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.617 ' HD2' ' HB2' ' A' ' 3' ' ' ASN . 47.3 ttt180 -77.5 -34.87 54.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.568 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -59.14 -25.77 64.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 0.0 110.822 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 135' ' ' VAL . 22.7 tp -65.46 -41.07 93.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.118 0.485 . . . . 0.0 109.778 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.527 ' CZ ' HG23 ' A' ' 135' ' ' VAL . 5.0 m-85 -66.29 -38.77 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.73 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.4 -41.51 95.25 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.753 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -68.63 -39.1 80.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.288 0.566 . . . . 0.0 110.203 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.551 ' HB3' HG12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.98 -21.65 64.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.759 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m 71.24 32.37 2.21 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.192 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 103' ' ' TYR . 24.6 mm -75.7 146.39 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.307 175.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -87.16 164.08 16.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.711 -171.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.38 138.2 27.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -125.64 113.01 16.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 pt-20 -105.25 119.73 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.535 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 120' ' ' GLU . 1.9 m -90.2 150.36 3.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.56 132.07 55.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.297 0.57 . . . . 0.0 110.925 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 18.5 m80 -81.61 -176.46 0.78 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 90.0 Cg_exo -46.59 158.39 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.328 1.352 . . . . 0.0 111.092 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.61 -44.93 95.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -84.42 -19.77 0.26 Allowed Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -168.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 39.9 Cg_exo -41.87 -22.76 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.532 1.488 . . . . 0.0 111.436 162.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.424 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER 72.58 20.8 3.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.49 166.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.7 150.27 34.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.573 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -129.42 137.31 50.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.228 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.402 ' HB3' HG22 ' A' ' 110' ' ' VAL . 3.2 tm-20 -90.57 111.94 23.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 1.8 p -102.56 102.89 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 110.098 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.9 m -87.41 126.25 34.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.252 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.2 mt -87.59 111.47 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.404 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.659 HH12 ' HA ' ' A' ' 126' ' ' GLU . 1.3 tmm_? -84.22 95.48 8.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.502 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' A' ' 131' ' ' ILE . . . -70.86 155.41 40.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.124 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.659 ' HA ' HH12 ' A' ' 124' ' ' ARG . 22.1 mm-40 -73.44 -4.09 31.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.677 0.275 . . . . 0.0 111.578 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.51 159.49 44.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.9 m -80.36 120.04 23.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.891 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.67 69.2 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.522 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.4 m 55.18 70.83 0.59 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.506 ' CG2' ' HD3' ' A' ' 132' ' ' PRO . 5.2 tt -64.21 -33.82 10.18 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.506 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 45.3 Cg_endo -92.88 126.7 0.69 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.008 1.805 . . . . 0.0 111.679 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -85.18 -29.07 25.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.924 0.392 . . . . 0.0 111.054 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.53 10.56 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.384 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.634 HG11 HD21 ' A' ' 95' ' ' LEU . 9.3 p -72.37 -16.11 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.256 0.551 . . . . 0.0 111.011 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.476 HD11 HD13 ' A' ' 21' ' ' LEU . 5.8 pt -88.3 89.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.1 pt -73.21 -19.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.836 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.435 ' HB2' HG13 ' A' ' 94' ' ' VAL . . . -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.598 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -130.14 125.23 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.81 153.97 48.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 tt -99.84 157.66 16.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.2 tt -136.05 129.27 47.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.262 0.553 . . . . 0.0 112.34 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 78.95 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.462 173.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.646 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 70.9 mt . . . . . 0 N--CA 1.466 0.325 0 C-N-CA 123.069 0.548 . . . . 0.0 111.342 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.566 ' HA ' ' NH1' ' A' ' 97' ' ' ARG . 64.6 t30 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -131.76 122.73 26.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 69' ' ' ILE . 5.1 mp -100.51 130.64 46.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.29 129.39 55.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.6 OUTLIER -142.04 151.88 42.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -133.92 156.96 22.6 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.707 HG23 ' HB3' ' A' ' 91' ' ' TYR . 6.4 tt -144.04 141.0 25.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.181 0.515 . . . . 0.0 111.003 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -25.14 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.522 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.6 51.94 1.78 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 110.076 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 10.7 pt20 -52.48 -33.93 46.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -76.22 -37.49 57.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.879 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -39.62 93.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.879 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.12 -43.56 98.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.092 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 12' ' ' GLN . 66.7 mm-40 -67.18 -34.02 76.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.86 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.31 -32.99 55.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.563 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -92.4 -46.17 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.79 12.33 81.57 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.559 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.74 6.87 1.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.017 0.408 . . . . 0.0 111.173 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.553 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER 61.83 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.536 0.522 . . . . 0.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 56.59 118.23 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.705 1.202 . . . . 0.0 112.381 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.72 111.26 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.192 2.595 . . . . 0.0 112.593 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HZ2' ' CD ' ' A' ' 133' ' ' GLU . 48.9 pttt . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.983 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.3 mttt . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.224 0.083 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -54.26 -39.05 66.49 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.741 0.305 . . . . 0.0 111.03 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.89 -50.38 66.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.226 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.25 -39.06 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.643 0.258 . . . . 0.0 111.009 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.4 ' O ' HG13 ' A' ' 59' ' ' ILE . 11.9 m-85 -65.38 -51.35 61.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.38 90.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.975 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -64.81 -34.54 78.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.582 ' HG3' ' HD2' ' A' ' 68' ' ' TYR . 1.6 tm0? -60.83 -53.19 60.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 55' ' ' TYR . 19.4 mt -71.82 -41.38 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.053 -176.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.1 -67.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.068 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.4 -71.21 0.62 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.963 0.411 . . . . 0.0 110.845 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.4 138.98 3.82 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -152.71 47.37 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -90.07 6.67 41.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.854 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -100.91 -30.57 11.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.16 -72.39 0.19 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.223 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.95 -52.27 65.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.582 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 18.8 m-30 -117.61 161.06 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.601 HD13 HD22 ' A' ' 5' ' ' LEU . 3.4 tt -126.98 132.88 69.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.667 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.7 p -106.75 140.58 39.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.829 0.347 . . . . 0.0 110.722 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -129.07 133.6 47.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.845 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.483 ' HG1' ' HB ' ' A' ' 77' ' ' ILE . 4.4 p -74.51 163.88 27.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -18.13 58.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -99.65 135.71 40.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.961 0.41 . . . . 0.0 111.79 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.71 -20.79 61.94 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.009 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -69.33 -3.5 14.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.366 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.483 ' HB ' ' HG1' ' A' ' 72' ' ' THR . 3.9 tt -57.08 -34.46 45.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.245 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.22 -63.19 1.39 Allowed 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.757 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -67.73 -43.26 80.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.046 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.77 -46.96 85.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.088 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 17.8 t80 -64.55 -48.78 73.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -56.38 -59.72 4.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.165 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -64.92 -33.63 76.48 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.499 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m -73.03 -23.37 60.59 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.003 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m -84.05 -7.84 59.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.887 0.375 . . . . 0.0 110.025 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.47 39.8 98.1 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -68.05 -10.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -32.54 -35.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.954 0.784 . . . . 0.0 112.343 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.59 88.97 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.14 -152.67 19.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.604 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.707 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.7 t80 -119.65 150.63 40.01 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.534 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.4 tt -149.06 135.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.516 0.198 . . . . 0.0 110.589 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 15.8 p90 -131.46 156.32 45.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.174 0.512 . . . . 0.0 112.078 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.501 HG21 HG13 ' A' ' 137' ' ' ILE . 34.2 m -125.8 141.45 45.5 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.667 HD23 HG11 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -125.01 143.23 51.01 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.085 -175.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.427 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.9 t-20 -99.65 140.63 33.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -67.83 -46.04 72.95 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 -178.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.24 -33.71 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 135' ' ' VAL . 25.1 mt -64.0 -50.93 66.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.274 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.88 -41.01 95.98 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.93 -48.13 84.41 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.021 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.14 -32.86 71.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.452 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -68.8 -18.68 64.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.872 0.367 . . . . 0.0 110.172 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m 70.63 34.27 2.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.033 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -73.87 156.01 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.75 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 11.5 m-85 -76.6 101.25 5.63 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.607 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.75 115.89 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.238 0.542 . . . . 0.0 109.909 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.53 ' HB2' ' HD2' ' A' ' 124' ' ' ARG . 2.4 t80 -125.74 111.56 15.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.816 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -94.93 113.07 24.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.824 0.345 . . . . 0.0 110.174 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 120' ' ' GLU . 1.4 m -89.31 125.5 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.81 131.99 53.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.327 0.584 . . . . 0.0 110.552 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.7 m80 -79.21 -178.39 1.09 Allowed Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 88.9 Cg_exo -46.85 164.33 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.587 1.524 . . . . 0.0 112.166 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -49.11 -66.93 0.31 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -170.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -89.05 -9.66 0.14 Allowed Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 115.84 1.792 . . . . 0.0 115.84 -165.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 37.3 Cg_exo -42.53 -22.82 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.446 1.552 . . . . 0.0 112.017 163.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.1 33.81 3.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.29 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -144.41 127.35 16.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -123.81 102.2 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.513 ' HB2' HG21 ' A' ' 110' ' ' VAL . 57.0 mt-10 -73.65 98.09 2.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.216 0.531 . . . . 0.0 110.744 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 24.0 t -69.07 95.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.924 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 13.1 m -88.17 114.07 24.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 69' ' ' ILE . 4.9 mp -87.09 111.12 21.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.809 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.75 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 19.8 mtt180 -93.2 104.06 16.27 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.918 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 131' ' ' ILE . . . -69.62 144.03 53.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.15 -60.07 4.16 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.235 0.54 . . . . 0.0 109.756 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.839 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 16.1 t70 -87.72 127.95 35.3 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.787 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 51.9 t -52.79 113.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.505 0.503 . . . . 0.0 111.833 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.418 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . . . 91.23 67.47 1.16 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.433 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.2 m 58.6 72.66 0.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.858 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.09 -50.97 25.63 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.858 ' HD3' HG21 ' A' ' 131' ' ' ILE . 87.2 Cg_endo -97.83 116.0 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.498 2.132 . . . . 0.0 112.431 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.431 ' CD ' ' HZ2' ' A' ' 24' ' ' LYS . 2.2 pm0 -70.57 -5.14 26.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.37 -8.81 56.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.18 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.667 HG11 HD23 ' A' ' 95' ' ' LEU . 9.1 p -71.58 -14.05 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.638 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 136' ' ' ILE . 17.2 pt -87.76 92.91 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.501 HG13 HG21 ' A' ' 94' ' ' VAL . 27.7 pt -63.87 -30.99 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.905 -173.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.58 160.71 40.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.13 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -148.41 150.8 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.838 175.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -142.36 154.28 44.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -111.91 146.25 38.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 tt -140.66 118.93 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 111.097 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -118.04 68.6 0.77 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.364 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.799 179.028 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 97' ' ' ARG . 7.3 t-20 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -98.6 130.91 45.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.513 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 97' ' ' ARG . 44.2 mt -112.91 135.19 53.95 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -131.87 124.46 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.87 132.77 20.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.19 157.58 15.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.405 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 91' ' ' TYR . 5.3 tt -135.38 142.12 40.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.004 0.43 . . . . 0.0 110.216 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.74 -32.03 13.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.01 51.68 2.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.527 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 2.6 pt20 -55.13 -27.1 42.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.273 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -68.88 -49.21 60.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.93 -36.4 83.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.177 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.82 -58.18 9.75 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.358 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.35 -26.45 63.74 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -54.93 27.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.871 0.367 . . . . 0.0 110.037 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -73.52 -22.75 60.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.64 15.66 65.42 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.552 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -168.55 140.79 2.81 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 49.54 0.97 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.192 0.52 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 128' ' ' CYS . 29.8 tttp -168.64 126.41 0.89 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.382 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.85 -59.87 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.419 2.08 . . . . 0.0 111.868 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.329 179.58 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB2' ' H ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.569 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' H ' ' HB2' ' A' ' 51' ' ' LYS . 13.6 t-20 -64.65 -22.9 67.09 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.66 -67.27 0.32 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.357 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -33.46 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.53 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.439 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 2.3 m-85 -63.92 -64.64 0.84 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.48 84.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -59.19 -54.28 48.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.694 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 4.4 pt20 -61.07 -37.2 81.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.03 -37.4 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.753 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.27 -23.97 34.98 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 p -87.95 -49.44 7.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.136 0.493 . . . . 0.0 110.803 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.39 -71.53 0.19 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 64' ' ' TYR . 6.8 mt -159.53 76.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.152 0.501 . . . . 0.0 109.782 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CE1' HD22 ' A' ' 63' ' ' LEU . 2.0 p90 45.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.684 1.194 . . . . 0.0 112.986 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 6.2 p-10 166.59 -45.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.912 -168.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' A' ' 64' ' ' TYR . . . 166.07 -8.01 0.06 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.993 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.62 -28.01 63.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.996 0.398 . . . . 0.0 111.57 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -118.85 163.58 16.68 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.447 HG23 ' HB ' ' A' ' 123' ' ' ILE . 1.4 tt -121.07 119.04 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.284 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 13.0 m -99.45 131.56 45.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.869 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 t -119.04 170.37 9.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.189 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -122.82 152.51 40.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HG1' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -59.66 -14.06 12.32 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 177.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.2 108.04 18.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -59.46 -18.01 36.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.594 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -79.07 -2.32 39.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.828 0.347 . . . . 0.0 110.465 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.3 tt -51.26 -29.36 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.788 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.27 -60.14 3.93 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.804 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.413 ' NZ ' ' OG1' ' A' ' 83' ' ' THR . 0.4 OUTLIER -70.57 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.111 -175.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -62.3 -45.62 92.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.978 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -63.38 -49.18 74.83 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.849 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 -55.26 25.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.942 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.413 ' OG1' ' NZ ' ' A' ' 79' ' ' LYS . 29.8 m -62.66 -35.91 81.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -66.33 -27.81 68.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.5 m -93.82 -0.3 55.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.97 40.44 90.97 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.51 -9.57 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.36 -172.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.663 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 mp0 -41.68 -28.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.328 0.651 . . . . 0.0 112.146 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -123.63 90.62 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.97 -150.92 12.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.274 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.644 ' HB3' HG21 ' A' ' 9' ' ' ILE . 6.2 t80 -121.93 149.58 43.23 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.566 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -141.47 143.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -131.53 144.05 50.83 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.199 0.524 . . . . 0.0 111.187 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 137' ' ' ILE . 17.9 m -118.64 138.85 48.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.561 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.553 HD23 HG11 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.08 142.79 51.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.867 -171.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -79.94 114.24 18.71 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.503 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -69.41 -33.52 73.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.745 -176.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.11 -26.66 66.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.628 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.11 -46.01 89.33 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -60.84 -38.47 85.59 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.47 -43.73 97.26 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.917 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -39.67 93.07 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.068 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -71.06 -18.29 62.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.434 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.3 m 69.86 39.34 1.46 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -68.47 160.83 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.413 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -78.4 99.0 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -170.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -103.18 100.14 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -100.67 116.14 31.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.074 0.464 . . . . 0.0 110.069 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.471 ' HB2' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -85.22 138.25 32.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.613 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.68 144.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 145.91 47.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.32 170.59 15.4 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.861 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -45.67 170.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.657 2.238 . . . . 0.0 113.36 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -47.08 -53.82 11.85 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -170.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.504 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.2 t-20 -98.72 -17.05 0.2 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 34.2 Cg_exo -40.83 -26.39 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 120.993 1.39 . . . . 0.0 111.34 162.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 77.5 -11.35 1.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.901 163.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -113.3 159.34 19.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.297 0.57 . . . . 0.0 112.043 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 109' ' ' GLU . 29.6 tttp -131.87 122.34 25.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -104.48 115.13 29.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.155 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.83 113.37 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.154 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 14.3 m -81.4 117.71 22.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.776 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.447 ' HB ' HG23 ' A' ' 69' ' ' ILE . 15.0 mm -87.84 98.27 7.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.751 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -89.19 102.63 15.29 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.041 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 131' ' ' ILE . . . -69.84 152.32 44.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.758 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.433 ' H ' HD11 ' A' ' 131' ' ' ILE . 40.3 mt-10 -59.4 -41.9 90.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.469 ' HB3' HG21 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.07 145.02 50.12 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.07 176.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.411 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 1.4 t -64.02 133.77 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.55 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.05 70.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.546 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.9 m 56.89 72.9 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -43.95 -55.38 9.35 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.415 173.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 63.6 Cg_endo -95.62 114.95 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.931 2.421 . . . . 0.0 112.218 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.59 -22.65 66.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.103 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -77.19 -15.34 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.553 HG11 HD23 ' A' ' 95' ' ' LEU . 2.6 p -69.69 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.34 92.15 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.493 HG13 HG21 ' A' ' 94' ' ' VAL . 24.6 pt -67.83 -27.89 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.945 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.36 157.8 36.29 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.946 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -150.49 140.88 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.273 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.53 160.34 40.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.774 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -112.57 149.11 33.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.744 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.4 tt -141.26 138.87 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -125.79 31.6 5.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.668 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.663 HG12 ' HB3' ' A' ' 88' ' ' GLU . 42.6 mt . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 122.642 0.377 . . . . 0.0 110.02 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 t80 66.15 112.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.546 0.528 . . . . 0.0 111.947 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.519 HD23 HG21 ' A' ' 71' ' ' THR . 13.4 mt -99.82 124.87 45.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -115.75 124.03 49.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.475 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -145.92 156.95 43.87 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -122.23 155.92 16.88 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.945 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 34.9 mt -109.38 143.92 18.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -35.58 75.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.764 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t 177.69 155.62 0.33 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 110.035 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.7 -32.05 68.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.999 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.671 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.42 -42.72 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.023 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' HG3' HG23 ' A' ' 9' ' ' ILE . 48.8 mt-10 -55.01 -60.46 3.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.189 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.8 -41.86 78.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.213 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.18 -31.43 72.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.439 . . . . 0.0 110.785 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.03 -13.87 40.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.212 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.33 7.17 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.028 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 72.7 81.87 0.13 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.53 0.732 . . . . 0.0 110.672 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 4.2 mm? 64.64 37.53 7.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.984 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER 73.15 152.88 0.15 Allowed Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.79 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.76 118.15 5.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.628 2.218 . . . . 0.0 111.905 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.565 ' NZ ' ' HA ' ' A' ' 126' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -45.04 -55.18 5.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.145 0.498 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.65 21.82 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.328 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 10.8 p -63.59 -31.38 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.013 -175.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.459 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 2.3 m-85 -65.0 -58.99 4.66 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.76 63.28 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.823 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.514 ' NE2' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -64.31 -47.04 80.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.696 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.537 HE21 ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -62.58 -40.44 96.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.396 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.6 mt -82.82 -40.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.562 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -65.5 -50.54 64.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.609 ' HB ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.28 -21.57 39.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.119 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.53 76.3 0.73 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.587 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.609 HD22 ' HB ' ' A' ' 61' ' ' THR . 1.8 pt? -148.44 59.84 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.6 0.714 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 -24.19 65.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.006 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.443 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 6.7 p-10 -73.22 -12.6 60.93 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.687 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.91 -92.74 0.33 Allowed Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.541 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 80.8 m -69.5 -34.97 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.485 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 22.0 m-85 -95.51 158.47 15.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.332 -172.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.637 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 5.3 mp -89.52 97.83 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -83.39 119.14 24.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.168 -178.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.519 HG21 HD23 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -140.32 155.37 46.84 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.953 0.406 . . . . 0.0 111.049 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -87.83 156.46 19.38 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -32.39 73.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -88.68 133.37 34.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -63.97 -19.47 65.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.67 -2.21 6.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.269 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -57.75 -27.2 29.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.209 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.46 -63.18 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.071 0.462 . . . . 0.0 112.017 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -66.8 -43.85 82.78 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.873 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.269 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -70.82 -52.47 20.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.067 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -56.99 -42.59 80.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.426 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -76.23 -50.35 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.559 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -64.68 -26.24 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -91.6 0.25 57.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.192 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.89 32.64 73.86 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.533 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 87' ' ' ILE . 7.0 mt -73.1 -7.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.686 ' HG3' HD12 ' A' ' 144' ' ' ILE . 38.0 tp10 -28.76 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.715 1.206 . . . . 0.0 113.231 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -130.07 90.17 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.1 -157.7 20.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.181 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.624 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 8.2 t80 -117.63 153.56 33.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.503 0.321 . . . . 0.0 110.451 -176.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.557 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 29.3 mt -132.53 140.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.433 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 16.8 p90 -131.96 134.3 45.48 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.28 0.562 . . . . 0.0 110.856 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.6 134.72 63.15 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.031 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.44 HD23 ' HE2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -122.15 143.19 49.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.738 -173.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -82.3 125.41 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' PHE . 61.7 ttp85 -70.3 -45.06 67.06 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -22.58 66.83 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 -175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 135' ' ' VAL . 4.8 tp -65.5 -32.67 74.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 10.6 m-85 -66.49 -44.57 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.65 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.7 -42.57 91.28 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.655 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -43.25 96.77 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 109.932 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 3.1 m-85 -62.73 -23.01 66.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.378 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m 72.98 23.6 2.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.127 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.482 HG13 ' HB3' ' A' ' 103' ' ' TYR . 3.8 mt -70.91 148.14 10.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.074 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.775 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 22.4 m-85 -78.15 105.23 9.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.946 0.403 . . . . 0.0 111.041 -166.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.19 109.89 20.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 124' ' ' ARG . 7.5 t80 -129.72 128.28 42.16 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.057 0.456 . . . . 0.0 110.336 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.52 155.07 22.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.831 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 m -129.63 145.97 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.19 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -113.42 136.13 53.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.171 0.51 . . . . 0.0 110.646 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -79.92 -174.68 0.51 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.553 175.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 95.6 Cg_exo -46.91 169.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.026 1.817 . . . . 0.0 113.181 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.31 -65.58 0.54 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -98.81 -8.59 0.12 Allowed Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -167.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 115' ' ' ASN . 63.1 Cg_exo -43.93 -27.12 1.57 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 121.562 1.594 . . . . 0.0 111.083 164.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 65.58 20.78 11.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.356 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.65 123.73 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.11 0.481 . . . . 0.0 111.128 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HD3' ' HB3' ' A' ' 111' ' ' GLU . 6.7 ttpt -121.41 112.48 18.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.124 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.48 121.43 26.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.268 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.02 98.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.641 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.523 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -94.97 121.1 36.23 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.29 -178.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.637 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 24.6 mm -86.94 101.73 11.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.474 0.654 . . . . 0.0 109.765 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.775 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 2.2 mmt180 -77.5 95.08 4.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.94 161.49 30.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.712 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' NZ ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -60.76 -47.2 87.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.831 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.75 160.85 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.09 144.33 40.53 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.627 0.58 . . . . 0.0 111.896 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.6 41.59 6.79 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.865 -0.607 . . . . 0.0 114.262 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.57 71.52 0.44 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.068 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.736 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.44 -45.94 33.29 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.736 ' HD3' HG21 ' A' ' 131' ' ' ILE . 70.8 Cg_endo -91.27 128.46 1.2 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.938 1.759 . . . . 0.0 113.033 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.34 -33.49 49.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 61.0 mt-10 -63.27 -22.47 66.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.634 -173.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.636 ' HA ' HD23 ' A' ' 99' ' ' LEU . 5.0 p -70.48 -19.47 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 111.233 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.6 mt -86.96 92.06 3.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 pt -67.59 -32.03 55.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.187 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -157.38 159.38 37.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.316 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.615 ' HD2' ' HE2' ' A' ' 91' ' ' TYR . 7.3 mtmp? -130.34 131.2 45.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.397 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -118.03 161.06 20.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.245 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 tt -122.19 147.47 46.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.3 tt -130.67 124.22 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.231 0.539 . . . . 0.0 110.473 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.02 57.96 1.53 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.528 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.686 HD12 ' HG3' ' A' ' 88' ' ' GLU . 16.3 mm . . . . . 0 N--CA 1.468 0.425 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--O 1.234 0.252 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -98.53 120.96 39.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.145 -172.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.451 HD11 ' HE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -121.29 142.38 50.0 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -113.53 139.3 49.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.528 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.86 157.56 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -128.76 157.54 21.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.809 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.856 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 54.2 mt -118.56 128.8 75.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 122.866 0.466 . . . . 0.0 110.164 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -25.19 16.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.08 0.467 . . . . 0.0 110.497 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.5 p -97.95 53.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.718 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -54.78 -26.42 34.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.065 -178.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -75.31 -50.84 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.108 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 1.5 t70 -59.62 -46.33 89.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.058 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.45 ' CD ' ' HZ1' ' A' ' 139' ' ' LYS . 4.3 tm-20 -57.51 -58.88 6.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.616 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -65.91 -26.98 67.86 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.421 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.72 -43.52 79.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.043 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.36 -24.52 46.4 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.52 70.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.594 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.679 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -174.37 173.78 2.93 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.7 mt -79.47 44.65 0.62 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.359 0.264 . . . . 0.0 111.045 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm 49.29 73.73 0.94 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.795 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 97.5 Cg_endo -76.16 63.94 6.99 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.04 2.493 . . . . 0.0 112.795 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.928 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.9 tttt . . . . . 0 C--O 1.244 0.763 0 CA-C-O 122.003 0.906 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 13.6 p-10 -61.13 -16.88 49.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.262 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.82 -55.36 30.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 51' ' ' LYS . 4.3 p -67.96 -35.56 72.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 34.3 m-85 -59.62 -61.52 2.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.9 0.381 . . . . 0.0 110.251 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.962 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -56.18 -43.34 78.34 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.272 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -65.1 -53.57 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mt -63.76 -30.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.638 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.84 -64.42 1.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.897 0.38 . . . . 0.0 111.713 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 m -93.94 -64.6 1.06 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.8 -105.41 0.06 OUTLIER Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 114.232 -170.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 7.6 tp 61.0 34.33 19.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.762 0.791 . . . . 0.0 109.583 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.555 ' H ' ' HD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -84.5 11.83 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.356 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 t70 69.59 -143.98 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.99 -78.66 0.52 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.568 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.42 -37.03 85.7 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 109.983 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.414 ' CE1' ' HG2' ' A' ' 124' ' ' ARG . 21.5 m-85 -126.93 142.62 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.758 HG13 ' HB ' ' A' ' 123' ' ' ILE . 5.6 pt -105.42 111.11 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 111.355 -169.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 1.5 m -91.39 131.15 37.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.9 t -132.86 143.38 49.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.235 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.497 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.79 153.25 33.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.929 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -172.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -117.85 136.02 53.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.655 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -52.77 -18.77 2.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.262 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -48.86 -30.12 5.44 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.942 0.401 . . . . 0.0 110.773 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 72' ' ' THR . 1.1 tt -48.17 -37.5 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.694 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.54 68.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.018 0.437 . . . . 0.0 111.332 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -73.52 -43.44 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.895 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -57.96 -47.69 82.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.983 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -66.29 -56.98 8.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.285 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.17 74.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.06 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -81.85 -48.67 11.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.637 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -70.73 -18.87 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 m -99.6 0.8 42.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.0 110.506 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.28 29.92 66.75 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.768 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -13.81 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.957 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 142' ' ' ILE . 2.3 tt0 -48.64 -26.09 2.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.789 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.421 ' HB2' HG13 ' A' ' 144' ' ' ILE . 4.3 t30 -108.13 95.66 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.433 -0.167 . . . . 0.0 110.596 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.52 -127.95 2.52 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.007 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.856 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 1.7 t80 -124.23 151.6 43.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.492 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 11.1 pt -139.69 133.63 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.228 0.211 . . . . 0.0 110.483 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 22.0 p90 -131.22 137.37 48.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.378 0.609 . . . . 0.0 111.249 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 138' ' ' ALA . 13.6 m -116.56 146.02 21.54 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.8 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.567 HD23 ' HB ' ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.3 143.35 51.25 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.223 -173.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.653 ' HB2' HD11 ' A' ' 137' ' ' ILE . 60.8 t-20 -95.2 139.64 31.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.147 0.498 . . . . 0.0 110.566 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -69.39 -35.08 75.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -53.84 -33.81 57.38 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.4 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -58.93 -49.02 79.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.455 ' HE1' HG13 ' A' ' 135' ' ' VAL . 20.0 m-85 -72.94 -31.93 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.581 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.25 -42.62 99.72 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.86 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -70.71 -50.62 34.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.258 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -63.38 -21.2 66.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.212 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m 65.77 39.96 4.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.311 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -66.38 154.84 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 12.3 m-30 -75.44 141.93 43.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.923 -167.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 129.26 56.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.405 ' HD1' HG13 ' A' ' 110' ' ' VAL . 21.9 t80 -131.69 112.34 12.47 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.54 119.9 31.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.405 HG13 ' HD1' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -112.34 148.5 15.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 110.422 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.5 46.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.007 171.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.655 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 14.2 m80 -78.42 -169.7 0.21 Allowed Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 85.1 Cg_exo -48.12 139.64 20.64 Favored 'Trans proline' 0 C--N 1.358 1.051 0 CA-C-N 121.285 1.495 . . . . 0.0 109.416 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -56.26 -48.19 77.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -89.3 -14.35 0.2 Allowed Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 96.7 Cg_exo -51.62 -17.45 4.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.249 1.482 . . . . 0.0 110.333 157.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.411 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 7.2 m-20 72.99 21.77 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.513 171.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.67 121.28 42.11 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.627 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -138.73 125.06 20.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.735 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.33 140.5 50.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.14 113.07 32.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.214 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 56.4 m -87.34 122.01 30.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.386 0.612 . . . . 0.0 110.989 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.758 ' HB ' HG13 ' A' ' 69' ' ' ILE . 14.4 mt -89.12 109.0 19.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.593 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.495 ' O ' HG22 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -88.94 95.93 10.51 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.461 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.501 ' HB2' HG23 ' A' ' 131' ' ' ILE . . . -69.46 148.86 48.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.156 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -59.51 -41.96 91.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.969 0.414 . . . . 0.0 110.957 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.79 159.92 15.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.536 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 105.49 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.874 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.14 70.92 1.23 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.597 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.73 73.59 0.44 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 172.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.575 ' CG2' ' HD3' ' A' ' 132' ' ' PRO . 1.6 tt -54.76 -41.59 90.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.575 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 20.2 Cg_endo -91.93 126.72 0.92 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.808 1.672 . . . . 0.0 111.881 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -18.04 63.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -79.9 4.98 15.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.567 ' HB ' HD23 ' A' ' 95' ' ' LEU . 3.7 m -58.39 -30.15 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.824 0.345 . . . . 0.0 111.498 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.1 pt -87.96 89.91 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.18 0.515 . . . . 0.0 109.961 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 96' ' ' ASN . 12.3 pt -70.78 -28.16 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.648 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.464 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -155.06 124.92 6.56 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HZ1' ' CD ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -121.97 132.46 54.55 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.44 159.37 42.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.185 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tt -100.32 144.39 29.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 88' ' ' GLU . 15.0 tt -124.33 135.66 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 110.489 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 144' ' ' ILE . 6.4 tp10 -115.39 47.23 1.34 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.822 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 143' ' ' GLU . 1.2 tt . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 123.106 0.562 . . . . 0.0 111.793 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.564 ' H ' ' HD2' ' A' ' 97' ' ' ARG . 8.7 t-20 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.765 0.317 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -121.43 120.98 36.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -106.21 144.91 32.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.251 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.61 138.35 47.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.461 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.676 HH11 HD12 ' A' ' 21' ' ' LEU . 44.9 ttt180 -139.21 111.1 7.25 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -107.15 157.85 15.36 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.603 HG12 ' H ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -148.73 136.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 16.19 14.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.065 0.459 . . . . 0.0 110.959 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.603 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.7 58.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.512 . . . . 0.0 109.804 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.5 ' NE2' ' HB2' ' A' ' 91' ' ' TYR . 2.0 mp0 -58.02 -21.56 45.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -68.98 -47.62 65.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.78 -42.58 99.76 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.891 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.06 -53.12 59.96 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.473 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -66.83 -24.95 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.638 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -93.88 -15.41 25.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.48 -9.81 75.68 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.448 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.562 ' HB2' ' HG3' ' A' ' 23' ' ' PRO . 1.6 mm-40 -174.71 -169.59 0.43 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.676 HD12 HH11 ' A' ' 7' ' ' ARG . 0.5 OUTLIER -77.2 61.29 2.07 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.003 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.49 ' HB3' ' HG ' ' A' ' 130' ' ' CYS . 15.8 tttm 52.67 69.07 2.56 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.562 ' HG3' ' HB2' ' A' ' 20' ' ' GLN . 86.0 Cg_endo -83.14 82.57 2.1 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.787 2.325 . . . . 0.0 112.077 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG3' ' H ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -48.52 -31.54 6.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.452 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 51' ' ' LYS . . . -55.62 -65.5 0.58 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.05 -32.31 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.768 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -66.04 -61.03 2.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.92 84.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -62.68 -44.54 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -49.65 66.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.686 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 82.0 mt -62.65 -36.12 73.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.621 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.95 -52.34 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.217 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.7 p -64.39 -76.63 0.07 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.463 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.21 7.22 11.7 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.361 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 43.6 tp 64.24 -79.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.58 0.352 . . . . 0.0 110.334 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -107.22 64.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -38.46 88.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.881 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.21 -1.58 0.55 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.129 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.3 m -78.04 -15.74 58.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.827 0.313 . . . . 0.0 111.275 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -121.29 157.12 31.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.224 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 31.0 mt -98.03 100.81 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.936 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m -77.21 114.32 15.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.548 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.32 168.9 16.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 110.715 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -112.31 152.2 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -25.67 68.06 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.77 133.25 34.0 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.127 -0.358 . . . . 0.0 110.497 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -59.62 -25.79 64.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.679 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.53 -6.82 58.78 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.418 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -23.88 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.006 0.432 . . . . 0.0 110.52 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.736 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -71.36 -44.07 65.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -57.99 -51.58 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.782 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.27 -48.02 83.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.212 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -55.83 -44.86 78.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.552 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -70.62 -43.03 70.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.5 m -63.51 -28.52 70.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.328 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 p -86.84 -5.52 59.08 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 110.6 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.17 89.85 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 82' ' ' ALA . 3.1 tp -69.1 -8.92 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 142' ' ' ILE . 43.9 mt-10 -28.52 -49.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.558 0.743 . . . . 0.0 112.741 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -121.14 91.11 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.49 -143.93 5.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.091 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.5 ' HB2' ' NE2' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -122.85 150.16 43.24 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.038 0.535 . . . . 0.0 110.352 -174.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.607 HG13 ' HG3' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -142.86 137.8 27.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 110.198 176.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -118.34 145.77 44.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 138' ' ' ALA . 2.1 t -106.63 128.78 61.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.525 172.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 142.01 51.37 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.951 0.782 . . . . 0.0 109.119 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.433 ' HB2' HD12 ' A' ' 137' ' ' ILE . 7.3 t-20 -113.24 144.56 42.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.908 0.385 . . . . 0.0 111.557 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -64.1 -39.54 94.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.269 -175.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -69.53 -26.33 64.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.193 0.52 . . . . 0.0 109.915 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 137' ' ' ILE . 12.4 tp -66.51 -39.19 88.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.399 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.541 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 48.1 m-85 -61.72 -42.8 99.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.441 174.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -38.99 90.45 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.907 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -62.05 -44.07 97.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.199 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 17.6 m-85 -76.99 -12.0 59.88 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.891 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m 70.66 27.62 3.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.457 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 132' ' ' PRO . 18.4 mt -72.24 148.09 9.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.545 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 69.4 m-85 -89.81 122.77 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.565 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.79 138.62 31.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.15 112.06 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 119.28 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.131 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -87.29 129.65 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -121.55 128.75 52.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.466 0.651 . . . . 0.0 110.847 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.646 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 50.5 m80 -80.33 -174.81 0.52 Allowed Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 80.6 Cg_exo -46.19 149.37 2.52 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.211 1.274 . . . . 0.0 111.232 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -52.0 -51.42 57.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -166.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.405 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -99.84 -13.45 0.17 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 92.2 Cg_exo -50.15 -16.25 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.943 0 CA-C-N 121.767 1.667 . . . . 0.0 110.903 163.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 t-20 69.37 28.59 4.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.778 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 112' ' ' HIS . 20.3 tp10 -103.09 98.4 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.364 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -131.14 108.75 9.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.779 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.524 ' HB3' HG21 ' A' ' 110' ' ' VAL . 6.7 tm-20 -99.7 115.1 28.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.99 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.49 101.1 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.092 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.557 ' HB ' ' HE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -93.79 127.92 39.76 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 28.2 mm -88.43 102.9 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.283 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.557 ' HE ' ' HB ' ' A' ' 122' ' ' THR . 6.9 mmt180 -86.0 101.72 13.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.841 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -69.71 156.71 38.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.18 -29.51 70.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.261 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -147.34 161.17 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.719 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.94 47.13 4.57 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.542 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.53 ' SG ' ' NH2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 48.68 63.82 1.95 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.777 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -50.73 -45.77 86.28 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.777 ' HD3' HG21 ' A' ' 131' ' ' ILE . 92.8 Cg_endo -93.14 109.5 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.669 1.579 . . . . 0.0 112.295 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -61.93 -27.74 69.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.965 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.493 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -88.01 11.96 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.886 -178.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.617 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 13.1 p -59.77 -24.44 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 111.556 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -88.34 104.36 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.873 0.844 . . . . 0.0 109.782 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.682 HG21 HD21 ' A' ' 99' ' ' LEU . 1.6 pt -63.12 -26.61 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 94' ' ' VAL . . . -145.82 146.0 30.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.326 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -128.26 123.14 33.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.607 ' HG3' HG13 ' A' ' 92' ' ' ILE . 1.9 pt-20 -140.49 160.29 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.159 0.504 . . . . 0.0 111.122 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -111.26 151.76 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.612 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.8 tt -128.45 132.06 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.769 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -128.02 29.78 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 10.2 tp . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 122.341 1.067 . . . . 0.0 111.195 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -114.83 161.25 18.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 111.182 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -100.53 154.93 18.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.89 141.25 38.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.374 0.607 . . . . 0.0 111.267 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.555 ' HB2' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -144.07 156.07 44.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.703 176.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.596 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -137.74 157.65 24.25 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.453 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -147.27 140.31 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.447 -178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 6.26 14.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.488 0.661 . . . . 0.0 109.296 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.536 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.36 49.08 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.603 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -59.91 -26.73 66.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -61.09 -46.57 90.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.753 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.8 -47.16 86.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.96 -50.03 69.91 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.448 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -72.0 -24.24 61.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -74.46 -42.41 59.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 110.718 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -94.1 -16.1 24.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.51 89.32 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.0 159.2 36.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.555 HD21 ' H ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -81.18 130.92 35.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.468 ' HE2' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 50.98 151.91 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 125.075 1.35 . . . . 0.0 113.835 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.52 -164.39 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 111.663 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.237 0.395 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.9 mttt . . . . . 0 C--O 1.238 0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -60.81 -22.46 64.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.657 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -65.84 0.57 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.444 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -68.68 -27.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -63.17 1.36 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.416 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.97 87.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.437 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -55.92 -52.48 63.96 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.174 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 26.9 tp60 -66.39 -54.87 19.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.244 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.58 -37.14 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.464 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -80.29 -58.47 3.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.51 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -69.27 -19.84 63.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.57 -175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.63 -111.71 0.77 Allowed Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 13.5 tp -162.07 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.629 ' HH ' HG11 ' A' ' 110' ' ' VAL . 15.4 m-85 -105.36 -38.05 6.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.267 0.556 . . . . 0.0 109.523 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.65 -155.24 0.22 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.074 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.01 -14.61 76.85 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.487 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.473 ' HA ' ' N ' ' A' ' 129' ' ' GLY . 97.6 m -61.5 -50.55 72.28 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.429 0.292 . . . . 0.0 111.212 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -104.33 160.2 15.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.262 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 mp -110.53 99.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.59 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.81 115.41 21.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.7 m -140.89 129.41 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -82.22 151.14 26.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.003 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.07 10.73 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.895 0.378 . . . . 0.0 111.823 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.43 123.46 48.11 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -49.2 -28.47 4.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -64.81 -19.97 66.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.69 0.281 . . . . 0.0 111.07 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -28.72 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.557 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -51.64 68.16 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.273 0.558 . . . . 0.0 110.651 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.94 -43.62 67.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.616 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.05 -47.87 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.099 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.35 -54.22 36.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.553 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -54.35 -43.89 71.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.544 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 m -73.76 -48.31 32.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 m -68.84 -18.22 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.496 ' HB2' HG13 ' A' ' 87' ' ' ILE . 18.0 m -92.78 -3.38 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.528 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.77 96.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.251 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.596 HD13 ' HA3' ' A' ' 8' ' ' GLY . 15.8 mt -79.61 -8.44 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 121.957 0.103 . . . . 0.0 111.041 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' O ' HG12 ' A' ' 142' ' ' ILE . 10.8 mt-10 -33.28 -39.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -119.85 100.87 7.49 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.77 16.74 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.445 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.5 128.18 54.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 -175.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.4 mt -105.03 133.36 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.17 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 7' ' ' ARG . 21.5 m-85 -116.38 146.1 42.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.38 122.53 40.37 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.958 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.58 140.86 48.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.071 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.5 138.43 36.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -40.64 80.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -172.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.25 -10.36 59.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.575 0.226 . . . . 0.0 111.19 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 99' ' ' LEU . 12.4 mt -68.96 -42.58 76.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.592 ' HB3' HD13 ' A' ' 105' ' ' ILE . 3.3 m-85 -68.34 -43.48 77.41 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.683 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.84 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.993 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.63 -41.68 71.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.8 -19.52 65.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.3 m 72.9 38.23 0.74 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.001 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.592 HD13 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -75.89 166.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -75.51 109.32 8.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.341 -175.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.39 99.82 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -110.85 114.13 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.902 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.32 113.97 25.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.415 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.629 HG11 ' HH ' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -87.54 115.12 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -103.19 137.11 41.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.329 0.585 . . . . 0.0 111.264 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -87.95 174.37 5.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.558 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 52.7 Cg_exo -49.44 159.6 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.924 1.749 . . . . 0.0 112.575 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.34 -65.07 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.418 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.1 t-20 -92.76 -18.44 0.23 Allowed Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 44.5 Cg_exo -44.46 -18.82 0.21 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 121.551 1.59 . . . . 0.0 112.051 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.409 ' N ' ' C ' ' A' ' 115' ' ' ASN . 2.2 t-20 73.64 12.01 4.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.607 167.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -103.46 122.11 44.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 111.014 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -142.9 109.4 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.283 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' HB3' HG12 ' A' ' 110' ' ' VAL . 14.3 tt0 -100.52 132.61 45.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.96 104.37 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -84.59 114.59 22.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.172 0.51 . . . . 0.0 110.166 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 46.0 mm -88.01 100.62 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.663 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.706 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -86.32 93.16 9.02 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.008 179.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.17 151.76 46.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.435 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.569 ' HA ' HH21 ' A' ' 124' ' ' ARG . 3.3 mm-40 -65.37 -11.04 38.35 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -170.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 32.2 t0 -145.26 156.19 43.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.27 132.54 47.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 111.468 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.473 ' N ' ' HA ' ' A' ' 67' ' ' CYS . . . 91.29 33.05 8.32 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.127 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 60.95 70.88 0.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.983 0.42 . . . . 0.0 110.356 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.819 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -37.83 -54.82 2.3 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.819 ' HD3' HG21 ' A' ' 131' ' ' ILE . 20.1 Cg_endo -93.11 128.64 0.72 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.306 2.004 . . . . 0.0 112.493 -174.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -81.36 -7.17 59.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -83.71 -4.78 58.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.456 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 132' ' ' PRO . 28.2 m -81.84 -9.41 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 110.247 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.08 89.73 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.5 pt -63.79 -35.07 71.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.702 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.32 167.96 28.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 111.772 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 160.54 43.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.368 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -141.34 160.58 39.83 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.015 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -105.37 149.43 26.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.4 tt -139.38 130.88 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.461 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -122.93 35.95 4.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.774 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt . . . . . 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.82 -179.695 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.403 ' H ' ' HB3' ' A' ' 97' ' ' ARG . 47.4 t30 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.6 128.87 35.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -175.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.636 ' HG ' ' HB ' ' A' ' 71' ' ' THR . 7.0 mp -100.7 135.94 41.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.443 ' HD2' HD12 ' A' ' 92' ' ' ILE . 1.4 m-85 -121.57 124.59 44.72 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.174 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.81 150.2 43.02 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA3' HG13 ' A' ' 87' ' ' ILE . . . -129.95 158.26 22.23 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.326 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.51 HG13 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.46 140.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 122.774 0.43 . . . . 0.0 110.468 -175.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 9' ' ' ILE . 2.5 p -89.24 -39.36 13.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.202 -0.311 . . . . 0.0 110.346 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' SER . 7.8 t 174.88 -150.26 0.01 OUTLIER 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.059 0.544 . . . . 0.0 109.79 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -56.77 -40.49 75.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 14.1 pm0 -56.42 -32.55 64.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.972 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -84.98 -31.93 23.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.52 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.796 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -52.56 -51.01 61.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -73.33 -40.17 64.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.14 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . 23.7 t30 -57.55 -48.16 80.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.62 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.87 -35.49 26.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' NZ ' ' A' ' 24' ' ' LYS . . . 68.8 16.02 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.895 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -132.52 4.09 3.93 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.796 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 33.3 tp -71.0 -54.17 12.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.558 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -88.44 132.92 37.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.271 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.23 112.54 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.783 2.322 . . . . 0.0 111.962 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.513 ' HE2' ' HA3' ' A' ' 129' ' ' GLY . 7.0 pttt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.005 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.482 0 CA-C-O 121.576 0.703 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -53.87 -29.7 42.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.95 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 57' ' ' HIS . . . -54.6 -66.6 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.935 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.73 -37.64 80.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.518 0.199 . . . . 0.0 110.994 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -64.15 1.04 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.981 0.42 . . . . 0.0 110.662 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.53 90.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.172 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 6.1 m-70 -58.65 -46.88 86.18 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.839 -177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -60.05 -51.72 68.45 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.548 HD11 HH22 ' A' ' 124' ' ' ARG . 84.5 mt -58.62 -46.28 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.548 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -77.0 -39.77 49.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.3 m -80.35 -42.8 22.25 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -173.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.16 11.38 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.569 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 37.7 tp 63.32 -75.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.89 0.476 . . . . 0.0 110.885 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.415 ' CE1' HG22 ' A' ' 122' ' ' THR . 17.8 m-85 -131.02 68.15 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.558 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.431 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -58.91 -43.72 91.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.191 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.13 -11.93 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.453 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.89 -29.89 69.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.289 0.545 . . . . 0.0 110.849 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.61 160.06 19.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.575 HG13 HD21 ' A' ' 5' ' ' LEU . 3.0 tp -115.05 123.68 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 110.369 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -105.59 147.69 28.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.809 -174.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.682 HG23 HG12 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -137.78 148.78 45.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.283 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.402 ' H ' HD13 ' A' ' 77' ' ' ILE . 2.9 m -81.49 155.85 25.6 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.217 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -25.9 65.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -85.88 129.01 34.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.705 0.288 . . . . 0.0 110.739 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.83 -18.39 64.08 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.5 -9.69 44.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 2.2 tt -46.71 -31.83 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.56 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.6 -62.81 1.48 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.357 0.598 . . . . 0.0 111.289 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -70.16 -41.49 73.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.825 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.61 -45.27 92.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.306 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.486 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 5.8 t80 -68.58 -53.81 20.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.175 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.81 75.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.498 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m -74.82 -52.58 11.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.665 0.269 . . . . 0.0 111.259 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -70.72 -10.4 59.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -105.07 3.78 30.81 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.297 -0.252 . . . . 0.0 110.865 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.47 36.25 76.34 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.945 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.532 HG13 ' HA3' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -89.76 -9.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.741 -176.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.18 -28.25 0.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.174 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -107.39 109.08 20.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.94 -126.44 3.55 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.145 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.43 150.86 51.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.456 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 16.9 tt -145.18 133.87 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.846 0.355 . . . . 0.0 110.067 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -128.8 154.98 45.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.162 0.506 . . . . 0.0 111.099 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 21.6 m -122.84 145.31 29.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.596 0.713 . . . . 0.0 111.494 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.784 HD21 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -120.15 141.2 50.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.327 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.421 ' HB2' HD13 ' A' ' 137' ' ' ILE . 61.0 t-20 -105.81 128.74 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.084 -0.385 . . . . 0.0 111.427 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.403 ' HB3' ' H ' ' A' ' 3' ' ' ASN . 19.2 ttp180 -67.35 -34.19 76.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.021 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.18 -36.38 72.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.17 -38.92 89.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -71.56 -34.27 69.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.84 -39.04 96.96 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -65.94 -43.13 88.92 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -65.45 -18.58 65.42 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.648 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 m 71.89 30.43 2.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.677 0.751 . . . . 0.0 110.423 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.3 mt -72.38 156.77 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.473 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.587 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 15.2 m-85 -78.5 138.27 38.34 Favored 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -118.61 104.72 10.9 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -109.62 112.25 24.22 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -99.46 111.6 23.93 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -83.76 107.02 14.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.9 129.73 44.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.043 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.537 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 48.6 m170 -83.09 178.21 2.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.458 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 81.7 Cg_exo -48.15 168.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.011 1.807 . . . . 0.0 112.511 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.46 -70.11 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 2.0 t-20 -77.42 -21.42 0.37 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -167.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 18.2 Cg_exo -39.13 -22.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.832 1.688 . . . . 0.0 112.244 166.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 73.09 6.25 5.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.919 164.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.24 140.07 52.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.223 0.535 . . . . 0.0 112.058 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 98.31 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.583 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -70.39 105.42 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -173.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 71' ' ' THR . 2.2 p -82.66 104.33 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.574 0.702 . . . . 0.0 109.63 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 3.2 m -97.39 130.4 44.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.528 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.615 HD12 HD23 ' A' ' 5' ' ' LEU . 2.0 mp -87.64 107.08 16.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.003 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.587 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 6.7 mmm180 -87.0 91.7 8.79 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.227 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -72.92 148.97 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.78 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -60.28 3.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.468 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.61 141.29 29.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.112 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.66 114.91 7.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.393 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.513 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . 91.43 70.71 1.19 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.194 -0.527 . . . . 0.0 114.088 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 72.0 m 59.45 72.71 0.51 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 170.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.634 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.59 -43.43 83.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.792 174.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.634 ' HD3' HG21 ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.28 135.66 9.66 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.873 1.715 . . . . 0.0 112.246 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -71.65 -26.64 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.095 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.23 10.88 13.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.006 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.784 HG22 HD21 ' A' ' 95' ' ' LEU . 8.0 p -52.54 -35.79 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 110.779 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.48 HG13 HG12 ' A' ' 135' ' ' VAL . 66.6 mt -93.37 95.36 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 138' ' ' ALA . 1.2 pt -76.04 -35.99 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.326 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 137' ' ' ILE . . . -146.18 157.97 43.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.592 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -133.61 148.47 51.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.739 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.55 154.8 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.747 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 tt -112.14 147.62 35.72 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.6 140.65 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -138.08 53.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.194 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 125.052 1.341 . . . . 0.0 113.884 177.293 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.81 149.58 37.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.288 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.09 131.65 45.92 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' HA ' HG13 ' A' ' 94' ' ' VAL . 3.1 t80 -96.82 112.42 24.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.479 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -130.59 155.87 45.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.0 158.33 22.27 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.619 HG23 ' HB3' ' A' ' 91' ' ' TYR . 4.7 tt -143.99 152.78 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -175.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.01 14.14 3.54 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.234 0.54 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' H ' HG12 ' A' ' 9' ' ' ILE . 1.8 t 58.9 -97.15 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' H ' ' HB3' ' A' ' 11' ' ' CYS . 56.6 mt-30 -66.17 -46.7 76.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.943 -167.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.98 -57.03 14.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.24 -43.38 98.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.802 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -51.1 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -59.9 -44.8 94.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -63.29 -51.04 67.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.046 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m-80 -78.76 -27.67 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.905 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 20' ' ' GLN . . . 90.34 47.17 3.87 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -172.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 41.6 mm-40 103.91 -144.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.858 1.663 . . . . 0.0 108.434 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.36 52.93 2.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.411 0.551 . . . . 0.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 18' ' ' ASN . 22.9 mtpp 68.52 131.4 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.857 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.7 142.66 9.25 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.242 0.671 0 CA-C-O 121.609 0.719 . . . . 0.0 111.561 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 22.3 p-10 -58.43 -21.81 52.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.547 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.66 -55.71 31.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.563 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -35.01 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.774 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.416 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 6.5 m-85 -63.21 -40.77 98.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.52 97.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.826 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -61.95 -38.35 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.133 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 38.9 tt0 -58.55 -57.9 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.65 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.07 -45.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.46 -54.73 6.31 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.935 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -82.84 -18.64 39.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.67 0.272 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . 91.41 30.53 10.67 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.808 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER 44.53 22.05 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.059 0.944 . . . . 0.0 113.083 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 54.84 17.15 1.67 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.977 0.511 . . . . 0.0 111.354 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 36.47 47.02 0.47 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.944 0.898 . . . . 0.0 111.869 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -35.68 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.718 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.61 84.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.425 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -130.19 162.17 29.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.446 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.42 99.06 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.591 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.409 ' OG ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -86.3 124.13 32.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.027 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 121' ' ' VAL . 14.6 t -140.03 161.37 37.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.52 ' H ' HG13 ' A' ' 77' ' ' ILE . 2.1 m -90.17 154.83 19.46 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 m -61.58 -28.31 69.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 110.456 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -87.17 135.49 33.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -19.87 49.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.163 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -6.09 18.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.52 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -51.73 -30.85 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.194 173.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.06 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -72.06 -43.74 64.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.592 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 81' ' ' PHE . 8.5 tttt -61.05 -53.34 58.41 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.434 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 58.8 t80 -67.51 -50.37 59.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.759 -175.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.72 -52.01 66.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.54 -175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 -37.98 76.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.606 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -68.95 -24.83 64.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.684 0.278 . . . . 0.0 111.029 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -89.3 1.76 55.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.78 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.88 99.84 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.661 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 pt -61.4 -9.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.635 0.218 . . . . 0.0 111.49 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -33.84 -45.33 0.19 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.238 0.336 . . . . 0.0 110.791 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -132.21 123.8 27.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.79 -153.48 24.89 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.71 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HB3' HG23 ' A' ' 9' ' ' ILE . 7.1 t80 -122.33 149.85 43.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.465 HD11 ' OH ' ' A' ' 6' ' ' TYR . 62.1 mt -130.98 133.02 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.514 -177.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 32.6 p90 -132.37 129.67 39.7 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 111.233 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 6' ' ' TYR . 2.6 m -112.59 130.99 65.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.182 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.504 HD21 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -110.37 141.24 43.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.28 -175.033 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.415 ' HB2' HG23 ' A' ' 137' ' ' ILE . 10.3 t-20 -83.11 149.76 26.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 107' ' ' GLU . 9.0 ttt180 -99.99 -20.2 16.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -35.28 78.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.128 0.49 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp -64.05 -38.12 89.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.036 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 135' ' ' VAL . 5.9 m-30 -64.86 -39.23 93.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.72 51.64 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.824 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -64.1 -29.94 71.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.429 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 4.5 m-30 -82.85 -16.97 45.59 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.715 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.7 m 64.96 47.36 2.6 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.621 0.724 . . . . 0.0 110.275 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 125' ' ' ALA . 24.9 mm -77.06 150.1 6.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.92 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -96.4 103.56 15.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.951 0.405 . . . . 0.0 111.402 -168.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 2.1 pt-20 -93.3 108.17 19.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.111 0.481 . . . . 0.0 110.103 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -99.86 114.26 27.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.337 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 11.6 pt-20 -85.82 120.03 26.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.822 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -92.5 107.76 19.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.76 ' HB3' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -114.21 161.04 18.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.132 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -129.19 172.32 7.32 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.2 168.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.37 2.047 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 1.5 pm0 -55.97 -51.22 68.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.3 t-20 -83.64 -28.42 0.42 Allowed Pre-proline 0 N--CA 1.471 0.609 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -169.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 22.1 Cg_exo -37.17 -21.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.485 2.123 . . . . 0.0 113.378 170.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.4 t-20 83.65 -3.94 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.35 0.66 . . . . 0.0 112.005 163.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.404 ' CD ' ' HZ3' ' A' ' 80' ' ' LYS . 4.6 mm-40 -122.48 145.5 48.25 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.239 0.542 . . . . 0.0 111.846 -172.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.76 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 16.8 tttm -150.05 95.48 2.29 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -100.13 117.01 33.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 0.0 111.175 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 22.8 t -89.22 107.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.434 HG22 HD23 ' A' ' 63' ' ' LEU . 5.2 m -91.28 113.65 25.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.926 0.393 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . 4.5 mt -88.31 103.53 13.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.98 115.16 27.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.267 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.56 ' HA ' HD11 ' A' ' 105' ' ' ILE . . . -74.44 163.44 27.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.728 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -39.44 -39.85 0.74 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.497 0.498 . . . . 0.0 111.439 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -157.45 161.67 38.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.06 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.5 m -62.24 160.9 12.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 112.01 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.39 31.13 9.87 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.221 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.4 m 48.97 69.33 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.661 0.384 . . . . 0.0 111.876 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.707 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -53.77 -46.35 98.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.723 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.707 ' HD3' HG21 ' A' ' 131' ' ' ILE . 91.0 Cg_endo -92.73 108.74 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 121.854 1.703 . . . . 0.0 112.038 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.41 -5.84 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.63 -3.42 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.517 HG22 ' CZ ' ' A' ' 100' ' ' PHE . 9.5 p -76.3 -21.11 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.9 pt -86.59 89.74 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.726 0.774 . . . . 0.0 109.341 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 96' ' ' ASN . 14.2 pt -74.94 -37.07 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.046 -174.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.564 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -136.76 127.84 27.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.812 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -123.07 136.52 54.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.431 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -141.26 159.46 42.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.239 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.2 tt -112.72 152.18 29.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 125.89 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.357 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HG3' HD21 ' A' ' 141' ' ' LEU . 6.3 mt-10 -133.92 93.87 3.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.936 -178.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.51 153.94 24.01 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.997 -0.44 . . . . 0.0 111.243 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 144.82 51.12 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.107 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -111.7 132.68 54.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.428 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 0.9 OUTLIER -141.14 105.93 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.345 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.616 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -92.73 155.37 22.55 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.698 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.2 mt -131.34 129.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 0.0 110.607 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -24.45 23.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.214 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 48.88 1.67 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.146 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.483 ' NE2' ' HA2' ' A' ' 90' ' ' GLY . 27.5 mt-30 -56.76 -32.24 65.41 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.87 -49.36 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.933 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.11 -44.1 91.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.569 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.68 -48.17 82.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.341 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -67.76 -32.76 73.58 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -72.1 -38.39 69.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -83.05 -22.55 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.033 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 76.79 5.52 84.01 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.813 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 1.4 mt-30 -156.01 165.28 36.91 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.249 0.62 . . . . 0.0 109.441 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.61 56.47 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.65 137.11 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.063 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.11 73.28 4.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.801 2.334 . . . . 0.0 112.489 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 pttp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.302 179.068 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 111.065 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -14.66 63.13 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.79 -52.84 8.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.24 -35.05 70.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.08 0.467 . . . . 0.0 109.827 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -61.39 -50.3 73.42 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.29 72.53 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.769 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -61.59 -52.78 62.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.064 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.556 ' HB2' HD11 ' A' ' 63' ' ' LEU . 18.6 tm0? -59.52 -40.22 86.43 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.399 0.618 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.55 -38.49 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.31 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -84.5 -69.92 0.61 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.99 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 -24.97 18.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.84 162.35 26.83 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 58' ' ' GLN . 13.7 mt -155.57 152.65 29.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.359 0.599 . . . . 0.0 110.151 -175.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -62.51 83.91 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.048 172.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.71 82.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.737 0.78 . . . . 0.0 111.417 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' TYR . . . -145.86 -32.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.9 m -55.17 -28.07 50.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.4 0.619 . . . . 0.0 110.006 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.51 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 30.3 m-85 -103.59 161.2 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.825 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 69' ' ' ILE . 4.2 mp -101.29 100.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.014 0.435 . . . . 0.0 110.288 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -78.84 123.1 26.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.931 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.83 152.69 50.56 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.496 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 6.0 m -105.24 159.9 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -28.42 66.68 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.013 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -100.34 134.23 43.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -58.72 -19.55 41.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.375 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.553 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 12.4 mm-40 -52.91 -24.85 10.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -49.81 -35.7 10.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.069 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.05 74.76 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.408 0.623 . . . . 0.0 110.609 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -69.41 -47.07 65.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.761 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 53.2 mttm -63.29 -48.51 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.334 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.616 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -63.1 -47.42 82.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.883 -177.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -57.07 -57.47 12.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.195 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 m -60.65 -45.05 95.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.832 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 m -60.61 -29.88 69.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -83.8 -6.7 59.49 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.26 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 45.82 18.11 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.608 HG21 ' HB1' ' A' ' 82' ' ' ALA . 7.2 tp -68.49 -18.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -32.43 -44.36 0.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.015 0.822 . . . . 0.0 112.468 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -130.95 101.74 5.75 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.483 ' HA2' ' NE2' ' A' ' 12' ' ' GLN . . . 170.83 -166.82 40.01 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.321 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -93.05 142.99 26.68 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.013 0.525 . . . . 0.0 109.825 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -134.86 112.79 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.125 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 2.7 m-85 -95.05 129.66 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.223 0.535 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 138' ' ' ALA . 1.0 OUTLIER -102.83 113.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.932 178.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.457 HD21 HG11 ' A' ' 135' ' ' VAL . 3.6 mp -112.43 140.96 46.73 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.466 0.479 . . . . 0.0 109.839 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -91.61 129.43 37.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -80.76 -28.38 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.914 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.18 -33.6 71.13 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.46 ' HB3' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -61.07 -38.54 86.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.012 175.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -66.49 -44.05 83.69 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.202 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.76 -45.24 96.83 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.901 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -61.84 -43.67 98.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.231 0.539 . . . . 0.0 110.016 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.41 -21.64 63.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.516 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.2 m 68.59 37.83 2.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.041 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 125' ' ' ALA . 17.5 mm -67.65 153.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.245 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.67 104.14 14.39 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 121.038 0.447 . . . . 0.0 110.859 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -88.04 110.72 20.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.48 113.22 25.83 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -105.86 130.03 53.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.66 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 m -117.22 131.66 69.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.557 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.8 pm0 -87.78 131.34 34.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.2 m170 -83.37 175.69 4.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 82.3 Cg_exo -45.95 164.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 113.138 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -51.09 -55.84 15.65 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -168.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.489 ' N ' ' HG2' ' A' ' 114' ' ' GLU . 2.1 t-20 -103.28 -9.32 0.12 Allowed Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 42.7 Cg_exo -43.07 -27.34 0.96 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 121.708 1.646 . . . . 0.0 110.867 162.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 t30 67.64 31.57 5.98 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.605 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.89 145.89 29.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 110.834 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 111' ' ' GLU . 5.5 mptt -123.09 130.4 52.73 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.266 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.8 108.4 16.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.148 0.499 . . . . 0.0 110.23 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.08 96.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.461 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.27 117.05 29.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.3 mm -87.3 106.36 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.026 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.51 ' HA ' ' CD1' ' A' ' 68' ' ' TYR . 26.0 mmt180 -85.19 100.23 11.62 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.138 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -85.57 161.04 19.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.468 ' HB2' HD12 ' A' ' 131' ' ' ILE . 33.2 mt-10 -65.21 -21.05 66.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.073 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.714 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -137.52 161.18 37.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.56 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.1 m -71.85 99.61 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.256 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.35 71.55 1.21 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.1 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.9 71.84 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -58.95 -44.21 98.61 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.631 ' HD3' HG23 ' A' ' 131' ' ' ILE . 65.6 Cg_endo -74.51 109.69 2.95 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.444 1.429 . . . . 0.0 112.23 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -63.15 -21.57 66.29 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.46 -15.43 59.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.442 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.555 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.4 p -70.47 -22.12 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.55 97.03 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.431 0.634 . . . . 0.0 109.554 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 pt -69.04 -28.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.46 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.536 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -155.73 141.9 18.36 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.505 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 95.26 5.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 108.956 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -95.08 157.75 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.283 0.564 . . . . 0.0 111.493 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -137.0 147.9 46.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.642 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.73 138.34 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.399 . . . . 0.0 110.624 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -129.21 53.83 1.86 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 CA--C 1.531 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.628 -177.232 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -125.49 119.32 27.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.662 HD22 ' HB ' ' A' ' 71' ' ' THR . 29.4 mt -99.22 124.52 44.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.291 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.23 114.62 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.904 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -139.77 144.38 37.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.616 ' HA3' HD12 ' A' ' 87' ' ' ILE . . . -114.19 158.51 14.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.504 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.597 HG12 ' H ' ' A' ' 11' ' ' CYS . 4.3 tt -151.45 168.21 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.82 0.448 . . . . 0.0 110.294 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.98 -14.55 38.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.226 0.536 . . . . 0.0 109.999 172.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER 60.16 -86.27 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.597 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -37.77 -57.13 1.02 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -61.85 -56.18 22.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.361 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.85 -41.54 97.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.31 0.576 . . . . 0.0 111.006 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.78 -52.5 50.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.271 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -63.51 -36.73 84.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.898 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -68.84 -55.47 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.209 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.41 -8.7 54.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.725 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.57 1.26 89.24 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 179.65 -175.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.32 67.31 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt 54.21 64.47 6.32 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.103 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.46 62.71 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.573 2.182 . . . . 0.0 112.202 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.4 mttm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 -177.703 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.54 -25.92 64.93 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.333 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.05 -54.59 42.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 110.524 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.49 -36.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.41 -55.4 21.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.048 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.39 90.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.543 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -57.14 -54.4 47.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.056 0.455 . . . . 0.0 110.188 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.538 ' HG3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -59.91 -32.58 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -176.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.538 HG13 ' HG3' ' A' ' 58' ' ' GLN . 59.6 mt -88.77 -70.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.82 -45.67 93.54 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.138 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -81.65 -19.29 42.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.982 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 51.21 4.2 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.333 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 40.7 mt 64.05 79.83 0.25 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.828 0.451 . . . . 0.0 110.868 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -53.87 -27.26 29.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.646 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.77 150.82 12.13 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.58 69.13 2.38 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.768 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -16.38 27.9 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -119.41 152.43 36.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.156 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.502 HG13 HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -107.88 110.17 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.492 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 3.2 m -99.93 136.04 40.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.838 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.662 ' HB ' HD22 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -141.06 155.41 46.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 175.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 m -86.67 162.33 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 110.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -44.48 96.76 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 6.8 t70 -83.68 136.92 34.02 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 -174.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -56.92 -21.94 33.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 74' ' ' ASP . 10.0 pt-20 -61.18 -16.85 49.18 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.789 0.328 . . . . 0.0 110.937 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -29.29 11.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.133 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.84 -66.36 0.42 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.956 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.15 -35.67 71.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.37 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -62.13 -44.45 96.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -67.16 -51.24 56.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.918 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -54.77 -46.21 74.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.327 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -69.43 -44.1 72.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.664 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 m -73.52 -18.78 61.05 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.0 m -101.5 10.68 40.13 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.537 0.208 . . . . 0.0 111.267 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.79 21.18 69.09 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.169 -0.468 . . . . 0.0 113.029 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.616 HD12 ' HA3' ' A' ' 8' ' ' GLY . 18.1 mt -72.8 -8.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 88' ' ' GLU . 23.6 mt-10 -39.45 -34.41 0.21 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.545 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -130.45 89.54 2.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.42 -144.98 6.64 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.228 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -127.18 150.72 49.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.488 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -133.25 143.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 178.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 43.1 p90 -129.65 139.3 51.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.271 0.557 . . . . 0.0 110.843 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.561 HG23 ' HB1' ' A' ' 138' ' ' ALA . 1.4 m -126.16 139.92 50.18 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.866 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.792 HD22 HG11 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -126.05 141.04 52.12 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.024 -174.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.645 ' HB2' HD12 ' A' ' 137' ' ' ILE . 38.4 t-20 -96.97 139.84 32.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.86 0.362 . . . . 0.0 110.769 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -25.92 67.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.78 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.88 -35.26 70.74 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.238 0.542 . . . . 0.0 109.892 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 96' ' ' ASN . 4.4 mm? -75.94 -50.81 13.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.482 -174.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -30.21 68.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.57 87.52 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.06 -40.01 87.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HB3' HD13 ' A' ' 105' ' ' ILE . 1.8 m-85 -68.96 -22.0 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.944 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m 66.75 38.43 3.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.66 0.743 . . . . 0.0 109.803 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -71.69 163.88 3.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.642 -178.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 5.2 m-30 -75.53 161.61 29.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.544 -171.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -141.23 155.9 45.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.297 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.441 ' HB2' HH11 ' A' ' 124' ' ' ARG . 0.3 OUTLIER -155.28 110.84 3.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -108.71 120.03 41.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 110.343 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.6 149.21 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.991 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -105.25 142.57 34.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.018 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -174.41 0.48 Allowed Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' ' HD2' ' A' ' 116' ' ' PRO . 99.3 Cg_exo -45.79 163.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.414 1.409 . . . . 0.0 111.811 171.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -51.83 64.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.455 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -103.69 -9.26 0.12 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -168.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 40.8 Cg_exo -42.13 -23.22 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 CA-C-N 121.683 1.637 . . . . 0.0 112.161 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 70.55 30.07 3.23 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.567 169.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.69 150.82 46.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.087 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -129.77 129.79 44.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.616 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -94.65 103.13 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.942 0.401 . . . . 0.0 109.986 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 4.4 p -92.54 110.11 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.482 0.658 . . . . 0.0 110.442 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 87.6 m -91.68 114.74 27.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.519 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.545 HD12 HD21 ' A' ' 5' ' ' LEU . 2.1 mp -87.82 129.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.618 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -111.8 119.34 38.26 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 -173.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.1 149.45 49.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.67 -57.23 13.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 131' ' ' ILE . 4.2 t0 -97.57 158.88 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.056 169.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.28 160.36 31.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.993 0.425 . . . . 0.0 110.767 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.29 32.13 60.5 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.043 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m 57.49 71.31 0.59 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.155 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.809 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -35.52 -49.64 1.35 Allowed Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.809 ' HD3' HG21 ' A' ' 131' ' ' ILE . 84.7 Cg_endo -99.87 109.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.336 2.024 . . . . 0.0 112.019 174.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 3.87 15.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.873 0.368 . . . . 0.0 110.606 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.85 -9.58 39.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.792 HG11 HD22 ' A' ' 95' ' ' LEU . 6.8 p -71.42 -9.26 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.585 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.6 pt -86.1 91.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 96' ' ' ASN . 11.6 pt -63.41 -29.92 48.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.446 -173.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 94' ' ' VAL . . . -148.74 148.83 30.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.215 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -150.45 135.37 17.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -142.63 153.14 43.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.032 -171.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -95.44 150.79 19.9 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tt -139.37 120.23 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.443 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.56 70.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.186 0.517 . . . . 0.0 110.227 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 CA--C 1.533 0.321 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.355 177.288 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -109.2 133.95 52.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 60.3 mt -113.69 147.18 38.64 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -140.1 135.1 32.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.493 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tpt180 -148.37 155.96 41.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -137.49 157.52 24.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.758 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.9 tt -138.43 133.14 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 110.47 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -31.31 27.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.536 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 53.22 2.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.802 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . 13.3 tm0? -56.58 -27.32 57.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.09 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -74.96 -39.34 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.948 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.87 -48.1 75.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.319 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -66.16 -35.28 80.06 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.411 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 tt0 -63.57 -43.35 97.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.02 -40.58 98.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.341 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.97 -31.95 71.18 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.364 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.48 7.69 71.9 Favored Glycine 0 C--O 1.234 0.129 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.652 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 4.6 mm-40 -170.93 -178.05 2.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.2 mt -82.06 38.42 0.53 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.219 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm 53.3 60.74 11.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.23 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 55.4 Cg_endo -69.09 149.95 71.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.321 2.014 . . . . 0.0 110.97 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.505 -173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.455 0 CA-C-O 121.464 0.65 . . . . 0.0 112.698 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -48.26 -31.89 6.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.131 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.75 -60.42 3.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG13 ' HH ' ' A' ' 68' ' ' TYR . 2.2 p -62.91 -32.71 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -62.64 -53.15 58.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.166 0.508 . . . . 0.0 110.418 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.06 99.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.666 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -64.8 -48.96 72.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -70.6 -22.13 62.58 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.836 -175.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.538 HD11 ' NH2' ' A' ' 124' ' ' ARG . 17.0 mm -92.35 -54.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 0.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.91 -50.29 13.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.512 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -80.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.605 0.241 . . . . 0.0 111.412 -173.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.15 79.13 1.62 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 19.8 tp -57.33 86.06 0.01 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 111.535 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 61.55 60.27 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.0 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -34.19 68.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.372 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.33 -13.95 0.45 Allowed Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.353 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.417 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . 13.9 m -61.3 -33.0 72.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.592 ' HH ' HG13 ' A' ' 54' ' ' VAL . 19.8 m-30 -106.71 153.51 22.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.05 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.3 mt -93.1 99.6 9.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.833 0.349 . . . . 0.0 110.53 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.78 112.86 24.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.567 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -122.16 170.39 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.919 0.39 . . . . 0.0 111.005 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -98.78 158.29 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.966 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -16.97 64.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.53 134.08 45.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.156 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.7 -19.09 63.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.794 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.17 -16.51 45.42 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.666 0.27 . . . . 0.0 110.655 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -30.62 14.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.902 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.76 -60.37 3.55 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.155 0.502 . . . . 0.0 111.352 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.65 -35.44 65.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.185 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -60.63 -47.67 85.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.808 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -64.38 -51.73 61.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.46 -59.21 5.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -66.87 -35.54 80.26 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.861 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.0 m -73.49 -17.85 61.18 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.444 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 m -99.78 -2.85 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.6 0.238 . . . . 0.0 110.682 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.87 31.59 78.9 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 -9.75 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.031 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -47.48 -27.36 1.71 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.694 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.447 HD22 HD13 ' A' ' 144' ' ' ILE . 6.3 m-20 -110.11 88.48 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.99 -138.74 5.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.364 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.63 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 1.7 t80 -123.49 148.48 46.19 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.743 0.417 . . . . 0.0 110.022 -174.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.432 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 pt -140.09 139.15 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 10.6 p90 -132.13 132.21 43.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.933 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.1 m -109.98 139.69 32.17 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 CA-C-O 121.333 0.587 . . . . 0.0 110.729 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.3 mp -121.09 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.005 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -85.46 125.81 33.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.891 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.477 HH21 ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -69.49 -53.61 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -171.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.64 -20.37 65.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.061 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 135' ' ' VAL . 15.0 tp -64.61 -34.77 79.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.183 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.509 ' CE1' HG13 ' A' ' 135' ' ' VAL . 0.2 OUTLIER -67.01 -43.89 81.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.618 176.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.96 94.84 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.638 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -59.78 -50.38 74.06 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -64.98 -20.81 66.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.603 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 m 68.88 37.85 2.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.499 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -71.97 158.86 6.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.804 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.6 m-85 -77.08 102.49 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.301 -166.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.477 ' CD ' HH21 ' A' ' 97' ' ' ARG . 41.4 mt-10 -91.63 126.51 36.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.264 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.602 ' HB2' ' HD3' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -134.32 111.01 9.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.5 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -117.0 118.03 31.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.126 0.489 . . . . 0.0 109.706 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -99.81 135.66 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.344 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -92.77 142.37 27.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.342 0.592 . . . . 0.0 110.557 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.23 175.84 2.25 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.28 160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.906 1.737 . . . . 0.0 111.844 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.85 -41.23 97.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -167.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -86.26 -25.39 0.34 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.151 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 26.0 Cg_exo -39.37 -23.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.928 1.752 . . . . 0.0 112.091 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 m-20 76.15 6.22 3.68 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.223 164.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -150.11 160.72 43.44 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.951 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.42 148.55 48.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.775 174.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -96.02 105.25 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.024 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 109' ' ' GLU . 33.7 t -89.25 102.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.3 m -104.63 109.59 21.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.189 0.518 . . . . 0.0 111.248 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -89.85 116.81 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.709 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.804 ' HG2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -103.04 118.68 37.35 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.833 0.825 . . . . 0.0 110.076 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.77 163.35 20.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.958 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.492 ' HB3' HD11 ' A' ' 131' ' ' ILE . 18.3 tt0 -51.55 -29.18 16.05 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.616 0.573 . . . . 0.0 111.719 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.416 ' H ' HG21 ' A' ' 131' ' ' ILE . 36.3 t0 -140.3 160.43 40.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.471 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 1.5 t -67.42 128.27 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.578 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.93 59.69 1.85 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.578 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.3 m 47.46 70.4 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.826 HG22 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -54.71 -44.87 99.58 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.826 ' HD3' HG22 ' A' ' 131' ' ' ILE . 91.1 Cg_endo -94.0 124.59 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.112 1.875 . . . . 0.0 112.32 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -84.3 -14.9 48.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -61.4 -29.89 70.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.903 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.611 ' HA ' HD21 ' A' ' 99' ' ' LEU . 22.3 m -72.93 -12.51 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.48 93.63 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 pt -71.9 -26.45 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.923 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.65 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -144.45 139.79 28.55 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.409 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -132.48 126.92 34.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.278 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.76 160.25 40.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.592 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.423 HD23 ' HG3' ' A' ' 143' ' ' GLU . 3.1 tt -102.55 153.47 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.5 tt -137.26 133.84 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.329 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.423 ' HG3' HD23 ' A' ' 141' ' ' LEU . 31.4 mt-10 -134.0 74.68 1.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.954 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 89' ' ' ASN . 7.2 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.514 0.673 . . . . 0.0 110.677 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 141.44 48.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.594 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -99.97 135.14 41.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -96.15 141.18 29.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 0.0 110.664 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.13 123.01 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.397 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.518 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -119.8 157.33 15.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.863 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.511 HG22 ' HD1' ' A' ' 91' ' ' TYR . 8.3 tt -149.71 159.09 5.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.113 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 25.59 5.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.125 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.58 64.83 1.09 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.417 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.63 -23.84 67.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.558 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -61.7 -44.83 96.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.455 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.55 -41.65 88.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.234 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -59.66 -42.16 92.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.383 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -71.73 -33.55 68.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.13 -48.4 35.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -87.75 -27.71 22.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.61 75.2 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.993 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -153.02 17.57 0.57 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.89 0.345 . . . . 0.0 111.578 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.88 98.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.21 0.319 . . . . 0.0 110.686 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 10.2 mmmm 68.4 137.69 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.175 0.59 . . . . 0.0 110.879 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' HE2' ' A' ' 22' ' ' LYS . 93.9 Cg_endo -79.7 149.56 20.94 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.396 2.064 . . . . 0.0 111.987 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.45 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt . . . . . 0 C--O 1.239 0.546 0 CA-C-O 121.885 0.85 . . . . 0.0 113.083 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.45 -24.31 54.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.809 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.43 -68.44 0.17 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.096 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG21 ' SG ' ' A' ' 67' ' ' CYS . 3.6 p -79.96 -26.27 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.189 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.36 -53.62 49.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.93 0.395 . . . . 0.0 110.039 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.549 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.403 ' HD2' ' HG1' ' A' ' 61' ' ' THR . 20.9 t-160 -56.24 -52.23 65.22 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.043 0.449 . . . . 0.0 109.941 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -62.4 -48.78 78.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.236 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.74 -41.2 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -84.71 -54.62 4.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.588 0.232 . . . . 0.0 111.401 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.403 ' HG1' ' HD2' ' A' ' 57' ' ' HIS . 88.2 m -74.92 -31.62 61.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -175.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.24 -161.89 12.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.142 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.45 73.22 6.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.612 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -71.58 -14.43 62.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.16 -171.52 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.651 171.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.45 -50.7 4.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.807 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.587 ' SG ' HG21 ' A' ' 54' ' ' VAL . 34.6 t -84.87 -46.1 11.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -115.21 143.77 44.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.257 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.91 99.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.943 0.401 . . . . 0.0 110.229 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 m -80.49 122.67 27.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.653 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 5' ' ' LEU . 2.2 m -127.21 131.36 50.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.091 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.605 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -80.36 167.87 19.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.618 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.1 p -81.82 9.64 7.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.064 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.92 133.28 56.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.165 0.507 . . . . 0.0 110.899 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -65.17 -19.75 66.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.008 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.57 -5.14 49.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.021 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.605 HD13 ' H ' ' A' ' 72' ' ' THR . 2.7 tt -48.22 -34.51 4.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.547 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.74 -53.57 56.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -70.59 -46.04 64.19 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.769 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -60.03 -48.23 82.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.53 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 6.0 t80 -67.35 -53.96 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.109 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.532 ' HB1' HG23 ' A' ' 87' ' ' ILE . . . -56.61 -42.83 79.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.332 -176.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 m -70.85 -48.16 55.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.227 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 -20.55 66.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.691 0.282 . . . . 0.0 111.54 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -93.83 9.62 36.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.87 36.71 67.23 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.785 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.532 HG23 ' HB1' ' A' ' 82' ' ' ALA . 3.3 tp -70.76 -10.2 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 2.0 tm-20 -38.56 -37.51 0.32 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.502 0.501 . . . . 0.0 111.193 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.07 89.18 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.85 -152.61 11.96 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.139 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.511 ' HD1' HG22 ' A' ' 9' ' ' ILE . 48.0 t80 -129.89 135.87 48.86 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.503 ' HB ' HG12 ' A' ' 87' ' ' ILE . 9.9 tt -139.97 138.9 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.42 . . . . 0.0 111.516 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -131.8 156.75 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.545 HG21 ' HB3' ' A' ' 138' ' ' ALA . 1.7 m -128.17 137.35 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -113.82 140.63 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.356 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -81.92 146.28 29.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.711 0.291 . . . . 0.0 110.702 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -94.27 -24.98 17.23 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.36 -43.4 67.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.345 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.465 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -67.14 -36.92 82.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.939 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.72 99.6 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -59.19 -53.44 58.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.339 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -70.93 -16.75 62.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.043 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m 63.88 47.97 3.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.509 0.671 . . . . 0.0 110.222 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -62.62 163.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.523 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.575 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 7.3 m-85 -74.6 99.78 3.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.129 0.49 . . . . 0.0 110.491 -170.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.94 101.61 13.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.766 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.499 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 54.6 t80 -116.49 125.3 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.1 140.61 47.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.804 0.335 . . . . 0.0 111.264 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 120' ' ' GLU . 2.5 m -123.92 150.13 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.291 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.18 142.34 27.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.89 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 118' ' ' GLU . 3.0 m170 -84.99 175.09 4.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.535 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.0 Cg_exo -50.4 170.2 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.025 1.817 . . . . 0.0 112.461 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -53.13 -64.68 0.74 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -166.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.452 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.5 t-20 -93.79 -12.47 0.18 Allowed Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.535 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 52.0 Cg_exo -44.87 -24.04 1.1 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 CA-C-N 121.421 1.543 . . . . 0.0 111.174 163.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 72.25 -11.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.541 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 3.8 mt-10 -102.67 155.15 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.143 0.497 . . . . 0.0 111.029 -172.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -115.03 133.75 55.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.486 ' HB3' HG22 ' A' ' 110' ' ' VAL . 1.1 tm-20 -89.04 135.32 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.36 100.4 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.467 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -74.23 113.27 11.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.299 177.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 HD23 ' A' ' 5' ' ' LEU . 7.0 mm -87.45 100.19 9.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.575 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 48.6 mtt-85 -101.59 110.13 22.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.437 -172.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.5 160.34 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.365 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.49 -49.94 68.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.678 ' H ' HG23 ' A' ' 131' ' ' ILE . 30.5 t70 -110.18 160.28 16.63 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.15 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 12.3 t -80.39 129.41 34.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.91 69.2 1.19 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.975 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 31.2 m 46.87 70.29 0.41 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.78 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -69.33 -44.44 26.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.78 ' HD3' HG21 ' A' ' 131' ' ' ILE . 83.5 Cg_endo -97.92 109.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.451 2.101 . . . . 0.0 111.707 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.63 -27.46 45.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.638 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.18 -9.07 58.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 95' ' ' LEU . 6.4 p -73.13 -15.18 17.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.9 mt -86.94 89.64 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.6 pt -80.23 -28.03 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.422 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.545 ' HB3' HG21 ' A' ' 94' ' ' VAL . . . -128.17 140.12 52.1 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' OH ' ' A' ' 91' ' ' TYR . 12.1 ttmt -141.62 126.49 18.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.273 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.37 131.41 24.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.775 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tt -92.68 151.89 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -140.52 122.29 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.177 0.513 . . . . 0.0 112.031 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -126.79 93.16 3.7 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.001 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 2.1 mt . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 123.407 0.683 . . . . 0.0 111.778 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.93 174.93 10.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.554 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.534 HD11 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -118.97 159.07 24.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.098 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.425 ' HE2' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.67 132.39 55.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 -177.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.504 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 12.1 ttt180 -131.49 94.77 3.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -90.42 157.48 25.74 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.142 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.7 mt -125.47 128.71 72.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.869 0.366 . . . . 0.0 110.122 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.86 -31.01 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.858 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.7 p -94.43 55.32 1.96 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.92 -29.44 8.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.315 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -70.85 -38.8 73.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.386 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.655 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -72.96 -36.18 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.722 -179.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.55 -53.39 28.78 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.454 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -59.81 -36.06 75.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.92 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 15.3 t-20 -68.27 -39.88 82.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.183 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -67.18 -32.47 73.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.293 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 2.36 73.36 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.116 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -169.86 177.75 4.28 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.1 mt -81.38 49.02 1.22 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.479 0.18 . . . . 0.0 111.166 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt 54.7 69.26 2.15 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.415 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 67.1 Cg_endo -86.21 148.57 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.71 2.273 . . . . 0.0 112.233 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tptt . . . . . 0 C--O 1.236 0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 177.681 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.69 -53.03 34.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.024 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.56 -61.97 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 HG11 HH21 ' A' ' 124' ' ' ARG . 3.5 p -67.9 -37.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -172.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.476 ' O ' HG12 ' A' ' 59' ' ' ILE . 6.5 m-85 -63.41 -59.49 4.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.08 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.98 83.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.081 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.41 -29.58 69.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.704 HE22 ' HB3' ' A' ' 67' ' ' CYS . 8.6 tp-100 -67.62 -45.21 76.09 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 109.834 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 55' ' ' TYR . 18.4 mm -66.02 -31.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.437 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -81.58 -74.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.559 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 p -95.68 -38.72 10.24 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.39 48.18 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mp 59.97 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 111.37 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -95.72 64.33 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.365 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 63.54 -74.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.675 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.45 66.84 0.51 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.704 ' HB3' HE22 ' A' ' 58' ' ' GLN . 8.0 t -56.93 -42.7 80.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.959 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.626 ' HD2' ' HG2' ' A' ' 58' ' ' GLN . 21.4 m-85 -123.39 159.72 28.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.37 104.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 21.3 m -87.39 111.22 20.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 t -123.85 157.22 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.42 ' HG1' ' HB ' ' A' ' 77' ' ' ILE . 36.1 p -87.52 158.49 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -13.16 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.807 0.336 . . . . 0.0 110.9 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -79.79 130.53 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.832 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -58.61 -24.07 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.643 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.02 1.03 22.19 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.669 0.271 . . . . 0.0 111.0 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.42 ' HB ' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -48.93 -34.06 5.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.651 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.04 -57.56 12.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 111.372 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -70.42 -43.09 70.67 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.832 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -60.62 -46.46 90.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.282 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -68.82 -44.39 73.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.294 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -57.2 -50.61 72.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.68 -44.4 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -15.64 63.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.419 ' HB2' HG13 ' A' ' 87' ' ' ILE . 6.8 m -105.42 2.75 28.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.22 96.6 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.253 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.568 HD13 ' HA3' ' A' ' 8' ' ' GLY . 10.1 mt -91.01 -7.8 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -29.21 -43.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.732 0.813 . . . . 0.0 113.186 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -125.17 92.72 3.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.03 -144.73 6.35 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.917 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.425 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -105.09 143.37 33.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.72 0.408 . . . . 0.0 110.448 -175.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.507 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 5.4 pt -139.88 113.92 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 110.296 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -101.99 156.31 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -129.36 136.92 58.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.535 HD22 HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -128.34 133.9 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.295 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.459 ' HB2' HG21 ' A' ' 137' ' ' ILE . 48.5 t-20 -79.5 134.83 36.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.485 0.183 . . . . 0.0 110.701 -175.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -51.64 13.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.333 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.43 -17.8 64.85 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.782 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.17 -45.61 90.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.344 0.592 . . . . 0.0 109.536 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.483 ' HE2' HD12 ' A' ' 5' ' ' LEU . 59.9 m-85 -66.48 -35.48 80.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.951 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.59 93.1 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.952 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -72.41 -37.2 68.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.136 0.493 . . . . 0.0 110.023 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -75.76 -23.39 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m 69.71 33.93 2.82 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.788 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -65.13 163.92 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.922 174.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.554 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.3 m-85 -74.45 99.29 3.51 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.593 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -96.8 99.32 10.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.75 112.39 24.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.614 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -105.02 107.45 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.925 0.393 . . . . 0.0 110.177 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.577 HG12 ' HB3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -91.25 107.54 18.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.35 129.04 34.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.528 0.68 . . . . 0.0 109.455 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -80.75 169.35 19.82 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.146 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.82 167.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.217 1.945 . . . . 0.0 112.407 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.81 -55.96 28.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.45 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.0 OUTLIER -87.88 -14.74 0.21 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -168.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 45.6 Cg_exo -43.44 -23.36 0.47 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 121.392 1.533 . . . . 0.0 111.298 162.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 67.84 27.82 7.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.584 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -160.33 154.51 23.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.239 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 135.96 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.577 ' HB3' HG12 ' A' ' 110' ' ' VAL . 19.0 tt0 -98.5 113.56 25.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.428 . . . . 0.0 111.016 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 t -95.73 103.77 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.981 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 58.3 m -93.19 112.47 24.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.413 HG21 ' CD2' ' A' ' 100' ' ' PHE . 4.2 mp -88.68 110.04 20.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.586 ' O ' HG22 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -100.41 116.82 33.26 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.558 178.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.99 159.55 33.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.052 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 126' ' ' GLU . 1.2 mm-40 -48.16 -59.55 3.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 111.012 -176.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.752 ' H ' HG21 ' A' ' 131' ' ' ILE . 48.4 t0 -104.63 154.98 19.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.622 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -76.41 140.68 41.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' A' ' 67' ' ' CYS . . . 90.9 49.34 3.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.766 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.504 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 32.0 m 52.14 70.88 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.047 0.451 . . . . 0.0 112.206 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.752 HG21 ' H ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -69.28 -38.35 10.42 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.605 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 95.4 Cg_endo -82.68 118.88 2.87 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 121.267 1.311 . . . . 0.0 112.005 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.1 -31.27 69.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.28 10.07 9.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.494 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.605 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 4.2 p -63.29 -29.8 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.611 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.49 93.38 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.459 HG21 ' HB2' ' A' ' 96' ' ' ASN . 18.0 pt -74.86 -32.71 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.102 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.557 ' HB2' HG22 ' A' ' 94' ' ' VAL . . . -161.56 166.78 26.48 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.371 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -145.42 144.49 30.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.167 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -141.08 160.44 40.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.851 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.39 148.39 25.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.07 137.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.192 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 105.64 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.205 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.562 -176.826 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HZ ' ' HB3' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -157.73 154.65 28.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.097 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.478 ' HB2' HD12 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -122.68 151.02 41.94 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.837 0.351 . . . . 0.0 110.597 -174.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.63 136.61 52.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.044 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 15.2 tpt180 -142.43 102.39 4.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.77 137.12 13.22 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.46 129.66 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.207 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -28.57 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 110.313 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -90.09 42.29 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.808 -178.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.24 -34.59 23.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.148 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -68.93 -42.99 76.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.563 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.6 t70 -65.4 -42.55 92.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' A' ' 21' ' ' LEU . 2.1 tt0 -61.85 -54.83 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.718 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.65 -32.5 71.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.785 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -35.03 74.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.931 0.396 . . . . 0.0 110.189 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -73.87 -24.31 59.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.784 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.05 5.41 89.73 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.37 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -169.7 162.16 9.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.559 HD11 ' HG ' ' A' ' 130' ' ' CYS . 1.5 mt -69.33 73.32 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 66.27 149.47 0.12 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.919 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 145.53 82.1 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.592 2.195 . . . . 0.0 111.734 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.508 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.511 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -53.3 -27.47 23.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.36 -66.43 0.39 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.733 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -30.82 49.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.664 0.268 . . . . 0.0 110.96 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.67 ' HA ' ' NH1' ' A' ' 124' ' ' ARG . 22.6 m-30 -62.35 -61.54 2.38 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.649 0.262 . . . . 0.0 110.591 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.75 77.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -52.11 -59.33 4.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.522 ' NE2' ' SG ' ' A' ' 128' ' ' CYS . 1.4 tp-100 -65.72 -51.32 60.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.003 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.466 HG13 ' HE1' ' A' ' 64' ' ' TYR . 2.7 tt -76.91 -24.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.78 -35.89 12.54 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.571 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -89.68 -58.8 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.581 0.229 . . . . 0.0 111.321 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.38 -128.1 6.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.198 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -156.18 -157.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.5 m-85 -98.26 -6.85 30.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.092 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -60.78 91.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 111.288 -172.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.64 -39.03 3.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.222 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.609 ' SG ' ' CZ ' ' A' ' 68' ' ' TYR . 51.8 t -78.92 -48.22 14.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.144 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.609 ' CZ ' ' SG ' ' A' ' 67' ' ' CYS . 30.3 m-85 -129.17 162.68 27.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.658 0.383 . . . . 0.0 110.467 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.6 mp -92.15 99.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 111.019 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 m -75.73 109.96 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.443 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -118.26 129.09 55.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.275 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.556 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.1 m -75.91 157.46 33.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.07 9.86 16.03 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.643 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 76' ' ' GLU . 16.2 t70 -109.33 135.7 49.96 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.494 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -55.46 -26.15 40.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' HG3' ' HE2' ' A' ' 75' ' ' LYS . 11.2 mt-10 -82.81 2.03 36.13 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 121.999 0.12 . . . . 0.0 111.075 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -44.61 -38.57 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.457 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HB3' ' HZ ' ' A' ' 4' ' ' PHE . . . -60.03 -55.88 28.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.226 0.536 . . . . 0.0 110.988 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.79 -42.09 67.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.275 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.299 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -65.74 -49.48 68.29 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.703 ' HB2' HG21 ' A' ' 87' ' ' ILE . . . -53.5 -56.46 16.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.303 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -63.3 -39.85 95.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.222 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 m -65.58 -25.6 67.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.941 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -90.4 0.18 57.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.696 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 54.8 30.78 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.703 HG21 ' HB2' ' A' ' 82' ' ' ALA . 4.2 tp -77.12 -9.9 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HG2' HD13 ' A' ' 144' ' ' ILE . 4.2 tt0 -33.32 -47.72 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.492 0.495 . . . . 0.0 111.281 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -131.36 118.01 19.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.938 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 166.25 -168.44 39.9 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.091 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.85 137.55 32.24 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.91 0.484 . . . . 0.0 109.744 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.48 111.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.7 0.286 . . . . 0.0 110.287 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 3.6 m-30 -111.68 143.4 42.64 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.663 HG21 ' HB1' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -129.97 130.32 66.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.02 178.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.525 HD21 HG13 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -125.04 141.34 52.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.497 -177.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 99' ' ' LEU . 23.5 t-20 -85.58 132.53 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -62.48 -48.25 80.44 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.709 -175.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 1.3 tp -62.84 -43.33 99.09 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CD2' HG21 ' A' ' 123' ' ' ILE . 33.2 m-85 -62.91 -41.05 99.33 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.592 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.62 -36.03 88.04 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.802 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.07 -44.94 83.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -69.26 -16.62 63.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.3 m 72.13 31.0 2.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.608 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 124' ' ' ARG . 1.7 mt -75.55 157.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 124' ' ' ARG . 7.7 m-85 -83.6 101.95 11.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.734 -163.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -94.87 105.74 17.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.663 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.422 ' HE2' ' HE ' ' A' ' 124' ' ' ARG . 10.6 p90 -126.57 145.27 50.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.991 0.425 . . . . 0.0 110.032 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -95.45 125.27 39.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.689 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 120' ' ' GLU . 1.6 p -90.75 106.85 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.8 145.98 27.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -108.36 170.58 5.34 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.7 Cg_exo -47.7 170.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.452 2.101 . . . . 0.0 113.068 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -46.57 -67.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -93.28 -11.81 0.17 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 35.8 Cg_exo -43.88 -20.49 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 CA-C-N 121.556 1.592 . . . . 0.0 112.683 164.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.09 9.39 6.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.407 0.683 . . . . 0.0 111.708 170.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -110.09 115.61 30.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.217 0.532 . . . . 0.0 112.102 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -138.33 95.75 3.06 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 110' ' ' VAL . 9.7 tt0 -93.96 140.21 29.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.737 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.92 106.26 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -92.47 121.86 34.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 18.1 mm -88.71 93.42 4.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.153 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.67 ' NH1' ' HA ' ' A' ' 55' ' ' TYR . 6.8 tpp180 -82.1 99.71 9.36 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.192 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.441 ' HB3' HG22 ' A' ' 131' ' ' ILE . . . -70.52 160.51 32.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.828 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.09 -30.81 66.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -147.44 160.87 42.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.522 ' SG ' ' NE2' ' A' ' 58' ' ' GLN . 76.7 m -61.7 149.94 38.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.983 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.42 26.78 50.43 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.873 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.559 ' HG ' HD11 ' A' ' 21' ' ' LEU . 1.8 m 57.21 72.0 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.708 0.29 . . . . 0.0 110.485 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.796 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -38.85 -46.2 3.17 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.796 ' HD3' HG21 ' A' ' 131' ' ' ILE . 85.2 Cg_endo -85.68 107.67 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 120.651 1.268 . . . . 0.0 111.07 173.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -24.69 64.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.263 0.554 . . . . 0.0 110.528 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.56 3.52 15.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.374 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.525 HG13 HD21 ' A' ' 95' ' ' LEU . 2.4 p -77.9 -8.76 11.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.267 0.556 . . . . 0.0 110.733 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mm -86.2 96.14 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 pt -64.12 -32.99 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.137 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB1' HG21 ' A' ' 94' ' ' VAL . . . -144.68 136.3 25.61 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.024 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.1 mtmt -111.42 129.08 56.13 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.328 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -140.98 160.46 40.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.541 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 tt -135.93 150.3 49.25 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.84 147.93 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.801 -176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.28 103.4 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.791 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.414 HD13 ' HG2' ' A' ' 88' ' ' GLU . 20.2 mm . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.242 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 97' ' ' ARG . 38.0 p90 39.73 -170.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.688 1.195 . . . . 0.0 113.54 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -147.33 160.59 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.21 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -121.19 129.56 53.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.628 -170.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.507 ' HD2' HG23 ' A' ' 69' ' ' ILE . 18.0 ttt180 -140.95 155.12 46.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.92 158.07 16.65 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.931 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.808 HG23 ' HB3' ' A' ' 91' ' ' TYR . 1.1 tt -139.07 129.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.122 0.487 . . . . 0.0 110.468 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.14 -2.04 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 109.378 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 35.93 1.82 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.659 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -56.74 -32.73 65.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.444 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.56 -38.76 77.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.814 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 -45.75 92.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.909 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.03 -52.2 66.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.42 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.49 -27.63 66.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -71.74 -40.96 69.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -85.13 -28.4 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.87 51.32 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 21' ' ' LEU . 4.1 tt0 174.44 158.36 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.528 0.731 . . . . 0.0 109.498 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.491 ' N ' ' HG2' ' A' ' 20' ' ' GLN . 54.0 mt -65.02 97.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.86 154.31 0.14 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.803 0.69 . . . . 0.0 110.645 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.97 167.2 26.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.765 2.31 . . . . 0.0 112.483 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm . . . . . 0 C--O 1.234 0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.074 178.322 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.457 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 111.832 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -59.66 -27.24 66.21 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.845 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.44 -60.23 4.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.528 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.8 p -63.35 -35.4 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.509 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.1 m-85 -59.88 -63.17 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.573 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.2 -46.33 79.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.175 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -62.05 -46.28 89.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 0.0 111.007 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 1.3 pt20 -70.05 -30.26 67.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.316 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.4 HD13 ' HG3' ' A' ' 58' ' ' GLN . 1.2 mp -81.21 -47.39 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.661 0.267 . . . . 0.0 110.722 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.79 -57.18 5.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.004 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.7 m -74.67 -26.35 59.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.03 78.83 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.222 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.55 HD11 ' H ' ' A' ' 65' ' ' ASP . 0.8 OUTLIER -65.68 -33.38 75.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.174 -178.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 t80 33.74 46.87 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.795 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.55 ' H ' HD11 ' A' ' 63' ' ' LEU . 37.4 t70 -90.4 -0.27 57.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 109.408 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.07 144.81 46.67 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.417 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 p -71.21 0.77 7.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -65.31 158.79 25.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.507 HG23 ' HD2' ' A' ' 7' ' ' ARG . 18.1 mt -102.75 138.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.95 131.0 42.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 172.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 5' ' ' LEU . 96.9 m -140.8 110.1 6.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 3.4 m -68.97 152.85 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.103 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 10.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -136.96 142.4 42.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.526 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -54.47 -19.81 6.44 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.733 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.21 -31.21 13.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.862 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -48.07 -31.08 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.27 -54.72 40.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -45.41 62.93 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.765 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -58.52 -49.18 78.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.352 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 7' ' ' ARG . 27.2 t80 -67.48 -49.22 64.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.475 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.57 -47.11 76.96 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.507 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -75.91 -39.32 56.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.814 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.3 m -72.69 -20.15 61.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -96.62 3.66 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.5 76.03 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.655 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.439 HD13 ' HA3' ' A' ' 8' ' ' GLY . 4.6 mt -72.97 -7.26 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.508 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.8 mt-10 -28.68 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -126.46 99.97 6.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.997 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.49 -139.97 5.34 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.77 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.808 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.2 t80 -124.47 150.88 45.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.497 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.3 pt -136.84 142.54 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 111.103 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -132.63 135.11 45.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 111.704 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 m -113.92 139.3 40.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.564 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -125.97 142.04 51.7 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.124 -173.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -79.68 124.59 28.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.815 0.341 . . . . 0.0 111.139 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.532 ' HB2' HD22 ' A' ' 5' ' ' LEU . 46.9 ttt180 -75.64 -32.76 60.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.49 79.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 135' ' ' VAL . 9.6 tp -65.27 -37.73 88.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.793 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.529 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 22.6 m-85 -62.07 -42.71 99.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.761 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.13 -36.25 92.07 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.655 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.62 -48.3 69.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.133 0.492 . . . . 0.0 109.901 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -66.43 -16.45 64.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.584 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m 67.69 30.84 6.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.37 0.605 . . . . 0.0 110.291 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 124' ' ' ARG . 3.5 mt -68.91 152.2 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.778 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.32 101.42 10.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 111.187 -166.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -106.36 120.65 42.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.954 0.407 . . . . 0.0 110.097 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -115.74 120.08 38.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.712 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 tt0 -91.44 132.81 35.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 111.233 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 m -117.75 149.16 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.774 171.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.62 135.14 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 110.631 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -79.44 178.06 2.54 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.526 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.7 Cg_exo -50.08 158.01 2.55 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.229 1.286 . . . . 0.0 111.427 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.54 -70.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' ' 115' ' ' ASN . 0.6 OUTLIER -88.88 -9.7 0.14 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -166.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 68.0 Cg_exo -47.26 -24.32 3.7 Favored 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.535 1.584 . . . . 0.0 110.716 161.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.58 32.29 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.032 169.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.72 105.09 13.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.395 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -104.56 107.33 18.22 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.47 125.7 48.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 19.1 t -116.75 106.46 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.37 116.48 22.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.758 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 5' ' ' LEU . 9.5 mm -87.77 110.82 21.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.82 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.509 ' O ' HG22 ' A' ' 105' ' ' ILE . 1.4 mtt-85 -111.96 106.77 15.55 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.816 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.91 162.3 28.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.64 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.34 -24.83 67.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.332 0.586 . . . . 0.0 110.376 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.24 162.42 33.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.236 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.3 t -80.44 144.39 32.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.47 32.19 14.23 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.529 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.7 m 57.48 68.49 0.84 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.256 0.551 . . . . 0.0 110.537 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.783 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -46.56 -49.89 43.71 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.959 -175.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.783 ' HD3' HG23 ' A' ' 131' ' ' ILE . 93.9 Cg_endo -88.44 107.73 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.33 1.353 . . . . 0.0 112.118 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -76.83 2.15 15.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.108 0.48 . . . . 0.0 110.763 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -90.36 -15.37 31.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.667 ' HA ' HD22 ' A' ' 99' ' ' LEU . 4.0 p -81.58 -14.05 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 139' ' ' LYS . 1.1 tt -87.65 97.54 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.0 pt -75.45 -29.65 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.63 -170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -151.7 146.17 25.58 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.634 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.572 ' HB3' HD12 ' A' ' 136' ' ' ILE . 45.7 pttt -150.32 130.18 13.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.765 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.68 160.7 39.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.889 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 tt -75.74 145.98 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.435 ' HB ' HG12 ' A' ' 92' ' ' ILE . 20.4 tt -125.3 141.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 0.0 110.214 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -149.17 126.6 11.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.552 -177.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 5.1 tt . . . . . 0 C--O 1.238 0.449 0 O-C-N 124.183 0.927 . . . . 0.0 108.952 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 97' ' ' ARG . 53.0 t30 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.03 125.71 35.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.272 -175.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 3.9 mp -100.64 152.39 20.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.81 133.54 36.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.344 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.67 ' HG3' HH11 ' A' ' 7' ' ' ARG . 0.9 OUTLIER -147.69 130.1 15.75 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' HA3' HG21 ' A' ' 92' ' ' ILE . . . -125.23 157.17 19.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.011 -176.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.25 128.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -15.6 18.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.252 0.549 . . . . 0.0 110.214 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -83.34 60.82 5.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.48 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -27.26 19.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -49.33 28.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.449 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.6 OUTLIER -56.65 -43.2 80.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.204 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -33.01 64.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.438 -177.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -79.46 -16.71 55.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.495 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.12 -40.08 24.62 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.631 ' ND2' ' H ' ' A' ' 22' ' ' LYS . 13.0 t30 -89.15 -65.48 1.01 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.88 41.73 8.03 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.55 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -175.53 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.8 mt 53.07 42.62 32.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.52 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.631 ' H ' ' ND2' ' A' ' 18' ' ' ASN . 17.3 ttpp 44.6 74.84 0.73 Allowed Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 123.127 0.571 . . . . 0.0 112.178 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HD3' HD22 ' A' ' 18' ' ' ASN . 71.0 Cg_endo -84.37 161.78 13.0 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.796 2.331 . . . . 0.0 112.947 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.736 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.9 mttm . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -61.33 -23.81 65.99 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.452 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.85 -61.02 2.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.353 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.94 -30.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.032 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -61.88 -50.43 72.27 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.87 88.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.331 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -56.12 -46.62 79.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.262 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.507 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 2.0 tt0 -59.88 -56.08 26.18 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.427 -176.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -74.46 -33.67 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.667 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.47 -63.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.395 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -84.28 -45.33 12.95 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.066 0.46 . . . . 0.0 111.451 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.02 108.78 2.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.068 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -123.06 52.06 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 109.761 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -91.07 38.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.174 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -77.83 -24.09 48.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.99 -14.74 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.017 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.401 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -55.64 -55.73 28.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.499 0.19 . . . . 0.0 110.827 177.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.419 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 16.5 m-85 -127.81 154.45 45.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.21 102.89 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.017 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.14 132.42 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.394 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -135.54 108.53 7.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.19 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.16 164.23 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.23 -176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -35.88 48.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -100.4 132.9 45.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -60.87 -19.65 60.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -54.05 -18.06 3.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.06 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -44.52 -33.61 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.836 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.43 -66.89 0.34 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.154 0.502 . . . . 0.0 112.035 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.17 -37.51 78.22 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.334 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -63.86 -41.74 97.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.113 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.73 -46.46 72.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -57.25 -52.61 64.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.0 m -68.74 -50.63 49.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 m -68.06 -14.82 63.27 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -103.23 4.84 37.15 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.143 -0.348 . . . . 0.0 111.003 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.56 24.53 73.89 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.066 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 82' ' ' ALA . 6.9 mt -81.12 -8.09 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.509 0.195 . . . . 0.0 110.772 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.489 ' O ' HG12 ' A' ' 142' ' ' ILE . 16.9 mt-10 -37.58 -39.04 0.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.637 0.775 . . . . 0.0 112.866 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -109.86 87.64 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.74 -141.2 5.33 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.901 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -134.87 125.86 27.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.472 HG21 ' HA3' ' A' ' 8' ' ' GLY . 2.0 pt -119.89 147.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 2.8 p90 -130.44 148.58 52.27 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.278 0.561 . . . . 0.0 110.608 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 138' ' ' ALA . 2.0 m -113.35 140.22 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.264 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.2 mp -119.59 143.16 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.579 ' HB3' HG21 ' A' ' 137' ' ' ILE . 6.7 t30 -102.55 133.74 47.03 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.657 ' HG2' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -64.82 -42.82 94.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.045 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -34.02 65.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.213 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.09 -50.76 64.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.368 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.4 -29.95 68.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.432 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.98 -47.24 91.35 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.475 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.92 79.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.062 0.458 . . . . 0.0 110.236 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -70.92 -20.16 62.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m 66.24 46.67 1.99 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.507 0.67 . . . . 0.0 110.569 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 125' ' ' ALA . 9.0 mm -79.31 152.15 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.078 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.486 ' HB3' ' HG2' ' A' ' 124' ' ' ARG . 4.2 t80 -75.44 122.61 24.07 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 110.939 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -104.84 106.52 17.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.512 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -103.44 113.42 26.91 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.875 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.27 109.25 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.016 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -88.2 115.69 28.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 137.4 40.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.551 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.01 170.37 9.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.511 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 78.1 Cg_exo -50.21 157.1 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.377 1.384 . . . . 0.0 111.063 173.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.64 -57.73 5.8 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -168.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.456 HD21 ' HA ' ' A' ' 115' ' ' ASN . 0.8 OUTLIER -91.51 -17.55 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -168.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 38.2 Cg_exo -42.23 -22.8 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.37 1.525 . . . . 0.0 111.808 164.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 115' ' ' ASN . 16.9 m-20 68.74 8.51 6.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.102 166.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -111.58 138.04 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -141.6 145.88 35.58 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.547 ' HB3' HG13 ' A' ' 110' ' ' VAL . 1.7 tm-20 -122.12 125.08 45.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.98 95.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.5 m -87.08 113.88 23.21 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.572 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.604 HG13 HD21 ' A' ' 5' ' ' LEU . 48.6 mm -88.25 97.25 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.436 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HG2' ' HB3' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.534 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HA ' HD13 ' A' ' 105' ' ' ILE . . . -69.46 159.65 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' A' ' 131' ' ' ILE . 7.1 mp0 -50.81 -48.24 59.72 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 111.506 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.442 ' H ' HG21 ' A' ' 131' ' ' ILE . 3.6 t0 -119.18 160.43 22.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 0.0 110.074 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.01 128.56 34.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.178 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 93.17 65.16 1.07 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.244 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.03 70.43 0.47 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.565 ' CG2' ' HD3' ' A' ' 132' ' ' PRO . 7.4 tt -68.18 -37.24 10.57 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.649 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.565 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 59.3 Cg_endo -98.52 118.91 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.385 2.057 . . . . 0.0 111.808 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -7.31 53.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.276 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.21 6.91 23.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.193 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.494 ' HB ' HD21 ' A' ' 95' ' ' LEU . 6.0 m -60.31 -22.8 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.554 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.7 mt -87.63 88.22 2.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 109.866 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.579 HG21 ' HB3' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -79.91 -29.77 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -153.81 166.98 31.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.302 172.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.57 159.09 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.074 0.464 . . . . 0.0 110.879 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -141.14 140.75 34.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.019 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -95.09 149.63 21.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 88' ' ' GLU . 16.5 tt -140.99 141.64 31.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.518 . . . . 0.0 111.68 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.568 ' O ' ' HB ' ' A' ' 144' ' ' ILE . 4.8 tt0 -139.01 22.45 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.747 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 143' ' ' GLU . 10.3 tp . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 125.513 1.525 . . . . 0.0 109.096 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -109.49 156.47 20.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.718 0.294 . . . . 0.0 110.826 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.79 HD13 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -99.55 139.9 34.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -106.61 128.29 54.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.676 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 135.66 20.8 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -110.87 158.3 14.46 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.321 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 2.3 mt -113.89 129.32 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.762 0.425 . . . . 0.0 110.161 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.34 25.39 11.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.338 0.589 . . . . 0.0 109.899 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.89 58.98 0.79 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.916 -173.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 mp0 -51.15 -42.4 60.75 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.36 -32.79 73.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.051 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.777 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.4 m-20 -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.961 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -60.38 -45.35 93.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 109.666 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -62.71 -42.72 99.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.51 -43.36 97.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 110.499 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -71.94 -24.85 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.444 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.09 -10.84 72.74 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.262 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -172.6 172.73 4.18 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 mt -65.03 91.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.32 0.387 . . . . 0.0 110.602 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.569 ' HE3' ' SG ' ' A' ' 128' ' ' CYS . 15.2 tptp 74.7 132.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.891 0.744 . . . . 0.0 110.746 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.01 132.64 18.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.298 1.998 . . . . 0.0 111.046 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 2.2 mmmm . . . . . 0 C--O 1.234 0.243 0 CA-C-O 120.662 0.267 . . . . 0.0 110.293 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.296 0.57 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.83 -23.53 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.021 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.2 -60.68 3.23 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.85 -32.77 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.647 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -60.41 -51.4 69.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.37 78.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.79 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -58.19 -50.55 73.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.687 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.545 ' HG3' ' CD2' ' A' ' 68' ' ' TYR . 9.4 mm100 -55.39 -49.01 73.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 mt -74.53 -46.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.493 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -61.96 -48.24 81.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.074 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 3.6 m -77.59 -32.38 53.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.66 53.96 9.18 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.174 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 58' ' ' GLN . 2.7 mp -81.05 -75.87 0.26 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 52.28 39.4 27.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.431 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -90.73 -57.29 2.87 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.713 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.32 -60.4 0.17 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.24 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 74.1 m -51.76 -52.96 44.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.545 ' CD2' ' HG3' ' A' ' 58' ' ' GLN . 18.1 m-30 -120.51 145.05 47.68 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.85 128.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.3 m -87.6 130.82 34.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.79 HG22 HD13 ' A' ' 5' ' ' LEU . 13.4 m -127.74 137.77 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.14 148.01 24.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.453 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.77 10.47 3.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 0.0 111.377 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.75 121.99 28.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -63.0 -19.63 64.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 80' ' ' LYS . 6.9 pt-20 -90.13 0.34 57.21 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.66 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 tt -49.64 -29.83 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.775 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.66 -68.9 0.15 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.908 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -28.45 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . 9.7 tttp -56.23 -49.79 73.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.496 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.18 -49.47 50.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.741 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.9 68.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.485 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -73.74 -48.91 28.36 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.596 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -65.59 -21.37 66.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 m -95.47 0.38 53.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.05 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 31.01 72.43 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.831 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -8.8 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.639 -173.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 142' ' ' ILE . 31.1 mm-40 -40.27 -34.29 0.31 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.487 . . . . 0.0 112.101 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -112.26 96.76 6.2 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.45 -135.52 3.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.022 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.528 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.94 150.31 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.082 0.553 . . . . 0.0 109.609 -175.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.537 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 pt -142.97 133.08 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -131.72 154.97 48.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.1 0.476 . . . . 0.0 111.379 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.529 HG23 ' HB1' ' A' ' 138' ' ' ALA . 32.9 m -129.84 136.63 58.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.459 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -113.64 141.95 46.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.809 -177.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -83.8 143.4 29.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.56 -27.98 21.04 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.689 0.28 . . . . 0.0 111.073 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.0 -33.51 62.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.509 ' O ' ' HB2' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -61.44 -41.57 97.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.064 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.11 -41.23 70.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.043 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.22 91.08 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.05 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -74.73 -43.45 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.0 109.576 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.06 -25.22 66.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.569 -177.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m 67.21 28.63 8.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 110.046 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -66.43 164.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.294 176.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.751 ' HB3' ' HB2' ' A' ' 124' ' ' ARG . 4.0 t80 -73.45 99.35 2.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.293 0.568 . . . . 0.0 110.381 -167.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -95.3 100.02 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.012 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.525 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 4.1 t80 -124.73 113.47 18.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -97.64 142.14 29.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.81 132.07 49.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.469 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 6.5 pt-20 -129.57 136.13 49.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.084 0.468 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 178.06 2.63 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.736 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.76 171.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.028 1.819 . . . . 0.0 112.28 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.9 -67.87 0.23 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.8 t-20 -86.15 -11.08 0.17 Allowed Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -166.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 43.7 Cg_exo -42.35 -25.48 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 121.439 1.55 . . . . 0.0 111.271 162.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.9 3.8 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.656 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.74 130.72 53.26 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 111.646 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 111' ' ' GLU . 17.6 ptmt -150.97 141.62 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.763 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -122.62 132.91 54.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.91 112.42 25.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.924 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 2.7 m -88.78 114.9 25.9 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.779 0.324 . . . . 0.0 110.383 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pt -87.45 113.4 24.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.751 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 23.1 mtt-85 -114.91 88.51 2.88 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.744 -172.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 131' ' ' ILE . . . -69.87 123.23 20.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.583 172.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -51.77 -46.43 64.12 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.386 0.429 . . . . 0.0 111.637 -168.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.705 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 2.0 t70 -80.21 122.66 27.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.569 ' SG ' ' HE3' ' A' ' 22' ' ' LYS . 7.4 t -54.02 119.56 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.459 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.94 56.89 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.936 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.8 m 63.26 74.82 0.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 19.3 tt -45.44 -35.27 3.08 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.618 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 91.9 Cg_endo -96.42 109.1 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 121.595 1.53 . . . . 0.0 111.592 169.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -63.8 -22.78 67.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.392 0.615 . . . . 0.0 109.842 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.21 -7.68 43.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.556 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.3 p -77.26 -15.25 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.078 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.86 89.96 3.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.441 HG13 HG22 ' A' ' 94' ' ' VAL . 14.5 pt -74.74 -30.62 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.275 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 94' ' ' VAL . . . -150.0 148.14 28.69 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.41 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -143.94 127.74 17.26 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.323 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -131.11 152.23 50.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.273 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.57 150.07 23.78 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.7 tt -140.19 135.41 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -120.84 42.82 2.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.241 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.483 -173.705 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.03 155.47 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.261 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.476 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -100.29 146.09 27.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.14 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.532 ' HE1' ' HB ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -113.57 130.96 56.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.744 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.25 126.78 23.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.653 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -109.6 157.84 14.86 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -129.94 132.66 65.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 -177.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -22.22 19.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.401 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -84.8 49.03 1.64 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.499 -177.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.506 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -57.78 -26.11 61.46 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 2.2 pt20 -63.43 -41.48 98.68 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.848 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -69.65 -41.46 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.677 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.93 -55.86 29.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -63.24 -39.51 94.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.072 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.59 -37.33 87.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 110.448 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -23.98 37.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 65.78 14.5 60.79 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 13.2 mt-30 -156.38 172.87 17.76 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.11 42.29 0.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.822 0.344 . . . . 0.0 110.751 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 45.61 59.23 15.03 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.16 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.91 171.71 9.21 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.95 2.433 . . . . 0.0 113.177 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.087 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -53.79 -34.87 60.48 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.6 -57.04 12.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.897 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.6 -34.37 69.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.507 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -58.4 -64.22 1.0 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.109 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.86 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.23 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.642 ' HB3' HD23 ' A' ' 63' ' ' LEU . 1.1 t-80 -64.92 -49.65 69.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.355 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.555 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 35.9 tt0 -66.1 -38.1 87.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.1 -34.4 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.7 -74.22 0.42 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.836 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -64.41 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.484 0.659 . . . . 0.0 111.441 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 58' ' ' GLN . . . 133.75 158.99 8.82 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 57' ' ' HIS . 2.6 pt? -175.96 -44.49 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.066 0.433 . . . . 0.0 111.233 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.435 ' CE2' ' SG ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -114.35 89.26 3.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.752 -174.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.56 134.86 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.725 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.4 -7.56 81.72 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.369 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -73.45 -35.63 65.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.19 0.519 . . . . 0.0 110.58 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.53 160.75 30.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.783 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.708 HG12 ' HB ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -105.06 100.69 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -175.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' THR . 0.0 OUTLIER -85.95 125.23 33.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.611 176.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.638 HG22 HD11 ' A' ' 77' ' ' ILE . 97.3 m -137.44 148.56 46.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 110.541 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.38 170.55 9.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -177.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.21 4.74 9.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.53 135.92 47.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.332 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -66.35 -23.35 66.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.84 -16.13 62.69 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.74 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.638 HD11 HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -48.39 -34.27 5.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 123.387 0.43 . . . . 0.0 110.977 176.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.46 -53.99 51.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -75.11 -40.35 59.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.888 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -59.5 -52.3 66.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.04 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 1.4 t80 -64.74 -45.84 84.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.469 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.547 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -52.36 -59.15 4.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.272 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -64.5 -39.13 93.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -66.71 -26.66 67.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.685 0.279 . . . . 0.0 111.429 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -90.09 2.05 55.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.84 0.352 . . . . 0.0 110.478 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.34 33.36 84.26 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.538 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.547 HG12 ' HB1' ' A' ' 82' ' ' ALA . 1.8 pp -65.44 -9.96 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -29.22 -50.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.181 0.925 . . . . 0.0 112.323 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -118.36 89.66 3.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.48 -149.58 10.25 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.989 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.506 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 6.7 t80 -115.92 145.44 42.9 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.733 0.413 . . . . 0.0 110.524 -175.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.532 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 1.9 pt -143.54 129.46 16.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.422 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 15.5 p90 -130.71 144.36 51.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.102 0.477 . . . . 0.0 111.232 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.763 HG21 ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.95 135.94 46.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.164 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -118.15 130.34 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.131 177.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.58 ' HB3' HD13 ' A' ' 99' ' ' LEU . 59.3 t30 -79.8 141.68 36.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.576 0.227 . . . . 0.0 111.011 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -80.07 -50.95 9.63 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.63 -22.46 65.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 111.088 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 96' ' ' ASN . 18.8 mt -64.15 -37.43 87.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -63.28 -44.27 95.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.698 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.73 -37.47 83.84 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -66.61 -36.64 83.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 110.499 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -83.94 -7.87 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.173 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.0 m 69.56 34.67 2.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.27 0.557 . . . . 0.0 110.791 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 125' ' ' ALA . 1.2 mp -74.22 157.18 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.919 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -77.12 101.22 6.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.114 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.81 99.96 12.87 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -104.65 113.36 26.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -111.06 126.21 54.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 120' ' ' GLU . 3.7 m -108.26 132.01 57.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -111.65 133.77 53.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.577 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.83 174.55 5.76 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.495 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 84.5 Cg_exo -48.37 170.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.447 2.098 . . . . 0.0 113.25 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -40.79 -71.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.1 t-20 -100.13 -9.17 0.13 Allowed Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 47.4 Cg_exo -42.34 -26.98 0.63 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 CA-C-N 121.846 1.695 . . . . 0.0 111.09 165.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.65 26.45 9.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.386 168.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 116' ' ' PRO . 89.8 mt-10 -114.39 118.09 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -124.83 112.59 16.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 110' ' ' VAL . 8.5 tt0 -96.26 106.16 18.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 109.991 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.56 95.86 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.618 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 70' ' ' SER . 0.2 OUTLIER -81.07 107.11 13.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.175 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.708 ' HB ' HG12 ' A' ' 69' ' ' ILE . 23.0 mm -87.85 106.68 16.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.482 ' O ' HG21 ' A' ' 105' ' ' ILE . 37.7 mtt85 -104.46 119.12 38.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.241 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.548 ' HA ' HG13 ' A' ' 105' ' ' ILE . . . -68.9 155.31 40.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.934 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.79 -49.4 62.78 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.313 0.578 . . . . 0.0 110.098 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.47 ' H ' HG23 ' A' ' 131' ' ' ILE . 1.2 t0 -122.35 156.09 34.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.991 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.435 ' SG ' ' CE2' ' A' ' 64' ' ' TYR . 20.5 t -73.07 150.28 42.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 111.236 -175.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.61 51.87 2.97 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.098 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 41.62 70.34 0.28 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.865 0.466 . . . . 0.0 112.243 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.783 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -56.17 -48.5 96.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.755 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.783 ' HD3' HG21 ' A' ' 131' ' ' ILE . 87.1 Cg_endo -100.31 109.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.591 2.194 . . . . 0.0 112.395 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -77.37 -0.48 25.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.665 0.269 . . . . 0.0 111.301 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -87.81 -5.33 58.67 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.291 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.469 HG23 HD22 ' A' ' 95' ' ' LEU . 30.9 m -76.21 -17.25 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.84 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.3 pt -86.11 89.89 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.738 0.78 . . . . 0.0 109.378 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.61 -31.06 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.305 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.763 ' HB1' HG21 ' A' ' 94' ' ' VAL . . . -142.18 146.21 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.415 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -151.66 114.92 4.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.856 177.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.61 160.5 39.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.65 156.63 16.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.034 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 87' ' ' ILE . 13.8 tt -134.16 137.76 51.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -119.83 90.43 3.33 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.028 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 123.528 0.731 . . . . 0.0 111.49 -178.314 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -116.07 150.46 37.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.212 0.53 . . . . 0.0 111.577 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.1 OUTLIER -100.53 151.35 21.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.97 132.57 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -173.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 7' ' ' ARG . 27.6 ttt-85 -140.15 99.39 3.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.406 0.622 . . . . 0.0 109.41 171.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.556 ' H ' ' HE2' ' A' ' 81' ' ' PHE . . . -89.13 154.74 24.67 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 11' ' ' CYS . 39.0 mt -121.16 133.24 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.823 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -122.37 17.68 10.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.47 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.604 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -123.5 46.68 2.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.646 -179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -54.02 -29.79 45.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.752 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -63.99 -42.29 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.073 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -69.13 -45.29 70.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.068 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -38.6 83.44 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.205 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -69.74 -41.98 74.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.9 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.97 -41.25 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -80.41 -27.21 38.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 6.79 85.64 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -164.49 178.37 7.46 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.11 61.08 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.079 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.459 ' HZ2' ' CG ' ' A' ' 14' ' ' ASP . 1.0 OUTLIER 32.76 71.91 0.65 Allowed Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.397 1.079 . . . . 0.0 113.047 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.54 169.85 8.02 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.002 2.468 . . . . 0.0 112.258 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.811 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.712 0.292 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.99 -59.57 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.151 -175.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.29 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.265 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.25 -37.35 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.516 -171.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.7 m-85 -77.58 -42.4 35.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.538 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.66 75.44 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 109.976 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.16 -48.72 69.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 62' ' ' GLY . 1.4 tt0 -57.98 -29.79 65.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.954 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.7 mt -93.56 -52.78 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.337 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -77.13 -49.56 14.96 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.828 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.98 -32.88 24.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.104 0.478 . . . . 0.0 111.244 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 58' ' ' GLN . . . 134.59 172.11 12.71 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 70' ' ' SER . 84.3 mt -58.83 -15.3 11.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 111.507 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 74.31 -28.0 0.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 164.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.79 101.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.999 0.428 . . . . 0.0 111.664 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.49 -112.8 0.31 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.776 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.4 p -76.99 -34.88 57.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.765 -177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -83.15 145.61 29.11 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.459 HD13 HD12 ' A' ' 123' ' ' ILE . 21.4 mt -117.94 128.06 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.39 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HD11 ' A' ' 63' ' ' LEU . 5.3 p -95.22 113.95 25.68 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 5' ' ' LEU . 7.8 p -122.77 144.43 49.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.622 0.249 . . . . 0.0 110.801 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.0 m -87.81 150.2 23.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.831 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -16.06 62.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -79.35 135.52 36.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.858 0.361 . . . . 0.0 110.519 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.601 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 7.5 ttpm? -62.41 -20.9 64.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -72.63 -4.19 29.44 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.4 tt -51.29 -34.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.326 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.5 -58.91 6.52 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.151 0.5 . . . . 0.0 111.068 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.31 -43.52 70.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.058 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.95 -44.54 94.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.225 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.556 ' HE2' ' H ' ' A' ' 8' ' ' GLY . 87.5 t80 -65.98 -55.37 17.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.003 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.43 73.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.671 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -72.73 -45.91 56.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.604 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.1 m -70.7 -17.15 62.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.6 m -92.9 -4.2 53.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.555 0.217 . . . . 0.0 111.001 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 37.6 95.23 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.88 -8.8 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.365 -0.417 . . . . 0.0 111.653 -171.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -42.37 -32.75 0.55 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -119.13 90.79 3.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.49 -145.97 8.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.375 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.603 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -107.68 146.79 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.252 0.221 . . . . 0.0 110.458 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 mt -138.68 118.44 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.89 143.4 50.13 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.75 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.822 HG21 ' HB2' ' A' ' 138' ' ' ALA . 2.4 m -120.75 149.38 23.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-O 121.275 0.56 . . . . 0.0 111.123 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.574 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -122.92 134.91 54.34 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.523 -174.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.53 ' HB2' HD12 ' A' ' 137' ' ' ILE . 31.0 t30 -87.22 115.75 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.714 0.292 . . . . 0.0 110.944 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.44 -30.08 70.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.42 ' HB3' ' OD1' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -63.21 -36.37 83.43 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 134' ' ' GLU . 32.2 tp -69.14 -40.41 78.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -62.5 -34.74 77.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.388 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.74 -39.94 98.0 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.519 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -63.55 -42.1 98.39 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.085 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.484 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 19.4 m-85 -74.07 -16.94 61.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.964 0.412 . . . . 0.0 110.339 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.5 m 65.42 33.8 8.6 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.101 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.557 HG23 ' HA ' ' A' ' 125' ' ' ALA . 75.3 mt -63.23 147.79 11.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.234 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.624 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 1.6 m-85 -75.21 150.13 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 0.0 110.642 -167.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.25 118.05 8.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.585 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.502 ' HD2' ' NH2' ' A' ' 124' ' ' ARG . 72.6 t80 -127.52 117.58 22.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.614 ' HG2' HG21 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -92.5 133.24 36.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.84 -177.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -97.91 134.11 37.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -96.71 133.06 41.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.362 0.601 . . . . 0.0 111.209 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.87 171.81 11.55 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 168.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.5 Cg_exo -46.63 164.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.824 1.682 . . . . 0.0 112.136 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -47.56 -67.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.453 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -87.18 -13.69 0.2 Allowed Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -167.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 31.5 Cg_exo -42.59 -23.63 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 121.454 1.555 . . . . 0.0 111.774 163.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.41 23.67 9.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.895 170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.11 134.87 54.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.88 -172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 11.8 mmmm -125.39 106.57 9.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.065 172.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.557 ' HB3' HG21 ' A' ' 110' ' ' VAL . 2.7 tp10 -79.29 91.92 5.08 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 110.201 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.614 HG21 ' HG2' ' A' ' 109' ' ' GLU . 17.5 t -73.43 98.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -84.16 114.84 22.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.459 HD12 HD13 ' A' ' 69' ' ' ILE . 1.6 pp -86.45 129.66 37.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 109.463 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.624 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.32 108.08 14.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.731 -173.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.557 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -78.45 161.11 27.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.405 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 -6.27 42.3 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.865 0.364 . . . . 0.0 110.455 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.668 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 3.9 t70 -153.48 159.71 42.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 m -85.85 133.51 33.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.899 0.381 . . . . 0.0 111.235 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.38 49.68 2.96 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.447 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 57.76 70.3 0.66 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.816 0.341 . . . . 0.0 111.672 173.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.728 HG22 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -61.61 -45.7 93.62 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.728 ' HD3' HG22 ' A' ' 131' ' ' ILE . 59.1 Cg_endo -70.91 129.95 17.18 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.436 1.424 . . . . 0.0 112.096 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -64.14 -24.92 67.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.046 0.45 . . . . 0.0 110.881 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.497 ' HB3' HD21 ' A' ' 99' ' ' LEU . 3.7 mp0 -88.74 10.63 20.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.574 HG22 HD23 ' A' ' 95' ' ' LEU . 10.0 p -59.31 -31.61 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.937 0.399 . . . . 0.0 111.646 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.8 mt -89.17 88.2 2.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 96' ' ' ASN . 1.1 pt -79.36 -28.4 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.822 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -146.98 141.55 26.57 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.633 171.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.09 124.92 19.7 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.773 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.8 157.14 45.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.74 146.47 36.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.19 135.45 54.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 0.0 111.492 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.94 51.64 2.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.947 177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.327 -178.144 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 2' ' ' GLY . 8.8 tmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.491 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . 77.09 -72.37 2.1 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.617 ' HB2' ' HD2' ' A' ' 97' ' ' ARG . 5.9 m120 -155.08 153.81 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -99.01 114.19 26.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.359 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.5 143.31 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.473 ' HE1' ' HB ' ' A' ' 92' ' ' ILE . 1.3 t80 -138.18 134.01 33.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.538 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.05 141.98 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -127.57 157.78 21.03 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.9 tt -138.42 136.91 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.002 0.43 . . . . 0.0 110.701 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.2 m -100.05 -16.61 17.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.24 0.543 . . . . 0.0 109.976 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -86.89 51.19 2.17 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -21.89 42.95 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.643 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -63.3 -55.72 22.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.717 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.383 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' HG3' HD22 ' A' ' 21' ' ' LEU . 6.3 tm-20 -55.83 -57.29 12.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.813 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -70.17 -29.81 66.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.355 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.06 -43.8 64.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -78.77 -23.91 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.993 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.99 24.39 73.1 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.186 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 5.7 mt-30 -161.54 27.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.126 0.171 . . . . 0.0 110.751 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.48 HD22 ' HG3' ' A' ' 15' ' ' GLU . 15.5 mt 73.57 -43.43 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -164.76 141.97 5.11 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -171.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.63 138.3 79.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.41 2.074 . . . . 0.0 112.071 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.93 166.58 23.0 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.95 75.73 0.13 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -78.44 153.11 31.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.753 0.311 . . . . 0.0 111.678 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.37 -154.25 0.31 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.056 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 74.71 -77.89 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.328 0.651 . . . . 0.0 111.232 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 56.54 61.08 2.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.187 0.517 . . . . 0.0 111.119 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -178.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.857 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.03 -70.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.827 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.5 mm 64.64 122.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.145 0.578 . . . . 0.0 111.615 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -148.08 137.78 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.436 ' HD1' ' HA ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -87.96 68.33 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 110.288 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -70.27 161.8 29.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.043 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.28 -39.81 43.95 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 89.26 3.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 166.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -76.56 62.7 1.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.702 -168.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -79.39 57.7 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -76.87 -19.04 57.93 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.4 -136.93 1.0 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.135 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.8 -122.83 0.64 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.861 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 23.1 mmmt -82.28 -80.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.848 0.356 . . . . 0.0 110.52 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.53 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.931 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.31 158.03 9.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.767 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -112.52 105.6 13.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.831 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.5 -152.73 7.27 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.007 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.24 -172.97 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.254 2.636 . . . . 0.0 112.006 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 50' ' ' VAL . 16.5 m 67.98 117.09 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.64 0.588 . . . . 0.0 111.532 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 49' ' ' SER . 0.3 OUTLIER 61.38 -175.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.92 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.462 ' N ' HG12 ' A' ' 50' ' ' VAL . 19.5 mtpt 68.47 177.64 0.25 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.582 0.706 . . . . 0.0 111.821 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -58.63 -24.61 61.44 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.346 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.83 1.0 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.555 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.421 HG11 ' OH ' ' A' ' 68' ' ' TYR . 2.3 p -69.42 -38.68 77.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.236 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.402 ' CZ ' ' HG3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -62.1 -57.02 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.073 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.05 85.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -58.23 -49.98 75.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -70.72 -35.93 72.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.0 -42.39 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 111.03 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -92.22 -60.25 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.821 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -90.8 -73.25 0.54 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.795 0.331 . . . . 0.0 111.727 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 66.29 3.85 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.254 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 13.6 tp -62.46 90.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.079 0.466 . . . . 0.0 110.907 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 64.1 47.5 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.739 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -15.44 63.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.81 5.56 Favored Glycine 0 C--N 1.329 0.14 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.432 ' SG ' ' CE1' ' A' ' 68' ' ' TYR . 13.9 t -59.01 -50.44 74.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.432 ' CE1' ' SG ' ' A' ' 67' ' ' CYS . 12.1 m-85 -106.33 160.35 15.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.072 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.21 99.49 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -78.82 126.43 30.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.698 179.014 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.415 HG22 HG13 ' A' ' 121' ' ' VAL . 15.4 t -140.21 152.25 45.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.596 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.512 ' H ' HD11 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -89.46 169.11 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.85 10.17 3.59 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -116.79 127.44 54.34 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -69.8 -19.23 63.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.053 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.62 0.47 26.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.512 HD11 ' H ' ' A' ' 72' ' ' THR . 1.2 tt -52.27 -27.08 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.854 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.65 68.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.221 0.534 . . . . 0.0 110.839 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -49.22 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 -177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -62.92 -41.78 99.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.492 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -69.4 -43.52 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.259 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.73 99.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.071 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -69.92 -52.99 19.95 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -65.89 -21.97 66.48 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.509 ' HB2' HG13 ' A' ' 87' ' ' ILE . 12.3 m -97.77 0.06 46.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.45 29.25 74.5 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.505 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.509 HG13 ' HB2' ' A' ' 85' ' ' SER . 4.4 mt -80.3 -8.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 122.811 -0.229 . . . . 0.0 111.06 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.646 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 3.8 tt0 -45.17 -27.52 0.62 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.908 0.385 . . . . 0.0 111.306 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.8 89.98 3.24 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.66 -148.14 12.1 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.233 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -116.68 146.21 42.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.839 0.456 . . . . 0.0 110.306 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.496 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 pt -144.69 141.86 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 6.8 p90 -131.63 152.88 50.48 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.017 0.437 . . . . 0.0 111.2 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.435 HG13 ' HB2' ' A' ' 138' ' ' ALA . 1.5 m -118.83 142.59 33.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.274 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.634 HD21 HG11 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -134.22 142.69 47.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.672 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -98.15 142.18 30.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.617 ' HD2' ' HB2' ' A' ' 3' ' ' ASN . 47.3 ttt180 -77.5 -34.87 54.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.568 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -59.14 -25.77 64.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 0.0 110.822 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 135' ' ' VAL . 22.7 tp -65.46 -41.07 93.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.118 0.485 . . . . 0.0 109.778 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.527 ' CZ ' HG23 ' A' ' 135' ' ' VAL . 5.0 m-85 -66.29 -38.77 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.73 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.4 -41.51 95.25 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.753 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -68.63 -39.1 80.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.288 0.566 . . . . 0.0 110.203 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.551 ' HB3' HG12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.98 -21.65 64.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.759 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m 71.24 32.37 2.21 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.192 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 103' ' ' TYR . 24.6 mm -75.7 146.39 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.307 175.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -87.16 164.08 16.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.711 -171.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.38 138.2 27.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -125.64 113.01 16.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 pt-20 -105.25 119.73 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.535 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 120' ' ' GLU . 1.9 m -90.2 150.36 3.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.56 132.07 55.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.297 0.57 . . . . 0.0 110.925 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 18.5 m80 -81.61 -176.46 0.78 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 90.0 Cg_exo -46.59 158.39 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.328 1.352 . . . . 0.0 111.092 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.61 -44.93 95.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -84.42 -19.77 0.26 Allowed Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -168.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 39.9 Cg_exo -41.87 -22.76 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.532 1.488 . . . . 0.0 111.436 162.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.424 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER 72.58 20.8 3.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.49 166.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.7 150.27 34.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.573 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -129.42 137.31 50.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.228 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.402 ' HB3' HG22 ' A' ' 110' ' ' VAL . 3.2 tm-20 -90.57 111.94 23.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 1.8 p -102.56 102.89 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 110.098 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.9 m -87.41 126.25 34.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.252 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.2 mt -87.59 111.47 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.404 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.659 HH12 ' HA ' ' A' ' 126' ' ' GLU . 1.3 tmm_? -84.22 95.48 8.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.502 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' A' ' 131' ' ' ILE . . . -70.86 155.41 40.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.124 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.659 ' HA ' HH12 ' A' ' 124' ' ' ARG . 22.1 mm-40 -73.44 -4.09 31.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.677 0.275 . . . . 0.0 111.578 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.51 159.49 44.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.9 m -80.36 120.04 23.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.891 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.67 69.2 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.522 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.4 m 55.18 70.83 0.59 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.506 ' CG2' ' HD3' ' A' ' 132' ' ' PRO . 5.2 tt -64.21 -33.82 10.18 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.506 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 45.3 Cg_endo -92.88 126.7 0.69 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.008 1.805 . . . . 0.0 111.679 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -85.18 -29.07 25.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.924 0.392 . . . . 0.0 111.054 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.53 10.56 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.384 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.634 HG11 HD21 ' A' ' 95' ' ' LEU . 9.3 p -72.37 -16.11 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.256 0.551 . . . . 0.0 111.011 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.476 HD11 HD13 ' A' ' 21' ' ' LEU . 5.8 pt -88.3 89.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.1 pt -73.21 -19.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.836 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.435 ' HB2' HG13 ' A' ' 94' ' ' VAL . . . -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.598 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -130.14 125.23 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.81 153.97 48.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 tt -99.84 157.66 16.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.2 tt -136.05 129.27 47.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.262 0.553 . . . . 0.0 112.34 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 78.95 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.462 173.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.646 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 70.9 mt 66.44 108.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.069 0.548 . . . . 0.0 111.342 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -81.96 66.21 7.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.503 0.668 . . . . 0.0 110.195 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.1 tp -78.59 164.1 24.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.874 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 70.48 -158.15 0.14 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.8 m170 69.56 -71.72 0.12 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.469 0.708 . . . . 0.0 111.021 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -95.79 0.34 52.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 111.096 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.61 69.16 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 110.234 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -68.17 -31.53 71.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -168.89 -42.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.313 173.689 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.73 -171.45 21.9 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.151 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.566 ' HA ' ' NH1' ' A' ' 97' ' ' ARG . 64.6 t30 -177.94 -82.17 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -131.76 122.73 26.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 69' ' ' ILE . 5.1 mp -100.51 130.64 46.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.29 129.39 55.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.6 OUTLIER -142.04 151.88 42.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -133.92 156.96 22.6 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.707 HG23 ' HB3' ' A' ' 91' ' ' TYR . 6.4 tt -144.04 141.0 25.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.181 0.515 . . . . 0.0 111.003 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -25.14 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.522 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.6 51.94 1.78 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 110.076 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 10.7 pt20 -52.48 -33.93 46.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -76.22 -37.49 57.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.879 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -39.62 93.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.879 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.12 -43.56 98.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.092 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 12' ' ' GLN . 66.7 mm-40 -67.18 -34.02 76.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.86 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.31 -32.99 55.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.563 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -92.4 -46.17 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.79 12.33 81.57 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.559 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.74 6.87 1.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.017 0.408 . . . . 0.0 111.173 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER 61.83 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.536 0.522 . . . . 0.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 56.59 118.23 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.705 1.202 . . . . 0.0 112.381 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.72 111.26 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.192 2.595 . . . . 0.0 112.593 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HZ2' ' CD ' ' A' ' 133' ' ' GLU . 48.9 pttt -67.34 169.25 9.18 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.983 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.82 -105.25 0.72 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.502 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -179.39 -172.55 0.23 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.42 -177.11 4.51 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.237 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -158.35 133.37 8.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -86.36 -31.95 21.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 0.0 110.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.2 m -79.85 90.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.488 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.22 162.94 0.18 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.568 ' HA ' ' HG2' ' A' ' 51' ' ' LYS . 26.7 mm -74.31 137.93 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.964 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -110.15 136.63 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.06 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.459 ' HB2' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -127.36 135.66 50.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.813 -177.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' HB2' HD21 ' A' ' 52' ' ' ASN . 11.0 t0 -95.46 103.14 14.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.69 -154.03 25.25 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -115.86 79.13 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.3 0.571 . . . . 0.0 110.35 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.92 120.64 6.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.645 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -104.18 141.49 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.459 ' OH ' ' HB2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -156.24 -156.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.29 179.24 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -159.17 48.97 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.351 0.596 . . . . 0.0 109.939 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.62 135.06 28.51 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.913 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -142.63 53.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 127' ' ' ASP . . . -132.79 169.4 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m 65.22 73.75 0.4 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.61 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 78.56 0.66 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.931 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.51 -163.54 20.38 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -87.44 -173.96 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.04 2.493 . . . . 0.0 111.56 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m 55.64 -134.66 1.41 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.353 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.838 HG11 ' HG3' ' A' ' 51' ' ' LYS . 2.4 p 46.78 -158.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.201 0.6 . . . . 0.0 111.13 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.838 ' HG3' HG11 ' A' ' 50' ' ' VAL . 44.3 mttt 47.2 -127.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.148 0.431 . . . . 0.0 111.224 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.425 HD21 ' HB2' ' A' ' 35' ' ' ASP . 8.9 m120 -54.26 -39.05 66.49 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.741 0.305 . . . . 0.0 111.03 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.89 -50.38 66.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.226 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.784 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 8.6 p -67.25 -39.06 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.643 0.258 . . . . 0.0 111.009 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.4 ' O ' HG13 ' A' ' 59' ' ' ILE . 11.9 m-85 -65.38 -51.35 61.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.38 90.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.975 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -64.81 -34.54 78.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.582 ' HG3' ' HD2' ' A' ' 68' ' ' TYR . 1.6 tm0? -60.83 -53.19 60.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 55' ' ' TYR . 19.4 mt -71.82 -41.38 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.053 -176.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.1 -67.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.068 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.4 -71.21 0.62 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.963 0.411 . . . . 0.0 110.845 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.4 138.98 3.82 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -152.71 47.37 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -90.07 6.67 41.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.854 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -100.91 -30.57 11.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.16 -72.39 0.19 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.223 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.95 -52.27 65.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.582 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 18.8 m-30 -117.61 161.06 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.601 HD13 HD22 ' A' ' 5' ' ' LEU . 3.4 tt -126.98 132.88 69.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.667 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.7 p -106.75 140.58 39.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.829 0.347 . . . . 0.0 110.722 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -129.07 133.6 47.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.845 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.483 ' HG1' ' HB ' ' A' ' 77' ' ' ILE . 4.4 p -74.51 163.88 27.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -18.13 58.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -99.65 135.71 40.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.961 0.41 . . . . 0.0 111.79 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.71 -20.79 61.94 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.009 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -69.33 -3.5 14.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.366 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.483 ' HB ' ' HG1' ' A' ' 72' ' ' THR . 3.9 tt -57.08 -34.46 45.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.245 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.22 -63.19 1.39 Allowed 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.757 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -67.73 -43.26 80.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.046 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.77 -46.96 85.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.088 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 17.8 t80 -64.55 -48.78 73.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.532 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -56.38 -59.72 4.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.165 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -64.92 -33.63 76.48 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.499 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m -73.03 -23.37 60.59 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.003 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m -84.05 -7.84 59.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.887 0.375 . . . . 0.0 110.025 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.47 39.8 98.1 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -68.05 -10.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -32.54 -35.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.954 0.784 . . . . 0.0 112.343 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.59 88.97 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.14 -152.67 19.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.604 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.707 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.7 t80 -119.65 150.63 40.01 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.534 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.4 tt -149.06 135.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.516 0.198 . . . . 0.0 110.589 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 15.8 p90 -131.46 156.32 45.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.174 0.512 . . . . 0.0 112.078 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG21 HG13 ' A' ' 137' ' ' ILE . 34.2 m -125.8 141.45 45.5 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.667 HD23 HG11 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -125.01 143.23 51.01 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.085 -175.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.427 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.9 t-20 -99.65 140.63 33.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.566 ' NH1' ' HA ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -67.83 -46.04 72.95 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 -178.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.24 -33.71 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 135' ' ' VAL . 25.1 mt -64.0 -50.93 66.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.274 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.88 -41.01 95.98 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.93 -48.13 84.41 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.021 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.14 -32.86 71.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.452 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -68.8 -18.68 64.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.872 0.367 . . . . 0.0 110.172 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m 70.63 34.27 2.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.033 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -73.87 156.01 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.75 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 11.5 m-85 -76.6 101.25 5.63 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.607 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.75 115.89 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.238 0.542 . . . . 0.0 109.909 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.53 ' HB2' ' HD2' ' A' ' 124' ' ' ARG . 2.4 t80 -125.74 111.56 15.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.816 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -94.93 113.07 24.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.824 0.345 . . . . 0.0 110.174 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 120' ' ' GLU . 1.4 m -89.31 125.5 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.81 131.99 53.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.327 0.584 . . . . 0.0 110.552 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.7 m80 -79.21 -178.39 1.09 Allowed Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 88.9 Cg_exo -46.85 164.33 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.587 1.524 . . . . 0.0 112.166 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -49.11 -66.93 0.31 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -170.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -89.05 -9.66 0.14 Allowed Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 115.84 1.792 . . . . 0.0 115.84 -165.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 37.3 Cg_exo -42.53 -22.82 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.446 1.552 . . . . 0.0 112.017 163.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.1 33.81 3.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.29 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -144.41 127.35 16.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -123.81 102.2 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.513 ' HB2' HG21 ' A' ' 110' ' ' VAL . 57.0 mt-10 -73.65 98.09 2.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.216 0.531 . . . . 0.0 110.744 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 24.0 t -69.07 95.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.924 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 13.1 m -88.17 114.07 24.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 69' ' ' ILE . 4.9 mp -87.09 111.12 21.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.809 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.75 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 19.8 mtt180 -93.2 104.06 16.27 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.918 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 131' ' ' ILE . . . -69.62 144.03 53.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.15 -60.07 4.16 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.235 0.54 . . . . 0.0 109.756 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.839 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 16.1 t70 -87.72 127.95 35.3 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.787 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 51.9 t -52.79 113.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.505 0.503 . . . . 0.0 111.833 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.418 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . . . 91.23 67.47 1.16 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.433 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.2 m 58.6 72.66 0.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.858 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.09 -50.97 25.63 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.858 ' HD3' HG21 ' A' ' 131' ' ' ILE . 87.2 Cg_endo -97.83 116.0 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.498 2.132 . . . . 0.0 112.431 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.431 ' CD ' ' HZ2' ' A' ' 24' ' ' LYS . 2.2 pm0 -70.57 -5.14 26.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.37 -8.81 56.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.18 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.667 HG11 HD23 ' A' ' 95' ' ' LEU . 9.1 p -71.58 -14.05 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.638 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.404 ' O ' HG13 ' A' ' 136' ' ' ILE . 17.2 pt -87.76 92.91 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.501 HG13 HG21 ' A' ' 94' ' ' VAL . 27.7 pt -63.87 -30.99 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.905 -173.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.58 160.71 40.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.13 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -148.41 150.8 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.838 175.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -142.36 154.28 44.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -111.91 146.25 38.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 tt -140.66 118.93 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 111.097 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -118.04 68.6 0.77 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.364 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.6 mt 63.36 119.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.799 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -79.1 -21.14 47.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.67 107.67 18.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.979 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 53.84 63.57 2.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.25 0.548 . . . . 0.0 110.795 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -58.26 -25.53 61.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.146 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -127.0 76.05 1.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -45.4 116.85 1.24 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.491 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -82.82 98.49 9.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.545 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -70.37 86.97 0.61 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.308 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.571 176.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 140.84 124.95 2.1 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.421 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 97' ' ' ARG . 7.3 t-20 -172.56 152.0 2.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -98.6 130.91 45.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.513 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 97' ' ' ARG . 44.2 mt -112.91 135.19 53.95 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -131.87 124.46 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.87 132.77 20.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.19 157.58 15.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.405 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 91' ' ' TYR . 5.3 tt -135.38 142.12 40.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.004 0.43 . . . . 0.0 110.216 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.74 -32.03 13.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.01 51.68 2.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.527 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 2.6 pt20 -55.13 -27.1 42.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.273 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -68.88 -49.21 60.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.93 -36.4 83.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.177 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.82 -58.18 9.75 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.358 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.35 -26.45 63.74 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -54.93 27.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.871 0.367 . . . . 0.0 110.037 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -73.52 -22.75 60.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.64 15.66 65.42 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.552 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -168.55 140.79 2.81 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 49.54 0.97 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.192 0.52 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 128' ' ' CYS . 29.8 tttp -168.64 126.41 0.89 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.382 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.85 -59.87 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.419 2.08 . . . . 0.0 111.868 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -174.41 159.53 3.06 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.329 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 162.94 36.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.174 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -159.12 137.33 10.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' ' 126' ' ' GLU . 6.5 pttp -113.46 160.64 18.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.427 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.6 78.49 0.48 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -68.65 88.42 0.35 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.729 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.75 13.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 110.55 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.41 -177.7 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.521 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.67 HD13 ' HE2' ' A' ' 51' ' ' LYS . 4.9 mt 64.04 155.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.892 0.745 . . . . 0.0 111.688 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ttp-105 -175.2 97.24 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.186 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.89 -46.13 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 t0 62.62 -162.22 0.28 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.42 -93.57 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.289 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -80.06 -43.75 21.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.623 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 40' ' ' TYR . 16.6 p90 -146.68 141.2 26.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -60.24 3.76 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.026 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.429 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 2.3 t80 63.16 79.67 0.25 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 1.3 p30 -125.77 -56.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.945 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.01 -85.76 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 170.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -157.53 155.9 31.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 111.021 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.13 -44.84 0.07 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.044 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 106.52 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.705 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.0 m170 55.71 29.25 13.45 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.036 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.48 69.36 0.45 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.737 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.57 -42.13 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.642 2.228 . . . . 0.0 112.007 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.93 69.96 6.4 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.155 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 51' ' ' LYS . 3.1 p -167.85 -49.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.059 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.67 ' HE2' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.88 -99.82 0.0 OUTLIER 'General case' 0 C--O 1.24 0.569 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 -171.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' H ' ' HB2' ' A' ' 51' ' ' LYS . 13.6 t-20 -64.65 -22.9 67.09 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.66 -67.27 0.32 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.357 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -33.46 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.53 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.439 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 2.3 m-85 -63.92 -64.64 0.84 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.48 84.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -59.19 -54.28 48.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.694 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 4.4 pt20 -61.07 -37.2 81.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.03 -37.4 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.753 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.27 -23.97 34.98 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 p -87.95 -49.44 7.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.136 0.493 . . . . 0.0 110.803 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.39 -71.53 0.19 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD22 ' CE1' ' A' ' 64' ' ' TYR . 6.8 mt -159.53 76.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.152 0.501 . . . . 0.0 109.782 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.515 ' CE1' HD22 ' A' ' 63' ' ' LEU . 2.0 p90 45.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.684 1.194 . . . . 0.0 112.986 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 6.2 p-10 166.59 -45.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.912 -168.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' N ' ' HD2' ' A' ' 64' ' ' TYR . . . 166.07 -8.01 0.06 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.993 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.62 -28.01 63.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.996 0.398 . . . . 0.0 111.57 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -118.85 163.58 16.68 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.447 HG23 ' HB ' ' A' ' 123' ' ' ILE . 1.4 tt -121.07 119.04 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.284 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 13.0 m -99.45 131.56 45.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.869 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 t -119.04 170.37 9.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.189 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -122.82 152.51 40.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HG1' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -59.66 -14.06 12.32 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 177.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.2 108.04 18.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -59.46 -18.01 36.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.594 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -79.07 -2.32 39.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.828 0.347 . . . . 0.0 110.465 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.3 tt -51.26 -29.36 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.788 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.27 -60.14 3.93 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.804 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.413 ' NZ ' ' OG1' ' A' ' 83' ' ' THR . 0.4 OUTLIER -70.57 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.111 -175.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -62.3 -45.62 92.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.978 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -63.38 -49.18 74.83 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.849 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 -55.26 25.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.942 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.413 ' OG1' ' NZ ' ' A' ' 79' ' ' LYS . 29.8 m -62.66 -35.91 81.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -66.33 -27.81 68.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.5 m -93.82 -0.3 55.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.97 40.44 90.97 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.51 -9.57 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.36 -172.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.663 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 mp0 -41.68 -28.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.328 0.651 . . . . 0.0 112.146 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -123.63 90.62 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.97 -150.92 12.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.274 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.644 ' HB3' HG21 ' A' ' 9' ' ' ILE . 6.2 t80 -121.93 149.58 43.23 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.566 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -141.47 143.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -131.53 144.05 50.83 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.199 0.524 . . . . 0.0 111.187 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 137' ' ' ILE . 17.9 m -118.64 138.85 48.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.561 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.553 HD23 HG11 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.08 142.79 51.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.867 -171.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -79.94 114.24 18.71 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.503 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -69.41 -33.52 73.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.745 -176.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.11 -26.66 66.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.628 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.11 -46.01 89.33 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -60.84 -38.47 85.59 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.47 -43.73 97.26 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.917 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -39.67 93.07 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.068 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -71.06 -18.29 62.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.434 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.3 m 69.86 39.34 1.46 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -68.47 160.83 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.413 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -78.4 99.0 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -170.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -103.18 100.14 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -100.67 116.14 31.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.074 0.464 . . . . 0.0 110.069 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.471 ' HB2' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -85.22 138.25 32.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.613 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.68 144.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 145.91 47.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.32 170.59 15.4 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.861 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -45.67 170.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.657 2.238 . . . . 0.0 113.36 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -47.08 -53.82 11.85 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -170.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.504 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.2 t-20 -98.72 -17.05 0.2 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 34.2 Cg_exo -40.83 -26.39 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 120.993 1.39 . . . . 0.0 111.34 162.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 77.5 -11.35 1.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.901 163.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -113.3 159.34 19.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.297 0.57 . . . . 0.0 112.043 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 109' ' ' GLU . 29.6 tttp -131.87 122.34 25.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -104.48 115.13 29.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.155 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.83 113.37 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.154 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 14.3 m -81.4 117.71 22.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.776 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.447 ' HB ' HG23 ' A' ' 69' ' ' ILE . 15.0 mm -87.84 98.27 7.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.751 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -89.19 102.63 15.29 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.041 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 131' ' ' ILE . . . -69.84 152.32 44.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.758 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' ' 27' ' ' LYS . 40.3 mt-10 -59.4 -41.9 90.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.469 ' HB3' HG21 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.07 145.02 50.12 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.07 176.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.411 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 1.4 t -64.02 133.77 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.55 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.05 70.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.546 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.9 m 56.89 72.9 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -43.95 -55.38 9.35 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.415 173.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 63.6 Cg_endo -95.62 114.95 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.931 2.421 . . . . 0.0 112.218 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.59 -22.65 66.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.103 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -77.19 -15.34 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.553 HG11 HD23 ' A' ' 95' ' ' LEU . 2.6 p -69.69 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.34 92.15 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.493 HG13 HG21 ' A' ' 94' ' ' VAL . 24.6 pt -67.83 -27.89 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.945 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.36 157.8 36.29 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.946 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -150.49 140.88 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.273 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.53 160.34 40.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.774 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -112.57 149.11 33.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.744 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.4 tt -141.26 138.87 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -125.79 31.6 5.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.668 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.663 HG12 ' HB3' ' A' ' 88' ' ' GLU . 42.6 mt 61.21 -76.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.642 0.377 . . . . 0.0 110.02 -171.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.486 ' OD1' ' HA ' ' A' ' 148' ' ' HIS . 31.9 t30 54.71 71.79 0.51 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.644 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.2 tp -88.93 -58.49 2.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.746 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 148' ' ' HIS . 6.8 pt-20 -96.85 1.18 50.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.718 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.486 ' HA ' ' OD1' ' A' ' 145' ' ' ASN . 51.2 m170 72.65 -65.35 0.36 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.398 0.679 . . . . 0.0 110.268 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -144.36 140.13 28.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -79.65 54.8 1.86 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.201 0.524 . . . . 0.0 111.191 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -77.01 98.02 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.726 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.58 -50.13 40.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 73.7 t60 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.45 -177.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.39 154.03 42.24 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.25 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -82.02 27.83 0.46 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.219 0.208 . . . . 0.0 111.442 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 t80 66.15 112.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.546 0.528 . . . . 0.0 111.947 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD23 HG21 ' A' ' 71' ' ' THR . 13.4 mt -99.82 124.87 45.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -115.75 124.03 49.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.475 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -145.92 156.95 43.87 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -122.23 155.92 16.88 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.945 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 34.9 mt -109.38 143.92 18.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -35.58 75.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.764 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t 177.69 155.62 0.33 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 110.035 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.7 -32.05 68.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.999 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.671 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.42 -42.72 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.023 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' HG3' HG23 ' A' ' 9' ' ' ILE . 48.8 mt-10 -55.01 -60.46 3.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.189 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.8 -41.86 78.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.213 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.18 -31.43 72.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.439 . . . . 0.0 110.785 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.03 -13.87 40.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.212 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.33 7.17 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.028 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 72.7 81.87 0.13 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.53 0.732 . . . . 0.0 110.672 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 4.2 mm? 64.64 37.53 7.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.984 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER 73.15 152.88 0.15 Allowed Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.79 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.76 118.15 5.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.628 2.218 . . . . 0.0 111.905 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -174.72 4.55 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 164.65 -143.58 8.65 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.859 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -165.56 157.25 14.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -128.08 -43.39 1.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 -145.04 0.27 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.498 0.319 . . . . 0.0 110.694 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -174.67 -55.83 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -83.23 -162.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.672 171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 43' ' ' LYS . . . -53.12 163.06 0.58 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.276 0.56 . . . . 0.0 111.822 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 1.2 mm -114.9 163.74 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.891 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 2.0 tpm_? -96.13 99.78 11.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 169.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -166.23 101.1 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.31 178.99 7.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.98 -136.0 12.98 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.976 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -57.77 -42.94 85.1 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.887 0.375 . . . . 0.0 110.927 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 38' ' ' PHE . 2.8 m-30 -76.83 -31.74 57.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.2 tptp 52.61 47.22 25.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 111.633 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 19.6 m-30 -85.82 124.55 32.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -88.17 -96.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -173.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.19 123.35 7.67 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.642 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 16.9 tttt -77.77 78.66 4.27 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 69.28 -72.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.0 m -155.15 -61.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -139.64 144.02 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.027 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.2 96.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.321 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.67 -28.59 37.24 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.884 2.389 . . . . 0.0 110.984 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 p -68.35 91.22 0.38 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.702 HG23 ' H ' ' A' ' 51' ' ' LYS . 1.6 p -175.08 -166.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.544 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -45.46 -48.88 13.85 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.018 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 10.9 t30 -45.04 -55.18 5.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.145 0.498 . . . . 0.0 111.287 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.65 21.82 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.328 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 10.8 p -63.59 -31.38 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.013 -175.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.459 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 2.3 m-85 -65.0 -58.99 4.66 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.76 63.28 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.823 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.514 ' NE2' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -64.31 -47.04 80.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.696 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.537 HE21 ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -62.58 -40.44 96.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.396 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.6 mt -82.82 -40.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.562 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -65.5 -50.54 64.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.609 ' HB ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.28 -21.57 39.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.119 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.53 76.3 0.73 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.587 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.609 HD22 ' HB ' ' A' ' 61' ' ' THR . 1.8 pt? -148.44 59.84 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.6 0.714 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 -24.19 65.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.006 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.443 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 6.7 p-10 -73.22 -12.6 60.93 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.687 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.91 -92.74 0.33 Allowed Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.541 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 80.8 m -69.5 -34.97 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.485 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 22.0 m-85 -95.51 158.47 15.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.332 -172.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.637 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 5.3 mp -89.52 97.83 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -83.39 119.14 24.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.168 -178.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.519 HG21 HD23 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -140.32 155.37 46.84 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.953 0.406 . . . . 0.0 111.049 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -87.83 156.46 19.38 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -32.39 73.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -88.68 133.37 34.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -63.97 -19.47 65.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.67 -2.21 6.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.269 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -57.75 -27.2 29.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.209 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.46 -63.18 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.071 0.462 . . . . 0.0 112.017 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -66.8 -43.85 82.78 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.873 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.269 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -70.82 -52.47 20.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.067 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -56.99 -42.59 80.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.426 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -76.23 -50.35 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.559 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -64.68 -26.24 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -91.6 0.25 57.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.192 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.89 32.64 73.86 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.533 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 87' ' ' ILE . 7.0 mt -73.1 -7.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.686 ' HG3' HD12 ' A' ' 144' ' ' ILE . 38.0 tp10 -28.76 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.715 1.206 . . . . 0.0 113.231 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -130.07 90.17 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.1 -157.7 20.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.181 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.624 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 8.2 t80 -117.63 153.56 33.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.503 0.321 . . . . 0.0 110.451 -176.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.557 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 29.3 mt -132.53 140.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.433 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 16.8 p90 -131.96 134.3 45.48 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.28 0.562 . . . . 0.0 110.856 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.6 134.72 63.15 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.031 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.44 HD23 ' HE2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -122.15 143.19 49.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.738 -173.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -82.3 125.41 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' PHE . 61.7 ttp85 -70.3 -45.06 67.06 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -22.58 66.83 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 -175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 135' ' ' VAL . 4.8 tp -65.5 -32.67 74.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 10.6 m-85 -66.49 -44.57 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.65 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.7 -42.57 91.28 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.655 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -43.25 96.77 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 109.932 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 3.1 m-85 -62.73 -23.01 66.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.378 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m 72.98 23.6 2.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.127 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.482 HG13 ' HB3' ' A' ' 103' ' ' TYR . 3.8 mt -70.91 148.14 10.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.074 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.775 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 22.4 m-85 -78.15 105.23 9.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.946 0.403 . . . . 0.0 111.041 -166.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.19 109.89 20.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 124' ' ' ARG . 7.5 t80 -129.72 128.28 42.16 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.057 0.456 . . . . 0.0 110.336 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.52 155.07 22.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.831 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 m -129.63 145.97 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.19 174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -113.42 136.13 53.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.171 0.51 . . . . 0.0 110.646 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -79.92 -174.68 0.51 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.553 175.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 95.6 Cg_exo -46.91 169.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.026 1.817 . . . . 0.0 113.181 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.31 -65.58 0.54 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -98.81 -8.59 0.12 Allowed Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -167.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 115' ' ' ASN . 63.1 Cg_exo -43.93 -27.12 1.57 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 121.562 1.594 . . . . 0.0 111.083 164.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 65.58 20.78 11.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.356 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.65 123.73 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.11 0.481 . . . . 0.0 111.128 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HD3' ' HB3' ' A' ' 111' ' ' GLU . 6.7 ttpt -121.41 112.48 18.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.124 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.48 121.43 26.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.268 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.02 98.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.641 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.523 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -94.97 121.1 36.23 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.29 -178.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.637 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 24.6 mm -86.94 101.73 11.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.474 0.654 . . . . 0.0 109.765 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.775 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 2.2 mmt180 -77.5 95.08 4.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.94 161.49 30.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.712 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' NZ ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -60.76 -47.2 87.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.831 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.75 160.85 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.09 144.33 40.53 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.627 0.58 . . . . 0.0 111.896 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.6 41.59 6.79 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.865 -0.607 . . . . 0.0 114.262 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.57 71.52 0.44 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.068 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.736 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.44 -45.94 33.29 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.736 ' HD3' HG21 ' A' ' 131' ' ' ILE . 70.8 Cg_endo -91.27 128.46 1.2 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.938 1.759 . . . . 0.0 113.033 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.34 -33.49 49.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 61.0 mt-10 -63.27 -22.47 66.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.634 -173.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.636 ' HA ' HD23 ' A' ' 99' ' ' LEU . 5.0 p -70.48 -19.47 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 111.233 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.6 mt -86.96 92.06 3.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 pt -67.59 -32.03 55.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.187 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -157.38 159.38 37.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.316 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.615 ' HD2' ' HE2' ' A' ' 91' ' ' TYR . 7.3 mtmp? -130.34 131.2 45.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.397 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -118.03 161.06 20.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.245 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 tt -122.19 147.47 46.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.3 tt -130.67 124.22 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.231 0.539 . . . . 0.0 110.473 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.02 57.96 1.53 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.528 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.686 HD12 ' HG3' ' A' ' 88' ' ' GLU . 16.3 mm 69.45 119.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -80.95 -164.97 0.81 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.714 HD21 ' H ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -88.7 -9.59 51.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.09 157.77 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.882 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -82.67 151.4 26.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.677 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.512 ' HE2' HG21 ' A' ' 144' ' ' ILE . 14.5 m-70 -121.89 163.84 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.114 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.05 79.52 0.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.176 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -173.36 -58.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.864 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -173.68 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.165 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.066 174.121 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mmt . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.168 0.509 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.32 170.28 29.85 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.361 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -161.11 156.23 24.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -98.53 120.96 39.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.145 -172.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.451 HD11 ' HE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -121.29 142.38 50.0 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -113.53 139.3 49.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.528 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.86 157.56 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -128.76 157.54 21.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.809 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.856 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 54.2 mt -118.56 128.8 75.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 122.866 0.466 . . . . 0.0 110.164 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -25.19 16.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.08 0.467 . . . . 0.0 110.497 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.5 p -97.95 53.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.718 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -54.78 -26.42 34.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.065 -178.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -75.31 -50.84 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.108 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 1.5 t70 -59.62 -46.33 89.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.058 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.45 ' CD ' ' HZ1' ' A' ' 139' ' ' LYS . 4.3 tm-20 -57.51 -58.88 6.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.616 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -65.91 -26.98 67.86 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.421 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.72 -43.52 79.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.043 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.36 -24.52 46.4 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.52 70.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.594 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.679 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -174.37 173.78 2.93 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.7 mt -79.47 44.65 0.62 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.359 0.264 . . . . 0.0 111.045 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm 49.29 73.73 0.94 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.795 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 97.5 Cg_endo -76.16 63.94 6.99 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.04 2.493 . . . . 0.0 112.795 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 63.32 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.928 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.27 83.33 0.35 Allowed Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.547 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -119.53 104.05 9.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -145.75 169.41 18.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.97 133.73 10.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.554 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -156.26 137.61 13.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.414 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.55 62.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.298 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.58 -52.95 0.07 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -78.51 75.75 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.014 0.435 . . . . 0.0 111.231 -173.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 136.77 55.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.009 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -112.45 56.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.313 0.577 . . . . 0.0 110.051 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.27 -43.18 57.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.932 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.73 -43.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.57 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.33 88.55 0.08 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.71 87.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.109 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -148.21 -170.01 3.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.001 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.42 169.3 9.87 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.85 -160.27 0.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.87 123.09 30.68 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.779 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HG3' ' HB2' ' A' ' 29' ' ' GLU . 2.5 ttmm -176.56 -49.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.044 0.45 . . . . 0.0 109.814 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.96 82.05 1.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.346 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -75.51 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -78.75 74.15 5.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.114 0.483 . . . . 0.0 110.188 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.49 125.93 1.7 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.567 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -84.7 -29.97 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.122 2.548 . . . . 0.0 112.511 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -73.32 156.72 38.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.741 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t 57.46 -126.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.631 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.489 ' O ' HG13 ' A' ' 54' ' ' VAL . 6.9 tttt 60.36 -166.79 0.19 Allowed 'General case' 0 C--O 1.244 0.763 0 CA-C-O 122.003 0.906 . . . . 0.0 112.587 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 13.6 p-10 -61.13 -16.88 49.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.262 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.82 -55.36 30.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 51' ' ' LYS . 4.3 p -67.96 -35.56 72.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 34.3 m-85 -59.62 -61.52 2.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.9 0.381 . . . . 0.0 110.251 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.962 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -56.18 -43.34 78.34 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.272 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -65.1 -53.57 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mt -63.76 -30.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.638 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.84 -64.42 1.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.897 0.38 . . . . 0.0 111.713 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 m -93.94 -64.6 1.06 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.8 -105.41 0.06 OUTLIER Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 114.232 -170.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 7.6 tp 61.0 34.33 19.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.762 0.791 . . . . 0.0 109.583 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.555 ' H ' ' HD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -84.5 11.83 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.356 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 t70 69.59 -143.98 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.99 -78.66 0.52 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.568 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.42 -37.03 85.7 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 109.983 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.414 ' CE1' ' HG2' ' A' ' 124' ' ' ARG . 21.5 m-85 -126.93 142.62 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.758 HG13 ' HB ' ' A' ' 123' ' ' ILE . 5.6 pt -105.42 111.11 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 111.355 -169.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 1.5 m -91.39 131.15 37.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.9 t -132.86 143.38 49.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.235 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.497 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.79 153.25 33.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.929 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -172.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -117.85 136.02 53.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.655 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -52.77 -18.77 2.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.262 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -48.86 -30.12 5.44 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.942 0.401 . . . . 0.0 110.773 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 72' ' ' THR . 1.1 tt -48.17 -37.5 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.694 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.54 68.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.018 0.437 . . . . 0.0 111.332 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -73.52 -43.44 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.895 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -57.96 -47.69 82.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.983 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -66.29 -56.98 8.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.285 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.17 74.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.06 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -81.85 -48.67 11.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.637 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -70.73 -18.87 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 m -99.6 0.8 42.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.0 110.506 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.28 29.92 66.75 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.768 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -13.81 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.957 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.442 ' O ' HG12 ' A' ' 142' ' ' ILE . 2.3 tt0 -48.64 -26.09 2.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.789 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.421 ' HB2' HG13 ' A' ' 144' ' ' ILE . 4.3 t30 -108.13 95.66 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.433 -0.167 . . . . 0.0 110.596 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.52 -127.95 2.52 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.007 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.856 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 1.7 t80 -124.23 151.6 43.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.492 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 11.1 pt -139.69 133.63 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.228 0.211 . . . . 0.0 110.483 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 22.0 p90 -131.22 137.37 48.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.378 0.609 . . . . 0.0 111.249 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 138' ' ' ALA . 13.6 m -116.56 146.02 21.54 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.8 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.567 HD23 ' HB ' ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.3 143.35 51.25 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.223 -173.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.653 ' HB2' HD11 ' A' ' 137' ' ' ILE . 60.8 t-20 -95.2 139.64 31.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.147 0.498 . . . . 0.0 110.566 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -69.39 -35.08 75.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -53.84 -33.81 57.38 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.4 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -58.93 -49.02 79.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.455 ' HE1' HG13 ' A' ' 135' ' ' VAL . 20.0 m-85 -72.94 -31.93 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.581 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.25 -42.62 99.72 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.86 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -70.71 -50.62 34.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.258 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -63.38 -21.2 66.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.212 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m 65.77 39.96 4.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.311 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -66.38 154.84 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 12.3 m-30 -75.44 141.93 43.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.923 -167.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 129.26 56.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.405 ' HD1' HG13 ' A' ' 110' ' ' VAL . 21.9 t80 -131.69 112.34 12.47 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.54 119.9 31.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.405 HG13 ' HD1' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -112.34 148.5 15.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 110.422 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.5 46.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.007 171.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.655 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 14.2 m80 -78.42 -169.7 0.21 Allowed Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.655 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 85.1 Cg_exo -48.12 139.64 20.64 Favored 'Trans proline' 0 C--N 1.358 1.051 0 CA-C-N 121.285 1.495 . . . . 0.0 109.416 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -56.26 -48.19 77.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -89.3 -14.35 0.2 Allowed Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.579 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 96.7 Cg_exo -51.62 -17.45 4.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.249 1.482 . . . . 0.0 110.333 157.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.411 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 7.2 m-20 72.99 21.77 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.513 171.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.67 121.28 42.11 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.627 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -138.73 125.06 20.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.735 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.33 140.5 50.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.14 113.07 32.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.214 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 56.4 m -87.34 122.01 30.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.386 0.612 . . . . 0.0 110.989 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.758 ' HB ' HG13 ' A' ' 69' ' ' ILE . 14.4 mt -89.12 109.0 19.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.593 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.495 ' O ' HG22 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -88.94 95.93 10.51 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.461 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.501 ' HB2' HG23 ' A' ' 131' ' ' ILE . . . -69.46 148.86 48.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.156 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -59.51 -41.96 91.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.969 0.414 . . . . 0.0 110.957 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.79 159.92 15.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.536 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 105.49 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.874 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.14 70.92 1.23 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.597 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.73 73.59 0.44 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 172.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.575 ' CG2' ' HD3' ' A' ' 132' ' ' PRO . 1.6 tt -54.76 -41.59 90.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.575 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 20.2 Cg_endo -91.93 126.72 0.92 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.808 1.672 . . . . 0.0 111.881 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -18.04 63.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -79.9 4.98 15.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.567 ' HB ' HD23 ' A' ' 95' ' ' LEU . 3.7 m -58.39 -30.15 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.824 0.345 . . . . 0.0 111.498 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.1 pt -87.96 89.91 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.18 0.515 . . . . 0.0 109.961 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 96' ' ' ASN . 12.3 pt -70.78 -28.16 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.648 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.464 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -155.06 124.92 6.56 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HZ1' ' CD ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -121.97 132.46 54.55 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.44 159.37 42.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.185 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tt -100.32 144.39 29.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 88' ' ' GLU . 15.0 tt -124.33 135.66 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 110.489 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 144' ' ' ILE . 6.4 tp10 -115.39 47.23 1.34 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.822 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 143' ' ' GLU . 1.2 tt 69.29 176.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.106 0.562 . . . . 0.0 111.793 173.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.425 ' N ' HG21 ' A' ' 144' ' ' ILE . 3.7 t-20 -75.8 57.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.558 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.95 -57.48 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -80.57 61.16 4.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.126 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -132.4 61.07 1.67 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.1 t60 40.23 57.73 2.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.298 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -73.32 124.33 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 21.5 t-80 -141.27 26.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.432 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 3.8 m170 72.2 155.57 0.16 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.239 -174.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.319 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.32 -152.26 50.71 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.23 -0.509 . . . . 0.0 112.191 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.564 ' H ' ' HD2' ' A' ' 97' ' ' ARG . 8.7 t-20 -134.56 154.91 51.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.765 0.317 . . . . 0.0 110.405 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -121.43 120.98 36.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -106.21 144.91 32.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.251 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.61 138.35 47.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.461 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.676 HH11 HD12 ' A' ' 21' ' ' LEU . 44.9 ttt180 -139.21 111.1 7.25 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -107.15 157.85 15.36 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.603 HG12 ' H ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -148.73 136.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 16.19 14.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.065 0.459 . . . . 0.0 110.959 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.603 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.7 58.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.512 . . . . 0.0 109.804 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.5 ' NE2' ' HB2' ' A' ' 91' ' ' TYR . 2.0 mp0 -58.02 -21.56 45.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -68.98 -47.62 65.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.78 -42.58 99.76 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.891 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.06 -53.12 59.96 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.473 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -66.83 -24.95 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.638 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -93.88 -15.41 25.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.48 -9.81 75.68 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.448 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.562 ' HB2' ' HG3' ' A' ' 23' ' ' PRO . 1.6 mm-40 -174.71 -169.59 0.43 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.676 HD12 HH11 ' A' ' 7' ' ' ARG . 0.5 OUTLIER -77.2 61.29 2.07 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.003 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.49 ' HB3' ' HG ' ' A' ' 130' ' ' CYS . 15.8 tttm 52.67 69.07 2.56 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.562 ' HG3' ' HB2' ' A' ' 20' ' ' GLN . 86.0 Cg_endo -83.14 82.57 2.1 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.787 2.325 . . . . 0.0 112.077 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -115.85 -152.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.7 173.95 31.98 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.31 176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 153.94 33.63 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.817 0.447 . . . . 0.0 109.856 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HG3' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -115.45 138.59 50.85 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -85.99 49.49 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.145 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 64.45 -74.05 0.05 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.329 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 59.2 t -84.9 -85.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 30' ' ' VAL . . . 168.6 179.02 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.111 0.564 . . . . 0.0 110.404 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -107.97 44.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.439 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -44.13 103.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.207 -174.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.469 ' HD1' ' H ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -64.36 -24.65 67.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.58 -178.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' H ' ' HD1' ' A' ' 34' ' ' TYR . 2.4 t70 59.92 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.585 0.553 . . . . 0.0 110.602 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . -157.49 177.74 34.16 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 37' ' ' LYS . 3.6 mppt? 59.59 13.97 3.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.23 0.515 . . . . 0.0 110.473 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 48.27 39.99 13.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.118 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -87.51 95.05 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.707 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -79.65 45.09 0.66 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.68 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.21 31.89 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.46 -150.6 7.8 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.127 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 14.6 tttt -77.38 94.05 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.277 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.55 84.64 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.744 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -61.52 -66.78 0.48 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.473 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -142.54 152.76 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.064 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.64 127.51 0.89 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.3 -24.25 27.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.629 2.219 . . . . 0.0 111.177 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.57 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 46.9 m -126.36 85.56 2.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.466 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' A' ' 49' ' ' SER . 4.8 p 165.21 168.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.062 0.945 . . . . 0.0 109.206 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 50.09 -159.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 172.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -48.52 -31.54 6.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.452 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.424 ' H ' ' HG3' ' A' ' 51' ' ' LYS . . . -55.62 -65.5 0.58 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.05 -32.31 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.768 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -66.04 -61.03 2.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.92 84.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -62.68 -44.54 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -49.65 66.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.686 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 82.0 mt -62.65 -36.12 73.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.621 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.95 -52.34 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.217 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.7 p -64.39 -76.63 0.07 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.463 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.21 7.22 11.7 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.361 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 43.6 tp 64.24 -79.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.58 0.352 . . . . 0.0 110.334 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -107.22 64.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -38.46 88.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.881 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.21 -1.58 0.55 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.129 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.3 m -78.04 -15.74 58.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.827 0.313 . . . . 0.0 111.275 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -121.29 157.12 31.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.224 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 31.0 mt -98.03 100.81 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.936 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m -77.21 114.32 15.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.548 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.32 168.9 16.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 110.715 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -112.31 152.2 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -25.67 68.06 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.77 133.25 34.0 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.127 -0.358 . . . . 0.0 110.497 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -59.62 -25.79 64.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.679 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.53 -6.82 58.78 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.418 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -23.88 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.006 0.432 . . . . 0.0 110.52 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.736 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -71.36 -44.07 65.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -57.99 -51.58 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.782 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.27 -48.02 83.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.212 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -55.83 -44.86 78.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.552 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -70.62 -43.03 70.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.5 m -63.51 -28.52 70.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.328 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 p -86.84 -5.52 59.08 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 110.6 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.17 89.85 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.468 HG22 ' HB3' ' A' ' 82' ' ' ALA . 3.1 tp -69.1 -8.92 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 142' ' ' ILE . 43.9 mt-10 -28.52 -49.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.558 0.743 . . . . 0.0 112.741 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -121.14 91.11 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.49 -143.93 5.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.091 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.5 ' HB2' ' NE2' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -122.85 150.16 43.24 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.038 0.535 . . . . 0.0 110.352 -174.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.607 HG13 ' HG3' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -142.86 137.8 27.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 110.198 176.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -118.34 145.77 44.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 138' ' ' ALA . 2.1 t -106.63 128.78 61.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.525 172.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 142.01 51.37 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.951 0.782 . . . . 0.0 109.119 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.433 ' HB2' HD12 ' A' ' 137' ' ' ILE . 7.3 t-20 -113.24 144.56 42.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.908 0.385 . . . . 0.0 111.557 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -64.1 -39.54 94.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.269 -175.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -69.53 -26.33 64.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.193 0.52 . . . . 0.0 109.915 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.682 HD21 HG21 ' A' ' 137' ' ' ILE . 12.4 tp -66.51 -39.19 88.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.399 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.541 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 48.1 m-85 -61.72 -42.8 99.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.441 174.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -38.99 90.45 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.907 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -62.05 -44.07 97.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.199 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 17.6 m-85 -76.99 -12.0 59.88 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.891 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m 70.66 27.62 3.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.457 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 132' ' ' PRO . 18.4 mt -72.24 148.09 9.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.545 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 69.4 m-85 -89.81 122.77 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.565 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.79 138.62 31.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.15 112.06 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 119.28 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.131 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -87.29 129.65 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -121.55 128.75 52.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.466 0.651 . . . . 0.0 110.847 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.646 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 50.5 m80 -80.33 -174.81 0.52 Allowed Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 80.6 Cg_exo -46.19 149.37 2.52 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.211 1.274 . . . . 0.0 111.232 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -52.0 -51.42 57.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -166.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.405 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -99.84 -13.45 0.17 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 92.2 Cg_exo -50.15 -16.25 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.943 0 CA-C-N 121.767 1.667 . . . . 0.0 110.903 163.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 t-20 69.37 28.59 4.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.778 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 112' ' ' HIS . 20.3 tp10 -103.09 98.4 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.364 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -131.14 108.75 9.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.779 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.524 ' HB3' HG21 ' A' ' 110' ' ' VAL . 6.7 tm-20 -99.7 115.1 28.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.99 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.49 101.1 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.092 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.557 ' HB ' ' HE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -93.79 127.92 39.76 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 28.2 mm -88.43 102.9 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.283 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.557 ' HE ' ' HB ' ' A' ' 122' ' ' THR . 6.9 mmt180 -86.0 101.72 13.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.841 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.4 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -69.71 156.71 38.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' CD ' ' HZ2' ' A' ' 27' ' ' LYS . 9.4 tt0 -65.18 -29.51 70.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.261 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -147.34 161.17 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.719 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.94 47.13 4.57 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.542 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.53 ' SG ' ' NH2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 48.68 63.82 1.95 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.777 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -50.73 -45.77 86.28 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.777 ' HD3' HG21 ' A' ' 131' ' ' ILE . 92.8 Cg_endo -93.14 109.5 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.669 1.579 . . . . 0.0 112.295 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -61.93 -27.74 69.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.965 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.493 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -88.01 11.96 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.886 -178.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.617 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 13.1 p -59.77 -24.44 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 111.556 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -88.34 104.36 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.873 0.844 . . . . 0.0 109.782 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.682 HG21 HD21 ' A' ' 99' ' ' LEU . 1.6 pt -63.12 -26.61 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 94' ' ' VAL . . . -145.82 146.0 30.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.326 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -128.26 123.14 33.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.607 ' HG3' HG13 ' A' ' 92' ' ' ILE . 1.9 pt-20 -140.49 160.29 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.159 0.504 . . . . 0.0 111.122 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -111.26 151.76 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.612 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.8 tt -128.45 132.06 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.769 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.623 ' HG3' ' HB3' ' A' ' 145' ' ' ASN . 8.1 pt-20 -128.02 29.78 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -173.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 10.2 tp 37.91 44.97 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 122.341 1.067 . . . . 0.0 111.195 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.623 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.5 t30 -148.15 170.47 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.396 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.14 168.07 10.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.64 89.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -83.4 70.43 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -63.83 128.48 35.99 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.407 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 80.32 0.22 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.485 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -152.27 131.4 12.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.219 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 70.47 1.61 3.71 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.454 0.471 . . . . 0.0 110.632 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.896 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.859 0.362 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.13 97.21 0.27 Allowed Glycine 0 C--N 1.333 0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.615 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -159.91 158.6 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -114.83 161.25 18.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 111.182 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -100.53 154.93 18.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.89 141.25 38.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.374 0.607 . . . . 0.0 111.267 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.555 ' HB2' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -144.07 156.07 44.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.703 176.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.596 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -137.74 157.65 24.25 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.453 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -147.27 140.31 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.447 -178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 6.26 14.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.488 0.661 . . . . 0.0 109.296 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.536 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.36 49.08 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.603 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -59.91 -26.73 66.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -61.09 -46.57 90.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.753 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.8 -47.16 86.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.96 -50.03 69.91 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.448 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -72.0 -24.24 61.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -74.46 -42.41 59.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 110.718 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -94.1 -16.1 24.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.51 89.32 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.0 159.2 36.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.555 HD21 ' H ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -81.18 130.92 35.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.468 ' HE2' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 50.98 151.91 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 125.075 1.35 . . . . 0.0 113.835 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.52 -164.39 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 111.663 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.22 129.68 4.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.65 12.2 8.33 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.885 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 127' ' ' ASP . 30.9 t-20 -93.92 131.0 39.79 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 122.797 -0.237 . . . . 0.0 110.497 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -155.66 70.69 0.72 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.449 0.642 . . . . 0.0 110.09 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 43' ' ' LYS . . . -138.73 31.14 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.839 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 57.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.27 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -144.72 100.99 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.687 ' HB3' HG13 ' A' ' 50' ' ' VAL . . . -74.47 -32.37 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.725 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 40' ' ' TYR . 7.9 mt -94.86 99.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.063 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -98.25 3.82 48.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.634 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 66.73 -65.27 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.904 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 66.82 16.33 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 122.955 0.502 . . . . 0.0 111.246 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.43 -59.62 3.67 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.059 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -1.41 17.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.5 t80 71.85 -5.79 1.61 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.546 0.338 . . . . 0.0 111.708 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -83.51 -18.67 37.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.834 0.349 . . . . 0.0 110.448 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.486 ' CE1' HG23 ' A' ' 32' ' ' ILE . 10.5 m-85 65.03 176.08 0.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.0 -176.15 5.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.95 -77.23 0.19 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.893 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.68 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 58.24 -90.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 111.012 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.414 ' H ' ' HB3' ' A' ' 43' ' ' LYS . . . -85.09 66.16 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 110.589 -178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.54 -51.5 69.61 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -106.54 44.21 1.08 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.899 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.99 138.18 9.59 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.133 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -90.38 -177.89 1.36 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.092 2.528 . . . . 0.0 112.119 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m 69.42 -176.39 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.264 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 51' ' ' LYS . 1.3 t 55.23 -168.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.283 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.747 ' H ' HG12 ' A' ' 50' ' ' VAL . 70.9 mttt 59.57 -170.94 0.13 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 112.565 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -60.81 -22.46 64.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.657 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -65.84 0.57 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.444 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -68.68 -27.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -63.17 1.36 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.416 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.97 87.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.437 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -55.92 -52.48 63.96 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.174 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 26.9 tp60 -66.39 -54.87 19.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.244 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.58 -37.14 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.464 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -80.29 -58.47 3.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.51 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -69.27 -19.84 63.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.57 -175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.63 -111.71 0.77 Allowed Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 13.5 tp -162.07 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.629 ' HH ' HG11 ' A' ' 110' ' ' VAL . 15.4 m-85 -105.36 -38.05 6.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.267 0.556 . . . . 0.0 109.523 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.65 -155.24 0.22 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.074 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.01 -14.61 76.85 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.487 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.473 ' HA ' ' N ' ' A' ' 129' ' ' GLY . 97.6 m -61.5 -50.55 72.28 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.429 0.292 . . . . 0.0 111.212 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -104.33 160.2 15.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.262 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 mp -110.53 99.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.59 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.81 115.41 21.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 96.7 m -140.89 129.41 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -82.22 151.14 26.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.003 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.07 10.73 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.895 0.378 . . . . 0.0 111.823 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.43 123.46 48.11 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -49.2 -28.47 4.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -64.81 -19.97 66.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.69 0.281 . . . . 0.0 111.07 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -28.72 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.557 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -51.64 68.16 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.273 0.558 . . . . 0.0 110.651 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.94 -43.62 67.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.616 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.05 -47.87 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.099 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.35 -54.22 36.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.553 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -54.35 -43.89 71.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.544 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 m -73.76 -48.31 32.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 m -68.84 -18.22 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.496 ' HB2' HG13 ' A' ' 87' ' ' ILE . 18.0 m -92.78 -3.38 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.528 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.77 96.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.251 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.596 HD13 ' HA3' ' A' ' 8' ' ' GLY . 15.8 mt -79.61 -8.44 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 121.957 0.103 . . . . 0.0 111.041 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' O ' HG12 ' A' ' 142' ' ' ILE . 10.8 mt-10 -33.28 -39.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -119.85 100.87 7.49 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.77 16.74 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.445 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.5 128.18 54.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 -175.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.4 mt -105.03 133.36 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.17 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.411 ' HB2' ' HB3' ' A' ' 7' ' ' ARG . 21.5 m-85 -116.38 146.1 42.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.38 122.53 40.37 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.958 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.681 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.58 140.86 48.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.071 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.5 138.43 36.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -40.64 80.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -172.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.25 -10.36 59.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.575 0.226 . . . . 0.0 111.19 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 99' ' ' LEU . 12.4 mt -68.96 -42.58 76.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.592 ' HB3' HD13 ' A' ' 105' ' ' ILE . 3.3 m-85 -68.34 -43.48 77.41 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.683 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.84 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.993 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.63 -41.68 71.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.8 -19.52 65.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.3 m 72.9 38.23 0.74 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.001 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.592 HD13 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -75.89 166.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -75.51 109.32 8.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.341 -175.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.39 99.82 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -110.85 114.13 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.902 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.32 113.97 25.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.415 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.629 HG11 ' HH ' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -87.54 115.12 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -103.19 137.11 41.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.329 0.585 . . . . 0.0 111.264 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -87.95 174.37 5.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.558 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 52.7 Cg_exo -49.44 159.6 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.924 1.749 . . . . 0.0 112.575 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.34 -65.07 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.1 t-20 -92.76 -18.44 0.23 Allowed Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.558 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 44.5 Cg_exo -44.46 -18.82 0.21 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 121.551 1.59 . . . . 0.0 112.051 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.409 ' N ' ' C ' ' A' ' 115' ' ' ASN . 2.2 t-20 73.64 12.01 4.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.607 167.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -103.46 122.11 44.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 111.014 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -142.9 109.4 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.283 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' HB3' HG12 ' A' ' 110' ' ' VAL . 14.3 tt0 -100.52 132.61 45.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.96 104.37 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -84.59 114.59 22.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.172 0.51 . . . . 0.0 110.166 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 46.0 mm -88.01 100.62 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.663 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.706 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -86.32 93.16 9.02 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.008 179.331 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.17 151.76 46.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.435 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.569 ' HA ' HH21 ' A' ' 124' ' ' ARG . 3.3 mm-40 -65.37 -11.04 38.35 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -170.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 32.2 t0 -145.26 156.19 43.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.27 132.54 47.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 111.468 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.473 ' N ' ' HA ' ' A' ' 67' ' ' CYS . . . 91.29 33.05 8.32 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.127 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 60.95 70.88 0.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.983 0.42 . . . . 0.0 110.356 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.819 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -37.83 -54.82 2.3 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.819 ' HD3' HG21 ' A' ' 131' ' ' ILE . 20.1 Cg_endo -93.11 128.64 0.72 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.306 2.004 . . . . 0.0 112.493 -174.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -81.36 -7.17 59.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -83.71 -4.78 58.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.456 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 132' ' ' PRO . 28.2 m -81.84 -9.41 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 110.247 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.08 89.73 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.5 pt -63.79 -35.07 71.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.702 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.32 167.96 28.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 111.772 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 160.54 43.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.368 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -141.34 160.58 39.83 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.015 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -105.37 149.43 26.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.4 tt -139.38 130.88 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.461 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -122.93 35.95 4.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.774 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt 61.34 -83.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.82 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.99 142.67 27.78 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.326 0.584 . . . . 0.0 111.717 -171.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -131.53 156.74 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.02 174.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.51 ' HB2' HD22 ' A' ' 146' ' ' LEU . 0.0 OUTLIER 67.59 116.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.422 0.451 . . . . 0.0 110.037 -175.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -66.98 -25.52 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.598 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -70.3 -22.56 62.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.98 125.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.063 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.33 134.5 49.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.254 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -97.13 -10.6 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.053 178.325 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.55 -154.92 52.74 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.73 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.403 ' H ' ' HB3' ' A' ' 97' ' ' ARG . 47.4 t30 -150.73 159.52 44.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.6 128.87 35.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -175.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.636 ' HG ' ' HB ' ' A' ' 71' ' ' THR . 7.0 mp -100.7 135.94 41.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.443 ' HD2' HD12 ' A' ' 92' ' ' ILE . 1.4 m-85 -121.57 124.59 44.72 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.174 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.81 150.2 43.02 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA3' HG13 ' A' ' 87' ' ' ILE . . . -129.95 158.26 22.23 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.326 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.51 HG13 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.46 140.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 122.774 0.43 . . . . 0.0 110.468 -175.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 9' ' ' ILE . 2.5 p -89.24 -39.36 13.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.202 -0.311 . . . . 0.0 110.346 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' SER . 7.8 t 174.88 -150.26 0.01 OUTLIER 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.059 0.544 . . . . 0.0 109.79 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -56.77 -40.49 75.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 14.1 pm0 -56.42 -32.55 64.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.972 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.5 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -84.98 -31.93 23.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.52 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.796 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -52.56 -51.01 61.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -73.33 -40.17 64.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.14 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . 23.7 t30 -57.55 -48.16 80.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.62 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.87 -35.49 26.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' NZ ' ' A' ' 24' ' ' LYS . . . 68.8 16.02 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.895 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -132.52 4.09 3.93 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.796 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 33.3 tp -71.0 -54.17 12.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.558 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -88.44 132.92 37.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.271 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.23 112.54 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.783 2.322 . . . . 0.0 111.962 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.513 ' HE2' ' HA3' ' A' ' 129' ' ' GLY . 7.0 pttt -112.08 -12.66 13.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.005 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.45 154.54 33.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.164 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.47 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 7.0 t-20 -98.87 -75.58 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.826 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HB3' HG13 ' A' ' 131' ' ' ILE . 6.2 ptpp? 152.74 161.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.681 1.193 . . . . 0.0 109.768 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.581 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . . . -177.36 -95.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.206 0.316 . . . . 0.0 111.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.48 ' H ' HG21 ' A' ' 50' ' ' VAL . 2.2 tm-20 65.45 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.959 0.504 . . . . 0.0 110.453 -172.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.5 136.09 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 111.531 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 61.35 23.3 13.56 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.73 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.46 ' HB ' ' CD1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -78.99 74.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.215 0.531 . . . . 0.0 110.439 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -59.46 95.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.285 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.78 92.19 2.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.09 104.63 0.32 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.924 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 -91.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.759 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.12 178.99 4.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.525 0.202 . . . . 0.0 111.326 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.501 ' HZ ' ' HB2' ' A' ' 108' ' ' TYR . 25.2 m-85 72.31 158.88 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.209 0.943 . . . . 0.0 111.827 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -113.16 92.37 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.777 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.46 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 27.4 m-85 -80.65 83.5 6.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.353 0.596 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -88.74 -23.75 22.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.75 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.87 56.99 2.1 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -50.81 -40.8 56.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.015 0.526 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . . . -143.64 -166.74 2.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 110.849 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 46' ' ' HIS . 1.6 m -147.36 174.93 11.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.469 ' H ' HG23 ' A' ' 45' ' ' THR . 0.2 OUTLIER 83.02 -47.47 0.14 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.515 0.726 . . . . 0.0 111.457 173.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.581 ' HA3' ' HB2' ' A' ' 28' ' ' ALA . . . -49.48 115.04 2.59 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.264 0.353 . . . . 0.0 112.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -81.28 -34.43 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.89 2.393 . . . . 0.0 112.616 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.25 62.92 4.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.812 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 51' ' ' LYS . 6.7 p -162.51 -148.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.353 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.753 ' H ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 71.01 177.59 0.27 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.576 0.703 . . . . 0.0 111.948 172.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -53.87 -29.7 42.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.95 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 57' ' ' HIS . . . -54.6 -66.6 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.935 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -63.73 -37.64 80.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.518 0.199 . . . . 0.0 110.994 -177.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -64.15 1.04 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.981 0.42 . . . . 0.0 110.662 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.53 90.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.172 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 6.1 m-70 -58.65 -46.88 86.18 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.839 -177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.431 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -60.05 -51.72 68.45 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.548 HD11 HH22 ' A' ' 124' ' ' ARG . 84.5 mt -58.62 -46.28 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.548 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -77.0 -39.77 49.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.3 m -80.35 -42.8 22.25 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -173.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.16 11.38 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.569 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 37.7 tp 63.32 -75.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.89 0.476 . . . . 0.0 110.885 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.415 ' CE1' HG22 ' A' ' 122' ' ' THR . 17.8 m-85 -131.02 68.15 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.558 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.431 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -58.91 -43.72 91.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.191 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.13 -11.93 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.453 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.89 -29.89 69.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.289 0.545 . . . . 0.0 110.849 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.61 160.06 19.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.575 HG13 HD21 ' A' ' 5' ' ' LEU . 3.0 tp -115.05 123.68 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 110.369 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -105.59 147.69 28.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.809 -174.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.682 HG23 HG12 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -137.78 148.78 45.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.283 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.402 ' H ' HD13 ' A' ' 77' ' ' ILE . 2.9 m -81.49 155.85 25.6 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.217 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -25.9 65.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -85.88 129.01 34.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.705 0.288 . . . . 0.0 110.739 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.83 -18.39 64.08 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.5 -9.69 44.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 2.2 tt -46.71 -31.83 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.56 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.6 -62.81 1.48 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.357 0.598 . . . . 0.0 111.289 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -70.16 -41.49 73.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.825 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.61 -45.27 92.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.306 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.486 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 5.8 t80 -68.58 -53.81 20.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.175 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.81 75.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.498 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m -74.82 -52.58 11.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.665 0.269 . . . . 0.0 111.259 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -70.72 -10.4 59.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -105.07 3.78 30.81 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.297 -0.252 . . . . 0.0 110.865 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.47 36.25 76.34 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.945 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.532 HG13 ' HA3' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -89.76 -9.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.741 -176.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.18 -28.25 0.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.174 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -107.39 109.08 20.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.94 -126.44 3.55 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.145 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.43 150.86 51.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.456 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 16.9 tt -145.18 133.87 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.846 0.355 . . . . 0.0 110.067 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -128.8 154.98 45.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.162 0.506 . . . . 0.0 111.099 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 21.6 m -122.84 145.31 29.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.596 0.713 . . . . 0.0 111.494 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.784 HD21 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -120.15 141.2 50.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.327 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.421 ' HB2' HD13 ' A' ' 137' ' ' ILE . 61.0 t-20 -105.81 128.74 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.084 -0.385 . . . . 0.0 111.427 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.403 ' HB3' ' H ' ' A' ' 3' ' ' ASN . 19.2 ttp180 -67.35 -34.19 76.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.021 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.18 -36.38 72.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.17 -38.92 89.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -71.56 -34.27 69.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.84 -39.04 96.96 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -65.94 -43.13 88.92 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -65.45 -18.58 65.42 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.648 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 m 71.89 30.43 2.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.677 0.751 . . . . 0.0 110.423 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.3 mt -72.38 156.77 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.473 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.587 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 15.2 m-85 -78.5 138.27 38.34 Favored 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -118.61 104.72 10.9 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.501 ' HB2' ' HZ ' ' A' ' 38' ' ' PHE . 15.3 t80 -109.62 112.25 24.22 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -99.46 111.6 23.93 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -83.76 107.02 14.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.9 129.73 44.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.043 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.537 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 48.6 m170 -83.09 178.21 2.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.458 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 81.7 Cg_exo -48.15 168.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.011 1.807 . . . . 0.0 112.511 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.46 -70.11 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 2.0 t-20 -77.42 -21.42 0.37 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -167.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 18.2 Cg_exo -39.13 -22.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.832 1.688 . . . . 0.0 112.244 166.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 73.09 6.25 5.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.919 164.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.24 140.07 52.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.223 0.535 . . . . 0.0 112.058 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 98.31 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.583 ' HB3' HG11 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -70.39 105.42 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -173.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.682 HG12 HG23 ' A' ' 71' ' ' THR . 2.2 p -82.66 104.33 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.574 0.702 . . . . 0.0 109.63 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 3.2 m -97.39 130.4 44.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.528 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.615 HD12 HD23 ' A' ' 5' ' ' LEU . 2.0 mp -87.64 107.08 16.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.003 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.587 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 6.7 mmm180 -87.0 91.7 8.79 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.227 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -72.92 148.97 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.78 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -61.25 -60.28 3.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.468 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.61 141.29 29.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.112 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.66 114.91 7.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.393 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.513 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . 91.43 70.71 1.19 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.194 -0.527 . . . . 0.0 114.088 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 72.0 m 59.45 72.71 0.51 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 170.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.634 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.59 -43.43 83.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.792 174.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.634 ' HD3' HG21 ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.28 135.66 9.66 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.873 1.715 . . . . 0.0 112.246 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -71.65 -26.64 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.095 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.23 10.88 13.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.006 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.784 HG22 HD21 ' A' ' 95' ' ' LEU . 8.0 p -52.54 -35.79 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 110.779 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.48 HG13 HG12 ' A' ' 135' ' ' VAL . 66.6 mt -93.37 95.36 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 138' ' ' ALA . 1.2 pt -76.04 -35.99 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.326 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 137' ' ' ILE . . . -146.18 157.97 43.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.592 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -133.61 148.47 51.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.739 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.55 154.8 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.747 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 tt -112.14 147.62 35.72 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.6 140.65 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -138.08 53.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.194 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.475 HG13 ' HB2' ' A' ' 146' ' ' LEU . 5.2 tp 36.16 99.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.052 1.341 . . . . 0.0 113.884 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -72.17 73.43 0.93 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.787 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.475 ' HB2' HG13 ' A' ' 144' ' ' ILE . 20.2 tp -94.83 -62.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.879 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.63 61.07 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.151 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -108.51 12.5 26.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.907 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -113.34 129.83 56.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.887 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -67.2 -31.98 72.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -82.56 71.54 9.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -57.46 132.58 53.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.552 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.546 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.938 0.399 . . . . 0.0 110.376 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.82 71.74 2.12 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.44 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -85.82 122.83 30.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.81 149.58 37.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.288 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.09 131.65 45.92 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' HA ' HG13 ' A' ' 94' ' ' VAL . 3.1 t80 -96.82 112.42 24.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.479 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -130.59 155.87 45.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.0 158.33 22.27 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.619 HG23 ' HB3' ' A' ' 91' ' ' TYR . 4.7 tt -143.99 152.78 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -175.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.01 14.14 3.54 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.234 0.54 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' H ' HG12 ' A' ' 9' ' ' ILE . 1.8 t 58.9 -97.15 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' H ' ' HB3' ' A' ' 11' ' ' CYS . 56.6 mt-30 -66.17 -46.7 76.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.943 -167.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.98 -57.03 14.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.24 -43.38 98.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.802 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -51.1 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -59.9 -44.8 94.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -63.29 -51.04 67.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.046 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m-80 -78.76 -27.67 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.905 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 20' ' ' GLN . . . 90.34 47.17 3.87 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -172.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 41.6 mm-40 103.91 -144.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.858 1.663 . . . . 0.0 108.434 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.36 52.93 2.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.411 0.551 . . . . 0.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 18' ' ' ASN . 22.9 mtpp 68.52 131.4 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.857 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.7 142.66 9.25 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.61 136.49 57.05 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.48 -89.26 0.09 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.171 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.0 OUTLIER -165.07 139.22 4.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.966 0.412 . . . . 0.0 110.741 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HZ1' ' CD ' ' A' ' 126' ' ' GLU . 8.8 mtpm? -80.28 168.49 18.98 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -113.33 -143.3 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.323 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -139.28 -169.32 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.92 60.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.846 0.832 . . . . 0.0 110.56 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 41' ' ' ASP . . . -143.28 26.23 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.148 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.524 HG22 ' CE2' ' A' ' 106' ' ' PHE . 45.1 mm -113.81 97.26 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.287 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -103.79 165.53 10.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.363 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -142.35 137.2 30.35 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.61 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.449 . . . . 0.0 109.994 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.92 -45.47 0.29 Allowed Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -115.91 45.46 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -73.89 142.88 45.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.956 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.95 136.65 35.28 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.208 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CZ ' HG21 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -120.67 124.97 46.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 1.3 t70 -145.98 -150.4 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.58 -66.64 3.84 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -90.04 65.29 6.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.448 . . . . 0.0 109.837 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.47 72.65 0.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.308 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 m -151.54 154.77 37.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.393 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -75.62 116.51 16.41 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.23 155.28 21.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.991 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.4 -28.12 12.56 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.885 2.39 . . . . 0.0 112.239 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.418 ' O ' ' NZ ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -72.66 144.04 47.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.317 -176.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG23 ' H ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER 50.64 -175.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.101 0.96 . . . . 0.0 112.856 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER 72.79 175.52 0.28 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.609 0.719 . . . . 0.0 111.561 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 22.3 p-10 -58.43 -21.81 52.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.547 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.66 -55.71 31.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.563 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -35.01 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.774 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.416 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 6.5 m-85 -63.21 -40.77 98.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.52 97.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.826 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -61.95 -38.35 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.133 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 38.9 tt0 -58.55 -57.9 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.65 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.07 -45.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.46 -54.73 6.31 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.935 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -82.84 -18.64 39.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.67 0.272 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . 91.41 30.53 10.67 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.808 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER 44.53 22.05 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.059 0.944 . . . . 0.0 113.083 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 54.84 17.15 1.67 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.977 0.511 . . . . 0.0 111.354 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 36.47 47.02 0.47 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.944 0.898 . . . . 0.0 111.869 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -35.68 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.718 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.61 84.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.425 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -130.19 162.17 29.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.446 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.8 mp -93.42 99.06 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.591 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.409 ' OG ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -86.3 124.13 32.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.027 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 121' ' ' VAL . 14.6 t -140.03 161.37 37.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.52 ' H ' HG13 ' A' ' 77' ' ' ILE . 2.1 m -90.17 154.83 19.46 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 m -61.58 -28.31 69.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 110.456 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -87.17 135.49 33.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.23 -19.87 49.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.163 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -6.09 18.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.52 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -51.73 -30.85 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.194 173.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.06 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -72.06 -43.74 64.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.592 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 81' ' ' PHE . 8.5 tttt -61.05 -53.34 58.41 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.434 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 58.8 t80 -67.51 -50.37 59.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.759 -175.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.72 -52.01 66.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.54 -175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 -37.98 76.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.606 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -68.95 -24.83 64.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.684 0.278 . . . . 0.0 111.029 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -89.3 1.76 55.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.78 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.88 99.84 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.661 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 pt -61.4 -9.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.635 0.218 . . . . 0.0 111.49 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -33.84 -45.33 0.19 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.238 0.336 . . . . 0.0 110.791 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -132.21 123.8 27.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.79 -153.48 24.89 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.71 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HB3' HG23 ' A' ' 9' ' ' ILE . 7.1 t80 -122.33 149.85 43.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.465 HD11 ' OH ' ' A' ' 6' ' ' TYR . 62.1 mt -130.98 133.02 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.514 -177.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 32.6 p90 -132.37 129.67 39.7 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 111.233 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' A' ' 6' ' ' TYR . 2.6 m -112.59 130.99 65.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.182 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.504 HD21 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -110.37 141.24 43.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.28 -175.033 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.415 ' HB2' HG23 ' A' ' 137' ' ' ILE . 10.3 t-20 -83.11 149.76 26.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.412 HH21 ' CD ' ' A' ' 107' ' ' GLU . 9.0 ttt180 -99.99 -20.2 16.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -35.28 78.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.128 0.49 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp -64.05 -38.12 89.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.036 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.517 ' CZ ' HG22 ' A' ' 135' ' ' VAL . 5.9 m-30 -64.86 -39.23 93.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.72 51.64 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.824 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -64.1 -29.94 71.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.429 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 4.5 m-30 -82.85 -16.97 45.59 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.715 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.7 m 64.96 47.36 2.6 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.621 0.724 . . . . 0.0 110.275 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 125' ' ' ALA . 24.9 mm -77.06 150.1 6.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.92 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.524 ' CE2' HG22 ' A' ' 32' ' ' ILE . 16.0 m-30 -96.4 103.56 15.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.951 0.405 . . . . 0.0 111.402 -168.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 2.1 pt-20 -93.3 108.17 19.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.111 0.481 . . . . 0.0 110.103 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -99.86 114.26 27.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.337 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 11.6 pt-20 -85.82 120.03 26.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.822 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -92.5 107.76 19.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.76 ' HB3' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -114.21 161.04 18.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.132 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -129.19 172.32 7.32 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.2 168.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.37 2.047 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 1.5 pm0 -55.97 -51.22 68.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.495 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.3 t-20 -83.64 -28.42 0.42 Allowed Pre-proline 0 N--CA 1.471 0.609 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -169.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 22.1 Cg_exo -37.17 -21.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.485 2.123 . . . . 0.0 113.378 170.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.4 t-20 83.65 -3.94 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.35 0.66 . . . . 0.0 112.005 163.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.404 ' CD ' ' HZ3' ' A' ' 80' ' ' LYS . 4.6 mm-40 -122.48 145.5 48.25 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.239 0.542 . . . . 0.0 111.846 -172.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.76 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 16.8 tttm -150.05 95.48 2.29 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -100.13 117.01 33.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 0.0 111.175 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 22.8 t -89.22 107.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.434 HG22 HD23 ' A' ' 63' ' ' LEU . 5.2 m -91.28 113.65 25.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.926 0.393 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . 4.5 mt -88.31 103.53 13.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.98 115.16 27.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.267 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.56 ' HA ' HD11 ' A' ' 105' ' ' ILE . . . -74.44 163.44 27.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.728 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.432 ' CD ' ' HZ1' ' A' ' 27' ' ' LYS . 27.4 tt0 -39.44 -39.85 0.74 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.497 0.498 . . . . 0.0 111.439 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -157.45 161.67 38.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.06 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.5 m -62.24 160.9 12.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 112.01 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.39 31.13 9.87 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.221 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.4 m 48.97 69.33 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.661 0.384 . . . . 0.0 111.876 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.707 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -53.77 -46.35 98.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.723 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.707 ' HD3' HG21 ' A' ' 131' ' ' ILE . 91.0 Cg_endo -92.73 108.74 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 121.854 1.703 . . . . 0.0 112.038 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.41 -5.84 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.63 -3.42 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.517 HG22 ' CZ ' ' A' ' 100' ' ' PHE . 9.5 p -76.3 -21.11 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.9 pt -86.59 89.74 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.726 0.774 . . . . 0.0 109.341 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 96' ' ' ASN . 14.2 pt -74.94 -37.07 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.046 -174.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.564 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -136.76 127.84 27.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.812 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -123.07 136.52 54.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.431 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -141.26 159.46 42.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.239 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.2 tt -112.72 152.18 29.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 125.89 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.357 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HG3' HD21 ' A' ' 141' ' ' LEU . 6.3 mt-10 -133.92 93.87 3.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.8 mt 70.73 107.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.936 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -86.18 60.77 6.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.451 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.67 -33.5 66.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.284 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 154.99 17.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.35 39.59 0.83 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.4 t60 72.01 -12.82 0.64 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -170.31 109.12 0.36 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' A' ' 152' ' ' HIS . 15.3 t-80 -109.45 -13.44 14.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.164 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.485 ' HB3' ' O ' ' A' ' 151' ' ' HIS . 16.3 t-80 77.11 -49.06 0.54 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.628 0.771 . . . . 0.0 110.86 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 C--O 1.246 0.914 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.414 ' C ' ' HB3' ' A' ' 97' ' ' ARG . . . -143.67 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.13 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 90.45 -106.61 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 110.16 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.51 153.94 24.01 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.997 -0.44 . . . . 0.0 111.243 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 144.82 51.12 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.107 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -111.7 132.68 54.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.428 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 0.9 OUTLIER -141.14 105.93 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.345 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.616 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -92.73 155.37 22.55 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.698 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.2 mt -131.34 129.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 0.0 110.607 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -24.45 23.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.214 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 48.88 1.67 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.146 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.483 ' NE2' ' HA2' ' A' ' 90' ' ' GLY . 27.5 mt-30 -56.76 -32.24 65.41 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.87 -49.36 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.933 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.11 -44.1 91.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.569 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.68 -48.17 82.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.341 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -67.76 -32.76 73.58 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -72.1 -38.39 69.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -83.05 -22.55 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.033 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 76.79 5.52 84.01 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.813 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 1.4 mt-30 -156.01 165.28 36.91 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.249 0.62 . . . . 0.0 109.441 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.61 56.47 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.65 137.11 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.063 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.11 73.28 4.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.801 2.334 . . . . 0.0 112.489 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -108.82 146.77 33.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.302 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -155.24 73.9 0.24 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -81.86 69.65 8.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 16.3 mmmt -110.17 109.0 19.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 178.81 -31.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.269 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 27' ' ' LYS . 1.4 mp0 71.61 -64.53 0.38 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.032 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.563 HG12 HG23 ' A' ' 45' ' ' THR . 99.3 t 69.75 147.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 122.948 0.499 . . . . 0.0 111.732 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 143.9 41.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.433 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.532 HG13 ' HB3' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -134.45 136.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.989 -175.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -144.49 91.75 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 110.985 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -144.11 135.73 25.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.195 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.62 157.64 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.39 -178.25 17.26 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -85.83 23.65 1.41 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.502 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -76.63 106.95 8.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -72.74 71.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 109.908 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 32' ' ' ILE . 11.5 m-85 -64.62 146.76 54.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.636 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.94 -98.36 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.11 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.31 99.04 1.75 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.739 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.62 162.51 41.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.7 -77.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.366 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.563 HG23 HG12 ' A' ' 30' ' ' VAL . 3.4 m 57.81 67.56 0.95 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.922 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -103.26 4.41 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.87 177.82 46.83 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -87.38 -163.96 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.122 2.548 . . . . 0.0 112.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 m 61.18 73.43 0.48 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.483 0.658 . . . . 0.0 111.153 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.525 HG23 ' H ' ' A' ' 51' ' ' LYS . 5.7 p -103.57 172.84 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.93 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' H ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -44.2 -61.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.065 174.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.412 ' HB3' HG21 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.46 -14.66 63.13 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -175.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.79 -52.84 8.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.24 -35.05 70.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.08 0.467 . . . . 0.0 109.827 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -61.39 -50.3 73.42 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.29 72.53 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.769 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -61.59 -52.78 62.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.064 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.556 ' HB2' HD11 ' A' ' 63' ' ' LEU . 18.6 tm0? -59.52 -40.22 86.43 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.399 0.618 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.55 -38.49 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.31 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -84.5 -69.92 0.61 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.99 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 -24.97 18.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.84 162.35 26.83 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 58' ' ' GLN . 13.7 mt -155.57 152.65 29.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.359 0.599 . . . . 0.0 110.151 -175.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -62.51 83.91 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.048 172.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.71 82.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.737 0.78 . . . . 0.0 111.417 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' TYR . . . -145.86 -32.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.9 m -55.17 -28.07 50.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.4 0.619 . . . . 0.0 110.006 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.51 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 30.3 m-85 -103.59 161.2 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.825 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 69' ' ' ILE . 4.2 mp -101.29 100.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.014 0.435 . . . . 0.0 110.288 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -78.84 123.1 26.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.931 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.83 152.69 50.56 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.496 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 6.0 m -105.24 159.9 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -28.42 66.68 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.013 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -100.34 134.23 43.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -58.72 -19.55 41.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.375 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.553 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 12.4 mm-40 -52.91 -24.85 10.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -49.81 -35.7 10.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.069 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.05 74.76 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.408 0.623 . . . . 0.0 110.609 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -69.41 -47.07 65.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.761 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 53.2 mttm -63.29 -48.51 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.334 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.616 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -63.1 -47.42 82.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.883 -177.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -57.07 -57.47 12.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.195 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 m -60.65 -45.05 95.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.832 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 m -60.61 -29.88 69.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -83.8 -6.7 59.49 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.26 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 45.82 18.11 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.608 HG21 ' HB1' ' A' ' 82' ' ' ALA . 7.2 tp -68.49 -18.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -32.43 -44.36 0.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.015 0.822 . . . . 0.0 112.468 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -130.95 101.74 5.75 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.483 ' HA2' ' NE2' ' A' ' 12' ' ' GLN . . . 170.83 -166.82 40.01 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.321 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -93.05 142.99 26.68 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.013 0.525 . . . . 0.0 109.825 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.419 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -134.86 112.79 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.125 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 2.7 m-85 -95.05 129.66 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.223 0.535 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 138' ' ' ALA . 1.0 OUTLIER -102.83 113.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.932 178.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.457 HD21 HG11 ' A' ' 135' ' ' VAL . 3.6 mp -112.43 140.96 46.73 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.466 0.479 . . . . 0.0 109.839 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -91.61 129.43 37.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.414 ' HB3' ' C ' ' A' ' 2' ' ' GLY . 6.1 ttp85 -80.76 -28.38 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.914 -175.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.18 -33.6 71.13 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.46 ' HB3' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -61.07 -38.54 86.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.012 175.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -66.49 -44.05 83.69 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.202 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.76 -45.24 96.83 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.901 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -61.84 -43.67 98.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.231 0.539 . . . . 0.0 110.016 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.41 -21.64 63.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.516 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.2 m 68.59 37.83 2.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.041 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 125' ' ' ALA . 17.5 mm -67.65 153.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.245 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.67 104.14 14.39 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 121.038 0.447 . . . . 0.0 110.859 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -88.04 110.72 20.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.48 113.22 25.83 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -105.86 130.03 53.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.66 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 m -117.22 131.66 69.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.557 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.415 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.8 pm0 -87.78 131.34 34.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.2 m170 -83.37 175.69 4.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 82.3 Cg_exo -45.95 164.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 113.138 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -51.09 -55.84 15.65 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -168.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.489 ' N ' ' HG2' ' A' ' 114' ' ' GLU . 2.1 t-20 -103.28 -9.32 0.12 Allowed Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 42.7 Cg_exo -43.07 -27.34 0.96 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 121.708 1.646 . . . . 0.0 110.867 162.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 t30 67.64 31.57 5.98 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.605 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.89 145.89 29.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 110.834 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 111' ' ' GLU . 5.5 mptt -123.09 130.4 52.73 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.266 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.8 108.4 16.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.148 0.499 . . . . 0.0 110.23 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.08 96.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.461 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.27 117.05 29.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.3 mm -87.3 106.36 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.026 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.51 ' HA ' ' CD1' ' A' ' 68' ' ' TYR . 26.0 mmt180 -85.19 100.23 11.62 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.138 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -85.57 161.04 19.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.468 ' HB2' HD12 ' A' ' 131' ' ' ILE . 33.2 mt-10 -65.21 -21.05 66.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.073 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.714 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -137.52 161.18 37.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.56 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.1 m -71.85 99.61 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.256 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.35 71.55 1.21 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.1 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.9 71.84 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -58.95 -44.21 98.61 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.631 ' HD3' HG23 ' A' ' 131' ' ' ILE . 65.6 Cg_endo -74.51 109.69 2.95 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.444 1.429 . . . . 0.0 112.23 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -63.15 -21.57 66.29 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.46 -15.43 59.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.442 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.555 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.4 p -70.47 -22.12 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.55 97.03 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.431 0.634 . . . . 0.0 109.554 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 pt -69.04 -28.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.46 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.536 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -155.73 141.9 18.36 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.505 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 95.26 5.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 108.956 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -95.08 157.75 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.283 0.564 . . . . 0.0 111.493 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -137.0 147.9 46.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.642 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.73 138.34 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.399 . . . . 0.0 110.624 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -129.21 53.83 1.86 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.2 mt 60.01 87.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.628 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -57.4 145.04 34.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.203 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.443 HD11 ' N ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -66.71 -22.33 66.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.657 0.265 . . . . 0.0 111.625 -176.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.443 ' N ' HD11 ' A' ' 146' ' ' LEU . 2.1 mm-40 -74.7 158.19 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.276 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -139.28 100.23 3.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.749 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 66.2 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.257 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -169.24 21.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.481 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 20.5 m80 47.96 -139.85 0.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.48 -177.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.481 ' H ' ' HB3' ' A' ' 151' ' ' HIS . 45.1 t60 -155.59 118.91 4.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 110.347 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.793 -0.622 . . . . 0.0 109.605 179.108 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' A' ' 97' ' ' ARG . 10.5 tpt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.722 0.296 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.41 -147.63 18.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.295 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -168.69 -97.7 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -125.49 119.32 27.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.662 HD22 ' HB ' ' A' ' 71' ' ' THR . 29.4 mt -99.22 124.52 44.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.291 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.23 114.62 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.904 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -139.77 144.38 37.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.616 ' HA3' HD12 ' A' ' 87' ' ' ILE . . . -114.19 158.51 14.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.504 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.597 HG12 ' H ' ' A' ' 11' ' ' CYS . 4.3 tt -151.45 168.21 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.82 0.448 . . . . 0.0 110.294 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.98 -14.55 38.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.226 0.536 . . . . 0.0 109.999 172.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER 60.16 -86.27 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.597 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -37.77 -57.13 1.02 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -61.85 -56.18 22.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.361 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.85 -41.54 97.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.31 0.576 . . . . 0.0 111.006 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.78 -52.5 50.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.271 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -63.51 -36.73 84.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.898 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -68.84 -55.47 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.209 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.41 -8.7 54.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.725 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.57 1.26 89.24 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 179.65 -175.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.32 67.31 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt 54.21 64.47 6.32 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.103 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.46 62.71 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.573 2.182 . . . . 0.0 112.202 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -85.76 61.33 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 26' ' ' ASN . . . -124.86 -171.46 13.32 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.411 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 25' ' ' GLY . 5.5 t-20 78.93 117.09 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.982 0.913 . . . . 0.0 111.027 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 45' ' ' THR . 8.7 tttt -137.33 -80.43 0.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.005 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.0 -85.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.008 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.429 ' HB2' ' H ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.61 -156.49 0.71 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.136 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.429 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 39.0 t -48.99 144.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 123.774 0.671 . . . . 0.0 112.294 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 44' ' ' ALA . . . -159.66 -157.33 0.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.312 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 48.2 mt 68.14 -93.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.094 0.558 . . . . 0.0 111.209 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 66.4 155.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 110.272 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' A' ' 38' ' ' PHE . 15.4 t80 -168.45 148.26 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.33 -45.87 14.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.515 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.75 85.52 0.16 Allowed Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 113.077 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? 64.7 -74.26 0.05 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.348 0.659 . . . . 0.0 111.012 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 34' ' ' TYR . 16.5 t80 61.64 68.28 0.71 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.526 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.08 44.54 1.02 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.16 0.505 . . . . 0.0 109.984 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.93 168.75 18.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.28 132.82 3.58 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -173.69 46.41 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.054 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.51 127.88 56.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.103 0.561 . . . . 0.0 110.364 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.439 ' H ' ' HB1' ' A' ' 31' ' ' ALA . . . -117.98 147.94 42.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.195 176.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.563 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -45.17 -59.56 2.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.581 0.753 . . . . 0.0 112.852 -176.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 4.5 m-70 -95.95 95.72 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 110.723 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -55.7 -51.9 51.92 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.471 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 47' ' ' GLY . 56.0 Cg_endo -70.07 -3.74 12.82 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.438 2.092 . . . . 0.0 112.926 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' A' ' 46' ' ' HIS . 12.9 t -126.28 -146.35 0.34 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.5 t 60.87 -111.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 35.5 pttt 30.91 -134.79 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.54 -25.92 64.93 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.333 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.05 -54.59 42.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 110.524 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.49 -36.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.41 -55.4 21.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.048 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.39 90.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.543 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -57.14 -54.4 47.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.056 0.455 . . . . 0.0 110.188 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.538 ' HG3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -59.91 -32.58 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -176.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.538 HG13 ' HG3' ' A' ' 58' ' ' GLN . 59.6 mt -88.77 -70.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.82 -45.67 93.54 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.138 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -81.65 -19.29 42.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.982 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 51.21 4.2 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.333 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 40.7 mt 64.05 79.83 0.25 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.828 0.451 . . . . 0.0 110.868 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -53.87 -27.26 29.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.646 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.77 150.82 12.13 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.58 69.13 2.38 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.768 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -16.38 27.9 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -119.41 152.43 36.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.156 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.502 HG13 HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -107.88 110.17 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.492 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 3.2 m -99.93 136.04 40.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.838 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.662 ' HB ' HD22 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -141.06 155.41 46.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 175.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 m -86.67 162.33 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 110.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -44.48 96.76 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 6.8 t70 -83.68 136.92 34.02 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 -174.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -56.92 -21.94 33.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 74' ' ' ASP . 10.0 pt-20 -61.18 -16.85 49.18 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.789 0.328 . . . . 0.0 110.937 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -29.29 11.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.133 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.84 -66.36 0.42 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.956 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.15 -35.67 71.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.37 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -62.13 -44.45 96.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -67.16 -51.24 56.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.918 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.595 ' HA ' HD13 ' A' ' 87' ' ' ILE . . . -54.77 -46.21 74.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.327 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -69.43 -44.1 72.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.664 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 m -73.52 -18.78 61.05 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.0 m -101.5 10.68 40.13 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.537 0.208 . . . . 0.0 111.267 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.79 21.18 69.09 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.169 -0.468 . . . . 0.0 113.029 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.616 HD12 ' HA3' ' A' ' 8' ' ' GLY . 18.1 mt -72.8 -8.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 88' ' ' GLU . 23.6 mt-10 -39.45 -34.41 0.21 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.545 177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -130.45 89.54 2.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.42 -144.98 6.64 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.228 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -127.18 150.72 49.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.488 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -133.25 143.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 178.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 43.1 p90 -129.65 139.3 51.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.271 0.557 . . . . 0.0 110.843 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.561 HG23 ' HB1' ' A' ' 138' ' ' ALA . 1.4 m -126.16 139.92 50.18 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.866 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.792 HD22 HG11 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -126.05 141.04 52.12 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.024 -174.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.645 ' HB2' HD12 ' A' ' 137' ' ' ILE . 38.4 t-20 -96.97 139.84 32.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.86 0.362 . . . . 0.0 110.769 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -66.25 -25.92 67.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.78 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.88 -35.26 70.74 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.238 0.542 . . . . 0.0 109.892 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 96' ' ' ASN . 4.4 mm? -75.94 -50.81 13.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.482 -174.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -30.21 68.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.57 87.52 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.06 -40.01 87.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HB3' HD13 ' A' ' 105' ' ' ILE . 1.8 m-85 -68.96 -22.0 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.944 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m 66.75 38.43 3.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.66 0.743 . . . . 0.0 109.803 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -71.69 163.88 3.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.642 -178.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 5.2 m-30 -75.53 161.61 29.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.544 -171.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -141.23 155.9 45.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.297 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.441 ' HB2' HH11 ' A' ' 124' ' ' ARG . 0.3 OUTLIER -155.28 110.84 3.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -108.71 120.03 41.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 110.343 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.6 149.21 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.991 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -105.25 142.57 34.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.018 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -174.41 0.48 Allowed Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' ' HD2' ' A' ' 116' ' ' PRO . 99.3 Cg_exo -45.79 163.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.414 1.409 . . . . 0.0 111.811 171.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -51.83 64.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -103.69 -9.26 0.12 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -168.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 40.8 Cg_exo -42.13 -23.22 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 CA-C-N 121.683 1.637 . . . . 0.0 112.161 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 70.55 30.07 3.23 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.567 169.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.69 150.82 46.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.087 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -129.77 129.79 44.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.616 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -94.65 103.13 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.942 0.401 . . . . 0.0 109.986 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 4.4 p -92.54 110.11 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.482 0.658 . . . . 0.0 110.442 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 87.6 m -91.68 114.74 27.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.519 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.545 HD12 HD21 ' A' ' 5' ' ' LEU . 2.1 mp -87.82 129.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.618 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -111.8 119.34 38.26 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 -173.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.1 149.45 49.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.67 -57.23 13.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.436 ' H ' HG23 ' A' ' 131' ' ' ILE . 4.2 t0 -97.57 158.88 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.056 169.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.28 160.36 31.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.993 0.425 . . . . 0.0 110.767 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.29 32.13 60.5 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.043 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m 57.49 71.31 0.59 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.155 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.809 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -35.52 -49.64 1.35 Allowed Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.809 ' HD3' HG21 ' A' ' 131' ' ' ILE . 84.7 Cg_endo -99.87 109.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.336 2.024 . . . . 0.0 112.019 174.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 3.87 15.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.873 0.368 . . . . 0.0 110.606 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.85 -9.58 39.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.792 HG11 HD22 ' A' ' 95' ' ' LEU . 6.8 p -71.42 -9.26 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.585 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.6 pt -86.1 91.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 96' ' ' ASN . 11.6 pt -63.41 -29.92 48.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.446 -173.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 94' ' ' VAL . . . -148.74 148.83 30.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.215 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -150.45 135.37 17.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -142.63 153.14 43.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.032 -171.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -95.44 150.79 19.9 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.497 HG13 ' OD1' ' A' ' 145' ' ' ASN . 7.4 tt -139.37 120.23 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.443 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.56 70.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.186 0.517 . . . . 0.0 110.227 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.1 mt 56.33 30.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.355 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.497 ' OD1' HG13 ' A' ' 142' ' ' ILE . 18.5 p-10 -94.18 -24.17 17.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 mp 64.49 -88.9 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.139 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -97.45 143.21 28.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -65.56 -29.71 70.35 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 61.72 83.35 0.15 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.203 173.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -78.88 87.67 4.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.643 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.6 m170 68.07 -147.02 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.455 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -65.66 134.33 53.0 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 111.587 -175.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.012 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.78 -80.22 0.68 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.277 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -155.99 174.67 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 110.473 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -109.2 133.95 52.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 60.3 mt -113.69 147.18 38.64 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -140.1 135.1 32.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.493 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tpt180 -148.37 155.96 41.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -137.49 157.52 24.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.758 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.9 tt -138.43 133.14 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 110.47 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -31.31 27.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.536 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 53.22 2.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.802 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . 13.3 tm0? -56.58 -27.32 57.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.09 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -74.96 -39.34 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.948 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.87 -48.1 75.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.319 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -66.16 -35.28 80.06 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.411 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.458 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 tt0 -63.57 -43.35 97.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.02 -40.58 98.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.341 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.97 -31.95 71.18 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.364 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.48 7.69 71.9 Favored Glycine 0 C--O 1.234 0.129 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.652 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 4.6 mm-40 -170.93 -178.05 2.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.2 mt -82.06 38.42 0.53 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.219 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm 53.3 60.74 11.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.23 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 55.4 Cg_endo -69.09 149.95 71.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.321 2.014 . . . . 0.0 110.97 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HB3' ' H ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -143.24 -138.5 0.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.505 -173.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.435 ' H ' ' HB3' ' A' ' 24' ' ' LYS . . . 125.31 57.58 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -172.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -74.44 80.57 1.92 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.893 0.377 . . . . 0.0 111.031 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? 65.55 -160.97 0.27 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.505 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.723 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . . . 64.19 21.18 12.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 110.289 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.22 105.98 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.264 -1.334 . . . . 0.0 112.729 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t 45.78 38.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 124.166 0.916 . . . . 0.0 112.078 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.619 ' HB1' ' HA3' ' A' ' 42' ' ' GLY . . . -149.75 -50.77 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.626 ' HA ' ' HB1' ' A' ' 28' ' ' ALA . 1.2 mm 52.41 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.77 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.9 ttm-85 -177.9 102.32 0.04 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.539 ' HD2' ' HB2' ' A' ' 38' ' ' PHE . 4.3 t80 -145.8 146.03 31.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.759 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -133.26 27.03 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.58 -119.4 2.65 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -89.11 25.95 1.72 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 109.759 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.539 ' HB2' ' HD2' ' A' ' 34' ' ' TYR . 26.3 m-85 -151.75 111.31 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.149 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -86.47 70.54 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.501 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 18.1 m-85 -89.42 85.71 6.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.989 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.98 54.12 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.392 0.615 . . . . 0.0 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.619 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . -89.89 -102.64 1.12 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.057 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 21.6 mmtt -84.14 173.69 10.86 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.383 0.273 . . . . 0.0 110.552 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.82 -106.05 0.38 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.611 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m 58.52 78.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.272 0.558 . . . . 0.0 111.225 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -76.56 76.49 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.202 0.525 . . . . 0.0 110.65 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.22 -105.6 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.907 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.471 ' O ' ' NZ ' ' A' ' 51' ' ' LYS . 31.1 Cg_endo -82.91 -133.92 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.152 2.568 . . . . 0.0 112.028 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 54.34 -161.81 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.468 0.707 . . . . 0.0 111.495 176.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -93.81 -105.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.426 -0.171 . . . . 0.0 111.107 -177.095 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HA ' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER 60.67 -169.42 0.16 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.464 0.65 . . . . 0.0 112.698 174.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -48.26 -31.89 6.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.131 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.75 -60.42 3.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG13 ' HH ' ' A' ' 68' ' ' TYR . 2.2 p -62.91 -32.71 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -62.64 -53.15 58.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.166 0.508 . . . . 0.0 110.418 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.06 99.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.666 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -64.8 -48.96 72.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -70.6 -22.13 62.58 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.836 -175.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.538 HD11 ' NH2' ' A' ' 124' ' ' ARG . 17.0 mm -92.35 -54.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 0.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.91 -50.29 13.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.512 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -80.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.605 0.241 . . . . 0.0 111.412 -173.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.15 79.13 1.62 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 19.8 tp -57.33 86.06 0.01 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 111.535 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 61.55 60.27 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.0 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -34.19 68.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.372 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.33 -13.95 0.45 Allowed Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.353 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.417 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . 13.9 m -61.3 -33.0 72.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.592 ' HH ' HG13 ' A' ' 54' ' ' VAL . 19.8 m-30 -106.71 153.51 22.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.05 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.3 mt -93.1 99.6 9.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.833 0.349 . . . . 0.0 110.53 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.78 112.86 24.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.567 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -122.16 170.39 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.919 0.39 . . . . 0.0 111.005 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -98.78 158.29 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.966 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -16.97 64.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.53 134.08 45.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.156 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.7 -19.09 63.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.794 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.17 -16.51 45.42 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.666 0.27 . . . . 0.0 110.655 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -30.62 14.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.902 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.76 -60.37 3.55 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.155 0.502 . . . . 0.0 111.352 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.65 -35.44 65.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.185 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -60.63 -47.67 85.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.808 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -64.38 -51.73 61.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.46 -59.21 5.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -66.87 -35.54 80.26 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.861 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.0 m -73.49 -17.85 61.18 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.444 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 m -99.78 -2.85 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.6 0.238 . . . . 0.0 110.682 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.87 31.59 78.9 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 -9.75 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.031 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -47.48 -27.36 1.71 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.694 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.447 HD22 HD13 ' A' ' 144' ' ' ILE . 6.3 m-20 -110.11 88.48 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.99 -138.74 5.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.364 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.63 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 1.7 t80 -123.49 148.48 46.19 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.743 0.417 . . . . 0.0 110.022 -174.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.432 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 pt -140.09 139.15 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 10.6 p90 -132.13 132.21 43.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.933 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.1 m -109.98 139.69 32.17 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 CA-C-O 121.333 0.587 . . . . 0.0 110.729 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.3 mp -121.09 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.005 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -85.46 125.81 33.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.891 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.477 HH21 ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -69.49 -53.61 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -171.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.64 -20.37 65.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.061 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 135' ' ' VAL . 15.0 tp -64.61 -34.77 79.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.183 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.509 ' CE1' HG13 ' A' ' 135' ' ' VAL . 0.2 OUTLIER -67.01 -43.89 81.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.618 176.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.96 94.84 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.638 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -59.78 -50.38 74.06 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -64.98 -20.81 66.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.603 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 m 68.88 37.85 2.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.499 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -71.97 158.86 6.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.804 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.6 m-85 -77.08 102.49 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.301 -166.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.477 ' CD ' HH21 ' A' ' 97' ' ' ARG . 41.4 mt-10 -91.63 126.51 36.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.264 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.602 ' HB2' ' HD3' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -134.32 111.01 9.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.5 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -117.0 118.03 31.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.126 0.489 . . . . 0.0 109.706 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -99.81 135.66 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.344 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -92.77 142.37 27.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.342 0.592 . . . . 0.0 110.557 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.23 175.84 2.25 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.28 160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.906 1.737 . . . . 0.0 111.844 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.85 -41.23 97.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -167.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -86.26 -25.39 0.34 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.151 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 26.0 Cg_exo -39.37 -23.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.928 1.752 . . . . 0.0 112.091 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 m-20 76.15 6.22 3.68 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.223 164.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -150.11 160.72 43.44 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.951 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.42 148.55 48.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.775 174.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -96.02 105.25 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.024 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 109' ' ' GLU . 33.7 t -89.25 102.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.3 m -104.63 109.59 21.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.189 0.518 . . . . 0.0 111.248 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -89.85 116.81 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.709 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.804 ' HG2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -103.04 118.68 37.35 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.833 0.825 . . . . 0.0 110.076 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.77 163.35 20.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.958 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.492 ' HB3' HD11 ' A' ' 131' ' ' ILE . 18.3 tt0 -51.55 -29.18 16.05 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.616 0.573 . . . . 0.0 111.719 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.416 ' H ' HG21 ' A' ' 131' ' ' ILE . 36.3 t0 -140.3 160.43 40.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.471 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 1.5 t -67.42 128.27 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.578 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.93 59.69 1.85 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.578 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.3 m 47.46 70.4 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.826 HG22 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -54.71 -44.87 99.58 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.826 ' HD3' HG22 ' A' ' 131' ' ' ILE . 91.1 Cg_endo -94.0 124.59 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.112 1.875 . . . . 0.0 112.32 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -84.3 -14.9 48.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -61.4 -29.89 70.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.903 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.611 ' HA ' HD21 ' A' ' 99' ' ' LEU . 22.3 m -72.93 -12.51 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.48 93.63 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 pt -71.9 -26.45 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.923 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.65 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -144.45 139.79 28.55 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.409 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -132.48 126.92 34.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.278 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.76 160.25 40.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.592 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.423 HD23 ' HG3' ' A' ' 143' ' ' GLU . 3.1 tt -102.55 153.47 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.5 tt -137.26 133.84 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.329 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.423 ' HG3' HD23 ' A' ' 141' ' ' LEU . 31.4 mt-10 -134.0 74.68 1.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.954 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 89' ' ' ASN . 7.2 mt 52.43 50.26 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.514 0.673 . . . . 0.0 110.677 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -64.91 -54.96 22.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.869 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.456 HD13 ' H ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -95.34 43.38 1.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -171.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -139.18 156.1 47.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.1 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -120.91 -6.47 9.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.101 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -79.95 68.61 6.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -96.94 -19.44 18.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.449 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -77.22 126.61 31.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.408 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 62.37 107.33 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.461 0.705 . . . . 0.0 112.586 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.177 177.613 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.32 179.97 22.88 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.663 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 84.72 171.17 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.114 0.966 . . . . 0.0 109.907 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 141.44 48.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.594 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -99.97 135.14 41.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -96.15 141.18 29.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 0.0 110.664 -175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.13 123.01 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.397 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.518 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -119.8 157.33 15.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.863 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.511 HG22 ' HD1' ' A' ' 91' ' ' TYR . 8.3 tt -149.71 159.09 5.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.113 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 25.59 5.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.125 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.58 64.83 1.09 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.417 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.63 -23.84 67.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.558 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -61.7 -44.83 96.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.455 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.55 -41.65 88.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.234 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -59.66 -42.16 92.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.383 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -71.73 -33.55 68.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.13 -48.4 35.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -87.75 -27.71 22.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.61 75.2 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.993 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -153.02 17.57 0.57 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.89 0.345 . . . . 0.0 111.578 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.88 98.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.21 0.319 . . . . 0.0 110.686 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 10.2 mmmm 68.4 137.69 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.175 0.59 . . . . 0.0 110.879 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' HE2' ' A' ' 22' ' ' LYS . 93.9 Cg_endo -79.7 149.56 20.94 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.396 2.064 . . . . 0.0 111.987 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -81.02 -174.67 4.98 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' HA3' ' HB2' ' A' ' 49' ' ' SER . . . -82.29 -145.49 5.41 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.384 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -163.43 -64.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.747 0.273 . . . . 0.0 111.021 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -129.98 142.12 50.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.932 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' GLU . . . -78.69 -56.35 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 26.8 tt0 72.63 -61.86 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.402 -176.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -111.29 170.41 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.777 0.323 . . . . 0.0 110.675 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.586 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . . . -77.7 163.28 26.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.396 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 7.7 mm -72.78 -44.23 59.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.601 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 4.3 mmt180 54.54 55.89 7.46 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.652 174.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.604 ' HD2' ' HB2' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -85.95 113.4 22.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.65 115.62 10.02 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -169.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.34 -72.04 2.39 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.911 170.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -53.83 -39.39 65.53 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.658 0.383 . . . . 0.0 112.003 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' HD2' ' A' ' 34' ' ' TYR . 15.3 m-85 -139.69 92.48 2.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.789 0.328 . . . . 0.0 110.716 -175.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -70.05 78.13 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.53 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -82.16 164.44 21.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.456 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -93.8 -108.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . 175.2 -67.96 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -81.24 54.17 2.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.357 0.598 . . . . 0.0 109.523 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.16 59.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 m 72.94 -57.18 0.64 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.18 0.592 . . . . 0.0 111.498 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.44 -36.09 80.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.62 71.69 0.46 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -90.25 -50.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.996 2.464 . . . . 0.0 114.408 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.403 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -89.35 42.69 1.1 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -103.44 -74.33 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.03 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 39.0 mtmt 58.26 179.13 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.885 0.85 . . . . 0.0 113.083 171.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.45 -24.31 54.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.809 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.43 -68.44 0.17 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.096 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG21 ' SG ' ' A' ' 67' ' ' CYS . 3.6 p -79.96 -26.27 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.189 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -63.36 -53.62 49.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.93 0.395 . . . . 0.0 110.039 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.549 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.403 ' HD2' ' HG1' ' A' ' 61' ' ' THR . 20.9 t-160 -56.24 -52.23 65.22 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.043 0.449 . . . . 0.0 109.941 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -62.4 -48.78 78.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.236 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.74 -41.2 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -84.71 -54.62 4.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.588 0.232 . . . . 0.0 111.401 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.403 ' HG1' ' HD2' ' A' ' 57' ' ' HIS . 88.2 m -74.92 -31.62 61.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -175.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.24 -161.89 12.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.142 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.45 73.22 6.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.612 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -71.58 -14.43 62.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.16 -171.52 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.651 171.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.45 -50.7 4.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.807 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.587 ' SG ' HG21 ' A' ' 54' ' ' VAL . 34.6 t -84.87 -46.1 11.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -115.21 143.77 44.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.257 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.91 99.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.943 0.401 . . . . 0.0 110.229 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.0 m -80.49 122.67 27.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.653 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.434 ' OG1' ' HB3' ' A' ' 5' ' ' LEU . 2.2 m -127.21 131.36 50.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.091 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.605 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -80.36 167.87 19.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.618 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.1 p -81.82 9.64 7.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.064 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.92 133.28 56.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.165 0.507 . . . . 0.0 110.899 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -65.17 -19.75 66.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.008 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.57 -5.14 49.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.021 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.605 HD13 ' H ' ' A' ' 72' ' ' THR . 2.7 tt -48.22 -34.51 4.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.547 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.74 -53.57 56.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -70.59 -46.04 64.19 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.769 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -60.03 -48.23 82.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.53 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 6.0 t80 -67.35 -53.96 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.109 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.532 ' HB1' HG23 ' A' ' 87' ' ' ILE . . . -56.61 -42.83 79.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.332 -176.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 m -70.85 -48.16 55.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.227 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 -20.55 66.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.691 0.282 . . . . 0.0 111.54 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -93.83 9.62 36.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.87 36.71 67.23 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.785 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.532 HG23 ' HB1' ' A' ' 82' ' ' ALA . 3.3 tp -70.76 -10.2 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 2.0 tm-20 -38.56 -37.51 0.32 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.502 0.501 . . . . 0.0 111.193 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.07 89.18 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.85 -152.61 11.96 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.139 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.511 ' HD1' HG22 ' A' ' 9' ' ' ILE . 48.0 t80 -129.89 135.87 48.86 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.503 ' HB ' HG12 ' A' ' 87' ' ' ILE . 9.9 tt -139.97 138.9 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.42 . . . . 0.0 111.516 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -131.8 156.75 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.545 HG21 ' HB3' ' A' ' 138' ' ' ALA . 1.7 m -128.17 137.35 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -113.82 140.63 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.356 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -81.92 146.28 29.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.711 0.291 . . . . 0.0 110.702 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -94.27 -24.98 17.23 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.36 -43.4 67.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.345 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.465 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -67.14 -36.92 82.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.939 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.72 99.6 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -59.19 -53.44 58.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.339 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -70.93 -16.75 62.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.043 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m 63.88 47.97 3.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.509 0.671 . . . . 0.0 110.222 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -62.62 163.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.523 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.575 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 7.3 m-85 -74.6 99.78 3.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.129 0.49 . . . . 0.0 110.491 -170.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.94 101.61 13.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.766 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.499 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 54.6 t80 -116.49 125.3 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.1 140.61 47.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.804 0.335 . . . . 0.0 111.264 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 120' ' ' GLU . 2.5 m -123.92 150.13 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.291 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.18 142.34 27.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.89 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 118' ' ' GLU . 3.0 m170 -84.99 175.09 4.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.535 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.0 Cg_exo -50.4 170.2 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.025 1.817 . . . . 0.0 112.461 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -53.13 -64.68 0.74 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -166.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.452 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.5 t-20 -93.79 -12.47 0.18 Allowed Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.535 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 52.0 Cg_exo -44.87 -24.04 1.1 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 CA-C-N 121.421 1.543 . . . . 0.0 111.174 163.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 72.25 -11.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.541 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 3.8 mt-10 -102.67 155.15 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.143 0.497 . . . . 0.0 111.029 -172.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -115.03 133.75 55.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.486 ' HB3' HG22 ' A' ' 110' ' ' VAL . 1.1 tm-20 -89.04 135.32 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.36 100.4 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.467 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -74.23 113.27 11.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.299 177.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 HD23 ' A' ' 5' ' ' LEU . 7.0 mm -87.45 100.19 9.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.575 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 48.6 mtt-85 -101.59 110.13 22.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.437 -172.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.5 160.34 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.365 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.49 -49.94 68.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.678 ' H ' HG23 ' A' ' 131' ' ' ILE . 30.5 t70 -110.18 160.28 16.63 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.15 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 12.3 t -80.39 129.41 34.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.91 69.2 1.19 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.975 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 31.2 m 46.87 70.29 0.41 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.78 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -69.33 -44.44 26.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.78 ' HD3' HG21 ' A' ' 131' ' ' ILE . 83.5 Cg_endo -97.92 109.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.451 2.101 . . . . 0.0 111.707 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.63 -27.46 45.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.638 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.18 -9.07 58.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 95' ' ' LEU . 6.4 p -73.13 -15.18 17.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.9 mt -86.94 89.64 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.6 pt -80.23 -28.03 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.422 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.545 ' HB3' HG21 ' A' ' 94' ' ' VAL . . . -128.17 140.12 52.1 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' OH ' ' A' ' 91' ' ' TYR . 12.1 ttmt -141.62 126.49 18.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.273 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.37 131.41 24.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.775 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 tt -92.68 151.89 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -140.52 122.29 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.177 0.513 . . . . 0.0 112.031 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -126.79 93.16 3.7 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.001 176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 2.1 mt 52.93 44.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.407 0.683 . . . . 0.0 111.778 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.89 65.91 6.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.333 0.587 . . . . 0.0 110.267 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.1 -85.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.267 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.51 166.48 11.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -162.37 66.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 0.0 110.494 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -76.95 -171.67 2.05 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.866 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.09 69.5 0.73 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.403 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 28.5 m170 65.91 -134.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.476 -174.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.403 ' H ' ' HB3' ' A' ' 151' ' ' HIS . 73.7 m80 65.2 13.56 8.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.233 0.54 . . . . 0.0 110.502 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.623 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.698 ' SD ' ' HD3' ' A' ' 97' ' ' ARG . 21.4 ttt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.753 0.311 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.22 45.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.689 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -149.54 153.19 36.79 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.93 174.93 10.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.554 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.534 HD11 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -118.97 159.07 24.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.098 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.425 ' HE2' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.67 132.39 55.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 -177.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.504 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 12.1 ttt180 -131.49 94.77 3.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -90.42 157.48 25.74 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.142 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.7 mt -125.47 128.71 72.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.869 0.366 . . . . 0.0 110.122 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.86 -31.01 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.858 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.7 p -94.43 55.32 1.96 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.92 -29.44 8.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.315 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -70.85 -38.8 73.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.386 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.655 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -72.96 -36.18 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.722 -179.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.55 -53.39 28.78 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.454 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -59.81 -36.06 75.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.92 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 15.3 t-20 -68.27 -39.88 82.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.183 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -67.18 -32.47 73.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.293 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 2.36 73.36 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.116 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -169.86 177.75 4.28 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.1 mt -81.38 49.02 1.22 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.479 0.18 . . . . 0.0 111.166 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt 54.7 69.26 2.15 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.415 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 67.1 Cg_endo -86.21 148.57 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.71 2.273 . . . . 0.0 112.233 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -148.79 4.69 0.66 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.31 96.54 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -152.97 21.77 0.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HZ2' ' CG ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -141.28 122.09 14.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 110.032 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.77 -110.71 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.543 -168.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 54.59 63.21 2.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.23 0.538 . . . . 0.0 110.168 -173.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.5 86.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.555 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 43' ' ' LYS . . . -131.97 27.43 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.962 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.512 HG21 ' HA3' ' A' ' 42' ' ' GLY . 2.3 pt -135.92 145.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.76 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -157.79 149.59 21.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -69.57 73.63 0.37 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.142 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -50.95 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.081 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.11 -44.96 0.65 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . 16.2 mttp -85.16 119.24 25.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -77.13 30.22 0.14 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 37' ' ' LYS . 32.7 mtpt -114.68 19.18 16.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 110.386 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 80.18 1.09 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 109.834 176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -68.03 78.75 0.23 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.512 ' HA3' HG21 ' A' ' 32' ' ' ILE . . . -87.22 -179.94 48.35 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.471 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' H ' ' HB3' ' A' ' 31' ' ' ALA . 45.4 mttm 67.07 179.61 0.22 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.906 0.482 . . . . 0.0 110.908 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.68 -156.67 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.311 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -15.13 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.695 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -34.73 69.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 175.84 73.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.006 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.29 -21.22 23.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.61 2.207 . . . . 0.0 111.67 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.3 p -91.41 15.35 12.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.57 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -51.53 -39.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.375 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -56.02 -68.85 0.17 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.69 -53.03 34.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.024 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.56 -61.97 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.552 HG11 HH21 ' A' ' 124' ' ' ARG . 3.5 p -67.9 -37.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -172.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.476 ' O ' HG12 ' A' ' 59' ' ' ILE . 6.5 m-85 -63.41 -59.49 4.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.08 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.98 83.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.081 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.41 -29.58 69.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.704 HE22 ' HB3' ' A' ' 67' ' ' CYS . 8.6 tp-100 -67.62 -45.21 76.09 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 109.834 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 55' ' ' TYR . 18.4 mm -66.02 -31.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.437 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -81.58 -74.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.559 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 p -95.68 -38.72 10.24 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.39 48.18 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mp 59.97 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 111.37 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -95.72 64.33 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.365 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 63.54 -74.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.675 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.45 66.84 0.51 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.704 ' HB3' HE22 ' A' ' 58' ' ' GLN . 8.0 t -56.93 -42.7 80.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.959 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.626 ' HD2' ' HG2' ' A' ' 58' ' ' GLN . 21.4 m-85 -123.39 159.72 28.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.37 104.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 21.3 m -87.39 111.22 20.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 t -123.85 157.22 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.42 ' HG1' ' HB ' ' A' ' 77' ' ' ILE . 36.1 p -87.52 158.49 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -13.16 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.807 0.336 . . . . 0.0 110.9 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -79.79 130.53 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.832 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -58.61 -24.07 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.643 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.02 1.03 22.19 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.669 0.271 . . . . 0.0 111.0 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.42 ' HB ' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -48.93 -34.06 5.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.651 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.04 -57.56 12.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 111.372 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -70.42 -43.09 70.67 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.832 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -60.62 -46.46 90.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.282 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -68.82 -44.39 73.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.294 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -57.2 -50.61 72.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.68 -44.4 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -15.64 63.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.419 ' HB2' HG13 ' A' ' 87' ' ' ILE . 6.8 m -105.42 2.75 28.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.22 96.6 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.253 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.568 HD13 ' HA3' ' A' ' 8' ' ' GLY . 10.1 mt -91.01 -7.8 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -29.21 -43.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.732 0.813 . . . . 0.0 113.186 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -125.17 92.72 3.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.03 -144.73 6.35 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.917 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.425 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -105.09 143.37 33.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.72 0.408 . . . . 0.0 110.448 -175.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.507 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 5.4 pt -139.88 113.92 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 110.296 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -101.99 156.31 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -129.36 136.92 58.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.535 HD22 HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -128.34 133.9 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.295 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.459 ' HB2' HG21 ' A' ' 137' ' ' ILE . 48.5 t-20 -79.5 134.83 36.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.485 0.183 . . . . 0.0 110.701 -175.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.698 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.69 -51.64 13.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.333 -176.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.43 -17.8 64.85 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.782 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.17 -45.61 90.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.344 0.592 . . . . 0.0 109.536 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.483 ' HE2' HD12 ' A' ' 5' ' ' LEU . 59.9 m-85 -66.48 -35.48 80.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.951 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.59 93.1 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.952 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -72.41 -37.2 68.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.136 0.493 . . . . 0.0 110.023 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -75.76 -23.39 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m 69.71 33.93 2.82 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.788 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -65.13 163.92 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.922 174.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.554 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.3 m-85 -74.45 99.29 3.51 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.593 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -96.8 99.32 10.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.75 112.39 24.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.614 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -105.02 107.45 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.925 0.393 . . . . 0.0 110.177 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.577 HG12 ' HB3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -91.25 107.54 18.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.35 129.04 34.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.528 0.68 . . . . 0.0 109.455 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -80.75 169.35 19.82 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.146 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.82 167.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.217 1.945 . . . . 0.0 112.407 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.81 -55.96 28.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.45 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.0 OUTLIER -87.88 -14.74 0.21 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -168.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 45.6 Cg_exo -43.44 -23.36 0.47 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 121.392 1.533 . . . . 0.0 111.298 162.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 67.84 27.82 7.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.584 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -160.33 154.51 23.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.239 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 135.96 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.577 ' HB3' HG12 ' A' ' 110' ' ' VAL . 19.0 tt0 -98.5 113.56 25.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.428 . . . . 0.0 111.016 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 t -95.73 103.77 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.981 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 58.3 m -93.19 112.47 24.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.413 HG21 ' CD2' ' A' ' 100' ' ' PHE . 4.2 mp -88.68 110.04 20.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.586 ' O ' HG22 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -100.41 116.82 33.26 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.558 178.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.99 159.55 33.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.052 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 126' ' ' GLU . 1.2 mm-40 -48.16 -59.55 3.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 111.012 -176.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.752 ' H ' HG21 ' A' ' 131' ' ' ILE . 48.4 t0 -104.63 154.98 19.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.622 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -76.41 140.68 41.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' A' ' 67' ' ' CYS . . . 90.9 49.34 3.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.766 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.504 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 32.0 m 52.14 70.88 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.047 0.451 . . . . 0.0 112.206 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.752 HG21 ' H ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -69.28 -38.35 10.42 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.605 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 95.4 Cg_endo -82.68 118.88 2.87 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 121.267 1.311 . . . . 0.0 112.005 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.1 -31.27 69.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.28 10.07 9.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.494 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.605 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 4.2 p -63.29 -29.8 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.611 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.49 93.38 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.459 HG21 ' HB2' ' A' ' 96' ' ' ASN . 18.0 pt -74.86 -32.71 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.102 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.557 ' HB2' HG22 ' A' ' 94' ' ' VAL . . . -161.56 166.78 26.48 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.371 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -145.42 144.49 30.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.167 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -141.08 160.44 40.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.851 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.39 148.39 25.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.07 137.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.192 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 105.64 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.205 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 72.5 mt 66.15 102.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.562 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -77.34 66.26 3.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.51 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 tp -92.11 -62.84 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.828 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -152.4 123.52 7.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.64 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -74.99 82.34 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -43.12 118.88 1.39 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.139 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -58.29 125.4 23.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.895 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -79.87 101.15 8.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.025 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -90.49 -42.73 10.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.64 178.059 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' SD ' HG23 ' A' ' 73' ' ' THR . 1.8 ttt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.53 -161.69 34.68 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.393 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -169.86 -50.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' HZ ' ' HB3' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -157.73 154.65 28.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.097 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.478 ' HB2' HD12 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -122.68 151.02 41.94 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.837 0.351 . . . . 0.0 110.597 -174.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.63 136.61 52.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.044 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 15.2 tpt180 -142.43 102.39 4.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.77 137.12 13.22 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.46 129.66 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.207 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -28.57 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 110.313 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -90.09 42.29 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.808 -178.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.24 -34.59 23.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.148 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -68.93 -42.99 76.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.563 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.6 t70 -65.4 -42.55 92.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' A' ' 21' ' ' LEU . 2.1 tt0 -61.85 -54.83 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.718 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.65 -32.5 71.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.785 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -35.03 74.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.931 0.396 . . . . 0.0 110.189 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -73.87 -24.31 59.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.784 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.05 5.41 89.73 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.37 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -169.7 162.16 9.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.559 HD11 ' HG ' ' A' ' 130' ' ' CYS . 1.5 mt -69.33 73.32 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 66.27 149.47 0.12 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.919 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 145.53 82.1 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.592 2.195 . . . . 0.0 111.734 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.26 139.42 37.4 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.508 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.05 99.17 0.18 Allowed Glycine 0 CA--C 1.517 0.179 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -93.0 156.1 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.278 0.561 . . . . 0.0 111.757 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -115.18 52.76 0.85 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.031 172.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -61.0 2.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.85 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 31' ' ' ALA . 2.0 mm-40 55.42 35.29 24.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 176.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 t 65.01 -3.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.338 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . . . -89.16 47.1 1.45 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.958 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG21 ' HZ ' ' A' ' 106' ' ' PHE . 11.9 mt -147.38 137.22 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.952 175.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -137.35 -29.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.364 -0.134 . . . . 0.0 111.133 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.8 t80 57.8 55.4 5.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.525 0.679 . . . . 0.0 110.172 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 82.99 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.132 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.04 -65.12 4.2 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -105.71 -179.57 3.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -74.32 69.09 1.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.101 0.476 . . . . 0.0 110.529 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -109.2 126.94 53.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.069 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -168.67 167.36 11.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.822 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 13.1 t70 -88.65 113.47 24.24 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.069 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 131.78 11.93 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.03 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -98.4 106.22 18.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.859 0.33 . . . . 0.0 110.919 -174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 53.81 -128.74 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.433 0.458 . . . . 0.0 111.534 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -75.66 -4.7 41.66 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.277 0.231 . . . . 0.0 111.276 -179.088 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 45' ' ' THR . 9.2 m80 76.11 -49.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.633 0.773 . . . . 0.0 111.461 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.87 -171.99 24.27 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.981 -0.447 . . . . 0.0 111.981 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -87.64 -3.12 7.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.526 . . . . 0.0 112.238 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 50' ' ' VAL . 60.5 m -128.24 155.4 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.941 -173.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 49' ' ' SER . 0.3 OUTLIER 61.25 172.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.799 0.84 . . . . 0.0 112.339 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.482 ' HE3' HG12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER 59.05 -172.18 0.11 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.746 174.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -53.3 -27.47 23.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.36 -66.43 0.39 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.733 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -30.82 49.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.664 0.268 . . . . 0.0 110.96 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.67 ' HA ' ' NH1' ' A' ' 124' ' ' ARG . 22.6 m-30 -62.35 -61.54 2.38 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.649 0.262 . . . . 0.0 110.591 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.75 77.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -52.11 -59.33 4.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.522 ' NE2' ' SG ' ' A' ' 128' ' ' CYS . 1.4 tp-100 -65.72 -51.32 60.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.003 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.466 HG13 ' HE1' ' A' ' 64' ' ' TYR . 2.7 tt -76.91 -24.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.78 -35.89 12.54 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.571 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -89.68 -58.8 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.581 0.229 . . . . 0.0 111.321 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.38 -128.1 6.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.198 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -156.18 -157.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.5 m-85 -98.26 -6.85 30.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.092 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -60.78 91.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 111.288 -172.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.64 -39.03 3.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.222 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.609 ' SG ' ' CZ ' ' A' ' 68' ' ' TYR . 51.8 t -78.92 -48.22 14.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.144 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.609 ' CZ ' ' SG ' ' A' ' 67' ' ' CYS . 30.3 m-85 -129.17 162.68 27.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.658 0.383 . . . . 0.0 110.467 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.6 mp -92.15 99.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 111.019 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 m -75.73 109.96 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.443 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -118.26 129.09 55.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.275 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.556 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.1 m -75.91 157.46 33.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.503 HG23 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -86.07 9.86 16.03 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.643 -177.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 76' ' ' GLU . 16.2 t70 -109.33 135.7 49.96 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.494 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -55.46 -26.15 40.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' HG3' ' HE2' ' A' ' 75' ' ' LYS . 11.2 mt-10 -82.81 2.03 36.13 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 121.999 0.12 . . . . 0.0 111.075 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -44.61 -38.57 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.457 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HB3' ' HZ ' ' A' ' 4' ' ' PHE . . . -60.03 -55.88 28.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.226 0.536 . . . . 0.0 110.988 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.79 -42.09 67.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.275 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.299 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -65.74 -49.48 68.29 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.703 ' HB2' HG21 ' A' ' 87' ' ' ILE . . . -53.5 -56.46 16.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.303 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -63.3 -39.85 95.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.222 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 m -65.58 -25.6 67.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.941 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -90.4 0.18 57.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.696 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 54.8 30.78 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.703 HG21 ' HB2' ' A' ' 82' ' ' ALA . 4.2 tp -77.12 -9.9 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HG2' HD13 ' A' ' 144' ' ' ILE . 4.2 tt0 -33.32 -47.72 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.492 0.495 . . . . 0.0 111.281 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -131.36 118.01 19.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.938 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 166.25 -168.44 39.9 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.091 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.85 137.55 32.24 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.91 0.484 . . . . 0.0 109.744 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.48 111.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.7 0.286 . . . . 0.0 110.287 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 3.6 m-30 -111.68 143.4 42.64 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.663 HG21 ' HB1' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -129.97 130.32 66.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.02 178.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.525 HD21 HG13 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -125.04 141.34 52.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.497 -177.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 99' ' ' LEU . 23.5 t-20 -85.58 132.53 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -62.48 -48.25 80.44 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.709 -175.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 1.3 tp -62.84 -43.33 99.09 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.401 ' CD2' HG21 ' A' ' 123' ' ' ILE . 33.2 m-85 -62.91 -41.05 99.33 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.592 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.62 -36.03 88.04 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.802 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.07 -44.94 83.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -69.26 -16.62 63.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.3 m 72.13 31.0 2.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.608 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 124' ' ' ARG . 1.7 mt -75.55 157.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' HZ ' HG21 ' A' ' 32' ' ' ILE . 7.7 m-85 -83.6 101.95 11.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.734 -163.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -94.87 105.74 17.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.663 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.422 ' HE2' ' HE ' ' A' ' 124' ' ' ARG . 10.6 p90 -126.57 145.27 50.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.991 0.425 . . . . 0.0 110.032 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -95.45 125.27 39.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.689 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 120' ' ' GLU . 1.6 p -90.75 106.85 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.8 145.98 27.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -108.36 170.58 5.34 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.7 Cg_exo -47.7 170.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.452 2.101 . . . . 0.0 113.068 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -46.57 -67.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -93.28 -11.81 0.17 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 35.8 Cg_exo -43.88 -20.49 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 CA-C-N 121.556 1.592 . . . . 0.0 112.683 164.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.09 9.39 6.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.407 0.683 . . . . 0.0 111.708 170.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -110.09 115.61 30.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.217 0.532 . . . . 0.0 112.102 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -138.33 95.75 3.06 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 110' ' ' VAL . 9.7 tt0 -93.96 140.21 29.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.737 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.92 106.26 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -92.47 121.86 34.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 18.1 mm -88.71 93.42 4.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.153 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.67 ' NH1' ' HA ' ' A' ' 55' ' ' TYR . 6.8 tpp180 -82.1 99.71 9.36 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.192 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.441 ' HB3' HG22 ' A' ' 131' ' ' ILE . . . -70.52 160.51 32.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.828 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.09 -30.81 66.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -147.44 160.87 42.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.522 ' SG ' ' NE2' ' A' ' 58' ' ' GLN . 76.7 m -61.7 149.94 38.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.983 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.42 26.78 50.43 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.873 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.559 ' HG ' HD11 ' A' ' 21' ' ' LEU . 1.8 m 57.21 72.0 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.708 0.29 . . . . 0.0 110.485 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.796 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -38.85 -46.2 3.17 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.796 ' HD3' HG21 ' A' ' 131' ' ' ILE . 85.2 Cg_endo -85.68 107.67 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 120.651 1.268 . . . . 0.0 111.07 173.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -24.69 64.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.263 0.554 . . . . 0.0 110.528 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.56 3.52 15.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.374 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.525 HG13 HD21 ' A' ' 95' ' ' LEU . 2.4 p -77.9 -8.76 11.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.267 0.556 . . . . 0.0 110.733 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mm -86.2 96.14 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 pt -64.12 -32.99 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.137 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.663 ' HB1' HG21 ' A' ' 94' ' ' VAL . . . -144.68 136.3 25.61 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.024 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.1 mtmt -111.42 129.08 56.13 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.328 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -140.98 160.46 40.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.541 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 tt -135.93 150.3 49.25 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 145' ' ' ASN . 21.2 tt -140.84 147.93 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.801 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.28 103.4 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.791 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.414 HD13 ' HG2' ' A' ' 88' ' ' GLU . 20.2 mm 61.56 85.53 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.242 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.641 ' HB2' HD11 ' A' ' 142' ' ' ILE . 25.5 t30 -65.26 -37.71 88.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.649 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.2 mt -131.92 172.68 12.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.212 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.88 -41.48 67.95 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.325 0.583 . . . . 0.0 110.049 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -132.99 177.23 7.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 51.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.395 0.617 . . . . 0.0 109.991 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 130.46 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.11 -19.54 36.52 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.501 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -134.7 151.98 51.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.903 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.838 178.519 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.18 85.1 0.81 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.024 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -113.63 3.56 15.71 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 97' ' ' ARG . 38.0 p90 39.73 -170.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.688 1.195 . . . . 0.0 113.54 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -147.33 160.59 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.21 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -121.19 129.56 53.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.628 -170.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.507 ' HD2' HG23 ' A' ' 69' ' ' ILE . 18.0 ttt180 -140.95 155.12 46.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.92 158.07 16.65 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.931 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.808 HG23 ' HB3' ' A' ' 91' ' ' TYR . 1.1 tt -139.07 129.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.122 0.487 . . . . 0.0 110.468 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.14 -2.04 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 109.378 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 35.93 1.82 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.659 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -56.74 -32.73 65.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.444 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.56 -38.76 77.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.814 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 -45.75 92.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.909 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.03 -52.2 66.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.42 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.49 -27.63 66.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -71.74 -40.96 69.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -85.13 -28.4 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.87 51.32 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 21' ' ' LEU . 4.1 tt0 174.44 158.36 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.528 0.731 . . . . 0.0 109.498 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.491 ' N ' ' HG2' ' A' ' 20' ' ' GLN . 54.0 mt -65.02 97.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.86 154.31 0.14 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.803 0.69 . . . . 0.0 110.645 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.97 167.2 26.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.765 2.31 . . . . 0.0 112.483 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -108.98 141.27 41.32 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.074 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' HA3' HG21 ' A' ' 45' ' ' THR . . . -112.07 -152.31 11.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.454 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 45' ' ' THR . 56.3 t30 -128.54 136.29 50.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -62.19 132.47 52.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.519 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.01 112.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.821 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 42' ' ' GLY . 2.6 tp10 -114.55 131.87 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.891 0.377 . . . . 0.0 110.934 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.89 5.99 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.875 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.07 -147.41 0.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.555 ' HA ' ' HB2' ' A' ' 52' ' ' ASN . 23.0 mt 75.55 104.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 123.658 0.783 . . . . 0.0 111.418 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -137.05 -45.61 0.57 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.511 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER 67.49 124.79 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.277 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.16 -18.52 65.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.7 4.77 81.23 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.136 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 52.04 58.35 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.65 -41.36 21.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.422 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.27 88.78 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.2 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.511 ' HE1' ' HB2' ' A' ' 34' ' ' TYR . 4.0 p90 -140.16 31.44 1.96 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.557 0.694 . . . . 0.0 109.624 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.49 148.08 25.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.805 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' A' ' 29' ' ' GLU . . . 151.24 -58.41 0.43 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.032 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' NZ ' HD13 ' A' ' 131' ' ' ILE . 58.0 tttt -132.54 116.89 17.29 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.861 -0.199 . . . . 0.0 111.347 -172.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.27 141.75 0.33 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.78 0.675 . . . . 0.0 109.453 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.456 HG21 ' HA3' ' A' ' 25' ' ' GLY . 35.6 m -69.26 152.7 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.017 0.437 . . . . 0.0 111.537 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -77.84 67.18 3.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.954 174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.97 -173.11 49.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.723 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.05 -22.48 41.41 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.942 2.428 . . . . 0.0 111.669 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 m -149.72 -107.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.702 HG13 ' H ' ' A' ' 51' ' ' LYS . 1.8 t 54.51 -174.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.573 0.349 . . . . 0.0 110.53 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.702 ' H ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER 57.74 -154.23 0.36 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 111.832 173.027 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.555 ' HB2' ' HA ' ' A' ' 32' ' ' ILE . 1.2 t30 -59.66 -27.24 66.21 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.845 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.44 -60.23 4.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.528 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.8 p -63.35 -35.4 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.509 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.1 m-85 -59.88 -63.17 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.573 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.2 -46.33 79.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.175 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -62.05 -46.28 89.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 0.0 111.007 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 1.3 pt20 -70.05 -30.26 67.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.316 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HD13 ' HG3' ' A' ' 58' ' ' GLN . 1.2 mp -81.21 -47.39 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.661 0.267 . . . . 0.0 110.722 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.79 -57.18 5.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.004 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.7 m -74.67 -26.35 59.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.03 78.83 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.222 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.55 HD11 ' H ' ' A' ' 65' ' ' ASP . 0.8 OUTLIER -65.68 -33.38 75.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.174 -178.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 t80 33.74 46.87 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.795 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.55 ' H ' HD11 ' A' ' 63' ' ' LEU . 37.4 t70 -90.4 -0.27 57.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 109.408 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.07 144.81 46.67 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.417 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 p -71.21 0.77 7.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -65.31 158.79 25.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.507 HG23 ' HD2' ' A' ' 7' ' ' ARG . 18.1 mt -102.75 138.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.95 131.0 42.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 172.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 5' ' ' LEU . 96.9 m -140.8 110.1 6.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 3.4 m -68.97 152.85 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.103 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 10.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -136.96 142.4 42.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.526 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -54.47 -19.81 6.44 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.733 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.21 -31.21 13.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.862 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -48.07 -31.08 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.27 -54.72 40.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -45.41 62.93 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.765 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -58.52 -49.18 78.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.352 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 7' ' ' ARG . 27.2 t80 -67.48 -49.22 64.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.475 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.57 -47.11 76.96 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.507 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -75.91 -39.32 56.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.814 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.3 m -72.69 -20.15 61.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -96.62 3.66 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.5 76.03 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.655 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.439 HD13 ' HA3' ' A' ' 8' ' ' GLY . 4.6 mt -72.97 -7.26 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.508 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.8 mt-10 -28.68 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -126.46 99.97 6.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.997 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.49 -139.97 5.34 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.77 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.808 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.2 t80 -124.47 150.88 45.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.497 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.3 pt -136.84 142.54 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 111.103 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -132.63 135.11 45.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 111.704 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 m -113.92 139.3 40.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.564 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.524 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -125.97 142.04 51.7 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.124 -173.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -79.68 124.59 28.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.815 0.341 . . . . 0.0 111.139 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.532 ' HB2' HD22 ' A' ' 5' ' ' LEU . 46.9 ttt180 -75.64 -32.76 60.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.49 79.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 135' ' ' VAL . 9.6 tp -65.27 -37.73 88.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.793 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.529 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 22.6 m-85 -62.07 -42.71 99.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.761 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.13 -36.25 92.07 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.655 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.62 -48.3 69.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.133 0.492 . . . . 0.0 109.901 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -66.43 -16.45 64.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.584 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m 67.69 30.84 6.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.37 0.605 . . . . 0.0 110.291 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 124' ' ' ARG . 3.5 mt -68.91 152.2 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.778 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.32 101.42 10.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 111.187 -166.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -106.36 120.65 42.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.954 0.407 . . . . 0.0 110.097 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -115.74 120.08 38.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.712 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 tt0 -91.44 132.81 35.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 111.233 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 m -117.75 149.16 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.774 171.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.62 135.14 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 110.631 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -79.44 178.06 2.54 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.526 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.7 Cg_exo -50.08 158.01 2.55 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.229 1.286 . . . . 0.0 111.427 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.54 -70.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' ' 115' ' ' ASN . 0.6 OUTLIER -88.88 -9.7 0.14 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -166.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 68.0 Cg_exo -47.26 -24.32 3.7 Favored 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.535 1.584 . . . . 0.0 110.716 161.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.58 32.29 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.032 169.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.72 105.09 13.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.395 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -104.56 107.33 18.22 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.47 125.7 48.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 19.1 t -116.75 106.46 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.37 116.48 22.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.758 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 5' ' ' LEU . 9.5 mm -87.77 110.82 21.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.82 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.509 ' O ' HG22 ' A' ' 105' ' ' ILE . 1.4 mtt-85 -111.96 106.77 15.55 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.816 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.91 162.3 28.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.64 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.34 -24.83 67.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.332 0.586 . . . . 0.0 110.376 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.24 162.42 33.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.236 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.3 t -80.44 144.39 32.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.47 32.19 14.23 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.529 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.7 m 57.48 68.49 0.84 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.256 0.551 . . . . 0.0 110.537 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.783 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -46.56 -49.89 43.71 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.959 -175.702 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.783 ' HD3' HG23 ' A' ' 131' ' ' ILE . 93.9 Cg_endo -88.44 107.73 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.33 1.353 . . . . 0.0 112.118 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -76.83 2.15 15.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.108 0.48 . . . . 0.0 110.763 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -90.36 -15.37 31.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.667 ' HA ' HD22 ' A' ' 99' ' ' LEU . 4.0 p -81.58 -14.05 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.572 HD12 ' HB3' ' A' ' 139' ' ' LYS . 1.1 tt -87.65 97.54 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.0 pt -75.45 -29.65 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.63 -170.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -151.7 146.17 25.58 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.634 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.572 ' HB3' HD12 ' A' ' 136' ' ' ILE . 45.7 pttt -150.32 130.18 13.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.765 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.68 160.7 39.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.889 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 tt -75.74 145.98 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.435 ' HB ' HG12 ' A' ' 92' ' ' ILE . 20.4 tt -125.3 141.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 0.0 110.214 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -149.17 126.6 11.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.552 -177.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 5.1 tt -45.97 93.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 124.183 0.927 . . . . 0.0 108.952 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 179.83 -37.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.938 -165.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tt 71.24 107.43 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.01 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 61.16 7.58 1.67 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.834 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 20.62 5.12 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.633 0.373 . . . . 0.0 110.324 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.8 p80 25.47 56.04 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.423 1.089 . . . . 0.0 112.525 -172.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -177.24 -71.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.043 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 47.31 62.38 2.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.106 0.479 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -68.99 115.26 8.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.823 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.332 178.52 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 mmm . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.99 -173.52 13.36 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.096 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 97' ' ' ARG . 53.0 t30 -61.02 159.04 12.25 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.03 125.71 35.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.272 -175.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 3.9 mp -100.64 152.39 20.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.81 133.54 36.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.344 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.67 ' HG3' HH11 ' A' ' 7' ' ' ARG . 0.9 OUTLIER -147.69 130.1 15.75 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' HA3' HG21 ' A' ' 92' ' ' ILE . . . -125.23 157.17 19.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.011 -176.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.25 128.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -15.6 18.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.252 0.549 . . . . 0.0 110.214 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -83.34 60.82 5.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.48 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -27.26 19.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -49.33 28.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.449 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.6 OUTLIER -56.65 -43.2 80.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.204 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -33.01 64.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.438 -177.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -79.46 -16.71 55.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.495 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.12 -40.08 24.62 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.631 ' ND2' ' H ' ' A' ' 22' ' ' LYS . 13.0 t30 -89.15 -65.48 1.01 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.88 41.73 8.03 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.55 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -175.53 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.8 mt 53.07 42.62 32.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.52 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.631 ' H ' ' ND2' ' A' ' 18' ' ' ASN . 17.3 ttpp 44.6 74.84 0.73 Allowed Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 123.127 0.571 . . . . 0.0 112.178 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HD3' HD22 ' A' ' 18' ' ' ASN . 71.0 Cg_endo -84.37 161.78 13.0 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.796 2.331 . . . . 0.0 112.947 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HG2' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -165.48 149.79 8.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.736 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.96 166.99 23.24 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.383 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.57 179.61 1.71 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.543 0.337 . . . . 0.0 110.337 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 9.0 mptt -74.22 145.96 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -173.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.96 -69.68 0.66 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.752 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 171.66 -157.44 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.193 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.1 75.28 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.206 0.527 . . . . 0.0 109.836 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.21 6.36 49.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.83 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mt -134.75 117.93 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.546 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -145.79 76.26 1.46 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.447 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 21.2 m-30 -85.27 -106.72 0.05 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -170.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -156.19 -141.78 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.455 -0.153 . . . . 0.0 110.921 -168.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.39 142.56 42.8 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.724 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 59.55 23.64 12.33 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.938 0.495 . . . . 0.0 110.833 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 20.0 m-85 -129.17 40.63 3.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.957 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 77.53 0.11 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.566 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -155.27 111.78 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.441 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -19.28 57.49 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.85 -71.28 0.27 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.129 -0.558 . . . . 0.0 111.793 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HE2' ' HG2' ' A' ' 126' ' ' GLU . 34.7 ttpt 66.11 -71.82 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.551 . . . . 0.0 110.322 -177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 127' ' ' ASP . . . -94.15 129.8 40.6 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -158.48 36.45 0.23 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.281 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -118.2 3.58 11.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.526 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.64 -166.38 4.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.679 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.626 ' HD3' ' HG2' ' A' ' 24' ' ' LYS . 42.3 Cg_endo -65.72 -48.36 3.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.569 2.179 . . . . 0.0 112.036 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -144.08 134.69 24.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.637 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 HG13 ' H ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -135.76 -163.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.505 ' H ' HG13 ' A' ' 50' ' ' VAL . 33.9 mttm 55.39 -157.04 0.24 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.764 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -61.33 -23.81 65.99 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.452 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.85 -61.02 2.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.353 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.94 -30.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.032 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -61.88 -50.43 72.27 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.87 88.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.331 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -56.12 -46.62 79.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.262 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.507 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 2.0 tt0 -59.88 -56.08 26.18 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.427 -176.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -74.46 -33.67 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.667 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.47 -63.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.395 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -84.28 -45.33 12.95 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.066 0.46 . . . . 0.0 111.451 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.02 108.78 2.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.068 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -123.06 52.06 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 109.761 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -91.07 38.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.174 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -77.83 -24.09 48.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.99 -14.74 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.017 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.401 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -55.64 -55.73 28.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.499 0.19 . . . . 0.0 110.827 177.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.419 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 16.5 m-85 -127.81 154.45 45.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.21 102.89 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.017 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.14 132.42 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.394 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -135.54 108.53 7.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.19 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.16 164.23 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.23 -176.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -35.88 48.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -100.4 132.9 45.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -60.87 -19.65 60.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -54.05 -18.06 3.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.06 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -44.52 -33.61 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.836 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.43 -66.89 0.34 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.154 0.502 . . . . 0.0 112.035 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.17 -37.51 78.22 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.334 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -63.86 -41.74 97.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.113 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.73 -46.46 72.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' A' ' 87' ' ' ILE . . . -57.25 -52.61 64.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.0 m -68.74 -50.63 49.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 m -68.06 -14.82 63.27 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -103.23 4.84 37.15 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.143 -0.348 . . . . 0.0 111.003 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.56 24.53 73.89 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.066 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 82' ' ' ALA . 6.9 mt -81.12 -8.09 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.509 0.195 . . . . 0.0 110.772 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.489 ' O ' HG12 ' A' ' 142' ' ' ILE . 16.9 mt-10 -37.58 -39.04 0.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.637 0.775 . . . . 0.0 112.866 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -109.86 87.64 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.74 -141.2 5.33 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.901 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -134.87 125.86 27.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.472 HG21 ' HA3' ' A' ' 8' ' ' GLY . 2.0 pt -119.89 147.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 2.8 p90 -130.44 148.58 52.27 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.278 0.561 . . . . 0.0 110.608 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.468 HG21 ' HB2' ' A' ' 138' ' ' ALA . 2.0 m -113.35 140.22 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.264 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.2 mp -119.59 143.16 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.579 ' HB3' HG21 ' A' ' 137' ' ' ILE . 6.7 t30 -102.55 133.74 47.03 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.657 ' HG2' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -64.82 -42.82 94.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.045 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -34.02 65.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.213 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.09 -50.76 64.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.368 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.4 -29.95 68.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.432 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.98 -47.24 91.35 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.475 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.92 79.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.062 0.458 . . . . 0.0 110.236 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -70.92 -20.16 62.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m 66.24 46.67 1.99 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.507 0.67 . . . . 0.0 110.569 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 125' ' ' ALA . 9.0 mm -79.31 152.15 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.078 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.486 ' HB3' ' HG2' ' A' ' 124' ' ' ARG . 4.2 t80 -75.44 122.61 24.07 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 110.939 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -104.84 106.52 17.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.512 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -103.44 113.42 26.91 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.875 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.27 109.25 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.016 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -88.2 115.69 28.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 137.4 40.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.551 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.01 170.37 9.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.511 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 78.1 Cg_exo -50.21 157.1 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.377 1.384 . . . . 0.0 111.063 173.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.64 -57.73 5.8 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -168.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.456 HD21 ' HA ' ' A' ' 115' ' ' ASN . 0.8 OUTLIER -91.51 -17.55 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -168.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 38.2 Cg_exo -42.23 -22.8 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.37 1.525 . . . . 0.0 111.808 164.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 115' ' ' ASN . 16.9 m-20 68.74 8.51 6.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.102 166.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -111.58 138.04 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -141.6 145.88 35.58 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.547 ' HB3' HG13 ' A' ' 110' ' ' VAL . 1.7 tm-20 -122.12 125.08 45.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.98 95.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.5 m -87.08 113.88 23.21 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.572 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.604 HG13 HD21 ' A' ' 5' ' ' LEU . 48.6 mm -88.25 97.25 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.436 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HG2' ' HB3' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.534 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HA ' HD13 ' A' ' 105' ' ' ILE . . . -69.46 159.65 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' A' ' 131' ' ' ILE . 7.1 mp0 -50.81 -48.24 59.72 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 111.506 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.442 ' H ' HG21 ' A' ' 131' ' ' ILE . 3.6 t0 -119.18 160.43 22.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 0.0 110.074 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.01 128.56 34.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.178 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 93.17 65.16 1.07 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.244 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.03 70.43 0.47 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.565 ' CG2' ' HD3' ' A' ' 132' ' ' PRO . 7.4 tt -68.18 -37.24 10.57 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.649 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.565 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 59.3 Cg_endo -98.52 118.91 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.385 2.057 . . . . 0.0 111.808 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -7.31 53.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.276 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.21 6.91 23.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.193 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.494 ' HB ' HD21 ' A' ' 95' ' ' LEU . 6.0 m -60.31 -22.8 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.554 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.7 mt -87.63 88.22 2.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 109.866 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.579 HG21 ' HB3' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -79.91 -29.77 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -153.81 166.98 31.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.302 172.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.57 159.09 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.074 0.464 . . . . 0.0 110.879 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -141.14 140.75 34.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.019 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -95.09 149.63 21.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 88' ' ' GLU . 16.5 tt -140.99 141.64 31.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.518 . . . . 0.0 111.68 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.568 ' O ' ' HB ' ' A' ' 144' ' ' ILE . 4.8 tt0 -139.01 22.45 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.747 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 143' ' ' GLU . 10.3 tp 147.29 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.513 1.525 . . . . 0.0 109.096 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -100.18 88.53 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.5 tp -141.37 75.44 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.472 ' HB3' ' H ' ' A' ' 148' ' ' HIS . 2.4 mm-40 55.2 -105.78 0.29 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.812 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.472 ' H ' ' HB3' ' A' ' 147' ' ' GLU . 70.5 m-70 -112.13 142.16 44.93 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -83.25 95.16 8.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.804 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -65.99 91.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.438 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -74.26 73.18 1.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.835 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.25 175.11 6.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.693 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.203 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.92 -90.22 0.47 Allowed Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.418 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -151.6 169.24 22.59 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -109.49 156.47 20.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.718 0.294 . . . . 0.0 110.826 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.79 HD13 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -99.55 139.9 34.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -106.61 128.29 54.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.676 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 135.66 20.8 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -110.87 158.3 14.46 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.321 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 2.3 mt -113.89 129.32 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.762 0.425 . . . . 0.0 110.161 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.34 25.39 11.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.338 0.589 . . . . 0.0 109.899 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.89 58.98 0.79 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.916 -173.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 mp0 -51.15 -42.4 60.75 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.36 -32.79 73.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.051 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.777 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.4 m-20 -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.961 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -60.38 -45.35 93.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 109.666 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -62.71 -42.72 99.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.51 -43.36 97.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 110.499 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -71.94 -24.85 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.444 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.09 -10.84 72.74 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.262 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -172.6 172.73 4.18 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 mt -65.03 91.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.32 0.387 . . . . 0.0 110.602 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.569 ' HE3' ' SG ' ' A' ' 128' ' ' CYS . 15.2 tptp 74.7 132.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.891 0.744 . . . . 0.0 110.746 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.01 132.64 18.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.298 1.998 . . . . 0.0 111.046 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 2.2 mmmm -84.16 142.16 30.53 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.662 0.267 . . . . 0.0 110.293 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.01 59.39 4.91 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.273 -0.489 . . . . 0.0 114.035 -172.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.406 ' ND2' ' HG2' ' A' ' 27' ' ' LYS . 56.0 t30 45.92 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.293 0.637 . . . . 0.0 112.571 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.9 pttp -172.02 -172.74 1.02 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.732 0.413 . . . . 0.0 109.952 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 30' ' ' VAL . . . -179.19 -46.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 110.918 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 71.7 -18.27 0.31 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.377 0.671 . . . . 0.0 112.746 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 28' ' ' ALA . 3.5 m -57.82 132.54 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.39 176.49 4.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.514 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.688 HG22 ' HA ' ' A' ' 51' ' ' LYS . 1.1 mm -111.94 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.94 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -76.08 69.68 2.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -67.7 122.17 17.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.372 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.87 76.11 0.89 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.302 0.572 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . 175.45 41.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.783 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 21.2 mtpp 74.47 -58.81 0.57 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.653 0.781 . . . . 0.0 111.918 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -70.44 81.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 111.484 -175.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.85 83.01 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.911 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' CZ ' HG13 ' A' ' 32' ' ' ILE . 31.4 p90 -74.89 138.43 42.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 110.943 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -107.0 157.5 17.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.714 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.12 169.63 30.73 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.363 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HZ2' ' HA ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -150.42 133.68 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 131' ' ' ILE . . . -67.12 -55.52 13.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 111.01 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.33 -78.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.769 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -100.21 174.59 6.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.301 -178.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.14 70.39 0.07 OUTLIER Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.543 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HG2' ' H ' ' A' ' 49' ' ' SER . 78.1 Cg_endo -84.51 -56.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.702 2.268 . . . . 0.0 112.314 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.461 ' H ' ' HG2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -89.27 53.44 2.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 -176.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.648 HG22 ' H ' ' A' ' 51' ' ' LYS . 14.8 p -114.63 -127.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.908 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.688 ' HA ' HG22 ' A' ' 32' ' ' ILE . 20.4 mtpp 59.59 -167.37 0.17 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.296 0.57 . . . . 0.0 112.059 174.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.83 -23.53 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.021 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.2 -60.68 3.23 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.85 -32.77 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.647 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -60.41 -51.4 69.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.37 78.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.79 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -58.19 -50.55 73.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.687 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.545 ' HG3' ' CD2' ' A' ' 68' ' ' TYR . 9.4 mm100 -55.39 -49.01 73.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 mt -74.53 -46.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.493 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -61.96 -48.24 81.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.074 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 3.6 m -77.59 -32.38 53.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.66 53.96 9.18 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.174 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 58' ' ' GLN . 2.7 mp -81.05 -75.87 0.26 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 52.28 39.4 27.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.431 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -90.73 -57.29 2.87 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.713 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.32 -60.4 0.17 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.24 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 74.1 m -51.76 -52.96 44.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.545 ' CD2' ' HG3' ' A' ' 58' ' ' GLN . 18.1 m-30 -120.51 145.05 47.68 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.85 128.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.3 m -87.6 130.82 34.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.79 HG22 HD13 ' A' ' 5' ' ' LEU . 13.4 m -127.74 137.77 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.14 148.01 24.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.453 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.77 10.47 3.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 0.0 111.377 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.75 121.99 28.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -63.0 -19.63 64.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 80' ' ' LYS . 6.9 pt-20 -90.13 0.34 57.21 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.66 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.0 tt -49.64 -29.83 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.775 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.66 -68.9 0.15 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.908 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -28.45 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . 9.7 tttp -56.23 -49.79 73.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.496 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.18 -49.47 50.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.741 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.9 68.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.485 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -73.74 -48.91 28.36 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.596 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -65.59 -21.37 66.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 m -95.47 0.38 53.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.05 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 31.01 72.43 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.831 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -8.8 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.639 -173.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 142' ' ' ILE . 31.1 mm-40 -40.27 -34.29 0.31 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.487 . . . . 0.0 112.101 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -112.26 96.76 6.2 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.45 -135.52 3.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.022 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.528 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.94 150.31 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.082 0.553 . . . . 0.0 109.609 -175.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.537 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 pt -142.97 133.08 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -131.72 154.97 48.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.1 0.476 . . . . 0.0 111.379 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.529 HG23 ' HB1' ' A' ' 138' ' ' ALA . 32.9 m -129.84 136.63 58.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.459 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -113.64 141.95 46.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.809 -177.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -83.8 143.4 29.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.56 -27.98 21.04 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.689 0.28 . . . . 0.0 111.073 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.0 -33.51 62.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.509 ' O ' ' HB2' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -61.44 -41.57 97.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.064 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.11 -41.23 70.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.043 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.22 91.08 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.05 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -74.73 -43.45 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.0 109.576 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.06 -25.22 66.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.569 -177.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m 67.21 28.63 8.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 110.046 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -66.43 164.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.294 176.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.751 ' HB3' ' HB2' ' A' ' 124' ' ' ARG . 4.0 t80 -73.45 99.35 2.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.293 0.568 . . . . 0.0 110.381 -167.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -95.3 100.02 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.012 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.525 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 4.1 t80 -124.73 113.47 18.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -97.64 142.14 29.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.81 132.07 49.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.469 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 6.5 pt-20 -129.57 136.13 49.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.084 0.468 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 178.06 2.63 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.736 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.76 171.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.028 1.819 . . . . 0.0 112.28 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.9 -67.87 0.23 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.8 t-20 -86.15 -11.08 0.17 Allowed Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -166.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 43.7 Cg_exo -42.35 -25.48 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 121.439 1.55 . . . . 0.0 111.271 162.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.9 3.8 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.656 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.74 130.72 53.26 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 111.646 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 111' ' ' GLU . 17.6 ptmt -150.97 141.62 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.763 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -122.62 132.91 54.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.91 112.42 25.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.924 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 2.7 m -88.78 114.9 25.9 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.779 0.324 . . . . 0.0 110.383 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pt -87.45 113.4 24.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.751 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 23.1 mtt-85 -114.91 88.51 2.88 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.744 -172.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 131' ' ' ILE . . . -69.87 123.23 20.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.583 172.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -51.77 -46.43 64.12 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.386 0.429 . . . . 0.0 111.637 -168.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.705 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 2.0 t70 -80.21 122.66 27.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.569 ' SG ' ' HE3' ' A' ' 22' ' ' LYS . 7.4 t -54.02 119.56 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.459 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.94 56.89 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.936 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.8 m 63.26 74.82 0.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 19.3 tt -45.44 -35.27 3.08 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.618 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 91.9 Cg_endo -96.42 109.1 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 121.595 1.53 . . . . 0.0 111.592 169.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -63.8 -22.78 67.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.392 0.615 . . . . 0.0 109.842 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.21 -7.68 43.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.556 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.613 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.3 p -77.26 -15.25 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.078 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.86 89.96 3.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.441 HG13 HG22 ' A' ' 94' ' ' VAL . 14.5 pt -74.74 -30.62 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.275 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.529 ' HB1' HG23 ' A' ' 94' ' ' VAL . . . -150.0 148.14 28.69 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.41 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -143.94 127.74 17.26 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.323 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -131.11 152.23 50.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.273 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.57 150.07 23.78 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.7 tt -140.19 135.41 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -120.84 42.82 2.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.241 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.8 mt 70.34 94.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.483 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -30.01 70.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.621 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 129.0 38.59 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.915 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 140.55 58.77 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.537 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -129.88 66.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.41 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.99 57.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.036 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -166.28 42.11 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.387 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.6 m170 53.49 -97.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.932 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -152.17 15.45 0.62 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.289 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.129 -177.479 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.849 0.357 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.91 43.86 32.8 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.357 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.54 65.49 9.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.03 155.47 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.261 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.476 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -100.29 146.09 27.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.14 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.532 ' HE1' ' HB ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -113.57 130.96 56.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.744 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.25 126.78 23.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.653 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -109.6 157.84 14.86 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -129.94 132.66 65.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 -177.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -22.22 19.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.401 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -84.8 49.03 1.64 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.499 -177.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.506 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -57.78 -26.11 61.46 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 2.2 pt20 -63.43 -41.48 98.68 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.848 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -69.65 -41.46 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.677 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.93 -55.86 29.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -63.24 -39.51 94.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.072 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.59 -37.33 87.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 110.448 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -23.98 37.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 65.78 14.5 60.79 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 13.2 mt-30 -156.38 172.87 17.76 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.11 42.29 0.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.822 0.344 . . . . 0.0 110.751 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 45.61 59.23 15.03 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.16 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.91 171.71 9.21 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.95 2.433 . . . . 0.0 113.177 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -135.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.087 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . 94.05 99.0 1.58 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.136 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.43 -9.82 40.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 0.0 110.407 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 71.83 115.0 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.577 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.619 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . . . -139.5 5.91 2.26 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.646 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' CD ' HH22 ' A' ' 33' ' ' ARG . 0.3 OUTLIER -64.11 128.9 37.82 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.35 0.595 . . . . 0.0 110.968 -178.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -164.59 -39.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.297 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.2 17.68 4.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -76.84 76.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.408 0.623 . . . . 0.0 110.565 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.409 HH22 ' CD ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.12 -11.45 14.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.779 -177.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.5 t80 75.77 -42.36 0.46 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.705 0.802 . . . . 0.0 112.307 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -62.3 -13.99 34.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.796 0.331 . . . . 0.0 111.348 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.93 31.39 5.63 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 tptm 69.48 -79.16 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.384 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -168.76 -99.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? 57.78 22.82 8.9 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.023 0.439 . . . . 0.0 111.71 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -83.28 60.95 5.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.272 0.558 . . . . 0.0 109.733 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.02 77.65 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.899 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA2' ' HG3' ' A' ' 51' ' ' LYS . . . 64.17 -159.38 40.68 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.299 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HG2' ' HB2' ' A' ' 28' ' ' ALA . 20.3 mttt -93.3 52.27 1.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 70.07 -68.75 0.19 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.821 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -70.51 -50.23 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.717 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -131.55 149.8 52.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.335 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.34 61.1 0.3 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.519 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -85.73 -8.37 8.21 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -144.86 163.2 34.83 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.741 HG12 ' H ' ' A' ' 51' ' ' LYS . 1.4 t 51.95 -160.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.176 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.741 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 52.9 -146.2 0.54 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.02 0.528 . . . . 0.0 111.605 172.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 38' ' ' PHE . 1.8 t30 -53.79 -34.87 60.48 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.6 -57.04 12.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.897 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.6 -34.37 69.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.507 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -58.4 -64.22 1.0 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.109 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.86 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.23 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.642 ' HB3' HD23 ' A' ' 63' ' ' LEU . 1.1 t-80 -64.92 -49.65 69.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.355 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.555 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 35.9 tt0 -66.1 -38.1 87.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.1 -34.4 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.7 -74.22 0.42 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.836 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -64.41 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.484 0.659 . . . . 0.0 111.441 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 58' ' ' GLN . . . 133.75 158.99 8.82 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 57' ' ' HIS . 2.6 pt? -175.96 -44.49 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.066 0.433 . . . . 0.0 111.233 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.435 ' CE2' ' SG ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -114.35 89.26 3.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.752 -174.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.56 134.86 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.725 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.4 -7.56 81.72 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.369 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -73.45 -35.63 65.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.19 0.519 . . . . 0.0 110.58 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.53 160.75 30.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.783 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.708 HG12 ' HB ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -105.06 100.69 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -175.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.586 ' HB3' HG22 ' A' ' 122' ' ' THR . 0.0 OUTLIER -85.95 125.23 33.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.611 176.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.638 HG22 HD11 ' A' ' 77' ' ' ILE . 97.3 m -137.44 148.56 46.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 110.541 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.38 170.55 9.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -177.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.21 4.74 9.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.53 135.92 47.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.332 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -66.35 -23.35 66.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.84 -16.13 62.69 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.74 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.638 HD11 HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -48.39 -34.27 5.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 123.387 0.43 . . . . 0.0 110.977 176.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.46 -53.99 51.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -75.11 -40.35 59.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.888 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -59.5 -52.3 66.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.04 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 1.4 t80 -64.74 -45.84 84.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.469 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.547 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -52.36 -59.15 4.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.272 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -64.5 -39.13 93.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -66.71 -26.66 67.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.685 0.279 . . . . 0.0 111.429 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -90.09 2.05 55.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.84 0.352 . . . . 0.0 110.478 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.34 33.36 84.26 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.538 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.547 HG12 ' HB1' ' A' ' 82' ' ' ALA . 1.8 pp -65.44 -9.96 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -29.22 -50.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.181 0.925 . . . . 0.0 112.323 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -118.36 89.66 3.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.48 -149.58 10.25 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.989 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.506 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 6.7 t80 -115.92 145.44 42.9 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.733 0.413 . . . . 0.0 110.524 -175.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.532 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 1.9 pt -143.54 129.46 16.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.422 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 15.5 p90 -130.71 144.36 51.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.102 0.477 . . . . 0.0 111.232 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.763 HG21 ' HB1' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.95 135.94 46.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.164 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -118.15 130.34 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.131 177.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.58 ' HB3' HD13 ' A' ' 99' ' ' LEU . 59.3 t30 -79.8 141.68 36.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.576 0.227 . . . . 0.0 111.011 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -80.07 -50.95 9.63 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.63 -22.46 65.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 111.088 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 96' ' ' ASN . 18.8 mt -64.15 -37.43 87.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -63.28 -44.27 95.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.698 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.73 -37.47 83.84 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -66.61 -36.64 83.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 110.499 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -83.94 -7.87 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.173 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.0 m 69.56 34.67 2.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.27 0.557 . . . . 0.0 110.791 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 125' ' ' ALA . 1.2 mp -74.22 157.18 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.919 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -77.12 101.22 6.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.114 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.81 99.96 12.87 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.407 ' HE2' ' HZ ' ' A' ' 38' ' ' PHE . 1.2 t80 -104.65 113.36 26.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.428 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -111.06 126.21 54.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 120' ' ' GLU . 3.7 m -108.26 132.01 57.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -111.65 133.77 53.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.577 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.83 174.55 5.76 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.495 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 84.5 Cg_exo -48.37 170.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.447 2.098 . . . . 0.0 113.25 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -40.79 -71.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.1 t-20 -100.13 -9.17 0.13 Allowed Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.495 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 47.4 Cg_exo -42.34 -26.98 0.63 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 CA-C-N 121.846 1.695 . . . . 0.0 111.09 165.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.65 26.45 9.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.386 168.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 116' ' ' PRO . 89.8 mt-10 -114.39 118.09 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -124.83 112.59 16.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 110' ' ' VAL . 8.5 tt0 -96.26 106.16 18.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 109.991 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.56 95.86 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.618 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 70' ' ' SER . 0.2 OUTLIER -81.07 107.11 13.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.175 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.708 ' HB ' HG12 ' A' ' 69' ' ' ILE . 23.0 mm -87.85 106.68 16.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.482 ' O ' HG21 ' A' ' 105' ' ' ILE . 37.7 mtt85 -104.46 119.12 38.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.241 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.548 ' HA ' HG13 ' A' ' 105' ' ' ILE . . . -68.9 155.31 40.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.934 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.79 -49.4 62.78 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.313 0.578 . . . . 0.0 110.098 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.56 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.2 t0 -122.35 156.09 34.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.991 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.435 ' SG ' ' CE2' ' A' ' 64' ' ' TYR . 20.5 t -73.07 150.28 42.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 111.236 -175.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.61 51.87 2.97 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.098 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 41.62 70.34 0.28 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.865 0.466 . . . . 0.0 112.243 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.783 HG21 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -56.17 -48.5 96.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.755 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.783 ' HD3' HG21 ' A' ' 131' ' ' ILE . 87.1 Cg_endo -100.31 109.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.591 2.194 . . . . 0.0 112.395 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -77.37 -0.48 25.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.665 0.269 . . . . 0.0 111.301 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -87.81 -5.33 58.67 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.291 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.469 HG23 HD22 ' A' ' 95' ' ' LEU . 30.9 m -76.21 -17.25 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.84 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.3 pt -86.11 89.89 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.738 0.78 . . . . 0.0 109.378 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.61 -31.06 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.305 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.763 ' HB1' HG21 ' A' ' 94' ' ' VAL . . . -142.18 146.21 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.415 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -151.66 114.92 4.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.856 177.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.61 160.5 39.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.65 156.63 16.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.034 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 87' ' ' ILE . 13.8 tt -134.16 137.76 51.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 146' ' ' LEU . 4.4 tm-20 -119.83 90.43 3.33 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.028 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.7 pt 37.7 -133.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.528 0.731 . . . . 0.0 111.49 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -88.73 56.59 3.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.048 0.451 . . . . 0.0 110.04 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.51 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -58.9 150.84 23.12 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.94 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -3.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 172.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 71.89 47.66 0.31 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.845 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -161.39 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.506 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 51.49 -163.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.091 0.556 . . . . 0.0 111.932 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -121.96 150.03 42.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -98.56 118.77 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.501 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.74 138.43 3.16 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -161.91 163.59 29.05 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -116.07 150.46 37.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.212 0.53 . . . . 0.0 111.577 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.1 OUTLIER -100.53 151.35 21.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.97 132.57 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -173.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 7' ' ' ARG . 27.6 ttt-85 -140.15 99.39 3.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.406 0.622 . . . . 0.0 109.41 171.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.556 ' H ' ' HE2' ' A' ' 81' ' ' PHE . . . -89.13 154.74 24.67 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 11' ' ' CYS . 39.0 mt -121.16 133.24 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.823 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -122.37 17.68 10.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.47 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.604 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -123.5 46.68 2.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.646 -179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -54.02 -29.79 45.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.752 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -63.99 -42.29 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.073 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -69.13 -45.29 70.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.068 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -38.6 83.44 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.205 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -69.74 -41.98 74.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.9 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.97 -41.25 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -80.41 -27.21 38.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 6.79 85.64 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -164.49 178.37 7.46 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.11 61.08 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.079 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' HZ2' ' CG ' ' A' ' 14' ' ' ASP . 1.0 OUTLIER 32.76 71.91 0.65 Allowed Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.397 1.079 . . . . 0.0 113.047 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.54 169.85 8.02 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.002 2.468 . . . . 0.0 112.258 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.26 -54.3 1.48 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.811 177.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.27 5.09 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.883 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -93.42 119.03 32.05 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HZ2' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -156.07 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -171.09 -138.06 0.02 OUTLIER 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.681 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.0 144.28 30.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.995 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.78 124.48 9.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.54 34.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 110.212 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.634 HG23 ' HE2' ' A' ' 51' ' ' LYS . 41.0 mt -128.57 138.74 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.549 -176.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 10.6 mmp_? -111.3 149.26 31.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.789 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.56 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -164.55 -166.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.246 175.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.51 71.02 3.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.033 0.444 . . . . 0.0 111.607 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.25 -80.19 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.618 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -56.27 -29.08 60.67 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . 3.4 m-85 -72.0 85.3 0.99 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.779 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.755 ' HE2' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -84.93 88.98 7.48 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.179 0.514 . . . . 0.0 111.331 -179.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 38' ' ' PHE . 67.4 m-85 -78.57 109.58 12.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.17 -20.43 32.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.573 0.225 . . . . 0.0 111.24 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.46 174.66 20.59 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.868 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -157.78 -170.51 3.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 49' ' ' SER . . . -135.93 -173.68 3.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.5 m -49.29 134.22 18.62 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.443 0.465 . . . . 0.0 111.656 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -63.59 132.24 50.56 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.6 -82.33 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 49' ' ' SER . 74.2 Cg_endo -70.21 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.904 2.402 . . . . 0.0 110.551 173.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.601 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 0.2 OUTLIER 67.62 162.17 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.225 0.535 . . . . 0.0 111.85 171.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.6 p -67.86 -55.27 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.55 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.634 ' HE2' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -53.44 -60.33 3.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.712 0.292 . . . . 0.0 111.17 -175.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 5.2 m-20 -50.99 -59.57 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.151 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.29 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.265 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.25 -37.35 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.516 -171.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.7 m-85 -77.58 -42.4 35.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.538 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.66 75.44 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 109.976 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.16 -48.72 69.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 62' ' ' GLY . 1.4 tt0 -57.98 -29.79 65.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.954 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.7 mt -93.56 -52.78 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.337 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -77.13 -49.56 14.96 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.828 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.98 -32.88 24.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.104 0.478 . . . . 0.0 111.244 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 58' ' ' GLN . . . 134.59 172.11 12.71 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 70' ' ' SER . 84.3 mt -58.83 -15.3 11.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 111.507 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 74.31 -28.0 0.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 164.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.79 101.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.999 0.428 . . . . 0.0 111.664 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.49 -112.8 0.31 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.776 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.4 p -76.99 -34.88 57.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.765 -177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -83.15 145.61 29.11 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.459 HD13 HD12 ' A' ' 123' ' ' ILE . 21.4 mt -117.94 128.06 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.39 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HD11 ' A' ' 63' ' ' LEU . 5.3 p -95.22 113.95 25.68 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.463 HG21 ' HB2' ' A' ' 5' ' ' LEU . 7.8 p -122.77 144.43 49.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.622 0.249 . . . . 0.0 110.801 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.0 m -87.81 150.2 23.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.831 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -16.06 62.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -79.35 135.52 36.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.858 0.361 . . . . 0.0 110.519 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.601 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 7.5 ttpm? -62.41 -20.9 64.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -72.63 -4.19 29.44 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.4 tt -51.29 -34.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.326 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.5 -58.91 6.52 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.151 0.5 . . . . 0.0 111.068 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.31 -43.52 70.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.058 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.95 -44.54 94.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.225 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.556 ' HE2' ' H ' ' A' ' 8' ' ' GLY . 87.5 t80 -65.98 -55.37 17.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.003 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.43 73.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.671 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -72.73 -45.91 56.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.604 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.1 m -70.7 -17.15 62.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.6 m -92.9 -4.2 53.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.555 0.217 . . . . 0.0 111.001 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 37.6 95.23 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.88 -8.8 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.365 -0.417 . . . . 0.0 111.653 -171.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -42.37 -32.75 0.55 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -119.13 90.79 3.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.49 -145.97 8.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.375 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.603 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -107.68 146.79 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.252 0.221 . . . . 0.0 110.458 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 mt -138.68 118.44 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.89 143.4 50.13 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.75 173.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.822 HG21 ' HB2' ' A' ' 138' ' ' ALA . 2.4 m -120.75 149.38 23.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-O 121.275 0.56 . . . . 0.0 111.123 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.574 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -122.92 134.91 54.34 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.523 -174.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.53 ' HB2' HD12 ' A' ' 137' ' ' ILE . 31.0 t30 -87.22 115.75 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.714 0.292 . . . . 0.0 110.944 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.44 -30.08 70.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.42 ' HB3' ' OD1' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -63.21 -36.37 83.43 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.644 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 134' ' ' GLU . 32.2 tp -69.14 -40.41 78.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -62.5 -34.74 77.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.388 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.74 -39.94 98.0 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.519 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -63.55 -42.1 98.39 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.085 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.484 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 19.4 m-85 -74.07 -16.94 61.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.964 0.412 . . . . 0.0 110.339 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.755 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 2.5 m 65.42 33.8 8.6 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.101 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.557 HG23 ' HA ' ' A' ' 125' ' ' ALA . 75.3 mt -63.23 147.79 11.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.234 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.624 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 1.6 m-85 -75.21 150.13 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 0.0 110.642 -167.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.25 118.05 8.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.585 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.503 ' HB2' ' HZ ' ' A' ' 38' ' ' PHE . 72.6 t80 -127.52 117.58 22.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.614 ' HG2' HG21 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -92.5 133.24 36.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.84 -177.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -97.91 134.11 37.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -96.71 133.06 41.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.362 0.601 . . . . 0.0 111.209 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.87 171.81 11.55 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 168.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.5 Cg_exo -46.63 164.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.824 1.682 . . . . 0.0 112.136 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -47.56 -67.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.453 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -87.18 -13.69 0.2 Allowed Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -167.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 31.5 Cg_exo -42.59 -23.63 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 121.454 1.555 . . . . 0.0 111.774 163.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.41 23.67 9.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.895 170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.11 134.87 54.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.88 -172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 119' ' ' LYS . 11.8 mmmm -125.39 106.57 9.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.065 172.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.557 ' HB3' HG21 ' A' ' 110' ' ' VAL . 2.7 tp10 -79.29 91.92 5.08 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 110.201 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.614 HG21 ' HG2' ' A' ' 109' ' ' GLU . 17.5 t -73.43 98.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -84.16 114.84 22.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.459 HD12 HD13 ' A' ' 69' ' ' ILE . 1.6 pp -86.45 129.66 37.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 109.463 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.624 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.32 108.08 14.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.731 -173.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.557 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -78.45 161.11 27.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.405 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 -6.27 42.3 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.865 0.364 . . . . 0.0 110.455 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.668 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 3.9 t70 -153.48 159.71 42.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 m -85.85 133.51 33.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.899 0.381 . . . . 0.0 111.235 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.38 49.68 2.96 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.447 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 57.76 70.3 0.66 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.816 0.341 . . . . 0.0 111.672 173.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.728 HG22 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -61.61 -45.7 93.62 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.728 ' HD3' HG22 ' A' ' 131' ' ' ILE . 59.1 Cg_endo -70.91 129.95 17.18 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.436 1.424 . . . . 0.0 112.096 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -64.14 -24.92 67.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.046 0.45 . . . . 0.0 110.881 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.497 ' HB3' HD21 ' A' ' 99' ' ' LEU . 3.7 mp0 -88.74 10.63 20.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.574 HG22 HD23 ' A' ' 95' ' ' LEU . 10.0 p -59.31 -31.61 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.937 0.399 . . . . 0.0 111.646 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.8 mt -89.17 88.2 2.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 96' ' ' ASN . 1.1 pt -79.36 -28.4 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.822 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -146.98 141.55 26.57 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.633 171.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.09 124.92 19.7 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.773 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.8 157.14 45.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.74 146.47 36.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.19 135.45 54.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 0.0 111.492 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.94 51.64 2.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.947 177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.1 mt 70.56 -66.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.327 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.1 t30 54.2 77.84 0.18 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.328 0.585 . . . . 0.0 110.815 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -50.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.65 150.18 43.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.61 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -106.6 11.41 30.53 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.485 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 65.14 53.4 1.35 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.835 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -48.64 -43.57 36.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.69 143.12 49.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.972 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -77.77 -37.44 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.077 0.465 . . . . 0.0 110.203 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.348 177.52 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.633 ' HB2' ' HD2' ' A' ' 97' ' ' ARG . 5.9 m120 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -99.01 114.19 26.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.359 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.5 143.31 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.486 ' OH ' HD12 ' A' ' 92' ' ' ILE . 1.3 t80 -138.18 134.01 33.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.548 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.05 141.98 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -127.57 157.78 21.03 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 91' ' ' TYR . 13.9 tt -138.42 136.91 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.002 0.43 . . . . 0.0 110.701 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.2 m -100.05 -16.61 17.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.24 0.543 . . . . 0.0 109.976 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -86.89 51.19 2.17 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -21.89 42.95 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.643 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -63.3 -55.72 22.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.717 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.383 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HG3' HD23 ' A' ' 21' ' ' LEU . 6.3 tm-20 -55.83 -57.29 12.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.813 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -70.17 -29.81 66.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.355 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.06 -43.8 64.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -78.77 -23.91 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.993 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.99 24.39 73.1 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.186 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 5.7 mt-30 -161.54 27.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.126 0.171 . . . . 0.0 110.751 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 136' ' ' ILE . 15.5 mt 73.57 -43.43 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -164.76 141.97 5.11 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -171.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.63 138.3 79.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.41 2.074 . . . . 0.0 112.071 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.397 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt . . . . . 0 C--O 1.242 0.661 0 CA-C-O 121.582 0.706 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -58.63 -24.61 61.44 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.346 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.83 1.0 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.555 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG13 ' OH ' ' A' ' 68' ' ' TYR . 2.3 p -69.42 -38.68 77.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.236 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -62.1 -57.02 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.073 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.05 85.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -58.23 -49.98 75.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -70.72 -35.93 72.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.0 -42.39 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 111.03 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -92.22 -60.25 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.821 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -90.8 -73.25 0.54 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.795 0.331 . . . . 0.0 111.727 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 66.29 3.85 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.254 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 13.6 tp -62.46 90.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.079 0.466 . . . . 0.0 110.907 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 64.1 47.5 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.739 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -15.44 63.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.81 5.56 Favored Glycine 0 C--N 1.329 0.14 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.432 ' SG ' ' CE1' ' A' ' 68' ' ' TYR . 13.9 t -59.01 -50.44 74.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.432 ' CE1' ' SG ' ' A' ' 67' ' ' CYS . 12.1 m-85 -106.33 160.35 15.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.072 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.21 99.49 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -78.82 126.43 30.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.698 179.014 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.469 HG23 HG13 ' A' ' 121' ' ' VAL . 15.4 t -140.21 152.25 45.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.596 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.572 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -89.46 169.11 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.85 10.17 3.59 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -116.79 127.44 54.34 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -69.8 -19.23 63.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.053 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.62 0.47 26.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 72' ' ' THR . 1.2 tt -52.27 -27.08 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.854 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.65 68.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.221 0.534 . . . . 0.0 110.839 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -49.22 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 -177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -62.92 -41.78 99.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.492 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -69.4 -43.52 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.259 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -63.0 -42.73 99.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.071 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -69.92 -52.99 19.95 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -65.89 -21.97 66.48 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.532 ' HB2' HG13 ' A' ' 87' ' ' ILE . 12.3 m -97.77 0.06 46.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.45 29.25 74.5 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.505 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 85' ' ' SER . 4.4 mt -80.3 -8.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 122.811 -0.229 . . . . 0.0 111.06 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 3.8 tt0 -45.17 -27.52 0.62 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.908 0.385 . . . . 0.0 111.306 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.8 89.98 3.24 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.66 -148.14 12.1 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.233 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.451 ' HB3' HG23 ' A' ' 9' ' ' ILE . 3.3 t80 -116.68 146.21 42.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.839 0.456 . . . . 0.0 110.306 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.515 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 pt -144.69 141.86 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 6.8 p90 -131.63 152.88 50.48 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.017 0.437 . . . . 0.0 111.2 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.5 m -118.83 142.59 33.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.274 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -134.22 142.69 47.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.672 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -98.15 142.18 30.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.633 ' HD2' ' HB2' ' A' ' 3' ' ' ASN . 47.3 ttt180 -77.5 -34.87 54.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.568 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -59.14 -25.77 64.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 0.0 110.822 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 135' ' ' VAL . 22.7 tp -65.46 -41.07 93.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.118 0.485 . . . . 0.0 109.778 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 5.0 m-85 -66.29 -38.77 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.73 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.4 -41.51 95.25 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.753 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -68.63 -39.1 80.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.288 0.566 . . . . 0.0 110.203 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.564 ' HB3' HG12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.98 -21.65 64.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.759 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m 71.24 32.37 2.21 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.192 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.564 HG12 ' HB3' ' A' ' 103' ' ' TYR . 24.6 mm -75.7 146.39 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.307 175.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.558 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -87.16 164.08 16.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.711 -171.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.38 138.2 27.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -125.64 113.01 16.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 pt-20 -105.25 119.73 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.535 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 120' ' ' GLU . 1.9 m -90.2 150.36 3.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.56 132.07 55.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.297 0.57 . . . . 0.0 110.925 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 18.5 m80 -81.61 -176.46 0.78 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 90.0 Cg_exo -46.59 158.39 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.328 1.352 . . . . 0.0 111.092 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.61 -44.93 95.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 5.9 t-20 -84.42 -19.77 0.26 Allowed Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -168.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 39.9 Cg_exo -41.87 -22.76 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.532 1.488 . . . . 0.0 111.436 162.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.424 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER 72.58 20.8 3.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.49 166.228 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.7 150.27 34.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.573 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -129.42 137.31 50.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.228 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.434 ' HB3' HG22 ' A' ' 110' ' ' VAL . 3.2 tm-20 -90.57 111.94 23.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.469 HG13 HG23 ' A' ' 71' ' ' THR . 1.8 p -102.56 102.89 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 110.098 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.9 m -87.41 126.25 34.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.252 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.2 mt -87.59 111.47 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.404 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.673 HH12 ' HA ' ' A' ' 126' ' ' GLU . 1.3 tmm_? -84.22 95.48 8.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.502 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.654 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.86 155.41 40.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.124 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.673 ' HA ' HH12 ' A' ' 124' ' ' ARG . 22.1 mm-40 -73.44 -4.09 31.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.677 0.275 . . . . 0.0 111.578 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.51 159.49 44.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.9 m -80.36 120.04 23.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.891 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.67 69.2 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.522 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.4 m 55.18 70.83 0.59 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.654 HG22 ' HB1' ' A' ' 125' ' ' ALA . 5.2 tt -64.21 -33.82 10.18 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.505 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 45.3 Cg_endo -92.88 126.7 0.69 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.008 1.805 . . . . 0.0 111.679 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -85.18 -29.07 25.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.924 0.392 . . . . 0.0 111.054 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.53 10.56 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.384 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 95' ' ' LEU . 9.3 p -72.37 -16.11 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.256 0.551 . . . . 0.0 111.011 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.625 HD13 HD11 ' A' ' 21' ' ' LEU . 5.8 pt -88.3 89.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.1 pt -73.21 -19.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.836 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.598 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.575 ' HD3' HD12 ' A' ' 136' ' ' ILE . 28.7 mtmm -130.14 125.23 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.81 153.97 48.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 tt -99.84 157.66 16.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.2 tt -136.05 129.27 47.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.262 0.553 . . . . 0.0 112.34 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 78.95 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.462 173.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.656 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 70.9 mt . . . . . 0 N--CA 1.466 0.325 0 C-N-CA 123.069 0.548 . . . . 0.0 111.342 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.579 ' HA ' ' NH1' ' A' ' 97' ' ' ARG . 64.6 t30 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -131.76 122.73 26.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 5.1 mp -100.51 130.64 46.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.29 129.39 55.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.6 OUTLIER -142.04 151.88 42.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -133.92 156.96 22.6 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.794 HG23 ' HB3' ' A' ' 91' ' ' TYR . 6.4 tt -144.04 141.0 25.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.181 0.515 . . . . 0.0 111.003 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -25.14 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.522 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.6 51.94 1.78 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 110.076 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 10.7 pt20 -52.48 -33.93 46.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -76.22 -37.49 57.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.879 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -39.62 93.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.879 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.12 -43.56 98.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.092 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 12' ' ' GLN . 66.7 mm-40 -67.18 -34.02 76.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.86 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.31 -32.99 55.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.563 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HB3' ' OE1' ' A' ' 20' ' ' GLN . 64.4 m-20 -92.4 -46.17 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.79 12.33 81.57 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.559 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -145.74 6.87 1.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.017 0.408 . . . . 0.0 111.173 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER 61.83 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.536 0.522 . . . . 0.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 56.59 118.23 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.705 1.202 . . . . 0.0 112.381 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.72 111.26 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.192 2.595 . . . . 0.0 112.593 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.983 179.288 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.3 mttt . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.224 0.083 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -54.26 -39.05 66.49 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.741 0.305 . . . . 0.0 111.03 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.89 -50.38 66.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.226 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.25 -39.06 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.643 0.258 . . . . 0.0 111.009 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.38 -51.35 61.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.206 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.38 90.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.975 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -64.81 -34.54 78.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.591 ' HG3' ' HD2' ' A' ' 68' ' ' TYR . 1.6 tm0? -60.83 -53.19 60.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.82 -41.38 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.053 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.1 -67.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.068 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.4 -71.21 0.62 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.963 0.411 . . . . 0.0 110.845 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.4 138.98 3.82 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -152.71 47.37 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -90.07 6.67 41.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.854 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -100.91 -30.57 11.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.16 -72.39 0.19 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.223 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.95 -52.27 65.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.591 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 18.8 m-30 -117.61 161.06 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.605 HG23 ' HB ' ' A' ' 123' ' ' ILE . 3.4 tt -126.98 132.88 69.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.667 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.7 p -106.75 140.58 39.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.829 0.347 . . . . 0.0 110.722 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -129.07 133.6 47.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.845 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.457 ' H ' HD12 ' A' ' 77' ' ' ILE . 4.4 p -74.51 163.88 27.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -18.13 58.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -99.65 135.71 40.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.961 0.41 . . . . 0.0 111.79 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.71 -20.79 61.94 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.009 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -69.33 -3.5 14.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.366 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 3.9 tt -57.08 -34.46 45.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.245 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.22 -63.19 1.39 Allowed 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.757 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -67.73 -43.26 80.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.046 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.77 -46.96 85.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.088 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 17.8 t80 -64.55 -48.78 73.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -56.38 -59.72 4.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.165 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -64.92 -33.63 76.48 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.499 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m -73.03 -23.37 60.59 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.003 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m -84.05 -7.84 59.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.887 0.375 . . . . 0.0 110.025 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.47 39.8 98.1 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -68.05 -10.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -32.54 -35.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.954 0.784 . . . . 0.0 112.343 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.59 88.97 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.14 -152.67 19.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.604 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.794 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.7 t80 -119.65 150.63 40.01 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.4 tt -149.06 135.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.516 0.198 . . . . 0.0 110.589 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 15.8 p90 -131.46 156.32 45.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.174 0.512 . . . . 0.0 112.078 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.516 HG23 HG13 ' A' ' 137' ' ' ILE . 34.2 m -125.8 141.45 45.5 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -125.01 143.23 51.01 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.085 -175.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.466 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.9 t-20 -99.65 140.63 33.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.579 ' NH1' ' HA ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -67.83 -46.04 72.95 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 -178.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.24 -33.71 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 135' ' ' VAL . 25.1 mt -64.0 -50.93 66.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.274 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.88 -41.01 95.98 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.93 -48.13 84.41 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.021 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.14 -32.86 71.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.452 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -68.8 -18.68 64.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.872 0.367 . . . . 0.0 110.172 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m 70.63 34.27 2.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.033 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -73.87 156.01 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.772 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 11.5 m-85 -76.6 101.25 5.63 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.607 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.75 115.89 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.238 0.542 . . . . 0.0 109.909 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.543 ' HB2' ' HD2' ' A' ' 124' ' ' ARG . 2.4 t80 -125.74 111.56 15.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.816 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -94.93 113.07 24.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.824 0.345 . . . . 0.0 110.174 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 120' ' ' GLU . 1.4 m -89.31 125.5 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.81 131.99 53.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.327 0.584 . . . . 0.0 110.552 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.7 m80 -79.21 -178.39 1.09 Allowed Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 88.9 Cg_exo -46.85 164.33 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.587 1.524 . . . . 0.0 112.166 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -49.11 -66.93 0.31 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -170.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.471 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 3.2 t-20 -89.05 -9.66 0.14 Allowed Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 115.84 1.792 . . . . 0.0 115.84 -165.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 37.3 Cg_exo -42.53 -22.82 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.446 1.552 . . . . 0.0 112.017 163.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.1 33.81 3.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.29 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -144.41 127.35 16.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -123.81 102.2 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HB2' HG22 ' A' ' 110' ' ' VAL . 57.0 mt-10 -73.65 98.09 2.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.216 0.531 . . . . 0.0 110.744 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 24.0 t -69.07 95.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.924 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 13.1 m -88.17 114.07 24.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.605 ' HB ' HG23 ' A' ' 69' ' ' ILE . 4.9 mp -87.09 111.12 21.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.809 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 19.8 mtt180 -93.2 104.06 16.27 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.918 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.572 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.62 144.03 53.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.15 -60.07 4.16 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.235 0.54 . . . . 0.0 109.756 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.865 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 16.1 t70 -87.72 127.95 35.3 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.787 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 51.9 t -52.79 113.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.505 0.503 . . . . 0.0 111.833 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . . . 91.23 67.47 1.16 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.433 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.2 m 58.6 72.66 0.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.913 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.09 -50.97 25.63 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.913 ' HD3' HG23 ' A' ' 131' ' ' ILE . 87.2 Cg_endo -97.83 116.0 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.498 2.132 . . . . 0.0 112.431 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.57 -5.14 26.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.37 -8.81 56.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.18 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.657 HG13 HD23 ' A' ' 95' ' ' LEU . 9.1 p -71.58 -14.05 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.638 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 136' ' ' ILE . 17.2 pt -87.76 92.91 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.516 HG13 HG23 ' A' ' 94' ' ' VAL . 27.7 pt -63.87 -30.99 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.905 -173.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.58 160.71 40.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.13 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -148.41 150.8 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.838 175.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -142.36 154.28 44.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -111.91 146.25 38.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 tt -140.66 118.93 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 111.097 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -118.04 68.6 0.77 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.364 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.799 179.028 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 97' ' ' ARG . 7.3 t-20 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -98.6 130.91 45.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.513 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 97' ' ' ARG . 44.2 mt -112.91 135.19 53.95 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -131.87 124.46 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.87 132.77 20.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.19 157.58 15.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.405 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.701 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.3 tt -135.38 142.12 40.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.004 0.43 . . . . 0.0 110.216 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.74 -32.03 13.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.01 51.68 2.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.527 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 2.6 pt20 -55.13 -27.1 42.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.273 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -68.88 -49.21 60.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.93 -36.4 83.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.177 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.82 -58.18 9.75 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.358 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.35 -26.45 63.74 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -54.93 27.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.871 0.367 . . . . 0.0 110.037 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.52 -22.75 60.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.64 15.66 65.42 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.552 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -168.55 140.79 2.81 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 49.54 0.97 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.192 0.52 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 128' ' ' CYS . 29.8 tttp -168.64 126.41 0.89 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.382 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.85 -59.87 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.419 2.08 . . . . 0.0 111.868 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.329 179.58 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.569 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.65 -22.9 67.09 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.66 -67.27 0.32 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.357 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -33.46 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.53 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 2.3 m-85 -63.92 -64.64 0.84 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.48 84.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -59.19 -54.28 48.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.694 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 4.4 pt20 -61.07 -37.2 81.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.03 -37.4 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.753 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.27 -23.97 34.98 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 p -87.95 -49.44 7.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.136 0.493 . . . . 0.0 110.803 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.39 -71.53 0.19 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.541 HD22 ' CE1' ' A' ' 64' ' ' TYR . 6.8 mt -159.53 76.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.152 0.501 . . . . 0.0 109.782 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE1' HD22 ' A' ' 63' ' ' LEU . 2.0 p90 45.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.684 1.194 . . . . 0.0 112.986 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 6.2 p-10 166.59 -45.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.912 -168.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' N ' ' HD2' ' A' ' 64' ' ' TYR . . . 166.07 -8.01 0.06 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.993 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.62 -28.01 63.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.996 0.398 . . . . 0.0 111.57 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.42 ' HE2' HE22 ' A' ' 58' ' ' GLN . 12.3 m-30 -118.85 163.58 16.68 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 123' ' ' ILE . 1.4 tt -121.07 119.04 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.284 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 13.0 m -99.45 131.56 45.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.869 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 t -119.04 170.37 9.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.189 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -122.82 152.51 40.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -14.06 12.32 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.2 108.04 18.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -59.46 -18.01 36.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.594 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -79.07 -2.32 39.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.828 0.347 . . . . 0.0 110.465 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.3 tt -51.26 -29.36 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.788 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.27 -60.14 3.93 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.804 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.111 -175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -62.3 -45.62 92.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.978 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -63.38 -49.18 74.83 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.849 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 -55.26 25.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.942 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.8 m -62.66 -35.91 81.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -66.33 -27.81 68.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.5 m -93.82 -0.3 55.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.97 40.44 90.97 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.51 -9.57 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.36 -172.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.684 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 mp0 -41.68 -28.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.328 0.651 . . . . 0.0 112.146 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -123.63 90.62 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.97 -150.92 12.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.274 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.701 ' HB3' HG23 ' A' ' 9' ' ' ILE . 6.2 t80 -121.93 149.58 43.23 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.583 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -141.47 143.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.022 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 52.8 p90 -131.53 144.05 50.83 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.199 0.524 . . . . 0.0 111.187 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.509 HG23 HG13 ' A' ' 137' ' ' ILE . 17.9 m -118.64 138.85 48.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.561 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD23 HG13 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.08 142.79 51.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.867 -171.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.44 ' OD1' HD13 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -79.94 114.24 18.71 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.498 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -69.41 -33.52 73.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.745 -176.264 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.11 -26.66 66.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.628 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 99' ' ' LEU . 11.4 mt -63.11 -46.01 89.33 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -60.84 -38.47 85.59 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.47 -43.73 97.26 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.917 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -39.67 93.07 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.068 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.501 ' HB2' HD13 ' A' ' 105' ' ' ILE . 15.4 m-30 -71.06 -18.29 62.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.434 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.3 m 69.86 39.34 1.46 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 103' ' ' TYR . 1.1 mp -68.47 160.83 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.413 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.769 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -78.4 99.0 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -170.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -103.18 100.14 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -100.67 116.14 31.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.074 0.464 . . . . 0.0 110.069 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.494 ' HB2' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -85.22 138.25 32.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.613 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.68 144.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 145.91 47.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.32 170.59 15.4 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.861 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -45.67 170.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.657 2.238 . . . . 0.0 113.36 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -47.08 -53.82 11.85 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -170.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.518 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 48.1 t30 -98.72 -17.05 0.2 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 34.2 Cg_exo -40.83 -26.39 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 120.993 1.39 . . . . 0.0 111.34 162.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 77.5 -11.35 1.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.901 163.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -113.3 159.34 19.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.297 0.57 . . . . 0.0 112.043 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 109' ' ' GLU . 29.6 tttp -131.87 122.34 25.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -104.48 115.13 29.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.155 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.83 113.37 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.154 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 14.3 m -81.4 117.71 22.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.776 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 69' ' ' ILE . 15.0 mm -87.84 98.27 7.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.769 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -89.19 102.63 15.29 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.041 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HB1' ' CG1' ' A' ' 131' ' ' ILE . . . -69.84 152.32 44.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.758 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.4 -41.9 90.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.458 ' HB3' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.07 145.02 50.12 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.07 176.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.411 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 1.4 t -64.02 133.77 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.55 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.05 70.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.546 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.9 m 56.89 72.9 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.508 ' CG1' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -43.95 -55.38 9.35 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.415 173.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 63.6 Cg_endo -95.62 114.95 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.931 2.421 . . . . 0.0 112.218 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.59 -22.65 66.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.103 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -77.19 -15.34 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.563 HG13 HD23 ' A' ' 95' ' ' LEU . 2.6 p -69.69 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.34 92.15 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.509 HG13 HG23 ' A' ' 94' ' ' VAL . 24.6 pt -67.83 -27.89 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.945 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.36 157.8 36.29 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.946 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 59.3 pttt -150.49 140.88 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.273 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.53 160.34 40.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.774 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -112.57 149.11 33.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.744 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 144' ' ' ILE . 18.4 tt -141.26 138.87 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -125.79 31.6 5.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.668 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.684 HG12 ' HB3' ' A' ' 88' ' ' GLU . 42.6 mt . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 122.642 0.377 . . . . 0.0 110.02 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 t80 66.15 112.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.546 0.528 . . . . 0.0 111.947 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 71' ' ' THR . 13.4 mt -99.82 124.87 45.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -115.75 124.03 49.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -145.92 156.95 43.87 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.258 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -122.23 155.92 16.88 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.945 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 34.9 mt -109.38 143.92 18.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -35.58 75.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.764 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t 177.69 155.62 0.33 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 110.035 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -58.7 -32.05 68.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.999 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.671 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.42 -42.72 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.023 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG3' HG21 ' A' ' 9' ' ' ILE . 48.8 mt-10 -55.01 -60.46 3.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.189 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.8 -41.86 78.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.213 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.18 -31.43 72.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.439 . . . . 0.0 110.785 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.03 -13.87 40.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.212 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.33 7.17 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.028 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 72.7 81.87 0.13 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.53 0.732 . . . . 0.0 110.672 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 4.2 mm? 64.64 37.53 7.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.984 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER 73.15 152.88 0.15 Allowed Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.79 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.76 118.15 5.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.628 2.218 . . . . 0.0 111.905 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.565 ' NZ ' ' HA ' ' A' ' 126' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -45.04 -55.18 5.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.145 0.498 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.65 21.82 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.328 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 10.8 p -63.59 -31.38 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.013 -175.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.458 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 2.3 m-85 -65.0 -58.99 4.66 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.76 63.28 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.823 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.52 ' NE2' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -64.31 -47.04 80.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.696 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.58 HE21 ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -62.58 -40.44 96.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.396 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.6 mt -82.82 -40.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.562 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -65.5 -50.54 64.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.628 ' HB ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.28 -21.57 39.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.119 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.53 76.3 0.73 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.587 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.628 HD22 ' HB ' ' A' ' 61' ' ' THR . 1.8 pt? -148.44 59.84 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.6 0.714 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.438 ' HE2' HG11 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -67.86 -24.19 65.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.006 -177.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 6.7 p-10 -73.22 -12.6 60.93 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.687 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.91 -92.74 0.33 Allowed Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.541 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 80.8 m -69.5 -34.97 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.499 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 22.0 m-85 -95.51 158.47 15.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.332 -172.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 5.3 mp -89.52 97.83 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -83.39 119.14 24.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.168 -178.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.483 HG21 HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -140.32 155.37 46.84 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.953 0.406 . . . . 0.0 111.049 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.46 ' H ' HD12 ' A' ' 77' ' ' ILE . 2.6 m -87.83 156.46 19.38 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -32.39 73.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -88.68 133.37 34.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -63.97 -19.47 65.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.67 -2.21 6.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.269 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -57.75 -27.2 29.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.209 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.46 -63.18 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.071 0.462 . . . . 0.0 112.017 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -66.8 -43.85 82.78 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.873 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.269 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -70.82 -52.47 20.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.067 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -56.99 -42.59 80.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.426 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -76.23 -50.35 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.559 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -64.68 -26.24 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -91.6 0.25 57.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.192 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.89 32.64 73.86 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.533 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 82' ' ' ALA . 7.0 mt -73.1 -7.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.715 ' HG3' HD13 ' A' ' 144' ' ' ILE . 38.0 tp10 -28.76 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.715 1.206 . . . . 0.0 113.231 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -130.07 90.17 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.1 -157.7 20.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.181 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 8.2 t80 -117.63 153.56 33.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.503 0.321 . . . . 0.0 110.451 -176.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.577 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 29.3 mt -132.53 140.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.433 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 16.8 p90 -131.96 134.3 45.48 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.28 0.562 . . . . 0.0 110.856 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.6 134.72 63.15 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.031 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.451 HD21 ' HE2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -122.15 143.19 49.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.738 -173.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -82.3 125.41 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 100' ' ' PHE . 61.7 ttp85 -70.3 -45.06 67.06 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -22.58 66.83 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 -175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 135' ' ' VAL . 4.8 tp -65.5 -32.67 74.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 10.6 m-85 -66.49 -44.57 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.65 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.7 -42.57 91.28 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.655 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -43.25 96.77 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 109.932 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 3.1 m-85 -62.73 -23.01 66.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.378 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m 72.98 23.6 2.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.127 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.499 HG13 ' HB3' ' A' ' 103' ' ' TYR . 3.8 mt -70.91 148.14 10.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.074 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 22.4 m-85 -78.15 105.23 9.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.946 0.403 . . . . 0.0 111.041 -166.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.19 109.89 20.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 124' ' ' ARG . 7.5 t80 -129.72 128.28 42.16 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.057 0.456 . . . . 0.0 110.336 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.52 155.07 22.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.831 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 64' ' ' TYR . 11.3 m -129.63 145.97 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.19 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.567 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -113.42 136.13 53.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.171 0.51 . . . . 0.0 110.646 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -79.92 -174.68 0.51 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.553 175.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 95.6 Cg_exo -46.91 169.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.026 1.817 . . . . 0.0 113.181 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.31 -65.58 0.54 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 30.0 t30 -98.81 -8.59 0.12 Allowed Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -167.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 115' ' ' ASN . 63.1 Cg_exo -43.93 -27.12 1.57 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 121.562 1.594 . . . . 0.0 111.083 164.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 65.58 20.78 11.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.356 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 112' ' ' HIS . 4.9 pt-20 -112.65 123.73 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.11 0.481 . . . . 0.0 111.128 -177.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 111' ' ' GLU . 6.7 ttpt -121.41 112.48 18.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.124 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.48 121.43 26.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.268 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.02 98.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.641 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.527 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -94.97 121.1 36.23 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.29 -178.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 24.6 mm -86.94 101.73 11.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.474 0.654 . . . . 0.0 109.765 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.787 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 2.2 mmt180 -77.5 95.08 4.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.94 161.49 30.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.712 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' NZ ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -60.76 -47.2 87.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.831 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.75 160.85 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.09 144.33 40.53 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.627 0.58 . . . . 0.0 111.896 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.6 41.59 6.79 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.865 -0.607 . . . . 0.0 114.262 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.57 71.52 0.44 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.068 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.794 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.44 -45.94 33.29 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.794 ' HD3' HG23 ' A' ' 131' ' ' ILE . 70.8 Cg_endo -91.27 128.46 1.2 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.938 1.759 . . . . 0.0 113.033 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.34 -33.49 49.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 61.0 mt-10 -63.27 -22.47 66.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.634 -173.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.688 ' HA ' HD23 ' A' ' 99' ' ' LEU . 5.0 p -70.48 -19.47 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 111.233 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.6 mt -86.96 92.06 3.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 pt -67.59 -32.03 55.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.187 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -157.38 159.38 37.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.316 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.618 ' HD2' ' HE2' ' A' ' 91' ' ' TYR . 7.3 mtmp? -130.34 131.2 45.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.397 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -118.03 161.06 20.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.245 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 tt -122.19 147.47 46.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.3 tt -130.67 124.22 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.231 0.539 . . . . 0.0 110.473 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.02 57.96 1.53 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.528 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.715 HD13 ' HG3' ' A' ' 88' ' ' GLU . 16.3 mm . . . . . 0 N--CA 1.468 0.425 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--O 1.234 0.252 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -98.53 120.96 39.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.145 -172.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.461 HD11 ' HE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -121.29 142.38 50.0 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -113.53 139.3 49.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.86 157.56 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -128.76 157.54 21.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.809 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.877 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 54.2 mt -118.56 128.8 75.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 122.866 0.466 . . . . 0.0 110.164 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -25.19 16.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.08 0.467 . . . . 0.0 110.497 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.5 p -97.95 53.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.718 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.559 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -54.78 -26.42 34.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.065 -178.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -75.31 -50.84 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.108 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 1.5 t70 -59.62 -46.33 89.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.058 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.472 ' HG3' HD13 ' A' ' 9' ' ' ILE . 4.3 tm-20 -57.51 -58.88 6.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.616 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -65.91 -26.98 67.86 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.421 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.72 -43.52 79.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.043 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.36 -24.52 46.4 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.52 70.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.594 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.697 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -174.37 173.78 2.93 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.7 mt -79.47 44.65 0.62 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.359 0.264 . . . . 0.0 111.045 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm 49.29 73.73 0.94 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.795 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 97.5 Cg_endo -76.16 63.94 6.99 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.04 2.493 . . . . 0.0 112.795 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.928 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 54' ' ' VAL . 6.9 tttt . . . . . 0 C--O 1.244 0.763 0 CA-C-O 122.003 0.906 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 13.6 p-10 -61.13 -16.88 49.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.262 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.82 -55.36 30.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.3 p -67.96 -35.56 72.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 34.3 m-85 -59.62 -61.52 2.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.9 0.381 . . . . 0.0 110.251 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.962 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -56.18 -43.34 78.34 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.272 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -65.1 -53.57 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mt -63.76 -30.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.638 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.84 -64.42 1.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.897 0.38 . . . . 0.0 111.713 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 m -93.94 -64.6 1.06 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.8 -105.41 0.06 OUTLIER Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 114.232 -170.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 7.6 tp 61.0 34.33 19.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.762 0.791 . . . . 0.0 109.583 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.623 ' H ' ' HD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -84.5 11.83 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.356 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 t70 69.59 -143.98 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.99 -78.66 0.52 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.568 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.42 -37.03 85.7 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 109.983 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 124' ' ' ARG . 21.5 m-85 -126.93 142.62 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.787 HG13 ' HB ' ' A' ' 123' ' ' ILE . 5.6 pt -105.42 111.11 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 111.355 -169.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 1.5 m -91.39 131.15 37.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.9 t -132.86 143.38 49.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.235 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.618 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.79 153.25 33.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.929 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -172.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -117.85 136.02 53.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.655 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -52.77 -18.77 2.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.262 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 44.1 tp10 -48.86 -30.12 5.44 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.942 0.401 . . . . 0.0 110.773 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.618 HD12 ' H ' ' A' ' 72' ' ' THR . 1.1 tt -48.17 -37.5 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.694 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.54 68.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.018 0.437 . . . . 0.0 111.332 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -73.52 -43.44 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.895 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HG3' ' HG3' ' A' ' 76' ' ' GLU . 15.4 mmtm -57.96 -47.69 82.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.983 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -66.29 -56.98 8.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.285 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.17 74.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.06 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -81.85 -48.67 11.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.637 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -70.73 -18.87 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 m -99.6 0.8 42.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.0 110.506 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.28 29.92 66.75 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.768 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -13.81 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.957 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 142' ' ' ILE . 2.3 tt0 -48.64 -26.09 2.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.789 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.423 ' HB2' HG13 ' A' ' 144' ' ' ILE . 4.3 t30 -108.13 95.66 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.433 -0.167 . . . . 0.0 110.596 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.52 -127.95 2.52 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.007 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.877 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 1.7 t80 -124.23 151.6 43.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 11.1 pt -139.69 133.63 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.228 0.211 . . . . 0.0 110.483 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 22.0 p90 -131.22 137.37 48.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.378 0.609 . . . . 0.0 111.249 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 138' ' ' ALA . 13.6 m -116.56 146.02 21.54 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.8 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.583 HD23 ' HB ' ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.3 143.35 51.25 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.223 -173.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.682 ' HB2' HD13 ' A' ' 137' ' ' ILE . 60.8 t-20 -95.2 139.64 31.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.147 0.498 . . . . 0.0 110.566 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -69.39 -35.08 75.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -53.84 -33.81 57.38 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.4 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -58.93 -49.02 79.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.463 ' HE1' HG12 ' A' ' 135' ' ' VAL . 20.0 m-85 -72.94 -31.93 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.581 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.25 -42.62 99.72 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.86 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -70.71 -50.62 34.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.258 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -63.38 -21.2 66.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.212 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m 65.77 39.96 4.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.311 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -66.38 154.84 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 12.3 m-30 -75.44 141.93 43.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.923 -167.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 129.26 56.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 110' ' ' VAL . 21.9 t80 -131.69 112.34 12.47 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.54 119.9 31.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.411 HG12 ' HD1' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -112.34 148.5 15.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 110.422 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.5 46.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.007 171.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.675 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 14.2 m80 -78.42 -169.7 0.21 Allowed Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 85.1 Cg_exo -48.12 139.64 20.64 Favored 'Trans proline' 0 C--N 1.358 1.051 0 CA-C-N 121.285 1.495 . . . . 0.0 109.416 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -56.26 -48.19 77.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -89.3 -14.35 0.2 Allowed Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 96.7 Cg_exo -51.62 -17.45 4.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.249 1.482 . . . . 0.0 110.333 157.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.409 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 7.2 m-20 72.99 21.77 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.513 171.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.67 121.28 42.11 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.627 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -138.73 125.06 20.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.735 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.33 140.5 50.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.14 113.07 32.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.214 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 56.4 m -87.34 122.01 30.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.386 0.612 . . . . 0.0 110.989 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.787 ' HB ' HG13 ' A' ' 69' ' ' ILE . 14.4 mt -89.12 109.0 19.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.593 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.94 95.93 10.51 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.461 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.654 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.46 148.86 48.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.156 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -59.51 -41.96 91.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.969 0.414 . . . . 0.0 110.957 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.79 159.92 15.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.536 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 105.49 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.874 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.14 70.92 1.23 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.597 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.73 73.59 0.44 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 172.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.682 HG23 ' HD3' ' A' ' 132' ' ' PRO . 1.6 tt -54.76 -41.59 90.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.682 ' HD3' HG23 ' A' ' 131' ' ' ILE . 20.2 Cg_endo -91.93 126.72 0.92 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.808 1.672 . . . . 0.0 111.881 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -18.04 63.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -79.9 4.98 15.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.583 ' HB ' HD23 ' A' ' 95' ' ' LEU . 3.7 m -58.39 -30.15 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.824 0.345 . . . . 0.0 111.498 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.1 pt -87.96 89.91 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.18 0.515 . . . . 0.0 109.961 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 96' ' ' ASN . 12.3 pt -70.78 -28.16 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.648 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.473 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -155.06 124.92 6.56 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.405 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -121.97 132.46 54.55 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.115 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.44 159.37 42.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.185 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tt -100.32 144.39 29.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 88' ' ' GLU . 15.0 tt -124.33 135.66 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 110.489 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 144' ' ' ILE . 6.4 tp10 -115.39 47.23 1.34 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.822 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 143' ' ' GLU . 1.2 tt . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 123.106 0.562 . . . . 0.0 111.793 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.765 0.317 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -121.43 120.98 36.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 5' ' ' LEU . 2.3 mm? -106.21 144.91 32.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.251 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' HE1' HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -132.61 138.35 47.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.461 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.67 HH11 HD12 ' A' ' 21' ' ' LEU . 44.9 ttt180 -139.21 111.1 7.25 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -107.15 157.85 15.36 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.643 HG12 ' H ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -148.73 136.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.103 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 16.19 14.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.065 0.459 . . . . 0.0 110.959 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.7 58.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.512 . . . . 0.0 109.804 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 91' ' ' TYR . 2.0 mp0 -58.02 -21.56 45.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -68.98 -47.62 65.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.78 -42.58 99.76 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.891 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.06 -53.12 59.96 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.473 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -66.83 -24.95 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.638 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -93.88 -15.41 25.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.48 -9.81 75.68 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.448 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.567 ' HB2' ' HG3' ' A' ' 23' ' ' PRO . 1.6 mm-40 -174.71 -169.59 0.43 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.67 HD12 HH11 ' A' ' 7' ' ' ARG . 0.5 OUTLIER -77.2 61.29 2.07 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.003 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 52.67 69.07 2.56 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.567 ' HG3' ' HB2' ' A' ' 20' ' ' GLN . 86.0 Cg_endo -83.14 82.57 2.1 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.787 2.325 . . . . 0.0 112.077 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.468 ' HG3' ' H ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -48.52 -31.54 6.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.452 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 51' ' ' LYS . . . -55.62 -65.5 0.58 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.05 -32.31 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.768 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -66.04 -61.03 2.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.92 84.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -62.68 -44.54 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -49.65 66.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.686 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 82.0 mt -62.65 -36.12 73.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.621 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.95 -52.34 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.217 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.7 p -64.39 -76.63 0.07 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.463 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.21 7.22 11.7 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.361 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 43.6 tp 64.24 -79.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.58 0.352 . . . . 0.0 110.334 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -107.22 64.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -38.46 88.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.881 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.21 -1.58 0.55 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.129 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.3 m -78.04 -15.74 58.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.827 0.313 . . . . 0.0 111.275 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -121.29 157.12 31.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.224 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 31.0 mt -98.03 100.81 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.936 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m -77.21 114.32 15.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.548 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.32 168.9 16.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 110.715 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -112.31 152.2 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -25.67 68.06 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.77 133.25 34.0 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.127 -0.358 . . . . 0.0 110.497 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -59.62 -25.79 64.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.679 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.53 -6.82 58.78 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.418 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -23.88 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.006 0.432 . . . . 0.0 110.52 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.736 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -71.36 -44.07 65.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -57.99 -51.58 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.782 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.27 -48.02 83.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.212 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -55.83 -44.86 78.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.552 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -70.62 -43.03 70.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.5 m -63.51 -28.52 70.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.328 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 p -86.84 -5.52 59.08 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 110.6 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.17 89.85 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 92' ' ' ILE . 3.1 tp -69.1 -8.92 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 142' ' ' ILE . 43.9 mt-10 -28.52 -49.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.558 0.743 . . . . 0.0 112.741 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -121.14 91.11 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.49 -143.93 5.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.091 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.502 ' HB2' ' NE2' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -122.85 150.16 43.24 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.038 0.535 . . . . 0.0 110.352 -174.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.611 HG13 ' HG3' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -142.86 137.8 27.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 110.198 176.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -118.34 145.77 44.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.571 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 2.1 t -106.63 128.78 61.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.525 172.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 142.01 51.37 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.951 0.782 . . . . 0.0 109.119 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.547 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.3 t-20 -113.24 144.56 42.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.908 0.385 . . . . 0.0 111.557 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.556 ' HA ' ' HD2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -64.1 -39.54 94.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.269 -175.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -69.53 -26.33 64.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.193 0.52 . . . . 0.0 109.915 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.74 HD22 HG23 ' A' ' 137' ' ' ILE . 12.4 tp -66.51 -39.19 88.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.399 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.556 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 48.1 m-85 -61.72 -42.8 99.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.441 174.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -38.99 90.45 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.907 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -62.05 -44.07 97.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.199 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.498 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 17.6 m-85 -76.99 -12.0 59.88 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.891 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m 70.66 27.62 3.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.457 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.548 HD11 ' HG3' ' A' ' 132' ' ' PRO . 18.4 mt -72.24 148.09 9.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.545 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 69.4 m-85 -89.81 122.77 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.565 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.79 138.62 31.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.15 112.06 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 119.28 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.131 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -87.29 129.65 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -121.55 128.75 52.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.466 0.651 . . . . 0.0 110.847 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 50.5 m80 -80.33 -174.81 0.52 Allowed Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 80.6 Cg_exo -46.19 149.37 2.52 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.211 1.274 . . . . 0.0 111.232 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -52.0 -51.42 57.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -166.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.405 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -99.84 -13.45 0.17 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 92.2 Cg_exo -50.15 -16.25 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.943 0 CA-C-N 121.767 1.667 . . . . 0.0 110.903 163.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 t-20 69.37 28.59 4.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.778 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 112' ' ' HIS . 20.3 tp10 -103.09 98.4 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.364 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -131.14 108.75 9.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.779 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.556 ' HB3' HG22 ' A' ' 110' ' ' VAL . 6.7 tm-20 -99.7 115.1 28.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.99 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.49 101.1 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.092 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.553 ' HB ' ' HE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -93.79 127.92 39.76 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 28.2 mm -88.43 102.9 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.283 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.553 ' HE ' ' HB ' ' A' ' 122' ' ' THR . 6.9 mmt180 -86.0 101.72 13.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.841 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.422 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -69.71 156.71 38.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.18 -29.51 70.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.261 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -147.34 161.17 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.719 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.94 47.13 4.57 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.542 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.53 ' SG ' ' NH2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 48.68 63.82 1.95 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.923 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -50.73 -45.77 86.28 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.923 ' HD3' HG23 ' A' ' 131' ' ' ILE . 92.8 Cg_endo -93.14 109.5 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.669 1.579 . . . . 0.0 112.295 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -61.93 -27.74 69.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.965 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.498 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -88.01 11.96 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.886 -178.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.615 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 13.1 p -59.77 -24.44 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 111.556 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -88.34 104.36 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.873 0.844 . . . . 0.0 109.782 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.74 HG23 HD22 ' A' ' 99' ' ' LEU . 1.6 pt -63.12 -26.61 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . . . -145.82 146.0 30.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.326 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -128.26 123.14 33.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.611 ' HG3' HG13 ' A' ' 92' ' ' ILE . 1.9 pt-20 -140.49 160.29 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.159 0.504 . . . . 0.0 111.122 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -111.26 151.76 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.612 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.8 tt -128.45 132.06 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.769 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -128.02 29.78 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 10.2 tp . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 122.341 1.067 . . . . 0.0 111.195 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 97' ' ' ARG . 12.5 p-10 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -114.83 161.25 18.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 111.182 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -100.53 154.93 18.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.022 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.89 141.25 38.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.374 0.607 . . . . 0.0 111.267 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.581 ' HB2' HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -144.07 156.07 44.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.703 176.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -137.74 157.65 24.25 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.453 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.591 HG23 ' H ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -147.27 140.31 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.447 -178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 6.26 14.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.488 0.661 . . . . 0.0 109.296 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.591 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.36 49.08 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.603 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -59.91 -26.73 66.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -61.09 -46.57 90.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.753 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.8 -47.16 86.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.96 -50.03 69.91 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.448 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -72.0 -24.24 61.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -74.46 -42.41 59.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 110.718 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -94.1 -16.1 24.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.51 89.32 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.0 159.2 36.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -81.18 130.92 35.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HE2' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 50.98 151.91 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 125.075 1.35 . . . . 0.0 113.835 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.52 -164.39 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 111.663 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.237 0.395 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.9 mttt . . . . . 0 C--O 1.238 0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -60.81 -22.46 64.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.657 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -65.84 0.57 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.444 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -68.68 -27.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -63.17 1.36 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.416 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.97 87.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.437 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -55.92 -52.48 63.96 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.174 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 26.9 tp60 -66.39 -54.87 19.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.244 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.58 -37.14 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.464 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -80.29 -58.47 3.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.51 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -69.27 -19.84 63.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.57 -175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.63 -111.71 0.77 Allowed Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 13.5 tp -162.07 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.409 ' H ' ' HB3' ' A' ' 63' ' ' LEU . 15.4 m-85 -105.36 -38.05 6.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.267 0.556 . . . . 0.0 109.523 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.65 -155.24 0.22 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.074 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.01 -14.61 76.85 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.487 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.52 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 97.6 m -61.5 -50.55 72.28 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.429 0.292 . . . . 0.0 111.212 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -104.33 160.2 15.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.262 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 mp -110.53 99.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.59 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.81 115.41 21.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.421 HG21 ' HA ' ' A' ' 5' ' ' LEU . 96.7 m -140.89 129.41 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -82.22 151.14 26.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.003 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.07 10.73 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.895 0.378 . . . . 0.0 111.823 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.43 123.46 48.11 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -49.2 -28.47 4.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -64.81 -19.97 66.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.69 0.281 . . . . 0.0 111.07 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -28.72 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.557 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -51.64 68.16 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.273 0.558 . . . . 0.0 110.651 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.94 -43.62 67.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.616 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.05 -47.87 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.099 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.35 -54.22 36.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -54.35 -43.89 71.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.544 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 m -73.76 -48.31 32.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 m -68.84 -18.22 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB2' HG13 ' A' ' 87' ' ' ILE . 18.0 m -92.78 -3.38 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.528 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.77 96.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.251 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 82' ' ' ALA . 15.8 mt -79.61 -8.44 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 121.957 0.103 . . . . 0.0 111.041 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 142' ' ' ILE . 10.8 mt-10 -33.28 -39.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -119.85 100.87 7.49 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.77 16.74 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.445 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -109.5 128.18 54.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 -175.163 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.4 mt -105.03 133.36 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.17 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 7' ' ' ARG . 21.5 m-85 -116.38 146.1 42.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -134.38 122.53 40.37 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.958 176.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.733 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.58 140.86 48.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.071 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.43 ' HB2' HG21 ' A' ' 137' ' ' ILE . 24.5 t-20 -80.5 138.43 36.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -68.61 -40.64 80.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -172.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.25 -10.36 59.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.575 0.226 . . . . 0.0 111.19 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.96 -42.58 76.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.604 ' HB3' HD12 ' A' ' 105' ' ' ILE . 3.3 m-85 -68.34 -43.48 77.41 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.683 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.84 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.993 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.63 -41.68 71.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.8 -19.52 65.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.3 m 72.9 38.23 0.74 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.001 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -75.89 166.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.279 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -75.51 109.32 8.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.341 -175.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.39 99.82 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -110.85 114.13 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.902 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.32 113.97 25.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.415 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -87.54 115.12 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -103.19 137.11 41.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.329 0.585 . . . . 0.0 111.264 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -87.95 174.37 5.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.572 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 52.7 Cg_exo -49.44 159.6 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.924 1.749 . . . . 0.0 112.575 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.474 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -44.34 -65.07 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.418 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 50.3 t30 -92.76 -18.44 0.23 Allowed Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 44.5 Cg_exo -44.46 -18.82 0.21 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 121.551 1.59 . . . . 0.0 112.051 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.409 ' N ' ' C ' ' A' ' 115' ' ' ASN . 2.2 t-20 73.64 12.01 4.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.607 167.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -103.46 122.11 44.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 111.014 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -142.9 109.4 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.283 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.571 ' HB3' HG13 ' A' ' 110' ' ' VAL . 14.3 tt0 -100.52 132.61 45.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.96 104.37 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -84.59 114.59 22.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.172 0.51 . . . . 0.0 110.166 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 46.0 mm -88.01 100.62 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.663 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.732 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -86.32 93.16 9.02 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.008 179.331 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.17 151.76 46.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.435 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.589 ' HA ' HH21 ' A' ' 124' ' ' ARG . 3.3 mm-40 -65.37 -11.04 38.35 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -170.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.688 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 32.2 t0 -145.26 156.19 43.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.27 132.54 47.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 111.468 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 91.29 33.05 8.32 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.127 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 60.95 70.88 0.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.983 0.42 . . . . 0.0 110.356 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.899 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -37.83 -54.82 2.3 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.899 ' HD3' HG23 ' A' ' 131' ' ' ILE . 20.1 Cg_endo -93.11 128.64 0.72 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.306 2.004 . . . . 0.0 112.493 -174.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -81.36 -7.17 59.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -83.71 -4.78 58.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.456 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 132' ' ' PRO . 28.2 m -81.84 -9.41 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 110.247 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.08 89.73 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 96' ' ' ASN . 5.5 pt -63.79 -35.07 71.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.702 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 94' ' ' VAL . . . -155.32 167.96 28.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 111.772 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 160.54 43.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.368 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -141.34 160.58 39.83 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.015 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -105.37 149.43 26.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.4 tt -139.38 130.88 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.461 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -122.93 35.95 4.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.774 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt . . . . . 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.82 -179.695 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.6 128.87 35.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -175.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.648 HD21 HD13 ' A' ' 123' ' ' ILE . 7.0 mp -100.7 135.94 41.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.508 ' HD2' HD11 ' A' ' 92' ' ' ILE . 1.4 m-85 -121.57 124.59 44.72 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.174 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.81 150.2 43.02 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.538 ' HA3' HG13 ' A' ' 87' ' ' ILE . . . -129.95 158.26 22.23 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.326 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.562 HG13 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.46 140.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 122.774 0.43 . . . . 0.0 110.468 -175.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.49 ' N ' HG12 ' A' ' 9' ' ' ILE . 2.5 p -89.24 -39.36 13.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.202 -0.311 . . . . 0.0 110.346 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' SER . 7.8 t 174.88 -150.26 0.01 OUTLIER 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.059 0.544 . . . . 0.0 109.79 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -56.77 -40.49 75.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 14.1 pm0 -56.42 -32.55 64.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.972 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -84.98 -31.93 23.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.52 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.803 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -52.56 -51.01 61.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.161 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -73.33 -40.17 64.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.14 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . 23.7 t30 -57.55 -48.16 80.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.62 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.87 -35.49 26.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' NZ ' ' A' ' 24' ' ' LYS . . . 68.8 16.02 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.895 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -132.52 4.09 3.93 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.803 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 33.3 tp -71.0 -54.17 12.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.558 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -88.44 132.92 37.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.271 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 130' ' ' CYS . 32.1 Cg_exo -59.23 112.54 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.783 2.322 . . . . 0.0 111.962 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' HA3' ' A' ' 129' ' ' GLY . 7.0 pttt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.005 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.482 0 CA-C-O 121.576 0.703 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -53.87 -29.7 42.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.95 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 57' ' ' HIS . . . -54.6 -66.6 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.935 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.73 -37.64 80.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.518 0.199 . . . . 0.0 110.994 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -64.15 1.04 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.981 0.42 . . . . 0.0 110.662 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.53 90.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.172 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 6.1 m-70 -58.65 -46.88 86.18 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.839 -177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -60.05 -51.72 68.45 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.572 HD11 HH22 ' A' ' 124' ' ' ARG . 84.5 mt -58.62 -46.28 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.548 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -77.0 -39.77 49.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.3 m -80.35 -42.8 22.25 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -173.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.16 11.38 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.569 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 37.7 tp 63.32 -75.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.89 0.476 . . . . 0.0 110.885 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 122' ' ' THR . 17.8 m-85 -131.02 68.15 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.558 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -58.91 -43.72 91.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.191 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.13 -11.93 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.453 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.89 -29.89 69.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.289 0.545 . . . . 0.0 110.849 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.61 160.06 19.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.6 HG13 HD23 ' A' ' 5' ' ' LEU . 3.0 tp -115.05 123.68 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 110.369 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -105.59 147.69 28.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.809 -174.041 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.705 HG22 HG13 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -137.78 148.78 45.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.283 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.538 ' H ' HD12 ' A' ' 77' ' ' ILE . 2.9 m -81.49 155.85 25.6 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.217 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -25.9 65.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -85.88 129.01 34.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.705 0.288 . . . . 0.0 110.739 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.83 -18.39 64.08 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.5 -9.69 44.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 ' H ' ' A' ' 72' ' ' THR . 2.2 tt -46.71 -31.83 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.56 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.6 -62.81 1.48 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.357 0.598 . . . . 0.0 111.289 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -70.16 -41.49 73.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.825 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.61 -45.27 92.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.306 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 5.8 t80 -68.58 -53.81 20.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.175 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.81 75.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.498 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m -74.82 -52.58 11.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.665 0.269 . . . . 0.0 111.259 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -70.72 -10.4 59.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -105.07 3.78 30.81 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.297 -0.252 . . . . 0.0 110.865 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.47 36.25 76.34 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.945 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.538 HG13 ' HA3' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -89.76 -9.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.741 -176.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.18 -28.25 0.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.174 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -107.39 109.08 20.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.94 -126.44 3.55 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.145 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.43 150.86 51.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.508 HD11 ' HD2' ' A' ' 6' ' ' TYR . 16.9 tt -145.18 133.87 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.846 0.355 . . . . 0.0 110.067 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -128.8 154.98 45.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.162 0.506 . . . . 0.0 111.099 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 21.6 m -122.84 145.31 29.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.596 0.713 . . . . 0.0 111.494 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.799 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -120.15 141.2 50.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.327 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.465 ' HB2' HD13 ' A' ' 137' ' ' ILE . 61.0 t-20 -105.81 128.74 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.084 -0.385 . . . . 0.0 111.427 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -67.35 -34.19 76.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.021 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.18 -36.38 72.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.17 -38.92 89.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -71.56 -34.27 69.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.84 -39.04 96.96 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -65.94 -43.13 88.92 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -65.45 -18.58 65.42 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.648 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 m 71.89 30.43 2.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.677 0.751 . . . . 0.0 110.423 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.3 mt -72.38 156.77 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.473 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 15.2 m-85 -78.5 138.27 38.34 Favored 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -118.61 104.72 10.9 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -109.62 112.25 24.22 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -99.46 111.6 23.93 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -83.76 107.02 14.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.9 129.73 44.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.043 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 48.6 m170 -83.09 178.21 2.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.458 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 81.7 Cg_exo -48.15 168.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.011 1.807 . . . . 0.0 112.511 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.46 -70.11 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 66.1 t30 -77.42 -21.42 0.37 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -167.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 18.2 Cg_exo -39.13 -22.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.832 1.688 . . . . 0.0 112.244 166.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 73.09 6.25 5.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.919 164.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.24 140.07 52.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.223 0.535 . . . . 0.0 112.058 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 98.31 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.602 ' HB3' HG13 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -70.39 105.42 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -173.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.705 HG13 HG22 ' A' ' 71' ' ' THR . 2.2 p -82.66 104.33 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.574 0.702 . . . . 0.0 109.63 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 3.2 m -97.39 130.4 44.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.528 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.648 HD13 HD21 ' A' ' 5' ' ' LEU . 2.0 mp -87.64 107.08 16.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.003 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 6.7 mmm180 -87.0 91.7 8.79 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.227 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -72.92 148.97 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.78 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -60.28 3.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.468 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.61 141.29 29.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.112 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.66 114.91 7.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.393 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . 91.43 70.71 1.19 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.194 -0.527 . . . . 0.0 114.088 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 23' ' ' PRO . 72.0 m 59.45 72.71 0.51 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 170.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.648 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.59 -43.43 83.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.792 174.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.648 ' HD3' HG23 ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.28 135.66 9.66 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.873 1.715 . . . . 0.0 112.246 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -71.65 -26.64 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.095 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.23 10.88 13.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.006 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.799 HG22 HD23 ' A' ' 95' ' ' LEU . 8.0 p -52.54 -35.79 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 110.779 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.541 HG13 HG13 ' A' ' 135' ' ' VAL . 66.6 mt -93.37 95.36 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 138' ' ' ALA . 1.2 pt -76.04 -35.99 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.326 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 137' ' ' ILE . . . -146.18 157.97 43.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.592 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -133.61 148.47 51.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.739 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.55 154.8 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.747 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 tt -112.14 147.62 35.72 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.6 140.65 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -138.08 53.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.194 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 125.052 1.341 . . . . 0.0 113.884 177.293 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.81 149.58 37.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.288 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.409 HD11 ' HD2' ' A' ' 97' ' ' ARG . 0.8 OUTLIER -100.09 131.65 45.92 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' HA ' HG12 ' A' ' 94' ' ' VAL . 3.1 t80 -96.82 112.42 24.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.479 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -130.59 155.87 45.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.0 158.33 22.27 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.693 HG23 ' HB3' ' A' ' 91' ' ' TYR . 4.7 tt -143.99 152.78 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -175.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.01 14.14 3.54 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.234 0.54 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 9' ' ' ILE . 1.8 t 58.9 -97.15 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -66.17 -46.7 76.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.943 -167.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.98 -57.03 14.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.24 -43.38 98.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.802 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -51.1 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -59.9 -44.8 94.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -63.29 -51.04 67.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.046 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m-80 -78.76 -27.67 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.905 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 20' ' ' GLN . . . 90.34 47.17 3.87 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -172.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 41.6 mm-40 103.91 -144.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.858 1.663 . . . . 0.0 108.434 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.36 52.93 2.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.411 0.551 . . . . 0.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' ASN . 22.9 mtpp 68.52 131.4 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.857 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.7 142.66 9.25 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.242 0.671 0 CA-C-O 121.609 0.719 . . . . 0.0 111.561 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 22.3 p-10 -58.43 -21.81 52.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.547 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.66 -55.71 31.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.563 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -35.01 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.774 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 6.5 m-85 -63.21 -40.77 98.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.52 97.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.826 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -61.95 -38.35 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.133 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 11.3 tt0 -58.55 -57.9 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.65 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.07 -45.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.46 -54.73 6.31 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.935 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -82.84 -18.64 39.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.67 0.272 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . 91.41 30.53 10.67 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.808 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER 44.53 22.05 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.059 0.944 . . . . 0.0 113.083 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 54.84 17.15 1.67 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.977 0.511 . . . . 0.0 111.354 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 36.47 47.02 0.47 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.944 0.898 . . . . 0.0 111.869 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -35.68 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.718 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.61 84.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.425 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.443 ' HB2' HD13 ' A' ' 63' ' ' LEU . 19.9 m-85 -130.19 162.17 29.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.446 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.8 mp -93.42 99.06 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.591 -176.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.425 ' OG ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -86.3 124.13 32.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.027 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 121' ' ' VAL . 14.6 t -140.03 161.37 37.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.539 ' H ' HG13 ' A' ' 77' ' ' ILE . 2.1 m -90.17 154.83 19.46 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 m -61.58 -28.31 69.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 110.456 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -87.17 135.49 33.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.23 -19.87 49.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.163 177.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -6.09 18.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -51.73 -30.85 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.194 173.157 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.06 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -72.06 -43.74 64.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.592 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 81' ' ' PHE . 8.5 tttt -61.05 -53.34 58.41 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.441 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 58.8 t80 -67.51 -50.37 59.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.759 -175.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB1' ' CD1' ' A' ' 87' ' ' ILE . . . -56.72 -52.01 66.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.54 -175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 -37.98 76.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.606 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -68.95 -24.83 64.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.684 0.278 . . . . 0.0 111.029 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -89.3 1.76 55.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.78 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.88 99.84 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.661 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' CD1' ' HB1' ' A' ' 82' ' ' ALA . 2.8 pt -61.4 -9.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.635 0.218 . . . . 0.0 111.49 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -33.84 -45.33 0.19 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.238 0.336 . . . . 0.0 110.791 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -132.21 123.8 27.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.79 -153.48 24.89 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.71 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.693 ' HB3' HG23 ' A' ' 9' ' ' ILE . 7.1 t80 -122.33 149.85 43.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.477 HD13 ' OH ' ' A' ' 6' ' ' TYR . 62.1 mt -130.98 133.02 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.514 -177.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 32.6 p90 -132.37 129.67 39.7 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 111.233 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 138' ' ' ALA . 2.6 m -112.59 130.99 65.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.182 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -110.37 141.24 43.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.28 -175.033 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.46 ' HB2' HG21 ' A' ' 137' ' ' ILE . 10.3 t-20 -83.11 149.76 26.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.427 HH21 ' CD ' ' A' ' 107' ' ' GLU . 9.0 ttt180 -99.99 -20.2 16.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -35.28 78.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.128 0.49 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp -64.05 -38.12 89.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.036 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 5.9 m-30 -64.86 -39.23 93.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.72 51.64 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.824 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -64.1 -29.94 71.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.435 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 4.5 m-30 -82.85 -16.97 45.59 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.715 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.7 m 64.96 47.36 2.6 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.621 0.724 . . . . 0.0 110.275 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 125' ' ' ALA . 24.9 mm -77.06 150.1 6.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.92 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -96.4 103.56 15.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.951 0.405 . . . . 0.0 111.402 -168.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 2.1 pt-20 -93.3 108.17 19.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.111 0.481 . . . . 0.0 110.103 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -99.86 114.26 27.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.337 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 11.6 pt-20 -85.82 120.03 26.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.822 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -92.5 107.76 19.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -114.21 161.04 18.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.132 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -129.19 172.32 7.32 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.2 168.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.37 2.047 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 1.5 pm0 -55.97 -51.22 68.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.511 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 54.1 t30 -83.64 -28.42 0.42 Allowed Pre-proline 0 N--CA 1.471 0.609 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -169.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 22.1 Cg_exo -37.17 -21.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.485 2.123 . . . . 0.0 113.378 170.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.4 t-20 83.65 -3.94 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.35 0.66 . . . . 0.0 112.005 163.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.48 145.5 48.25 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.239 0.542 . . . . 0.0 111.846 -172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.756 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 16.8 tttm -150.05 95.48 2.29 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -100.13 117.01 33.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 0.0 111.175 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 22.8 t -89.22 107.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.456 HG21 HD22 ' A' ' 63' ' ' LEU . 5.2 m -91.28 113.65 25.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.926 0.393 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . 4.5 mt -88.31 103.53 13.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.98 115.16 27.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.267 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -74.44 163.44 27.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.728 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -39.44 -39.85 0.74 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.497 0.498 . . . . 0.0 111.439 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -157.45 161.67 38.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.06 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.5 m -62.24 160.9 12.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 112.01 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.39 31.13 9.87 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.221 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.4 m 48.97 69.33 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.661 0.384 . . . . 0.0 111.876 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.749 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -53.77 -46.35 98.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.723 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.749 ' HD3' HG23 ' A' ' 131' ' ' ILE . 91.0 Cg_endo -92.73 108.74 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 121.854 1.703 . . . . 0.0 112.038 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.41 -5.84 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.63 -3.42 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 95' ' ' LEU . 9.5 p -76.3 -21.11 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.9 pt -86.59 89.74 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.726 0.774 . . . . 0.0 109.341 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' A' ' 96' ' ' ASN . 14.2 pt -74.94 -37.07 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.046 -174.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.611 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -136.76 127.84 27.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.812 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -123.07 136.52 54.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.431 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -141.26 159.46 42.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.239 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.2 tt -112.72 152.18 29.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 125.89 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.357 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.43 ' HG3' HD21 ' A' ' 141' ' ' LEU . 6.3 mt-10 -133.92 93.87 3.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.936 -178.999 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.51 153.94 24.01 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.997 -0.44 . . . . 0.0 111.243 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 144.82 51.12 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.107 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -111.7 132.68 54.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.428 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 0.9 OUTLIER -141.14 105.93 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.345 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.657 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -92.73 155.37 22.55 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.698 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 58.2 mt -131.34 129.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 0.0 110.607 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -24.45 23.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.214 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 48.88 1.67 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.146 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 12' ' ' GLN . 11.8 mt-30 -56.76 -32.24 65.41 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.87 -49.36 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.933 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.11 -44.1 91.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.569 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.68 -48.17 82.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.341 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -67.76 -32.76 73.58 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -72.1 -38.39 69.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -83.05 -22.55 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.033 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 76.79 5.52 84.01 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.813 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 1.4 mt-30 -156.01 165.28 36.91 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.249 0.62 . . . . 0.0 109.441 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.61 56.47 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.65 137.11 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.063 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.11 73.28 4.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.801 2.334 . . . . 0.0 112.489 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 pttp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.302 179.068 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 111.065 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.46 -14.66 63.13 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.79 -52.84 8.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' OH ' ' A' ' 68' ' ' TYR . 13.8 p -63.24 -35.05 70.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.08 0.467 . . . . 0.0 109.827 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -61.39 -50.3 73.42 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.29 72.53 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.769 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -61.59 -52.78 62.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.064 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.686 ' HB2' HD12 ' A' ' 63' ' ' LEU . 18.6 tm0? -59.52 -40.22 86.43 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.399 0.618 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.55 -38.49 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.31 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -84.5 -69.92 0.61 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.99 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 -24.97 18.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.84 162.35 26.83 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 58' ' ' GLN . 13.7 mt -155.57 152.65 29.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.359 0.599 . . . . 0.0 110.151 -175.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -62.51 83.91 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.048 172.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.71 82.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.737 0.78 . . . . 0.0 111.417 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' TYR . . . -145.86 -32.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.9 m -55.17 -28.07 50.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.4 0.619 . . . . 0.0 110.006 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.527 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 30.3 m-85 -103.59 161.2 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.825 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.2 mp -101.29 100.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.014 0.435 . . . . 0.0 110.288 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -78.84 123.1 26.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.931 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.83 152.69 50.56 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.495 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 6.0 m -105.24 159.9 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -28.42 66.68 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.013 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -100.34 134.23 43.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -58.72 -19.55 41.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.375 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.557 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 12.4 mm-40 -52.91 -24.85 10.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -49.81 -35.7 10.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.069 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.05 74.76 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.408 0.623 . . . . 0.0 110.609 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -69.41 -47.07 65.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.761 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 53.2 mttm -63.29 -48.51 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.334 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.657 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -63.1 -47.42 82.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.883 -177.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.636 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -57.07 -57.47 12.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.195 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 m -60.65 -45.05 95.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.832 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 m -60.61 -29.88 69.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -83.8 -6.7 59.49 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.26 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 45.82 18.11 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.636 HG21 ' HB1' ' A' ' 82' ' ' ALA . 7.2 tp -68.49 -18.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -32.43 -44.36 0.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.015 0.822 . . . . 0.0 112.468 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -130.95 101.74 5.75 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.83 -166.82 40.01 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.321 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.45 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -93.05 142.99 26.68 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.013 0.525 . . . . 0.0 109.825 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -134.86 112.79 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.125 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 2.7 m-85 -95.05 129.66 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.223 0.535 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.83 113.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.932 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 95' ' ' LEU . 3.6 mp -112.43 140.96 46.73 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.466 0.479 . . . . 0.0 109.839 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -91.61 129.43 37.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -80.76 -28.38 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.914 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.18 -33.6 71.13 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.44 ' HB3' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -61.07 -38.54 86.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.012 175.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 4.9 m-85 -66.49 -44.05 83.69 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.202 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.76 -45.24 96.83 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.901 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -61.84 -43.67 98.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.231 0.539 . . . . 0.0 110.016 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.41 -21.64 63.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.516 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.2 m 68.59 37.83 2.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.041 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.545 HG23 ' HA ' ' A' ' 125' ' ' ALA . 17.5 mm -67.65 153.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.245 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.67 104.14 14.39 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 121.038 0.447 . . . . 0.0 110.859 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -88.04 110.72 20.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.406 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -100.48 113.22 25.83 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -105.86 130.03 53.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.66 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 m -117.22 131.66 69.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.557 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.8 pm0 -87.78 131.34 34.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.2 m170 -83.37 175.69 4.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.518 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 82.3 Cg_exo -45.95 164.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 113.138 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -51.09 -55.84 15.65 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -168.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.479 ' N ' ' HG2' ' A' ' 114' ' ' GLU . 60.7 t30 -103.28 -9.32 0.12 Allowed Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 42.7 Cg_exo -43.07 -27.34 0.96 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 121.708 1.646 . . . . 0.0 110.867 162.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 t30 67.64 31.57 5.98 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.605 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.89 145.89 29.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 110.834 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 111' ' ' GLU . 5.5 mptt -123.09 130.4 52.73 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.266 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.8 108.4 16.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.148 0.499 . . . . 0.0 110.23 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.08 96.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.461 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.27 117.05 29.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.3 mm -87.3 106.36 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.026 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 68' ' ' TYR . 26.0 mmt180 -85.19 100.23 11.62 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.138 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.545 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -85.57 161.04 19.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.572 ' HB2' HD13 ' A' ' 131' ' ' ILE . 33.2 mt-10 -65.21 -21.05 66.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.073 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -137.52 161.18 37.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.56 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.1 m -71.85 99.61 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.256 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.35 71.55 1.21 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.1 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.9 71.84 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.718 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -58.95 -44.21 98.61 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.694 ' HD3' HG23 ' A' ' 131' ' ' ILE . 65.6 Cg_endo -74.51 109.69 2.95 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.444 1.429 . . . . 0.0 112.23 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -63.15 -21.57 66.29 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.46 -15.43 59.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.442 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.4 p -70.47 -22.12 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.55 97.03 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.431 0.634 . . . . 0.0 109.554 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 pt -69.04 -28.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.46 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.73 141.9 18.36 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.505 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 95.26 5.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 108.956 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -95.08 157.75 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.283 0.564 . . . . 0.0 111.493 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -137.0 147.9 46.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.642 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.73 138.34 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.399 . . . . 0.0 110.624 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -129.21 53.83 1.86 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 CA--C 1.531 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.628 -177.232 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -125.49 119.32 27.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.721 HD21 HD13 ' A' ' 123' ' ' ILE . 29.4 mt -99.22 124.52 44.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.291 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.23 114.62 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.904 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -139.77 144.38 37.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.519 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -114.19 158.51 14.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.504 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.609 HG12 ' H ' ' A' ' 11' ' ' CYS . 4.3 tt -151.45 168.21 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.82 0.448 . . . . 0.0 110.294 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.98 -14.55 38.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.226 0.536 . . . . 0.0 109.999 172.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER 60.16 -86.27 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.597 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -37.77 -57.13 1.02 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -61.85 -56.18 22.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.361 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.85 -41.54 97.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.31 0.576 . . . . 0.0 111.006 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.78 -52.5 50.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.271 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -63.51 -36.73 84.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.898 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -68.84 -55.47 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.209 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.41 -8.7 54.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.725 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.57 1.26 89.24 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 179.65 -175.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.32 67.31 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt 54.21 64.47 6.32 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.103 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.46 62.71 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.573 2.182 . . . . 0.0 112.202 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.4 mttm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 -177.703 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.54 -25.92 64.93 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.333 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.05 -54.59 42.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 110.524 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.49 -36.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.41 -55.4 21.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.048 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.39 90.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.543 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -57.14 -54.4 47.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.056 0.455 . . . . 0.0 110.188 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.564 ' HG3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -59.91 -32.58 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -176.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 58' ' ' GLN . 59.6 mt -88.77 -70.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.82 -45.67 93.54 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.138 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -81.65 -19.29 42.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.982 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 51.21 4.2 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.333 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 40.7 mt 64.05 79.83 0.25 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.828 0.451 . . . . 0.0 110.868 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -53.87 -27.26 29.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.646 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.77 150.82 12.13 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.58 69.13 2.38 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.768 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -16.38 27.9 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -119.41 152.43 36.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.156 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.525 ' HB ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -107.88 110.17 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.492 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 3.2 m -99.93 136.04 40.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.838 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.683 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -141.06 155.41 46.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 175.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 m -86.67 162.33 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 110.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -44.48 96.76 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 6.8 t70 -83.68 136.92 34.02 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 -174.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -56.92 -21.94 33.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' A' ' 74' ' ' ASP . 10.0 pt-20 -61.18 -16.85 49.18 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.789 0.328 . . . . 0.0 110.937 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -29.29 11.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.133 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.84 -66.36 0.42 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.956 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.15 -35.67 71.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.37 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -62.13 -44.45 96.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -67.16 -51.24 56.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.918 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.668 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -54.77 -46.21 74.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.327 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -69.43 -44.1 72.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.664 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 m -73.52 -18.78 61.05 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' HG13 ' A' ' 87' ' ' ILE . 19.0 m -101.5 10.68 40.13 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.537 0.208 . . . . 0.0 111.267 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.79 21.18 69.09 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.169 -0.468 . . . . 0.0 113.029 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 82' ' ' ALA . 18.1 mt -72.8 -8.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -39.45 -34.41 0.21 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.545 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -130.45 89.54 2.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.42 -144.98 6.64 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.228 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -127.18 150.72 49.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.567 HG23 HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -133.25 143.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 178.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.412 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 43.1 p90 -129.65 139.3 51.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.271 0.557 . . . . 0.0 110.843 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.4 m -126.16 139.92 50.18 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.866 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.801 HD23 HG13 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -126.05 141.04 52.12 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.024 -174.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.657 ' HB2' HD13 ' A' ' 137' ' ' ILE . 38.4 t-20 -96.97 139.84 32.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.86 0.362 . . . . 0.0 110.769 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -25.92 67.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.78 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.88 -35.26 70.74 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.238 0.542 . . . . 0.0 109.892 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 96' ' ' ASN . 4.4 mm? -75.94 -50.81 13.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.482 -174.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -30.21 68.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.57 87.52 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.06 -40.01 87.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 105' ' ' ILE . 1.8 m-85 -68.96 -22.0 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.944 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m 66.75 38.43 3.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.66 0.743 . . . . 0.0 109.803 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -71.69 163.88 3.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.642 -178.206 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 5.2 m-30 -75.53 161.61 29.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.544 -171.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -141.23 155.9 45.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.297 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.465 ' HB2' HH11 ' A' ' 124' ' ' ARG . 0.3 OUTLIER -155.28 110.84 3.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.539 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -108.71 120.03 41.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 110.343 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.6 149.21 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.991 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -105.25 142.57 34.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.018 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -174.41 0.48 Allowed Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 116' ' ' PRO . 99.3 Cg_exo -45.79 163.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.414 1.409 . . . . 0.0 111.811 171.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -51.83 64.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -103.69 -9.26 0.12 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -168.201 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 40.8 Cg_exo -42.13 -23.22 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 CA-C-N 121.683 1.637 . . . . 0.0 112.161 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.55 30.07 3.23 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.567 169.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.69 150.82 46.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.087 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -129.77 129.79 44.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.616 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -94.65 103.13 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.942 0.401 . . . . 0.0 109.986 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 4.4 p -92.54 110.11 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.482 0.658 . . . . 0.0 110.442 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 87.6 m -91.68 114.74 27.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.519 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.721 HD13 HD21 ' A' ' 5' ' ' LEU . 2.1 mp -87.82 129.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.623 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -111.8 119.34 38.26 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 -173.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.1 149.45 49.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.67 -57.23 13.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.57 158.88 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.056 169.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.28 160.36 31.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.993 0.425 . . . . 0.0 110.767 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.29 32.13 60.5 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.043 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m 57.49 71.31 0.59 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.155 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.85 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -35.52 -49.64 1.35 Allowed Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.85 ' HD3' HG23 ' A' ' 131' ' ' ILE . 84.7 Cg_endo -99.87 109.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.336 2.024 . . . . 0.0 112.019 174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 3.87 15.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.873 0.368 . . . . 0.0 110.606 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.85 -9.58 39.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.801 HG13 HD23 ' A' ' 95' ' ' LEU . 6.8 p -71.42 -9.26 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.585 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.6 pt -86.1 91.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 96' ' ' ASN . 11.6 pt -63.41 -29.92 48.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.446 -173.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.609 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -148.74 148.83 30.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.215 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -150.45 135.37 17.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -142.63 153.14 43.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.032 -171.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -95.44 150.79 19.9 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tt -139.37 120.23 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.443 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.56 70.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.186 0.517 . . . . 0.0 110.227 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 CA--C 1.533 0.321 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.355 177.288 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -109.2 133.95 52.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 60.3 mt -113.69 147.18 38.64 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -140.1 135.1 32.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.493 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tpt180 -148.37 155.96 41.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -137.49 157.52 24.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.758 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.9 tt -138.43 133.14 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 110.47 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -31.31 27.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.536 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 53.22 2.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.802 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . 13.3 tm0? -56.58 -27.32 57.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.09 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -74.96 -39.34 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.948 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.87 -48.1 75.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.319 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -66.16 -35.28 80.06 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.411 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.453 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 tt0 -63.57 -43.35 97.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.02 -40.58 98.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.341 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.97 -31.95 71.18 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.364 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.48 7.69 71.9 Favored Glycine 0 C--O 1.234 0.129 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.652 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.486 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 4.6 mm-40 -170.93 -178.05 2.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.2 mt -82.06 38.42 0.53 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.219 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm 53.3 60.74 11.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.23 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 55.4 Cg_endo -69.09 149.95 71.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.321 2.014 . . . . 0.0 110.97 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.505 -173.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.455 0 CA-C-O 121.464 0.65 . . . . 0.0 112.698 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -48.26 -31.89 6.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.131 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.75 -60.42 3.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 51' ' ' LYS . 2.2 p -62.91 -32.71 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -62.64 -53.15 58.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.166 0.508 . . . . 0.0 110.418 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.06 99.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.666 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -64.8 -48.96 72.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -70.6 -22.13 62.58 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.836 -175.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.549 HD11 ' NH2' ' A' ' 124' ' ' ARG . 17.0 mm -92.35 -54.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 0.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.91 -50.29 13.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.512 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -80.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.605 0.241 . . . . 0.0 111.412 -173.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.15 79.13 1.62 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 19.8 tp -57.33 86.06 0.01 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 111.535 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 122' ' ' THR . 20.9 m-85 61.55 60.27 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.0 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -34.19 68.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.372 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.33 -13.95 0.45 Allowed Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.353 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.437 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . 13.9 m -61.3 -33.0 72.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 58' ' ' GLN . 19.8 m-30 -106.71 153.51 22.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.05 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.3 mt -93.1 99.6 9.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.833 0.349 . . . . 0.0 110.53 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.78 112.86 24.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.567 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -122.16 170.39 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.919 0.39 . . . . 0.0 111.005 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -98.78 158.29 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.966 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -16.97 64.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.53 134.08 45.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.156 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.7 -19.09 63.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.794 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.17 -16.51 45.42 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.666 0.27 . . . . 0.0 110.655 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -30.62 14.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.902 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.76 -60.37 3.55 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.155 0.502 . . . . 0.0 111.352 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.65 -35.44 65.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.185 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -60.63 -47.67 85.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.808 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -64.38 -51.73 61.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.46 -59.21 5.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -66.87 -35.54 80.26 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.861 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.0 m -73.49 -17.85 61.18 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.444 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 m -99.78 -2.85 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.6 0.238 . . . . 0.0 110.682 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.87 31.59 78.9 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 -9.75 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.031 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -47.48 -27.36 1.71 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.694 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.11 88.48 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.99 -138.74 5.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.364 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.695 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.7 t80 -123.49 148.48 46.19 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.743 0.417 . . . . 0.0 110.022 -174.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.449 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 pt -140.09 139.15 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 10.6 p90 -132.13 132.21 43.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.933 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.1 m -109.98 139.69 32.17 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 CA-C-O 121.333 0.587 . . . . 0.0 110.729 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.3 mp -121.09 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.005 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -85.46 125.81 33.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.891 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.495 HH21 ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -69.49 -53.61 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -171.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.64 -20.37 65.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.061 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 135' ' ' VAL . 15.0 tp -64.61 -34.77 79.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.183 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.534 ' CE1' HG11 ' A' ' 135' ' ' VAL . 0.2 OUTLIER -67.01 -43.89 81.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.618 176.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.96 94.84 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.638 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -59.78 -50.38 74.06 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -64.98 -20.81 66.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.603 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 m 68.88 37.85 2.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.499 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -71.97 158.86 6.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.836 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.6 m-85 -77.08 102.49 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.301 -166.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.495 ' CD ' HH21 ' A' ' 97' ' ' ARG . 41.4 mt-10 -91.63 126.51 36.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.264 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.632 ' HB2' ' HD3' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -134.32 111.01 9.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.19 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -117.0 118.03 31.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.126 0.489 . . . . 0.0 109.706 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -99.81 135.66 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.344 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -92.77 142.37 27.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.342 0.592 . . . . 0.0 110.557 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.23 175.84 2.25 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.28 160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.906 1.737 . . . . 0.0 111.844 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.85 -41.23 97.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -167.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 9.8 t-20 -86.26 -25.39 0.34 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 26.0 Cg_exo -39.37 -23.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.928 1.752 . . . . 0.0 112.091 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 m-20 76.15 6.22 3.68 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.223 164.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -150.11 160.72 43.44 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.951 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.42 148.55 48.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.775 174.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -96.02 105.25 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.024 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 109' ' ' GLU . 33.7 t -89.25 102.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.451 HG21 ' CE1' ' A' ' 64' ' ' TYR . 5.3 m -104.63 109.59 21.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.189 0.518 . . . . 0.0 111.248 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.408 HG21 ' CD2' ' A' ' 100' ' ' PHE . 5.1 mp -89.85 116.81 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.836 ' HG2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -103.04 118.68 37.35 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.833 0.825 . . . . 0.0 110.076 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.77 163.35 20.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.958 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.598 ' HB3' HD13 ' A' ' 131' ' ' ILE . 18.3 tt0 -51.55 -29.18 16.05 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.616 0.573 . . . . 0.0 111.719 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.415 ' H ' ' CG2' ' A' ' 131' ' ' ILE . 36.3 t0 -140.3 160.43 40.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.471 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 1.5 t -67.42 128.27 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.578 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.93 59.69 1.85 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.578 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.3 m 47.46 70.4 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.896 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -54.71 -44.87 99.58 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.896 ' HD3' HG23 ' A' ' 131' ' ' ILE . 91.1 Cg_endo -94.0 124.59 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.112 1.875 . . . . 0.0 112.32 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -84.3 -14.9 48.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -61.4 -29.89 70.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.903 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.64 ' HA ' HD23 ' A' ' 99' ' ' LEU . 22.3 m -72.93 -12.51 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.48 93.63 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 pt -71.9 -26.45 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.923 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -144.45 139.79 28.55 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.409 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -132.48 126.92 34.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.278 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.76 160.25 40.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.592 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.479 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.1 tt -102.55 153.47 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.5 tt -137.26 133.84 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.329 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.479 ' HG3' HD21 ' A' ' 141' ' ' LEU . 31.4 mt-10 -134.0 74.68 1.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.954 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.2 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.514 0.673 . . . . 0.0 110.677 178.293 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 141.44 48.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.594 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.611 HD22 HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -99.97 135.14 41.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HD2' HD11 ' A' ' 92' ' ' ILE . 1.6 m-85 -96.15 141.18 29.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 0.0 110.664 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.13 123.01 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.397 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.551 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -119.8 157.33 15.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.863 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.545 HG22 ' HD1' ' A' ' 91' ' ' TYR . 8.3 tt -149.71 159.09 5.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.113 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 25.59 5.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.125 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.58 64.83 1.09 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.417 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.63 -23.84 67.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.558 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -61.7 -44.83 96.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.455 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.55 -41.65 88.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.234 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -59.66 -42.16 92.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.383 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -71.73 -33.55 68.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.13 -48.4 35.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -87.75 -27.71 22.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.61 75.2 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.993 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -153.02 17.57 0.57 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.89 0.345 . . . . 0.0 111.578 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.88 98.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.21 0.319 . . . . 0.0 110.686 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 10.2 mmmm 68.4 137.69 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.175 0.59 . . . . 0.0 110.879 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' HE2' ' A' ' 22' ' ' LYS . 93.9 Cg_endo -79.7 149.56 20.94 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.396 2.064 . . . . 0.0 111.987 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.45 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt . . . . . 0 C--O 1.239 0.546 0 CA-C-O 121.885 0.85 . . . . 0.0 113.083 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.45 -24.31 54.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.809 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.43 -68.44 0.17 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.096 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG21 ' SG ' ' A' ' 67' ' ' CYS . 3.6 p -79.96 -26.27 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.189 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.8 m-85 -63.36 -53.62 49.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.93 0.395 . . . . 0.0 110.039 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.549 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -56.24 -52.23 65.22 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.043 0.449 . . . . 0.0 109.941 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -62.4 -48.78 78.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.236 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 55' ' ' TYR . 46.7 mm -69.74 -41.2 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -84.71 -54.62 4.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.588 0.232 . . . . 0.0 111.401 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.2 m -74.92 -31.62 61.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.24 -161.89 12.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.142 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 ' OG ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -79.45 73.22 6.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.612 -176.277 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -71.58 -14.43 62.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.16 -171.52 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.651 171.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.45 -50.7 4.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.807 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 54' ' ' VAL . 34.6 t -84.87 -46.1 11.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -115.21 143.77 44.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.257 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.91 99.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.943 0.401 . . . . 0.0 110.229 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.433 ' OG ' HD11 ' A' ' 63' ' ' LEU . 60.0 m -80.49 122.67 27.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.653 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 5' ' ' LEU . 2.2 m -127.21 131.36 50.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.091 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.68 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -80.36 167.87 19.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.618 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.1 p -81.82 9.64 7.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.064 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -116.92 133.28 56.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.165 0.507 . . . . 0.0 110.899 -177.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -65.17 -19.75 66.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.008 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 27.7 mm-40 -77.57 -5.14 49.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.021 -176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.68 HD12 ' H ' ' A' ' 72' ' ' THR . 2.7 tt -48.22 -34.51 4.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.547 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.74 -53.57 56.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -70.59 -46.04 64.19 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.769 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -60.03 -48.23 82.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.53 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.551 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 6.0 t80 -67.35 -53.96 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.109 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -56.61 -42.83 79.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.332 -176.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 m -70.85 -48.16 55.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.227 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 -20.55 66.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.691 0.282 . . . . 0.0 111.54 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -93.83 9.62 36.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.87 36.71 67.23 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.785 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.534 HG21 ' HB1' ' A' ' 82' ' ' ALA . 3.3 tp -70.76 -10.2 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 2.0 tm-20 -38.56 -37.51 0.32 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.502 0.501 . . . . 0.0 111.193 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.07 89.18 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.85 -152.61 11.96 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.139 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' A' ' 9' ' ' ILE . 48.0 t80 -129.89 135.87 48.86 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HB ' HG12 ' A' ' 87' ' ' ILE . 9.9 tt -139.97 138.9 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.42 . . . . 0.0 111.516 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -131.8 156.75 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.7 m -128.17 137.35 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.477 HD23 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -113.82 140.63 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.356 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -81.92 146.28 29.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.711 0.291 . . . . 0.0 110.702 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -94.27 -24.98 17.23 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.36 -43.4 67.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.345 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.465 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 3.6 m-85 -67.14 -36.92 82.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.939 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.72 99.6 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -59.19 -53.44 58.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.339 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -70.93 -16.75 62.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.043 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m 63.88 47.97 3.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.509 0.671 . . . . 0.0 110.222 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -62.62 163.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.523 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 7.3 m-85 -74.6 99.78 3.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.129 0.49 . . . . 0.0 110.491 -170.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.94 101.61 13.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.766 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.512 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 54.6 t80 -116.49 125.3 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.1 140.61 47.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.804 0.335 . . . . 0.0 111.264 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 120' ' ' GLU . 2.5 m -123.92 150.13 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.291 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.18 142.34 27.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.89 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' GLU . 3.0 m170 -84.99 175.09 4.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.535 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.0 Cg_exo -50.4 170.2 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.025 1.817 . . . . 0.0 112.461 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -53.13 -64.68 0.74 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -166.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.452 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 59.2 t30 -93.79 -12.47 0.18 Allowed Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.535 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 52.0 Cg_exo -44.87 -24.04 1.1 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 CA-C-N 121.421 1.543 . . . . 0.0 111.174 163.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.25 -11.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.541 166.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 3.8 mt-10 -102.67 155.15 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.143 0.497 . . . . 0.0 111.029 -172.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -115.03 133.75 55.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HB3' HG22 ' A' ' 110' ' ' VAL . 1.1 tm-20 -89.04 135.32 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.36 100.4 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.459 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -74.23 113.27 11.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.299 177.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.611 HG13 HD22 ' A' ' 5' ' ' LEU . 7.0 mm -87.45 100.19 9.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 48.6 mtt-85 -101.59 110.13 22.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.437 -172.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.5 160.34 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.365 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 131' ' ' ILE . 18.7 mt-10 -54.49 -49.94 68.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -176.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.677 ' H ' HG21 ' A' ' 131' ' ' ILE . 30.5 t70 -110.18 160.28 16.63 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.15 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 12.3 t -80.39 129.41 34.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.91 69.2 1.19 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.975 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 31.2 m 46.87 70.29 0.41 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.869 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -69.33 -44.44 26.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.869 ' HD3' HG23 ' A' ' 131' ' ' ILE . 83.5 Cg_endo -97.92 109.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.451 2.101 . . . . 0.0 111.707 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.63 -27.46 45.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.638 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.18 -9.07 58.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 132' ' ' PRO . 6.4 p -73.13 -15.18 17.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.9 mt -86.94 89.64 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.6 pt -80.23 -28.03 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.422 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.682 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -128.17 140.12 52.1 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.464 ' HG3' ' OH ' ' A' ' 91' ' ' TYR . 12.1 ttmt -141.62 126.49 18.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.273 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.37 131.41 24.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.775 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' A' ' 143' ' ' GLU . 2.9 tt -92.68 151.89 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 171.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -140.52 122.29 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.177 0.513 . . . . 0.0 112.031 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.468 ' HG3' HD21 ' A' ' 141' ' ' LEU . 26.9 mt-10 -126.79 93.16 3.7 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.001 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 2.1 mt . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 123.407 0.683 . . . . 0.0 111.778 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.93 174.93 10.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.554 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -118.97 159.07 24.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.098 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' HE2' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.67 132.39 55.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 -177.017 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.504 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 12.1 ttt180 -131.49 94.77 3.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -90.42 157.48 25.74 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.142 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 HD11 HD22 ' A' ' 21' ' ' LEU . 49.7 mt -125.47 128.71 72.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.869 0.366 . . . . 0.0 110.122 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.86 -31.01 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.858 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.7 p -94.43 55.32 1.96 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -49.92 -29.44 8.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.315 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -70.85 -38.8 73.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.386 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -72.96 -36.18 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.722 -179.057 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.55 -53.39 28.78 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.454 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -59.81 -36.06 75.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.92 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 15.3 t-20 -68.27 -39.88 82.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.183 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -67.18 -32.47 73.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.293 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 2.36 73.36 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.116 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -169.86 177.75 4.28 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 9' ' ' ILE . 7.1 mt -81.38 49.02 1.22 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.479 0.18 . . . . 0.0 111.166 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt 54.7 69.26 2.15 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.415 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 67.1 Cg_endo -86.21 148.57 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.71 2.273 . . . . 0.0 112.233 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tptt . . . . . 0 C--O 1.236 0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 177.681 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.69 -53.03 34.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.024 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.56 -61.97 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG11 HH21 ' A' ' 124' ' ' ARG . 3.5 p -67.9 -37.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -172.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.489 ' O ' HG12 ' A' ' 59' ' ' ILE . 6.5 m-85 -63.41 -59.49 4.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.08 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.98 83.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.081 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.41 -29.58 69.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.622 ' HG2' ' HD2' ' A' ' 68' ' ' TYR . 56.9 tp60 -67.62 -45.21 76.09 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 109.834 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 55' ' ' TYR . 18.4 mm -66.02 -31.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.437 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -81.58 -74.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.559 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 p -95.68 -38.72 10.24 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.39 48.18 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 58' ' ' GLN . 2.5 mp 59.97 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 111.37 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -95.72 64.33 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.365 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 63.54 -74.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.675 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.45 66.84 0.51 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 129' ' ' GLY . 8.0 t -56.93 -42.7 80.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.959 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.622 ' HD2' ' HG2' ' A' ' 58' ' ' GLN . 21.4 m-85 -123.39 159.72 28.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.37 104.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 21.3 m -87.39 111.22 20.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 t -123.85 157.22 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 p -87.52 158.49 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -13.16 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.807 0.336 . . . . 0.0 110.9 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -79.79 130.53 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.832 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -58.61 -24.07 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.643 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.02 1.03 22.19 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.669 0.271 . . . . 0.0 111.0 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -48.93 -34.06 5.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.651 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.04 -57.56 12.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 111.372 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -70.42 -43.09 70.67 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.832 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -60.62 -46.46 90.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.282 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 19.3 t80 -68.82 -44.39 73.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.294 -176.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -57.2 -50.61 72.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.68 -44.4 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -15.64 63.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.433 ' HB2' HG13 ' A' ' 87' ' ' ILE . 6.8 m -105.42 2.75 28.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.22 96.6 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.253 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 82' ' ' ALA . 10.1 mt -91.01 -7.8 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -29.21 -43.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.732 0.813 . . . . 0.0 113.186 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -125.17 92.72 3.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.03 -144.73 6.35 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.917 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -105.09 143.37 33.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.72 0.408 . . . . 0.0 110.448 -175.815 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 5.4 pt -139.88 113.92 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 110.296 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -101.99 156.31 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -129.36 136.92 58.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.559 HD23 HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -128.34 133.9 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.295 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.493 ' HB2' HG21 ' A' ' 137' ' ' ILE . 48.5 t-20 -79.5 134.83 36.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.485 0.183 . . . . 0.0 110.701 -175.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -51.64 13.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.333 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.43 -17.8 64.85 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.782 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.17 -45.61 90.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.344 0.592 . . . . 0.0 109.536 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.458 ' HE2' HD11 ' A' ' 5' ' ' LEU . 59.9 m-85 -66.48 -35.48 80.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.951 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.59 93.1 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.952 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -72.41 -37.2 68.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.136 0.493 . . . . 0.0 110.023 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -75.76 -23.39 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m 69.71 33.93 2.82 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.788 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -65.13 163.92 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.922 174.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.3 m-85 -74.45 99.29 3.51 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.593 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -96.8 99.32 10.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.75 112.39 24.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.614 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -105.02 107.45 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.925 0.393 . . . . 0.0 110.177 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.604 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -91.25 107.54 18.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.35 129.04 34.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.528 0.68 . . . . 0.0 109.455 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -80.75 169.35 19.82 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.146 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.82 167.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.217 1.945 . . . . 0.0 112.407 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.81 -55.96 28.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 46.4 t30 -87.88 -14.74 0.21 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -168.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 45.6 Cg_exo -43.44 -23.36 0.47 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 121.392 1.533 . . . . 0.0 111.298 162.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 67.84 27.82 7.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.584 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -160.33 154.51 23.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.239 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 135.96 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' A' ' 110' ' ' VAL . 19.0 tt0 -98.5 113.56 25.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.428 . . . . 0.0 111.016 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 t -95.73 103.77 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.981 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 58.3 m -93.19 112.47 24.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 100' ' ' PHE . 4.2 mp -88.68 110.04 20.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.596 ' O ' HG23 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -100.41 116.82 33.26 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.558 178.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.42 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -69.99 159.55 33.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.052 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 126' ' ' GLU . 1.2 mm-40 -48.16 -59.55 3.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 111.012 -176.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.668 ' H ' HG21 ' A' ' 131' ' ' ILE . 48.4 t0 -104.63 154.98 19.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.622 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -76.41 140.68 41.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' A' ' 67' ' ' CYS . . . 90.9 49.34 3.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.766 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.504 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 32.0 m 52.14 70.88 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.047 0.451 . . . . 0.0 112.206 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.668 HG21 ' H ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -69.28 -38.35 10.42 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.234 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.661 ' HD3' HG23 ' A' ' 131' ' ' ILE . 95.4 Cg_endo -82.68 118.88 2.87 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 121.267 1.311 . . . . 0.0 112.005 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.1 -31.27 69.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.28 10.07 9.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.494 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 4.2 p -63.29 -29.8 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.611 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.49 93.38 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.493 HG21 ' HB2' ' A' ' 96' ' ' ASN . 18.0 pt -74.86 -32.71 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.102 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -161.56 166.78 26.48 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.371 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -145.42 144.49 30.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.167 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -141.08 160.44 40.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.851 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.39 148.39 25.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.07 137.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.192 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 105.64 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.205 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.562 -176.826 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -157.73 154.65 28.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.097 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.505 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -122.68 151.02 41.94 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.837 0.351 . . . . 0.0 110.597 -174.036 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.63 136.61 52.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.044 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 15.2 tpt180 -142.43 102.39 4.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.77 137.12 13.22 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.46 129.66 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.207 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -28.57 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 110.313 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -90.09 42.29 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.808 -178.071 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.24 -34.59 23.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.148 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -68.93 -42.99 76.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.563 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.6 t70 -65.4 -42.55 92.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 21' ' ' LEU . 2.1 tt0 -61.85 -54.83 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.718 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.65 -32.5 71.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.785 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -35.03 74.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.931 0.396 . . . . 0.0 110.189 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -73.87 -24.31 59.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.784 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.05 5.41 89.73 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.37 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -169.7 162.16 9.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . 1.5 mt -69.33 73.32 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 66.27 149.47 0.12 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.919 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 145.53 82.1 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.592 2.195 . . . . 0.0 111.734 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.508 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.511 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -53.3 -27.47 23.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.36 -66.43 0.39 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.733 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -30.82 49.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.664 0.268 . . . . 0.0 110.96 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.675 ' HA ' ' NH1' ' A' ' 124' ' ' ARG . 22.6 m-30 -62.35 -61.54 2.38 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.649 0.262 . . . . 0.0 110.591 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.75 77.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -52.11 -59.33 4.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.522 ' NE2' ' SG ' ' A' ' 128' ' ' CYS . 1.4 tp-100 -65.72 -51.32 60.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.003 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.476 ' HB ' HH22 ' A' ' 124' ' ' ARG . 2.7 tt -76.91 -24.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.78 -35.89 12.54 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.571 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -89.68 -58.8 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.581 0.229 . . . . 0.0 111.321 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.38 -128.1 6.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.198 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -156.18 -157.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.5 m-85 -98.26 -6.85 30.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.092 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -60.78 91.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 111.288 -172.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.64 -39.03 3.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.222 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.609 ' SG ' ' CZ ' ' A' ' 68' ' ' TYR . 51.8 t -78.92 -48.22 14.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.144 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.609 ' CZ ' ' SG ' ' A' ' 67' ' ' CYS . 30.3 m-85 -129.17 162.68 27.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.658 0.383 . . . . 0.0 110.467 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.64 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.6 mp -92.15 99.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 111.019 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 m -75.73 109.96 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.443 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -118.26 129.09 55.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.275 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.627 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.1 m -75.91 157.46 33.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.07 9.86 16.03 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.643 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 76' ' ' GLU . 16.2 t70 -109.33 135.7 49.96 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.494 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -55.46 -26.15 40.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HG3' ' HE2' ' A' ' 75' ' ' LYS . 11.2 mt-10 -82.81 2.03 36.13 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 121.999 0.12 . . . . 0.0 111.075 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.627 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -44.61 -38.57 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.457 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 4' ' ' PHE . . . -60.03 -55.88 28.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.226 0.536 . . . . 0.0 110.988 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.79 -42.09 67.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.275 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.299 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 22.5 t80 -65.74 -49.48 68.29 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -53.5 -56.46 16.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.303 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -63.3 -39.85 95.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.222 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 m -65.58 -25.6 67.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.941 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -90.4 0.18 57.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.696 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 54.8 30.78 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.708 HG21 ' HB1' ' A' ' 82' ' ' ALA . 4.2 tp -77.12 -9.9 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' A' ' 144' ' ' ILE . 4.2 tt0 -33.32 -47.72 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.492 0.495 . . . . 0.0 111.281 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -131.36 118.01 19.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.938 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 166.25 -168.44 39.9 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.091 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.423 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.85 137.55 32.24 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.91 0.484 . . . . 0.0 109.744 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.48 111.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.7 0.286 . . . . 0.0 110.287 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 3.6 m-30 -111.68 143.4 42.64 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -129.97 130.32 66.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.02 178.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -125.04 141.34 52.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.497 -177.278 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 99' ' ' LEU . 23.5 t-20 -85.58 132.53 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -62.48 -48.25 80.44 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.709 -175.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 1.3 tp -62.84 -43.33 99.09 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.478 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 33.2 m-85 -62.91 -41.05 99.33 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.592 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.62 -36.03 88.04 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.802 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.07 -44.94 83.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -69.26 -16.62 63.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.3 m 72.13 31.0 2.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.608 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.7 mt -75.55 157.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' O ' ' HB3' ' A' ' 124' ' ' ARG . 7.7 m-85 -83.6 101.95 11.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.734 -163.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -94.87 105.74 17.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.663 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.444 ' HE2' ' HE ' ' A' ' 124' ' ' ARG . 10.6 p90 -126.57 145.27 50.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.991 0.425 . . . . 0.0 110.032 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -95.45 125.27 39.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.689 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 120' ' ' GLU . 1.6 p -90.75 106.85 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.8 145.98 27.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -108.36 170.58 5.34 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.7 Cg_exo -47.7 170.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.452 2.101 . . . . 0.0 113.068 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -46.57 -67.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 9.7 t-20 -93.28 -11.81 0.17 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 35.8 Cg_exo -43.88 -20.49 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 CA-C-N 121.556 1.592 . . . . 0.0 112.683 164.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.09 9.39 6.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.407 0.683 . . . . 0.0 111.708 170.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -110.09 115.61 30.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.217 0.532 . . . . 0.0 112.102 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -138.33 95.75 3.06 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.525 ' HB3' HG13 ' A' ' 110' ' ' VAL . 9.7 tt0 -93.96 140.21 29.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.737 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.92 106.26 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -92.47 121.86 34.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.64 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 18.1 mm -88.71 93.42 4.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.153 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.675 ' NH1' ' HA ' ' A' ' 55' ' ' TYR . 6.8 tpp180 -82.1 99.71 9.36 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.192 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.427 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.52 160.51 32.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.828 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.414 ' HB2' HD13 ' A' ' 131' ' ' ILE . 12.8 mt-10 -58.09 -30.81 66.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -147.44 160.87 42.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.522 ' SG ' ' NE2' ' A' ' 58' ' ' GLN . 76.7 m -61.7 149.94 38.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.983 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.42 26.78 50.43 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.873 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.471 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 1.8 m 57.21 72.0 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.708 0.29 . . . . 0.0 110.485 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.84 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -38.85 -46.2 3.17 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.84 ' HD3' HG23 ' A' ' 131' ' ' ILE . 85.2 Cg_endo -85.68 107.67 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 120.651 1.268 . . . . 0.0 111.07 173.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -24.69 64.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.263 0.554 . . . . 0.0 110.528 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.56 3.52 15.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.374 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.499 HG13 HD23 ' A' ' 95' ' ' LEU . 2.4 p -77.9 -8.76 11.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.267 0.556 . . . . 0.0 110.733 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mm -86.2 96.14 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 pt -64.12 -32.99 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.137 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -144.68 136.3 25.61 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.024 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.1 mtmt -111.42 129.08 56.13 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.328 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -140.98 160.46 40.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.541 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 tt -135.93 150.3 49.25 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.84 147.93 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.801 -176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.28 103.4 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.791 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.45 HD13 ' HG2' ' A' ' 88' ' ' GLU . 20.2 mm . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.242 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.6 p30 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' HA ' ' H ' ' A' ' 97' ' ' ARG . 38.0 p90 39.73 -170.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.688 1.195 . . . . 0.0 113.54 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -147.33 160.59 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.21 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.488 ' OH ' HD13 ' A' ' 92' ' ' ILE . 7.4 t80 -121.19 129.56 53.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.628 -170.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.53 HH11 HG12 ' A' ' 69' ' ' ILE . 18.0 ttt180 -140.95 155.12 46.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.92 158.07 16.65 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.931 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.826 HG23 ' HB3' ' A' ' 91' ' ' TYR . 1.1 tt -139.07 129.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.122 0.487 . . . . 0.0 110.468 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.14 -2.04 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 109.378 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 35.93 1.82 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.659 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -56.74 -32.73 65.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.444 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.56 -38.76 77.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.814 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 -45.75 92.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.909 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.03 -52.2 66.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.42 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.49 -27.63 66.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -71.74 -40.96 69.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -85.13 -28.4 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.87 51.32 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.494 ' HG2' ' N ' ' A' ' 21' ' ' LEU . 4.1 tt0 174.44 158.36 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.528 0.731 . . . . 0.0 109.498 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' N ' ' HG2' ' A' ' 20' ' ' GLN . 54.0 mt -65.02 97.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.86 154.31 0.14 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.803 0.69 . . . . 0.0 110.645 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.97 167.2 26.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.765 2.31 . . . . 0.0 112.483 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm . . . . . 0 C--O 1.234 0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.074 178.322 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 111.832 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -59.66 -27.24 66.21 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.845 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.44 -60.23 4.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.528 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.8 p -63.35 -35.4 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.509 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.1 m-85 -59.88 -63.17 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.573 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.2 -46.33 79.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.175 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -62.05 -46.28 89.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 0.0 111.007 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 1.3 pt20 -70.05 -30.26 67.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.316 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 ' HG3' ' A' ' 58' ' ' GLN . 1.2 mp -81.21 -47.39 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.661 0.267 . . . . 0.0 110.722 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.79 -57.18 5.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.004 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.403 ' HB ' HD23 ' A' ' 63' ' ' LEU . 11.7 m -74.67 -26.35 59.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.03 78.83 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.222 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 65' ' ' ASP . 0.8 OUTLIER -65.68 -33.38 75.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.174 -178.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 t80 33.74 46.87 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.795 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.523 ' H ' HD12 ' A' ' 63' ' ' LEU . 37.4 t70 -90.4 -0.27 57.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 109.408 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.07 144.81 46.67 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.417 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 p -71.21 0.77 7.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -65.31 158.79 25.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.53 HG12 HH11 ' A' ' 7' ' ' ARG . 18.1 mt -102.75 138.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.95 131.0 42.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 172.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 5' ' ' LEU . 96.9 m -140.8 110.1 6.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 3.4 m -68.97 152.85 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.103 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 10.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -136.96 142.4 42.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.526 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -54.47 -19.81 6.44 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.733 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.21 -31.21 13.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.862 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -48.07 -31.08 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.27 -54.72 40.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -45.41 62.93 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.765 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -58.52 -49.18 78.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.352 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 7' ' ' ARG . 27.2 t80 -67.48 -49.22 64.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.475 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -55.57 -47.11 76.96 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.507 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -75.91 -39.32 56.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.814 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.3 m -72.69 -20.15 61.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -96.62 3.66 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.5 76.03 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.655 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 82' ' ' ALA . 4.6 mt -72.97 -7.26 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.8 mt-10 -28.68 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -126.46 99.97 6.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.997 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.49 -139.97 5.34 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.77 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.826 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.2 t80 -124.47 150.88 45.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.3 pt -136.84 142.54 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 111.103 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -132.63 135.11 45.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 111.704 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 m -113.92 139.3 40.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.564 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -125.97 142.04 51.7 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.124 -173.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.447 ' HB2' HG21 ' A' ' 137' ' ' ILE . 30.4 t30 -79.68 124.59 28.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.815 0.341 . . . . 0.0 111.139 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.588 ' HB2' HD23 ' A' ' 5' ' ' LEU . 46.9 ttt180 -75.64 -32.76 60.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.49 79.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 135' ' ' VAL . 9.6 tp -65.27 -37.73 88.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.793 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 22.6 m-85 -62.07 -42.71 99.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.761 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.13 -36.25 92.07 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.655 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.62 -48.3 69.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.133 0.492 . . . . 0.0 109.901 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -66.43 -16.45 64.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.584 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m 67.69 30.84 6.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.37 0.605 . . . . 0.0 110.291 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 124' ' ' ARG . 3.5 mt -68.91 152.2 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.778 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.32 101.42 10.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 111.187 -166.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -106.36 120.65 42.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.954 0.407 . . . . 0.0 110.097 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -115.74 120.08 38.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.712 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 tt0 -91.44 132.81 35.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 111.233 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 m -117.75 149.16 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.774 171.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.62 135.14 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 110.631 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -79.44 178.06 2.54 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.7 Cg_exo -50.08 158.01 2.55 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.229 1.286 . . . . 0.0 111.427 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.54 -70.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 31.6 t30 -88.88 -9.7 0.14 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -166.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 68.0 Cg_exo -47.26 -24.32 3.7 Favored 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.535 1.584 . . . . 0.0 110.716 161.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 t30 70.58 32.29 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.032 169.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.72 105.09 13.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.395 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -104.56 107.33 18.22 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.47 125.7 48.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 19.1 t -116.75 106.46 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.37 116.48 22.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.758 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.476 HG13 HD22 ' A' ' 5' ' ' LEU . 9.5 mm -87.77 110.82 21.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.82 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.525 ' O ' HG23 ' A' ' 105' ' ' ILE . 1.4 mtt-85 -111.96 106.77 15.55 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.816 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.91 162.3 28.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.64 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.34 -24.83 67.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.332 0.586 . . . . 0.0 110.376 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.24 162.42 33.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.236 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.3 t -80.44 144.39 32.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.47 32.19 14.23 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.529 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.7 m 57.48 68.49 0.84 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.256 0.551 . . . . 0.0 110.537 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.851 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -46.56 -49.89 43.71 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.959 -175.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.851 ' HD3' HG23 ' A' ' 131' ' ' ILE . 93.9 Cg_endo -88.44 107.73 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.33 1.353 . . . . 0.0 112.118 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -76.83 2.15 15.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.108 0.48 . . . . 0.0 110.763 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -90.36 -15.37 31.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.727 ' HA ' HD23 ' A' ' 99' ' ' LEU . 4.0 p -81.58 -14.05 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 139' ' ' LYS . 1.1 tt -87.65 97.54 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.447 HG21 ' HB2' ' A' ' 96' ' ' ASN . 40.0 pt -75.45 -29.65 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.63 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -151.7 146.17 25.58 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.634 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.64 ' HB3' HD11 ' A' ' 136' ' ' ILE . 45.7 pttt -150.32 130.18 13.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.765 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.68 160.7 39.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.889 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 tt -75.74 145.98 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.453 ' HB ' HG12 ' A' ' 92' ' ' ILE . 20.4 tt -125.3 141.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 0.0 110.214 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -149.17 126.6 11.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.552 -177.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 5.1 tt . . . . . 0 C--O 1.238 0.449 0 O-C-N 124.183 0.927 . . . . 0.0 108.952 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.46 ' HB3' ' HG3' ' A' ' 97' ' ' ARG . 53.0 t30 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.03 125.71 35.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.272 -175.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 3.9 mp -100.64 152.39 20.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.81 133.54 36.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.344 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.662 ' HG3' HH11 ' A' ' 7' ' ' ARG . 0.9 OUTLIER -147.69 130.1 15.75 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.503 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -125.23 157.17 19.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.011 -176.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.25 128.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -15.6 18.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.252 0.549 . . . . 0.0 110.214 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -83.34 60.82 5.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.48 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -27.26 19.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -49.33 28.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.449 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.6 OUTLIER -56.65 -43.2 80.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.204 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -73.76 -33.01 64.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.438 -177.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -79.46 -16.71 55.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.495 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.12 -40.08 24.62 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.15 -65.48 1.01 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.88 41.73 8.03 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.55 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -175.53 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.414 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 17.8 mt 53.07 42.62 32.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.52 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp 44.6 74.84 0.73 Allowed Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 123.127 0.571 . . . . 0.0 112.178 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -84.37 161.78 13.0 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.796 2.331 . . . . 0.0 112.947 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.736 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 52' ' ' ASN . 33.9 mttm . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.444 ' H ' ' HB3' ' A' ' 51' ' ' LYS . 4.3 m-20 -61.33 -23.81 65.99 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.452 -176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.85 -61.02 2.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.353 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.94 -30.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.032 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -61.88 -50.43 72.27 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.87 88.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.331 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -56.12 -46.62 79.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.262 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.506 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 2.0 tt0 -59.88 -56.08 26.18 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.427 -176.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -74.46 -33.67 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.667 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.47 -63.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.395 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -84.28 -45.33 12.95 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.066 0.46 . . . . 0.0 111.451 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.02 108.78 2.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.068 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -123.06 52.06 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 109.761 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -91.07 38.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.174 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -77.83 -24.09 48.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.99 -14.74 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.017 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.502 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -55.64 -55.73 28.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.499 0.19 . . . . 0.0 110.827 177.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 16.5 m-85 -127.81 154.45 45.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.21 102.89 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.017 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.14 132.42 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.394 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -135.54 108.53 7.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.19 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.16 164.23 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.23 -176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -35.88 48.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -100.4 132.9 45.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -60.87 -19.65 60.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 16.6 tp10 -54.05 -18.06 3.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.06 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -44.52 -33.61 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.836 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.43 -66.89 0.34 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.154 0.502 . . . . 0.0 112.035 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.17 -37.51 78.22 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.334 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HG2' ' HG3' ' A' ' 76' ' ' GLU . 46.5 mmtm -63.86 -41.74 97.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.113 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.73 -46.46 72.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -57.25 -52.61 64.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.0 m -68.74 -50.63 49.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 m -68.06 -14.82 63.27 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' HG13 ' A' ' 87' ' ' ILE . 16.1 m -103.23 4.84 37.15 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.143 -0.348 . . . . 0.0 111.003 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.56 24.53 73.89 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.066 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 82' ' ' ALA . 6.9 mt -81.12 -8.09 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.509 0.195 . . . . 0.0 110.772 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' O ' HG12 ' A' ' 142' ' ' ILE . 16.9 mt-10 -37.58 -39.04 0.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.637 0.775 . . . . 0.0 112.866 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -109.86 87.64 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.74 -141.2 5.33 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.901 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -134.87 125.86 27.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.503 HG22 ' HA3' ' A' ' 8' ' ' GLY . 2.0 pt -119.89 147.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 2.8 p90 -130.44 148.58 52.27 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.278 0.561 . . . . 0.0 110.608 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.0 m -113.35 140.22 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.264 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.2 mp -119.59 143.16 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.597 ' HB3' HG21 ' A' ' 137' ' ' ILE . 6.7 t30 -102.55 133.74 47.03 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.683 ' HG2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -64.82 -42.82 94.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.045 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -34.02 65.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.213 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.09 -50.76 64.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.368 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.409 ' HD1' HG13 ' A' ' 105' ' ' ILE . 49.6 m-85 -68.4 -29.95 68.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.98 -47.24 91.35 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.475 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.92 79.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.062 0.458 . . . . 0.0 110.236 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -70.92 -20.16 62.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m 66.24 46.67 1.99 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.507 0.67 . . . . 0.0 110.569 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 125' ' ' ALA . 9.0 mm -79.31 152.15 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.078 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HB3' ' HG2' ' A' ' 124' ' ' ARG . 4.2 t80 -75.44 122.61 24.07 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 110.939 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -104.84 106.52 17.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.512 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -103.44 113.42 26.91 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.875 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.27 109.25 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.016 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -88.2 115.69 28.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 137.4 40.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.551 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.01 170.37 9.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.512 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 78.1 Cg_exo -50.21 157.1 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.377 1.384 . . . . 0.0 111.063 173.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.64 -57.73 5.8 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -168.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.463 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 38.5 t30 -91.51 -17.55 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -168.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 38.2 Cg_exo -42.23 -22.8 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.37 1.525 . . . . 0.0 111.808 164.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 115' ' ' ASN . 16.9 m-20 68.74 8.51 6.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.102 166.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -111.58 138.04 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -141.6 145.88 35.58 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 110' ' ' VAL . 1.7 tm-20 -122.12 125.08 45.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.98 95.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.5 m -87.08 113.88 23.21 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.572 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.637 HG13 HD21 ' A' ' 5' ' ' LEU . 48.6 mm -88.25 97.25 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.436 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.534 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.566 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -69.46 159.65 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.581 ' HB2' HD13 ' A' ' 131' ' ' ILE . 7.1 mp0 -50.81 -48.24 59.72 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 111.506 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -119.18 160.43 22.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 0.0 110.074 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.01 128.56 34.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.178 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.502 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 93.17 65.16 1.07 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.244 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.03 70.43 0.47 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 126' ' ' GLU . 7.4 tt -68.18 -37.24 10.57 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.649 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.564 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 59.3 Cg_endo -98.52 118.91 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.385 2.057 . . . . 0.0 111.808 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -7.31 53.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.276 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.21 6.91 23.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.193 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.552 ' HB ' HD23 ' A' ' 95' ' ' LEU . 6.0 m -60.31 -22.8 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.554 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.7 mt -87.63 88.22 2.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 109.866 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.597 HG21 ' HB3' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -79.91 -29.77 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.426 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.551 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -153.81 166.98 31.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.302 172.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.57 159.09 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.074 0.464 . . . . 0.0 110.879 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -141.14 140.75 34.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.019 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -95.09 149.63 21.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 88' ' ' GLU . 16.5 tt -140.99 141.64 31.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.518 . . . . 0.0 111.68 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.577 ' O ' ' HB ' ' A' ' 144' ' ' ILE . 4.8 tt0 -139.01 22.45 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.747 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 143' ' ' GLU . 10.3 tp . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 125.513 1.525 . . . . 0.0 109.096 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -109.49 156.47 20.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.718 0.294 . . . . 0.0 110.826 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.814 HD12 HG21 ' A' ' 71' ' ' THR . 0.2 OUTLIER -99.55 139.9 34.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -106.61 128.29 54.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.676 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 135.66 20.8 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -110.87 158.3 14.46 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.321 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.555 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 2.3 mt -113.89 129.32 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.762 0.425 . . . . 0.0 110.161 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.34 25.39 11.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.338 0.589 . . . . 0.0 109.899 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.795 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.89 58.98 0.79 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.916 -173.631 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 mp0 -51.15 -42.4 60.75 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.36 -32.79 73.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.051 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.795 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.4 m-20 -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.961 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -60.38 -45.35 93.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 109.666 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -62.71 -42.72 99.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.51 -43.36 97.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 110.499 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -71.94 -24.85 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.444 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.09 -10.84 72.74 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.262 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -172.6 172.73 4.18 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 mt -65.03 91.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.32 0.387 . . . . 0.0 110.602 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HE3' ' SG ' ' A' ' 128' ' ' CYS . 15.2 tptp 74.7 132.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.891 0.744 . . . . 0.0 110.746 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.01 132.64 18.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.298 1.998 . . . . 0.0 111.046 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 2.2 mmmm . . . . . 0 C--O 1.234 0.243 0 CA-C-O 120.662 0.267 . . . . 0.0 110.293 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.296 0.57 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.83 -23.53 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.021 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.2 -60.68 3.23 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.85 -32.77 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.647 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -60.41 -51.4 69.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.37 78.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.79 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -58.19 -50.55 73.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.687 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.562 ' HG3' ' CD2' ' A' ' 68' ' ' TYR . 9.4 mm100 -55.39 -49.01 73.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 mt -74.53 -46.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.493 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -61.96 -48.24 81.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.074 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 3.6 m -77.59 -32.38 53.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.66 53.96 9.18 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.174 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' H ' HD12 ' A' ' 63' ' ' LEU . 2.7 mp -81.05 -75.87 0.26 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 52.28 39.4 27.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.431 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -90.73 -57.29 2.87 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.713 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.32 -60.4 0.17 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.24 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 74.1 m -51.76 -52.96 44.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.562 ' CD2' ' HG3' ' A' ' 58' ' ' GLN . 18.1 m-30 -120.51 145.05 47.68 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.85 128.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.3 m -87.6 130.82 34.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.814 HG21 HD12 ' A' ' 5' ' ' LEU . 13.4 m -127.74 137.77 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.461 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -88.14 148.01 24.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.453 178.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.77 10.47 3.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 0.0 111.377 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.75 121.99 28.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -63.0 -19.63 64.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 80' ' ' LYS . 6.9 pt-20 -90.13 0.34 57.21 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.66 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 72' ' ' THR . 5.0 tt -49.64 -29.83 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.775 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.66 -68.9 0.15 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.908 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -28.45 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . 9.7 tttp -56.23 -49.79 73.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.496 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.18 -49.47 50.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.741 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.9 68.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.485 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -73.74 -48.91 28.36 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.596 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -65.59 -21.37 66.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 m -95.47 0.38 53.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.05 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 31.01 72.43 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.831 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -8.8 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.639 -173.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 142' ' ' ILE . 31.1 mm-40 -40.27 -34.29 0.31 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.487 . . . . 0.0 112.101 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -112.26 96.76 6.2 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.45 -135.52 3.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.022 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.555 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.94 150.31 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.082 0.553 . . . . 0.0 109.609 -175.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.551 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 pt -142.97 133.08 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -131.72 154.97 48.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.1 0.476 . . . . 0.0 111.379 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 138' ' ' ALA . 32.9 m -129.84 136.63 58.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.459 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -113.64 141.95 46.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.809 -177.547 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.455 ' HB3' HG21 ' A' ' 137' ' ' ILE . 3.3 p30 -83.8 143.4 29.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.56 -27.98 21.04 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.689 0.28 . . . . 0.0 111.073 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.0 -33.51 62.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -61.44 -41.57 97.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.064 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 22.6 m-85 -71.11 -41.23 70.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.22 91.08 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.05 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -74.73 -43.45 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.0 109.576 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.06 -25.22 66.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.569 -177.067 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m 67.21 28.63 8.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 110.046 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -66.43 164.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.294 176.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.78 ' HB3' ' HB2' ' A' ' 124' ' ' ARG . 4.0 t80 -73.45 99.35 2.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.293 0.568 . . . . 0.0 110.381 -167.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -95.3 100.02 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.012 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 4.1 t80 -124.73 113.47 18.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -97.64 142.14 29.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.81 132.07 49.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.491 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 6.5 pt-20 -129.57 136.13 49.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.084 0.468 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 178.06 2.63 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.736 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.76 171.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.028 1.819 . . . . 0.0 112.28 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.9 -67.87 0.23 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 61.4 t30 -86.15 -11.08 0.17 Allowed Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -166.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 43.7 Cg_exo -42.35 -25.48 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 121.439 1.55 . . . . 0.0 111.271 162.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.9 3.8 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.656 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.74 130.72 53.26 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 111.646 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 111' ' ' GLU . 17.6 ptmt -150.97 141.62 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.763 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -122.62 132.91 54.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.91 112.42 25.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.924 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 2.7 m -88.78 114.9 25.9 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.779 0.324 . . . . 0.0 110.383 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pt -87.45 113.4 24.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.78 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 23.1 mtt-85 -114.91 88.51 2.88 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.744 -172.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.664 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.87 123.23 20.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.583 172.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -51.77 -46.43 64.12 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.386 0.429 . . . . 0.0 111.637 -168.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.704 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 2.0 t70 -80.21 122.66 27.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.567 ' SG ' ' HE3' ' A' ' 22' ' ' LYS . 7.4 t -54.02 119.56 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.459 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.94 56.89 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.936 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.8 m 63.26 74.82 0.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.704 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 19.3 tt -45.44 -35.27 3.08 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.623 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 91.9 Cg_endo -96.42 109.1 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 121.595 1.53 . . . . 0.0 111.592 169.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -63.8 -22.78 67.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.392 0.615 . . . . 0.0 109.842 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.21 -7.68 43.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.556 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.3 p -77.26 -15.25 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.078 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.86 89.96 3.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.455 HG21 ' HB3' ' A' ' 96' ' ' ASN . 14.5 pt -74.74 -30.62 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.275 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -150.0 148.14 28.69 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.41 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -143.94 127.74 17.26 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.323 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -131.11 152.23 50.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.273 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.57 150.07 23.78 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.7 tt -140.19 135.41 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -120.84 42.82 2.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.241 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.483 -173.705 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.03 155.47 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.261 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.545 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -100.29 146.09 27.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.14 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.537 ' HE1' ' HB ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -113.57 130.96 56.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.744 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HG3' HG22 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -138.25 126.78 23.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.653 178.45 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -109.6 157.84 14.86 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -129.94 132.66 65.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 -177.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -22.22 19.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.401 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -84.8 49.03 1.64 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.499 -177.004 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.53 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -57.78 -26.11 61.46 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 2.2 pt20 -63.43 -41.48 98.68 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.848 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -69.65 -41.46 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.677 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.93 -55.86 29.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -63.24 -39.51 94.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.072 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.59 -37.33 87.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 110.448 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -23.98 37.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 65.78 14.5 60.79 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 13.2 mt-30 -156.38 172.87 17.76 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.11 42.29 0.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.822 0.344 . . . . 0.0 110.751 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 45.61 59.23 15.03 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.16 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.91 171.71 9.21 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.95 2.433 . . . . 0.0 113.177 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.087 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -53.79 -34.87 60.48 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.6 -57.04 12.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.897 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.6 -34.37 69.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.507 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -58.4 -64.22 1.0 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.109 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.86 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.23 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.692 ' HB3' HD22 ' A' ' 63' ' ' LEU . 1.1 t-80 -64.92 -49.65 69.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.355 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 35.9 tt0 -66.1 -38.1 87.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.1 -34.4 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.7 -74.22 0.42 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.836 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -64.41 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.484 0.659 . . . . 0.0 111.441 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 58' ' ' GLN . . . 133.75 158.99 8.82 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 57' ' ' HIS . 2.6 pt? -175.96 -44.49 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.066 0.433 . . . . 0.0 111.233 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.435 ' CE2' ' SG ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -114.35 89.26 3.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.752 -174.508 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.56 134.86 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.725 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.4 -7.56 81.72 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.369 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -73.45 -35.63 65.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.19 0.519 . . . . 0.0 110.58 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.53 160.75 30.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.783 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.731 HG12 ' HB ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -105.06 100.69 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -175.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HG23 ' A' ' 122' ' ' THR . 0.0 OUTLIER -85.95 125.23 33.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.611 176.003 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.644 HG23 HD12 ' A' ' 77' ' ' ILE . 97.3 m -137.44 148.56 46.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 110.541 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.38 170.55 9.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -177.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.21 4.74 9.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.53 135.92 47.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.332 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -66.35 -23.35 66.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.84 -16.13 62.69 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.74 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.644 HD12 HG23 ' A' ' 71' ' ' THR . 0.0 OUTLIER -48.39 -34.27 5.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 123.387 0.43 . . . . 0.0 110.977 176.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.46 -53.99 51.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 79' ' ' LYS . 24.1 ttpt -75.11 -40.35 59.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.888 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -59.5 -52.3 66.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.04 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 1.4 t80 -64.74 -45.84 84.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.469 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -52.36 -59.15 4.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.272 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -64.5 -39.13 93.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -66.71 -26.66 67.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.685 0.279 . . . . 0.0 111.429 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -90.09 2.05 55.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.84 0.352 . . . . 0.0 110.478 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.34 33.36 84.26 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.538 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.63 HD12 HG21 ' A' ' 142' ' ' ILE . 1.8 pp -65.44 -9.96 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -29.22 -50.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.181 0.925 . . . . 0.0 112.323 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -118.36 89.66 3.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.48 -149.58 10.25 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.989 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.53 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 6.7 t80 -115.92 145.44 42.9 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.733 0.413 . . . . 0.0 110.524 -175.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.537 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 1.9 pt -143.54 129.46 16.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.42 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 15.5 p90 -130.71 144.36 51.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.102 0.477 . . . . 0.0 111.232 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.787 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.95 135.94 46.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.164 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -118.15 130.34 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.131 177.304 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.618 ' HB3' HD12 ' A' ' 99' ' ' LEU . 59.3 t30 -79.8 141.68 36.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.576 0.227 . . . . 0.0 111.011 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 100' ' ' PHE . 16.2 ttt180 -80.07 -50.95 9.63 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.63 -22.46 65.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 111.088 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 96' ' ' ASN . 18.8 mt -64.15 -37.43 87.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.446 ' CE1' HG11 ' A' ' 135' ' ' VAL . 49.8 m-85 -63.28 -44.27 95.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.698 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.73 -37.47 83.84 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -66.61 -36.64 83.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 110.499 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -83.94 -7.87 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.173 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.0 m 69.56 34.67 2.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.27 0.557 . . . . 0.0 110.791 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.589 HG13 ' HA ' ' A' ' 125' ' ' ALA . 1.2 mp -74.22 157.18 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.919 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -77.12 101.22 6.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.114 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.81 99.96 12.87 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -104.65 113.36 26.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.06 126.21 54.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 120' ' ' GLU . 3.7 m -108.26 132.01 57.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -111.65 133.77 53.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.577 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.83 174.55 5.76 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 84.5 Cg_exo -48.37 170.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.447 2.098 . . . . 0.0 113.25 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -40.79 -71.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 47.6 t30 -100.13 -9.17 0.13 Allowed Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 47.4 Cg_exo -42.34 -26.98 0.63 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 CA-C-N 121.846 1.695 . . . . 0.0 111.09 165.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.65 26.45 9.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.386 168.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 116' ' ' PRO . 89.8 mt-10 -114.39 118.09 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -124.83 112.59 16.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 110' ' ' VAL . 8.5 tt0 -96.26 106.16 18.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 109.991 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.56 95.86 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.618 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 70' ' ' SER . 0.2 OUTLIER -81.07 107.11 13.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.175 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 69' ' ' ILE . 23.0 mm -87.85 106.68 16.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 105' ' ' ILE . 37.7 mtt85 -104.46 119.12 38.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.241 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.589 ' HA ' HG13 ' A' ' 105' ' ' ILE . . . -68.9 155.31 40.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.934 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.79 -49.4 62.78 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.313 0.578 . . . . 0.0 110.098 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.419 ' H ' HG21 ' A' ' 131' ' ' ILE . 1.2 t0 -122.35 156.09 34.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.991 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.435 ' SG ' ' CE2' ' A' ' 64' ' ' TYR . 20.5 t -73.07 150.28 42.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 111.236 -175.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.61 51.87 2.97 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.098 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 41.62 70.34 0.28 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.865 0.466 . . . . 0.0 112.243 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -56.17 -48.5 96.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.755 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.842 ' HD3' HG23 ' A' ' 131' ' ' ILE . 87.1 Cg_endo -100.31 109.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.591 2.194 . . . . 0.0 112.395 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -77.37 -0.48 25.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.665 0.269 . . . . 0.0 111.301 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -87.81 -5.33 58.67 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.291 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 95' ' ' LEU . 30.9 m -76.21 -17.25 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.84 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.3 pt -86.11 89.89 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.738 0.78 . . . . 0.0 109.378 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.61 -31.06 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.305 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -142.18 146.21 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.415 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -151.66 114.92 4.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.856 177.467 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.61 160.5 39.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.65 156.63 16.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.034 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.63 HG21 HD12 ' A' ' 87' ' ' ILE . 13.8 tt -134.16 137.76 51.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -119.83 90.43 3.33 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.028 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 123.528 0.731 . . . . 0.0 111.49 -178.314 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -116.07 150.46 37.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.212 0.53 . . . . 0.0 111.577 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.1 OUTLIER -100.53 151.35 21.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.97 132.57 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -173.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 7' ' ' ARG . 27.6 ttt-85 -140.15 99.39 3.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.406 0.622 . . . . 0.0 109.41 171.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.611 ' H ' ' HE2' ' A' ' 81' ' ' PHE . . . -89.13 154.74 24.67 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 39.0 mt -121.16 133.24 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.823 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -122.37 17.68 10.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.47 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.61 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -123.5 46.68 2.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.646 -179.622 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -54.02 -29.79 45.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.752 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -63.99 -42.29 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.073 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -69.13 -45.29 70.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.068 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -38.6 83.44 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.205 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -69.74 -41.98 74.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.9 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.97 -41.25 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -80.41 -27.21 38.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 6.79 85.64 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -164.49 178.37 7.46 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 136' ' ' ILE . 12.6 mt -80.11 61.08 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.079 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 32.76 71.91 0.65 Allowed Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.397 1.079 . . . . 0.0 113.047 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.54 169.85 8.02 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.002 2.468 . . . . 0.0 112.258 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.811 177.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.712 0.292 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.99 -59.57 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.151 -175.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.29 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.265 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.25 -37.35 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.516 -171.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.7 m-85 -77.58 -42.4 35.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.538 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.66 75.44 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 109.976 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.16 -48.72 69.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 62' ' ' GLY . 1.4 tt0 -57.98 -29.79 65.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.954 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.7 mt -93.56 -52.78 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.337 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -77.13 -49.56 14.96 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.828 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.98 -32.88 24.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.104 0.478 . . . . 0.0 111.244 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 58' ' ' GLN . . . 134.59 172.11 12.71 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 70' ' ' SER . 84.3 mt -58.83 -15.3 11.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 111.507 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 74.31 -28.0 0.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 164.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.79 101.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.999 0.428 . . . . 0.0 111.664 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.49 -112.8 0.31 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.776 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.4 p -76.99 -34.88 57.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.765 -177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -83.15 145.61 29.11 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.731 HD12 HD11 ' A' ' 123' ' ' ILE . 21.4 mt -117.94 128.06 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.39 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.638 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.3 p -95.22 113.95 25.68 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.541 HG21 ' HB2' ' A' ' 5' ' ' LEU . 7.8 p -122.77 144.43 49.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.622 0.249 . . . . 0.0 110.801 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.0 m -87.81 150.2 23.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.831 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -16.06 62.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -79.35 135.52 36.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.858 0.361 . . . . 0.0 110.519 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -62.41 -20.9 64.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -72.63 -4.19 29.44 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.4 tt -51.29 -34.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.326 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.5 -58.91 6.52 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.151 0.5 . . . . 0.0 111.068 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.31 -43.52 70.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.058 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.95 -44.54 94.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.225 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.611 ' HE2' ' H ' ' A' ' 8' ' ' GLY . 87.5 t80 -65.98 -55.37 17.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.003 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.43 73.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.671 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -72.73 -45.91 56.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.604 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.1 m -70.7 -17.15 62.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.6 m -92.9 -4.2 53.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.555 0.217 . . . . 0.0 111.001 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 37.6 95.23 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' HA ' HD13 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -90.88 -8.8 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.365 -0.417 . . . . 0.0 111.653 -171.862 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -42.37 -32.75 0.55 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -119.13 90.79 3.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.49 -145.97 8.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.375 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -107.68 146.79 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.252 0.221 . . . . 0.0 110.458 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 mt -138.68 118.44 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.406 ' OH ' ' HD3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -131.89 143.4 50.13 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.75 173.083 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.4 m -120.75 149.38 23.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-O 121.275 0.56 . . . . 0.0 111.123 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.662 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -122.92 134.91 54.34 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.523 -174.628 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.565 ' HB2' HD13 ' A' ' 137' ' ' ILE . 31.0 t30 -87.22 115.75 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.714 0.292 . . . . 0.0 110.944 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.44 -30.08 70.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -63.21 -36.37 83.43 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 134' ' ' GLU . 32.2 tp -69.14 -40.41 78.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -62.5 -34.74 77.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.388 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.74 -39.94 98.0 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.519 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -63.55 -42.1 98.39 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.085 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.481 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 19.4 m-85 -74.07 -16.94 61.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.964 0.412 . . . . 0.0 110.339 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.5 m 65.42 33.8 8.6 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.101 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 125' ' ' ALA . 75.3 mt -63.23 147.79 11.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.234 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.63 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 1.6 m-85 -75.21 150.13 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 0.0 110.642 -167.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.25 118.05 8.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.585 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.503 ' HD2' ' NH2' ' A' ' 124' ' ' ARG . 72.6 t80 -127.52 117.58 22.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.619 ' HG2' HG22 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -92.5 133.24 36.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.84 -177.476 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -97.91 134.11 37.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -96.71 133.06 41.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.362 0.601 . . . . 0.0 111.209 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.87 171.81 11.55 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 168.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.5 Cg_exo -46.63 164.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.824 1.682 . . . . 0.0 112.136 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -47.56 -67.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 5.5 t-20 -87.18 -13.69 0.2 Allowed Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -167.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 31.5 Cg_exo -42.59 -23.63 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 121.454 1.555 . . . . 0.0 111.774 163.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.41 23.67 9.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.895 170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.11 134.87 54.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.88 -172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -125.39 106.57 9.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.065 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.582 ' HB3' HG22 ' A' ' 110' ' ' VAL . 2.7 tp10 -79.29 91.92 5.08 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 110.201 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 109' ' ' GLU . 17.5 t -73.43 98.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.565 HG21 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -84.16 114.84 22.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.731 HD11 HD12 ' A' ' 69' ' ' ILE . 1.6 pp -86.45 129.66 37.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 109.463 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.63 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.32 108.08 14.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.731 -173.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.575 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -78.45 161.11 27.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.405 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 -6.27 42.3 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.865 0.364 . . . . 0.0 110.455 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 3.9 t70 -153.48 159.71 42.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 m -85.85 133.51 33.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.899 0.381 . . . . 0.0 111.235 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.38 49.68 2.96 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.447 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.444 ' HB3' HG11 ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.76 70.3 0.66 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.816 0.341 . . . . 0.0 111.672 173.18 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -61.61 -45.7 93.62 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.816 ' HD3' HG23 ' A' ' 131' ' ' ILE . 59.1 Cg_endo -70.91 129.95 17.18 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.436 1.424 . . . . 0.0 112.096 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -64.14 -24.92 67.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.046 0.45 . . . . 0.0 110.881 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HB3' HD21 ' A' ' 99' ' ' LEU . 3.7 mp0 -88.74 10.63 20.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.662 HG22 HD23 ' A' ' 95' ' ' LEU . 10.0 p -59.31 -31.61 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.937 0.399 . . . . 0.0 111.646 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.418 HG12 HD11 ' A' ' 21' ' ' LEU . 10.8 mt -89.17 88.2 2.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.565 HD13 ' HB2' ' A' ' 96' ' ' ASN . 1.1 pt -79.36 -28.4 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.958 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -146.98 141.55 26.57 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.633 171.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.09 124.92 19.7 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.773 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.8 157.14 45.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.74 146.47 36.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.19 135.45 54.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 0.0 111.492 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.94 51.64 2.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.947 177.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.327 -178.144 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 2' ' ' GLY . 8.8 tmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.491 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . 77.09 -72.37 2.1 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.633 ' HB2' ' HD2' ' A' ' 97' ' ' ARG . 5.9 m120 -155.08 153.81 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -99.01 114.19 26.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.359 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.5 143.31 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' OH ' HD12 ' A' ' 92' ' ' ILE . 1.3 t80 -138.18 134.01 33.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.548 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.05 141.98 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -127.57 157.78 21.03 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 91' ' ' TYR . 13.9 tt -138.42 136.91 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.002 0.43 . . . . 0.0 110.701 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.2 m -100.05 -16.61 17.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.24 0.543 . . . . 0.0 109.976 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -86.89 51.19 2.17 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -21.89 42.95 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.643 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -63.3 -55.72 22.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.717 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.383 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HG3' HD23 ' A' ' 21' ' ' LEU . 6.3 tm-20 -55.83 -57.29 12.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.813 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -70.17 -29.81 66.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.355 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.06 -43.8 64.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -78.77 -23.91 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.993 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.99 24.39 73.1 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.186 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 5.7 mt-30 -161.54 27.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.126 0.171 . . . . 0.0 110.751 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 136' ' ' ILE . 15.5 mt 73.57 -43.43 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -164.76 141.97 5.11 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -171.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.63 138.3 79.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.41 2.074 . . . . 0.0 112.071 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.93 166.58 23.0 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.95 75.73 0.13 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -78.44 153.11 31.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.753 0.311 . . . . 0.0 111.678 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.37 -154.25 0.31 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.056 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 74.71 -77.89 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.328 0.651 . . . . 0.0 111.232 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 56.54 61.08 2.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.187 0.517 . . . . 0.0 111.119 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -178.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.857 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.03 -70.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.827 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.5 mm 64.64 122.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.145 0.578 . . . . 0.0 111.615 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -148.08 137.78 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.451 ' HD1' ' HA ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -87.96 68.33 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 110.288 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -70.27 161.8 29.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.043 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.28 -39.81 43.95 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 89.26 3.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 166.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -76.56 62.7 1.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.702 -168.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -79.39 57.7 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -76.87 -19.04 57.93 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.4 -136.93 1.0 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.135 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.8 -122.83 0.64 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.861 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 23.1 mmmt -82.28 -80.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.848 0.356 . . . . 0.0 110.52 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.53 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.931 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.31 158.03 9.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.767 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -112.52 105.6 13.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.831 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.5 -152.73 7.27 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.007 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.24 -172.97 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.254 2.636 . . . . 0.0 112.006 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.481 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.5 m 67.98 117.09 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.64 0.588 . . . . 0.0 111.532 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER 61.38 -175.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.92 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.518 ' N ' HG13 ' A' ' 50' ' ' VAL . 19.5 mtpt 68.47 177.64 0.25 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.582 0.706 . . . . 0.0 111.821 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -58.63 -24.61 61.44 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.346 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.83 1.0 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.555 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG13 ' OH ' ' A' ' 68' ' ' TYR . 2.3 p -69.42 -38.68 77.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.236 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -62.1 -57.02 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.073 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.05 85.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -58.23 -49.98 75.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -70.72 -35.93 72.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.0 -42.39 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 111.03 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -92.22 -60.25 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.821 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -90.8 -73.25 0.54 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.795 0.331 . . . . 0.0 111.727 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 66.29 3.85 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.254 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 13.6 tp -62.46 90.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.079 0.466 . . . . 0.0 110.907 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 64.1 47.5 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.739 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -15.44 63.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.81 5.56 Favored Glycine 0 C--N 1.329 0.14 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.432 ' SG ' ' CE1' ' A' ' 68' ' ' TYR . 13.9 t -59.01 -50.44 74.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.432 ' CE1' ' SG ' ' A' ' 67' ' ' CYS . 12.1 m-85 -106.33 160.35 15.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.072 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.21 99.49 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -78.82 126.43 30.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.698 179.014 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.469 HG23 HG13 ' A' ' 121' ' ' VAL . 15.4 t -140.21 152.25 45.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.596 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.572 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -89.46 169.11 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.85 10.17 3.59 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -116.79 127.44 54.34 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -69.8 -19.23 63.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.053 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.62 0.47 26.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 72' ' ' THR . 1.2 tt -52.27 -27.08 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.854 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.65 68.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.221 0.534 . . . . 0.0 110.839 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -49.22 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 -177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -62.92 -41.78 99.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.492 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -69.4 -43.52 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.259 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -63.0 -42.73 99.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.071 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -69.92 -52.99 19.95 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -65.89 -21.97 66.48 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.532 ' HB2' HG13 ' A' ' 87' ' ' ILE . 12.3 m -97.77 0.06 46.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.45 29.25 74.5 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.505 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 85' ' ' SER . 4.4 mt -80.3 -8.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 122.811 -0.229 . . . . 0.0 111.06 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 3.8 tt0 -45.17 -27.52 0.62 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.908 0.385 . . . . 0.0 111.306 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.8 89.98 3.24 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.66 -148.14 12.1 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.233 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.451 ' HB3' HG23 ' A' ' 9' ' ' ILE . 3.3 t80 -116.68 146.21 42.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.839 0.456 . . . . 0.0 110.306 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.515 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 pt -144.69 141.86 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 6.8 p90 -131.63 152.88 50.48 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.017 0.437 . . . . 0.0 111.2 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.5 m -118.83 142.59 33.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.274 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -134.22 142.69 47.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.672 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -98.15 142.18 30.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.633 ' HD2' ' HB2' ' A' ' 3' ' ' ASN . 47.3 ttt180 -77.5 -34.87 54.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.568 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 9.8 p-10 -59.14 -25.77 64.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 0.0 110.822 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 135' ' ' VAL . 22.7 tp -65.46 -41.07 93.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.118 0.485 . . . . 0.0 109.778 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 5.0 m-85 -66.29 -38.77 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.73 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.4 -41.51 95.25 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.753 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -68.63 -39.1 80.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.288 0.566 . . . . 0.0 110.203 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.564 ' HB3' HG12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.98 -21.65 64.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.759 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m 71.24 32.37 2.21 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.192 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.564 HG12 ' HB3' ' A' ' 103' ' ' TYR . 24.6 mm -75.7 146.39 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.307 175.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.558 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -87.16 164.08 16.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.711 -171.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.38 138.2 27.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -125.64 113.01 16.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 pt-20 -105.25 119.73 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.535 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 120' ' ' GLU . 1.9 m -90.2 150.36 3.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.56 132.07 55.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.297 0.57 . . . . 0.0 110.925 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 18.5 m80 -81.61 -176.46 0.78 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 90.0 Cg_exo -46.59 158.39 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.328 1.352 . . . . 0.0 111.092 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.61 -44.93 95.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 5.9 t-20 -84.42 -19.77 0.26 Allowed Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -168.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 39.9 Cg_exo -41.87 -22.76 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.532 1.488 . . . . 0.0 111.436 162.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.424 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER 72.58 20.8 3.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.49 166.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.7 150.27 34.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.573 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -129.42 137.31 50.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.228 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.434 ' HB3' HG22 ' A' ' 110' ' ' VAL . 3.2 tm-20 -90.57 111.94 23.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.469 HG13 HG23 ' A' ' 71' ' ' THR . 1.8 p -102.56 102.89 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 110.098 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.9 m -87.41 126.25 34.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.252 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.2 mt -87.59 111.47 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.404 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.673 HH12 ' HA ' ' A' ' 126' ' ' GLU . 1.3 tmm_? -84.22 95.48 8.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.502 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.654 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.86 155.41 40.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.124 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.673 ' HA ' HH12 ' A' ' 124' ' ' ARG . 22.1 mm-40 -73.44 -4.09 31.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.677 0.275 . . . . 0.0 111.578 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.51 159.49 44.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.9 m -80.36 120.04 23.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.891 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.67 69.2 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.522 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.4 m 55.18 70.83 0.59 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.654 HG22 ' HB1' ' A' ' 125' ' ' ALA . 5.2 tt -64.21 -33.82 10.18 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.505 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 45.3 Cg_endo -92.88 126.7 0.69 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.008 1.805 . . . . 0.0 111.679 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -85.18 -29.07 25.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.924 0.392 . . . . 0.0 111.054 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.53 10.56 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.384 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 95' ' ' LEU . 9.3 p -72.37 -16.11 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.256 0.551 . . . . 0.0 111.011 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.625 HD13 HD11 ' A' ' 21' ' ' LEU . 5.8 pt -88.3 89.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.1 pt -73.21 -19.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.836 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.598 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.575 ' HD3' HD12 ' A' ' 136' ' ' ILE . 28.7 mtmm -130.14 125.23 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.81 153.97 48.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 tt -99.84 157.66 16.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.2 tt -136.05 129.27 47.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.262 0.553 . . . . 0.0 112.34 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 78.95 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.462 173.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.656 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 70.9 mt 66.44 108.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.069 0.548 . . . . 0.0 111.342 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -81.96 66.21 7.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.503 0.668 . . . . 0.0 110.195 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.1 tp -78.59 164.1 24.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.874 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 70.48 -158.15 0.14 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.8 m170 69.56 -71.72 0.12 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.469 0.708 . . . . 0.0 111.021 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -95.79 0.34 52.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 111.096 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.61 69.16 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 110.234 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -68.17 -31.53 71.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -168.89 -42.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.313 173.689 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.73 -171.45 21.9 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.151 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.579 ' HA ' ' NH1' ' A' ' 97' ' ' ARG . 64.6 t30 -177.94 -82.17 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -131.76 122.73 26.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 5.1 mp -100.51 130.64 46.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.29 129.39 55.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.6 OUTLIER -142.04 151.88 42.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -133.92 156.96 22.6 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.794 HG23 ' HB3' ' A' ' 91' ' ' TYR . 6.4 tt -144.04 141.0 25.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.181 0.515 . . . . 0.0 111.003 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -25.14 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.522 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.6 51.94 1.78 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 110.076 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 10.7 pt20 -52.48 -33.93 46.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -76.22 -37.49 57.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.879 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -39.62 93.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.879 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.12 -43.56 98.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.092 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 12' ' ' GLN . 66.7 mm-40 -67.18 -34.02 76.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.86 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.31 -32.99 55.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.563 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HB3' ' OE1' ' A' ' 20' ' ' GLN . 64.4 m-20 -92.4 -46.17 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.79 12.33 81.57 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.559 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -145.74 6.87 1.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.017 0.408 . . . . 0.0 111.173 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER 61.83 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.536 0.522 . . . . 0.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 56.59 118.23 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.705 1.202 . . . . 0.0 112.381 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.72 111.26 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.192 2.595 . . . . 0.0 112.593 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -67.34 169.25 9.18 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.983 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.82 -105.25 0.72 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.502 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -179.39 -172.55 0.23 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.42 -177.11 4.51 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.237 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -158.35 133.37 8.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -86.36 -31.95 21.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 0.0 110.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 30' ' ' VAL . 2.2 m -79.85 90.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.488 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.22 162.94 0.18 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.579 ' HA ' ' HG2' ' A' ' 51' ' ' LYS . 26.7 mm -74.31 137.93 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.964 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -110.15 136.63 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.06 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.475 ' HB2' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -127.36 135.66 50.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.813 -177.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' HB2' HD22 ' A' ' 52' ' ' ASN . 11.0 t0 -95.46 103.14 14.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.69 -154.03 25.25 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -115.86 79.13 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.3 0.571 . . . . 0.0 110.35 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.92 120.64 6.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.645 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -104.18 141.49 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' OH ' ' HB2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -156.24 -156.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.29 179.24 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -159.17 48.97 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.351 0.596 . . . . 0.0 109.939 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.62 135.06 28.51 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.913 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -142.63 53.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 127' ' ' ASP . . . -132.79 169.4 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m 65.22 73.75 0.4 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.61 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 78.56 0.66 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.931 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.51 -163.54 20.38 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -87.44 -173.96 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.04 2.493 . . . . 0.0 111.56 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m 55.64 -134.66 1.41 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.353 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.857 HG13 ' HG3' ' A' ' 51' ' ' LYS . 2.4 p 46.78 -158.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.201 0.6 . . . . 0.0 111.13 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.857 ' HG3' HG13 ' A' ' 50' ' ' VAL . 44.3 mttt 47.2 -127.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.148 0.431 . . . . 0.0 111.224 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.489 HD22 ' HB2' ' A' ' 35' ' ' ASP . 8.9 m120 -54.26 -39.05 66.49 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.741 0.305 . . . . 0.0 111.03 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.89 -50.38 66.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.226 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.804 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 8.6 p -67.25 -39.06 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.643 0.258 . . . . 0.0 111.009 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.38 -51.35 61.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.206 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.38 90.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.975 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -64.81 -34.54 78.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.591 ' HG3' ' HD2' ' A' ' 68' ' ' TYR . 1.6 tm0? -60.83 -53.19 60.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.82 -41.38 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.053 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.1 -67.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.068 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.4 -71.21 0.62 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.963 0.411 . . . . 0.0 110.845 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.4 138.98 3.82 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -152.71 47.37 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -90.07 6.67 41.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.854 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -100.91 -30.57 11.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.16 -72.39 0.19 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.223 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.95 -52.27 65.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.591 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 18.8 m-30 -117.61 161.06 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.605 HG23 ' HB ' ' A' ' 123' ' ' ILE . 3.4 tt -126.98 132.88 69.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.667 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.7 p -106.75 140.58 39.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.829 0.347 . . . . 0.0 110.722 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -129.07 133.6 47.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.845 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.457 ' H ' HD12 ' A' ' 77' ' ' ILE . 4.4 p -74.51 163.88 27.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -18.13 58.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -99.65 135.71 40.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.961 0.41 . . . . 0.0 111.79 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.71 -20.79 61.94 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.009 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -69.33 -3.5 14.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.366 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 3.9 tt -57.08 -34.46 45.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.245 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.22 -63.19 1.39 Allowed 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.757 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -67.73 -43.26 80.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.046 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.77 -46.96 85.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.088 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 17.8 t80 -64.55 -48.78 73.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -56.38 -59.72 4.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.165 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -64.92 -33.63 76.48 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.499 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m -73.03 -23.37 60.59 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.003 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m -84.05 -7.84 59.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.887 0.375 . . . . 0.0 110.025 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.47 39.8 98.1 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -68.05 -10.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -32.54 -35.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.954 0.784 . . . . 0.0 112.343 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.59 88.97 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.14 -152.67 19.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.604 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.794 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.7 t80 -119.65 150.63 40.01 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.4 tt -149.06 135.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.516 0.198 . . . . 0.0 110.589 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 15.8 p90 -131.46 156.32 45.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.174 0.512 . . . . 0.0 112.078 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.516 HG23 HG13 ' A' ' 137' ' ' ILE . 34.2 m -125.8 141.45 45.5 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -125.01 143.23 51.01 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.085 -175.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.466 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.9 t-20 -99.65 140.63 33.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.579 ' NH1' ' HA ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -67.83 -46.04 72.95 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 -178.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.24 -33.71 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 135' ' ' VAL . 25.1 mt -64.0 -50.93 66.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.274 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.88 -41.01 95.98 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.93 -48.13 84.41 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.021 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.14 -32.86 71.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.452 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -68.8 -18.68 64.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.872 0.367 . . . . 0.0 110.172 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m 70.63 34.27 2.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.033 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -73.87 156.01 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.772 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 11.5 m-85 -76.6 101.25 5.63 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.607 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.75 115.89 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.238 0.542 . . . . 0.0 109.909 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.543 ' HB2' ' HD2' ' A' ' 124' ' ' ARG . 2.4 t80 -125.74 111.56 15.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.816 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -94.93 113.07 24.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.824 0.345 . . . . 0.0 110.174 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 120' ' ' GLU . 1.4 m -89.31 125.5 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.81 131.99 53.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.327 0.584 . . . . 0.0 110.552 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.7 m80 -79.21 -178.39 1.09 Allowed Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 88.9 Cg_exo -46.85 164.33 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.587 1.524 . . . . 0.0 112.166 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -49.11 -66.93 0.31 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -170.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.471 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 3.2 t-20 -89.05 -9.66 0.14 Allowed Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 115.84 1.792 . . . . 0.0 115.84 -165.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 37.3 Cg_exo -42.53 -22.82 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.446 1.552 . . . . 0.0 112.017 163.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.1 33.81 3.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.29 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -144.41 127.35 16.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -123.81 102.2 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HB2' HG22 ' A' ' 110' ' ' VAL . 57.0 mt-10 -73.65 98.09 2.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.216 0.531 . . . . 0.0 110.744 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 24.0 t -69.07 95.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.924 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 13.1 m -88.17 114.07 24.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.605 ' HB ' HG23 ' A' ' 69' ' ' ILE . 4.9 mp -87.09 111.12 21.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.809 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 19.8 mtt180 -93.2 104.06 16.27 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.918 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.572 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.62 144.03 53.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.15 -60.07 4.16 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.235 0.54 . . . . 0.0 109.756 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.865 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 16.1 t70 -87.72 127.95 35.3 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.787 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 51.9 t -52.79 113.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.505 0.503 . . . . 0.0 111.833 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . . . 91.23 67.47 1.16 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.433 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.2 m 58.6 72.66 0.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.913 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.09 -50.97 25.63 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.913 ' HD3' HG23 ' A' ' 131' ' ' ILE . 87.2 Cg_endo -97.83 116.0 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.498 2.132 . . . . 0.0 112.431 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.57 -5.14 26.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.37 -8.81 56.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.18 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.657 HG13 HD23 ' A' ' 95' ' ' LEU . 9.1 p -71.58 -14.05 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.638 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 136' ' ' ILE . 17.2 pt -87.76 92.91 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.516 HG13 HG23 ' A' ' 94' ' ' VAL . 27.7 pt -63.87 -30.99 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.905 -173.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.58 160.71 40.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.13 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -148.41 150.8 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.838 175.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -142.36 154.28 44.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -111.91 146.25 38.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 tt -140.66 118.93 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 111.097 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -118.04 68.6 0.77 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.364 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.6 mt 63.36 119.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.799 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -79.1 -21.14 47.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.67 107.67 18.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.979 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 53.84 63.57 2.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.25 0.548 . . . . 0.0 110.795 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -58.26 -25.53 61.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.146 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -127.0 76.05 1.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -45.4 116.85 1.24 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.491 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -82.82 98.49 9.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.545 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -70.37 86.97 0.61 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.308 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.571 176.477 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 140.84 124.95 2.1 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.421 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 97' ' ' ARG . 7.3 t-20 -172.56 152.0 2.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -98.6 130.91 45.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.513 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 97' ' ' ARG . 44.2 mt -112.91 135.19 53.95 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -131.87 124.46 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.87 132.77 20.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.19 157.58 15.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.405 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.701 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.3 tt -135.38 142.12 40.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.004 0.43 . . . . 0.0 110.216 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.74 -32.03 13.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.01 51.68 2.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.527 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 2.6 pt20 -55.13 -27.1 42.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.273 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -68.88 -49.21 60.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.93 -36.4 83.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.177 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.82 -58.18 9.75 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.358 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.35 -26.45 63.74 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -54.93 27.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.871 0.367 . . . . 0.0 110.037 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.52 -22.75 60.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.64 15.66 65.42 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.552 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -168.55 140.79 2.81 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 49.54 0.97 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.192 0.52 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 128' ' ' CYS . 29.8 tttp -168.64 126.41 0.89 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.382 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.85 -59.87 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.419 2.08 . . . . 0.0 111.868 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -174.41 159.53 3.06 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.329 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 162.94 36.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.174 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -159.12 137.33 10.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -113.46 160.64 18.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.427 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.6 78.49 0.48 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -68.65 88.42 0.35 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.729 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.75 13.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 110.55 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.41 -177.7 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.521 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.715 HD11 ' HE2' ' A' ' 51' ' ' LYS . 4.9 mt 64.04 155.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.892 0.745 . . . . 0.0 111.688 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ttp-105 -175.2 97.24 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.186 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.89 -46.13 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 t0 62.62 -162.22 0.28 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.42 -93.57 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.289 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -80.06 -43.75 21.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.623 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 40' ' ' TYR . 16.6 p90 -146.68 141.2 26.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -60.24 3.76 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.026 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.444 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 2.3 t80 63.16 79.67 0.25 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 1.3 p30 -125.77 -56.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.945 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.01 -85.76 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 170.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -157.53 155.9 31.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 111.021 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.13 -44.84 0.07 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.044 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 106.52 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.705 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.0 m170 55.71 29.25 13.45 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.036 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.48 69.36 0.45 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.737 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.57 -42.13 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.642 2.228 . . . . 0.0 112.007 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.93 69.96 6.4 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.155 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 51' ' ' LYS . 3.1 p -167.85 -49.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.059 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.715 ' HE2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.88 -99.82 0.0 OUTLIER 'General case' 0 C--O 1.24 0.569 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 -171.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.65 -22.9 67.09 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.66 -67.27 0.32 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.357 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -33.46 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.53 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 2.3 m-85 -63.92 -64.64 0.84 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.48 84.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -59.19 -54.28 48.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.694 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 4.4 pt20 -61.07 -37.2 81.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.03 -37.4 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.753 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.27 -23.97 34.98 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 p -87.95 -49.44 7.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.136 0.493 . . . . 0.0 110.803 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.39 -71.53 0.19 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.541 HD22 ' CE1' ' A' ' 64' ' ' TYR . 6.8 mt -159.53 76.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.152 0.501 . . . . 0.0 109.782 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE1' HD22 ' A' ' 63' ' ' LEU . 2.0 p90 45.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.684 1.194 . . . . 0.0 112.986 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 6.2 p-10 166.59 -45.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.912 -168.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' N ' ' HD2' ' A' ' 64' ' ' TYR . . . 166.07 -8.01 0.06 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.993 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.62 -28.01 63.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.996 0.398 . . . . 0.0 111.57 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.42 ' HE2' HE22 ' A' ' 58' ' ' GLN . 12.3 m-30 -118.85 163.58 16.68 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 123' ' ' ILE . 1.4 tt -121.07 119.04 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.284 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 13.0 m -99.45 131.56 45.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.869 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 t -119.04 170.37 9.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.189 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -122.82 152.51 40.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -14.06 12.32 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.2 108.04 18.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -59.46 -18.01 36.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.594 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -79.07 -2.32 39.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.828 0.347 . . . . 0.0 110.465 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.3 tt -51.26 -29.36 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.788 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.27 -60.14 3.93 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.804 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.111 -175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -62.3 -45.62 92.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.978 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -63.38 -49.18 74.83 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.849 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 -55.26 25.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.942 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.8 m -62.66 -35.91 81.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -66.33 -27.81 68.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.5 m -93.82 -0.3 55.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.97 40.44 90.97 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.51 -9.57 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.36 -172.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.684 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 mp0 -41.68 -28.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.328 0.651 . . . . 0.0 112.146 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -123.63 90.62 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.97 -150.92 12.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.274 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.701 ' HB3' HG23 ' A' ' 9' ' ' ILE . 6.2 t80 -121.93 149.58 43.23 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.583 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -141.47 143.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.022 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 52.8 p90 -131.53 144.05 50.83 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.199 0.524 . . . . 0.0 111.187 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.509 HG23 HG13 ' A' ' 137' ' ' ILE . 17.9 m -118.64 138.85 48.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.561 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD23 HG13 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.08 142.79 51.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.867 -171.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.44 ' OD1' HD13 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -79.94 114.24 18.71 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.498 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -69.41 -33.52 73.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.745 -176.264 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.11 -26.66 66.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.628 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 99' ' ' LEU . 11.4 mt -63.11 -46.01 89.33 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -60.84 -38.47 85.59 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.47 -43.73 97.26 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.917 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -39.67 93.07 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.068 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.501 ' HB2' HD13 ' A' ' 105' ' ' ILE . 15.4 m-30 -71.06 -18.29 62.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.434 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.3 m 69.86 39.34 1.46 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 103' ' ' TYR . 1.1 mp -68.47 160.83 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.413 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.769 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -78.4 99.0 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -170.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -103.18 100.14 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -100.67 116.14 31.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.074 0.464 . . . . 0.0 110.069 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.494 ' HB2' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -85.22 138.25 32.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.613 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.68 144.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 145.91 47.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.32 170.59 15.4 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.861 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -45.67 170.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.657 2.238 . . . . 0.0 113.36 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -47.08 -53.82 11.85 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -170.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.518 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 48.1 t30 -98.72 -17.05 0.2 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 34.2 Cg_exo -40.83 -26.39 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 120.993 1.39 . . . . 0.0 111.34 162.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 77.5 -11.35 1.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.901 163.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -113.3 159.34 19.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.297 0.57 . . . . 0.0 112.043 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 109' ' ' GLU . 29.6 tttp -131.87 122.34 25.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -104.48 115.13 29.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.155 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.83 113.37 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.154 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 14.3 m -81.4 117.71 22.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.776 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 69' ' ' ILE . 15.0 mm -87.84 98.27 7.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.769 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -89.19 102.63 15.29 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.041 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HB1' ' CG1' ' A' ' 131' ' ' ILE . . . -69.84 152.32 44.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.758 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.4 -41.9 90.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.458 ' HB3' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.07 145.02 50.12 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.07 176.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.411 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 1.4 t -64.02 133.77 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.55 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.05 70.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.546 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.9 m 56.89 72.9 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.508 ' CG1' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -43.95 -55.38 9.35 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.415 173.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 63.6 Cg_endo -95.62 114.95 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.931 2.421 . . . . 0.0 112.218 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.59 -22.65 66.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.103 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -77.19 -15.34 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.563 HG13 HD23 ' A' ' 95' ' ' LEU . 2.6 p -69.69 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.34 92.15 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.509 HG13 HG23 ' A' ' 94' ' ' VAL . 24.6 pt -67.83 -27.89 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.945 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.36 157.8 36.29 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.946 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 59.3 pttt -150.49 140.88 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.273 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.53 160.34 40.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.774 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -112.57 149.11 33.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.744 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 144' ' ' ILE . 18.4 tt -141.26 138.87 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -125.79 31.6 5.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.668 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.684 HG12 ' HB3' ' A' ' 88' ' ' GLU . 42.6 mt 61.21 -76.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.642 0.377 . . . . 0.0 110.02 -171.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 148' ' ' HIS . 31.9 t30 54.71 71.79 0.51 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.644 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.2 tp -88.93 -58.49 2.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.746 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 148' ' ' HIS . 6.8 pt-20 -96.85 1.18 50.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.718 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.487 ' HA ' ' OD1' ' A' ' 145' ' ' ASN . 51.2 m170 72.65 -65.35 0.36 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.398 0.679 . . . . 0.0 110.268 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -144.36 140.13 28.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -79.65 54.8 1.86 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.201 0.524 . . . . 0.0 111.191 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -77.01 98.02 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.726 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.58 -50.13 40.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 73.7 t60 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.45 -177.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.39 154.03 42.24 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.25 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -82.02 27.83 0.46 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.219 0.208 . . . . 0.0 111.442 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 t80 66.15 112.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.546 0.528 . . . . 0.0 111.947 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 71' ' ' THR . 13.4 mt -99.82 124.87 45.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -115.75 124.03 49.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -145.92 156.95 43.87 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.258 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -122.23 155.92 16.88 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.945 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 34.9 mt -109.38 143.92 18.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -35.58 75.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.764 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t 177.69 155.62 0.33 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 110.035 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -58.7 -32.05 68.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.999 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.671 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.42 -42.72 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.023 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG3' HG21 ' A' ' 9' ' ' ILE . 48.8 mt-10 -55.01 -60.46 3.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.189 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.8 -41.86 78.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.213 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.18 -31.43 72.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.439 . . . . 0.0 110.785 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.03 -13.87 40.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.212 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.33 7.17 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.028 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 72.7 81.87 0.13 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.53 0.732 . . . . 0.0 110.672 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 4.2 mm? 64.64 37.53 7.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.984 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER 73.15 152.88 0.15 Allowed Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.79 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.76 118.15 5.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.628 2.218 . . . . 0.0 111.905 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -174.72 4.55 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 164.65 -143.58 8.65 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.859 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -165.56 157.25 14.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -128.08 -43.39 1.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 -145.04 0.27 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.498 0.319 . . . . 0.0 110.694 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -174.67 -55.83 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 31' ' ' ALA . 3.7 p -83.23 -162.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.672 171.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.651 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -53.12 163.06 0.58 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.276 0.56 . . . . 0.0 111.822 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 51' ' ' LYS . 1.2 mm -114.9 163.74 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.891 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.495 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 2.0 tpm_? -96.13 99.78 11.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 169.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -166.23 101.1 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.31 178.99 7.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.98 -136.0 12.98 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.976 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -57.77 -42.94 85.1 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.887 0.375 . . . . 0.0 110.927 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' A' ' 38' ' ' PHE . 2.8 m-30 -76.83 -31.74 57.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.2 tptp 52.61 47.22 25.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 111.633 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 19.6 m-30 -85.82 124.55 32.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -88.17 -96.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -173.067 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.19 123.35 7.67 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.642 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 16.9 tttt -77.77 78.66 4.27 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 69.28 -72.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.0 m -155.15 -61.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -139.64 144.02 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.027 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.2 96.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.321 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.67 -28.59 37.24 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.884 2.389 . . . . 0.0 110.984 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 p -68.35 91.22 0.38 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 51' ' ' LYS . 1.6 p -175.08 -166.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.544 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.731 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -45.46 -48.88 13.85 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.018 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 10.9 t30 -45.04 -55.18 5.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.145 0.498 . . . . 0.0 111.287 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.65 21.82 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.328 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 10.8 p -63.59 -31.38 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.013 -175.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.458 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 2.3 m-85 -65.0 -58.99 4.66 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.76 63.28 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.823 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.52 ' NE2' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -64.31 -47.04 80.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.696 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.58 HE21 ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -62.58 -40.44 96.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.396 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.6 mt -82.82 -40.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.562 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -65.5 -50.54 64.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.628 ' HB ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.28 -21.57 39.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.119 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.53 76.3 0.73 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.587 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.628 HD22 ' HB ' ' A' ' 61' ' ' THR . 1.8 pt? -148.44 59.84 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.6 0.714 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.438 ' HE2' HG11 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -67.86 -24.19 65.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.006 -177.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 6.7 p-10 -73.22 -12.6 60.93 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.687 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.91 -92.74 0.33 Allowed Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.541 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 80.8 m -69.5 -34.97 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.499 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 22.0 m-85 -95.51 158.47 15.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.332 -172.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 5.3 mp -89.52 97.83 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -83.39 119.14 24.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.168 -178.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.483 HG21 HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -140.32 155.37 46.84 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.953 0.406 . . . . 0.0 111.049 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.46 ' H ' HD12 ' A' ' 77' ' ' ILE . 2.6 m -87.83 156.46 19.38 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -32.39 73.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -88.68 133.37 34.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -63.97 -19.47 65.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.67 -2.21 6.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.269 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -57.75 -27.2 29.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.209 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.46 -63.18 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.071 0.462 . . . . 0.0 112.017 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -66.8 -43.85 82.78 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.873 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.269 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -70.82 -52.47 20.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.067 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -56.99 -42.59 80.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.426 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -76.23 -50.35 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.559 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -64.68 -26.24 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -91.6 0.25 57.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.192 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.89 32.64 73.86 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.533 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 82' ' ' ALA . 7.0 mt -73.1 -7.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.715 ' HG3' HD13 ' A' ' 144' ' ' ILE . 38.0 tp10 -28.76 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.715 1.206 . . . . 0.0 113.231 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -130.07 90.17 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.1 -157.7 20.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.181 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 8.2 t80 -117.63 153.56 33.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.503 0.321 . . . . 0.0 110.451 -176.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.577 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 29.3 mt -132.53 140.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.433 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 16.8 p90 -131.96 134.3 45.48 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.28 0.562 . . . . 0.0 110.856 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.6 134.72 63.15 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.031 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.451 HD21 ' HE2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -122.15 143.19 49.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.738 -173.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -82.3 125.41 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 100' ' ' PHE . 61.7 ttp85 -70.3 -45.06 67.06 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -22.58 66.83 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 -175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 135' ' ' VAL . 4.8 tp -65.5 -32.67 74.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 10.6 m-85 -66.49 -44.57 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.65 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.7 -42.57 91.28 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.655 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -43.25 96.77 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 109.932 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 3.1 m-85 -62.73 -23.01 66.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.378 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m 72.98 23.6 2.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.127 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.499 HG13 ' HB3' ' A' ' 103' ' ' TYR . 3.8 mt -70.91 148.14 10.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.074 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 22.4 m-85 -78.15 105.23 9.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.946 0.403 . . . . 0.0 111.041 -166.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.19 109.89 20.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 124' ' ' ARG . 7.5 t80 -129.72 128.28 42.16 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.057 0.456 . . . . 0.0 110.336 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.52 155.07 22.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.831 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 64' ' ' TYR . 11.3 m -129.63 145.97 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.19 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.567 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -113.42 136.13 53.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.171 0.51 . . . . 0.0 110.646 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -79.92 -174.68 0.51 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.553 175.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 95.6 Cg_exo -46.91 169.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.026 1.817 . . . . 0.0 113.181 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.31 -65.58 0.54 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 30.0 t30 -98.81 -8.59 0.12 Allowed Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -167.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 115' ' ' ASN . 63.1 Cg_exo -43.93 -27.12 1.57 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 121.562 1.594 . . . . 0.0 111.083 164.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 65.58 20.78 11.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.356 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 112' ' ' HIS . 4.9 pt-20 -112.65 123.73 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.11 0.481 . . . . 0.0 111.128 -177.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 111' ' ' GLU . 6.7 ttpt -121.41 112.48 18.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.124 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.48 121.43 26.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.268 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.02 98.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.641 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.527 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -94.97 121.1 36.23 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.29 -178.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 24.6 mm -86.94 101.73 11.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.474 0.654 . . . . 0.0 109.765 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.787 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 2.2 mmt180 -77.5 95.08 4.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.94 161.49 30.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.712 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' NZ ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -60.76 -47.2 87.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.831 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.75 160.85 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.09 144.33 40.53 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.627 0.58 . . . . 0.0 111.896 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.6 41.59 6.79 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.865 -0.607 . . . . 0.0 114.262 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.57 71.52 0.44 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.068 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.794 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.44 -45.94 33.29 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.794 ' HD3' HG23 ' A' ' 131' ' ' ILE . 70.8 Cg_endo -91.27 128.46 1.2 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.938 1.759 . . . . 0.0 113.033 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.34 -33.49 49.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 61.0 mt-10 -63.27 -22.47 66.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.634 -173.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.688 ' HA ' HD23 ' A' ' 99' ' ' LEU . 5.0 p -70.48 -19.47 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 111.233 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.6 mt -86.96 92.06 3.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 pt -67.59 -32.03 55.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.187 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -157.38 159.38 37.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.316 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.618 ' HD2' ' HE2' ' A' ' 91' ' ' TYR . 7.3 mtmp? -130.34 131.2 45.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.397 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -118.03 161.06 20.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.245 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 tt -122.19 147.47 46.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.3 tt -130.67 124.22 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.231 0.539 . . . . 0.0 110.473 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.02 57.96 1.53 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.528 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.715 HD13 ' HG3' ' A' ' 88' ' ' GLU . 16.3 mm 69.45 119.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -80.95 -164.97 0.81 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -88.7 -9.59 51.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.09 157.77 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.882 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -82.67 151.4 26.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.677 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -121.89 163.84 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.114 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.05 79.52 0.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.176 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -173.36 -58.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.864 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -173.68 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.165 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.066 174.121 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mmt . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.168 0.509 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.32 170.28 29.85 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.361 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -161.11 156.23 24.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -98.53 120.96 39.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.145 -172.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.461 HD11 ' HE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -121.29 142.38 50.0 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -113.53 139.3 49.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.86 157.56 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -128.76 157.54 21.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.809 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.877 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 54.2 mt -118.56 128.8 75.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 122.866 0.466 . . . . 0.0 110.164 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -25.19 16.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.08 0.467 . . . . 0.0 110.497 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.5 p -97.95 53.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.718 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.559 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -54.78 -26.42 34.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.065 -178.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -75.31 -50.84 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.108 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 1.5 t70 -59.62 -46.33 89.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.058 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' HG3' HD13 ' A' ' 9' ' ' ILE . 4.3 tm-20 -57.51 -58.88 6.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.616 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -65.91 -26.98 67.86 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.421 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.72 -43.52 79.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.043 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.36 -24.52 46.4 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.52 70.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.594 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.697 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -174.37 173.78 2.93 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.7 mt -79.47 44.65 0.62 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.359 0.264 . . . . 0.0 111.045 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm 49.29 73.73 0.94 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.795 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 97.5 Cg_endo -76.16 63.94 6.99 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.04 2.493 . . . . 0.0 112.795 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 63.32 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.928 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.27 83.33 0.35 Allowed Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.547 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -119.53 104.05 9.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -145.75 169.41 18.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.97 133.73 10.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.578 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -156.26 137.61 13.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.414 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.55 62.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.298 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.58 -52.95 0.07 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.435 HG22 ' HE1' ' A' ' 34' ' ' TYR . 2.8 mt -78.51 75.75 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.014 0.435 . . . . 0.0 111.231 -173.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 136.77 55.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.009 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.435 ' HE1' HG22 ' A' ' 32' ' ' ILE . 2.2 m-85 -112.45 56.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.313 0.577 . . . . 0.0 110.051 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.27 -43.18 57.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.932 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.73 -43.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.57 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.33 88.55 0.08 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.71 87.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.109 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -148.21 -170.01 3.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.001 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.42 169.3 9.87 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.85 -160.27 0.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.87 123.09 30.68 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.779 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HG3' ' HB2' ' A' ' 29' ' ' GLU . 2.5 ttmm -176.56 -49.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.044 0.45 . . . . 0.0 109.814 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.96 82.05 1.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.346 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -75.51 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -78.75 74.15 5.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.114 0.483 . . . . 0.0 110.188 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.49 125.93 1.7 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.567 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -84.7 -29.97 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.122 2.548 . . . . 0.0 112.511 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -73.32 156.72 38.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.741 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t 57.46 -126.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.631 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 54' ' ' VAL . 6.9 tttt 60.36 -166.79 0.19 Allowed 'General case' 0 C--O 1.244 0.763 0 CA-C-O 122.003 0.906 . . . . 0.0 112.587 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 13.6 p-10 -61.13 -16.88 49.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.262 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.82 -55.36 30.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.3 p -67.96 -35.56 72.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 34.3 m-85 -59.62 -61.52 2.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.9 0.381 . . . . 0.0 110.251 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.962 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -56.18 -43.34 78.34 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.272 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -65.1 -53.57 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mt -63.76 -30.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.638 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.84 -64.42 1.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.897 0.38 . . . . 0.0 111.713 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 m -93.94 -64.6 1.06 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.8 -105.41 0.06 OUTLIER Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 114.232 -170.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 7.6 tp 61.0 34.33 19.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.762 0.791 . . . . 0.0 109.583 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.623 ' H ' ' HD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -84.5 11.83 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.356 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 t70 69.59 -143.98 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.99 -78.66 0.52 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.568 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.42 -37.03 85.7 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 109.983 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 124' ' ' ARG . 21.5 m-85 -126.93 142.62 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.787 HG13 ' HB ' ' A' ' 123' ' ' ILE . 5.6 pt -105.42 111.11 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 111.355 -169.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 1.5 m -91.39 131.15 37.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.9 t -132.86 143.38 49.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.235 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.618 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.79 153.25 33.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.929 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -172.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -117.85 136.02 53.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.655 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -52.77 -18.77 2.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.262 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 44.1 tp10 -48.86 -30.12 5.44 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.942 0.401 . . . . 0.0 110.773 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.618 HD12 ' H ' ' A' ' 72' ' ' THR . 1.1 tt -48.17 -37.5 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.694 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.54 68.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.018 0.437 . . . . 0.0 111.332 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -73.52 -43.44 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.895 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HG3' ' HG3' ' A' ' 76' ' ' GLU . 15.4 mmtm -57.96 -47.69 82.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.983 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -66.29 -56.98 8.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.285 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.17 74.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.06 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -81.85 -48.67 11.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.637 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -70.73 -18.87 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 m -99.6 0.8 42.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.0 110.506 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.28 29.92 66.75 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.768 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -13.81 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.957 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 142' ' ' ILE . 2.3 tt0 -48.64 -26.09 2.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.789 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.423 ' HB2' HG13 ' A' ' 144' ' ' ILE . 4.3 t30 -108.13 95.66 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.433 -0.167 . . . . 0.0 110.596 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.52 -127.95 2.52 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.007 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.877 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 1.7 t80 -124.23 151.6 43.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 11.1 pt -139.69 133.63 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.228 0.211 . . . . 0.0 110.483 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 22.0 p90 -131.22 137.37 48.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.378 0.609 . . . . 0.0 111.249 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 138' ' ' ALA . 13.6 m -116.56 146.02 21.54 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.8 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.583 HD23 ' HB ' ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.3 143.35 51.25 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.223 -173.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.682 ' HB2' HD13 ' A' ' 137' ' ' ILE . 60.8 t-20 -95.2 139.64 31.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.147 0.498 . . . . 0.0 110.566 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -69.39 -35.08 75.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -53.84 -33.81 57.38 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.4 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -58.93 -49.02 79.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.463 ' HE1' HG12 ' A' ' 135' ' ' VAL . 20.0 m-85 -72.94 -31.93 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.581 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.25 -42.62 99.72 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.86 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -70.71 -50.62 34.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.258 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -63.38 -21.2 66.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.212 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m 65.77 39.96 4.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.311 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -66.38 154.84 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 12.3 m-30 -75.44 141.93 43.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.923 -167.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 129.26 56.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 110' ' ' VAL . 21.9 t80 -131.69 112.34 12.47 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.54 119.9 31.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.411 HG12 ' HD1' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -112.34 148.5 15.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 110.422 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.5 46.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.007 171.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.675 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 14.2 m80 -78.42 -169.7 0.21 Allowed Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 85.1 Cg_exo -48.12 139.64 20.64 Favored 'Trans proline' 0 C--N 1.358 1.051 0 CA-C-N 121.285 1.495 . . . . 0.0 109.416 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -56.26 -48.19 77.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -89.3 -14.35 0.2 Allowed Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 96.7 Cg_exo -51.62 -17.45 4.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.249 1.482 . . . . 0.0 110.333 157.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.409 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 7.2 m-20 72.99 21.77 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.513 171.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.67 121.28 42.11 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.627 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -138.73 125.06 20.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.735 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.33 140.5 50.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.14 113.07 32.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.214 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 56.4 m -87.34 122.01 30.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.386 0.612 . . . . 0.0 110.989 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.787 ' HB ' HG13 ' A' ' 69' ' ' ILE . 14.4 mt -89.12 109.0 19.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.593 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.94 95.93 10.51 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.461 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.654 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.46 148.86 48.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.156 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -59.51 -41.96 91.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.969 0.414 . . . . 0.0 110.957 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.79 159.92 15.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.536 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 105.49 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.874 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.14 70.92 1.23 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.597 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.73 73.59 0.44 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 172.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.682 HG23 ' HD3' ' A' ' 132' ' ' PRO . 1.6 tt -54.76 -41.59 90.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.682 ' HD3' HG23 ' A' ' 131' ' ' ILE . 20.2 Cg_endo -91.93 126.72 0.92 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.808 1.672 . . . . 0.0 111.881 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -18.04 63.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -79.9 4.98 15.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.583 ' HB ' HD23 ' A' ' 95' ' ' LEU . 3.7 m -58.39 -30.15 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.824 0.345 . . . . 0.0 111.498 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.1 pt -87.96 89.91 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.18 0.515 . . . . 0.0 109.961 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 96' ' ' ASN . 12.3 pt -70.78 -28.16 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.648 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.473 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -155.06 124.92 6.56 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.405 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -121.97 132.46 54.55 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.115 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.44 159.37 42.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.185 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tt -100.32 144.39 29.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 88' ' ' GLU . 15.0 tt -124.33 135.66 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 110.489 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 144' ' ' ILE . 6.4 tp10 -115.39 47.23 1.34 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.822 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 145' ' ' ASN . 1.2 tt 69.29 176.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.106 0.562 . . . . 0.0 111.793 173.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 144' ' ' ILE . 3.7 t-20 -75.8 57.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.558 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.95 -57.48 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -80.57 61.16 4.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.126 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -132.4 61.07 1.67 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.1 t60 40.23 57.73 2.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.298 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -73.32 124.33 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 21.5 t-80 -141.27 26.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.432 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 3.8 m170 72.2 155.57 0.16 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.239 -174.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.319 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.32 -152.26 50.71 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.23 -0.509 . . . . 0.0 112.191 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.606 ' H ' ' HD2' ' A' ' 97' ' ' ARG . 8.7 t-20 -134.56 154.91 51.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.765 0.317 . . . . 0.0 110.405 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -121.43 120.98 36.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 5' ' ' LEU . 2.3 mm? -106.21 144.91 32.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.251 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' HE1' HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -132.61 138.35 47.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.461 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.67 HH11 HD12 ' A' ' 21' ' ' LEU . 44.9 ttt180 -139.21 111.1 7.25 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -107.15 157.85 15.36 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.643 HG12 ' H ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -148.73 136.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 16.19 14.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.065 0.459 . . . . 0.0 110.959 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.7 58.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.512 . . . . 0.0 109.804 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 91' ' ' TYR . 2.0 mp0 -58.02 -21.56 45.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -68.98 -47.62 65.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.78 -42.58 99.76 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.891 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.06 -53.12 59.96 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.473 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -66.83 -24.95 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.638 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -93.88 -15.41 25.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.48 -9.81 75.68 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.448 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.567 ' HB2' ' HG3' ' A' ' 23' ' ' PRO . 1.6 mm-40 -174.71 -169.59 0.43 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.67 HD12 HH11 ' A' ' 7' ' ' ARG . 0.5 OUTLIER -77.2 61.29 2.07 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.003 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 52.67 69.07 2.56 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.567 ' HG3' ' HB2' ' A' ' 20' ' ' GLN . 86.0 Cg_endo -83.14 82.57 2.1 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.787 2.325 . . . . 0.0 112.077 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -115.85 -152.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 131' ' ' ILE . . . 74.7 173.95 31.98 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.31 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 153.94 33.63 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.817 0.447 . . . . 0.0 109.856 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.825 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -115.45 138.59 50.85 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -85.99 49.49 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.145 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 64.45 -74.05 0.05 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.329 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 59.2 t -84.9 -85.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 30' ' ' VAL . . . 168.6 179.02 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.111 0.564 . . . . 0.0 110.404 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -107.97 44.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.439 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -44.13 103.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.207 -174.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HD1' ' H ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -64.36 -24.65 67.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.58 -178.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.455 ' H ' ' HD1' ' A' ' 34' ' ' TYR . 2.4 t70 59.92 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.585 0.553 . . . . 0.0 110.602 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . -157.49 177.74 34.16 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 37' ' ' LYS . 3.6 mppt? 59.59 13.97 3.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.23 0.515 . . . . 0.0 110.473 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 48.27 39.99 13.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.118 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -87.51 95.05 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.707 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -79.65 45.09 0.66 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.68 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.21 31.89 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.46 -150.6 7.8 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.127 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 14.6 tttt -77.38 94.05 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.277 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.55 84.64 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.744 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -61.52 -66.78 0.48 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.473 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -142.54 152.76 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.064 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.64 127.51 0.89 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.3 -24.25 27.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.629 2.219 . . . . 0.0 111.177 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.583 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 46.9 m -126.36 85.56 2.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.466 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 49' ' ' SER . 4.8 p 165.21 168.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.062 0.945 . . . . 0.0 109.206 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.601 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 50.09 -159.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 172.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -48.52 -31.54 6.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.452 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 51' ' ' LYS . . . -55.62 -65.5 0.58 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' A' ' 50' ' ' VAL . 3.4 p -66.05 -32.31 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.768 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -66.04 -61.03 2.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.92 84.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -62.68 -44.54 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -49.65 66.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.686 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 82.0 mt -62.65 -36.12 73.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.621 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.95 -52.34 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.217 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.7 p -64.39 -76.63 0.07 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.463 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.21 7.22 11.7 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.361 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 43.6 tp 64.24 -79.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.58 0.352 . . . . 0.0 110.334 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -107.22 64.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -38.46 88.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.881 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.21 -1.58 0.55 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.129 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.3 m -78.04 -15.74 58.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.827 0.313 . . . . 0.0 111.275 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -121.29 157.12 31.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.224 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 31.0 mt -98.03 100.81 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.936 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m -77.21 114.32 15.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.548 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.32 168.9 16.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 110.715 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -112.31 152.2 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -25.67 68.06 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.77 133.25 34.0 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.127 -0.358 . . . . 0.0 110.497 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -59.62 -25.79 64.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.679 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.53 -6.82 58.78 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.418 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -23.88 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.006 0.432 . . . . 0.0 110.52 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.736 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -71.36 -44.07 65.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -57.99 -51.58 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.782 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.27 -48.02 83.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.212 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -55.83 -44.86 78.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.552 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -70.62 -43.03 70.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.5 m -63.51 -28.52 70.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.328 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 p -86.84 -5.52 59.08 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 110.6 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.17 89.85 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 92' ' ' ILE . 3.1 tp -69.1 -8.92 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 142' ' ' ILE . 43.9 mt-10 -28.52 -49.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.558 0.743 . . . . 0.0 112.741 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -121.14 91.11 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.49 -143.93 5.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.091 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.502 ' HB2' ' NE2' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -122.85 150.16 43.24 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.038 0.535 . . . . 0.0 110.352 -174.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.611 HG13 ' HG3' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -142.86 137.8 27.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 110.198 176.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -118.34 145.77 44.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.571 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 2.1 t -106.63 128.78 61.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.525 172.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 142.01 51.37 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.951 0.782 . . . . 0.0 109.119 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.547 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.3 t-20 -113.24 144.56 42.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.908 0.385 . . . . 0.0 111.557 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' HD2' ' H ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -64.1 -39.54 94.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.269 -175.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -69.53 -26.33 64.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.193 0.52 . . . . 0.0 109.915 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.74 HD22 HG23 ' A' ' 137' ' ' ILE . 12.4 tp -66.51 -39.19 88.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.399 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.556 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 48.1 m-85 -61.72 -42.8 99.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.441 174.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -38.99 90.45 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.907 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -62.05 -44.07 97.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.199 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.498 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 17.6 m-85 -76.99 -12.0 59.88 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.891 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m 70.66 27.62 3.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.457 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.548 HD11 ' HG3' ' A' ' 132' ' ' PRO . 18.4 mt -72.24 148.09 9.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.545 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 69.4 m-85 -89.81 122.77 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.565 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.79 138.62 31.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.15 112.06 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 119.28 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.131 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -87.29 129.65 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -121.55 128.75 52.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.466 0.651 . . . . 0.0 110.847 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 50.5 m80 -80.33 -174.81 0.52 Allowed Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 80.6 Cg_exo -46.19 149.37 2.52 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.211 1.274 . . . . 0.0 111.232 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -52.0 -51.42 57.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -166.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.405 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -99.84 -13.45 0.17 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 92.2 Cg_exo -50.15 -16.25 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.943 0 CA-C-N 121.767 1.667 . . . . 0.0 110.903 163.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 t-20 69.37 28.59 4.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.778 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 112' ' ' HIS . 20.3 tp10 -103.09 98.4 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.364 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -131.14 108.75 9.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.779 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.556 ' HB3' HG22 ' A' ' 110' ' ' VAL . 6.7 tm-20 -99.7 115.1 28.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.99 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.49 101.1 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.092 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.553 ' HB ' ' HE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -93.79 127.92 39.76 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 28.2 mm -88.43 102.9 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.283 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.553 ' HE ' ' HB ' ' A' ' 122' ' ' THR . 6.9 mmt180 -86.0 101.72 13.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.841 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.422 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -69.71 156.71 38.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.503 ' HG3' HD11 ' A' ' 32' ' ' ILE . 9.4 tt0 -65.18 -29.51 70.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.261 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -147.34 161.17 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.719 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.94 47.13 4.57 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.542 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.53 ' SG ' ' NH2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 48.68 63.82 1.95 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.923 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -50.73 -45.77 86.28 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.923 ' HD3' HG23 ' A' ' 131' ' ' ILE . 92.8 Cg_endo -93.14 109.5 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.669 1.579 . . . . 0.0 112.295 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -61.93 -27.74 69.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.965 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.498 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -88.01 11.96 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.886 -178.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.615 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 13.1 p -59.77 -24.44 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 111.556 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -88.34 104.36 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.873 0.844 . . . . 0.0 109.782 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.74 HG23 HD22 ' A' ' 99' ' ' LEU . 1.6 pt -63.12 -26.61 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . . . -145.82 146.0 30.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.326 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -128.26 123.14 33.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.611 ' HG3' HG13 ' A' ' 92' ' ' ILE . 1.9 pt-20 -140.49 160.29 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.159 0.504 . . . . 0.0 111.122 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -111.26 151.76 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.612 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.8 tt -128.45 132.06 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.769 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.629 ' HG3' ' HB3' ' A' ' 145' ' ' ASN . 8.1 pt-20 -128.02 29.78 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -173.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 10.2 tp 37.91 44.97 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 122.341 1.067 . . . . 0.0 111.195 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.629 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.5 t30 -148.15 170.47 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.396 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.14 168.07 10.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.64 89.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -83.4 70.43 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -63.83 128.48 35.99 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.407 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 80.32 0.22 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.485 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -152.27 131.4 12.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.219 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 70.47 1.61 3.71 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.454 0.471 . . . . 0.0 110.632 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.896 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.859 0.362 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.13 97.21 0.27 Allowed Glycine 0 C--N 1.333 0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.615 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 97' ' ' ARG . 12.5 p-10 -159.91 158.6 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -114.83 161.25 18.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 111.182 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -100.53 154.93 18.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.022 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.89 141.25 38.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.374 0.607 . . . . 0.0 111.267 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.581 ' HB2' HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -144.07 156.07 44.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.703 176.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -137.74 157.65 24.25 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.453 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.591 HG23 ' H ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -147.27 140.31 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.447 -178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 6.26 14.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.488 0.661 . . . . 0.0 109.296 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.591 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.36 49.08 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.603 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -59.91 -26.73 66.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -61.09 -46.57 90.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.753 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.8 -47.16 86.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.96 -50.03 69.91 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.448 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -72.0 -24.24 61.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -74.46 -42.41 59.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 110.718 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -94.1 -16.1 24.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.51 89.32 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.0 159.2 36.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -81.18 130.92 35.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HE2' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 50.98 151.91 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 125.075 1.35 . . . . 0.0 113.835 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.52 -164.39 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 111.663 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.22 129.68 4.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.65 12.2 8.33 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.885 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.466 ' HB3' HD12 ' A' ' 131' ' ' ILE . 30.9 t-20 -93.92 131.0 39.79 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 122.797 -0.237 . . . . 0.0 110.497 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -155.66 70.69 0.72 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.449 0.642 . . . . 0.0 110.09 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.545 ' HB1' ' HG3' ' A' ' 43' ' ' LYS . . . -138.73 31.14 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.839 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 57.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.27 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -144.72 100.99 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.694 ' HA ' ' HG2' ' A' ' 43' ' ' LYS . . . -74.47 -32.37 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.725 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.48 HG13 HG12 ' A' ' 50' ' ' VAL . 7.9 mt -94.86 99.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.063 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -98.25 3.82 48.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.634 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 66.73 -65.27 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.904 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 66.82 16.33 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 122.955 0.502 . . . . 0.0 111.246 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.43 -59.62 3.67 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.059 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -1.41 17.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.5 t80 71.85 -5.79 1.61 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.546 0.338 . . . . 0.0 111.708 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -83.51 -18.67 37.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.834 0.349 . . . . 0.0 110.448 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CE1' HG23 ' A' ' 32' ' ' ILE . 10.5 m-85 65.03 176.08 0.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.0 -176.15 5.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.95 -77.23 0.19 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.893 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.694 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 58.24 -90.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 111.012 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.09 66.16 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 110.589 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.54 -51.5 69.61 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -106.54 44.21 1.08 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.899 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.99 138.18 9.59 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.133 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -90.38 -177.89 1.36 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.092 2.528 . . . . 0.0 112.119 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m 69.42 -176.39 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.264 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.756 HG12 ' H ' ' A' ' 51' ' ' LYS . 1.3 t 55.23 -168.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.283 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.756 ' H ' HG12 ' A' ' 50' ' ' VAL . 70.9 mttt 59.57 -170.94 0.13 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 112.565 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -60.81 -22.46 64.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.657 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -65.84 0.57 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.444 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -68.68 -27.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -63.17 1.36 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.416 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.97 87.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.437 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -55.92 -52.48 63.96 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.174 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 26.9 tp60 -66.39 -54.87 19.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.244 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.58 -37.14 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.464 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -80.29 -58.47 3.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.51 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -69.27 -19.84 63.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.57 -175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.63 -111.71 0.77 Allowed Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 13.5 tp -162.07 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' H ' ' HB3' ' A' ' 63' ' ' LEU . 15.4 m-85 -105.36 -38.05 6.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.267 0.556 . . . . 0.0 109.523 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.65 -155.24 0.22 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.074 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.01 -14.61 76.85 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.487 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.52 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 97.6 m -61.5 -50.55 72.28 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.429 0.292 . . . . 0.0 111.212 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -104.33 160.2 15.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.262 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 mp -110.53 99.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.59 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.81 115.41 21.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.421 HG21 ' HA ' ' A' ' 5' ' ' LEU . 96.7 m -140.89 129.41 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -82.22 151.14 26.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.003 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.07 10.73 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.895 0.378 . . . . 0.0 111.823 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.43 123.46 48.11 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -49.2 -28.47 4.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -64.81 -19.97 66.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.69 0.281 . . . . 0.0 111.07 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -28.72 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.557 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -51.64 68.16 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.273 0.558 . . . . 0.0 110.651 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.94 -43.62 67.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.616 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.05 -47.87 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.099 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.35 -54.22 36.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -54.35 -43.89 71.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.544 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 m -73.76 -48.31 32.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 m -68.84 -18.22 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB2' HG13 ' A' ' 87' ' ' ILE . 18.0 m -92.78 -3.38 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.528 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.77 96.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.251 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 82' ' ' ALA . 15.8 mt -79.61 -8.44 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 121.957 0.103 . . . . 0.0 111.041 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 142' ' ' ILE . 10.8 mt-10 -33.28 -39.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -119.85 100.87 7.49 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.77 16.74 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.445 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -109.5 128.18 54.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 -175.163 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.4 mt -105.03 133.36 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.17 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 7' ' ' ARG . 21.5 m-85 -116.38 146.1 42.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -134.38 122.53 40.37 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.958 176.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.733 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.58 140.86 48.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.071 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.43 ' HB2' HG21 ' A' ' 137' ' ' ILE . 24.5 t-20 -80.5 138.43 36.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -68.61 -40.64 80.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -172.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.25 -10.36 59.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.575 0.226 . . . . 0.0 111.19 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.96 -42.58 76.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.604 ' HB3' HD12 ' A' ' 105' ' ' ILE . 3.3 m-85 -68.34 -43.48 77.41 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.683 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.84 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.993 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.63 -41.68 71.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.8 -19.52 65.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.3 m 72.9 38.23 0.74 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.001 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -75.89 166.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -75.51 109.32 8.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.341 -175.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.39 99.82 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -110.85 114.13 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.902 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.32 113.97 25.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.415 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -87.54 115.12 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -103.19 137.11 41.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.329 0.585 . . . . 0.0 111.264 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -87.95 174.37 5.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.572 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 52.7 Cg_exo -49.44 159.6 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.924 1.749 . . . . 0.0 112.575 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.474 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -44.34 -65.07 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 50.3 t30 -92.76 -18.44 0.23 Allowed Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 44.5 Cg_exo -44.46 -18.82 0.21 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 121.551 1.59 . . . . 0.0 112.051 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.409 ' N ' ' C ' ' A' ' 115' ' ' ASN . 2.2 t-20 73.64 12.01 4.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.607 167.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -103.46 122.11 44.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 111.014 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -142.9 109.4 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.283 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.571 ' HB3' HG13 ' A' ' 110' ' ' VAL . 14.3 tt0 -100.52 132.61 45.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.96 104.37 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -84.59 114.59 22.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.172 0.51 . . . . 0.0 110.166 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 46.0 mm -88.01 100.62 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.663 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.732 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -86.32 93.16 9.02 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.008 179.331 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.17 151.76 46.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.435 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.589 ' HA ' HH21 ' A' ' 124' ' ' ARG . 3.3 mm-40 -65.37 -11.04 38.35 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -170.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.688 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 32.2 t0 -145.26 156.19 43.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.27 132.54 47.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 111.468 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 91.29 33.05 8.32 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.127 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 60.95 70.88 0.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.983 0.42 . . . . 0.0 110.356 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.899 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -37.83 -54.82 2.3 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.899 ' HD3' HG23 ' A' ' 131' ' ' ILE . 20.1 Cg_endo -93.11 128.64 0.72 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.306 2.004 . . . . 0.0 112.493 -174.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -81.36 -7.17 59.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -83.71 -4.78 58.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.456 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 132' ' ' PRO . 28.2 m -81.84 -9.41 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 110.247 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.08 89.73 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 96' ' ' ASN . 5.5 pt -63.79 -35.07 71.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.702 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 94' ' ' VAL . . . -155.32 167.96 28.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 111.772 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 160.54 43.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.368 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -141.34 160.58 39.83 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.015 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -105.37 149.43 26.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.4 tt -139.38 130.88 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.461 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -122.93 35.95 4.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.774 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt 61.34 -83.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.82 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.99 142.67 27.78 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.326 0.584 . . . . 0.0 111.717 -171.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -131.53 156.74 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.02 174.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.537 ' HB2' HD22 ' A' ' 146' ' ' LEU . 0.0 OUTLIER 67.59 116.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.422 0.451 . . . . 0.0 110.037 -175.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -66.98 -25.52 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.598 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -70.3 -22.56 62.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.98 125.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.063 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.33 134.5 49.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.254 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -97.13 -10.6 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.053 178.325 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.55 -154.92 52.74 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.73 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' H ' ' HB3' ' A' ' 97' ' ' ARG . 47.4 t30 -150.73 159.52 44.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.6 128.87 35.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -175.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.648 HD21 HD13 ' A' ' 123' ' ' ILE . 7.0 mp -100.7 135.94 41.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.508 ' HD2' HD11 ' A' ' 92' ' ' ILE . 1.4 m-85 -121.57 124.59 44.72 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.174 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.81 150.2 43.02 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.538 ' HA3' HG13 ' A' ' 87' ' ' ILE . . . -129.95 158.26 22.23 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.326 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.562 HG13 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.46 140.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 122.774 0.43 . . . . 0.0 110.468 -175.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.49 ' N ' HG12 ' A' ' 9' ' ' ILE . 2.5 p -89.24 -39.36 13.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.202 -0.311 . . . . 0.0 110.346 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' SER . 7.8 t 174.88 -150.26 0.01 OUTLIER 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.059 0.544 . . . . 0.0 109.79 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -56.77 -40.49 75.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 14.1 pm0 -56.42 -32.55 64.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.972 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -84.98 -31.93 23.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.52 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.803 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -52.56 -51.01 61.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.161 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -73.33 -40.17 64.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.14 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . 23.7 t30 -57.55 -48.16 80.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.62 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.87 -35.49 26.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' NZ ' ' A' ' 24' ' ' LYS . . . 68.8 16.02 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.895 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -132.52 4.09 3.93 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.803 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 33.3 tp -71.0 -54.17 12.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.558 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -88.44 132.92 37.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.271 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 130' ' ' CYS . 32.1 Cg_exo -59.23 112.54 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.783 2.322 . . . . 0.0 111.962 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' HA3' ' A' ' 129' ' ' GLY . 7.0 pttt -112.08 -12.66 13.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.005 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.45 154.54 33.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.164 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 64.1 t30 -98.87 -75.58 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.826 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' HB3' HG13 ' A' ' 131' ' ' ILE . 6.2 ptpp? 152.74 161.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.681 1.193 . . . . 0.0 109.768 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.587 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . . . -177.36 -95.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.206 0.316 . . . . 0.0 111.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' H ' HG21 ' A' ' 50' ' ' VAL . 2.2 tm-20 65.45 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.959 0.504 . . . . 0.0 110.453 -172.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.5 136.09 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 111.531 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 61.35 23.3 13.56 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.73 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' CD1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -78.99 74.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.215 0.531 . . . . 0.0 110.439 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -59.46 95.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.285 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.78 92.19 2.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.09 104.63 0.32 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.924 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 -91.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.759 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.12 178.99 4.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.525 0.202 . . . . 0.0 111.326 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' HZ ' ' HB2' ' A' ' 108' ' ' TYR . 25.2 m-85 72.31 158.88 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.209 0.943 . . . . 0.0 111.827 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -113.16 92.37 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.777 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.472 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 27.4 m-85 -80.65 83.5 6.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.353 0.596 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -88.74 -23.75 22.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.75 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.87 56.99 2.1 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -50.81 -40.8 56.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.015 0.526 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . . . -143.64 -166.74 2.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 110.849 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 46' ' ' HIS . 1.6 m -147.36 174.93 11.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.486 ' H ' HG22 ' A' ' 45' ' ' THR . 0.2 OUTLIER 83.02 -47.47 0.14 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.515 0.726 . . . . 0.0 111.457 173.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.587 ' HA3' ' HB2' ' A' ' 28' ' ' ALA . . . -49.48 115.04 2.59 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.264 0.353 . . . . 0.0 112.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -81.28 -34.43 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.89 2.393 . . . . 0.0 112.616 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.25 62.92 4.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.812 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 51' ' ' LYS . 6.7 p -162.51 -148.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.353 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.775 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 71.01 177.59 0.27 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.576 0.703 . . . . 0.0 111.948 172.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -53.87 -29.7 42.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.95 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 57' ' ' HIS . . . -54.6 -66.6 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.935 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.73 -37.64 80.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.518 0.199 . . . . 0.0 110.994 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -64.15 1.04 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.981 0.42 . . . . 0.0 110.662 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.53 90.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.172 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 6.1 m-70 -58.65 -46.88 86.18 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.839 -177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -60.05 -51.72 68.45 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.572 HD11 HH22 ' A' ' 124' ' ' ARG . 84.5 mt -58.62 -46.28 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.548 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -77.0 -39.77 49.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.3 m -80.35 -42.8 22.25 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -173.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.16 11.38 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.569 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 37.7 tp 63.32 -75.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.89 0.476 . . . . 0.0 110.885 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 122' ' ' THR . 17.8 m-85 -131.02 68.15 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.558 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -58.91 -43.72 91.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.191 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.13 -11.93 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.453 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.89 -29.89 69.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.289 0.545 . . . . 0.0 110.849 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.61 160.06 19.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.6 HG13 HD23 ' A' ' 5' ' ' LEU . 3.0 tp -115.05 123.68 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 110.369 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -105.59 147.69 28.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.809 -174.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.705 HG22 HG13 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -137.78 148.78 45.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.283 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.538 ' H ' HD12 ' A' ' 77' ' ' ILE . 2.9 m -81.49 155.85 25.6 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.217 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -25.9 65.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -85.88 129.01 34.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.705 0.288 . . . . 0.0 110.739 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.83 -18.39 64.08 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.5 -9.69 44.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 ' H ' ' A' ' 72' ' ' THR . 2.2 tt -46.71 -31.83 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.56 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.6 -62.81 1.48 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.357 0.598 . . . . 0.0 111.289 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -70.16 -41.49 73.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.825 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.61 -45.27 92.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.306 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 5.8 t80 -68.58 -53.81 20.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.175 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.81 75.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.498 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m -74.82 -52.58 11.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.665 0.269 . . . . 0.0 111.259 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -70.72 -10.4 59.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -105.07 3.78 30.81 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.297 -0.252 . . . . 0.0 110.865 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.47 36.25 76.34 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.945 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.538 HG13 ' HA3' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -89.76 -9.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.741 -176.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.18 -28.25 0.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.174 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -107.39 109.08 20.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.94 -126.44 3.55 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.145 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.43 150.86 51.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.508 HD11 ' HD2' ' A' ' 6' ' ' TYR . 16.9 tt -145.18 133.87 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.846 0.355 . . . . 0.0 110.067 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -128.8 154.98 45.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.162 0.506 . . . . 0.0 111.099 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 21.6 m -122.84 145.31 29.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.596 0.713 . . . . 0.0 111.494 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.799 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -120.15 141.2 50.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.327 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.465 ' HB2' HD13 ' A' ' 137' ' ' ILE . 61.0 t-20 -105.81 128.74 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.084 -0.385 . . . . 0.0 111.427 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.452 ' HB3' ' H ' ' A' ' 3' ' ' ASN . 19.2 ttp180 -67.35 -34.19 76.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.021 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.18 -36.38 72.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.17 -38.92 89.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -71.56 -34.27 69.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.84 -39.04 96.96 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -65.94 -43.13 88.92 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -65.45 -18.58 65.42 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.648 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 m 71.89 30.43 2.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.677 0.751 . . . . 0.0 110.423 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.3 mt -72.38 156.77 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.473 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 15.2 m-85 -78.5 138.27 38.34 Favored 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -118.61 104.72 10.9 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.497 ' HB2' ' HZ ' ' A' ' 38' ' ' PHE . 15.3 t80 -109.62 112.25 24.22 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -99.46 111.6 23.93 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -83.76 107.02 14.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.9 129.73 44.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.043 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 48.6 m170 -83.09 178.21 2.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.458 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 81.7 Cg_exo -48.15 168.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.011 1.807 . . . . 0.0 112.511 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.46 -70.11 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 66.1 t30 -77.42 -21.42 0.37 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -167.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 18.2 Cg_exo -39.13 -22.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.832 1.688 . . . . 0.0 112.244 166.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 73.09 6.25 5.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.919 164.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.24 140.07 52.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.223 0.535 . . . . 0.0 112.058 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 98.31 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.602 ' HB3' HG13 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -70.39 105.42 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -173.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.705 HG13 HG22 ' A' ' 71' ' ' THR . 2.2 p -82.66 104.33 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.574 0.702 . . . . 0.0 109.63 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 3.2 m -97.39 130.4 44.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.528 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.648 HD13 HD21 ' A' ' 5' ' ' LEU . 2.0 mp -87.64 107.08 16.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.003 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 6.7 mmm180 -87.0 91.7 8.79 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.227 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -72.92 148.97 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.78 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -61.25 -60.28 3.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.468 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.61 141.29 29.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.112 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.66 114.91 7.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.393 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . 91.43 70.71 1.19 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.194 -0.527 . . . . 0.0 114.088 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 23' ' ' PRO . 72.0 m 59.45 72.71 0.51 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 170.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.648 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.59 -43.43 83.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.792 174.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.648 ' HD3' HG23 ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.28 135.66 9.66 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.873 1.715 . . . . 0.0 112.246 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -71.65 -26.64 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.095 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.23 10.88 13.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.006 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.799 HG22 HD23 ' A' ' 95' ' ' LEU . 8.0 p -52.54 -35.79 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 110.779 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.541 HG13 HG13 ' A' ' 135' ' ' VAL . 66.6 mt -93.37 95.36 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 138' ' ' ALA . 1.2 pt -76.04 -35.99 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.326 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 137' ' ' ILE . . . -146.18 157.97 43.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.592 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -133.61 148.47 51.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.739 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.55 154.8 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.747 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 tt -112.14 147.62 35.72 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.6 140.65 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -138.08 53.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.194 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.491 HG13 ' HB2' ' A' ' 146' ' ' LEU . 5.2 tp 36.16 99.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.052 1.341 . . . . 0.0 113.884 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -72.17 73.43 0.93 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.787 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.491 ' HB2' HG13 ' A' ' 144' ' ' ILE . 20.2 tp -94.83 -62.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.879 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.63 61.07 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.151 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -108.51 12.5 26.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.907 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -113.34 129.83 56.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.887 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -67.2 -31.98 72.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -82.56 71.54 9.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -57.46 132.58 53.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.552 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.546 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.938 0.399 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.82 71.74 2.12 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.44 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -85.82 122.83 30.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.81 149.58 37.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.288 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.409 HD11 ' HD2' ' A' ' 97' ' ' ARG . 0.8 OUTLIER -100.09 131.65 45.92 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' HA ' HG12 ' A' ' 94' ' ' VAL . 3.1 t80 -96.82 112.42 24.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.479 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -130.59 155.87 45.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.0 158.33 22.27 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.693 HG23 ' HB3' ' A' ' 91' ' ' TYR . 4.7 tt -143.99 152.78 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -175.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.01 14.14 3.54 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.234 0.54 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 9' ' ' ILE . 1.8 t 58.9 -97.15 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -66.17 -46.7 76.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.943 -167.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.98 -57.03 14.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.24 -43.38 98.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.802 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -51.1 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -59.9 -44.8 94.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -63.29 -51.04 67.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.046 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m-80 -78.76 -27.67 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.905 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 20' ' ' GLN . . . 90.34 47.17 3.87 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -172.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 41.6 mm-40 103.91 -144.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.858 1.663 . . . . 0.0 108.434 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.36 52.93 2.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.411 0.551 . . . . 0.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' ASN . 22.9 mtpp 68.52 131.4 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.857 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.7 142.66 9.25 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.61 136.49 57.05 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.48 -89.26 0.09 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.171 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -165.07 139.22 4.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.966 0.412 . . . . 0.0 110.741 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -80.28 168.49 18.98 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -113.33 -143.3 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.323 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -139.28 -169.32 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.92 60.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.846 0.832 . . . . 0.0 110.56 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -143.28 26.23 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.148 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.54 HG22 ' CE2' ' A' ' 106' ' ' PHE . 45.1 mm -113.81 97.26 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.287 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -103.79 165.53 10.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.363 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -142.35 137.2 30.35 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.61 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.449 . . . . 0.0 109.994 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.92 -45.47 0.29 Allowed Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -115.91 45.46 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -73.89 142.88 45.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.956 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.95 136.65 35.28 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.208 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -120.67 124.97 46.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.429 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 1.3 t70 -145.98 -150.4 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.58 -66.64 3.84 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -90.04 65.29 6.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.448 . . . . 0.0 109.837 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.47 72.65 0.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.308 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 m -151.54 154.77 37.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.393 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -75.62 116.51 16.41 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.23 155.28 21.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.991 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.4 -28.12 12.56 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.885 2.39 . . . . 0.0 112.239 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.66 144.04 47.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.317 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER 50.64 -175.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.101 0.96 . . . . 0.0 112.856 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 72.79 175.52 0.28 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.609 0.719 . . . . 0.0 111.561 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 22.3 p-10 -58.43 -21.81 52.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.547 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.66 -55.71 31.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.563 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -35.01 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.774 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 6.5 m-85 -63.21 -40.77 98.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.52 97.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.826 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -61.95 -38.35 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.133 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 11.3 tt0 -58.55 -57.9 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.65 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.07 -45.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.46 -54.73 6.31 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.935 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -82.84 -18.64 39.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.67 0.272 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . 91.41 30.53 10.67 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.808 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER 44.53 22.05 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.059 0.944 . . . . 0.0 113.083 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 54.84 17.15 1.67 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.977 0.511 . . . . 0.0 111.354 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 36.47 47.02 0.47 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.944 0.898 . . . . 0.0 111.869 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -35.68 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.718 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.61 84.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.425 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.443 ' HB2' HD13 ' A' ' 63' ' ' LEU . 19.9 m-85 -130.19 162.17 29.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.446 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.8 mp -93.42 99.06 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.591 -176.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.425 ' OG ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -86.3 124.13 32.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.027 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 121' ' ' VAL . 14.6 t -140.03 161.37 37.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.539 ' H ' HG13 ' A' ' 77' ' ' ILE . 2.1 m -90.17 154.83 19.46 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 m -61.58 -28.31 69.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 110.456 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -87.17 135.49 33.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.23 -19.87 49.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.163 177.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -6.09 18.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -51.73 -30.85 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.194 173.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.06 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -72.06 -43.74 64.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.592 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 81' ' ' PHE . 8.5 tttt -61.05 -53.34 58.41 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.441 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 58.8 t80 -67.51 -50.37 59.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.759 -175.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB1' ' CD1' ' A' ' 87' ' ' ILE . . . -56.72 -52.01 66.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.54 -175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 -37.98 76.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.606 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -68.95 -24.83 64.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.684 0.278 . . . . 0.0 111.029 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -89.3 1.76 55.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.78 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.88 99.84 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.661 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' CD1' ' HB1' ' A' ' 82' ' ' ALA . 2.8 pt -61.4 -9.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.635 0.218 . . . . 0.0 111.49 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -33.84 -45.33 0.19 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.238 0.336 . . . . 0.0 110.791 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -132.21 123.8 27.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.79 -153.48 24.89 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.71 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.693 ' HB3' HG23 ' A' ' 9' ' ' ILE . 7.1 t80 -122.33 149.85 43.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.477 HD13 ' OH ' ' A' ' 6' ' ' TYR . 62.1 mt -130.98 133.02 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.514 -177.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 32.6 p90 -132.37 129.67 39.7 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 111.233 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 138' ' ' ALA . 2.6 m -112.59 130.99 65.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.182 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -110.37 141.24 43.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.28 -175.033 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.46 ' HB2' HG21 ' A' ' 137' ' ' ILE . 10.3 t-20 -83.11 149.76 26.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.427 HH21 ' CD ' ' A' ' 107' ' ' GLU . 9.0 ttt180 -99.99 -20.2 16.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -35.28 78.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.128 0.49 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp -64.05 -38.12 89.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.036 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 5.9 m-30 -64.86 -39.23 93.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.72 51.64 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.824 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -64.1 -29.94 71.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.435 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 4.5 m-30 -82.85 -16.97 45.59 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.715 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.7 m 64.96 47.36 2.6 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.621 0.724 . . . . 0.0 110.275 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 125' ' ' ALA . 24.9 mm -77.06 150.1 6.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.92 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' CE2' HG22 ' A' ' 32' ' ' ILE . 16.0 m-30 -96.4 103.56 15.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.951 0.405 . . . . 0.0 111.402 -168.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 2.1 pt-20 -93.3 108.17 19.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.111 0.481 . . . . 0.0 110.103 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -99.86 114.26 27.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.337 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 11.6 pt-20 -85.82 120.03 26.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.822 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -92.5 107.76 19.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -114.21 161.04 18.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.132 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -129.19 172.32 7.32 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.2 168.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.37 2.047 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 1.5 pm0 -55.97 -51.22 68.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.511 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 54.1 t30 -83.64 -28.42 0.42 Allowed Pre-proline 0 N--CA 1.471 0.609 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -169.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 22.1 Cg_exo -37.17 -21.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.485 2.123 . . . . 0.0 113.378 170.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.4 t-20 83.65 -3.94 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.35 0.66 . . . . 0.0 112.005 163.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.48 145.5 48.25 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.239 0.542 . . . . 0.0 111.846 -172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.756 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 16.8 tttm -150.05 95.48 2.29 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -100.13 117.01 33.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 0.0 111.175 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 22.8 t -89.22 107.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.456 HG21 HD22 ' A' ' 63' ' ' LEU . 5.2 m -91.28 113.65 25.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.926 0.393 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . 4.5 mt -88.31 103.53 13.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.98 115.16 27.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.267 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -74.44 163.44 27.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.728 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -39.44 -39.85 0.74 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.497 0.498 . . . . 0.0 111.439 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -157.45 161.67 38.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.06 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.5 m -62.24 160.9 12.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 112.01 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.39 31.13 9.87 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.221 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.4 m 48.97 69.33 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.661 0.384 . . . . 0.0 111.876 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.749 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -53.77 -46.35 98.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.723 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.749 ' HD3' HG23 ' A' ' 131' ' ' ILE . 91.0 Cg_endo -92.73 108.74 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 121.854 1.703 . . . . 0.0 112.038 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.41 -5.84 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.63 -3.42 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 95' ' ' LEU . 9.5 p -76.3 -21.11 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.9 pt -86.59 89.74 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.726 0.774 . . . . 0.0 109.341 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' A' ' 96' ' ' ASN . 14.2 pt -74.94 -37.07 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.046 -174.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.611 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -136.76 127.84 27.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.812 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -123.07 136.52 54.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.431 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -141.26 159.46 42.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.239 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.2 tt -112.72 152.18 29.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 125.89 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.357 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.43 ' HG3' HD21 ' A' ' 141' ' ' LEU . 6.3 mt-10 -133.92 93.87 3.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.8 mt 70.73 107.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.936 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -86.18 60.77 6.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.451 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.67 -33.5 66.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.284 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 154.99 17.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.35 39.59 0.83 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.4 t60 72.01 -12.82 0.64 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -170.31 109.12 0.36 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 152' ' ' HIS . 15.3 t-80 -109.45 -13.44 14.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.164 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 151' ' ' HIS . 16.3 t-80 77.11 -49.06 0.54 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.628 0.771 . . . . 0.0 110.86 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 C--O 1.246 0.914 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.897 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 97' ' ' ARG . . . -143.67 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.13 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 90.45 -106.61 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 110.16 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.51 153.94 24.01 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.997 -0.44 . . . . 0.0 111.243 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 144.82 51.12 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.107 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -111.7 132.68 54.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.428 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 0.9 OUTLIER -141.14 105.93 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.345 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.657 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -92.73 155.37 22.55 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.698 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 58.2 mt -131.34 129.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 0.0 110.607 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -24.45 23.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.214 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 48.88 1.67 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.146 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 12' ' ' GLN . 11.8 mt-30 -56.76 -32.24 65.41 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.87 -49.36 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.933 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.11 -44.1 91.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.569 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.68 -48.17 82.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.341 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -67.76 -32.76 73.58 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -72.1 -38.39 69.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -83.05 -22.55 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.033 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 76.79 5.52 84.01 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.813 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 1.4 mt-30 -156.01 165.28 36.91 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.249 0.62 . . . . 0.0 109.441 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.61 56.47 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.65 137.11 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.063 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.11 73.28 4.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.801 2.334 . . . . 0.0 112.489 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -108.82 146.77 33.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.302 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -155.24 73.9 0.24 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -81.86 69.65 8.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 16.3 mmmt -110.17 109.0 19.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 178.81 -31.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.269 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 1.4 mp0 71.61 -64.53 0.38 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.032 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 45' ' ' THR . 99.3 t 69.75 147.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 122.948 0.499 . . . . 0.0 111.732 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 143.9 41.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.433 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.595 HG22 ' HB3' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -134.45 136.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.989 -175.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -144.49 91.75 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 110.985 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -144.11 135.73 25.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.195 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.62 157.64 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.39 -178.25 17.26 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -85.83 23.65 1.41 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.502 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -76.63 106.95 8.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -72.74 71.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 109.908 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.528 ' HB3' HG13 ' A' ' 32' ' ' ILE . 11.5 m-85 -64.62 146.76 54.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.636 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.94 -98.36 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.11 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.31 99.04 1.75 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.739 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -152.62 162.51 41.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.7 -77.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.366 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.576 HG23 HG13 ' A' ' 30' ' ' VAL . 3.4 m 57.81 67.56 0.95 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.922 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -103.26 4.41 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.87 177.82 46.83 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -87.38 -163.96 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.122 2.548 . . . . 0.0 112.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 m 61.18 73.43 0.48 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.483 0.658 . . . . 0.0 111.153 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.597 HG22 ' H ' ' A' ' 51' ' ' LYS . 5.7 p -103.57 172.84 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.93 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.597 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -44.2 -61.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.065 174.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.595 ' HB3' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.46 -14.66 63.13 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -175.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.79 -52.84 8.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' OH ' ' A' ' 68' ' ' TYR . 13.8 p -63.24 -35.05 70.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.08 0.467 . . . . 0.0 109.827 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -61.39 -50.3 73.42 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.29 72.53 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.769 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -61.59 -52.78 62.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.064 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.686 ' HB2' HD12 ' A' ' 63' ' ' LEU . 18.6 tm0? -59.52 -40.22 86.43 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.399 0.618 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.55 -38.49 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.31 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -84.5 -69.92 0.61 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.99 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 -24.97 18.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.84 162.35 26.83 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 58' ' ' GLN . 13.7 mt -155.57 152.65 29.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.359 0.599 . . . . 0.0 110.151 -175.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -62.51 83.91 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.048 172.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.71 82.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.737 0.78 . . . . 0.0 111.417 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' TYR . . . -145.86 -32.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.9 m -55.17 -28.07 50.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.4 0.619 . . . . 0.0 110.006 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.527 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 30.3 m-85 -103.59 161.2 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.825 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.2 mp -101.29 100.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.014 0.435 . . . . 0.0 110.288 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -78.84 123.1 26.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.931 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.83 152.69 50.56 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.495 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 6.0 m -105.24 159.9 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -28.42 66.68 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.013 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -100.34 134.23 43.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -58.72 -19.55 41.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.375 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.557 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 12.4 mm-40 -52.91 -24.85 10.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -49.81 -35.7 10.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.069 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.05 74.76 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.408 0.623 . . . . 0.0 110.609 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -69.41 -47.07 65.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.761 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 53.2 mttm -63.29 -48.51 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.334 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.657 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -63.1 -47.42 82.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.883 -177.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.636 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -57.07 -57.47 12.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.195 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 m -60.65 -45.05 95.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.832 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 m -60.61 -29.88 69.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -83.8 -6.7 59.49 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.26 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 45.82 18.11 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.636 HG21 ' HB1' ' A' ' 82' ' ' ALA . 7.2 tp -68.49 -18.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -32.43 -44.36 0.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.015 0.822 . . . . 0.0 112.468 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -130.95 101.74 5.75 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.83 -166.82 40.01 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.321 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.45 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -93.05 142.99 26.68 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.013 0.525 . . . . 0.0 109.825 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -134.86 112.79 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.125 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 2.7 m-85 -95.05 129.66 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.223 0.535 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.83 113.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.932 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 95' ' ' LEU . 3.6 mp -112.43 140.96 46.73 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.466 0.479 . . . . 0.0 109.839 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -91.61 129.43 37.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.421 ' HB3' ' C ' ' A' ' 2' ' ' GLY . 6.1 ttp85 -80.76 -28.38 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.914 -175.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.18 -33.6 71.13 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.44 ' HB3' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -61.07 -38.54 86.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.012 175.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 4.9 m-85 -66.49 -44.05 83.69 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.202 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.76 -45.24 96.83 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.901 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -61.84 -43.67 98.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.231 0.539 . . . . 0.0 110.016 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.41 -21.64 63.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.516 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.2 m 68.59 37.83 2.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.041 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.545 HG23 ' HA ' ' A' ' 125' ' ' ALA . 17.5 mm -67.65 153.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.245 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.67 104.14 14.39 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 121.038 0.447 . . . . 0.0 110.859 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -88.04 110.72 20.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.406 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -100.48 113.22 25.83 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -105.86 130.03 53.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.66 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 m -117.22 131.66 69.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.557 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.8 pm0 -87.78 131.34 34.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.2 m170 -83.37 175.69 4.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.518 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 82.3 Cg_exo -45.95 164.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 113.138 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -51.09 -55.84 15.65 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -168.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.479 ' N ' ' HG2' ' A' ' 114' ' ' GLU . 60.7 t30 -103.28 -9.32 0.12 Allowed Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 42.7 Cg_exo -43.07 -27.34 0.96 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 121.708 1.646 . . . . 0.0 110.867 162.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 t30 67.64 31.57 5.98 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.605 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.89 145.89 29.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 110.834 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 111' ' ' GLU . 5.5 mptt -123.09 130.4 52.73 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.266 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.8 108.4 16.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.148 0.499 . . . . 0.0 110.23 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.08 96.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.461 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.27 117.05 29.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.3 mm -87.3 106.36 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.026 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 68' ' ' TYR . 26.0 mmt180 -85.19 100.23 11.62 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.138 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.545 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -85.57 161.04 19.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.572 ' HB2' HD13 ' A' ' 131' ' ' ILE . 33.2 mt-10 -65.21 -21.05 66.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.073 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -137.52 161.18 37.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.56 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.1 m -71.85 99.61 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.256 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.35 71.55 1.21 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.1 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.9 71.84 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.718 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -58.95 -44.21 98.61 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.694 ' HD3' HG23 ' A' ' 131' ' ' ILE . 65.6 Cg_endo -74.51 109.69 2.95 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.444 1.429 . . . . 0.0 112.23 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -63.15 -21.57 66.29 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.46 -15.43 59.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.442 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.4 p -70.47 -22.12 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.55 97.03 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.431 0.634 . . . . 0.0 109.554 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 pt -69.04 -28.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.46 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.73 141.9 18.36 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.505 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 95.26 5.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 108.956 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -95.08 157.75 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.283 0.564 . . . . 0.0 111.493 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -137.0 147.9 46.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.642 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.73 138.34 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.399 . . . . 0.0 110.624 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -129.21 53.83 1.86 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.2 mt 60.01 87.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.628 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -57.4 145.04 34.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.203 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.471 HD13 ' N ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -66.71 -22.33 66.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.657 0.265 . . . . 0.0 111.625 -176.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.471 ' N ' HD13 ' A' ' 146' ' ' LEU . 2.1 mm-40 -74.7 158.19 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.276 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -139.28 100.23 3.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.749 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 66.2 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.257 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -169.24 21.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.431 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 20.5 m80 47.96 -139.85 0.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.48 -177.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.431 ' H ' ' HB3' ' A' ' 151' ' ' HIS . 45.1 t60 -155.59 118.91 4.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 110.347 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.793 -0.622 . . . . 0.0 109.605 179.108 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.531 ' O ' ' HB2' ' A' ' 97' ' ' ARG . 10.5 tpt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.722 0.296 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.41 -147.63 18.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.295 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -168.69 -97.7 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -125.49 119.32 27.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.721 HD21 HD13 ' A' ' 123' ' ' ILE . 29.4 mt -99.22 124.52 44.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.291 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.23 114.62 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.904 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -139.77 144.38 37.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -114.19 158.51 14.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.504 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.609 HG12 ' H ' ' A' ' 11' ' ' CYS . 4.3 tt -151.45 168.21 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.82 0.448 . . . . 0.0 110.294 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.98 -14.55 38.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.226 0.536 . . . . 0.0 109.999 172.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER 60.16 -86.27 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.597 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -37.77 -57.13 1.02 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -61.85 -56.18 22.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.361 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.85 -41.54 97.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.31 0.576 . . . . 0.0 111.006 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.78 -52.5 50.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.271 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -63.51 -36.73 84.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.898 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -68.84 -55.47 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.209 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.41 -8.7 54.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.725 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.57 1.26 89.24 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 179.65 -175.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.32 67.31 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt 54.21 64.47 6.32 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.103 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.46 62.71 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.573 2.182 . . . . 0.0 112.202 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -85.76 61.33 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 26' ' ' ASN . . . -124.86 -171.46 13.32 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.411 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 25' ' ' GLY . 5.5 t-20 78.93 117.09 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.982 0.913 . . . . 0.0 111.027 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 45' ' ' THR . 8.7 tttt -137.33 -80.43 0.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.005 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.0 -85.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.008 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.61 -156.49 0.71 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.136 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.49 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 39.0 t -48.99 144.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 123.774 0.671 . . . . 0.0 112.294 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.496 ' HB3' ' H ' ' A' ' 44' ' ' ALA . . . -159.66 -157.33 0.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.312 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 48.2 mt 68.14 -93.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.094 0.558 . . . . 0.0 111.209 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 66.4 155.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 110.272 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' HB3' ' CD1' ' A' ' 38' ' ' PHE . 15.4 t80 -168.45 148.26 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.33 -45.87 14.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.515 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.75 85.52 0.16 Allowed Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 113.077 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? 64.7 -74.26 0.05 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.348 0.659 . . . . 0.0 111.012 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 34' ' ' TYR . 16.5 t80 61.64 68.28 0.71 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.526 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.08 44.54 1.02 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.16 0.505 . . . . 0.0 109.984 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.93 168.75 18.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.28 132.82 3.58 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -173.69 46.41 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.054 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.51 127.88 56.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.103 0.561 . . . . 0.0 110.364 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' H ' ' HB3' ' A' ' 31' ' ' ALA . . . -117.98 147.94 42.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.195 176.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -45.17 -59.56 2.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.581 0.753 . . . . 0.0 112.852 -176.207 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 4.5 m-70 -95.95 95.72 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 110.723 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -55.7 -51.9 51.92 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.471 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 47' ' ' GLY . 56.0 Cg_endo -70.07 -3.74 12.82 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.438 2.092 . . . . 0.0 112.926 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 46' ' ' HIS . 12.9 t -126.28 -146.35 0.34 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 35.5 t 60.87 -111.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 35.5 pttt 30.91 -134.79 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.54 -25.92 64.93 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.333 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -61.05 -54.59 42.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 110.524 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.49 -36.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.41 -55.4 21.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.048 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.39 90.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.543 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -57.14 -54.4 47.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.056 0.455 . . . . 0.0 110.188 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.564 ' HG3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -59.91 -32.58 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -176.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 58' ' ' GLN . 59.6 mt -88.77 -70.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.82 -45.67 93.54 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.138 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -81.65 -19.29 42.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.982 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 51.21 4.2 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.333 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 40.7 mt 64.05 79.83 0.25 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.828 0.451 . . . . 0.0 110.868 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -53.87 -27.26 29.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.646 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.77 150.82 12.13 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.58 69.13 2.38 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.768 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -16.38 27.9 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -119.41 152.43 36.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.156 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.525 ' HB ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -107.88 110.17 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.492 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 3.2 m -99.93 136.04 40.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.838 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.683 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -141.06 155.41 46.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 175.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 m -86.67 162.33 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 110.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -44.48 96.76 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 6.8 t70 -83.68 136.92 34.02 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 -174.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -56.92 -21.94 33.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' A' ' 74' ' ' ASP . 10.0 pt-20 -61.18 -16.85 49.18 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.789 0.328 . . . . 0.0 110.937 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -29.29 11.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.133 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.84 -66.36 0.42 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.956 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.15 -35.67 71.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.37 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -62.13 -44.45 96.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -67.16 -51.24 56.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.918 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.668 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -54.77 -46.21 74.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.327 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -69.43 -44.1 72.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.664 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 m -73.52 -18.78 61.05 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' HG13 ' A' ' 87' ' ' ILE . 19.0 m -101.5 10.68 40.13 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.537 0.208 . . . . 0.0 111.267 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.79 21.18 69.09 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.169 -0.468 . . . . 0.0 113.029 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 82' ' ' ALA . 18.1 mt -72.8 -8.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -39.45 -34.41 0.21 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.545 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -130.45 89.54 2.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.42 -144.98 6.64 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.228 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -127.18 150.72 49.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.567 HG23 HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -133.25 143.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 178.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 43.1 p90 -129.65 139.3 51.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.271 0.557 . . . . 0.0 110.843 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.4 m -126.16 139.92 50.18 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.866 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.801 HD23 HG13 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -126.05 141.04 52.12 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.024 -174.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.657 ' HB2' HD13 ' A' ' 137' ' ' ILE . 38.4 t-20 -96.97 139.84 32.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.86 0.362 . . . . 0.0 110.769 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -66.25 -25.92 67.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.78 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.88 -35.26 70.74 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.238 0.542 . . . . 0.0 109.892 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 96' ' ' ASN . 4.4 mm? -75.94 -50.81 13.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.482 -174.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -30.21 68.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.57 87.52 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.06 -40.01 87.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 105' ' ' ILE . 1.8 m-85 -68.96 -22.0 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.944 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m 66.75 38.43 3.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.66 0.743 . . . . 0.0 109.803 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -71.69 163.88 3.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.642 -178.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 5.2 m-30 -75.53 161.61 29.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.544 -171.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -141.23 155.9 45.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.297 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.465 ' HB2' HH11 ' A' ' 124' ' ' ARG . 0.3 OUTLIER -155.28 110.84 3.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.539 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -108.71 120.03 41.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 110.343 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.6 149.21 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.991 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -105.25 142.57 34.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.018 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -174.41 0.48 Allowed Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 116' ' ' PRO . 99.3 Cg_exo -45.79 163.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.414 1.409 . . . . 0.0 111.811 171.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -51.83 64.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -103.69 -9.26 0.12 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -168.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 40.8 Cg_exo -42.13 -23.22 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 CA-C-N 121.683 1.637 . . . . 0.0 112.161 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.55 30.07 3.23 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.567 169.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.69 150.82 46.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.087 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -129.77 129.79 44.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.616 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -94.65 103.13 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.942 0.401 . . . . 0.0 109.986 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 4.4 p -92.54 110.11 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.482 0.658 . . . . 0.0 110.442 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 87.6 m -91.68 114.74 27.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.519 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.721 HD13 HD21 ' A' ' 5' ' ' LEU . 2.1 mp -87.82 129.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.623 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -111.8 119.34 38.26 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 -173.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.1 149.45 49.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.67 -57.23 13.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.57 158.88 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.056 169.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.28 160.36 31.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.993 0.425 . . . . 0.0 110.767 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.29 32.13 60.5 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.043 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m 57.49 71.31 0.59 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.155 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.85 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -35.52 -49.64 1.35 Allowed Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.85 ' HD3' HG23 ' A' ' 131' ' ' ILE . 84.7 Cg_endo -99.87 109.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.336 2.024 . . . . 0.0 112.019 174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 3.87 15.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.873 0.368 . . . . 0.0 110.606 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.85 -9.58 39.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.801 HG13 HD23 ' A' ' 95' ' ' LEU . 6.8 p -71.42 -9.26 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.585 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.6 pt -86.1 91.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 96' ' ' ASN . 11.6 pt -63.41 -29.92 48.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.446 -173.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.609 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -148.74 148.83 30.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.215 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -150.45 135.37 17.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -142.63 153.14 43.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.032 -171.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -95.44 150.79 19.9 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.508 HG13 ' OD1' ' A' ' 145' ' ' ASN . 7.4 tt -139.37 120.23 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.443 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.56 70.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.186 0.517 . . . . 0.0 110.227 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.1 mt 56.33 30.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.355 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.508 ' OD1' HG13 ' A' ' 142' ' ' ILE . 18.5 p-10 -94.18 -24.17 17.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 mp 64.49 -88.9 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.139 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 149' ' ' HIS . 33.6 tt0 -97.45 143.21 28.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -65.56 -29.71 70.35 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.432 ' H ' ' HG2' ' A' ' 147' ' ' GLU . 2.5 t-80 61.72 83.35 0.15 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.203 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -78.88 87.67 4.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.643 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.407 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 32.6 m170 68.07 -147.02 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.455 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.407 ' H ' ' HB3' ' A' ' 151' ' ' HIS . 71.0 t60 -65.66 134.33 53.0 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 111.587 -175.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.012 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.78 -80.22 0.68 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.277 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -155.99 174.67 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 110.473 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -109.2 133.95 52.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 60.3 mt -113.69 147.18 38.64 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -140.1 135.1 32.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.493 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tpt180 -148.37 155.96 41.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -137.49 157.52 24.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.758 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.9 tt -138.43 133.14 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 110.47 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -31.31 27.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.536 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 53.22 2.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.802 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . 13.3 tm0? -56.58 -27.32 57.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.09 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -74.96 -39.34 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.948 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.87 -48.1 75.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.319 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -66.16 -35.28 80.06 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.411 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 tt0 -63.57 -43.35 97.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.02 -40.58 98.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.341 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.97 -31.95 71.18 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.364 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.48 7.69 71.9 Favored Glycine 0 C--O 1.234 0.129 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.652 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.486 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 4.6 mm-40 -170.93 -178.05 2.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.2 mt -82.06 38.42 0.53 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.219 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm 53.3 60.74 11.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.23 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 55.4 Cg_endo -69.09 149.95 71.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.321 2.014 . . . . 0.0 110.97 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 -138.5 0.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.505 -173.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.31 57.58 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -74.44 80.57 1.92 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.893 0.377 . . . . 0.0 111.031 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB3' ' H ' ' A' ' 28' ' ' ALA . 1.4 mppt? 65.55 -160.97 0.27 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.505 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.746 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . . . 64.19 21.18 12.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 110.289 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.22 105.98 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.264 -1.334 . . . . 0.0 112.729 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t 45.78 38.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 124.166 0.916 . . . . 0.0 112.078 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.67 ' HB1' ' HA3' ' A' ' 42' ' ' GLY . . . -149.75 -50.77 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.729 HD11 ' HG3' ' A' ' 126' ' ' GLU . 1.2 mm 52.41 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.77 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.9 ttm-85 -177.9 102.32 0.04 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HD2' ' HB2' ' A' ' 38' ' ' PHE . 4.3 t80 -145.8 146.03 31.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.759 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -133.26 27.03 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.58 -119.4 2.65 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -89.11 25.95 1.72 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 109.759 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.553 ' HB2' ' HD2' ' A' ' 34' ' ' TYR . 26.3 m-85 -151.75 111.31 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.149 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -86.47 70.54 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.501 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 18.1 m-85 -89.42 85.71 6.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.989 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.98 54.12 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.392 0.615 . . . . 0.0 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.67 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . -89.89 -102.64 1.12 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.057 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.746 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 21.6 mmtt -84.14 173.69 10.86 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.383 0.273 . . . . 0.0 110.552 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.82 -106.05 0.38 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.611 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m 58.52 78.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.272 0.558 . . . . 0.0 111.225 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -76.56 76.49 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.202 0.525 . . . . 0.0 110.65 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.22 -105.6 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.907 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HB2' ' H ' ' A' ' 49' ' ' SER . 31.1 Cg_endo -82.91 -133.92 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.152 2.568 . . . . 0.0 112.028 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.482 ' H ' ' HB2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 54.34 -161.81 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.468 0.707 . . . . 0.0 111.495 176.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -93.81 -105.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.426 -0.171 . . . . 0.0 111.107 -177.095 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HA ' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER 60.67 -169.42 0.16 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.464 0.65 . . . . 0.0 112.698 174.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -48.26 -31.89 6.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.131 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.75 -60.42 3.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 2.2 p -62.91 -32.71 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -62.64 -53.15 58.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.166 0.508 . . . . 0.0 110.418 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.06 99.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.666 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -64.8 -48.96 72.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -70.6 -22.13 62.58 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.836 -175.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.549 HD11 ' NH2' ' A' ' 124' ' ' ARG . 17.0 mm -92.35 -54.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 0.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.91 -50.29 13.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.512 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -80.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.605 0.241 . . . . 0.0 111.412 -173.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.15 79.13 1.62 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 19.8 tp -57.33 86.06 0.01 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 111.535 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 122' ' ' THR . 20.9 m-85 61.55 60.27 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.0 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -34.19 68.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.372 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.33 -13.95 0.45 Allowed Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.353 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.437 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . 13.9 m -61.3 -33.0 72.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 58' ' ' GLN . 19.8 m-30 -106.71 153.51 22.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.05 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.3 mt -93.1 99.6 9.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.833 0.349 . . . . 0.0 110.53 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.78 112.86 24.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.567 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -122.16 170.39 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.919 0.39 . . . . 0.0 111.005 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -98.78 158.29 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.966 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -16.97 64.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.53 134.08 45.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.156 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.7 -19.09 63.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.794 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.17 -16.51 45.42 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.666 0.27 . . . . 0.0 110.655 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -30.62 14.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.902 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.76 -60.37 3.55 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.155 0.502 . . . . 0.0 111.352 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.65 -35.44 65.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.185 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -60.63 -47.67 85.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.808 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -64.38 -51.73 61.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.46 -59.21 5.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -66.87 -35.54 80.26 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.861 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.0 m -73.49 -17.85 61.18 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.444 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 m -99.78 -2.85 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.6 0.238 . . . . 0.0 110.682 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.87 31.59 78.9 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 -9.75 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.031 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -47.48 -27.36 1.71 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.694 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.11 88.48 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.99 -138.74 5.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.364 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.695 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.7 t80 -123.49 148.48 46.19 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.743 0.417 . . . . 0.0 110.022 -174.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.449 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 pt -140.09 139.15 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 10.6 p90 -132.13 132.21 43.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.933 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.1 m -109.98 139.69 32.17 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 CA-C-O 121.333 0.587 . . . . 0.0 110.729 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.3 mp -121.09 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.005 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -85.46 125.81 33.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.891 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.495 HH21 ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -69.49 -53.61 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -171.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.64 -20.37 65.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.061 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 135' ' ' VAL . 15.0 tp -64.61 -34.77 79.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.183 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.534 ' CE1' HG11 ' A' ' 135' ' ' VAL . 0.2 OUTLIER -67.01 -43.89 81.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.618 176.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.96 94.84 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.638 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -59.78 -50.38 74.06 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -64.98 -20.81 66.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.603 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 m 68.88 37.85 2.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.499 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -71.97 158.86 6.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.836 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.6 m-85 -77.08 102.49 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.301 -166.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.495 ' CD ' HH21 ' A' ' 97' ' ' ARG . 41.4 mt-10 -91.63 126.51 36.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.264 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.632 ' HB2' ' HD3' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -134.32 111.01 9.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.19 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -117.0 118.03 31.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.126 0.489 . . . . 0.0 109.706 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -99.81 135.66 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.344 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -92.77 142.37 27.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.342 0.592 . . . . 0.0 110.557 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.23 175.84 2.25 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.28 160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.906 1.737 . . . . 0.0 111.844 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.85 -41.23 97.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -167.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 9.8 t-20 -86.26 -25.39 0.34 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 26.0 Cg_exo -39.37 -23.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.928 1.752 . . . . 0.0 112.091 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 m-20 76.15 6.22 3.68 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.223 164.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -150.11 160.72 43.44 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.951 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.42 148.55 48.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.775 174.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -96.02 105.25 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.024 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 109' ' ' GLU . 33.7 t -89.25 102.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.451 HG21 ' CE1' ' A' ' 64' ' ' TYR . 5.3 m -104.63 109.59 21.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.189 0.518 . . . . 0.0 111.248 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.408 HG21 ' CD2' ' A' ' 100' ' ' PHE . 5.1 mp -89.85 116.81 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.836 ' HG2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -103.04 118.68 37.35 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.833 0.825 . . . . 0.0 110.076 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.77 163.35 20.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.958 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.729 ' HG3' HD11 ' A' ' 32' ' ' ILE . 18.3 tt0 -51.55 -29.18 16.05 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.616 0.573 . . . . 0.0 111.719 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.415 ' H ' ' CG2' ' A' ' 131' ' ' ILE . 36.3 t0 -140.3 160.43 40.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.471 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 1.5 t -67.42 128.27 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.578 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.93 59.69 1.85 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.578 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.3 m 47.46 70.4 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.896 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -54.71 -44.87 99.58 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.896 ' HD3' HG23 ' A' ' 131' ' ' ILE . 91.1 Cg_endo -94.0 124.59 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.112 1.875 . . . . 0.0 112.32 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -84.3 -14.9 48.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -61.4 -29.89 70.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.903 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.64 ' HA ' HD23 ' A' ' 99' ' ' LEU . 22.3 m -72.93 -12.51 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.48 93.63 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 pt -71.9 -26.45 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.923 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -144.45 139.79 28.55 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.409 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -132.48 126.92 34.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.278 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.76 160.25 40.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.592 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.479 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.1 tt -102.55 153.47 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.5 tt -137.26 133.84 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.329 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.479 ' HG3' HD21 ' A' ' 141' ' ' LEU . 31.4 mt-10 -134.0 74.68 1.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.954 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.2 mt 52.43 50.26 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.514 0.673 . . . . 0.0 110.677 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -64.91 -54.96 22.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.869 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.5 ' H ' HD22 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -95.34 43.38 1.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -171.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -139.18 156.1 47.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.1 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -120.91 -6.47 9.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.101 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -79.95 68.61 6.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -96.94 -19.44 18.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.449 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -77.22 126.61 31.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.408 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 62.37 107.33 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.461 0.705 . . . . 0.0 112.586 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.177 177.613 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.32 179.97 22.88 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.663 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 84.72 171.17 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.114 0.966 . . . . 0.0 109.907 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 141.44 48.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.594 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.611 HD22 HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -99.97 135.14 41.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HD2' HD11 ' A' ' 92' ' ' ILE . 1.6 m-85 -96.15 141.18 29.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 0.0 110.664 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.13 123.01 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.397 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.551 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -119.8 157.33 15.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.863 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.545 HG22 ' HD1' ' A' ' 91' ' ' TYR . 8.3 tt -149.71 159.09 5.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.113 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 25.59 5.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.125 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.58 64.83 1.09 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.417 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.63 -23.84 67.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.558 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -61.7 -44.83 96.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.455 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.55 -41.65 88.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.234 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -59.66 -42.16 92.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.383 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -71.73 -33.55 68.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.13 -48.4 35.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -87.75 -27.71 22.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.61 75.2 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.993 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -153.02 17.57 0.57 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.89 0.345 . . . . 0.0 111.578 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.88 98.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.21 0.319 . . . . 0.0 110.686 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 10.2 mmmm 68.4 137.69 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.175 0.59 . . . . 0.0 110.879 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' HE2' ' A' ' 22' ' ' LYS . 93.9 Cg_endo -79.7 149.56 20.94 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.396 2.064 . . . . 0.0 111.987 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -81.02 -174.67 4.98 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 49' ' ' SER . . . -82.29 -145.49 5.41 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.384 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -163.43 -64.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.747 0.273 . . . . 0.0 111.021 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -129.98 142.12 50.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.932 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 29' ' ' GLU . . . -78.69 -56.35 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 26.8 tt0 72.63 -61.86 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.402 -176.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -111.29 170.41 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.777 0.323 . . . . 0.0 110.675 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.612 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . . . -77.7 163.28 26.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.396 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 7.7 mm -72.78 -44.23 59.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.601 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 4.3 mmt180 54.54 55.89 7.46 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.652 174.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.608 ' HD2' ' HB2' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -85.95 113.4 22.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.65 115.62 10.02 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -169.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.34 -72.04 2.39 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.911 170.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -53.83 -39.39 65.53 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.658 0.383 . . . . 0.0 112.003 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.608 ' HB2' ' HD2' ' A' ' 34' ' ' TYR . 15.3 m-85 -139.69 92.48 2.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.789 0.328 . . . . 0.0 110.716 -175.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -70.05 78.13 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.53 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 22.1 m-85 -82.16 164.44 21.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.456 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -93.8 -108.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . 175.2 -67.96 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -81.24 54.17 2.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.357 0.598 . . . . 0.0 109.523 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.16 59.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 m 72.94 -57.18 0.64 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.18 0.592 . . . . 0.0 111.498 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.44 -36.09 80.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.62 71.69 0.46 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -90.25 -50.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.996 2.464 . . . . 0.0 114.408 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.412 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -89.35 42.69 1.1 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.54 HG23 HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -103.44 -74.33 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.03 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 39.0 mtmt 58.26 179.13 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.885 0.85 . . . . 0.0 113.083 171.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.45 -24.31 54.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.809 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.43 -68.44 0.17 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.096 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG21 ' SG ' ' A' ' 67' ' ' CYS . 3.6 p -79.96 -26.27 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.189 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.8 m-85 -63.36 -53.62 49.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.93 0.395 . . . . 0.0 110.039 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.549 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -56.24 -52.23 65.22 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.043 0.449 . . . . 0.0 109.941 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -62.4 -48.78 78.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.236 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 55' ' ' TYR . 46.7 mm -69.74 -41.2 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -84.71 -54.62 4.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.588 0.232 . . . . 0.0 111.401 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.2 m -74.92 -31.62 61.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.24 -161.89 12.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.142 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 ' OG ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -79.45 73.22 6.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.612 -176.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -71.58 -14.43 62.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.16 -171.52 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.651 171.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.45 -50.7 4.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.807 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 54' ' ' VAL . 34.6 t -84.87 -46.1 11.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -115.21 143.77 44.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.257 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.91 99.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.943 0.401 . . . . 0.0 110.229 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.433 ' OG ' HD11 ' A' ' 63' ' ' LEU . 60.0 m -80.49 122.67 27.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.653 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 5' ' ' LEU . 2.2 m -127.21 131.36 50.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.091 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.68 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -80.36 167.87 19.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.618 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.1 p -81.82 9.64 7.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.064 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -116.92 133.28 56.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.165 0.507 . . . . 0.0 110.899 -177.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -65.17 -19.75 66.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.008 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 27.7 mm-40 -77.57 -5.14 49.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.021 -176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.68 HD12 ' H ' ' A' ' 72' ' ' THR . 2.7 tt -48.22 -34.51 4.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.547 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.74 -53.57 56.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -70.59 -46.04 64.19 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.769 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -60.03 -48.23 82.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.53 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.551 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 6.0 t80 -67.35 -53.96 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.109 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -56.61 -42.83 79.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.332 -176.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 m -70.85 -48.16 55.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.227 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 -20.55 66.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.691 0.282 . . . . 0.0 111.54 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -93.83 9.62 36.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.87 36.71 67.23 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.785 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.534 HG21 ' HB1' ' A' ' 82' ' ' ALA . 3.3 tp -70.76 -10.2 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 2.0 tm-20 -38.56 -37.51 0.32 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.502 0.501 . . . . 0.0 111.193 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.07 89.18 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.85 -152.61 11.96 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.139 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' A' ' 9' ' ' ILE . 48.0 t80 -129.89 135.87 48.86 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HB ' HG12 ' A' ' 87' ' ' ILE . 9.9 tt -139.97 138.9 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.42 . . . . 0.0 111.516 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -131.8 156.75 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.7 m -128.17 137.35 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.477 HD23 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -113.82 140.63 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.356 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -81.92 146.28 29.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.711 0.291 . . . . 0.0 110.702 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -94.27 -24.98 17.23 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.36 -43.4 67.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.345 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.465 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 3.6 m-85 -67.14 -36.92 82.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.939 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.72 99.6 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -59.19 -53.44 58.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.339 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -70.93 -16.75 62.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.043 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m 63.88 47.97 3.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.509 0.671 . . . . 0.0 110.222 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -62.62 163.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.523 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 7.3 m-85 -74.6 99.78 3.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.129 0.49 . . . . 0.0 110.491 -170.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.94 101.61 13.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.766 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.512 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 54.6 t80 -116.49 125.3 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.1 140.61 47.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.804 0.335 . . . . 0.0 111.264 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 120' ' ' GLU . 2.5 m -123.92 150.13 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.291 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.18 142.34 27.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.89 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' GLU . 3.0 m170 -84.99 175.09 4.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.535 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.0 Cg_exo -50.4 170.2 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.025 1.817 . . . . 0.0 112.461 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -53.13 -64.68 0.74 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -166.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.452 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 59.2 t30 -93.79 -12.47 0.18 Allowed Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.535 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 52.0 Cg_exo -44.87 -24.04 1.1 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 CA-C-N 121.421 1.543 . . . . 0.0 111.174 163.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.25 -11.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.541 166.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 3.8 mt-10 -102.67 155.15 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.143 0.497 . . . . 0.0 111.029 -172.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -115.03 133.75 55.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HB3' HG22 ' A' ' 110' ' ' VAL . 1.1 tm-20 -89.04 135.32 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.36 100.4 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.459 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -74.23 113.27 11.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.299 177.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.611 HG13 HD22 ' A' ' 5' ' ' LEU . 7.0 mm -87.45 100.19 9.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 48.6 mtt-85 -101.59 110.13 22.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.437 -172.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.5 160.34 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.365 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 131' ' ' ILE . 18.7 mt-10 -54.49 -49.94 68.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -176.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.677 ' H ' HG21 ' A' ' 131' ' ' ILE . 30.5 t70 -110.18 160.28 16.63 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.15 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 12.3 t -80.39 129.41 34.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.91 69.2 1.19 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.975 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 31.2 m 46.87 70.29 0.41 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.869 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -69.33 -44.44 26.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.869 ' HD3' HG23 ' A' ' 131' ' ' ILE . 83.5 Cg_endo -97.92 109.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.451 2.101 . . . . 0.0 111.707 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.63 -27.46 45.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.638 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.18 -9.07 58.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 132' ' ' PRO . 6.4 p -73.13 -15.18 17.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.9 mt -86.94 89.64 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.6 pt -80.23 -28.03 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.422 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.682 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -128.17 140.12 52.1 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.464 ' HG3' ' OH ' ' A' ' 91' ' ' TYR . 12.1 ttmt -141.62 126.49 18.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.273 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.37 131.41 24.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.775 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' A' ' 143' ' ' GLU . 2.9 tt -92.68 151.89 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 171.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -140.52 122.29 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.177 0.513 . . . . 0.0 112.031 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.468 ' HG3' HD21 ' A' ' 141' ' ' LEU . 26.9 mt-10 -126.79 93.16 3.7 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.001 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 2.1 mt 52.93 44.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.407 0.683 . . . . 0.0 111.778 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.89 65.91 6.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.333 0.587 . . . . 0.0 110.267 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.1 -85.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.267 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.51 166.48 11.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -162.37 66.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 0.0 110.494 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -76.95 -171.67 2.05 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.866 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.09 69.5 0.73 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.5 m170 65.91 -134.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.476 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 73.7 m80 65.2 13.56 8.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.233 0.54 . . . . 0.0 110.502 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.623 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.708 ' SD ' ' HD3' ' A' ' 97' ' ' ARG . 21.4 ttt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.753 0.311 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.22 45.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.689 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -149.54 153.19 36.79 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.93 174.93 10.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.554 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -118.97 159.07 24.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.098 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' HE2' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.67 132.39 55.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 -177.017 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.504 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 12.1 ttt180 -131.49 94.77 3.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -90.42 157.48 25.74 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.142 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 HD11 HD22 ' A' ' 21' ' ' LEU . 49.7 mt -125.47 128.71 72.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.869 0.366 . . . . 0.0 110.122 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.86 -31.01 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.858 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.7 p -94.43 55.32 1.96 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -49.92 -29.44 8.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.315 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -70.85 -38.8 73.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.386 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -72.96 -36.18 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.722 -179.057 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.55 -53.39 28.78 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.454 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -59.81 -36.06 75.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.92 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 15.3 t-20 -68.27 -39.88 82.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.183 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -67.18 -32.47 73.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.293 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 2.36 73.36 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.116 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -169.86 177.75 4.28 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 9' ' ' ILE . 7.1 mt -81.38 49.02 1.22 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.479 0.18 . . . . 0.0 111.166 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt 54.7 69.26 2.15 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.415 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 67.1 Cg_endo -86.21 148.57 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.71 2.273 . . . . 0.0 112.233 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -148.79 4.69 0.66 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.31 96.54 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.97 21.77 0.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -173.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -141.28 122.09 14.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 110.032 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.77 -110.71 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.543 -168.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 54.59 63.21 2.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.23 0.538 . . . . 0.0 110.168 -173.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.5 86.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.555 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.501 ' HB3' ' H ' ' A' ' 43' ' ' LYS . . . -131.97 27.43 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.962 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.527 HG23 ' HA3' ' A' ' 42' ' ' GLY . 2.3 pt -135.92 145.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.76 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -157.79 149.59 21.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -69.57 73.63 0.37 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.142 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -50.95 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.081 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.11 -44.96 0.65 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -85.16 119.24 25.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -77.13 30.22 0.14 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -114.68 19.18 16.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 110.386 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 80.18 1.09 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 109.834 176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -68.03 78.75 0.23 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.527 ' HA3' HG23 ' A' ' 32' ' ' ILE . . . -87.22 -179.94 48.35 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.471 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.501 ' H ' ' HB3' ' A' ' 31' ' ' ALA . 45.4 mttm 67.07 179.61 0.22 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.906 0.482 . . . . 0.0 110.908 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.68 -156.67 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.311 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -15.13 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.695 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -34.73 69.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 175.84 73.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.006 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.29 -21.22 23.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.61 2.207 . . . . 0.0 111.67 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.3 p -91.41 15.35 12.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.57 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -51.53 -39.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.375 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HD3' ' H ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -56.02 -68.85 0.17 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.69 -53.03 34.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.024 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.56 -61.97 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG11 HH21 ' A' ' 124' ' ' ARG . 3.5 p -67.9 -37.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -172.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.489 ' O ' HG12 ' A' ' 59' ' ' ILE . 6.5 m-85 -63.41 -59.49 4.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.08 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.98 83.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.081 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.41 -29.58 69.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.622 ' HG2' ' HD2' ' A' ' 68' ' ' TYR . 56.9 tp60 -67.62 -45.21 76.09 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 109.834 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 55' ' ' TYR . 18.4 mm -66.02 -31.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.437 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -81.58 -74.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.559 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 p -95.68 -38.72 10.24 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.39 48.18 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 58' ' ' GLN . 2.5 mp 59.97 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 111.37 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -95.72 64.33 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.365 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 63.54 -74.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.675 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.45 66.84 0.51 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' SG ' ' N ' ' A' ' 129' ' ' GLY . 8.0 t -56.93 -42.7 80.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.959 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.622 ' HD2' ' HG2' ' A' ' 58' ' ' GLN . 21.4 m-85 -123.39 159.72 28.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.37 104.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 21.3 m -87.39 111.22 20.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 t -123.85 157.22 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 p -87.52 158.49 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -13.16 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.807 0.336 . . . . 0.0 110.9 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -79.79 130.53 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.832 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -58.61 -24.07 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.643 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.02 1.03 22.19 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.669 0.271 . . . . 0.0 111.0 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -48.93 -34.06 5.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.651 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.04 -57.56 12.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 111.372 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -70.42 -43.09 70.67 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.832 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -60.62 -46.46 90.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.282 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 19.3 t80 -68.82 -44.39 73.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.294 -176.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -57.2 -50.61 72.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.68 -44.4 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -15.64 63.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.433 ' HB2' HG13 ' A' ' 87' ' ' ILE . 6.8 m -105.42 2.75 28.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.22 96.6 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.253 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 82' ' ' ALA . 10.1 mt -91.01 -7.8 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -29.21 -43.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.732 0.813 . . . . 0.0 113.186 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -125.17 92.72 3.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.03 -144.73 6.35 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.917 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -105.09 143.37 33.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.72 0.408 . . . . 0.0 110.448 -175.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 5.4 pt -139.88 113.92 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 110.296 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -101.99 156.31 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -129.36 136.92 58.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.559 HD23 HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -128.34 133.9 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.295 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.493 ' HB2' HG21 ' A' ' 137' ' ' ILE . 48.5 t-20 -79.5 134.83 36.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.485 0.183 . . . . 0.0 110.701 -175.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.708 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.69 -51.64 13.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.333 -176.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.43 -17.8 64.85 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.782 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.17 -45.61 90.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.344 0.592 . . . . 0.0 109.536 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.458 ' HE2' HD11 ' A' ' 5' ' ' LEU . 59.9 m-85 -66.48 -35.48 80.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.951 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.59 93.1 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.952 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -72.41 -37.2 68.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.136 0.493 . . . . 0.0 110.023 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -75.76 -23.39 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m 69.71 33.93 2.82 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.788 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -65.13 163.92 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.922 174.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.3 m-85 -74.45 99.29 3.51 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.593 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -96.8 99.32 10.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.75 112.39 24.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.614 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -105.02 107.45 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.925 0.393 . . . . 0.0 110.177 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.604 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -91.25 107.54 18.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.35 129.04 34.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.528 0.68 . . . . 0.0 109.455 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -80.75 169.35 19.82 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.146 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.82 167.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.217 1.945 . . . . 0.0 112.407 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.81 -55.96 28.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 46.4 t30 -87.88 -14.74 0.21 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -168.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 45.6 Cg_exo -43.44 -23.36 0.47 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 121.392 1.533 . . . . 0.0 111.298 162.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 67.84 27.82 7.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.584 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -160.33 154.51 23.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.239 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 135.96 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' A' ' 110' ' ' VAL . 19.0 tt0 -98.5 113.56 25.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.428 . . . . 0.0 111.016 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 t -95.73 103.77 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.981 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 58.3 m -93.19 112.47 24.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 100' ' ' PHE . 4.2 mp -88.68 110.04 20.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.596 ' O ' HG23 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -100.41 116.82 33.26 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.558 178.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.42 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -69.99 159.55 33.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.052 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 126' ' ' GLU . 1.2 mm-40 -48.16 -59.55 3.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 111.012 -176.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.668 ' H ' HG21 ' A' ' 131' ' ' ILE . 48.4 t0 -104.63 154.98 19.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.622 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -76.41 140.68 41.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' A' ' 67' ' ' CYS . . . 90.9 49.34 3.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.766 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.504 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 32.0 m 52.14 70.88 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.047 0.451 . . . . 0.0 112.206 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.668 HG21 ' H ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -69.28 -38.35 10.42 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.234 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.661 ' HD3' HG23 ' A' ' 131' ' ' ILE . 95.4 Cg_endo -82.68 118.88 2.87 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 121.267 1.311 . . . . 0.0 112.005 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.1 -31.27 69.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.28 10.07 9.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.494 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 4.2 p -63.29 -29.8 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.611 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.49 93.38 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.493 HG21 ' HB2' ' A' ' 96' ' ' ASN . 18.0 pt -74.86 -32.71 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.102 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -161.56 166.78 26.48 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.371 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -145.42 144.49 30.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.167 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -141.08 160.44 40.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.851 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.39 148.39 25.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.07 137.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.192 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 105.64 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.205 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 72.5 mt 66.15 102.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.562 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -77.34 66.26 3.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.51 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 tp -92.11 -62.84 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.828 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -152.4 123.52 7.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.64 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -74.99 82.34 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -43.12 118.88 1.39 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.139 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -58.29 125.4 23.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.895 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -79.87 101.15 8.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.025 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -90.49 -42.73 10.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.64 178.059 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.521 ' SD ' HG22 ' A' ' 73' ' ' THR . 1.8 ttt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.53 -161.69 34.68 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.393 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -169.86 -50.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -157.73 154.65 28.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.097 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.505 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -122.68 151.02 41.94 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.837 0.351 . . . . 0.0 110.597 -174.036 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.63 136.61 52.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.044 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 15.2 tpt180 -142.43 102.39 4.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.77 137.12 13.22 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.46 129.66 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.207 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -28.57 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 110.313 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -90.09 42.29 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.808 -178.071 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.24 -34.59 23.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.148 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -68.93 -42.99 76.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.563 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.6 t70 -65.4 -42.55 92.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 21' ' ' LEU . 2.1 tt0 -61.85 -54.83 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.718 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.65 -32.5 71.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.785 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -35.03 74.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.931 0.396 . . . . 0.0 110.189 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -73.87 -24.31 59.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.784 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.05 5.41 89.73 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.37 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -169.7 162.16 9.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . 1.5 mt -69.33 73.32 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 66.27 149.47 0.12 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.919 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 145.53 82.1 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.592 2.195 . . . . 0.0 111.734 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.26 139.42 37.4 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.508 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.05 99.17 0.18 Allowed Glycine 0 CA--C 1.517 0.179 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -93.0 156.1 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.278 0.561 . . . . 0.0 111.757 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -115.18 52.76 0.85 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.031 172.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -61.0 2.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.85 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 31' ' ' ALA . 2.0 mm-40 55.42 35.29 24.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 176.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 t 65.01 -3.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.338 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -89.16 47.1 1.45 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.958 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG12 ' HE3' ' A' ' 51' ' ' LYS . 11.9 mt -147.38 137.22 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.952 175.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -137.35 -29.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.364 -0.134 . . . . 0.0 111.133 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.8 t80 57.8 55.4 5.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.525 0.679 . . . . 0.0 110.172 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 82.99 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.132 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.04 -65.12 4.2 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -105.71 -179.57 3.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -74.32 69.09 1.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.101 0.476 . . . . 0.0 110.529 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -109.2 126.94 53.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.069 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.6 OUTLIER -168.67 167.36 11.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 -176.138 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.834 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 13.1 t70 -88.65 113.47 24.24 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.069 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 131.78 11.93 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.03 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -98.4 106.22 18.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.859 0.33 . . . . 0.0 110.919 -174.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 53.81 -128.74 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.433 0.458 . . . . 0.0 111.534 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -75.66 -4.7 41.66 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.277 0.231 . . . . 0.0 111.276 -179.088 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 45' ' ' THR . 9.2 m80 76.11 -49.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.633 0.773 . . . . 0.0 111.461 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.87 -171.99 24.27 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.981 -0.447 . . . . 0.0 111.981 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -87.64 -3.12 7.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.526 . . . . 0.0 112.238 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 50' ' ' VAL . 60.5 m -128.24 155.4 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.941 -173.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 49' ' ' SER . 0.3 OUTLIER 61.25 172.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.799 0.84 . . . . 0.0 112.339 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.478 ' HE3' HG12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER 59.05 -172.18 0.11 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.746 174.014 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -53.3 -27.47 23.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.36 -66.43 0.39 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.733 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -30.82 49.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.664 0.268 . . . . 0.0 110.96 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.675 ' HA ' ' NH1' ' A' ' 124' ' ' ARG . 22.6 m-30 -62.35 -61.54 2.38 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.649 0.262 . . . . 0.0 110.591 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.75 77.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -52.11 -59.33 4.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.522 ' NE2' ' SG ' ' A' ' 128' ' ' CYS . 1.4 tp-100 -65.72 -51.32 60.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.003 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.476 ' HB ' HH22 ' A' ' 124' ' ' ARG . 2.7 tt -76.91 -24.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.78 -35.89 12.54 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.571 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -89.68 -58.8 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.581 0.229 . . . . 0.0 111.321 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.38 -128.1 6.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.198 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -156.18 -157.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.5 m-85 -98.26 -6.85 30.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.092 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -60.78 91.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 111.288 -172.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.64 -39.03 3.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.222 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.609 ' SG ' ' CZ ' ' A' ' 68' ' ' TYR . 51.8 t -78.92 -48.22 14.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.144 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.609 ' CZ ' ' SG ' ' A' ' 67' ' ' CYS . 30.3 m-85 -129.17 162.68 27.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.658 0.383 . . . . 0.0 110.467 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.64 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.6 mp -92.15 99.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 111.019 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 m -75.73 109.96 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.443 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -118.26 129.09 55.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.275 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.627 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.1 m -75.91 157.46 33.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.521 HG22 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -86.07 9.86 16.03 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.643 -177.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 76' ' ' GLU . 16.2 t70 -109.33 135.7 49.96 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.494 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -55.46 -26.15 40.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HG3' ' HE2' ' A' ' 75' ' ' LYS . 11.2 mt-10 -82.81 2.03 36.13 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 121.999 0.12 . . . . 0.0 111.075 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.627 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -44.61 -38.57 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.457 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 4' ' ' PHE . . . -60.03 -55.88 28.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.226 0.536 . . . . 0.0 110.988 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.79 -42.09 67.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.275 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.299 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 22.5 t80 -65.74 -49.48 68.29 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -53.5 -56.46 16.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.303 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -63.3 -39.85 95.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.222 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 m -65.58 -25.6 67.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.941 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -90.4 0.18 57.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.696 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 54.8 30.78 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.708 HG21 ' HB1' ' A' ' 82' ' ' ALA . 4.2 tp -77.12 -9.9 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' A' ' 144' ' ' ILE . 4.2 tt0 -33.32 -47.72 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.492 0.495 . . . . 0.0 111.281 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -131.36 118.01 19.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.938 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 166.25 -168.44 39.9 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.091 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.85 137.55 32.24 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.91 0.484 . . . . 0.0 109.744 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.48 111.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.7 0.286 . . . . 0.0 110.287 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 3.6 m-30 -111.68 143.4 42.64 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -129.97 130.32 66.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.02 178.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -125.04 141.34 52.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.497 -177.278 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 99' ' ' LEU . 23.5 t-20 -85.58 132.53 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -62.48 -48.25 80.44 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.709 -175.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 1.3 tp -62.84 -43.33 99.09 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.478 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 33.2 m-85 -62.91 -41.05 99.33 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.592 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.62 -36.03 88.04 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.802 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.07 -44.94 83.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -69.26 -16.62 63.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.3 m 72.13 31.0 2.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.608 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.7 mt -75.55 157.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.476 ' HZ ' HG21 ' A' ' 32' ' ' ILE . 7.7 m-85 -83.6 101.95 11.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.734 -163.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -94.87 105.74 17.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.663 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.444 ' HE2' ' HE ' ' A' ' 124' ' ' ARG . 10.6 p90 -126.57 145.27 50.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.991 0.425 . . . . 0.0 110.032 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -95.45 125.27 39.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.689 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 120' ' ' GLU . 1.6 p -90.75 106.85 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.8 145.98 27.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -108.36 170.58 5.34 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.7 Cg_exo -47.7 170.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.452 2.101 . . . . 0.0 113.068 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -46.57 -67.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 9.7 t-20 -93.28 -11.81 0.17 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 35.8 Cg_exo -43.88 -20.49 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 CA-C-N 121.556 1.592 . . . . 0.0 112.683 164.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.09 9.39 6.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.407 0.683 . . . . 0.0 111.708 170.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -110.09 115.61 30.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.217 0.532 . . . . 0.0 112.102 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -138.33 95.75 3.06 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.525 ' HB3' HG13 ' A' ' 110' ' ' VAL . 9.7 tt0 -93.96 140.21 29.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.737 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.92 106.26 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -92.47 121.86 34.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.64 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 18.1 mm -88.71 93.42 4.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.153 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.675 ' NH1' ' HA ' ' A' ' 55' ' ' TYR . 6.8 tpp180 -82.1 99.71 9.36 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.192 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.427 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.52 160.51 32.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.828 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.414 ' HB2' HD13 ' A' ' 131' ' ' ILE . 12.8 mt-10 -58.09 -30.81 66.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -147.44 160.87 42.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.522 ' SG ' ' NE2' ' A' ' 58' ' ' GLN . 76.7 m -61.7 149.94 38.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.983 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.42 26.78 50.43 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.873 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.471 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 1.8 m 57.21 72.0 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.708 0.29 . . . . 0.0 110.485 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.84 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -38.85 -46.2 3.17 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.84 ' HD3' HG23 ' A' ' 131' ' ' ILE . 85.2 Cg_endo -85.68 107.67 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 120.651 1.268 . . . . 0.0 111.07 173.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -24.69 64.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.263 0.554 . . . . 0.0 110.528 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.56 3.52 15.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.374 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.499 HG13 HD23 ' A' ' 95' ' ' LEU . 2.4 p -77.9 -8.76 11.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.267 0.556 . . . . 0.0 110.733 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mm -86.2 96.14 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 pt -64.12 -32.99 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.137 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -144.68 136.3 25.61 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.024 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.1 mtmt -111.42 129.08 56.13 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.328 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -140.98 160.46 40.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.541 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 tt -135.93 150.3 49.25 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 145' ' ' ASN . 21.2 tt -140.84 147.93 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.801 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.28 103.4 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.791 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.45 HD13 ' HG2' ' A' ' 88' ' ' GLU . 20.2 mm 61.56 85.53 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.242 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.698 ' HB2' HD11 ' A' ' 142' ' ' ILE . 25.5 t30 -65.26 -37.71 88.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.649 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.2 mt -131.92 172.68 12.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.212 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.88 -41.48 67.95 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.325 0.583 . . . . 0.0 110.049 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -132.99 177.23 7.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 51.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.395 0.617 . . . . 0.0 109.991 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 130.46 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -83.11 -19.54 36.52 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.501 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -134.7 151.98 51.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.903 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.838 178.519 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.18 85.1 0.81 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.024 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -113.63 3.56 15.71 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' HA ' ' H ' ' A' ' 97' ' ' ARG . 38.0 p90 39.73 -170.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.688 1.195 . . . . 0.0 113.54 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -147.33 160.59 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.21 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.488 ' OH ' HD13 ' A' ' 92' ' ' ILE . 7.4 t80 -121.19 129.56 53.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.628 -170.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.53 HH11 HG12 ' A' ' 69' ' ' ILE . 18.0 ttt180 -140.95 155.12 46.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.92 158.07 16.65 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.931 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.826 HG23 ' HB3' ' A' ' 91' ' ' TYR . 1.1 tt -139.07 129.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.122 0.487 . . . . 0.0 110.468 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.14 -2.04 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 109.378 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 35.93 1.82 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.659 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -56.74 -32.73 65.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.444 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.56 -38.76 77.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.814 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 -45.75 92.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.909 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.03 -52.2 66.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.42 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.49 -27.63 66.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -71.74 -40.96 69.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -85.13 -28.4 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.87 51.32 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.494 ' HG2' ' N ' ' A' ' 21' ' ' LEU . 4.1 tt0 174.44 158.36 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.528 0.731 . . . . 0.0 109.498 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' N ' ' HG2' ' A' ' 20' ' ' GLN . 54.0 mt -65.02 97.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.86 154.31 0.14 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.803 0.69 . . . . 0.0 110.645 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.97 167.2 26.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.765 2.31 . . . . 0.0 112.483 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -108.98 141.27 41.32 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.074 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.435 ' HA3' HG21 ' A' ' 45' ' ' THR . . . -112.07 -152.31 11.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.454 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' THR . 56.3 t30 -128.54 136.29 50.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -62.19 132.47 52.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.519 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.01 112.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.821 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' ' H ' ' A' ' 42' ' ' GLY . 2.6 tp10 -114.55 131.87 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.891 0.377 . . . . 0.0 110.934 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.89 5.99 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.875 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.07 -147.41 0.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' A' ' 52' ' ' ASN . 23.0 mt 75.55 104.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 123.658 0.783 . . . . 0.0 111.418 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -137.05 -45.61 0.57 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.508 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER 67.49 124.79 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.277 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.16 -18.52 65.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.7 4.77 81.23 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.136 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 52.04 58.35 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.65 -41.36 21.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.422 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.27 88.78 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.2 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HE1' ' HB2' ' A' ' 34' ' ' TYR . 4.0 p90 -140.16 31.44 1.96 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.557 0.694 . . . . 0.0 109.624 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.49 148.08 25.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.805 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' H ' ' HG2' ' A' ' 29' ' ' GLU . . . 151.24 -58.41 0.43 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.032 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' NZ ' HD11 ' A' ' 131' ' ' ILE . 58.0 tttt -132.54 116.89 17.29 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.861 -0.199 . . . . 0.0 111.347 -172.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.27 141.75 0.33 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.78 0.675 . . . . 0.0 109.453 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.435 HG21 ' HA3' ' A' ' 25' ' ' GLY . 35.6 m -69.26 152.7 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.017 0.437 . . . . 0.0 111.537 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -77.84 67.18 3.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.954 174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.97 -173.11 49.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.723 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.05 -22.48 41.41 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.942 2.428 . . . . 0.0 111.669 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 m -149.72 -107.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 51' ' ' LYS . 1.8 t 54.51 -174.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.573 0.349 . . . . 0.0 110.53 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.718 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER 57.74 -154.23 0.36 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 111.832 173.027 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.578 ' HB2' ' HA ' ' A' ' 32' ' ' ILE . 1.2 t30 -59.66 -27.24 66.21 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.845 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.44 -60.23 4.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.528 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.8 p -63.35 -35.4 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.509 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.1 m-85 -59.88 -63.17 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.573 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.2 -46.33 79.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.175 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -62.05 -46.28 89.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 0.0 111.007 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 1.3 pt20 -70.05 -30.26 67.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.316 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 ' HG3' ' A' ' 58' ' ' GLN . 1.2 mp -81.21 -47.39 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.661 0.267 . . . . 0.0 110.722 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.79 -57.18 5.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.004 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.403 ' HB ' HD23 ' A' ' 63' ' ' LEU . 11.7 m -74.67 -26.35 59.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.03 78.83 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.222 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 65' ' ' ASP . 0.8 OUTLIER -65.68 -33.38 75.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.174 -178.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 t80 33.74 46.87 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.795 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.523 ' H ' HD12 ' A' ' 63' ' ' LEU . 37.4 t70 -90.4 -0.27 57.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 109.408 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.07 144.81 46.67 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.417 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 p -71.21 0.77 7.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -65.31 158.79 25.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.53 HG12 HH11 ' A' ' 7' ' ' ARG . 18.1 mt -102.75 138.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.95 131.0 42.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 172.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 5' ' ' LEU . 96.9 m -140.8 110.1 6.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 3.4 m -68.97 152.85 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.103 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 10.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -136.96 142.4 42.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.526 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -54.47 -19.81 6.44 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.733 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.21 -31.21 13.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.862 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -48.07 -31.08 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.27 -54.72 40.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -45.41 62.93 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.765 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -58.52 -49.18 78.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.352 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 7' ' ' ARG . 27.2 t80 -67.48 -49.22 64.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.475 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -55.57 -47.11 76.96 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.507 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -75.91 -39.32 56.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.814 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.3 m -72.69 -20.15 61.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -96.62 3.66 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.5 76.03 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.655 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 82' ' ' ALA . 4.6 mt -72.97 -7.26 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.8 mt-10 -28.68 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -126.46 99.97 6.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.997 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.49 -139.97 5.34 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.77 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.826 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.2 t80 -124.47 150.88 45.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.3 pt -136.84 142.54 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 111.103 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -132.63 135.11 45.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 111.704 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 m -113.92 139.3 40.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.564 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -125.97 142.04 51.7 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.124 -173.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.447 ' HB2' HG21 ' A' ' 137' ' ' ILE . 30.4 t30 -79.68 124.59 28.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.815 0.341 . . . . 0.0 111.139 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.588 ' HB2' HD23 ' A' ' 5' ' ' LEU . 46.9 ttt180 -75.64 -32.76 60.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.49 79.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 135' ' ' VAL . 9.6 tp -65.27 -37.73 88.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.793 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 22.6 m-85 -62.07 -42.71 99.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.761 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.13 -36.25 92.07 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.655 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.62 -48.3 69.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.133 0.492 . . . . 0.0 109.901 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -66.43 -16.45 64.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.584 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m 67.69 30.84 6.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.37 0.605 . . . . 0.0 110.291 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 124' ' ' ARG . 3.5 mt -68.91 152.2 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.778 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.32 101.42 10.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 111.187 -166.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -106.36 120.65 42.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.954 0.407 . . . . 0.0 110.097 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -115.74 120.08 38.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.712 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 tt0 -91.44 132.81 35.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 111.233 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 m -117.75 149.16 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.774 171.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.62 135.14 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 110.631 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -79.44 178.06 2.54 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.7 Cg_exo -50.08 158.01 2.55 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.229 1.286 . . . . 0.0 111.427 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.54 -70.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 31.6 t30 -88.88 -9.7 0.14 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -166.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 68.0 Cg_exo -47.26 -24.32 3.7 Favored 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.535 1.584 . . . . 0.0 110.716 161.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 t30 70.58 32.29 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.032 169.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.72 105.09 13.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.395 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -104.56 107.33 18.22 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.47 125.7 48.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 19.1 t -116.75 106.46 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.37 116.48 22.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.758 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.476 HG13 HD22 ' A' ' 5' ' ' LEU . 9.5 mm -87.77 110.82 21.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.82 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.525 ' O ' HG23 ' A' ' 105' ' ' ILE . 1.4 mtt-85 -111.96 106.77 15.55 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.816 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.91 162.3 28.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.64 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.34 -24.83 67.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.332 0.586 . . . . 0.0 110.376 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.24 162.42 33.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.236 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.3 t -80.44 144.39 32.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.47 32.19 14.23 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.529 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.7 m 57.48 68.49 0.84 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.256 0.551 . . . . 0.0 110.537 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.851 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -46.56 -49.89 43.71 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.959 -175.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.851 ' HD3' HG23 ' A' ' 131' ' ' ILE . 93.9 Cg_endo -88.44 107.73 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.33 1.353 . . . . 0.0 112.118 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -76.83 2.15 15.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.108 0.48 . . . . 0.0 110.763 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -90.36 -15.37 31.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.727 ' HA ' HD23 ' A' ' 99' ' ' LEU . 4.0 p -81.58 -14.05 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 139' ' ' LYS . 1.1 tt -87.65 97.54 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.447 HG21 ' HB2' ' A' ' 96' ' ' ASN . 40.0 pt -75.45 -29.65 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.63 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -151.7 146.17 25.58 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.634 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.64 ' HB3' HD11 ' A' ' 136' ' ' ILE . 45.7 pttt -150.32 130.18 13.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.765 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.68 160.7 39.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.889 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 tt -75.74 145.98 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.453 ' HB ' HG12 ' A' ' 92' ' ' ILE . 20.4 tt -125.3 141.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 0.0 110.214 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -149.17 126.6 11.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.552 -177.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 5.1 tt -45.97 93.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 124.183 0.927 . . . . 0.0 108.952 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 179.83 -37.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.938 -165.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tt 71.24 107.43 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.01 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 61.16 7.58 1.67 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.834 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 20.62 5.12 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.633 0.373 . . . . 0.0 110.324 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.8 p80 25.47 56.04 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.423 1.089 . . . . 0.0 112.525 -172.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -177.24 -71.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.043 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 47.31 62.38 2.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.106 0.479 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -68.99 115.26 8.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.823 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.332 178.52 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 mmm . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.99 -173.52 13.36 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.096 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.46 ' HB3' ' HG3' ' A' ' 97' ' ' ARG . 53.0 t30 -61.02 159.04 12.25 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.03 125.71 35.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.272 -175.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 3.9 mp -100.64 152.39 20.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.81 133.54 36.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.344 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.662 ' HG3' HH11 ' A' ' 7' ' ' ARG . 0.9 OUTLIER -147.69 130.1 15.75 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.503 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -125.23 157.17 19.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.011 -176.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.25 128.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -15.6 18.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.252 0.549 . . . . 0.0 110.214 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -83.34 60.82 5.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.48 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -27.26 19.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -49.33 28.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.449 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.6 OUTLIER -56.65 -43.2 80.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.204 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -73.76 -33.01 64.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.438 -177.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -79.46 -16.71 55.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.495 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.12 -40.08 24.62 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -89.15 -65.48 1.01 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.88 41.73 8.03 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.55 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -175.53 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 17.8 mt 53.07 42.62 32.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.52 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp 44.6 74.84 0.73 Allowed Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 123.127 0.571 . . . . 0.0 112.178 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -84.37 161.78 13.0 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.796 2.331 . . . . 0.0 112.947 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.656 ' HG2' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -165.48 149.79 8.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.736 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.96 166.99 23.24 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.383 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.57 179.61 1.71 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.543 0.337 . . . . 0.0 110.337 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 9.0 mptt -74.22 145.96 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -173.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.96 -69.68 0.66 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.752 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 171.66 -157.44 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.193 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.1 75.28 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.206 0.527 . . . . 0.0 109.836 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.21 6.36 49.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.83 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mt -134.75 117.93 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.546 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -145.79 76.26 1.46 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 21.2 m-30 -85.27 -106.72 0.05 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -170.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -156.19 -141.78 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.455 -0.153 . . . . 0.0 110.921 -168.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.39 142.56 42.8 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.724 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 59.55 23.64 12.33 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.938 0.495 . . . . 0.0 110.833 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 20.0 m-85 -129.17 40.63 3.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.957 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 77.53 0.11 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.566 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' OH ' ' HA ' ' A' ' 126' ' ' GLU . 21.0 t80 -155.27 111.78 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.441 -174.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -19.28 57.49 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.85 -71.28 0.27 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.129 -0.558 . . . . 0.0 111.793 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt 66.11 -71.82 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.551 . . . . 0.0 110.322 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 127' ' ' ASP . . . -94.15 129.8 40.6 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -158.48 36.45 0.23 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.281 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -118.2 3.58 11.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.526 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.64 -166.38 4.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.679 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.656 ' HD3' ' HG2' ' A' ' 24' ' ' LYS . 42.3 Cg_endo -65.72 -48.36 3.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.569 2.179 . . . . 0.0 112.036 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -144.08 134.69 24.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.637 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -135.76 -163.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.512 ' H ' HG12 ' A' ' 50' ' ' VAL . 33.9 mttm 55.39 -157.04 0.24 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.764 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.444 ' H ' ' HB3' ' A' ' 51' ' ' LYS . 4.3 m-20 -61.33 -23.81 65.99 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.452 -176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.85 -61.02 2.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.353 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.94 -30.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.032 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -61.88 -50.43 72.27 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.87 88.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.331 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -56.12 -46.62 79.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.262 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.506 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 2.0 tt0 -59.88 -56.08 26.18 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.427 -176.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -74.46 -33.67 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.667 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.47 -63.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.395 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -84.28 -45.33 12.95 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.066 0.46 . . . . 0.0 111.451 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.02 108.78 2.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.068 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -123.06 52.06 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 109.761 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -91.07 38.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.174 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -77.83 -24.09 48.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.99 -14.74 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.017 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.502 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -55.64 -55.73 28.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.499 0.19 . . . . 0.0 110.827 177.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 16.5 m-85 -127.81 154.45 45.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.21 102.89 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.017 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.14 132.42 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.394 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -135.54 108.53 7.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.19 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.16 164.23 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.23 -176.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -35.88 48.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -100.4 132.9 45.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -60.87 -19.65 60.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 16.6 tp10 -54.05 -18.06 3.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.06 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -44.52 -33.61 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.836 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.43 -66.89 0.34 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.154 0.502 . . . . 0.0 112.035 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.17 -37.51 78.22 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.334 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HG2' ' HG3' ' A' ' 76' ' ' GLU . 46.5 mmtm -63.86 -41.74 97.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.113 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.73 -46.46 72.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -57.25 -52.61 64.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.0 m -68.74 -50.63 49.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 m -68.06 -14.82 63.27 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' HG13 ' A' ' 87' ' ' ILE . 16.1 m -103.23 4.84 37.15 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.143 -0.348 . . . . 0.0 111.003 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.56 24.53 73.89 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.066 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 82' ' ' ALA . 6.9 mt -81.12 -8.09 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.509 0.195 . . . . 0.0 110.772 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' O ' HG12 ' A' ' 142' ' ' ILE . 16.9 mt-10 -37.58 -39.04 0.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.637 0.775 . . . . 0.0 112.866 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -109.86 87.64 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.74 -141.2 5.33 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.901 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -134.87 125.86 27.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.503 HG22 ' HA3' ' A' ' 8' ' ' GLY . 2.0 pt -119.89 147.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 2.8 p90 -130.44 148.58 52.27 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.278 0.561 . . . . 0.0 110.608 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.0 m -113.35 140.22 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.264 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.2 mp -119.59 143.16 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.597 ' HB3' HG21 ' A' ' 137' ' ' ILE . 6.7 t30 -102.55 133.74 47.03 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.683 ' HG2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -64.82 -42.82 94.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.045 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -34.02 65.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.213 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.09 -50.76 64.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.368 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.409 ' HD1' HG13 ' A' ' 105' ' ' ILE . 49.6 m-85 -68.4 -29.95 68.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.98 -47.24 91.35 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.475 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.92 79.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.062 0.458 . . . . 0.0 110.236 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -70.92 -20.16 62.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m 66.24 46.67 1.99 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.507 0.67 . . . . 0.0 110.569 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 125' ' ' ALA . 9.0 mm -79.31 152.15 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.078 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HB3' ' HG2' ' A' ' 124' ' ' ARG . 4.2 t80 -75.44 122.61 24.07 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 110.939 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -104.84 106.52 17.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.512 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -103.44 113.42 26.91 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.875 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.27 109.25 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.016 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -88.2 115.69 28.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 137.4 40.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.551 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.01 170.37 9.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.512 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 78.1 Cg_exo -50.21 157.1 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.377 1.384 . . . . 0.0 111.063 173.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.64 -57.73 5.8 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -168.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.463 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 38.5 t30 -91.51 -17.55 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -168.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 38.2 Cg_exo -42.23 -22.8 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.37 1.525 . . . . 0.0 111.808 164.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 115' ' ' ASN . 16.9 m-20 68.74 8.51 6.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.102 166.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -111.58 138.04 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -141.6 145.88 35.58 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 110' ' ' VAL . 1.7 tm-20 -122.12 125.08 45.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.98 95.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.5 m -87.08 113.88 23.21 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.572 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.637 HG13 HD21 ' A' ' 5' ' ' LEU . 48.6 mm -88.25 97.25 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.436 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.534 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.566 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -69.46 159.65 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.581 ' HB2' HD13 ' A' ' 131' ' ' ILE . 7.1 mp0 -50.81 -48.24 59.72 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 111.506 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.451 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 3.6 t0 -119.18 160.43 22.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 0.0 110.074 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.01 128.56 34.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.178 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.502 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 93.17 65.16 1.07 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.244 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.03 70.43 0.47 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 126' ' ' GLU . 7.4 tt -68.18 -37.24 10.57 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.649 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.564 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 59.3 Cg_endo -98.52 118.91 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.385 2.057 . . . . 0.0 111.808 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -7.31 53.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.276 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.21 6.91 23.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.193 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.552 ' HB ' HD23 ' A' ' 95' ' ' LEU . 6.0 m -60.31 -22.8 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.554 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.7 mt -87.63 88.22 2.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 109.866 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.597 HG21 ' HB3' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -79.91 -29.77 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.426 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.551 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -153.81 166.98 31.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.302 172.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.57 159.09 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.074 0.464 . . . . 0.0 110.879 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -141.14 140.75 34.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.019 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -95.09 149.63 21.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 88' ' ' GLU . 16.5 tt -140.99 141.64 31.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.518 . . . . 0.0 111.68 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.577 ' O ' ' HB ' ' A' ' 144' ' ' ILE . 4.8 tt0 -139.01 22.45 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.747 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 143' ' ' GLU . 10.3 tp 147.29 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.513 1.525 . . . . 0.0 109.096 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -100.18 88.53 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.5 tp -141.37 75.44 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 148' ' ' HIS . 2.4 mm-40 55.2 -105.78 0.29 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.812 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.446 ' H ' ' HB3' ' A' ' 147' ' ' GLU . 70.5 m-70 -112.13 142.16 44.93 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -83.25 95.16 8.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.804 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -65.99 91.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.438 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -74.26 73.18 1.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.835 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.25 175.11 6.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.693 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.203 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.92 -90.22 0.47 Allowed Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.418 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -151.6 169.24 22.59 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -109.49 156.47 20.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.718 0.294 . . . . 0.0 110.826 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.814 HD12 HG21 ' A' ' 71' ' ' THR . 0.2 OUTLIER -99.55 139.9 34.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -106.61 128.29 54.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.676 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 135.66 20.8 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -110.87 158.3 14.46 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.321 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.555 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 2.3 mt -113.89 129.32 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.762 0.425 . . . . 0.0 110.161 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.34 25.39 11.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.338 0.589 . . . . 0.0 109.899 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.795 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.89 58.98 0.79 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.916 -173.631 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 mp0 -51.15 -42.4 60.75 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.36 -32.79 73.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.051 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.795 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.4 m-20 -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.961 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -60.38 -45.35 93.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 109.666 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -62.71 -42.72 99.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.51 -43.36 97.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 110.499 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -71.94 -24.85 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.444 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.09 -10.84 72.74 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.262 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -172.6 172.73 4.18 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 mt -65.03 91.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.32 0.387 . . . . 0.0 110.602 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HE3' ' SG ' ' A' ' 128' ' ' CYS . 15.2 tptp 74.7 132.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.891 0.744 . . . . 0.0 110.746 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.01 132.64 18.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.298 1.998 . . . . 0.0 111.046 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 2.2 mmmm -84.16 142.16 30.53 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.662 0.267 . . . . 0.0 110.293 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.01 59.39 4.91 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.273 -0.489 . . . . 0.0 114.035 -172.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 45.92 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.293 0.637 . . . . 0.0 112.571 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.9 pttp -172.02 -172.74 1.02 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.732 0.413 . . . . 0.0 109.952 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HB1' HG22 ' A' ' 30' ' ' VAL . . . -179.19 -46.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 110.918 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 71.7 -18.27 0.31 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.377 0.671 . . . . 0.0 112.746 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.472 HG22 ' HB1' ' A' ' 28' ' ' ALA . 3.5 m -57.82 132.54 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.39 176.49 4.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.514 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.723 HG23 ' HA ' ' A' ' 51' ' ' LYS . 1.1 mm -111.94 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.94 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -76.08 69.68 2.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -67.7 122.17 17.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.372 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.87 76.11 0.89 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.302 0.572 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . 175.45 41.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.783 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 21.2 mtpp 74.47 -58.81 0.57 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.653 0.781 . . . . 0.0 111.918 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -70.44 81.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 111.484 -175.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.85 83.01 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.911 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CZ ' HG13 ' A' ' 32' ' ' ILE . 31.4 p90 -74.89 138.43 42.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 110.943 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -107.0 157.5 17.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.714 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.12 169.63 30.73 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.363 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' HZ2' ' HA ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -150.42 133.68 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.12 -55.52 13.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 111.01 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.33 -78.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.769 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -100.21 174.59 6.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.301 -178.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.14 70.39 0.07 OUTLIER Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.543 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.436 ' HG2' ' H ' ' A' ' 49' ' ' SER . 78.1 Cg_endo -84.51 -56.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.702 2.268 . . . . 0.0 112.314 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.436 ' H ' ' HG2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -89.27 53.44 2.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 -176.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.637 HG22 ' H ' ' A' ' 51' ' ' LYS . 14.8 p -114.63 -127.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.908 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.723 ' HA ' HG23 ' A' ' 32' ' ' ILE . 20.4 mtpp 59.59 -167.37 0.17 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.296 0.57 . . . . 0.0 112.059 174.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.83 -23.53 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.021 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.2 -60.68 3.23 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.85 -32.77 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.647 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -60.41 -51.4 69.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.37 78.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.79 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -58.19 -50.55 73.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.687 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.562 ' HG3' ' CD2' ' A' ' 68' ' ' TYR . 9.4 mm100 -55.39 -49.01 73.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 mt -74.53 -46.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.493 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -61.96 -48.24 81.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.074 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 3.6 m -77.59 -32.38 53.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.66 53.96 9.18 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.174 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' H ' HD12 ' A' ' 63' ' ' LEU . 2.7 mp -81.05 -75.87 0.26 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 52.28 39.4 27.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.431 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -90.73 -57.29 2.87 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.713 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.32 -60.4 0.17 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.24 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 74.1 m -51.76 -52.96 44.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.562 ' CD2' ' HG3' ' A' ' 58' ' ' GLN . 18.1 m-30 -120.51 145.05 47.68 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.85 128.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.3 m -87.6 130.82 34.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.814 HG21 HD12 ' A' ' 5' ' ' LEU . 13.4 m -127.74 137.77 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.461 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -88.14 148.01 24.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.453 178.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.77 10.47 3.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 0.0 111.377 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.75 121.99 28.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -63.0 -19.63 64.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 80' ' ' LYS . 6.9 pt-20 -90.13 0.34 57.21 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.66 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 72' ' ' THR . 5.0 tt -49.64 -29.83 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.775 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.66 -68.9 0.15 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.908 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -28.45 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . 9.7 tttp -56.23 -49.79 73.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.496 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.18 -49.47 50.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.741 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.9 68.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.485 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -73.74 -48.91 28.36 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.596 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -65.59 -21.37 66.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 m -95.47 0.38 53.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.05 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 31.01 72.43 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.831 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -8.8 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.639 -173.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 142' ' ' ILE . 31.1 mm-40 -40.27 -34.29 0.31 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.487 . . . . 0.0 112.101 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -112.26 96.76 6.2 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.45 -135.52 3.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.022 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.555 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.94 150.31 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.082 0.553 . . . . 0.0 109.609 -175.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.551 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 pt -142.97 133.08 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -131.72 154.97 48.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.1 0.476 . . . . 0.0 111.379 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 138' ' ' ALA . 32.9 m -129.84 136.63 58.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.459 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -113.64 141.95 46.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.809 -177.547 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.455 ' HB3' HG21 ' A' ' 137' ' ' ILE . 3.3 p30 -83.8 143.4 29.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.56 -27.98 21.04 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.689 0.28 . . . . 0.0 111.073 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.0 -33.51 62.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -61.44 -41.57 97.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.064 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 22.6 m-85 -71.11 -41.23 70.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.22 91.08 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.05 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -74.73 -43.45 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.0 109.576 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.06 -25.22 66.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.569 -177.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m 67.21 28.63 8.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 110.046 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -66.43 164.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.294 176.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.78 ' HB3' ' HB2' ' A' ' 124' ' ' ARG . 4.0 t80 -73.45 99.35 2.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.293 0.568 . . . . 0.0 110.381 -167.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -95.3 100.02 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.012 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 4.1 t80 -124.73 113.47 18.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -97.64 142.14 29.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.81 132.07 49.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.491 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 6.5 pt-20 -129.57 136.13 49.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.084 0.468 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 178.06 2.63 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.736 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.76 171.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.028 1.819 . . . . 0.0 112.28 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.9 -67.87 0.23 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 61.4 t30 -86.15 -11.08 0.17 Allowed Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -166.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 43.7 Cg_exo -42.35 -25.48 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 121.439 1.55 . . . . 0.0 111.271 162.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.9 3.8 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.656 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.74 130.72 53.26 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 111.646 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 111' ' ' GLU . 17.6 ptmt -150.97 141.62 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.763 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -122.62 132.91 54.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.91 112.42 25.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.924 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 2.7 m -88.78 114.9 25.9 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.779 0.324 . . . . 0.0 110.383 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pt -87.45 113.4 24.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.78 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 23.1 mtt-85 -114.91 88.51 2.88 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.744 -172.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.664 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.87 123.23 20.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.583 172.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -51.77 -46.43 64.12 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.386 0.429 . . . . 0.0 111.637 -168.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.704 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 2.0 t70 -80.21 122.66 27.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.567 ' SG ' ' HE3' ' A' ' 22' ' ' LYS . 7.4 t -54.02 119.56 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.459 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.94 56.89 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.936 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.8 m 63.26 74.82 0.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.704 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 19.3 tt -45.44 -35.27 3.08 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.623 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 91.9 Cg_endo -96.42 109.1 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 121.595 1.53 . . . . 0.0 111.592 169.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -63.8 -22.78 67.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.392 0.615 . . . . 0.0 109.842 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.21 -7.68 43.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.556 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.3 p -77.26 -15.25 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.078 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.86 89.96 3.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.455 HG21 ' HB3' ' A' ' 96' ' ' ASN . 14.5 pt -74.74 -30.62 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.275 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -150.0 148.14 28.69 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.41 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -143.94 127.74 17.26 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.323 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -131.11 152.23 50.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.273 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.57 150.07 23.78 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.7 tt -140.19 135.41 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -120.84 42.82 2.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.241 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.8 mt 70.34 94.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.483 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -30.01 70.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.621 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 129.0 38.59 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.915 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 140.55 58.77 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.537 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -129.88 66.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.41 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.99 57.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.036 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -166.28 42.11 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.387 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.6 m170 53.49 -97.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.932 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -152.17 15.45 0.62 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.289 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.129 -177.479 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.849 0.357 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.91 43.86 32.8 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.357 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.54 65.49 9.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.03 155.47 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.261 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.545 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -100.29 146.09 27.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.14 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.537 ' HE1' ' HB ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -113.57 130.96 56.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.744 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HG3' HG22 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -138.25 126.78 23.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.653 178.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -109.6 157.84 14.86 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -129.94 132.66 65.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 -177.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -22.22 19.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.401 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -84.8 49.03 1.64 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.499 -177.004 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.53 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -57.78 -26.11 61.46 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 2.2 pt20 -63.43 -41.48 98.68 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.848 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -69.65 -41.46 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.677 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.93 -55.86 29.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -63.24 -39.51 94.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.072 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.59 -37.33 87.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 110.448 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -23.98 37.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 65.78 14.5 60.79 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 13.2 mt-30 -156.38 172.87 17.76 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.11 42.29 0.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.822 0.344 . . . . 0.0 110.751 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 45.61 59.23 15.03 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.16 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.91 171.71 9.21 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.95 2.433 . . . . 0.0 113.177 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -135.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.087 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . 94.05 99.0 1.58 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.136 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.43 -9.82 40.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 0.0 110.407 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 71.83 115.0 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.577 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.627 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . . . -139.5 5.91 2.26 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.646 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.421 ' CD ' HH22 ' A' ' 33' ' ' ARG . 0.3 OUTLIER -64.11 128.9 37.82 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.35 0.595 . . . . 0.0 110.968 -178.402 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -164.59 -39.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.297 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.2 17.68 4.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -76.84 76.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.408 0.623 . . . . 0.0 110.565 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.421 HH22 ' CD ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.12 -11.45 14.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.779 -177.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.5 t80 75.77 -42.36 0.46 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.705 0.802 . . . . 0.0 112.307 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -62.3 -13.99 34.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.796 0.331 . . . . 0.0 111.348 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.93 31.39 5.63 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 tptm 69.48 -79.16 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.384 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.44 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -168.76 -99.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? 57.78 22.82 8.9 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.023 0.439 . . . . 0.0 111.71 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -83.28 60.95 5.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.272 0.558 . . . . 0.0 109.733 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.02 77.65 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.899 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 47' ' ' GLY . . . 64.17 -159.38 40.68 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.299 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HG2' ' HB2' ' A' ' 28' ' ' ALA . 20.3 mttt -93.3 52.27 1.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 70.07 -68.75 0.19 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.821 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -70.51 -50.23 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.717 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -131.55 149.8 52.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.335 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.34 61.1 0.3 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.519 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -85.73 -8.37 8.21 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -144.86 163.2 34.83 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 51' ' ' LYS . 1.4 t 51.95 -160.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.176 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.744 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 52.9 -146.2 0.54 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.02 0.528 . . . . 0.0 111.605 172.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 38' ' ' PHE . 1.8 t30 -53.79 -34.87 60.48 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.6 -57.04 12.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.897 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.6 -34.37 69.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.507 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -58.4 -64.22 1.0 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.109 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.86 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.23 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.692 ' HB3' HD22 ' A' ' 63' ' ' LEU . 1.1 t-80 -64.92 -49.65 69.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.355 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 35.9 tt0 -66.1 -38.1 87.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.1 -34.4 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.7 -74.22 0.42 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.836 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -64.41 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.484 0.659 . . . . 0.0 111.441 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 58' ' ' GLN . . . 133.75 158.99 8.82 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 57' ' ' HIS . 2.6 pt? -175.96 -44.49 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.066 0.433 . . . . 0.0 111.233 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.435 ' CE2' ' SG ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -114.35 89.26 3.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.752 -174.508 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.56 134.86 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.725 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.4 -7.56 81.72 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.369 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -73.45 -35.63 65.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.19 0.519 . . . . 0.0 110.58 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.53 160.75 30.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.783 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.731 HG12 ' HB ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -105.06 100.69 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -175.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HG23 ' A' ' 122' ' ' THR . 0.0 OUTLIER -85.95 125.23 33.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.611 176.003 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.644 HG23 HD12 ' A' ' 77' ' ' ILE . 97.3 m -137.44 148.56 46.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 110.541 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.38 170.55 9.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -177.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.21 4.74 9.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.53 135.92 47.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.332 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -66.35 -23.35 66.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.84 -16.13 62.69 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.74 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.644 HD12 HG23 ' A' ' 71' ' ' THR . 0.0 OUTLIER -48.39 -34.27 5.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 123.387 0.43 . . . . 0.0 110.977 176.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.46 -53.99 51.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 79' ' ' LYS . 24.1 ttpt -75.11 -40.35 59.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.888 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -59.5 -52.3 66.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.04 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 1.4 t80 -64.74 -45.84 84.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.469 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -52.36 -59.15 4.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.272 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -64.5 -39.13 93.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -66.71 -26.66 67.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.685 0.279 . . . . 0.0 111.429 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -90.09 2.05 55.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.84 0.352 . . . . 0.0 110.478 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.34 33.36 84.26 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.538 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.63 HD12 HG21 ' A' ' 142' ' ' ILE . 1.8 pp -65.44 -9.96 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -29.22 -50.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.181 0.925 . . . . 0.0 112.323 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -118.36 89.66 3.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.48 -149.58 10.25 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.989 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.53 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 6.7 t80 -115.92 145.44 42.9 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.733 0.413 . . . . 0.0 110.524 -175.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.537 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 1.9 pt -143.54 129.46 16.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.42 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 15.5 p90 -130.71 144.36 51.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.102 0.477 . . . . 0.0 111.232 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.787 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.95 135.94 46.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.164 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -118.15 130.34 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.131 177.304 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.618 ' HB3' HD12 ' A' ' 99' ' ' LEU . 59.3 t30 -79.8 141.68 36.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.576 0.227 . . . . 0.0 111.011 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 100' ' ' PHE . 16.2 ttt180 -80.07 -50.95 9.63 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.63 -22.46 65.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 111.088 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 96' ' ' ASN . 18.8 mt -64.15 -37.43 87.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.446 ' CE1' HG11 ' A' ' 135' ' ' VAL . 49.8 m-85 -63.28 -44.27 95.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.698 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.73 -37.47 83.84 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -66.61 -36.64 83.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 110.499 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -83.94 -7.87 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.173 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.0 m 69.56 34.67 2.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.27 0.557 . . . . 0.0 110.791 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.589 HG13 ' HA ' ' A' ' 125' ' ' ALA . 1.2 mp -74.22 157.18 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.919 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -77.12 101.22 6.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.114 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.81 99.96 12.87 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.401 ' HE2' ' HZ ' ' A' ' 38' ' ' PHE . 1.2 t80 -104.65 113.36 26.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.06 126.21 54.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 120' ' ' GLU . 3.7 m -108.26 132.01 57.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -111.65 133.77 53.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.577 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.83 174.55 5.76 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 84.5 Cg_exo -48.37 170.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.447 2.098 . . . . 0.0 113.25 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -40.79 -71.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 47.6 t30 -100.13 -9.17 0.13 Allowed Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 47.4 Cg_exo -42.34 -26.98 0.63 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 CA-C-N 121.846 1.695 . . . . 0.0 111.09 165.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.65 26.45 9.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.386 168.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 116' ' ' PRO . 89.8 mt-10 -114.39 118.09 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -124.83 112.59 16.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 110' ' ' VAL . 8.5 tt0 -96.26 106.16 18.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 109.991 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.56 95.86 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.618 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 70' ' ' SER . 0.2 OUTLIER -81.07 107.11 13.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.175 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 69' ' ' ILE . 23.0 mm -87.85 106.68 16.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 105' ' ' ILE . 37.7 mtt85 -104.46 119.12 38.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.241 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.589 ' HA ' HG13 ' A' ' 105' ' ' ILE . . . -68.9 155.31 40.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.934 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.79 -49.4 62.78 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.313 0.578 . . . . 0.0 110.098 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.575 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.2 t0 -122.35 156.09 34.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.991 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.435 ' SG ' ' CE2' ' A' ' 64' ' ' TYR . 20.5 t -73.07 150.28 42.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 111.236 -175.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.61 51.87 2.97 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.098 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 41.62 70.34 0.28 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.865 0.466 . . . . 0.0 112.243 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -56.17 -48.5 96.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.755 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.842 ' HD3' HG23 ' A' ' 131' ' ' ILE . 87.1 Cg_endo -100.31 109.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.591 2.194 . . . . 0.0 112.395 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -77.37 -0.48 25.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.665 0.269 . . . . 0.0 111.301 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -87.81 -5.33 58.67 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.291 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 95' ' ' LEU . 30.9 m -76.21 -17.25 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.84 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.3 pt -86.11 89.89 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.738 0.78 . . . . 0.0 109.378 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.61 -31.06 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.305 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -142.18 146.21 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.415 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -151.66 114.92 4.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.856 177.467 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.61 160.5 39.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.65 156.63 16.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.034 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.63 HG21 HD12 ' A' ' 87' ' ' ILE . 13.8 tt -134.16 137.76 51.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 146' ' ' LEU . 4.4 tm-20 -119.83 90.43 3.33 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.028 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.7 pt 37.7 -133.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.528 0.731 . . . . 0.0 111.49 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -88.73 56.59 3.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.048 0.451 . . . . 0.0 110.04 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -58.9 150.84 23.12 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.94 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -3.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 172.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 71.89 47.66 0.31 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.845 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -161.39 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.506 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 51.49 -163.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.091 0.556 . . . . 0.0 111.932 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -121.96 150.03 42.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -98.56 118.77 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.501 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.74 138.43 3.16 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -161.91 163.59 29.05 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -116.07 150.46 37.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.212 0.53 . . . . 0.0 111.577 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.1 OUTLIER -100.53 151.35 21.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.97 132.57 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -173.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 7' ' ' ARG . 27.6 ttt-85 -140.15 99.39 3.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.406 0.622 . . . . 0.0 109.41 171.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.611 ' H ' ' HE2' ' A' ' 81' ' ' PHE . . . -89.13 154.74 24.67 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 39.0 mt -121.16 133.24 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.823 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -122.37 17.68 10.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.47 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.61 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -123.5 46.68 2.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.646 -179.622 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -54.02 -29.79 45.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.752 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -63.99 -42.29 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.073 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -69.13 -45.29 70.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.068 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -38.6 83.44 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.205 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -69.74 -41.98 74.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.9 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.97 -41.25 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -80.41 -27.21 38.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 6.79 85.64 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -164.49 178.37 7.46 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 136' ' ' ILE . 12.6 mt -80.11 61.08 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.079 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 32.76 71.91 0.65 Allowed Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.397 1.079 . . . . 0.0 113.047 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.54 169.85 8.02 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.002 2.468 . . . . 0.0 112.258 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -126.26 -54.3 1.48 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.811 177.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.27 5.09 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.883 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -93.42 119.03 32.05 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.07 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' H ' ' A' ' 43' ' ' LYS . . . -171.09 -138.06 0.02 OUTLIER 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.681 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.0 144.28 30.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.995 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.78 124.48 9.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.54 34.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 110.212 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.68 HG23 ' HE2' ' A' ' 51' ' ' LYS . 41.0 mt -128.57 138.74 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.549 -176.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 10.6 mmp_? -111.3 149.26 31.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.789 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.581 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -164.55 -166.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.246 175.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.51 71.02 3.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.033 0.444 . . . . 0.0 111.607 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.25 -80.19 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.618 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -56.27 -29.08 60.67 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . 3.4 m-85 -72.0 85.3 0.99 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.779 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.764 ' HE2' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -84.93 88.98 7.48 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.179 0.514 . . . . 0.0 111.331 -179.472 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 38' ' ' PHE . 67.4 m-85 -78.57 109.58 12.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.17 -20.43 32.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.573 0.225 . . . . 0.0 111.24 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.46 174.66 20.59 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.868 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 28' ' ' ALA . 11.4 pttp -157.78 -170.51 3.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.643 ' HB3' ' HA ' ' A' ' 49' ' ' SER . . . -135.93 -173.68 3.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.5 m -49.29 134.22 18.62 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.443 0.465 . . . . 0.0 111.656 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -63.59 132.24 50.56 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.6 -82.33 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 74.2 Cg_endo -70.21 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.904 2.402 . . . . 0.0 110.551 173.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.643 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 0.2 OUTLIER 67.62 162.17 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.225 0.535 . . . . 0.0 111.85 171.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 p -67.86 -55.27 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.55 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.68 ' HE2' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -53.44 -60.33 3.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.712 0.292 . . . . 0.0 111.17 -175.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 5.2 m-20 -50.99 -59.57 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.151 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.29 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.265 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 50' ' ' VAL . 2.8 p -64.25 -37.35 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.516 -171.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.7 m-85 -77.58 -42.4 35.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.538 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.66 75.44 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 109.976 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.16 -48.72 69.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 62' ' ' GLY . 1.4 tt0 -57.98 -29.79 65.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.954 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.7 mt -93.56 -52.78 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.337 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -77.13 -49.56 14.96 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.828 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.98 -32.88 24.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.104 0.478 . . . . 0.0 111.244 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 58' ' ' GLN . . . 134.59 172.11 12.71 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 70' ' ' SER . 84.3 mt -58.83 -15.3 11.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 111.507 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 74.31 -28.0 0.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 164.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.79 101.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.999 0.428 . . . . 0.0 111.664 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.49 -112.8 0.31 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.776 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.4 p -76.99 -34.88 57.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.765 -177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -83.15 145.61 29.11 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.731 HD12 HD11 ' A' ' 123' ' ' ILE . 21.4 mt -117.94 128.06 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.39 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.638 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.3 p -95.22 113.95 25.68 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.541 HG21 ' HB2' ' A' ' 5' ' ' LEU . 7.8 p -122.77 144.43 49.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.622 0.249 . . . . 0.0 110.801 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.0 m -87.81 150.2 23.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.831 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -16.06 62.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -79.35 135.52 36.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.858 0.361 . . . . 0.0 110.519 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -62.41 -20.9 64.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -72.63 -4.19 29.44 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.4 tt -51.29 -34.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.326 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.5 -58.91 6.52 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.151 0.5 . . . . 0.0 111.068 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.31 -43.52 70.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.058 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.95 -44.54 94.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.225 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.611 ' HE2' ' H ' ' A' ' 8' ' ' GLY . 87.5 t80 -65.98 -55.37 17.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.003 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.43 73.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.671 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -72.73 -45.91 56.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.604 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.1 m -70.7 -17.15 62.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.6 m -92.9 -4.2 53.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.555 0.217 . . . . 0.0 111.001 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 37.6 95.23 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' HA ' HD13 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -90.88 -8.8 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.365 -0.417 . . . . 0.0 111.653 -171.862 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -42.37 -32.75 0.55 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -119.13 90.79 3.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.49 -145.97 8.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.375 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -107.68 146.79 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.252 0.221 . . . . 0.0 110.458 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 mt -138.68 118.44 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.406 ' OH ' ' HD3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -131.89 143.4 50.13 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.75 173.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.4 m -120.75 149.38 23.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-O 121.275 0.56 . . . . 0.0 111.123 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.662 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -122.92 134.91 54.34 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.523 -174.628 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.565 ' HB2' HD13 ' A' ' 137' ' ' ILE . 31.0 t30 -87.22 115.75 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.714 0.292 . . . . 0.0 110.944 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.44 -30.08 70.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -63.21 -36.37 83.43 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 134' ' ' GLU . 32.2 tp -69.14 -40.41 78.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -62.5 -34.74 77.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.388 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.74 -39.94 98.0 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.519 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -63.55 -42.1 98.39 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.085 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.481 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 19.4 m-85 -74.07 -16.94 61.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.964 0.412 . . . . 0.0 110.339 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.764 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 2.5 m 65.42 33.8 8.6 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.101 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 125' ' ' ALA . 75.3 mt -63.23 147.79 11.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.234 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.63 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 1.6 m-85 -75.21 150.13 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 0.0 110.642 -167.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.25 118.05 8.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.585 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.509 ' HB2' ' HZ ' ' A' ' 38' ' ' PHE . 72.6 t80 -127.52 117.58 22.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.619 ' HG2' HG22 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -92.5 133.24 36.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.84 -177.476 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -97.91 134.11 37.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -96.71 133.06 41.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.362 0.601 . . . . 0.0 111.209 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.87 171.81 11.55 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 168.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.5 Cg_exo -46.63 164.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.824 1.682 . . . . 0.0 112.136 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -47.56 -67.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 5.5 t-20 -87.18 -13.69 0.2 Allowed Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -167.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 31.5 Cg_exo -42.59 -23.63 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 121.454 1.555 . . . . 0.0 111.774 163.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.41 23.67 9.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.895 170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.11 134.87 54.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.88 -172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -125.39 106.57 9.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.065 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.582 ' HB3' HG22 ' A' ' 110' ' ' VAL . 2.7 tp10 -79.29 91.92 5.08 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 110.201 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 109' ' ' GLU . 17.5 t -73.43 98.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.565 HG21 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -84.16 114.84 22.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.731 HD11 HD12 ' A' ' 69' ' ' ILE . 1.6 pp -86.45 129.66 37.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 109.463 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.63 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.32 108.08 14.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.731 -173.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.575 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -78.45 161.11 27.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.405 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 -6.27 42.3 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.865 0.364 . . . . 0.0 110.455 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 3.9 t70 -153.48 159.71 42.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 m -85.85 133.51 33.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.899 0.381 . . . . 0.0 111.235 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.38 49.68 2.96 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.447 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.444 ' HB3' HG11 ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.76 70.3 0.66 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.816 0.341 . . . . 0.0 111.672 173.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -61.61 -45.7 93.62 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.816 ' HD3' HG23 ' A' ' 131' ' ' ILE . 59.1 Cg_endo -70.91 129.95 17.18 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.436 1.424 . . . . 0.0 112.096 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -64.14 -24.92 67.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.046 0.45 . . . . 0.0 110.881 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HB3' HD21 ' A' ' 99' ' ' LEU . 3.7 mp0 -88.74 10.63 20.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.662 HG22 HD23 ' A' ' 95' ' ' LEU . 10.0 p -59.31 -31.61 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.937 0.399 . . . . 0.0 111.646 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.418 HG12 HD11 ' A' ' 21' ' ' LEU . 10.8 mt -89.17 88.2 2.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.565 HD13 ' HB2' ' A' ' 96' ' ' ASN . 1.1 pt -79.36 -28.4 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.958 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -146.98 141.55 26.57 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.633 171.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.09 124.92 19.7 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.773 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.8 157.14 45.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.74 146.47 36.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.19 135.45 54.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 0.0 111.492 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.94 51.64 2.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.947 177.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.1 mt 70.56 -66.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.327 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.1 t30 54.2 77.84 0.18 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.328 0.585 . . . . 0.0 110.815 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -50.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.65 150.18 43.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.61 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -106.6 11.41 30.53 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.485 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 65.14 53.4 1.35 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.835 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -48.64 -43.57 36.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.69 143.12 49.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.972 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -77.77 -37.44 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.077 0.465 . . . . 0.0 110.203 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.348 177.52 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.633 ' HB2' ' HD2' ' A' ' 97' ' ' ARG . 5.9 m120 . . . . . 0 C--O 1.235 0.335 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -99.01 114.19 26.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.359 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.5 143.31 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.486 ' OH ' HD12 ' A' ' 92' ' ' ILE . 1.3 t80 -138.18 134.01 33.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.548 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.05 141.98 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -127.57 157.78 21.03 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 91' ' ' TYR . 13.9 tt -138.42 136.91 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.002 0.43 . . . . 0.0 110.701 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.2 m -100.05 -16.61 17.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.24 0.543 . . . . 0.0 109.976 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -86.89 51.19 2.17 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -21.89 42.95 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.643 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -63.3 -55.72 22.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.717 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.383 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HG3' HD23 ' A' ' 21' ' ' LEU . 6.3 tm-20 -55.83 -57.29 12.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.813 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -70.17 -29.81 66.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.355 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.06 -43.8 64.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -78.77 -23.91 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.993 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.99 24.39 73.1 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.186 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 5.7 mt-30 -161.54 27.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.126 0.171 . . . . 0.0 110.751 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 136' ' ' ILE . 15.5 mt 73.57 -43.43 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -164.76 141.97 5.11 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -171.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.63 138.3 79.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.41 2.074 . . . . 0.0 112.071 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.237 0.397 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt . . . . . 0 C--O 1.242 0.661 0 CA-C-O 121.582 0.706 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -58.63 -24.61 61.44 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.346 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.83 1.0 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.555 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG13 ' OH ' ' A' ' 68' ' ' TYR . 2.3 p -69.42 -38.68 77.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.236 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -62.1 -57.02 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.073 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.05 85.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -58.23 -49.98 75.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -70.72 -35.93 72.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.0 -42.39 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 111.03 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -92.22 -60.25 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.821 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -90.8 -73.25 0.54 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.795 0.331 . . . . 0.0 111.727 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 66.29 3.85 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.254 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 13.6 tp -62.46 90.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.079 0.466 . . . . 0.0 110.907 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 64.1 47.5 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.739 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -15.44 63.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.81 5.56 Favored Glycine 0 C--N 1.329 0.14 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.432 ' SG ' ' CE1' ' A' ' 68' ' ' TYR . 13.9 t -59.01 -50.44 74.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.432 ' CE1' ' SG ' ' A' ' 67' ' ' CYS . 12.1 m-85 -106.33 160.35 15.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.072 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.21 99.49 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -78.82 126.43 30.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.698 179.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.469 HG23 HG13 ' A' ' 121' ' ' VAL . 15.4 t -140.21 152.25 45.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.596 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.572 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -89.46 169.11 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.85 10.17 3.59 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -116.79 127.44 54.34 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -69.8 -19.23 63.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.053 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.62 0.47 26.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 72' ' ' THR . 1.2 tt -52.27 -27.08 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.854 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.65 68.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.221 0.534 . . . . 0.0 110.839 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -49.22 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 -177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -62.92 -41.78 99.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.492 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -69.4 -43.52 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.259 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -63.0 -42.73 99.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.071 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -69.92 -52.99 19.95 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -65.89 -21.97 66.48 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.532 ' HB2' HG13 ' A' ' 87' ' ' ILE . 12.3 m -97.77 0.06 46.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.45 29.25 74.5 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.505 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 85' ' ' SER . 4.4 mt -80.3 -8.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 122.811 -0.229 . . . . 0.0 111.06 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 3.8 tt0 -45.17 -27.52 0.62 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.908 0.385 . . . . 0.0 111.306 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.8 89.98 3.24 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.66 -148.14 12.1 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.233 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.451 ' HB3' HG23 ' A' ' 9' ' ' ILE . 3.3 t80 -116.68 146.21 42.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.839 0.456 . . . . 0.0 110.306 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.515 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 pt -144.69 141.86 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 6.8 p90 -131.63 152.88 50.48 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.017 0.437 . . . . 0.0 111.2 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.5 m -118.83 142.59 33.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.274 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -134.22 142.69 47.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.672 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -98.15 142.18 30.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.633 ' HD2' ' HB2' ' A' ' 3' ' ' ASN . 47.3 ttt180 -77.5 -34.87 54.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.568 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -59.14 -25.77 64.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 0.0 110.822 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 135' ' ' VAL . 22.7 tp -65.46 -41.07 93.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.118 0.485 . . . . 0.0 109.778 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 5.0 m-85 -66.29 -38.77 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.73 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.4 -41.51 95.25 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.753 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -68.63 -39.1 80.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.288 0.566 . . . . 0.0 110.203 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.564 ' HB3' HG12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.98 -21.65 64.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.759 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m 71.24 32.37 2.21 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.192 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.564 HG12 ' HB3' ' A' ' 103' ' ' TYR . 24.6 mm -75.7 146.39 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.307 175.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.558 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -87.16 164.08 16.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.711 -171.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.38 138.2 27.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -125.64 113.01 16.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 pt-20 -105.25 119.73 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.535 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 120' ' ' GLU . 1.9 m -90.2 150.36 3.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.56 132.07 55.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.297 0.57 . . . . 0.0 110.925 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 18.5 m80 -81.61 -176.46 0.78 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 90.0 Cg_exo -46.59 158.39 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.328 1.352 . . . . 0.0 111.092 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.61 -44.93 95.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -84.42 -19.77 0.26 Allowed Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -168.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 39.9 Cg_exo -41.87 -22.76 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.532 1.488 . . . . 0.0 111.436 162.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.424 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER 72.58 20.8 3.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.49 166.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.7 150.27 34.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.573 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -129.42 137.31 50.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.228 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.434 ' HB3' HG22 ' A' ' 110' ' ' VAL . 3.2 tm-20 -90.57 111.94 23.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.469 HG13 HG23 ' A' ' 71' ' ' THR . 1.8 p -102.56 102.89 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 110.098 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.9 m -87.41 126.25 34.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.252 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.2 mt -87.59 111.47 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.404 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.673 HH12 ' HA ' ' A' ' 126' ' ' GLU . 1.3 tmm_? -84.22 95.48 8.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.502 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.654 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.86 155.41 40.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.124 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.673 ' HA ' HH12 ' A' ' 124' ' ' ARG . 22.1 mm-40 -73.44 -4.09 31.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.677 0.275 . . . . 0.0 111.578 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.51 159.49 44.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.9 m -80.36 120.04 23.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.891 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.67 69.2 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.522 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.4 m 55.18 70.83 0.59 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.654 HG22 ' HB1' ' A' ' 125' ' ' ALA . 5.2 tt -64.21 -33.82 10.18 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.505 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 45.3 Cg_endo -92.88 126.7 0.69 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.008 1.805 . . . . 0.0 111.679 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -85.18 -29.07 25.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.924 0.392 . . . . 0.0 111.054 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.53 10.56 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.384 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 95' ' ' LEU . 9.3 p -72.37 -16.11 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.256 0.551 . . . . 0.0 111.011 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.625 HD13 HD11 ' A' ' 21' ' ' LEU . 5.8 pt -88.3 89.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.1 pt -73.21 -19.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.836 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.598 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.575 ' HD3' HD12 ' A' ' 136' ' ' ILE . 28.7 mtmm -130.14 125.23 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.81 153.97 48.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 tt -99.84 157.66 16.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.2 tt -136.05 129.27 47.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.262 0.553 . . . . 0.0 112.34 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 78.95 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.462 173.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.656 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 70.9 mt . . . . . 0 N--CA 1.466 0.325 0 C-N-CA 123.069 0.548 . . . . 0.0 111.342 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.579 ' HA ' ' NH1' ' A' ' 97' ' ' ARG . 64.6 t30 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -131.76 122.73 26.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 5.1 mp -100.51 130.64 46.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.29 129.39 55.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.6 OUTLIER -142.04 151.88 42.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -133.92 156.96 22.6 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.794 HG23 ' HB3' ' A' ' 91' ' ' TYR . 6.4 tt -144.04 141.0 25.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.181 0.515 . . . . 0.0 111.003 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -25.14 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.522 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.6 51.94 1.78 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 110.076 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 10.7 pt20 -52.48 -33.93 46.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -76.22 -37.49 57.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.879 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -39.62 93.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.879 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.12 -43.56 98.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.092 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 12' ' ' GLN . 66.7 mm-40 -67.18 -34.02 76.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.86 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.31 -32.99 55.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.563 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HB3' ' OE1' ' A' ' 20' ' ' GLN . 64.4 m-20 -92.4 -46.17 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.79 12.33 81.57 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.559 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -145.74 6.87 1.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.017 0.408 . . . . 0.0 111.173 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER 61.83 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.536 0.522 . . . . 0.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 56.59 118.23 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.705 1.202 . . . . 0.0 112.381 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.72 111.26 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.192 2.595 . . . . 0.0 112.593 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 pttt . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.983 179.288 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 44.3 mttt . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.224 0.083 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -54.26 -39.05 66.49 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.741 0.305 . . . . 0.0 111.03 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.89 -50.38 66.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.226 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.25 -39.06 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.643 0.258 . . . . 0.0 111.009 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.38 -51.35 61.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.206 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.38 90.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.975 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -64.81 -34.54 78.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.591 ' HG3' ' HD2' ' A' ' 68' ' ' TYR . 1.6 tm0? -60.83 -53.19 60.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.82 -41.38 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.053 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.1 -67.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.068 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.4 -71.21 0.62 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.963 0.411 . . . . 0.0 110.845 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.4 138.98 3.82 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -152.71 47.37 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -90.07 6.67 41.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.854 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -100.91 -30.57 11.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.16 -72.39 0.19 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.223 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.95 -52.27 65.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.591 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 18.8 m-30 -117.61 161.06 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.605 HG23 ' HB ' ' A' ' 123' ' ' ILE . 3.4 tt -126.98 132.88 69.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.667 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.7 p -106.75 140.58 39.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.829 0.347 . . . . 0.0 110.722 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -129.07 133.6 47.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.845 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.457 ' H ' HD12 ' A' ' 77' ' ' ILE . 4.4 p -74.51 163.88 27.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -18.13 58.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -99.65 135.71 40.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.961 0.41 . . . . 0.0 111.79 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.71 -20.79 61.94 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.009 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -69.33 -3.5 14.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.366 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 3.9 tt -57.08 -34.46 45.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.245 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.22 -63.19 1.39 Allowed 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.757 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -67.73 -43.26 80.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.046 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.77 -46.96 85.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.088 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 17.8 t80 -64.55 -48.78 73.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -56.38 -59.72 4.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.165 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -64.92 -33.63 76.48 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.499 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m -73.03 -23.37 60.59 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.003 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m -84.05 -7.84 59.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.887 0.375 . . . . 0.0 110.025 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.47 39.8 98.1 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -68.05 -10.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -32.54 -35.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.954 0.784 . . . . 0.0 112.343 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.59 88.97 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.14 -152.67 19.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.604 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.794 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.7 t80 -119.65 150.63 40.01 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.4 tt -149.06 135.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.516 0.198 . . . . 0.0 110.589 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 15.8 p90 -131.46 156.32 45.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.174 0.512 . . . . 0.0 112.078 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.516 HG23 HG13 ' A' ' 137' ' ' ILE . 34.2 m -125.8 141.45 45.5 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -125.01 143.23 51.01 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.085 -175.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.466 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.9 t-20 -99.65 140.63 33.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.579 ' NH1' ' HA ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -67.83 -46.04 72.95 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 -178.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.24 -33.71 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 135' ' ' VAL . 25.1 mt -64.0 -50.93 66.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.274 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.88 -41.01 95.98 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.93 -48.13 84.41 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.021 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.14 -32.86 71.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.452 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -68.8 -18.68 64.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.872 0.367 . . . . 0.0 110.172 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m 70.63 34.27 2.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.033 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -73.87 156.01 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.772 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 11.5 m-85 -76.6 101.25 5.63 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.607 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.75 115.89 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.238 0.542 . . . . 0.0 109.909 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.543 ' HB2' ' HD2' ' A' ' 124' ' ' ARG . 2.4 t80 -125.74 111.56 15.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.816 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -94.93 113.07 24.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.824 0.345 . . . . 0.0 110.174 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 120' ' ' GLU . 1.4 m -89.31 125.5 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.81 131.99 53.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.327 0.584 . . . . 0.0 110.552 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.7 m80 -79.21 -178.39 1.09 Allowed Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 88.9 Cg_exo -46.85 164.33 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.587 1.524 . . . . 0.0 112.166 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -49.11 -66.93 0.31 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -170.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.471 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -89.05 -9.66 0.14 Allowed Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 115.84 1.792 . . . . 0.0 115.84 -165.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 37.3 Cg_exo -42.53 -22.82 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.446 1.552 . . . . 0.0 112.017 163.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.1 33.81 3.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.29 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -144.41 127.35 16.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -123.81 102.2 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HB2' HG22 ' A' ' 110' ' ' VAL . 57.0 mt-10 -73.65 98.09 2.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.216 0.531 . . . . 0.0 110.744 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 24.0 t -69.07 95.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.924 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 13.1 m -88.17 114.07 24.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.605 ' HB ' HG23 ' A' ' 69' ' ' ILE . 4.9 mp -87.09 111.12 21.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.809 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 19.8 mtt180 -93.2 104.06 16.27 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.918 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.572 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.62 144.03 53.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.15 -60.07 4.16 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.235 0.54 . . . . 0.0 109.756 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.865 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 16.1 t70 -87.72 127.95 35.3 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.787 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 51.9 t -52.79 113.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.505 0.503 . . . . 0.0 111.833 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . . . 91.23 67.47 1.16 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.433 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.2 m 58.6 72.66 0.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.913 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.09 -50.97 25.63 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.913 ' HD3' HG23 ' A' ' 131' ' ' ILE . 87.2 Cg_endo -97.83 116.0 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.498 2.132 . . . . 0.0 112.431 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.57 -5.14 26.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.37 -8.81 56.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.18 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.657 HG13 HD23 ' A' ' 95' ' ' LEU . 9.1 p -71.58 -14.05 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.638 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 136' ' ' ILE . 17.2 pt -87.76 92.91 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.516 HG13 HG23 ' A' ' 94' ' ' VAL . 27.7 pt -63.87 -30.99 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.905 -173.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.58 160.71 40.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.13 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -148.41 150.8 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.838 175.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -142.36 154.28 44.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -111.91 146.25 38.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 tt -140.66 118.93 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 111.097 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -118.04 68.6 0.77 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.364 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.799 179.028 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 97' ' ' ARG . 7.3 t-20 . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -98.6 130.91 45.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.513 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 97' ' ' ARG . 44.2 mt -112.91 135.19 53.95 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -131.87 124.46 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.87 132.77 20.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.19 157.58 15.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.405 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.701 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.3 tt -135.38 142.12 40.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.004 0.43 . . . . 0.0 110.216 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.74 -32.03 13.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.01 51.68 2.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.527 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 2.6 pt20 -55.13 -27.1 42.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.273 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -68.88 -49.21 60.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.93 -36.4 83.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.177 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.82 -58.18 9.75 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.358 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.35 -26.45 63.74 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -54.93 27.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.871 0.367 . . . . 0.0 110.037 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -73.52 -22.75 60.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.64 15.66 65.42 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.552 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -168.55 140.79 2.81 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 49.54 0.97 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.192 0.52 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 128' ' ' CYS . 29.8 tttp -168.64 126.41 0.89 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.382 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.85 -59.87 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.419 2.08 . . . . 0.0 111.868 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.329 179.58 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.569 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.65 -22.9 67.09 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.66 -67.27 0.32 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.357 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -33.46 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.53 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 2.3 m-85 -63.92 -64.64 0.84 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.48 84.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -59.19 -54.28 48.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.694 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 4.4 pt20 -61.07 -37.2 81.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.03 -37.4 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.753 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.27 -23.97 34.98 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 p -87.95 -49.44 7.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.136 0.493 . . . . 0.0 110.803 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.39 -71.53 0.19 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.541 HD22 ' CE1' ' A' ' 64' ' ' TYR . 6.8 mt -159.53 76.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.152 0.501 . . . . 0.0 109.782 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE1' HD22 ' A' ' 63' ' ' LEU . 2.0 p90 45.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.684 1.194 . . . . 0.0 112.986 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 6.2 p-10 166.59 -45.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.912 -168.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' N ' ' HD2' ' A' ' 64' ' ' TYR . . . 166.07 -8.01 0.06 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.993 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.62 -28.01 63.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.996 0.398 . . . . 0.0 111.57 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.42 ' HE2' HE22 ' A' ' 58' ' ' GLN . 12.3 m-30 -118.85 163.58 16.68 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 123' ' ' ILE . 1.4 tt -121.07 119.04 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.284 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 13.0 m -99.45 131.56 45.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.869 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 t -119.04 170.37 9.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.189 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -122.82 152.51 40.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -14.06 12.32 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.2 108.04 18.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -59.46 -18.01 36.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.594 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -79.07 -2.32 39.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.828 0.347 . . . . 0.0 110.465 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.3 tt -51.26 -29.36 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.788 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.27 -60.14 3.93 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.804 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.111 -175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -62.3 -45.62 92.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.978 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -63.38 -49.18 74.83 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.849 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 -55.26 25.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.942 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.8 m -62.66 -35.91 81.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -66.33 -27.81 68.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.5 m -93.82 -0.3 55.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.97 40.44 90.97 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.51 -9.57 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.36 -172.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.684 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 mp0 -41.68 -28.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.328 0.651 . . . . 0.0 112.146 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -123.63 90.62 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.97 -150.92 12.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.274 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.701 ' HB3' HG23 ' A' ' 9' ' ' ILE . 6.2 t80 -121.93 149.58 43.23 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.583 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -141.47 143.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 52.8 p90 -131.53 144.05 50.83 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.199 0.524 . . . . 0.0 111.187 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.509 HG23 HG13 ' A' ' 137' ' ' ILE . 17.9 m -118.64 138.85 48.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.561 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD23 HG13 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.08 142.79 51.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.867 -171.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.44 ' OD1' HD13 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -79.94 114.24 18.71 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.498 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -69.41 -33.52 73.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.745 -176.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.11 -26.66 66.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.628 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 99' ' ' LEU . 11.4 mt -63.11 -46.01 89.33 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -60.84 -38.47 85.59 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.47 -43.73 97.26 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.917 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -39.67 93.07 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.068 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.501 ' HB2' HD13 ' A' ' 105' ' ' ILE . 15.4 m-30 -71.06 -18.29 62.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.434 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.3 m 69.86 39.34 1.46 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 103' ' ' TYR . 1.1 mp -68.47 160.83 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.413 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.769 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -78.4 99.0 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -170.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -103.18 100.14 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -100.67 116.14 31.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.074 0.464 . . . . 0.0 110.069 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.494 ' HB2' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -85.22 138.25 32.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.613 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.68 144.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 145.91 47.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.32 170.59 15.4 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.861 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -45.67 170.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.657 2.238 . . . . 0.0 113.36 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -47.08 -53.82 11.85 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -170.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.518 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.2 t-20 -98.72 -17.05 0.2 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 34.2 Cg_exo -40.83 -26.39 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 120.993 1.39 . . . . 0.0 111.34 162.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 77.5 -11.35 1.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.901 163.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -113.3 159.34 19.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.297 0.57 . . . . 0.0 112.043 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 109' ' ' GLU . 29.6 tttp -131.87 122.34 25.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -104.48 115.13 29.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.155 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.83 113.37 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.154 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 14.3 m -81.4 117.71 22.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.776 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 69' ' ' ILE . 15.0 mm -87.84 98.27 7.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.769 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -89.19 102.63 15.29 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.041 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HB1' ' CG1' ' A' ' 131' ' ' ILE . . . -69.84 152.32 44.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.758 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.4 -41.9 90.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.458 ' HB3' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.07 145.02 50.12 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.07 176.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.411 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 1.4 t -64.02 133.77 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.55 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.05 70.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.546 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.9 m 56.89 72.9 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.508 ' CG1' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -43.95 -55.38 9.35 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.415 173.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 63.6 Cg_endo -95.62 114.95 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.931 2.421 . . . . 0.0 112.218 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.59 -22.65 66.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.103 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -77.19 -15.34 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.563 HG13 HD23 ' A' ' 95' ' ' LEU . 2.6 p -69.69 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.34 92.15 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.509 HG13 HG23 ' A' ' 94' ' ' VAL . 24.6 pt -67.83 -27.89 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.945 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.36 157.8 36.29 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.946 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 59.3 pttt -150.49 140.88 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.273 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.53 160.34 40.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.774 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -112.57 149.11 33.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.744 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 144' ' ' ILE . 18.4 tt -141.26 138.87 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -125.79 31.6 5.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.668 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.684 HG12 ' HB3' ' A' ' 88' ' ' GLU . 42.6 mt . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 122.642 0.377 . . . . 0.0 110.02 -171.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 . . . . . 0 N--CA 1.467 0.387 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 t80 66.15 112.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.546 0.528 . . . . 0.0 111.947 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 71' ' ' THR . 13.4 mt -99.82 124.87 45.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -115.75 124.03 49.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -145.92 156.95 43.87 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -122.23 155.92 16.88 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.945 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 34.9 mt -109.38 143.92 18.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -35.58 75.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.764 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t 177.69 155.62 0.33 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 110.035 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.7 -32.05 68.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.999 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.671 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.42 -42.72 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.023 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG3' HG21 ' A' ' 9' ' ' ILE . 48.8 mt-10 -55.01 -60.46 3.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.189 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.8 -41.86 78.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.213 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.18 -31.43 72.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.439 . . . . 0.0 110.785 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.03 -13.87 40.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.212 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.33 7.17 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.028 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 72.7 81.87 0.13 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.53 0.732 . . . . 0.0 110.672 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 4.2 mm? 64.64 37.53 7.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.984 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER 73.15 152.88 0.15 Allowed Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.79 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.76 118.15 5.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.628 2.218 . . . . 0.0 111.905 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.565 ' NZ ' ' HA ' ' A' ' 126' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.218 -0.571 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -45.04 -55.18 5.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.145 0.498 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.65 21.82 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.328 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 10.8 p -63.59 -31.38 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.013 -175.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.458 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 2.3 m-85 -65.0 -58.99 4.66 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.76 63.28 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.823 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.52 ' NE2' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -64.31 -47.04 80.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.696 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.58 HE21 ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -62.58 -40.44 96.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.396 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.6 mt -82.82 -40.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.562 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -65.5 -50.54 64.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.628 ' HB ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.28 -21.57 39.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.119 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.53 76.3 0.73 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.587 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.628 HD22 ' HB ' ' A' ' 61' ' ' THR . 1.8 pt? -148.44 59.84 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.6 0.714 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.438 ' HE2' HG11 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -67.86 -24.19 65.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.006 -177.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 6.7 p-10 -73.22 -12.6 60.93 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.687 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.91 -92.74 0.33 Allowed Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.541 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 80.8 m -69.5 -34.97 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.499 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 22.0 m-85 -95.51 158.47 15.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.332 -172.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 5.3 mp -89.52 97.83 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -83.39 119.14 24.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.168 -178.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.483 HG21 HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -140.32 155.37 46.84 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.953 0.406 . . . . 0.0 111.049 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.46 ' H ' HD12 ' A' ' 77' ' ' ILE . 2.6 m -87.83 156.46 19.38 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -32.39 73.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -88.68 133.37 34.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -63.97 -19.47 65.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.67 -2.21 6.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.269 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -57.75 -27.2 29.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.209 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.46 -63.18 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.071 0.462 . . . . 0.0 112.017 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -66.8 -43.85 82.78 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.873 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.269 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -70.82 -52.47 20.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.067 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -56.99 -42.59 80.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.426 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -76.23 -50.35 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.559 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -64.68 -26.24 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -91.6 0.25 57.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.192 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.89 32.64 73.86 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.533 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 82' ' ' ALA . 7.0 mt -73.1 -7.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.715 ' HG3' HD13 ' A' ' 144' ' ' ILE . 38.0 tp10 -28.76 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.715 1.206 . . . . 0.0 113.231 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -130.07 90.17 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.1 -157.7 20.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.181 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 8.2 t80 -117.63 153.56 33.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.503 0.321 . . . . 0.0 110.451 -176.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.577 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 29.3 mt -132.53 140.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.433 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 16.8 p90 -131.96 134.3 45.48 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.28 0.562 . . . . 0.0 110.856 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.6 134.72 63.15 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.031 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.451 HD21 ' HE2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -122.15 143.19 49.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.738 -173.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -82.3 125.41 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 100' ' ' PHE . 61.7 ttp85 -70.3 -45.06 67.06 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -22.58 66.83 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 -175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 135' ' ' VAL . 4.8 tp -65.5 -32.67 74.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 10.6 m-85 -66.49 -44.57 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.65 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.7 -42.57 91.28 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.655 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -43.25 96.77 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 109.932 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 3.1 m-85 -62.73 -23.01 66.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.378 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m 72.98 23.6 2.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.127 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.499 HG13 ' HB3' ' A' ' 103' ' ' TYR . 3.8 mt -70.91 148.14 10.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.074 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 22.4 m-85 -78.15 105.23 9.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.946 0.403 . . . . 0.0 111.041 -166.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.19 109.89 20.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 124' ' ' ARG . 7.5 t80 -129.72 128.28 42.16 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.057 0.456 . . . . 0.0 110.336 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.52 155.07 22.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.831 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 64' ' ' TYR . 11.3 m -129.63 145.97 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.19 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.567 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -113.42 136.13 53.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.171 0.51 . . . . 0.0 110.646 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -79.92 -174.68 0.51 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.553 175.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 95.6 Cg_exo -46.91 169.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.026 1.817 . . . . 0.0 113.181 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.31 -65.58 0.54 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -98.81 -8.59 0.12 Allowed Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -167.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 115' ' ' ASN . 63.1 Cg_exo -43.93 -27.12 1.57 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 121.562 1.594 . . . . 0.0 111.083 164.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 65.58 20.78 11.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.356 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 112' ' ' HIS . 4.9 pt-20 -112.65 123.73 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.11 0.481 . . . . 0.0 111.128 -177.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 111' ' ' GLU . 6.7 ttpt -121.41 112.48 18.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.124 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.48 121.43 26.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.268 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.02 98.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.641 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.527 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -94.97 121.1 36.23 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.29 -178.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 24.6 mm -86.94 101.73 11.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.474 0.654 . . . . 0.0 109.765 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.787 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 2.2 mmt180 -77.5 95.08 4.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.94 161.49 30.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.712 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' NZ ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -60.76 -47.2 87.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.831 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.75 160.85 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.09 144.33 40.53 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.627 0.58 . . . . 0.0 111.896 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.6 41.59 6.79 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.865 -0.607 . . . . 0.0 114.262 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.57 71.52 0.44 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.068 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.794 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.44 -45.94 33.29 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.794 ' HD3' HG23 ' A' ' 131' ' ' ILE . 70.8 Cg_endo -91.27 128.46 1.2 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.938 1.759 . . . . 0.0 113.033 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.34 -33.49 49.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 61.0 mt-10 -63.27 -22.47 66.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.634 -173.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.688 ' HA ' HD23 ' A' ' 99' ' ' LEU . 5.0 p -70.48 -19.47 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 111.233 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.6 mt -86.96 92.06 3.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 pt -67.59 -32.03 55.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.187 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -157.38 159.38 37.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.316 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.618 ' HD2' ' HE2' ' A' ' 91' ' ' TYR . 7.3 mtmp? -130.34 131.2 45.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.397 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -118.03 161.06 20.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.245 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 tt -122.19 147.47 46.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.3 tt -130.67 124.22 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.231 0.539 . . . . 0.0 110.473 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.02 57.96 1.53 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.528 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.715 HD13 ' HG3' ' A' ' 88' ' ' GLU . 16.3 mm . . . . . 0 N--CA 1.468 0.425 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 C--O 1.234 0.252 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -98.53 120.96 39.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.145 -172.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.461 HD11 ' HE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -121.29 142.38 50.0 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -113.53 139.3 49.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.86 157.56 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -128.76 157.54 21.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.809 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.877 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 54.2 mt -118.56 128.8 75.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 122.866 0.466 . . . . 0.0 110.164 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -25.19 16.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.08 0.467 . . . . 0.0 110.497 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.5 p -97.95 53.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.718 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.559 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -54.78 -26.42 34.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.065 -178.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -75.31 -50.84 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.108 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 1.5 t70 -59.62 -46.33 89.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.058 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.472 ' HG3' HD13 ' A' ' 9' ' ' ILE . 4.3 tm-20 -57.51 -58.88 6.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.616 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -65.91 -26.98 67.86 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.421 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.72 -43.52 79.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.043 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.36 -24.52 46.4 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.52 70.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.594 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.697 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -174.37 173.78 2.93 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.7 mt -79.47 44.65 0.62 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.359 0.264 . . . . 0.0 111.045 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm 49.29 73.73 0.94 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.795 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 97.5 Cg_endo -76.16 63.94 6.99 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.04 2.493 . . . . 0.0 112.795 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.928 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 54' ' ' VAL . 6.9 tttt . . . . . 0 C--O 1.244 0.763 0 CA-C-O 122.003 0.906 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 13.6 p-10 -61.13 -16.88 49.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.262 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.82 -55.36 30.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.3 p -67.96 -35.56 72.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 34.3 m-85 -59.62 -61.52 2.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.9 0.381 . . . . 0.0 110.251 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.962 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -56.18 -43.34 78.34 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.272 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -65.1 -53.57 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mt -63.76 -30.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.638 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.84 -64.42 1.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.897 0.38 . . . . 0.0 111.713 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 m -93.94 -64.6 1.06 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.8 -105.41 0.06 OUTLIER Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 114.232 -170.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 7.6 tp 61.0 34.33 19.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.762 0.791 . . . . 0.0 109.583 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.623 ' H ' ' HD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -84.5 11.83 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.356 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 t70 69.59 -143.98 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.99 -78.66 0.52 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.568 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.42 -37.03 85.7 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 109.983 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 124' ' ' ARG . 21.5 m-85 -126.93 142.62 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.787 HG13 ' HB ' ' A' ' 123' ' ' ILE . 5.6 pt -105.42 111.11 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 111.355 -169.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 1.5 m -91.39 131.15 37.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.9 t -132.86 143.38 49.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.235 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.618 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.79 153.25 33.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.929 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -172.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -117.85 136.02 53.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.655 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -52.77 -18.77 2.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.262 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 44.1 tp10 -48.86 -30.12 5.44 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.942 0.401 . . . . 0.0 110.773 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.618 HD12 ' H ' ' A' ' 72' ' ' THR . 1.1 tt -48.17 -37.5 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.694 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.54 68.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.018 0.437 . . . . 0.0 111.332 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -73.52 -43.44 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.895 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HG3' ' HG3' ' A' ' 76' ' ' GLU . 15.4 mmtm -57.96 -47.69 82.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.983 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -66.29 -56.98 8.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.285 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.17 74.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.06 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -81.85 -48.67 11.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.637 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -70.73 -18.87 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 m -99.6 0.8 42.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.0 110.506 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.28 29.92 66.75 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.768 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -13.81 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.957 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 142' ' ' ILE . 2.3 tt0 -48.64 -26.09 2.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.789 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.423 ' HB2' HG13 ' A' ' 144' ' ' ILE . 4.3 t30 -108.13 95.66 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.433 -0.167 . . . . 0.0 110.596 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.52 -127.95 2.52 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.007 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.877 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 1.7 t80 -124.23 151.6 43.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 11.1 pt -139.69 133.63 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.228 0.211 . . . . 0.0 110.483 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 22.0 p90 -131.22 137.37 48.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.378 0.609 . . . . 0.0 111.249 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 138' ' ' ALA . 13.6 m -116.56 146.02 21.54 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.8 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.583 HD23 ' HB ' ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.3 143.35 51.25 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.223 -173.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.682 ' HB2' HD13 ' A' ' 137' ' ' ILE . 60.8 t-20 -95.2 139.64 31.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.147 0.498 . . . . 0.0 110.566 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -69.39 -35.08 75.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -53.84 -33.81 57.38 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.4 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -58.93 -49.02 79.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.463 ' HE1' HG12 ' A' ' 135' ' ' VAL . 20.0 m-85 -72.94 -31.93 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.581 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.25 -42.62 99.72 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.86 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -70.71 -50.62 34.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.258 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -63.38 -21.2 66.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.212 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m 65.77 39.96 4.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.311 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -66.38 154.84 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 12.3 m-30 -75.44 141.93 43.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.923 -167.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 129.26 56.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 110' ' ' VAL . 21.9 t80 -131.69 112.34 12.47 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.54 119.9 31.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.411 HG12 ' HD1' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -112.34 148.5 15.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 110.422 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.5 46.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.007 171.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.675 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 14.2 m80 -78.42 -169.7 0.21 Allowed Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 85.1 Cg_exo -48.12 139.64 20.64 Favored 'Trans proline' 0 C--N 1.358 1.051 0 CA-C-N 121.285 1.495 . . . . 0.0 109.416 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -56.26 -48.19 77.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -89.3 -14.35 0.2 Allowed Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 96.7 Cg_exo -51.62 -17.45 4.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.249 1.482 . . . . 0.0 110.333 157.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.409 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 7.2 m-20 72.99 21.77 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.513 171.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.67 121.28 42.11 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.627 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -138.73 125.06 20.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.735 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.33 140.5 50.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.14 113.07 32.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.214 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 56.4 m -87.34 122.01 30.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.386 0.612 . . . . 0.0 110.989 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.787 ' HB ' HG13 ' A' ' 69' ' ' ILE . 14.4 mt -89.12 109.0 19.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.593 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.94 95.93 10.51 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.461 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.654 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.46 148.86 48.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.156 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -59.51 -41.96 91.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.969 0.414 . . . . 0.0 110.957 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.79 159.92 15.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.536 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 105.49 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.874 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.14 70.92 1.23 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.597 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.73 73.59 0.44 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 172.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.682 HG23 ' HD3' ' A' ' 132' ' ' PRO . 1.6 tt -54.76 -41.59 90.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.682 ' HD3' HG23 ' A' ' 131' ' ' ILE . 20.2 Cg_endo -91.93 126.72 0.92 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.808 1.672 . . . . 0.0 111.881 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -18.04 63.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -79.9 4.98 15.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.583 ' HB ' HD23 ' A' ' 95' ' ' LEU . 3.7 m -58.39 -30.15 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.824 0.345 . . . . 0.0 111.498 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.1 pt -87.96 89.91 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.18 0.515 . . . . 0.0 109.961 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 96' ' ' ASN . 12.3 pt -70.78 -28.16 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.648 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.473 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -155.06 124.92 6.56 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.405 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -121.97 132.46 54.55 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.44 159.37 42.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.185 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tt -100.32 144.39 29.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 88' ' ' GLU . 15.0 tt -124.33 135.66 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 110.489 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 144' ' ' ILE . 6.4 tp10 -115.39 47.23 1.34 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.822 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 143' ' ' GLU . 1.2 tt . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 123.106 0.562 . . . . 0.0 111.793 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.765 0.317 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -121.43 120.98 36.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 5' ' ' LEU . 2.3 mm? -106.21 144.91 32.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.251 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' HE1' HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -132.61 138.35 47.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.461 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.67 HH11 HD12 ' A' ' 21' ' ' LEU . 44.9 ttt180 -139.21 111.1 7.25 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -107.15 157.85 15.36 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.643 HG12 ' H ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -148.73 136.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 16.19 14.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.065 0.459 . . . . 0.0 110.959 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.7 58.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.512 . . . . 0.0 109.804 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 91' ' ' TYR . 2.0 mp0 -58.02 -21.56 45.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -68.98 -47.62 65.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.78 -42.58 99.76 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.891 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.06 -53.12 59.96 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.473 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -66.83 -24.95 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.638 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -93.88 -15.41 25.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.48 -9.81 75.68 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.448 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.567 ' HB2' ' HG3' ' A' ' 23' ' ' PRO . 1.6 mm-40 -174.71 -169.59 0.43 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.67 HD12 HH11 ' A' ' 7' ' ' ARG . 0.5 OUTLIER -77.2 61.29 2.07 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.003 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 52.67 69.07 2.56 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.567 ' HG3' ' HB2' ' A' ' 20' ' ' GLN . 86.0 Cg_endo -83.14 82.57 2.1 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.787 2.325 . . . . 0.0 112.077 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.468 ' HG3' ' H ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -48.52 -31.54 6.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.452 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 51' ' ' LYS . . . -55.62 -65.5 0.58 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.05 -32.31 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.768 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -66.04 -61.03 2.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.92 84.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -62.68 -44.54 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -49.65 66.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.686 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 82.0 mt -62.65 -36.12 73.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.621 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.95 -52.34 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.217 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.7 p -64.39 -76.63 0.07 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.463 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.21 7.22 11.7 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.361 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 43.6 tp 64.24 -79.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.58 0.352 . . . . 0.0 110.334 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -107.22 64.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -38.46 88.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.881 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.21 -1.58 0.55 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.129 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.3 m -78.04 -15.74 58.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.827 0.313 . . . . 0.0 111.275 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -121.29 157.12 31.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.224 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 31.0 mt -98.03 100.81 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.936 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m -77.21 114.32 15.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.548 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.32 168.9 16.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 110.715 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -112.31 152.2 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -25.67 68.06 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.77 133.25 34.0 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.127 -0.358 . . . . 0.0 110.497 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -59.62 -25.79 64.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.679 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.53 -6.82 58.78 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.418 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -23.88 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.006 0.432 . . . . 0.0 110.52 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.736 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -71.36 -44.07 65.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -57.99 -51.58 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.782 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.27 -48.02 83.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.212 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -55.83 -44.86 78.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.552 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -70.62 -43.03 70.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.5 m -63.51 -28.52 70.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.328 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 p -86.84 -5.52 59.08 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 110.6 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.17 89.85 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 92' ' ' ILE . 3.1 tp -69.1 -8.92 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 142' ' ' ILE . 43.9 mt-10 -28.52 -49.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.558 0.743 . . . . 0.0 112.741 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -121.14 91.11 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.49 -143.93 5.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.091 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.502 ' HB2' ' NE2' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -122.85 150.16 43.24 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.038 0.535 . . . . 0.0 110.352 -174.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.611 HG13 ' HG3' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -142.86 137.8 27.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 110.198 176.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -118.34 145.77 44.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.571 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 2.1 t -106.63 128.78 61.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.525 172.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 142.01 51.37 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.951 0.782 . . . . 0.0 109.119 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.547 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.3 t-20 -113.24 144.56 42.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.908 0.385 . . . . 0.0 111.557 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.556 ' HA ' ' HD2' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -64.1 -39.54 94.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.269 -175.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -69.53 -26.33 64.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.193 0.52 . . . . 0.0 109.915 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.74 HD22 HG23 ' A' ' 137' ' ' ILE . 12.4 tp -66.51 -39.19 88.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.399 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.556 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 48.1 m-85 -61.72 -42.8 99.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.441 174.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -38.99 90.45 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.907 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -62.05 -44.07 97.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.199 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.498 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 17.6 m-85 -76.99 -12.0 59.88 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.891 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m 70.66 27.62 3.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.457 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.548 HD11 ' HG3' ' A' ' 132' ' ' PRO . 18.4 mt -72.24 148.09 9.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.545 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 69.4 m-85 -89.81 122.77 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.565 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.79 138.62 31.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.15 112.06 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 119.28 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.131 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -87.29 129.65 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -121.55 128.75 52.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.466 0.651 . . . . 0.0 110.847 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 50.5 m80 -80.33 -174.81 0.52 Allowed Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 80.6 Cg_exo -46.19 149.37 2.52 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.211 1.274 . . . . 0.0 111.232 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -52.0 -51.42 57.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -166.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.405 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -99.84 -13.45 0.17 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 92.2 Cg_exo -50.15 -16.25 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.943 0 CA-C-N 121.767 1.667 . . . . 0.0 110.903 163.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 t-20 69.37 28.59 4.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.778 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 112' ' ' HIS . 20.3 tp10 -103.09 98.4 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.364 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -131.14 108.75 9.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.779 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.556 ' HB3' HG22 ' A' ' 110' ' ' VAL . 6.7 tm-20 -99.7 115.1 28.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.99 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.49 101.1 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.092 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.553 ' HB ' ' HE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -93.79 127.92 39.76 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 28.2 mm -88.43 102.9 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.283 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.553 ' HE ' ' HB ' ' A' ' 122' ' ' THR . 6.9 mmt180 -86.0 101.72 13.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.841 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.422 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -69.71 156.71 38.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.18 -29.51 70.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.261 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -147.34 161.17 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.719 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.94 47.13 4.57 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.542 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.53 ' SG ' ' NH2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 48.68 63.82 1.95 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.923 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -50.73 -45.77 86.28 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.923 ' HD3' HG23 ' A' ' 131' ' ' ILE . 92.8 Cg_endo -93.14 109.5 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.669 1.579 . . . . 0.0 112.295 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -61.93 -27.74 69.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.965 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.498 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -88.01 11.96 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.886 -178.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.615 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 13.1 p -59.77 -24.44 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 111.556 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -88.34 104.36 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.873 0.844 . . . . 0.0 109.782 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.74 HG23 HD22 ' A' ' 99' ' ' LEU . 1.6 pt -63.12 -26.61 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . . . -145.82 146.0 30.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.326 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -128.26 123.14 33.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.611 ' HG3' HG13 ' A' ' 92' ' ' ILE . 1.9 pt-20 -140.49 160.29 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.159 0.504 . . . . 0.0 111.122 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -111.26 151.76 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.612 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.8 tt -128.45 132.06 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.769 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -128.02 29.78 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 10.2 tp . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 122.341 1.067 . . . . 0.0 111.195 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 97' ' ' ARG . 12.5 p-10 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -114.83 161.25 18.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 111.182 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -100.53 154.93 18.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.89 141.25 38.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.374 0.607 . . . . 0.0 111.267 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.581 ' HB2' HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -144.07 156.07 44.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.703 176.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -137.74 157.65 24.25 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.453 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.591 HG23 ' H ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -147.27 140.31 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.447 -178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 6.26 14.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.488 0.661 . . . . 0.0 109.296 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.591 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.36 49.08 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.603 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -59.91 -26.73 66.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -61.09 -46.57 90.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.753 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.8 -47.16 86.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.96 -50.03 69.91 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.448 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -72.0 -24.24 61.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -74.46 -42.41 59.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 110.718 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -94.1 -16.1 24.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.51 89.32 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.0 159.2 36.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -81.18 130.92 35.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HE2' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 50.98 151.91 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 125.075 1.35 . . . . 0.0 113.835 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.52 -164.39 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 111.663 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.237 0.395 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.9 mttt . . . . . 0 C--O 1.238 0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -60.81 -22.46 64.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.657 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -65.84 0.57 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.444 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -68.68 -27.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -63.17 1.36 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.416 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.97 87.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.437 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -55.92 -52.48 63.96 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.174 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 26.9 tp60 -66.39 -54.87 19.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.244 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.58 -37.14 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.464 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -80.29 -58.47 3.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.51 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -69.27 -19.84 63.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.57 -175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.63 -111.71 0.77 Allowed Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 13.5 tp -162.07 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.409 ' H ' ' HB3' ' A' ' 63' ' ' LEU . 15.4 m-85 -105.36 -38.05 6.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.267 0.556 . . . . 0.0 109.523 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.65 -155.24 0.22 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.074 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.01 -14.61 76.85 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.487 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.52 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 97.6 m -61.5 -50.55 72.28 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.429 0.292 . . . . 0.0 111.212 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -104.33 160.2 15.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.262 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 mp -110.53 99.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.59 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.81 115.41 21.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.421 HG21 ' HA ' ' A' ' 5' ' ' LEU . 96.7 m -140.89 129.41 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -82.22 151.14 26.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.003 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.07 10.73 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.895 0.378 . . . . 0.0 111.823 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.43 123.46 48.11 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -49.2 -28.47 4.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -64.81 -19.97 66.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.69 0.281 . . . . 0.0 111.07 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -28.72 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.557 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -51.64 68.16 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.273 0.558 . . . . 0.0 110.651 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.94 -43.62 67.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.616 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.05 -47.87 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.099 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.35 -54.22 36.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -54.35 -43.89 71.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.544 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 m -73.76 -48.31 32.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 m -68.84 -18.22 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB2' HG13 ' A' ' 87' ' ' ILE . 18.0 m -92.78 -3.38 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.528 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.77 96.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.251 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 82' ' ' ALA . 15.8 mt -79.61 -8.44 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 121.957 0.103 . . . . 0.0 111.041 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 142' ' ' ILE . 10.8 mt-10 -33.28 -39.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -119.85 100.87 7.49 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.77 16.74 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.445 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -109.5 128.18 54.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 -175.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.4 mt -105.03 133.36 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.17 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 7' ' ' ARG . 21.5 m-85 -116.38 146.1 42.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -134.38 122.53 40.37 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.958 176.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.733 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.58 140.86 48.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.071 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.43 ' HB2' HG21 ' A' ' 137' ' ' ILE . 24.5 t-20 -80.5 138.43 36.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -68.61 -40.64 80.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -172.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.25 -10.36 59.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.575 0.226 . . . . 0.0 111.19 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.96 -42.58 76.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.604 ' HB3' HD12 ' A' ' 105' ' ' ILE . 3.3 m-85 -68.34 -43.48 77.41 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.683 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.84 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.993 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.63 -41.68 71.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.8 -19.52 65.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.3 m 72.9 38.23 0.74 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.001 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -75.89 166.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -75.51 109.32 8.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.341 -175.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.39 99.82 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -110.85 114.13 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.902 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.32 113.97 25.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.415 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -87.54 115.12 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -103.19 137.11 41.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.329 0.585 . . . . 0.0 111.264 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -87.95 174.37 5.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.572 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 52.7 Cg_exo -49.44 159.6 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.924 1.749 . . . . 0.0 112.575 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.474 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -44.34 -65.07 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.418 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.1 t-20 -92.76 -18.44 0.23 Allowed Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 44.5 Cg_exo -44.46 -18.82 0.21 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 121.551 1.59 . . . . 0.0 112.051 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.409 ' N ' ' C ' ' A' ' 115' ' ' ASN . 2.2 t-20 73.64 12.01 4.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.607 167.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -103.46 122.11 44.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 111.014 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -142.9 109.4 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.283 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.571 ' HB3' HG13 ' A' ' 110' ' ' VAL . 14.3 tt0 -100.52 132.61 45.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.96 104.37 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -84.59 114.59 22.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.172 0.51 . . . . 0.0 110.166 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 46.0 mm -88.01 100.62 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.663 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.732 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -86.32 93.16 9.02 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.008 179.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.17 151.76 46.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.435 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.589 ' HA ' HH21 ' A' ' 124' ' ' ARG . 3.3 mm-40 -65.37 -11.04 38.35 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -170.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.688 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 32.2 t0 -145.26 156.19 43.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.27 132.54 47.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 111.468 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 91.29 33.05 8.32 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.127 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 60.95 70.88 0.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.983 0.42 . . . . 0.0 110.356 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.899 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -37.83 -54.82 2.3 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.899 ' HD3' HG23 ' A' ' 131' ' ' ILE . 20.1 Cg_endo -93.11 128.64 0.72 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.306 2.004 . . . . 0.0 112.493 -174.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -81.36 -7.17 59.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -83.71 -4.78 58.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.456 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 132' ' ' PRO . 28.2 m -81.84 -9.41 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 110.247 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.08 89.73 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 96' ' ' ASN . 5.5 pt -63.79 -35.07 71.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.702 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 94' ' ' VAL . . . -155.32 167.96 28.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 111.772 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 160.54 43.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.368 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -141.34 160.58 39.83 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.015 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -105.37 149.43 26.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.4 tt -139.38 130.88 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.461 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -122.93 35.95 4.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.774 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt . . . . . 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.82 -179.695 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.4 t30 . . . . . 0 C--O 1.237 0.415 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.6 128.87 35.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -175.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.648 HD21 HD13 ' A' ' 123' ' ' ILE . 7.0 mp -100.7 135.94 41.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.508 ' HD2' HD11 ' A' ' 92' ' ' ILE . 1.4 m-85 -121.57 124.59 44.72 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.174 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.81 150.2 43.02 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.538 ' HA3' HG13 ' A' ' 87' ' ' ILE . . . -129.95 158.26 22.23 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.326 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.562 HG13 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.46 140.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 122.774 0.43 . . . . 0.0 110.468 -175.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.49 ' N ' HG12 ' A' ' 9' ' ' ILE . 2.5 p -89.24 -39.36 13.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.202 -0.311 . . . . 0.0 110.346 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' SER . 7.8 t 174.88 -150.26 0.01 OUTLIER 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.059 0.544 . . . . 0.0 109.79 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -56.77 -40.49 75.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 14.1 pm0 -56.42 -32.55 64.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.972 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -84.98 -31.93 23.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.52 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.803 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -52.56 -51.01 61.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -73.33 -40.17 64.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.14 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . 23.7 t30 -57.55 -48.16 80.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.62 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.87 -35.49 26.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' NZ ' ' A' ' 24' ' ' LYS . . . 68.8 16.02 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.895 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -132.52 4.09 3.93 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.803 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 33.3 tp -71.0 -54.17 12.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.558 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -88.44 132.92 37.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.271 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 130' ' ' CYS . 32.1 Cg_exo -59.23 112.54 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.783 2.322 . . . . 0.0 111.962 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' HA3' ' A' ' 129' ' ' GLY . 7.0 pttt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.005 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.482 0 CA-C-O 121.576 0.703 . . . . 0.0 111.948 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -53.87 -29.7 42.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.95 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 57' ' ' HIS . . . -54.6 -66.6 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.935 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.73 -37.64 80.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.518 0.199 . . . . 0.0 110.994 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -64.15 1.04 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.981 0.42 . . . . 0.0 110.662 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.53 90.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.172 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 6.1 m-70 -58.65 -46.88 86.18 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.839 -177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.428 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -60.05 -51.72 68.45 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.572 HD11 HH22 ' A' ' 124' ' ' ARG . 84.5 mt -58.62 -46.28 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.548 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -77.0 -39.77 49.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.3 m -80.35 -42.8 22.25 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -173.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.16 11.38 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.569 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 37.7 tp 63.32 -75.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.89 0.476 . . . . 0.0 110.885 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 122' ' ' THR . 17.8 m-85 -131.02 68.15 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.558 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -58.91 -43.72 91.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.191 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.13 -11.93 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.453 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.89 -29.89 69.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.289 0.545 . . . . 0.0 110.849 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.61 160.06 19.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.6 HG13 HD23 ' A' ' 5' ' ' LEU . 3.0 tp -115.05 123.68 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 110.369 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -105.59 147.69 28.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.809 -174.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.705 HG22 HG13 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -137.78 148.78 45.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.283 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.538 ' H ' HD12 ' A' ' 77' ' ' ILE . 2.9 m -81.49 155.85 25.6 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.217 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -25.9 65.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -85.88 129.01 34.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.705 0.288 . . . . 0.0 110.739 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.83 -18.39 64.08 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.5 -9.69 44.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 ' H ' ' A' ' 72' ' ' THR . 2.2 tt -46.71 -31.83 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.56 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.6 -62.81 1.48 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.357 0.598 . . . . 0.0 111.289 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -70.16 -41.49 73.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.825 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.61 -45.27 92.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.306 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 5.8 t80 -68.58 -53.81 20.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.175 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.81 75.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.498 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m -74.82 -52.58 11.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.665 0.269 . . . . 0.0 111.259 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -70.72 -10.4 59.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -105.07 3.78 30.81 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.297 -0.252 . . . . 0.0 110.865 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.47 36.25 76.34 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.945 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.538 HG13 ' HA3' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -89.76 -9.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.741 -176.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.18 -28.25 0.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.174 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -107.39 109.08 20.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.94 -126.44 3.55 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.145 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.43 150.86 51.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.508 HD11 ' HD2' ' A' ' 6' ' ' TYR . 16.9 tt -145.18 133.87 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.846 0.355 . . . . 0.0 110.067 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -128.8 154.98 45.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.162 0.506 . . . . 0.0 111.099 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 21.6 m -122.84 145.31 29.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.596 0.713 . . . . 0.0 111.494 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.799 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -120.15 141.2 50.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.327 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.465 ' HB2' HD13 ' A' ' 137' ' ' ILE . 61.0 t-20 -105.81 128.74 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.084 -0.385 . . . . 0.0 111.427 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -67.35 -34.19 76.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.021 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.18 -36.38 72.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.17 -38.92 89.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -71.56 -34.27 69.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.84 -39.04 96.96 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -65.94 -43.13 88.92 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -65.45 -18.58 65.42 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.648 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 m 71.89 30.43 2.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.677 0.751 . . . . 0.0 110.423 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.3 mt -72.38 156.77 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.473 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 15.2 m-85 -78.5 138.27 38.34 Favored 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -118.61 104.72 10.9 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -109.62 112.25 24.22 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -99.46 111.6 23.93 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -83.76 107.02 14.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.9 129.73 44.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.043 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 48.6 m170 -83.09 178.21 2.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.458 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 81.7 Cg_exo -48.15 168.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.011 1.807 . . . . 0.0 112.511 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.46 -70.11 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 2.0 t-20 -77.42 -21.42 0.37 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -167.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 18.2 Cg_exo -39.13 -22.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.832 1.688 . . . . 0.0 112.244 166.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 73.09 6.25 5.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.919 164.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.24 140.07 52.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.223 0.535 . . . . 0.0 112.058 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 98.31 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.602 ' HB3' HG13 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -70.39 105.42 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -173.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.705 HG13 HG22 ' A' ' 71' ' ' THR . 2.2 p -82.66 104.33 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.574 0.702 . . . . 0.0 109.63 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 3.2 m -97.39 130.4 44.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.528 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.648 HD13 HD21 ' A' ' 5' ' ' LEU . 2.0 mp -87.64 107.08 16.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.003 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 6.7 mmm180 -87.0 91.7 8.79 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.227 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -72.92 148.97 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.78 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.25 -60.28 3.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.468 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.61 141.29 29.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.112 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.66 114.91 7.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.393 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . 91.43 70.71 1.19 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.194 -0.527 . . . . 0.0 114.088 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 23' ' ' PRO . 72.0 m 59.45 72.71 0.51 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 170.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.648 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.59 -43.43 83.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.792 174.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.648 ' HD3' HG23 ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.28 135.66 9.66 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.873 1.715 . . . . 0.0 112.246 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -71.65 -26.64 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.095 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.23 10.88 13.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.006 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.799 HG22 HD23 ' A' ' 95' ' ' LEU . 8.0 p -52.54 -35.79 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 110.779 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.541 HG13 HG13 ' A' ' 135' ' ' VAL . 66.6 mt -93.37 95.36 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 138' ' ' ALA . 1.2 pt -76.04 -35.99 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.326 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 137' ' ' ILE . . . -146.18 157.97 43.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.592 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -133.61 148.47 51.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.739 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.55 154.8 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.747 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 tt -112.14 147.62 35.72 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.6 140.65 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -138.08 53.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.194 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 125.052 1.341 . . . . 0.0 113.884 177.293 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.81 149.58 37.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.288 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.409 HD11 ' HD2' ' A' ' 97' ' ' ARG . 0.8 OUTLIER -100.09 131.65 45.92 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' HA ' HG12 ' A' ' 94' ' ' VAL . 3.1 t80 -96.82 112.42 24.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.479 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -130.59 155.87 45.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.0 158.33 22.27 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.693 HG23 ' HB3' ' A' ' 91' ' ' TYR . 4.7 tt -143.99 152.78 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -175.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.01 14.14 3.54 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.234 0.54 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 9' ' ' ILE . 1.8 t 58.9 -97.15 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -66.17 -46.7 76.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.943 -167.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.98 -57.03 14.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.24 -43.38 98.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.802 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -51.1 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -59.9 -44.8 94.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -63.29 -51.04 67.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.046 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m-80 -78.76 -27.67 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.905 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 20' ' ' GLN . . . 90.34 47.17 3.87 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -172.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 41.6 mm-40 103.91 -144.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.858 1.663 . . . . 0.0 108.434 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.36 52.93 2.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.411 0.551 . . . . 0.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' ASN . 22.9 mtpp 68.52 131.4 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.857 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.7 142.66 9.25 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.242 0.671 0 CA-C-O 121.609 0.719 . . . . 0.0 111.561 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 22.3 p-10 -58.43 -21.81 52.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.547 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.66 -55.71 31.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.563 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -35.01 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.774 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 6.5 m-85 -63.21 -40.77 98.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.52 97.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.826 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -61.95 -38.35 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.133 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 38.9 tt0 -58.55 -57.9 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.65 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.07 -45.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.46 -54.73 6.31 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.935 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -82.84 -18.64 39.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.67 0.272 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . 91.41 30.53 10.67 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.808 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER 44.53 22.05 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.059 0.944 . . . . 0.0 113.083 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 54.84 17.15 1.67 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.977 0.511 . . . . 0.0 111.354 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 36.47 47.02 0.47 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.944 0.898 . . . . 0.0 111.869 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -35.68 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.718 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.61 84.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.425 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.443 ' HB2' HD13 ' A' ' 63' ' ' LEU . 19.9 m-85 -130.19 162.17 29.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.446 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.8 mp -93.42 99.06 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.591 -176.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.425 ' OG ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -86.3 124.13 32.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.027 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 121' ' ' VAL . 14.6 t -140.03 161.37 37.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.539 ' H ' HG13 ' A' ' 77' ' ' ILE . 2.1 m -90.17 154.83 19.46 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 m -61.58 -28.31 69.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 110.456 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -87.17 135.49 33.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.23 -19.87 49.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.163 177.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -6.09 18.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -51.73 -30.85 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.194 173.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.06 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -72.06 -43.74 64.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.592 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 81' ' ' PHE . 8.5 tttt -61.05 -53.34 58.41 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.441 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 58.8 t80 -67.51 -50.37 59.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.759 -175.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB1' ' CD1' ' A' ' 87' ' ' ILE . . . -56.72 -52.01 66.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.54 -175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 -37.98 76.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.606 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -68.95 -24.83 64.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.684 0.278 . . . . 0.0 111.029 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -89.3 1.76 55.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.78 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.88 99.84 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.661 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' CD1' ' HB1' ' A' ' 82' ' ' ALA . 2.8 pt -61.4 -9.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.635 0.218 . . . . 0.0 111.49 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -33.84 -45.33 0.19 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.238 0.336 . . . . 0.0 110.791 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -132.21 123.8 27.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.79 -153.48 24.89 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.71 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.693 ' HB3' HG23 ' A' ' 9' ' ' ILE . 7.1 t80 -122.33 149.85 43.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.477 HD13 ' OH ' ' A' ' 6' ' ' TYR . 62.1 mt -130.98 133.02 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.514 -177.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 32.6 p90 -132.37 129.67 39.7 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 111.233 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 138' ' ' ALA . 2.6 m -112.59 130.99 65.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.182 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -110.37 141.24 43.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.28 -175.033 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.46 ' HB2' HG21 ' A' ' 137' ' ' ILE . 10.3 t-20 -83.11 149.76 26.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.427 HH21 ' CD ' ' A' ' 107' ' ' GLU . 9.0 ttt180 -99.99 -20.2 16.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -35.28 78.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.128 0.49 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp -64.05 -38.12 89.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.036 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 5.9 m-30 -64.86 -39.23 93.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.72 51.64 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.824 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -64.1 -29.94 71.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.435 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 4.5 m-30 -82.85 -16.97 45.59 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.715 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.7 m 64.96 47.36 2.6 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.621 0.724 . . . . 0.0 110.275 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 125' ' ' ALA . 24.9 mm -77.06 150.1 6.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.92 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -96.4 103.56 15.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.951 0.405 . . . . 0.0 111.402 -168.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 2.1 pt-20 -93.3 108.17 19.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.111 0.481 . . . . 0.0 110.103 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -99.86 114.26 27.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.337 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 11.6 pt-20 -85.82 120.03 26.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.822 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -92.5 107.76 19.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -114.21 161.04 18.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.132 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -129.19 172.32 7.32 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.2 168.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.37 2.047 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 1.5 pm0 -55.97 -51.22 68.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.511 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.3 t-20 -83.64 -28.42 0.42 Allowed Pre-proline 0 N--CA 1.471 0.609 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -169.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 22.1 Cg_exo -37.17 -21.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.485 2.123 . . . . 0.0 113.378 170.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.4 t-20 83.65 -3.94 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.35 0.66 . . . . 0.0 112.005 163.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.48 145.5 48.25 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.239 0.542 . . . . 0.0 111.846 -172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.756 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 16.8 tttm -150.05 95.48 2.29 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -100.13 117.01 33.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 0.0 111.175 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 22.8 t -89.22 107.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.456 HG21 HD22 ' A' ' 63' ' ' LEU . 5.2 m -91.28 113.65 25.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.926 0.393 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . 4.5 mt -88.31 103.53 13.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.98 115.16 27.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.267 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -74.44 163.44 27.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.728 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -39.44 -39.85 0.74 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.497 0.498 . . . . 0.0 111.439 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -157.45 161.67 38.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.06 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.5 m -62.24 160.9 12.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 112.01 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.39 31.13 9.87 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.221 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.4 m 48.97 69.33 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.661 0.384 . . . . 0.0 111.876 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.749 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -53.77 -46.35 98.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.723 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.749 ' HD3' HG23 ' A' ' 131' ' ' ILE . 91.0 Cg_endo -92.73 108.74 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 121.854 1.703 . . . . 0.0 112.038 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.41 -5.84 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.63 -3.42 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 95' ' ' LEU . 9.5 p -76.3 -21.11 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.9 pt -86.59 89.74 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.726 0.774 . . . . 0.0 109.341 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' A' ' 96' ' ' ASN . 14.2 pt -74.94 -37.07 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.046 -174.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.611 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -136.76 127.84 27.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.812 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -123.07 136.52 54.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.431 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -141.26 159.46 42.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.239 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.2 tt -112.72 152.18 29.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 125.89 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.357 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.43 ' HG3' HD21 ' A' ' 141' ' ' LEU . 6.3 mt-10 -133.92 93.87 3.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.465 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.936 -178.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.51 153.94 24.01 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.997 -0.44 . . . . 0.0 111.243 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 144.82 51.12 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.107 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -111.7 132.68 54.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.428 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 0.9 OUTLIER -141.14 105.93 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.345 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.657 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -92.73 155.37 22.55 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.698 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 58.2 mt -131.34 129.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 0.0 110.607 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -24.45 23.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.214 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 48.88 1.67 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.146 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.494 ' NE2' ' HA2' ' A' ' 90' ' ' GLY . 27.5 mt-30 -56.76 -32.24 65.41 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.87 -49.36 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.933 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.11 -44.1 91.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.569 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.68 -48.17 82.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.341 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -67.76 -32.76 73.58 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -72.1 -38.39 69.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -83.05 -22.55 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.033 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 76.79 5.52 84.01 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.813 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 1.4 mt-30 -156.01 165.28 36.91 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.249 0.62 . . . . 0.0 109.441 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.61 56.47 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.65 137.11 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.063 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.11 73.28 4.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.801 2.334 . . . . 0.0 112.489 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 pttp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.302 179.068 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 111.065 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -14.66 63.13 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.79 -52.84 8.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' OH ' ' A' ' 68' ' ' TYR . 13.8 p -63.24 -35.05 70.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.08 0.467 . . . . 0.0 109.827 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -61.39 -50.3 73.42 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.29 72.53 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.769 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -61.59 -52.78 62.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.064 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.686 ' HB2' HD12 ' A' ' 63' ' ' LEU . 18.6 tm0? -59.52 -40.22 86.43 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.399 0.618 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.55 -38.49 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.31 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -84.5 -69.92 0.61 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.99 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 -24.97 18.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.84 162.35 26.83 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 58' ' ' GLN . 13.7 mt -155.57 152.65 29.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.359 0.599 . . . . 0.0 110.151 -175.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -62.51 83.91 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.048 172.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.71 82.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.737 0.78 . . . . 0.0 111.417 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' TYR . . . -145.86 -32.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.9 m -55.17 -28.07 50.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.4 0.619 . . . . 0.0 110.006 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.527 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 30.3 m-85 -103.59 161.2 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.825 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.2 mp -101.29 100.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.014 0.435 . . . . 0.0 110.288 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -78.84 123.1 26.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.931 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.83 152.69 50.56 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.495 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 6.0 m -105.24 159.9 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -28.42 66.68 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.013 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -100.34 134.23 43.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -58.72 -19.55 41.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.375 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.557 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 12.4 mm-40 -52.91 -24.85 10.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -49.81 -35.7 10.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.069 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.05 74.76 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.408 0.623 . . . . 0.0 110.609 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -69.41 -47.07 65.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.761 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 53.2 mttm -63.29 -48.51 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.334 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.657 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -63.1 -47.42 82.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.883 -177.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.636 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -57.07 -57.47 12.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.195 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 m -60.65 -45.05 95.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.832 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 m -60.61 -29.88 69.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -83.8 -6.7 59.49 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.26 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 45.82 18.11 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.636 HG21 ' HB1' ' A' ' 82' ' ' ALA . 7.2 tp -68.49 -18.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -32.43 -44.36 0.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.015 0.822 . . . . 0.0 112.468 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -130.95 101.74 5.75 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.494 ' HA2' ' NE2' ' A' ' 12' ' ' GLN . . . 170.83 -166.82 40.01 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.321 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.45 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -93.05 142.99 26.68 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.013 0.525 . . . . 0.0 109.825 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -134.86 112.79 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.125 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 2.7 m-85 -95.05 129.66 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.223 0.535 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.83 113.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.932 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 95' ' ' LEU . 3.6 mp -112.43 140.96 46.73 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.466 0.479 . . . . 0.0 109.839 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -91.61 129.43 37.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.1 ttp85 -80.76 -28.38 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.914 -175.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.18 -33.6 71.13 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.44 ' HB3' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -61.07 -38.54 86.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.012 175.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 4.9 m-85 -66.49 -44.05 83.69 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.202 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.76 -45.24 96.83 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.901 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -61.84 -43.67 98.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.231 0.539 . . . . 0.0 110.016 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.41 -21.64 63.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.516 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.2 m 68.59 37.83 2.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.041 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.545 HG23 ' HA ' ' A' ' 125' ' ' ALA . 17.5 mm -67.65 153.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.245 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.67 104.14 14.39 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 121.038 0.447 . . . . 0.0 110.859 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -88.04 110.72 20.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.406 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -100.48 113.22 25.83 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -105.86 130.03 53.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.66 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 m -117.22 131.66 69.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.557 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.8 pm0 -87.78 131.34 34.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.2 m170 -83.37 175.69 4.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.518 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 82.3 Cg_exo -45.95 164.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 113.138 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -51.09 -55.84 15.65 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -168.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.479 ' N ' ' HG2' ' A' ' 114' ' ' GLU . 2.1 t-20 -103.28 -9.32 0.12 Allowed Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 42.7 Cg_exo -43.07 -27.34 0.96 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 121.708 1.646 . . . . 0.0 110.867 162.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 t30 67.64 31.57 5.98 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.605 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.89 145.89 29.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 110.834 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 111' ' ' GLU . 5.5 mptt -123.09 130.4 52.73 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.266 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.8 108.4 16.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.148 0.499 . . . . 0.0 110.23 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.08 96.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.461 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.27 117.05 29.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.3 mm -87.3 106.36 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.026 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 68' ' ' TYR . 26.0 mmt180 -85.19 100.23 11.62 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.138 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.545 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -85.57 161.04 19.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.572 ' HB2' HD13 ' A' ' 131' ' ' ILE . 33.2 mt-10 -65.21 -21.05 66.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.073 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -137.52 161.18 37.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.56 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.1 m -71.85 99.61 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.256 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.35 71.55 1.21 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.1 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.9 71.84 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.718 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -58.95 -44.21 98.61 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.694 ' HD3' HG23 ' A' ' 131' ' ' ILE . 65.6 Cg_endo -74.51 109.69 2.95 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.444 1.429 . . . . 0.0 112.23 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -63.15 -21.57 66.29 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.46 -15.43 59.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.442 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.4 p -70.47 -22.12 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.55 97.03 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.431 0.634 . . . . 0.0 109.554 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 pt -69.04 -28.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.46 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.73 141.9 18.36 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.505 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 95.26 5.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 108.956 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -95.08 157.75 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.283 0.564 . . . . 0.0 111.493 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -137.0 147.9 46.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.642 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.73 138.34 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.399 . . . . 0.0 110.624 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -129.21 53.83 1.86 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 CA--C 1.531 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.628 -177.232 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -125.49 119.32 27.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.721 HD21 HD13 ' A' ' 123' ' ' ILE . 29.4 mt -99.22 124.52 44.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.291 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.23 114.62 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.904 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -139.77 144.38 37.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.519 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -114.19 158.51 14.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.504 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.609 HG12 ' H ' ' A' ' 11' ' ' CYS . 4.3 tt -151.45 168.21 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.82 0.448 . . . . 0.0 110.294 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.98 -14.55 38.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.226 0.536 . . . . 0.0 109.999 172.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER 60.16 -86.27 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.597 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -37.77 -57.13 1.02 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -61.85 -56.18 22.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.361 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.85 -41.54 97.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.31 0.576 . . . . 0.0 111.006 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.78 -52.5 50.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.271 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -63.51 -36.73 84.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.898 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -68.84 -55.47 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.209 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.41 -8.7 54.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.725 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.57 1.26 89.24 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 179.65 -175.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.32 67.31 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt 54.21 64.47 6.32 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.103 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.46 62.71 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.573 2.182 . . . . 0.0 112.202 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.4 mttm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 -177.703 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.5 pttt . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.54 -25.92 64.93 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.333 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.05 -54.59 42.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 110.524 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.49 -36.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.41 -55.4 21.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.048 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.39 90.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.543 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -57.14 -54.4 47.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.056 0.455 . . . . 0.0 110.188 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.564 ' HG3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -59.91 -32.58 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -176.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 58' ' ' GLN . 59.6 mt -88.77 -70.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.82 -45.67 93.54 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.138 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -81.65 -19.29 42.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.982 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 51.21 4.2 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.333 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 40.7 mt 64.05 79.83 0.25 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.828 0.451 . . . . 0.0 110.868 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -53.87 -27.26 29.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.646 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.77 150.82 12.13 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.58 69.13 2.38 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.768 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -16.38 27.9 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -119.41 152.43 36.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.156 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.525 ' HB ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -107.88 110.17 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.492 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 3.2 m -99.93 136.04 40.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.838 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.683 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -141.06 155.41 46.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 175.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 m -86.67 162.33 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 110.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -44.48 96.76 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 6.8 t70 -83.68 136.92 34.02 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 -174.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -56.92 -21.94 33.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' A' ' 74' ' ' ASP . 10.0 pt-20 -61.18 -16.85 49.18 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.789 0.328 . . . . 0.0 110.937 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -29.29 11.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.133 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.84 -66.36 0.42 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.956 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.15 -35.67 71.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.37 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -62.13 -44.45 96.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -67.16 -51.24 56.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.918 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.668 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -54.77 -46.21 74.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.327 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -69.43 -44.1 72.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.664 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 m -73.52 -18.78 61.05 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' HG13 ' A' ' 87' ' ' ILE . 19.0 m -101.5 10.68 40.13 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.537 0.208 . . . . 0.0 111.267 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.79 21.18 69.09 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.169 -0.468 . . . . 0.0 113.029 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 82' ' ' ALA . 18.1 mt -72.8 -8.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -39.45 -34.41 0.21 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.545 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -130.45 89.54 2.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.42 -144.98 6.64 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.228 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -127.18 150.72 49.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.567 HG23 HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -133.25 143.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 178.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.412 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 43.1 p90 -129.65 139.3 51.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.271 0.557 . . . . 0.0 110.843 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.4 m -126.16 139.92 50.18 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.866 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.801 HD23 HG13 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -126.05 141.04 52.12 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.024 -174.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.657 ' HB2' HD13 ' A' ' 137' ' ' ILE . 38.4 t-20 -96.97 139.84 32.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.86 0.362 . . . . 0.0 110.769 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -25.92 67.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.78 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.88 -35.26 70.74 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.238 0.542 . . . . 0.0 109.892 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 96' ' ' ASN . 4.4 mm? -75.94 -50.81 13.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.482 -174.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -30.21 68.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.57 87.52 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.06 -40.01 87.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 105' ' ' ILE . 1.8 m-85 -68.96 -22.0 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.944 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m 66.75 38.43 3.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.66 0.743 . . . . 0.0 109.803 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -71.69 163.88 3.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.642 -178.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 5.2 m-30 -75.53 161.61 29.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.544 -171.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -141.23 155.9 45.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.297 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.465 ' HB2' HH11 ' A' ' 124' ' ' ARG . 0.3 OUTLIER -155.28 110.84 3.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -108.71 120.03 41.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 110.343 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.6 149.21 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.991 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -105.25 142.57 34.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.018 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -174.41 0.48 Allowed Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 116' ' ' PRO . 99.3 Cg_exo -45.79 163.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.414 1.409 . . . . 0.0 111.811 171.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -51.83 64.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -103.69 -9.26 0.12 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -168.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 40.8 Cg_exo -42.13 -23.22 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 CA-C-N 121.683 1.637 . . . . 0.0 112.161 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 70.55 30.07 3.23 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.567 169.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.69 150.82 46.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.087 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -129.77 129.79 44.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.616 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -94.65 103.13 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.942 0.401 . . . . 0.0 109.986 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 4.4 p -92.54 110.11 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.482 0.658 . . . . 0.0 110.442 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 87.6 m -91.68 114.74 27.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.519 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.721 HD13 HD21 ' A' ' 5' ' ' LEU . 2.1 mp -87.82 129.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.623 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -111.8 119.34 38.26 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 -173.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.1 149.45 49.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.67 -57.23 13.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.57 158.88 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.056 169.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.28 160.36 31.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.993 0.425 . . . . 0.0 110.767 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.29 32.13 60.5 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.043 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m 57.49 71.31 0.59 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.155 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.85 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -35.52 -49.64 1.35 Allowed Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.85 ' HD3' HG23 ' A' ' 131' ' ' ILE . 84.7 Cg_endo -99.87 109.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.336 2.024 . . . . 0.0 112.019 174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 3.87 15.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.873 0.368 . . . . 0.0 110.606 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.85 -9.58 39.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.801 HG13 HD23 ' A' ' 95' ' ' LEU . 6.8 p -71.42 -9.26 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.585 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.6 pt -86.1 91.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 96' ' ' ASN . 11.6 pt -63.41 -29.92 48.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.446 -173.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.609 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -148.74 148.83 30.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.215 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -150.45 135.37 17.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -142.63 153.14 43.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.032 -171.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -95.44 150.79 19.9 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tt -139.37 120.23 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.443 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.56 70.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.186 0.517 . . . . 0.0 110.227 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 CA--C 1.533 0.321 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.355 177.288 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -109.2 133.95 52.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 60.3 mt -113.69 147.18 38.64 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -140.1 135.1 32.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.493 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tpt180 -148.37 155.96 41.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -137.49 157.52 24.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.758 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.9 tt -138.43 133.14 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 110.47 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -31.31 27.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.536 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 53.22 2.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.802 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . 13.3 tm0? -56.58 -27.32 57.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.09 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -74.96 -39.34 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.948 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.87 -48.1 75.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.319 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -66.16 -35.28 80.06 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.411 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.453 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 tt0 -63.57 -43.35 97.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.02 -40.58 98.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.341 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.97 -31.95 71.18 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.364 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.48 7.69 71.9 Favored Glycine 0 C--O 1.234 0.129 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.652 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.486 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 4.6 mm-40 -170.93 -178.05 2.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.2 mt -82.06 38.42 0.53 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.219 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm 53.3 60.74 11.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.23 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 55.4 Cg_endo -69.09 149.95 71.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.321 2.014 . . . . 0.0 110.97 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.505 -173.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.455 0 CA-C-O 121.464 0.65 . . . . 0.0 112.698 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -48.26 -31.89 6.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.131 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.75 -60.42 3.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 51' ' ' LYS . 2.2 p -62.91 -32.71 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -62.64 -53.15 58.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.166 0.508 . . . . 0.0 110.418 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.06 99.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.666 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -64.8 -48.96 72.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -70.6 -22.13 62.58 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.836 -175.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.549 HD11 ' NH2' ' A' ' 124' ' ' ARG . 17.0 mm -92.35 -54.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 0.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.91 -50.29 13.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.512 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -80.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.605 0.241 . . . . 0.0 111.412 -173.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.15 79.13 1.62 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 19.8 tp -57.33 86.06 0.01 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 111.535 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 122' ' ' THR . 20.9 m-85 61.55 60.27 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.0 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -34.19 68.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.372 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.33 -13.95 0.45 Allowed Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.353 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.437 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . 13.9 m -61.3 -33.0 72.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 58' ' ' GLN . 19.8 m-30 -106.71 153.51 22.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.05 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.3 mt -93.1 99.6 9.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.833 0.349 . . . . 0.0 110.53 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.78 112.86 24.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.567 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -122.16 170.39 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.919 0.39 . . . . 0.0 111.005 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -98.78 158.29 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.966 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -16.97 64.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.53 134.08 45.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.156 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.7 -19.09 63.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.794 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.17 -16.51 45.42 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.666 0.27 . . . . 0.0 110.655 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -30.62 14.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.902 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.76 -60.37 3.55 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.155 0.502 . . . . 0.0 111.352 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.65 -35.44 65.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.185 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -60.63 -47.67 85.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.808 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -64.38 -51.73 61.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.46 -59.21 5.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -66.87 -35.54 80.26 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.861 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.0 m -73.49 -17.85 61.18 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.444 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 m -99.78 -2.85 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.6 0.238 . . . . 0.0 110.682 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.87 31.59 78.9 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 -9.75 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.031 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -47.48 -27.36 1.71 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.694 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.487 HD21 HD11 ' A' ' 144' ' ' ILE . 6.3 m-20 -110.11 88.48 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.99 -138.74 5.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.364 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.695 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.7 t80 -123.49 148.48 46.19 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.743 0.417 . . . . 0.0 110.022 -174.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.449 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 pt -140.09 139.15 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 10.6 p90 -132.13 132.21 43.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.933 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.1 m -109.98 139.69 32.17 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 CA-C-O 121.333 0.587 . . . . 0.0 110.729 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.3 mp -121.09 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.005 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -85.46 125.81 33.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.891 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.495 HH21 ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -69.49 -53.61 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -171.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.64 -20.37 65.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.061 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 135' ' ' VAL . 15.0 tp -64.61 -34.77 79.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.183 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.534 ' CE1' HG11 ' A' ' 135' ' ' VAL . 0.2 OUTLIER -67.01 -43.89 81.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.618 176.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.96 94.84 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.638 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -59.78 -50.38 74.06 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -64.98 -20.81 66.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.603 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 m 68.88 37.85 2.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.499 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -71.97 158.86 6.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.836 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.6 m-85 -77.08 102.49 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.301 -166.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.495 ' CD ' HH21 ' A' ' 97' ' ' ARG . 41.4 mt-10 -91.63 126.51 36.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.264 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.632 ' HB2' ' HD3' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -134.32 111.01 9.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -117.0 118.03 31.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.126 0.489 . . . . 0.0 109.706 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -99.81 135.66 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.344 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -92.77 142.37 27.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.342 0.592 . . . . 0.0 110.557 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.23 175.84 2.25 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.28 160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.906 1.737 . . . . 0.0 111.844 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.85 -41.23 97.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -167.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -86.26 -25.39 0.34 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.151 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 26.0 Cg_exo -39.37 -23.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.928 1.752 . . . . 0.0 112.091 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 m-20 76.15 6.22 3.68 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.223 164.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -150.11 160.72 43.44 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.951 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.42 148.55 48.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.775 174.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -96.02 105.25 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.024 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 109' ' ' GLU . 33.7 t -89.25 102.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.451 HG21 ' CE1' ' A' ' 64' ' ' TYR . 5.3 m -104.63 109.59 21.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.189 0.518 . . . . 0.0 111.248 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.408 HG21 ' CD2' ' A' ' 100' ' ' PHE . 5.1 mp -89.85 116.81 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.836 ' HG2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -103.04 118.68 37.35 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.833 0.825 . . . . 0.0 110.076 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.77 163.35 20.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.958 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.598 ' HB3' HD13 ' A' ' 131' ' ' ILE . 18.3 tt0 -51.55 -29.18 16.05 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.616 0.573 . . . . 0.0 111.719 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.415 ' H ' ' CG2' ' A' ' 131' ' ' ILE . 36.3 t0 -140.3 160.43 40.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.471 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 1.5 t -67.42 128.27 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.578 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.93 59.69 1.85 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.578 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.3 m 47.46 70.4 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.896 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -54.71 -44.87 99.58 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.896 ' HD3' HG23 ' A' ' 131' ' ' ILE . 91.1 Cg_endo -94.0 124.59 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.112 1.875 . . . . 0.0 112.32 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -84.3 -14.9 48.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -61.4 -29.89 70.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.903 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.64 ' HA ' HD23 ' A' ' 99' ' ' LEU . 22.3 m -72.93 -12.51 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.48 93.63 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 pt -71.9 -26.45 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.923 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -144.45 139.79 28.55 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.409 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -132.48 126.92 34.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.278 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.76 160.25 40.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.592 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.479 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.1 tt -102.55 153.47 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.5 tt -137.26 133.84 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.329 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.479 ' HG3' HD21 ' A' ' 141' ' ' LEU . 31.4 mt-10 -134.0 74.68 1.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.954 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.487 HD11 HD21 ' A' ' 89' ' ' ASN . 7.2 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.514 0.673 . . . . 0.0 110.677 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 141.44 48.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.594 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.611 HD22 HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -99.97 135.14 41.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HD2' HD11 ' A' ' 92' ' ' ILE . 1.6 m-85 -96.15 141.18 29.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 0.0 110.664 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.13 123.01 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.397 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.551 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -119.8 157.33 15.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.863 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.545 HG22 ' HD1' ' A' ' 91' ' ' TYR . 8.3 tt -149.71 159.09 5.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.113 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 25.59 5.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.125 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.58 64.83 1.09 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.417 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.63 -23.84 67.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.558 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -61.7 -44.83 96.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.455 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.55 -41.65 88.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.234 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -59.66 -42.16 92.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.383 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -71.73 -33.55 68.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.13 -48.4 35.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -87.75 -27.71 22.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.61 75.2 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.993 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -153.02 17.57 0.57 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.89 0.345 . . . . 0.0 111.578 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.88 98.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.21 0.319 . . . . 0.0 110.686 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 10.2 mmmm 68.4 137.69 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.175 0.59 . . . . 0.0 110.879 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' HE2' ' A' ' 22' ' ' LYS . 93.9 Cg_endo -79.7 149.56 20.94 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.396 2.064 . . . . 0.0 111.987 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.45 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt . . . . . 0 C--O 1.239 0.546 0 CA-C-O 121.885 0.85 . . . . 0.0 113.083 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.45 -24.31 54.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.809 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.43 -68.44 0.17 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.096 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG21 ' SG ' ' A' ' 67' ' ' CYS . 3.6 p -79.96 -26.27 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.189 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.8 m-85 -63.36 -53.62 49.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.93 0.395 . . . . 0.0 110.039 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.549 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -56.24 -52.23 65.22 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.043 0.449 . . . . 0.0 109.941 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -62.4 -48.78 78.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.236 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 55' ' ' TYR . 46.7 mm -69.74 -41.2 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -84.71 -54.62 4.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.588 0.232 . . . . 0.0 111.401 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.2 m -74.92 -31.62 61.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.24 -161.89 12.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.142 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 ' OG ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -79.45 73.22 6.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.612 -176.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -71.58 -14.43 62.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.16 -171.52 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.651 171.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.45 -50.7 4.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.807 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 54' ' ' VAL . 34.6 t -84.87 -46.1 11.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -115.21 143.77 44.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.257 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.91 99.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.943 0.401 . . . . 0.0 110.229 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.433 ' OG ' HD11 ' A' ' 63' ' ' LEU . 60.0 m -80.49 122.67 27.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.653 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 5' ' ' LEU . 2.2 m -127.21 131.36 50.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.091 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.68 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -80.36 167.87 19.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.618 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.1 p -81.82 9.64 7.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.064 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -116.92 133.28 56.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.165 0.507 . . . . 0.0 110.899 -177.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -65.17 -19.75 66.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.008 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 27.7 mm-40 -77.57 -5.14 49.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.021 -176.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.68 HD12 ' H ' ' A' ' 72' ' ' THR . 2.7 tt -48.22 -34.51 4.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.547 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.74 -53.57 56.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -70.59 -46.04 64.19 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.769 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -60.03 -48.23 82.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.53 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.551 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 6.0 t80 -67.35 -53.96 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.109 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -56.61 -42.83 79.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.332 -176.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 m -70.85 -48.16 55.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.227 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 -20.55 66.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.691 0.282 . . . . 0.0 111.54 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -93.83 9.62 36.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.87 36.71 67.23 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.785 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.534 HG21 ' HB1' ' A' ' 82' ' ' ALA . 3.3 tp -70.76 -10.2 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 2.0 tm-20 -38.56 -37.51 0.32 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.502 0.501 . . . . 0.0 111.193 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.07 89.18 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.85 -152.61 11.96 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.139 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' A' ' 9' ' ' ILE . 48.0 t80 -129.89 135.87 48.86 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HB ' HG12 ' A' ' 87' ' ' ILE . 9.9 tt -139.97 138.9 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.42 . . . . 0.0 111.516 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -131.8 156.75 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.7 m -128.17 137.35 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.477 HD23 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -113.82 140.63 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.356 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -81.92 146.28 29.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.711 0.291 . . . . 0.0 110.702 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -94.27 -24.98 17.23 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.36 -43.4 67.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.345 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.465 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 3.6 m-85 -67.14 -36.92 82.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.939 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.72 99.6 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -59.19 -53.44 58.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.339 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -70.93 -16.75 62.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.043 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m 63.88 47.97 3.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.509 0.671 . . . . 0.0 110.222 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -62.62 163.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.523 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 7.3 m-85 -74.6 99.78 3.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.129 0.49 . . . . 0.0 110.491 -170.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.94 101.61 13.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.766 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.512 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 54.6 t80 -116.49 125.3 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.1 140.61 47.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.804 0.335 . . . . 0.0 111.264 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 120' ' ' GLU . 2.5 m -123.92 150.13 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.291 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.18 142.34 27.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.89 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' GLU . 3.0 m170 -84.99 175.09 4.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.535 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.0 Cg_exo -50.4 170.2 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.025 1.817 . . . . 0.0 112.461 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -53.13 -64.68 0.74 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -166.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.452 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.5 t-20 -93.79 -12.47 0.18 Allowed Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.535 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 52.0 Cg_exo -44.87 -24.04 1.1 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 CA-C-N 121.421 1.543 . . . . 0.0 111.174 163.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 72.25 -11.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.541 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 3.8 mt-10 -102.67 155.15 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.143 0.497 . . . . 0.0 111.029 -172.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -115.03 133.75 55.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HB3' HG22 ' A' ' 110' ' ' VAL . 1.1 tm-20 -89.04 135.32 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.36 100.4 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.459 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -74.23 113.27 11.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.299 177.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.611 HG13 HD22 ' A' ' 5' ' ' LEU . 7.0 mm -87.45 100.19 9.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 48.6 mtt-85 -101.59 110.13 22.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.437 -172.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.5 160.34 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.365 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 131' ' ' ILE . 18.7 mt-10 -54.49 -49.94 68.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -176.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.677 ' H ' HG21 ' A' ' 131' ' ' ILE . 30.5 t70 -110.18 160.28 16.63 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.15 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 12.3 t -80.39 129.41 34.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.91 69.2 1.19 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.975 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 31.2 m 46.87 70.29 0.41 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.869 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -69.33 -44.44 26.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.869 ' HD3' HG23 ' A' ' 131' ' ' ILE . 83.5 Cg_endo -97.92 109.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.451 2.101 . . . . 0.0 111.707 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.63 -27.46 45.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.638 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.18 -9.07 58.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 132' ' ' PRO . 6.4 p -73.13 -15.18 17.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.9 mt -86.94 89.64 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.6 pt -80.23 -28.03 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.422 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.682 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -128.17 140.12 52.1 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.464 ' HG3' ' OH ' ' A' ' 91' ' ' TYR . 12.1 ttmt -141.62 126.49 18.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.273 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.37 131.41 24.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.775 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' A' ' 143' ' ' GLU . 2.9 tt -92.68 151.89 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 171.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -140.52 122.29 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.177 0.513 . . . . 0.0 112.031 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.468 ' HG3' HD21 ' A' ' 141' ' ' LEU . 26.9 mt-10 -126.79 93.16 3.7 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.001 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 2.1 mt . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 123.407 0.683 . . . . 0.0 111.778 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.93 174.93 10.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.554 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -118.97 159.07 24.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.098 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.423 ' HE2' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.67 132.39 55.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 -177.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.504 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 12.1 ttt180 -131.49 94.77 3.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -90.42 157.48 25.74 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.142 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 HD11 HD22 ' A' ' 21' ' ' LEU . 49.7 mt -125.47 128.71 72.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.869 0.366 . . . . 0.0 110.122 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.86 -31.01 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.858 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.7 p -94.43 55.32 1.96 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -49.92 -29.44 8.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.315 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -70.85 -38.8 73.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.386 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -72.96 -36.18 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.722 -179.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.55 -53.39 28.78 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.454 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -59.81 -36.06 75.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.92 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 15.3 t-20 -68.27 -39.88 82.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.183 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -67.18 -32.47 73.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.293 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 2.36 73.36 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.116 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -169.86 177.75 4.28 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 9' ' ' ILE . 7.1 mt -81.38 49.02 1.22 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.479 0.18 . . . . 0.0 111.166 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt 54.7 69.26 2.15 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.415 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 67.1 Cg_endo -86.21 148.57 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.71 2.273 . . . . 0.0 112.233 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tptt . . . . . 0 C--O 1.236 0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 177.681 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.805 0.336 . . . . 0.0 110.6 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.69 -53.03 34.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.024 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.56 -61.97 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.595 HG11 HH21 ' A' ' 124' ' ' ARG . 3.5 p -67.9 -37.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -172.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.489 ' O ' HG12 ' A' ' 59' ' ' ILE . 6.5 m-85 -63.41 -59.49 4.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.08 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.98 83.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.081 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.41 -29.58 69.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.782 HE22 ' HB3' ' A' ' 67' ' ' CYS . 8.6 tp-100 -67.62 -45.21 76.09 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 109.834 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 55' ' ' TYR . 18.4 mm -66.02 -31.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.437 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -81.58 -74.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.559 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 p -95.68 -38.72 10.24 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.39 48.18 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 58' ' ' GLN . 2.5 mp 59.97 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 111.37 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -95.72 64.33 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.365 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 63.54 -74.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.675 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.45 66.84 0.51 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.782 ' HB3' HE22 ' A' ' 58' ' ' GLN . 8.0 t -56.93 -42.7 80.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.959 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.622 ' HD2' ' HG2' ' A' ' 58' ' ' GLN . 21.4 m-85 -123.39 159.72 28.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.37 104.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 21.3 m -87.39 111.22 20.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 t -123.85 157.22 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 p -87.52 158.49 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -13.16 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.807 0.336 . . . . 0.0 110.9 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -79.79 130.53 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.832 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -58.61 -24.07 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.643 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.02 1.03 22.19 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.669 0.271 . . . . 0.0 111.0 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -48.93 -34.06 5.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.651 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.04 -57.56 12.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 111.372 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -70.42 -43.09 70.67 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.832 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -60.62 -46.46 90.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.282 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 19.3 t80 -68.82 -44.39 73.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.294 -176.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -57.2 -50.61 72.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.68 -44.4 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -15.64 63.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.433 ' HB2' HG13 ' A' ' 87' ' ' ILE . 6.8 m -105.42 2.75 28.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.22 96.6 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.253 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 82' ' ' ALA . 10.1 mt -91.01 -7.8 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -29.21 -43.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.732 0.813 . . . . 0.0 113.186 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -125.17 92.72 3.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.03 -144.73 6.35 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.917 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -105.09 143.37 33.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.72 0.408 . . . . 0.0 110.448 -175.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 5.4 pt -139.88 113.92 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 110.296 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -101.99 156.31 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -129.36 136.92 58.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.559 HD23 HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -128.34 133.9 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.295 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.493 ' HB2' HG21 ' A' ' 137' ' ' ILE . 48.5 t-20 -79.5 134.83 36.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.485 0.183 . . . . 0.0 110.701 -175.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -51.64 13.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.333 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.43 -17.8 64.85 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.782 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.17 -45.61 90.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.344 0.592 . . . . 0.0 109.536 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.458 ' HE2' HD11 ' A' ' 5' ' ' LEU . 59.9 m-85 -66.48 -35.48 80.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.951 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.59 93.1 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.952 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -72.41 -37.2 68.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.136 0.493 . . . . 0.0 110.023 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -75.76 -23.39 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m 69.71 33.93 2.82 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.788 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -65.13 163.92 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.922 174.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.3 m-85 -74.45 99.29 3.51 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.593 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -96.8 99.32 10.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.75 112.39 24.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.614 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -105.02 107.45 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.925 0.393 . . . . 0.0 110.177 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.604 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -91.25 107.54 18.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.35 129.04 34.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.528 0.68 . . . . 0.0 109.455 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -80.75 169.35 19.82 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.146 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.82 167.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.217 1.945 . . . . 0.0 112.407 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.81 -55.96 28.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.0 OUTLIER -87.88 -14.74 0.21 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -168.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 45.6 Cg_exo -43.44 -23.36 0.47 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 121.392 1.533 . . . . 0.0 111.298 162.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 67.84 27.82 7.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.584 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -160.33 154.51 23.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.239 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 135.96 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' A' ' 110' ' ' VAL . 19.0 tt0 -98.5 113.56 25.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.428 . . . . 0.0 111.016 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 t -95.73 103.77 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.981 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 58.3 m -93.19 112.47 24.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 100' ' ' PHE . 4.2 mp -88.68 110.04 20.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.596 ' O ' HG23 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -100.41 116.82 33.26 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.558 178.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.42 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -69.99 159.55 33.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.052 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 126' ' ' GLU . 1.2 mm-40 -48.16 -59.55 3.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 111.012 -176.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.668 ' H ' HG21 ' A' ' 131' ' ' ILE . 48.4 t0 -104.63 154.98 19.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.622 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -76.41 140.68 41.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' A' ' 67' ' ' CYS . . . 90.9 49.34 3.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.766 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.504 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 32.0 m 52.14 70.88 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.047 0.451 . . . . 0.0 112.206 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.668 HG21 ' H ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -69.28 -38.35 10.42 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.661 ' HD3' HG23 ' A' ' 131' ' ' ILE . 95.4 Cg_endo -82.68 118.88 2.87 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 121.267 1.311 . . . . 0.0 112.005 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.1 -31.27 69.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.28 10.07 9.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.494 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 4.2 p -63.29 -29.8 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.611 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.49 93.38 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.493 HG21 ' HB2' ' A' ' 96' ' ' ASN . 18.0 pt -74.86 -32.71 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.102 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -161.56 166.78 26.48 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.371 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -145.42 144.49 30.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.167 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -141.08 160.44 40.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.851 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.39 148.39 25.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.07 137.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.192 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 105.64 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.205 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.562 -176.826 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -157.73 154.65 28.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.097 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.505 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -122.68 151.02 41.94 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.837 0.351 . . . . 0.0 110.597 -174.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.63 136.61 52.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.044 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.471 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 15.2 tpt180 -142.43 102.39 4.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.77 137.12 13.22 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.46 129.66 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.207 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -28.57 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 110.313 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -90.09 42.29 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.808 -178.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.24 -34.59 23.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.148 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -68.93 -42.99 76.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.563 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.6 t70 -65.4 -42.55 92.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 21' ' ' LEU . 2.1 tt0 -61.85 -54.83 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.718 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.65 -32.5 71.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.785 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -35.03 74.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.931 0.396 . . . . 0.0 110.189 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -73.87 -24.31 59.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.784 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.05 5.41 89.73 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.37 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -169.7 162.16 9.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . 1.5 mt -69.33 73.32 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 66.27 149.47 0.12 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.919 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 145.53 82.1 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.592 2.195 . . . . 0.0 111.734 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.508 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.511 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -53.3 -27.47 23.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.36 -66.43 0.39 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.733 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -30.82 49.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.664 0.268 . . . . 0.0 110.96 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.675 ' HA ' ' NH1' ' A' ' 124' ' ' ARG . 22.6 m-30 -62.35 -61.54 2.38 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.649 0.262 . . . . 0.0 110.591 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.75 77.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -52.11 -59.33 4.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.522 ' NE2' ' SG ' ' A' ' 128' ' ' CYS . 1.4 tp-100 -65.72 -51.32 60.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.003 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.476 ' HB ' HH22 ' A' ' 124' ' ' ARG . 2.7 tt -76.91 -24.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.78 -35.89 12.54 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.571 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -89.68 -58.8 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.581 0.229 . . . . 0.0 111.321 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.38 -128.1 6.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.198 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -156.18 -157.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.5 m-85 -98.26 -6.85 30.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.092 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -60.78 91.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 111.288 -172.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.64 -39.03 3.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.222 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.609 ' SG ' ' CZ ' ' A' ' 68' ' ' TYR . 51.8 t -78.92 -48.22 14.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.144 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.609 ' CZ ' ' SG ' ' A' ' 67' ' ' CYS . 30.3 m-85 -129.17 162.68 27.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.658 0.383 . . . . 0.0 110.467 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.64 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.6 mp -92.15 99.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 111.019 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 m -75.73 109.96 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.443 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -118.26 129.09 55.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.275 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.627 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.1 m -75.91 157.46 33.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.07 9.86 16.03 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.643 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 76' ' ' GLU . 16.2 t70 -109.33 135.7 49.96 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.494 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -55.46 -26.15 40.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HG3' ' HE2' ' A' ' 75' ' ' LYS . 11.2 mt-10 -82.81 2.03 36.13 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 121.999 0.12 . . . . 0.0 111.075 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.627 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -44.61 -38.57 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.457 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 4' ' ' PHE . . . -60.03 -55.88 28.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.226 0.536 . . . . 0.0 110.988 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.79 -42.09 67.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.275 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.299 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 22.5 t80 -65.74 -49.48 68.29 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -53.5 -56.46 16.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.303 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -63.3 -39.85 95.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.222 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 m -65.58 -25.6 67.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.941 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -90.4 0.18 57.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.696 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 54.8 30.78 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.708 HG21 ' HB1' ' A' ' 82' ' ' ALA . 4.2 tp -77.12 -9.9 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' A' ' 144' ' ' ILE . 4.2 tt0 -33.32 -47.72 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.492 0.495 . . . . 0.0 111.281 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -131.36 118.01 19.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.938 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 166.25 -168.44 39.9 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.091 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.423 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.85 137.55 32.24 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.91 0.484 . . . . 0.0 109.744 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.48 111.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.7 0.286 . . . . 0.0 110.287 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 3.6 m-30 -111.68 143.4 42.64 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -129.97 130.32 66.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.02 178.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -125.04 141.34 52.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.497 -177.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 99' ' ' LEU . 23.5 t-20 -85.58 132.53 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -62.48 -48.25 80.44 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.709 -175.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 1.3 tp -62.84 -43.33 99.09 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.478 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 33.2 m-85 -62.91 -41.05 99.33 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.592 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.62 -36.03 88.04 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.802 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.07 -44.94 83.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -69.26 -16.62 63.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.3 m 72.13 31.0 2.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.608 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.7 mt -75.55 157.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' O ' ' HB3' ' A' ' 124' ' ' ARG . 7.7 m-85 -83.6 101.95 11.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.734 -163.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -94.87 105.74 17.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.663 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.444 ' HE2' ' HE ' ' A' ' 124' ' ' ARG . 10.6 p90 -126.57 145.27 50.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.991 0.425 . . . . 0.0 110.032 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -95.45 125.27 39.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.689 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 120' ' ' GLU . 1.6 p -90.75 106.85 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.8 145.98 27.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -108.36 170.58 5.34 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.7 Cg_exo -47.7 170.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.452 2.101 . . . . 0.0 113.068 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -46.57 -67.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -93.28 -11.81 0.17 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 35.8 Cg_exo -43.88 -20.49 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 CA-C-N 121.556 1.592 . . . . 0.0 112.683 164.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.09 9.39 6.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.407 0.683 . . . . 0.0 111.708 170.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -110.09 115.61 30.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.217 0.532 . . . . 0.0 112.102 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -138.33 95.75 3.06 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.525 ' HB3' HG13 ' A' ' 110' ' ' VAL . 9.7 tt0 -93.96 140.21 29.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.737 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.92 106.26 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -92.47 121.86 34.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.64 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 18.1 mm -88.71 93.42 4.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.153 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.675 ' NH1' ' HA ' ' A' ' 55' ' ' TYR . 6.8 tpp180 -82.1 99.71 9.36 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.192 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.427 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.52 160.51 32.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.828 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.414 ' HB2' HD13 ' A' ' 131' ' ' ILE . 12.8 mt-10 -58.09 -30.81 66.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -147.44 160.87 42.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.522 ' SG ' ' NE2' ' A' ' 58' ' ' GLN . 76.7 m -61.7 149.94 38.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.983 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.42 26.78 50.43 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.873 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.471 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 1.8 m 57.21 72.0 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.708 0.29 . . . . 0.0 110.485 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.84 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -38.85 -46.2 3.17 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.84 ' HD3' HG23 ' A' ' 131' ' ' ILE . 85.2 Cg_endo -85.68 107.67 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 120.651 1.268 . . . . 0.0 111.07 173.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -24.69 64.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.263 0.554 . . . . 0.0 110.528 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.56 3.52 15.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.374 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.499 HG13 HD23 ' A' ' 95' ' ' LEU . 2.4 p -77.9 -8.76 11.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.267 0.556 . . . . 0.0 110.733 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mm -86.2 96.14 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 pt -64.12 -32.99 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.137 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -144.68 136.3 25.61 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.024 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.1 mtmt -111.42 129.08 56.13 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.328 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -140.98 160.46 40.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.541 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 tt -135.93 150.3 49.25 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 21.2 tt -140.84 147.93 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.801 -176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.28 103.4 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.791 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.45 HD13 ' HG2' ' A' ' 88' ' ' GLU . 20.2 mm . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.242 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' HA ' ' H ' ' A' ' 97' ' ' ARG . 38.0 p90 39.73 -170.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.688 1.195 . . . . 0.0 113.54 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -147.33 160.59 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.21 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.488 ' OH ' HD13 ' A' ' 92' ' ' ILE . 7.4 t80 -121.19 129.56 53.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.628 -170.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.53 HH11 HG12 ' A' ' 69' ' ' ILE . 18.0 ttt180 -140.95 155.12 46.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.92 158.07 16.65 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.931 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.826 HG23 ' HB3' ' A' ' 91' ' ' TYR . 1.1 tt -139.07 129.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.122 0.487 . . . . 0.0 110.468 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.14 -2.04 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 109.378 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 35.93 1.82 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.659 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -56.74 -32.73 65.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.444 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.56 -38.76 77.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.814 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 -45.75 92.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.909 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.03 -52.2 66.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.42 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.49 -27.63 66.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -71.74 -40.96 69.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -85.13 -28.4 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.87 51.32 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.494 ' HG2' ' N ' ' A' ' 21' ' ' LEU . 4.1 tt0 174.44 158.36 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.528 0.731 . . . . 0.0 109.498 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' N ' ' HG2' ' A' ' 20' ' ' GLN . 54.0 mt -65.02 97.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.86 154.31 0.14 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.803 0.69 . . . . 0.0 110.645 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.97 167.2 26.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.765 2.31 . . . . 0.0 112.483 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm . . . . . 0 C--O 1.234 0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.074 178.322 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 111.832 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -59.66 -27.24 66.21 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.845 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.44 -60.23 4.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.528 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.8 p -63.35 -35.4 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.509 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.1 m-85 -59.88 -63.17 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.573 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.2 -46.33 79.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.175 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -62.05 -46.28 89.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 0.0 111.007 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 1.3 pt20 -70.05 -30.26 67.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.316 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 ' HG3' ' A' ' 58' ' ' GLN . 1.2 mp -81.21 -47.39 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.661 0.267 . . . . 0.0 110.722 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.79 -57.18 5.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.004 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.403 ' HB ' HD23 ' A' ' 63' ' ' LEU . 11.7 m -74.67 -26.35 59.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.03 78.83 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.222 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 65' ' ' ASP . 0.8 OUTLIER -65.68 -33.38 75.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.174 -178.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 t80 33.74 46.87 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.795 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.523 ' H ' HD12 ' A' ' 63' ' ' LEU . 37.4 t70 -90.4 -0.27 57.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 109.408 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.07 144.81 46.67 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.417 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 p -71.21 0.77 7.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -65.31 158.79 25.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.53 HG12 HH11 ' A' ' 7' ' ' ARG . 18.1 mt -102.75 138.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.95 131.0 42.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 172.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 5' ' ' LEU . 96.9 m -140.8 110.1 6.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 3.4 m -68.97 152.85 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.103 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 10.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -136.96 142.4 42.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.526 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -54.47 -19.81 6.44 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.733 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.21 -31.21 13.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.862 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -48.07 -31.08 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.27 -54.72 40.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -45.41 62.93 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.765 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -58.52 -49.18 78.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.352 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 7' ' ' ARG . 27.2 t80 -67.48 -49.22 64.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.475 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -55.57 -47.11 76.96 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.507 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -75.91 -39.32 56.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.814 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.3 m -72.69 -20.15 61.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -96.62 3.66 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.5 76.03 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.655 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 82' ' ' ALA . 4.6 mt -72.97 -7.26 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.8 mt-10 -28.68 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -126.46 99.97 6.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.997 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.49 -139.97 5.34 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.77 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.826 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.2 t80 -124.47 150.88 45.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.3 pt -136.84 142.54 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 111.103 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -132.63 135.11 45.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 111.704 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 m -113.92 139.3 40.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.564 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -125.97 142.04 51.7 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.124 -173.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.447 ' HB2' HG21 ' A' ' 137' ' ' ILE . 30.4 t30 -79.68 124.59 28.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.815 0.341 . . . . 0.0 111.139 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.588 ' HB2' HD23 ' A' ' 5' ' ' LEU . 46.9 ttt180 -75.64 -32.76 60.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.49 79.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 135' ' ' VAL . 9.6 tp -65.27 -37.73 88.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.793 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 22.6 m-85 -62.07 -42.71 99.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.761 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.13 -36.25 92.07 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.655 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.62 -48.3 69.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.133 0.492 . . . . 0.0 109.901 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -66.43 -16.45 64.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.584 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m 67.69 30.84 6.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.37 0.605 . . . . 0.0 110.291 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 124' ' ' ARG . 3.5 mt -68.91 152.2 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.778 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.32 101.42 10.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 111.187 -166.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -106.36 120.65 42.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.954 0.407 . . . . 0.0 110.097 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -115.74 120.08 38.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.712 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 tt0 -91.44 132.81 35.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 111.233 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 m -117.75 149.16 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.774 171.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.62 135.14 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 110.631 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -79.44 178.06 2.54 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.7 Cg_exo -50.08 158.01 2.55 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.229 1.286 . . . . 0.0 111.427 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.54 -70.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -88.88 -9.7 0.14 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -166.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 68.0 Cg_exo -47.26 -24.32 3.7 Favored 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.535 1.584 . . . . 0.0 110.716 161.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.58 32.29 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.032 169.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.72 105.09 13.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.395 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -104.56 107.33 18.22 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.47 125.7 48.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 19.1 t -116.75 106.46 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.37 116.48 22.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.758 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.476 HG13 HD22 ' A' ' 5' ' ' LEU . 9.5 mm -87.77 110.82 21.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.82 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.525 ' O ' HG23 ' A' ' 105' ' ' ILE . 1.4 mtt-85 -111.96 106.77 15.55 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.816 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.91 162.3 28.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.64 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.34 -24.83 67.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.332 0.586 . . . . 0.0 110.376 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.24 162.42 33.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.236 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.3 t -80.44 144.39 32.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.47 32.19 14.23 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.529 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.7 m 57.48 68.49 0.84 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.256 0.551 . . . . 0.0 110.537 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.851 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -46.56 -49.89 43.71 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.959 -175.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.851 ' HD3' HG23 ' A' ' 131' ' ' ILE . 93.9 Cg_endo -88.44 107.73 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.33 1.353 . . . . 0.0 112.118 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -76.83 2.15 15.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.108 0.48 . . . . 0.0 110.763 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -90.36 -15.37 31.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.727 ' HA ' HD23 ' A' ' 99' ' ' LEU . 4.0 p -81.58 -14.05 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 139' ' ' LYS . 1.1 tt -87.65 97.54 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.447 HG21 ' HB2' ' A' ' 96' ' ' ASN . 40.0 pt -75.45 -29.65 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.63 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -151.7 146.17 25.58 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.634 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.64 ' HB3' HD11 ' A' ' 136' ' ' ILE . 45.7 pttt -150.32 130.18 13.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.765 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.68 160.7 39.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.889 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 tt -75.74 145.98 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.453 ' HB ' HG12 ' A' ' 92' ' ' ILE . 20.4 tt -125.3 141.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 0.0 110.214 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -149.17 126.6 11.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.552 -177.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 5.1 tt . . . . . 0 C--O 1.238 0.449 0 O-C-N 124.183 0.927 . . . . 0.0 108.952 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.46 ' HB3' ' HG3' ' A' ' 97' ' ' ARG . 53.0 t30 . . . . . 0 C--O 1.238 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.03 125.71 35.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.272 -175.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 3.9 mp -100.64 152.39 20.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.81 133.54 36.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.344 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.662 ' HG3' HH11 ' A' ' 7' ' ' ARG . 0.9 OUTLIER -147.69 130.1 15.75 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.503 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -125.23 157.17 19.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.011 -176.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.25 128.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -15.6 18.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.252 0.549 . . . . 0.0 110.214 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -83.34 60.82 5.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.48 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -27.26 19.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -49.33 28.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.449 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.6 OUTLIER -56.65 -43.2 80.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.204 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -73.76 -33.01 64.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.438 -177.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -79.46 -16.71 55.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.495 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.12 -40.08 24.62 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.692 ' ND2' ' H ' ' A' ' 22' ' ' LYS . 13.0 t30 -89.15 -65.48 1.01 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.88 41.73 8.03 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.55 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -175.53 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.414 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 17.8 mt 53.07 42.62 32.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.52 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.692 ' H ' ' ND2' ' A' ' 18' ' ' ASN . 17.3 ttpp 44.6 74.84 0.73 Allowed Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 123.127 0.571 . . . . 0.0 112.178 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HD3' HD21 ' A' ' 18' ' ' ASN . 71.0 Cg_endo -84.37 161.78 13.0 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.796 2.331 . . . . 0.0 112.947 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.736 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HB3' ' H ' ' A' ' 52' ' ' ASN . 33.9 mttm . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.444 ' H ' ' HB3' ' A' ' 51' ' ' LYS . 4.3 m-20 -61.33 -23.81 65.99 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.452 -176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.85 -61.02 2.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.353 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.94 -30.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.032 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -61.88 -50.43 72.27 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.87 88.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.331 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -56.12 -46.62 79.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.262 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.506 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 2.0 tt0 -59.88 -56.08 26.18 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.427 -176.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -74.46 -33.67 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.667 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.47 -63.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.395 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -84.28 -45.33 12.95 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.066 0.46 . . . . 0.0 111.451 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.02 108.78 2.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.068 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -123.06 52.06 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 109.761 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -91.07 38.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.174 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -77.83 -24.09 48.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.99 -14.74 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.017 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.502 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -55.64 -55.73 28.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.499 0.19 . . . . 0.0 110.827 177.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 16.5 m-85 -127.81 154.45 45.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.21 102.89 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.017 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.14 132.42 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.394 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -135.54 108.53 7.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.19 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.16 164.23 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.23 -176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -35.88 48.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -100.4 132.9 45.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -60.87 -19.65 60.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 16.6 tp10 -54.05 -18.06 3.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.06 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -44.52 -33.61 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.836 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.43 -66.89 0.34 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.154 0.502 . . . . 0.0 112.035 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.17 -37.51 78.22 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.334 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HG2' ' HG3' ' A' ' 76' ' ' GLU . 46.5 mmtm -63.86 -41.74 97.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.113 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.73 -46.46 72.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -57.25 -52.61 64.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.0 m -68.74 -50.63 49.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 m -68.06 -14.82 63.27 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' HG13 ' A' ' 87' ' ' ILE . 16.1 m -103.23 4.84 37.15 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.143 -0.348 . . . . 0.0 111.003 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.56 24.53 73.89 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.066 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 82' ' ' ALA . 6.9 mt -81.12 -8.09 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.509 0.195 . . . . 0.0 110.772 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.494 ' O ' HG12 ' A' ' 142' ' ' ILE . 16.9 mt-10 -37.58 -39.04 0.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.637 0.775 . . . . 0.0 112.866 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -109.86 87.64 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.74 -141.2 5.33 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.901 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -134.87 125.86 27.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.503 HG22 ' HA3' ' A' ' 8' ' ' GLY . 2.0 pt -119.89 147.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 2.8 p90 -130.44 148.58 52.27 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.278 0.561 . . . . 0.0 110.608 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.0 m -113.35 140.22 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.264 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.2 mp -119.59 143.16 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.597 ' HB3' HG21 ' A' ' 137' ' ' ILE . 6.7 t30 -102.55 133.74 47.03 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.683 ' HG2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -64.82 -42.82 94.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.045 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -34.02 65.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.213 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.09 -50.76 64.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.368 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.409 ' HD1' HG13 ' A' ' 105' ' ' ILE . 49.6 m-85 -68.4 -29.95 68.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.98 -47.24 91.35 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.475 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.92 79.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.062 0.458 . . . . 0.0 110.236 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -70.92 -20.16 62.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m 66.24 46.67 1.99 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.507 0.67 . . . . 0.0 110.569 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 125' ' ' ALA . 9.0 mm -79.31 152.15 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.078 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HB3' ' HG2' ' A' ' 124' ' ' ARG . 4.2 t80 -75.44 122.61 24.07 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 110.939 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -104.84 106.52 17.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.512 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -103.44 113.42 26.91 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.875 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.27 109.25 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.016 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -88.2 115.69 28.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 137.4 40.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.551 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.01 170.37 9.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.512 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 78.1 Cg_exo -50.21 157.1 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.377 1.384 . . . . 0.0 111.063 173.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.64 -57.73 5.8 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -168.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.463 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.8 OUTLIER -91.51 -17.55 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -168.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 38.2 Cg_exo -42.23 -22.8 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.37 1.525 . . . . 0.0 111.808 164.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 115' ' ' ASN . 16.9 m-20 68.74 8.51 6.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.102 166.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -111.58 138.04 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -141.6 145.88 35.58 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 110' ' ' VAL . 1.7 tm-20 -122.12 125.08 45.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.98 95.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.5 m -87.08 113.88 23.21 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.572 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.637 HG13 HD21 ' A' ' 5' ' ' LEU . 48.6 mm -88.25 97.25 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.436 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.534 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.566 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -69.46 159.65 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.581 ' HB2' HD13 ' A' ' 131' ' ' ILE . 7.1 mp0 -50.81 -48.24 59.72 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 111.506 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -119.18 160.43 22.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 0.0 110.074 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.01 128.56 34.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.178 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.502 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 93.17 65.16 1.07 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.244 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.03 70.43 0.47 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 126' ' ' GLU . 7.4 tt -68.18 -37.24 10.57 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.649 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.564 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 59.3 Cg_endo -98.52 118.91 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.385 2.057 . . . . 0.0 111.808 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -7.31 53.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.276 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.21 6.91 23.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.193 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.552 ' HB ' HD23 ' A' ' 95' ' ' LEU . 6.0 m -60.31 -22.8 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.554 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.7 mt -87.63 88.22 2.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 109.866 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.597 HG21 ' HB3' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -79.91 -29.77 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.551 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -153.81 166.98 31.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.302 172.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.57 159.09 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.074 0.464 . . . . 0.0 110.879 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -141.14 140.75 34.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.019 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -95.09 149.63 21.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 88' ' ' GLU . 16.5 tt -140.99 141.64 31.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.518 . . . . 0.0 111.68 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.577 ' O ' ' HB ' ' A' ' 144' ' ' ILE . 4.8 tt0 -139.01 22.45 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.747 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 143' ' ' GLU . 10.3 tp . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 125.513 1.525 . . . . 0.0 109.096 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -109.49 156.47 20.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.718 0.294 . . . . 0.0 110.826 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.814 HD12 HG21 ' A' ' 71' ' ' THR . 0.2 OUTLIER -99.55 139.9 34.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -106.61 128.29 54.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.676 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 135.66 20.8 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -110.87 158.3 14.46 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.321 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.555 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 2.3 mt -113.89 129.32 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.762 0.425 . . . . 0.0 110.161 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.34 25.39 11.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.338 0.589 . . . . 0.0 109.899 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.795 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.89 58.98 0.79 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.916 -173.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 mp0 -51.15 -42.4 60.75 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.36 -32.79 73.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.051 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.795 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.4 m-20 -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.961 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -60.38 -45.35 93.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 109.666 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -62.71 -42.72 99.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.51 -43.36 97.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 110.499 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -71.94 -24.85 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.444 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.09 -10.84 72.74 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.262 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -172.6 172.73 4.18 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 mt -65.03 91.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.32 0.387 . . . . 0.0 110.602 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HE3' ' SG ' ' A' ' 128' ' ' CYS . 15.2 tptp 74.7 132.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.891 0.744 . . . . 0.0 110.746 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.01 132.64 18.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.298 1.998 . . . . 0.0 111.046 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 2.2 mmmm . . . . . 0 C--O 1.234 0.243 0 CA-C-O 120.662 0.267 . . . . 0.0 110.293 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.296 0.57 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.83 -23.53 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.021 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.2 -60.68 3.23 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.85 -32.77 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.647 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -60.41 -51.4 69.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.37 78.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.79 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -58.19 -50.55 73.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.687 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.562 ' HG3' ' CD2' ' A' ' 68' ' ' TYR . 9.4 mm100 -55.39 -49.01 73.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 mt -74.53 -46.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.493 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -61.96 -48.24 81.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.074 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 3.6 m -77.59 -32.38 53.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.66 53.96 9.18 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.174 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' H ' HD12 ' A' ' 63' ' ' LEU . 2.7 mp -81.05 -75.87 0.26 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 52.28 39.4 27.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.431 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -90.73 -57.29 2.87 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.713 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.32 -60.4 0.17 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.24 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 74.1 m -51.76 -52.96 44.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.562 ' CD2' ' HG3' ' A' ' 58' ' ' GLN . 18.1 m-30 -120.51 145.05 47.68 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.85 128.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.3 m -87.6 130.82 34.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.814 HG21 HD12 ' A' ' 5' ' ' LEU . 13.4 m -127.74 137.77 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.461 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -88.14 148.01 24.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.453 178.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.77 10.47 3.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 0.0 111.377 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.75 121.99 28.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -63.0 -19.63 64.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 80' ' ' LYS . 6.9 pt-20 -90.13 0.34 57.21 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.66 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 72' ' ' THR . 5.0 tt -49.64 -29.83 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.775 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.66 -68.9 0.15 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.908 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -28.45 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . 9.7 tttp -56.23 -49.79 73.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.496 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.18 -49.47 50.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.741 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.9 68.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.485 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -73.74 -48.91 28.36 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.596 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -65.59 -21.37 66.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 m -95.47 0.38 53.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.05 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 31.01 72.43 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.831 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -8.8 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.639 -173.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 142' ' ' ILE . 31.1 mm-40 -40.27 -34.29 0.31 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.487 . . . . 0.0 112.101 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -112.26 96.76 6.2 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.45 -135.52 3.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.022 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.555 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.94 150.31 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.082 0.553 . . . . 0.0 109.609 -175.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.551 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 pt -142.97 133.08 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -131.72 154.97 48.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.1 0.476 . . . . 0.0 111.379 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 138' ' ' ALA . 32.9 m -129.84 136.63 58.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.459 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -113.64 141.95 46.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.809 -177.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.455 ' HB3' HG21 ' A' ' 137' ' ' ILE . 3.3 p30 -83.8 143.4 29.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.56 -27.98 21.04 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.689 0.28 . . . . 0.0 111.073 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.0 -33.51 62.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -61.44 -41.57 97.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.064 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 22.6 m-85 -71.11 -41.23 70.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.22 91.08 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.05 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -74.73 -43.45 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.0 109.576 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.06 -25.22 66.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.569 -177.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m 67.21 28.63 8.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 110.046 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -66.43 164.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.294 176.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.78 ' HB3' ' HB2' ' A' ' 124' ' ' ARG . 4.0 t80 -73.45 99.35 2.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.293 0.568 . . . . 0.0 110.381 -167.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -95.3 100.02 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.012 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 4.1 t80 -124.73 113.47 18.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -97.64 142.14 29.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.81 132.07 49.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.491 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 6.5 pt-20 -129.57 136.13 49.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.084 0.468 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 178.06 2.63 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.736 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.76 171.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.028 1.819 . . . . 0.0 112.28 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.9 -67.87 0.23 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.8 t-20 -86.15 -11.08 0.17 Allowed Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -166.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 43.7 Cg_exo -42.35 -25.48 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 121.439 1.55 . . . . 0.0 111.271 162.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.9 3.8 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.656 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.74 130.72 53.26 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 111.646 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 111' ' ' GLU . 17.6 ptmt -150.97 141.62 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.763 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -122.62 132.91 54.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.91 112.42 25.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.924 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 2.7 m -88.78 114.9 25.9 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.779 0.324 . . . . 0.0 110.383 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pt -87.45 113.4 24.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.78 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 23.1 mtt-85 -114.91 88.51 2.88 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.744 -172.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.664 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.87 123.23 20.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.583 172.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -51.77 -46.43 64.12 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.386 0.429 . . . . 0.0 111.637 -168.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.704 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 2.0 t70 -80.21 122.66 27.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.567 ' SG ' ' HE3' ' A' ' 22' ' ' LYS . 7.4 t -54.02 119.56 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.459 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.94 56.89 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.936 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.8 m 63.26 74.82 0.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.704 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 19.3 tt -45.44 -35.27 3.08 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.623 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 91.9 Cg_endo -96.42 109.1 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 121.595 1.53 . . . . 0.0 111.592 169.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -63.8 -22.78 67.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.392 0.615 . . . . 0.0 109.842 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.21 -7.68 43.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.556 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.3 p -77.26 -15.25 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.078 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.86 89.96 3.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.455 HG21 ' HB3' ' A' ' 96' ' ' ASN . 14.5 pt -74.74 -30.62 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.275 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -150.0 148.14 28.69 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.41 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -143.94 127.74 17.26 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.323 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -131.11 152.23 50.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.273 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.57 150.07 23.78 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.7 tt -140.19 135.41 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -120.84 42.82 2.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.241 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--O 1.234 0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.483 -173.705 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.03 155.47 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.261 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.545 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -100.29 146.09 27.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.537 ' HE1' ' HB ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -113.57 130.96 56.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.744 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HG3' HG22 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -138.25 126.78 23.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.653 178.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -109.6 157.84 14.86 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -129.94 132.66 65.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 -177.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -22.22 19.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.401 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -84.8 49.03 1.64 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.499 -177.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.53 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -57.78 -26.11 61.46 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 2.2 pt20 -63.43 -41.48 98.68 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.848 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -69.65 -41.46 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.677 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.93 -55.86 29.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -63.24 -39.51 94.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.072 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.59 -37.33 87.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 110.448 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -23.98 37.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 65.78 14.5 60.79 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 13.2 mt-30 -156.38 172.87 17.76 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.11 42.29 0.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.822 0.344 . . . . 0.0 110.751 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 45.61 59.23 15.03 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.16 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.91 171.71 9.21 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.95 2.433 . . . . 0.0 113.177 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.087 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -53.79 -34.87 60.48 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.6 -57.04 12.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.897 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.6 -34.37 69.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.507 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -58.4 -64.22 1.0 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.109 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.86 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.23 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.692 ' HB3' HD22 ' A' ' 63' ' ' LEU . 1.1 t-80 -64.92 -49.65 69.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.355 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 35.9 tt0 -66.1 -38.1 87.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.1 -34.4 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.7 -74.22 0.42 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.836 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -64.41 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.484 0.659 . . . . 0.0 111.441 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 58' ' ' GLN . . . 133.75 158.99 8.82 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 57' ' ' HIS . 2.6 pt? -175.96 -44.49 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.066 0.433 . . . . 0.0 111.233 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.435 ' CE2' ' SG ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -114.35 89.26 3.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.752 -174.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.56 134.86 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.725 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.4 -7.56 81.72 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.369 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -73.45 -35.63 65.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.19 0.519 . . . . 0.0 110.58 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.53 160.75 30.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.783 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.731 HG12 ' HB ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -105.06 100.69 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -175.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HG23 ' A' ' 122' ' ' THR . 0.0 OUTLIER -85.95 125.23 33.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.611 176.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.644 HG23 HD12 ' A' ' 77' ' ' ILE . 97.3 m -137.44 148.56 46.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 110.541 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.38 170.55 9.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -177.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.21 4.74 9.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.53 135.92 47.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.332 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -66.35 -23.35 66.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.84 -16.13 62.69 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.74 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.644 HD12 HG23 ' A' ' 71' ' ' THR . 0.0 OUTLIER -48.39 -34.27 5.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 123.387 0.43 . . . . 0.0 110.977 176.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.46 -53.99 51.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 79' ' ' LYS . 24.1 ttpt -75.11 -40.35 59.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.888 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -59.5 -52.3 66.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.04 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 1.4 t80 -64.74 -45.84 84.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.469 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -52.36 -59.15 4.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.272 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -64.5 -39.13 93.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -66.71 -26.66 67.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.685 0.279 . . . . 0.0 111.429 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -90.09 2.05 55.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.84 0.352 . . . . 0.0 110.478 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.34 33.36 84.26 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.538 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.63 HD12 HG21 ' A' ' 142' ' ' ILE . 1.8 pp -65.44 -9.96 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -29.22 -50.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.181 0.925 . . . . 0.0 112.323 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -118.36 89.66 3.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.48 -149.58 10.25 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.989 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.53 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 6.7 t80 -115.92 145.44 42.9 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.733 0.413 . . . . 0.0 110.524 -175.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.537 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 1.9 pt -143.54 129.46 16.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.42 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 15.5 p90 -130.71 144.36 51.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.102 0.477 . . . . 0.0 111.232 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.787 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.95 135.94 46.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.164 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -118.15 130.34 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.131 177.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.618 ' HB3' HD12 ' A' ' 99' ' ' LEU . 59.3 t30 -79.8 141.68 36.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.576 0.227 . . . . 0.0 111.011 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 100' ' ' PHE . 16.2 ttt180 -80.07 -50.95 9.63 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.63 -22.46 65.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 111.088 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 96' ' ' ASN . 18.8 mt -64.15 -37.43 87.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.446 ' CE1' HG11 ' A' ' 135' ' ' VAL . 49.8 m-85 -63.28 -44.27 95.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.698 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.73 -37.47 83.84 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -66.61 -36.64 83.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 110.499 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -83.94 -7.87 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.173 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.0 m 69.56 34.67 2.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.27 0.557 . . . . 0.0 110.791 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.589 HG13 ' HA ' ' A' ' 125' ' ' ALA . 1.2 mp -74.22 157.18 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.919 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -77.12 101.22 6.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.114 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.81 99.96 12.87 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -104.65 113.36 26.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.06 126.21 54.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 120' ' ' GLU . 3.7 m -108.26 132.01 57.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -111.65 133.77 53.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.577 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.83 174.55 5.76 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 84.5 Cg_exo -48.37 170.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.447 2.098 . . . . 0.0 113.25 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -40.79 -71.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.1 t-20 -100.13 -9.17 0.13 Allowed Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 47.4 Cg_exo -42.34 -26.98 0.63 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 CA-C-N 121.846 1.695 . . . . 0.0 111.09 165.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.65 26.45 9.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.386 168.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 116' ' ' PRO . 89.8 mt-10 -114.39 118.09 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -124.83 112.59 16.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 110' ' ' VAL . 8.5 tt0 -96.26 106.16 18.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 109.991 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.56 95.86 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.618 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 70' ' ' SER . 0.2 OUTLIER -81.07 107.11 13.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.175 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 69' ' ' ILE . 23.0 mm -87.85 106.68 16.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 105' ' ' ILE . 37.7 mtt85 -104.46 119.12 38.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.241 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.589 ' HA ' HG13 ' A' ' 105' ' ' ILE . . . -68.9 155.31 40.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.934 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.79 -49.4 62.78 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.313 0.578 . . . . 0.0 110.098 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.419 ' H ' HG21 ' A' ' 131' ' ' ILE . 1.2 t0 -122.35 156.09 34.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.991 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.435 ' SG ' ' CE2' ' A' ' 64' ' ' TYR . 20.5 t -73.07 150.28 42.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 111.236 -175.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.61 51.87 2.97 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.098 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 41.62 70.34 0.28 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.865 0.466 . . . . 0.0 112.243 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -56.17 -48.5 96.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.755 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.842 ' HD3' HG23 ' A' ' 131' ' ' ILE . 87.1 Cg_endo -100.31 109.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.591 2.194 . . . . 0.0 112.395 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -77.37 -0.48 25.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.665 0.269 . . . . 0.0 111.301 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -87.81 -5.33 58.67 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.291 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 95' ' ' LEU . 30.9 m -76.21 -17.25 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.84 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.3 pt -86.11 89.89 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.738 0.78 . . . . 0.0 109.378 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.61 -31.06 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.305 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -142.18 146.21 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.415 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -151.66 114.92 4.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.856 177.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.61 160.5 39.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.65 156.63 16.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.034 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.63 HG21 HD12 ' A' ' 87' ' ' ILE . 13.8 tt -134.16 137.76 51.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -119.83 90.43 3.33 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.028 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 N--CA 1.474 0.744 0 C-N-CA 123.528 0.731 . . . . 0.0 111.49 -178.314 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 C--O 1.238 0.481 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -116.07 150.46 37.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.212 0.53 . . . . 0.0 111.577 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.1 OUTLIER -100.53 151.35 21.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.97 132.57 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -173.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 7' ' ' ARG . 27.6 ttt-85 -140.15 99.39 3.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.406 0.622 . . . . 0.0 109.41 171.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.611 ' H ' ' HE2' ' A' ' 81' ' ' PHE . . . -89.13 154.74 24.67 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 39.0 mt -121.16 133.24 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.823 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -122.37 17.68 10.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.47 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.61 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -123.5 46.68 2.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.646 -179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -54.02 -29.79 45.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.752 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -63.99 -42.29 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.073 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -69.13 -45.29 70.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.068 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -38.6 83.44 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.205 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -69.74 -41.98 74.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.9 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.97 -41.25 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -80.41 -27.21 38.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 6.79 85.64 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -164.49 178.37 7.46 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 136' ' ' ILE . 12.6 mt -80.11 61.08 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.079 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 32.76 71.91 0.65 Allowed Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.397 1.079 . . . . 0.0 113.047 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.54 169.85 8.02 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.002 2.468 . . . . 0.0 112.258 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.324 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.811 177.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-O 120.712 0.292 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -50.99 -59.57 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.151 -175.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.29 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.265 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.25 -37.35 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.516 -171.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.7 m-85 -77.58 -42.4 35.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.538 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.66 75.44 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 109.976 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.16 -48.72 69.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 62' ' ' GLY . 1.4 tt0 -57.98 -29.79 65.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.954 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.7 mt -93.56 -52.78 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.337 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -77.13 -49.56 14.96 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.828 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.98 -32.88 24.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.104 0.478 . . . . 0.0 111.244 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 58' ' ' GLN . . . 134.59 172.11 12.71 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 70' ' ' SER . 84.3 mt -58.83 -15.3 11.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 111.507 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 74.31 -28.0 0.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 164.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.79 101.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.999 0.428 . . . . 0.0 111.664 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.49 -112.8 0.31 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.776 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.4 p -76.99 -34.88 57.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.765 -177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -83.15 145.61 29.11 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.731 HD12 HD11 ' A' ' 123' ' ' ILE . 21.4 mt -117.94 128.06 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.39 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.638 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.3 p -95.22 113.95 25.68 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.541 HG21 ' HB2' ' A' ' 5' ' ' LEU . 7.8 p -122.77 144.43 49.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.622 0.249 . . . . 0.0 110.801 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.0 m -87.81 150.2 23.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.831 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -16.06 62.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -79.35 135.52 36.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.858 0.361 . . . . 0.0 110.519 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -62.41 -20.9 64.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -72.63 -4.19 29.44 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.4 tt -51.29 -34.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.326 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.5 -58.91 6.52 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.151 0.5 . . . . 0.0 111.068 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.31 -43.52 70.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.058 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.95 -44.54 94.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.225 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.611 ' HE2' ' H ' ' A' ' 8' ' ' GLY . 87.5 t80 -65.98 -55.37 17.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.003 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.43 73.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.671 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -72.73 -45.91 56.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.604 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.1 m -70.7 -17.15 62.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.6 m -92.9 -4.2 53.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.555 0.217 . . . . 0.0 111.001 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 37.6 95.23 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' HA ' HD13 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -90.88 -8.8 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.365 -0.417 . . . . 0.0 111.653 -171.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -42.37 -32.75 0.55 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -119.13 90.79 3.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.49 -145.97 8.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.375 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -107.68 146.79 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.252 0.221 . . . . 0.0 110.458 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 mt -138.68 118.44 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.406 ' OH ' ' HD3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -131.89 143.4 50.13 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.75 173.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.4 m -120.75 149.38 23.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-O 121.275 0.56 . . . . 0.0 111.123 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.662 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -122.92 134.91 54.34 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.523 -174.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.565 ' HB2' HD13 ' A' ' 137' ' ' ILE . 31.0 t30 -87.22 115.75 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.714 0.292 . . . . 0.0 110.944 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.44 -30.08 70.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -63.21 -36.37 83.43 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 134' ' ' GLU . 32.2 tp -69.14 -40.41 78.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -62.5 -34.74 77.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.388 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.74 -39.94 98.0 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.519 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -63.55 -42.1 98.39 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.085 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.481 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 19.4 m-85 -74.07 -16.94 61.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.964 0.412 . . . . 0.0 110.339 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.5 m 65.42 33.8 8.6 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.101 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 125' ' ' ALA . 75.3 mt -63.23 147.79 11.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.234 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.63 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 1.6 m-85 -75.21 150.13 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 0.0 110.642 -167.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.25 118.05 8.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.585 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.503 ' HD2' ' NH2' ' A' ' 124' ' ' ARG . 72.6 t80 -127.52 117.58 22.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.619 ' HG2' HG22 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -92.5 133.24 36.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.84 -177.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -97.91 134.11 37.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -96.71 133.06 41.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.362 0.601 . . . . 0.0 111.209 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.87 171.81 11.55 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 168.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.5 Cg_exo -46.63 164.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.824 1.682 . . . . 0.0 112.136 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -47.56 -67.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -87.18 -13.69 0.2 Allowed Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -167.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 31.5 Cg_exo -42.59 -23.63 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 121.454 1.555 . . . . 0.0 111.774 163.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.41 23.67 9.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.895 170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.11 134.87 54.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.88 -172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -125.39 106.57 9.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.065 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.582 ' HB3' HG22 ' A' ' 110' ' ' VAL . 2.7 tp10 -79.29 91.92 5.08 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 110.201 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 109' ' ' GLU . 17.5 t -73.43 98.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.565 HG21 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -84.16 114.84 22.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.731 HD11 HD12 ' A' ' 69' ' ' ILE . 1.6 pp -86.45 129.66 37.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 109.463 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.63 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.32 108.08 14.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.731 -173.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.575 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -78.45 161.11 27.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.405 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 -6.27 42.3 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.865 0.364 . . . . 0.0 110.455 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 3.9 t70 -153.48 159.71 42.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 m -85.85 133.51 33.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.899 0.381 . . . . 0.0 111.235 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.38 49.68 2.96 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.447 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.444 ' HB3' HG11 ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.76 70.3 0.66 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.816 0.341 . . . . 0.0 111.672 173.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -61.61 -45.7 93.62 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.816 ' HD3' HG23 ' A' ' 131' ' ' ILE . 59.1 Cg_endo -70.91 129.95 17.18 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.436 1.424 . . . . 0.0 112.096 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -64.14 -24.92 67.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.046 0.45 . . . . 0.0 110.881 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HB3' HD21 ' A' ' 99' ' ' LEU . 3.7 mp0 -88.74 10.63 20.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.662 HG22 HD23 ' A' ' 95' ' ' LEU . 10.0 p -59.31 -31.61 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.937 0.399 . . . . 0.0 111.646 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.418 HG12 HD11 ' A' ' 21' ' ' LEU . 10.8 mt -89.17 88.2 2.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.565 HD13 ' HB2' ' A' ' 96' ' ' ASN . 1.1 pt -79.36 -28.4 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.958 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -146.98 141.55 26.57 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.633 171.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.09 124.92 19.7 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.773 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.8 157.14 45.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.74 146.47 36.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.19 135.45 54.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 0.0 111.492 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.94 51.64 2.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.947 177.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.327 -178.144 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' SD ' ' N ' ' A' ' 2' ' ' GLY . 8.8 tmm? . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.491 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . 77.09 -72.37 2.1 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.633 ' HB2' ' HD2' ' A' ' 97' ' ' ARG . 5.9 m120 -155.08 153.81 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -99.01 114.19 26.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.359 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mt -100.5 143.31 30.83 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' OH ' HD12 ' A' ' 92' ' ' ILE . 1.3 t80 -138.18 134.01 33.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.38 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.548 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.05 141.98 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -127.57 157.78 21.03 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 91' ' ' TYR . 13.9 tt -138.42 136.91 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.002 0.43 . . . . 0.0 110.701 -175.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.2 m -100.05 -16.61 17.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.24 0.543 . . . . 0.0 109.976 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -86.89 51.19 2.17 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.144 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -21.89 42.95 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.643 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -63.3 -55.72 22.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.717 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.97 -42.86 99.13 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.383 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HG3' HD23 ' A' ' 21' ' ' LEU . 6.3 tm-20 -55.83 -57.29 12.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.813 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -70.17 -29.81 66.78 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.355 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -72.06 -43.8 64.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.049 0.452 . . . . 0.0 110.635 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -78.77 -23.91 45.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.993 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.99 24.39 73.1 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.186 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 5.7 mt-30 -161.54 27.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.126 0.171 . . . . 0.0 110.751 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 136' ' ' ILE . 15.5 mt 73.57 -43.43 0.55 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -164.76 141.97 5.11 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -171.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.63 138.3 79.0 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.41 2.074 . . . . 0.0 112.071 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.93 166.58 23.0 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.888 0.375 . . . . 0.0 111.316 -176.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -166.95 75.73 0.13 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -78.44 153.11 31.74 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.753 0.311 . . . . 0.0 111.678 -174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.37 -154.25 0.31 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.056 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 74.71 -77.89 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.328 0.651 . . . . 0.0 111.232 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 56.54 61.08 2.8 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.187 0.517 . . . . 0.0 111.119 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -178.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.857 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.03 -70.17 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.827 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.5 mm 64.64 122.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.145 0.578 . . . . 0.0 111.615 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -148.08 137.78 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.451 ' HD1' ' HA ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -87.96 68.33 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 110.288 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -70.27 161.8 29.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.043 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.28 -39.81 43.95 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.82 89.26 3.09 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 166.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -76.56 62.7 1.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.702 -168.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -79.39 57.7 2.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -76.87 -19.04 57.93 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.172 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.4 -136.93 1.0 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.135 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.8 -122.83 0.64 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.861 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 23.1 mmmt -82.28 -80.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.848 0.356 . . . . 0.0 110.52 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.53 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.931 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.31 158.03 9.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.767 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -112.52 105.6 13.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.831 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.5 -152.73 7.27 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.007 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -89.24 -172.97 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.254 2.636 . . . . 0.0 112.006 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.481 ' O ' HG12 ' A' ' 50' ' ' VAL . 16.5 m 67.98 117.09 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.64 0.588 . . . . 0.0 111.532 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER 61.38 -175.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.92 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.518 ' N ' HG13 ' A' ' 50' ' ' VAL . 19.5 mtpt 68.47 177.64 0.25 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.582 0.706 . . . . 0.0 111.821 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -58.63 -24.61 61.44 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.346 173.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.88 -63.83 1.0 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.555 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG13 ' OH ' ' A' ' 68' ' ' TYR . 2.3 p -69.42 -38.68 77.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 121.091 -0.244 . . . . 0.0 111.236 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.407 ' CZ ' ' HG3' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -62.1 -57.02 13.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.942 0.401 . . . . 0.0 110.073 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.05 85.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.1 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -58.23 -49.98 75.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.647 0.261 . . . . 0.0 110.691 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -70.72 -35.93 72.97 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.029 -178.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.0 -42.39 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.921 0.391 . . . . 0.0 111.03 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -92.22 -60.25 1.89 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.821 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 m -90.8 -73.25 0.54 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.795 0.331 . . . . 0.0 111.727 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.47 66.29 3.85 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.254 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 13.6 tp -62.46 90.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.079 0.466 . . . . 0.0 110.907 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 64.1 47.5 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.739 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.4 -15.44 63.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.472 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 131.62 -7.81 5.56 Favored Glycine 0 C--N 1.329 0.14 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.432 ' SG ' ' CE1' ' A' ' 68' ' ' TYR . 13.9 t -59.01 -50.44 74.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.768 0.318 . . . . 0.0 110.604 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.432 ' CE1' ' SG ' ' A' ' 67' ' ' CYS . 12.1 m-85 -106.33 160.35 15.43 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.072 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mt -102.21 99.49 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -78.82 126.43 30.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.698 179.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.469 HG23 HG13 ' A' ' 121' ' ' VAL . 15.4 t -140.21 152.25 45.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.992 0.425 . . . . 0.0 110.596 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.572 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -89.46 169.11 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.85 10.17 3.59 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -116.79 127.44 54.34 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -69.8 -19.23 63.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.053 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.62 0.47 26.29 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 72' ' ' THR . 1.2 tt -52.27 -27.08 9.89 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.854 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.07 -51.65 68.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.221 0.534 . . . . 0.0 110.839 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -49.22 67.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.805 -177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -62.92 -41.78 99.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.492 -175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -69.4 -43.52 73.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.259 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -63.0 -42.73 99.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.071 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -69.92 -52.99 19.95 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -65.89 -21.97 66.48 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.532 ' HB2' HG13 ' A' ' 87' ' ' ILE . 12.3 m -97.77 0.06 46.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.45 29.25 74.5 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.505 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 85' ' ' SER . 4.4 mt -80.3 -8.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 122.811 -0.229 . . . . 0.0 111.06 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 3.8 tt0 -45.17 -27.52 0.62 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.908 0.385 . . . . 0.0 111.306 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.8 89.98 3.24 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.66 -148.14 12.1 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.233 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.451 ' HB3' HG23 ' A' ' 9' ' ' ILE . 3.3 t80 -116.68 146.21 42.91 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.839 0.456 . . . . 0.0 110.306 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.515 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 pt -144.69 141.86 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 6.8 p90 -131.63 152.88 50.48 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.017 0.437 . . . . 0.0 111.2 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.5 m -118.83 142.59 33.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.274 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -134.22 142.69 47.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.672 -175.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -98.15 142.18 30.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.822 0.344 . . . . 0.0 110.678 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.633 ' HD2' ' HB2' ' A' ' 3' ' ' ASN . 47.3 ttt180 -77.5 -34.87 54.0 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.568 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 9.8 p-10 -59.14 -25.77 64.17 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 0.0 110.822 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 135' ' ' VAL . 22.7 tp -65.46 -41.07 93.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.118 0.485 . . . . 0.0 109.778 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 5.0 m-85 -66.29 -38.77 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.73 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -58.4 -41.51 95.25 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.753 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -68.63 -39.1 80.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.288 0.566 . . . . 0.0 110.203 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.564 ' HB3' HG12 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -68.98 -21.65 64.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.759 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.9 m 71.24 32.37 2.21 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.523 0.678 . . . . 0.0 110.192 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.564 HG12 ' HB3' ' A' ' 103' ' ' TYR . 24.6 mm -75.7 146.39 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.307 175.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.558 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -87.16 164.08 16.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.008 0.432 . . . . 0.0 110.711 -171.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.38 138.2 27.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.989 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -125.64 113.01 16.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 pt-20 -105.25 119.73 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.535 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 120' ' ' GLU . 1.9 m -90.2 150.36 3.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -119.56 132.07 55.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.297 0.57 . . . . 0.0 110.925 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 18.5 m80 -81.61 -176.46 0.78 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 168.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 90.0 Cg_exo -46.59 158.39 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.328 1.352 . . . . 0.0 111.092 168.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.61 -44.93 95.74 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.481 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -84.42 -19.77 0.26 Allowed Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -168.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 39.9 Cg_exo -41.87 -22.76 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.532 1.488 . . . . 0.0 111.436 162.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.424 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.0 OUTLIER 72.58 20.8 3.75 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.49 166.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.7 150.27 34.02 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.573 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -129.42 137.31 50.83 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.228 174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.434 ' HB3' HG22 ' A' ' 110' ' ' VAL . 3.2 tm-20 -90.57 111.94 23.43 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.469 HG13 HG23 ' A' ' 71' ' ' THR . 1.8 p -102.56 102.89 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.521 0.677 . . . . 0.0 110.098 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 1.9 m -87.41 126.25 34.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.252 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.2 mt -87.59 111.47 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.091 0.472 . . . . 0.0 110.404 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.673 HH12 ' HA ' ' A' ' 126' ' ' GLU . 1.3 tmm_? -84.22 95.48 8.68 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.502 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.654 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.86 155.41 40.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.124 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.673 ' HA ' HH12 ' A' ' 124' ' ' ARG . 22.1 mm-40 -73.44 -4.09 31.54 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.677 0.275 . . . . 0.0 111.578 -177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -150.51 159.49 44.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.9 m -80.36 120.04 23.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.891 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.67 69.2 1.2 Allowed Glycine 0 C--N 1.332 0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.522 172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 4.4 m 55.18 70.83 0.59 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.654 HG22 ' HB1' ' A' ' 125' ' ' ALA . 5.2 tt -64.21 -33.82 10.18 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.505 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 45.3 Cg_endo -92.88 126.7 0.69 Allowed 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.008 1.805 . . . . 0.0 111.679 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -85.18 -29.07 25.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.924 0.392 . . . . 0.0 111.054 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.53 10.56 32.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.384 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 95' ' ' LEU . 9.3 p -72.37 -16.11 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.256 0.551 . . . . 0.0 111.011 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.625 HD13 HD11 ' A' ' 21' ' ' LEU . 5.8 pt -88.3 89.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.429 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 20.1 pt -73.21 -19.38 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.836 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -142.63 138.08 30.45 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.598 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.575 ' HD3' HD12 ' A' ' 136' ' ' ILE . 28.7 mtmm -130.14 125.23 34.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.56 175.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -138.81 153.97 48.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 tt -99.84 157.66 16.35 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.2 tt -136.05 129.27 47.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.262 0.553 . . . . 0.0 112.34 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 78.95 1.84 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.462 173.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.656 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 70.9 mt 66.44 108.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 123.069 0.548 . . . . 0.0 111.342 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -81.96 66.21 7.43 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.503 0.668 . . . . 0.0 110.195 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.1 tp -78.59 164.1 24.95 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.874 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 70.48 -158.15 0.14 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.8 m170 69.56 -71.72 0.12 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.469 0.708 . . . . 0.0 111.021 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -95.79 0.34 52.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 111.096 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.61 69.16 2.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.026 0.441 . . . . 0.0 110.234 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -68.17 -31.53 71.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.278 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -168.89 -42.43 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 17.1 p80 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.313 173.689 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.73 -171.45 21.9 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.151 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.579 ' HA ' ' NH1' ' A' ' 97' ' ' ARG . 64.6 t30 -177.94 -82.17 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -131.76 122.73 26.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 5.1 mp -100.51 130.64 46.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.29 129.39 55.87 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 0.6 OUTLIER -142.04 151.88 42.84 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -133.92 156.96 22.6 Favored Glycine 0 CA--C 1.517 0.21 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.794 HG23 ' HB3' ' A' ' 91' ' ' TYR . 6.4 tt -144.04 141.0 25.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.181 0.515 . . . . 0.0 111.003 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.03 -25.14 17.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.522 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.1 m -81.6 51.94 1.78 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.363 0.601 . . . . 0.0 110.076 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 10.7 pt20 -52.48 -33.93 46.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.186 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -76.22 -37.49 57.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.879 -174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.14 -39.62 93.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.879 176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.12 -43.56 98.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.092 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 12' ' ' GLN . 66.7 mm-40 -67.18 -34.02 76.63 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.86 176.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -77.31 -32.99 55.72 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.563 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' HB3' ' OE1' ' A' ' 20' ' ' GLN . 64.4 m-20 -92.4 -46.17 7.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.79 12.33 81.57 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.559 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -145.74 6.87 1.07 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.017 0.408 . . . . 0.0 111.173 179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER 61.83 95.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.536 0.522 . . . . 0.0 111.212 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' HG3' ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER 56.59 118.23 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.705 1.202 . . . . 0.0 112.381 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.72 111.26 0.47 Allowed 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.192 2.595 . . . . 0.0 112.593 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -67.34 169.25 9.18 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.983 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.82 -105.25 0.72 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.502 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -179.39 -172.55 0.23 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.631 0.253 . . . . 0.0 110.546 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.42 -177.11 4.51 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.237 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -158.35 133.37 8.49 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -86.36 -31.95 21.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 0.0 110.045 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 30' ' ' VAL . 2.2 m -79.85 90.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.488 173.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.22 162.94 0.18 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.579 ' HA ' ' HG2' ' A' ' 51' ' ' LYS . 26.7 mm -74.31 137.93 22.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.964 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -110.15 136.63 49.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.06 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.475 ' HB2' ' OH ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -127.36 135.66 50.81 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.813 -177.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' HB2' HD22 ' A' ' 52' ' ' ASN . 11.0 t0 -95.46 103.14 14.99 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.69 -154.03 25.25 Favored Glycine 0 C--O 1.236 0.23 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -115.86 79.13 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.3 0.571 . . . . 0.0 110.35 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -152.92 120.64 6.04 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.645 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -104.18 141.49 36.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.946 0.403 . . . . 0.0 110.82 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' OH ' ' HB2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -156.24 -156.05 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.29 179.24 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -159.17 48.97 0.33 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.351 0.596 . . . . 0.0 109.939 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.62 135.06 28.51 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.913 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -142.63 53.21 1.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.912 0.387 . . . . 0.0 110.389 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 127' ' ' ASP . . . -132.79 169.4 16.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.0 m 65.22 73.75 0.4 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.61 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 78.56 0.66 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.931 174.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.51 -163.54 20.38 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -87.44 -173.96 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.04 2.493 . . . . 0.0 111.56 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 m 55.64 -134.66 1.41 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.353 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.857 HG13 ' HG3' ' A' ' 51' ' ' LYS . 2.4 p 46.78 -158.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.201 0.6 . . . . 0.0 111.13 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.857 ' HG3' HG13 ' A' ' 50' ' ' VAL . 44.3 mttt 47.2 -127.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.148 0.431 . . . . 0.0 111.224 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.489 HD22 ' HB2' ' A' ' 35' ' ' ASP . 8.9 m120 -54.26 -39.05 66.49 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.741 0.305 . . . . 0.0 111.03 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.89 -50.38 66.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.226 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.804 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 8.6 p -67.25 -39.06 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.643 0.258 . . . . 0.0 111.009 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.38 -51.35 61.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.896 0.379 . . . . 0.0 110.206 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.67 -46.38 90.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.975 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -64.81 -34.54 78.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.667 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.591 ' HG3' ' HD2' ' A' ' 68' ' ' TYR . 1.6 tm0? -60.83 -53.19 60.41 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 mt -71.82 -41.38 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.053 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.1 -67.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.068 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.4 -71.21 0.62 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.963 0.411 . . . . 0.0 110.845 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.4 138.98 3.82 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -152.71 47.37 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -90.07 6.67 41.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.854 -175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -100.91 -30.57 11.59 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.189 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.16 -72.39 0.19 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.223 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.0 t -60.95 -52.27 65.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.591 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 18.8 m-30 -117.61 161.06 20.25 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.605 HG23 ' HB ' ' A' ' 123' ' ' ILE . 3.4 tt -126.98 132.88 69.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.667 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.7 p -106.75 140.58 39.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.829 0.347 . . . . 0.0 110.722 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 m -129.07 133.6 47.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.845 175.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.457 ' H ' HD12 ' A' ' 77' ' ' ILE . 4.4 p -74.51 163.88 27.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -18.13 58.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -99.65 135.71 40.66 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.961 0.41 . . . . 0.0 111.79 -174.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.71 -20.79 61.94 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.009 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -69.33 -3.5 14.33 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.77 -0.196 . . . . 0.0 111.366 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 3.9 tt -57.08 -34.46 45.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.245 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.22 -63.19 1.39 Allowed 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.98 0.419 . . . . 0.0 111.757 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.9 mmtp -67.73 -43.26 80.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.046 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -62.77 -46.96 85.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.088 -177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 17.8 t80 -64.55 -48.78 73.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -56.38 -59.72 4.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.165 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -64.92 -33.63 76.48 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.499 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.4 m -73.03 -23.37 60.59 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.003 179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.9 m -84.05 -7.84 59.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.887 0.375 . . . . 0.0 110.025 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.47 39.8 98.1 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.038 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -68.05 -10.32 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 111.394 0.146 . . . . 0.0 111.394 -177.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -32.54 -35.3 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.954 0.784 . . . . 0.0 112.343 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.59 88.97 2.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.14 -152.67 19.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.604 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.794 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.7 t80 -119.65 150.63 40.01 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.4 tt -149.06 135.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.516 0.198 . . . . 0.0 110.589 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 15.8 p90 -131.46 156.32 45.83 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.174 0.512 . . . . 0.0 112.078 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.516 HG23 HG13 ' A' ' 137' ' ' ILE . 34.2 m -125.8 141.45 45.5 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.209 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -125.01 143.23 51.01 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.085 -175.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.466 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.9 t-20 -99.65 140.63 33.56 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.631 0.253 . . . . 0.0 111.226 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.579 ' NH1' ' HA ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -67.83 -46.04 72.95 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.197 -178.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.24 -33.71 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 135' ' ' VAL . 25.1 mt -64.0 -50.93 66.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.274 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.88 -41.01 95.98 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.51 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.93 -48.13 84.41 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.021 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.14 -32.86 71.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.721 0.296 . . . . 0.0 110.452 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -68.8 -18.68 64.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.872 0.367 . . . . 0.0 110.172 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m 70.63 34.27 2.14 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.033 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -73.87 156.01 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.772 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 11.5 m-85 -76.6 101.25 5.63 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.607 -170.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.75 115.89 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.238 0.542 . . . . 0.0 109.909 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.543 ' HB2' ' HD2' ' A' ' 124' ' ' ARG . 2.4 t80 -125.74 111.56 15.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.816 -178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -94.93 113.07 24.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.824 0.345 . . . . 0.0 110.174 179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 120' ' ' GLU . 1.4 m -89.31 125.5 42.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -106.81 131.99 53.28 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.327 0.584 . . . . 0.0 110.552 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.49 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.7 m80 -79.21 -178.39 1.09 Allowed Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 88.9 Cg_exo -46.85 164.33 0.11 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 121.587 1.524 . . . . 0.0 112.166 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -49.11 -66.93 0.31 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -170.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.471 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -89.05 -9.66 0.14 Allowed Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 115.84 1.792 . . . . 0.0 115.84 -165.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 37.3 Cg_exo -42.53 -22.82 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.446 1.552 . . . . 0.0 112.017 163.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.1 33.81 3.26 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.29 169.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -144.41 127.35 16.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.898 0.38 . . . . 0.0 111.716 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -123.81 102.2 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.54 ' HB2' HG22 ' A' ' 110' ' ' VAL . 57.0 mt-10 -73.65 98.09 2.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.216 0.531 . . . . 0.0 110.744 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 24.0 t -69.07 95.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.924 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 13.1 m -88.17 114.07 24.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.764 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.605 ' HB ' HG23 ' A' ' 69' ' ' ILE . 4.9 mp -87.09 111.12 21.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.809 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.772 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 19.8 mtt180 -93.2 104.06 16.27 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.918 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.572 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.62 144.03 53.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.845 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.15 -60.07 4.16 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.235 0.54 . . . . 0.0 109.756 177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.865 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 16.1 t70 -87.72 127.95 35.3 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.787 173.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 51.9 t -52.79 113.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 123.505 0.503 . . . . 0.0 111.833 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.41 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . . . 91.23 67.47 1.16 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.433 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.2 m 58.6 72.66 0.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.913 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.09 -50.97 25.63 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.913 ' HD3' HG23 ' A' ' 131' ' ' ILE . 87.2 Cg_endo -97.83 116.0 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.498 2.132 . . . . 0.0 112.431 -178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.57 -5.14 26.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.37 -8.81 56.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.18 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.657 HG13 HD23 ' A' ' 95' ' ' LEU . 9.1 p -71.58 -14.05 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.835 0.35 . . . . 0.0 111.638 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 136' ' ' ILE . 17.2 pt -87.76 92.91 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.516 HG13 HG23 ' A' ' 94' ' ' VAL . 27.7 pt -63.87 -30.99 51.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.905 -173.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.58 160.71 40.7 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.13 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -148.41 150.8 34.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.838 175.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -142.36 154.28 44.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.348 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tt -111.91 146.25 38.09 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 173.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 tt -140.66 118.93 10.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 111.097 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -118.04 68.6 0.77 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.364 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 40.6 mt 63.36 119.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.799 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -79.1 -21.14 47.08 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.67 107.67 18.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.979 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 53.84 63.57 2.14 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.25 0.548 . . . . 0.0 110.795 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -58.26 -25.53 61.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.146 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -127.0 76.05 1.62 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -45.4 116.85 1.24 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.491 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -82.82 98.49 9.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.545 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -70.37 86.97 0.61 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.308 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.571 176.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 140.84 124.95 2.1 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.421 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 97' ' ' ARG . 7.3 t-20 -172.56 152.0 2.52 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -98.6 130.91 45.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.513 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 97' ' ' ARG . 44.2 mt -112.91 135.19 53.95 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 172.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -131.87 124.46 29.57 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.87 132.77 20.15 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.19 157.58 15.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.405 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.701 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.3 tt -135.38 142.12 40.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.004 0.43 . . . . 0.0 110.216 -177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.74 -32.03 13.51 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -85.01 51.68 2.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.527 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 2.6 pt20 -55.13 -27.1 42.9 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.273 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -68.88 -49.21 60.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.925 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.93 -36.4 83.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.177 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.82 -58.18 9.75 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.358 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -70.35 -26.45 63.74 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.179 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -54.93 27.21 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.871 0.367 . . . . 0.0 110.037 176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -73.52 -22.75 60.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.64 15.66 65.42 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.552 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -168.55 140.79 2.81 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 49.54 0.97 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.192 0.52 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 128' ' ' CYS . 29.8 tttp -168.64 126.41 0.89 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.382 -176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.85 -59.87 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.419 2.08 . . . . 0.0 111.868 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -174.41 159.53 3.06 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.329 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.39 162.94 36.73 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.174 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -159.12 137.33 10.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -113.46 160.64 18.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.727 0.299 . . . . 0.0 110.427 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -162.6 78.49 0.48 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.028 0.442 . . . . 0.0 110.309 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -68.65 88.42 0.35 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.729 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -131.75 13.63 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 110.55 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.41 -177.7 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.521 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.715 HD11 ' HE2' ' A' ' 51' ' ' LYS . 4.9 mt 64.04 155.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 O-C-N 123.892 0.745 . . . . 0.0 111.688 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.1 ttp-105 -175.2 97.24 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.186 177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.89 -46.13 9.16 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 t0 62.62 -162.22 0.28 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.614 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.42 -93.57 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.289 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -80.06 -43.75 21.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.038 0.447 . . . . 0.0 110.623 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 40' ' ' TYR . 16.6 p90 -146.68 141.2 26.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.149 -177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.0 -60.24 3.76 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.026 -176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.444 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 2.3 t80 63.16 79.67 0.25 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 1.3 p30 -125.77 -56.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.458 -0.792 . . . . 0.0 108.945 171.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.01 -85.76 0.01 OUTLIER Glycine 0 CA--C 1.522 0.518 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 170.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -157.53 155.9 31.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.852 0.358 . . . . 0.0 111.021 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.13 -44.84 0.07 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.044 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.06 106.52 0.17 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.705 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 32.0 m170 55.71 29.25 13.45 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.036 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.48 69.36 0.45 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.737 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.57 -42.13 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.642 2.228 . . . . 0.0 112.007 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.93 69.96 6.4 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.155 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 51' ' ' LYS . 3.1 p -167.85 -49.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.059 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.715 ' HE2' HD11 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -58.88 -99.82 0.0 OUTLIER 'General case' 0 C--O 1.24 0.569 0 CA-C-O 120.952 0.406 . . . . 0.0 111.952 -171.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.65 -22.9 67.09 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.66 -67.27 0.32 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.357 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -33.46 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.055 0 C-N-CA 121.054 -0.259 . . . . 0.0 110.53 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.45 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 2.3 m-85 -63.92 -64.64 0.84 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.3 -44.48 84.15 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.942 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -59.19 -54.28 48.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.694 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 4.4 pt20 -61.07 -37.2 81.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.176 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.03 -37.4 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.753 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.27 -23.97 34.98 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 p -87.95 -49.44 7.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.136 0.493 . . . . 0.0 110.803 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.39 -71.53 0.19 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.541 HD22 ' CE1' ' A' ' 64' ' ' TYR . 6.8 mt -159.53 76.57 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.152 0.501 . . . . 0.0 109.782 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.541 ' CE1' HD22 ' A' ' 63' ' ' LEU . 2.0 p90 45.28 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.684 1.194 . . . . 0.0 112.986 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 6.2 p-10 166.59 -45.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.912 -168.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' N ' ' HD2' ' A' ' 64' ' ' TYR . . . 166.07 -8.01 0.06 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.993 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.62 -28.01 63.28 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.996 0.398 . . . . 0.0 111.57 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.42 ' HE2' HE22 ' A' ' 58' ' ' GLN . 12.3 m-30 -118.85 163.58 16.68 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 123' ' ' ILE . 1.4 tt -121.07 119.04 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.284 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 13.0 m -99.45 131.56 45.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.869 176.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 t -119.04 170.37 9.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.189 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -122.82 152.51 40.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.66 -14.06 12.32 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 111.123 177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.2 108.04 18.74 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -59.46 -18.01 36.1 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.594 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -79.07 -2.32 39.95 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.828 0.347 . . . . 0.0 110.465 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.3 tt -51.26 -29.36 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.788 176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.27 -60.14 3.93 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.804 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.57 -37.64 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.111 -175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -62.3 -45.62 92.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.978 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -63.38 -49.18 74.83 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.849 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.2 -55.26 25.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.942 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.8 m -62.66 -35.91 81.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.566 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -66.33 -27.81 68.19 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.5 m -93.82 -0.3 55.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.78 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.97 40.44 90.97 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.51 -9.57 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.151 -0.525 . . . . 0.0 111.36 -172.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.684 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 mp0 -41.68 -28.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.328 0.651 . . . . 0.0 112.146 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -123.63 90.62 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.97 -150.92 12.89 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.274 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.701 ' HB3' HG23 ' A' ' 9' ' ' ILE . 6.2 t80 -121.93 149.58 43.23 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.583 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -141.47 143.4 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 179.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 52.8 p90 -131.53 144.05 50.83 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.199 0.524 . . . . 0.0 111.187 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.509 HG23 HG13 ' A' ' 137' ' ' ILE . 17.9 m -118.64 138.85 48.02 Favored 'Isoleucine or valine' 0 C--O 1.248 1.022 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.561 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD23 HG13 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.08 142.79 51.44 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.867 -171.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.44 ' OD1' HD13 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -79.94 114.24 18.71 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.498 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -69.41 -33.52 73.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.959 0.409 . . . . 0.0 110.745 -176.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -60.11 -26.66 66.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.628 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 99' ' ' LEU . 11.4 mt -63.11 -46.01 89.33 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -60.84 -38.47 85.59 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.47 -43.73 97.26 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.917 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -39.67 93.07 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.008 0.432 . . . . 0.0 110.068 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.501 ' HB2' HD13 ' A' ' 105' ' ' ILE . 15.4 m-30 -71.06 -18.29 62.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.434 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.3 m 69.86 39.34 1.46 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 103' ' ' TYR . 1.1 mp -68.47 160.83 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.413 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.769 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -78.4 99.0 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -170.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -103.18 100.14 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -100.67 116.14 31.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.074 0.464 . . . . 0.0 110.069 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.494 ' HB2' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -85.22 138.25 32.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.613 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.68 144.53 34.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.61 145.91 47.93 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -79.32 170.59 15.4 Favored Pre-proline 0 C--N 1.312 -1.029 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.861 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -45.67 170.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.657 2.238 . . . . 0.0 113.36 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -47.08 -53.82 11.85 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -170.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.518 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.2 t-20 -98.72 -17.05 0.2 Allowed Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 34.2 Cg_exo -40.83 -26.39 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 CA-C-N 120.993 1.39 . . . . 0.0 111.34 162.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 77.5 -11.35 1.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.901 163.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -113.3 159.34 19.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.297 0.57 . . . . 0.0 112.043 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 109' ' ' GLU . 29.6 tttp -131.87 122.34 25.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -104.48 115.13 29.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.155 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.83 113.37 37.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.154 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 14.3 m -81.4 117.71 22.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.776 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.528 ' HB ' HG23 ' A' ' 69' ' ' ILE . 15.0 mm -87.84 98.27 7.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.769 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -89.19 102.63 15.29 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.041 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HB1' ' CG1' ' A' ' 131' ' ' ILE . . . -69.84 152.32 44.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.758 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.4 -41.9 90.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.137 0.494 . . . . 0.0 110.406 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.458 ' HB3' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.07 145.02 50.12 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.07 176.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.411 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . 1.4 t -64.02 133.77 53.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.55 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 78.05 70.45 1.31 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.546 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 5.9 m 56.89 72.9 0.48 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.508 ' CG1' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -43.95 -55.38 9.35 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.415 173.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 63.6 Cg_endo -95.62 114.95 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.931 2.421 . . . . 0.0 112.218 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.59 -22.65 66.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 0.0 111.103 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.5 pm0 -77.19 -15.34 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.527 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.563 HG13 HD23 ' A' ' 95' ' ' LEU . 2.6 p -69.69 -16.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 -177.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.34 92.15 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.509 HG13 HG23 ' A' ' 94' ' ' VAL . 24.6 pt -67.83 -27.89 39.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.945 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.36 157.8 36.29 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.946 176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 59.3 pttt -150.49 140.88 22.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.273 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -140.53 160.34 40.22 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.774 -170.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -112.57 149.11 33.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.744 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 144' ' ' ILE . 18.4 tt -141.26 138.87 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -125.79 31.6 5.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.668 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.684 HG12 ' HB3' ' A' ' 88' ' ' GLU . 42.6 mt 61.21 -76.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 122.642 0.377 . . . . 0.0 110.02 -171.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 148' ' ' HIS . 31.9 t30 54.71 71.79 0.51 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.644 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 32.2 tp -88.93 -58.49 2.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.746 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 148' ' ' HIS . 6.8 pt-20 -96.85 1.18 50.32 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.718 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.487 ' HA ' ' OD1' ' A' ' 145' ' ' ASN . 51.2 m170 72.65 -65.35 0.36 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.398 0.679 . . . . 0.0 110.268 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -144.36 140.13 28.89 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -79.65 54.8 1.86 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.201 0.524 . . . . 0.0 111.191 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -77.01 98.02 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.726 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -70.58 -50.13 40.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.545 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 73.7 t60 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.45 -177.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.39 154.03 42.24 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.25 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -82.02 27.83 0.46 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.219 0.208 . . . . 0.0 111.442 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 t80 66.15 112.06 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.546 0.528 . . . . 0.0 111.947 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 71' ' ' THR . 13.4 mt -99.82 124.87 45.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -115.75 124.03 49.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER -145.92 156.95 43.87 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 175.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -122.23 155.92 16.88 Favored Glycine 0 N--CA 1.454 -0.133 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.945 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 34.9 mt -109.38 143.92 18.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -35.58 75.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.764 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 t 177.69 155.62 0.33 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 110.035 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -58.7 -32.05 68.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.999 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -62.17 -42.19 99.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.671 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.42 -42.72 98.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.023 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG3' HG21 ' A' ' 9' ' ' ILE . 48.8 mt-10 -55.01 -60.46 3.34 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.189 175.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.8 -41.86 78.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.213 -177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.18 -31.43 72.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.023 0.439 . . . . 0.0 110.785 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -88.03 -13.87 40.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.212 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.33 7.17 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.028 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 72.7 81.87 0.13 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.53 0.732 . . . . 0.0 110.672 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 22' ' ' LYS . 4.2 mm? 64.64 37.53 7.65 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.984 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER 73.15 152.88 0.15 Allowed Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.79 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.76 118.15 5.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.628 2.218 . . . . 0.0 111.905 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -174.72 4.55 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.719 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 164.65 -143.58 8.65 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.859 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -165.56 157.25 14.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -128.08 -43.39 1.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.6 -145.04 0.27 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.498 0.319 . . . . 0.0 110.694 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -174.67 -55.83 0.01 OUTLIER 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 31' ' ' ALA . 3.7 p -83.23 -162.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.672 171.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.651 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -53.12 163.06 0.58 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.276 0.56 . . . . 0.0 111.822 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' A' ' 51' ' ' LYS . 1.2 mm -114.9 163.74 11.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.891 -173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.495 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 2.0 tpm_? -96.13 99.78 11.49 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 169.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -166.23 101.1 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.31 178.99 7.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.19 -175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.98 -136.0 12.98 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.976 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -57.77 -42.94 85.1 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.887 0.375 . . . . 0.0 110.927 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' A' ' 38' ' ' PHE . 2.8 m-30 -76.83 -31.74 57.09 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.2 tptp 52.61 47.22 25.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.217 0.532 . . . . 0.0 111.633 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 19.6 m-30 -85.82 124.55 32.44 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -88.17 -96.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -173.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.19 123.35 7.67 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.642 -169.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 31' ' ' ALA . 16.9 tttt -77.77 78.66 4.27 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 69.28 -72.1 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 36.0 m -155.15 -61.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -139.64 144.02 37.46 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.027 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.2 96.68 0.17 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.321 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.67 -28.59 37.24 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.884 2.389 . . . . 0.0 110.984 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 p -68.35 91.22 0.38 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.841 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 51' ' ' LYS . 1.6 p -175.08 -166.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.8 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.544 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.731 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -45.46 -48.88 13.85 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.018 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 10.9 t30 -45.04 -55.18 5.82 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.145 0.498 . . . . 0.0 111.287 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.43 -54.65 21.82 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.328 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 10.8 p -63.59 -31.38 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.013 -175.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.458 ' OH ' ' HG3' ' A' ' 124' ' ' ARG . 2.3 m-85 -65.0 -58.99 4.66 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.76 63.28 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.823 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.52 ' NE2' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -64.31 -47.04 80.98 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.696 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.58 HE21 ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -62.58 -40.44 96.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.396 -175.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.6 mt -82.82 -40.99 17.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.562 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -65.5 -50.54 64.91 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.628 ' HB ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -81.28 -21.57 39.26 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.119 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.53 76.3 0.73 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.587 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.628 HD22 ' HB ' ' A' ' 61' ' ' THR . 1.8 pt? -148.44 59.84 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.6 0.714 . . . . 0.0 110.422 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.438 ' HE2' HG11 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -67.86 -24.19 65.23 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.006 -177.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HA ' ' OG ' ' A' ' 70' ' ' SER . 6.7 p-10 -73.22 -12.6 60.93 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.687 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.91 -92.74 0.33 Allowed Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.541 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 80.8 m -69.5 -34.97 75.09 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.499 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 22.0 m-85 -95.51 158.47 15.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.332 -172.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 5.3 mp -89.52 97.83 7.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -83.39 119.14 24.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.168 -178.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.483 HG21 HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -140.32 155.37 46.84 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.953 0.406 . . . . 0.0 111.049 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.46 ' H ' HD12 ' A' ' 77' ' ' ILE . 2.6 m -87.83 156.46 19.38 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.656 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.32 -32.39 73.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.564 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -88.68 133.37 34.23 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -63.97 -19.47 65.17 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.67 -2.21 6.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.269 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -57.75 -27.2 29.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.209 176.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.46 -63.18 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.071 0.462 . . . . 0.0 112.017 -172.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.9 ttmm -66.8 -43.85 82.78 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.873 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.51 -43.47 98.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.269 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -70.82 -52.47 20.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.067 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.561 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -56.99 -42.59 80.54 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.426 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -76.23 -50.35 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.559 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -64.68 -26.24 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -91.6 0.25 57.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.192 -176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.89 32.64 73.86 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.533 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 82' ' ' ALA . 7.0 mt -73.1 -7.42 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.712 0.292 . . . . 0.0 110.495 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.715 ' HG3' HD13 ' A' ' 144' ' ' ILE . 38.0 tp10 -28.76 -37.6 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.715 1.206 . . . . 0.0 113.231 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -130.07 90.17 2.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -179.1 -157.7 20.07 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.181 -177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 8.2 t80 -117.63 153.56 33.08 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.503 0.321 . . . . 0.0 110.451 -176.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.577 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 29.3 mt -132.53 140.46 47.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.433 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 16.8 p90 -131.96 134.3 45.48 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.28 0.562 . . . . 0.0 110.856 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.6 134.72 63.15 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.031 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.451 HD21 ' HE2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -122.15 143.19 49.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.738 -173.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -82.3 125.41 30.95 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 100' ' ' PHE . 61.7 ttp85 -70.3 -45.06 67.06 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.35 -22.58 66.83 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.854 0.359 . . . . 0.0 110.363 -175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' HA ' ' A' ' 135' ' ' VAL . 4.8 tp -65.5 -32.67 74.4 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 97' ' ' ARG . 10.6 m-85 -66.49 -44.57 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.65 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.7 -42.57 91.28 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.655 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -43.25 96.77 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 109.932 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.514 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 3.1 m-85 -62.73 -23.01 66.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.378 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m 72.98 23.6 2.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.127 -177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.499 HG13 ' HB3' ' A' ' 103' ' ' TYR . 3.8 mt -70.91 148.14 10.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.074 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 22.4 m-85 -78.15 105.23 9.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.946 0.403 . . . . 0.0 111.041 -166.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.19 109.89 20.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 124' ' ' ARG . 7.5 t80 -129.72 128.28 42.16 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.057 0.456 . . . . 0.0 110.336 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.52 155.07 22.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.831 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 64' ' ' TYR . 11.3 m -129.63 145.97 34.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.19 174.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.567 ' HB3' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -113.42 136.13 53.12 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.171 0.51 . . . . 0.0 110.646 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -79.92 -174.68 0.51 Allowed Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.553 175.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 95.6 Cg_exo -46.91 169.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 122.026 1.817 . . . . 0.0 113.181 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.31 -65.58 0.54 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -98.81 -8.59 0.12 Allowed Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -167.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 115' ' ' ASN . 63.1 Cg_exo -43.93 -27.12 1.57 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 121.562 1.594 . . . . 0.0 111.083 164.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 65.58 20.78 11.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.356 171.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HG3' ' HB2' ' A' ' 112' ' ' HIS . 4.9 pt-20 -112.65 123.73 50.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.11 0.481 . . . . 0.0 111.128 -177.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.567 ' HD3' ' HB3' ' A' ' 111' ' ' GLU . 6.7 ttpt -121.41 112.48 18.61 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.124 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.48 121.43 26.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.268 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.02 98.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.641 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.527 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -94.97 121.1 36.23 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.29 -178.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 24.6 mm -86.94 101.73 11.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 121.474 0.654 . . . . 0.0 109.765 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.787 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 2.2 mmt180 -77.5 95.08 4.41 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.448 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.94 161.49 30.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.712 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.565 ' HA ' ' NZ ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -60.76 -47.2 87.39 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.831 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -130.75 160.85 33.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 68.7 m -58.09 144.33 40.53 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.627 0.58 . . . . 0.0 111.896 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.6 41.59 6.79 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.865 -0.607 . . . . 0.0 114.262 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.57 71.52 0.44 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.068 174.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.794 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -45.44 -45.94 33.29 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.794 ' HD3' HG23 ' A' ' 131' ' ' ILE . 70.8 Cg_endo -91.27 128.46 1.2 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 C-N-CA 121.938 1.759 . . . . 0.0 113.033 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -78.34 -33.49 49.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.728 0.299 . . . . 0.0 111.209 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 61.0 mt-10 -63.27 -22.47 66.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.634 -173.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.688 ' HA ' HD23 ' A' ' 99' ' ' LEU . 5.0 p -70.48 -19.47 21.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.84 0.352 . . . . 0.0 111.233 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.6 mt -86.96 92.06 3.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.4 pt -67.59 -32.03 55.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.187 -172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -157.38 159.38 37.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.066 -0.654 . . . . 0.0 112.316 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.618 ' HD2' ' HE2' ' A' ' 91' ' ' TYR . 7.3 mtmp? -130.34 131.2 45.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.397 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -118.03 161.06 20.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.245 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 tt -122.19 147.47 46.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 173.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.3 tt -130.67 124.22 56.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.231 0.539 . . . . 0.0 110.473 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.02 57.96 1.53 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.528 -173.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.715 HD13 ' HG3' ' A' ' 88' ' ' GLU . 16.3 mm 69.45 119.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -80.95 -164.97 0.81 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.816 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -88.7 -9.59 51.44 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -169.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.09 157.77 18.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.882 -175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -82.67 151.4 26.29 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.677 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -121.89 163.84 18.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.114 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.05 79.52 0.33 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.176 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -173.36 -58.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.864 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -173.68 -36.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.165 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 . . . . . 0 C--O 1.242 0.682 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.066 174.121 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mmt . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.168 0.509 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.32 170.28 29.85 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.361 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -161.11 156.23 24.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -98.53 120.96 39.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.145 -172.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.461 HD11 ' HE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -121.29 142.38 50.0 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 172.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -113.53 139.3 49.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.981 -171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.86 157.56 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -128.76 157.54 21.53 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.809 -177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.877 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 54.2 mt -118.56 128.8 75.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 122.866 0.466 . . . . 0.0 110.164 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -25.19 16.68 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.08 0.467 . . . . 0.0 110.497 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.5 p -97.95 53.18 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.718 -177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.559 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -54.78 -26.42 34.37 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.065 -178.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -75.31 -50.84 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.108 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 1.5 t70 -59.62 -46.33 89.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.058 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' HG3' HD13 ' A' ' 9' ' ' ILE . 4.3 tm-20 -57.51 -58.88 6.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.616 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -65.91 -26.98 67.86 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.421 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -67.72 -43.52 79.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.975 0.417 . . . . 0.0 110.043 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -78.36 -24.52 46.4 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.52 70.57 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.594 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.697 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -174.37 173.78 2.93 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.7 mt -79.47 44.65 0.62 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.359 0.264 . . . . 0.0 111.045 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm 49.29 73.73 0.94 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.795 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 97.5 Cg_endo -76.16 63.94 6.99 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.04 2.493 . . . . 0.0 112.795 -174.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 63.32 6.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.928 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.27 83.33 0.35 Allowed Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.547 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -119.53 104.05 9.97 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -145.75 169.41 18.56 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.97 133.73 10.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.578 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -156.26 137.61 13.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.414 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.55 62.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.298 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.58 -52.95 0.07 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.435 HG22 ' HE1' ' A' ' 34' ' ' TYR . 2.8 mt -78.51 75.75 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.014 0.435 . . . . 0.0 111.231 -173.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 136.77 55.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.009 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.435 ' HE1' HG22 ' A' ' 32' ' ' ILE . 2.2 m-85 -112.45 56.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.313 0.577 . . . . 0.0 110.051 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -74.27 -43.18 57.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.932 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.73 -43.7 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.57 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.33 88.55 0.08 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -66.71 87.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.109 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -148.21 -170.01 3.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.001 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.42 169.3 9.87 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.85 -160.27 0.9 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.87 123.09 30.68 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.779 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HG3' ' HB2' ' A' ' 29' ' ' GLU . 2.5 ttmm -176.56 -49.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.044 0.45 . . . . 0.0 109.814 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -149.96 82.05 1.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.346 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -75.51 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.743 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -78.75 74.15 5.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.114 0.483 . . . . 0.0 110.188 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.49 125.93 1.7 Allowed Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.567 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -84.7 -29.97 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.122 2.548 . . . . 0.0 112.511 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.4 m -73.32 156.72 38.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.741 -171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t 57.46 -126.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.631 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.491 ' O ' HG12 ' A' ' 54' ' ' VAL . 6.9 tttt 60.36 -166.79 0.19 Allowed 'General case' 0 C--O 1.244 0.763 0 CA-C-O 122.003 0.906 . . . . 0.0 112.587 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 13.6 p-10 -61.13 -16.88 49.2 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.262 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.82 -55.36 30.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.159 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.3 p -67.96 -35.56 72.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.466 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 34.3 m-85 -59.62 -61.52 2.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.9 0.381 . . . . 0.0 110.251 177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.84 96.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.962 -178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -56.18 -43.34 78.34 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.272 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -65.1 -53.57 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mt -63.76 -30.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.638 -175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.84 -64.42 1.09 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.897 0.38 . . . . 0.0 111.713 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.5 m -93.94 -64.6 1.06 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.8 -105.41 0.06 OUTLIER Glycine 0 C--N 1.333 0.387 0 CA-C-N 116.141 -0.481 . . . . 0.0 114.232 -170.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 7.6 tp 61.0 34.33 19.39 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.762 0.791 . . . . 0.0 109.583 -173.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.623 ' H ' ' HD1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -84.5 11.83 8.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.356 -177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 t70 69.59 -143.98 0.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.99 -78.66 0.52 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.568 174.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.42 -37.03 85.7 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.03 0.443 . . . . 0.0 109.983 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.42 ' CE1' ' HG2' ' A' ' 124' ' ' ARG . 21.5 m-85 -126.93 142.62 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.787 HG13 ' HB ' ' A' ' 123' ' ' ILE . 5.6 pt -105.42 111.11 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.934 0.397 . . . . 0.0 111.355 -169.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 1.5 m -91.39 131.15 37.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.814 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.9 t -132.86 143.38 49.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.235 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.618 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -77.79 153.25 33.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.929 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -172.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -117.85 136.02 53.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.885 0.374 . . . . 0.0 110.655 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -52.77 -18.77 2.03 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.262 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 44.1 tp10 -48.86 -30.12 5.44 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.942 0.401 . . . . 0.0 110.773 176.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.618 HD12 ' H ' ' A' ' 72' ' ' THR . 1.1 tt -48.17 -37.5 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.694 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.54 68.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.018 0.437 . . . . 0.0 111.332 -173.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -73.52 -43.44 60.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.895 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HG3' ' HG3' ' A' ' 76' ' ' GLU . 15.4 mmtm -57.96 -47.69 82.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.983 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -66.29 -56.98 8.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.285 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.17 74.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.06 -173.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.2 m -81.85 -48.67 11.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.637 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -70.73 -18.87 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 m -99.6 0.8 42.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.705 0.288 . . . . 0.0 110.506 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.28 29.92 66.75 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.768 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 -13.81 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.767 0.318 . . . . 0.0 110.957 -174.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' HG12 ' A' ' 142' ' ' ILE . 2.3 tt0 -48.64 -26.09 2.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.789 176.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.423 ' HB2' HG13 ' A' ' 144' ' ' ILE . 4.3 t30 -108.13 95.66 5.83 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.433 -0.167 . . . . 0.0 110.596 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.52 -127.95 2.52 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.007 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.877 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 1.7 t80 -124.23 151.6 43.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 11.1 pt -139.69 133.63 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.228 0.211 . . . . 0.0 110.483 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' A' ' 7' ' ' ARG . 22.0 p90 -131.22 137.37 48.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.378 0.609 . . . . 0.0 111.249 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 138' ' ' ALA . 13.6 m -116.56 146.02 21.54 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.8 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.583 HD23 ' HB ' ' A' ' 135' ' ' VAL . 0.3 OUTLIER -127.3 143.35 51.25 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.223 -173.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.682 ' HB2' HD13 ' A' ' 137' ' ' ILE . 60.8 t-20 -95.2 139.64 31.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.147 0.498 . . . . 0.0 110.566 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -69.39 -35.08 75.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.409 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -53.84 -33.81 57.38 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.4 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 tp -58.93 -49.02 79.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.31 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.463 ' HE1' HG12 ' A' ' 135' ' ' VAL . 20.0 m-85 -72.94 -31.93 64.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.581 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.25 -42.62 99.72 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.86 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -70.71 -50.62 34.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.258 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -63.38 -21.2 66.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.212 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.9 m 65.77 39.96 4.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.311 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -66.38 154.84 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.521 ' HB2' ' HB3' ' A' ' 124' ' ' ARG . 12.3 m-30 -75.44 141.93 43.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.923 -167.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 129.26 56.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 110' ' ' VAL . 21.9 t80 -131.69 112.34 12.47 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.54 119.9 31.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.411 HG12 ' HD1' ' A' ' 108' ' ' TYR . 0.8 OUTLIER -112.34 148.5 15.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.317 0.58 . . . . 0.0 110.422 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.3 141.5 46.97 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.007 171.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.675 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 14.2 m80 -78.42 -169.7 0.21 Allowed Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.675 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 85.1 Cg_exo -48.12 139.64 20.64 Favored 'Trans proline' 0 C--N 1.358 1.051 0 CA-C-N 121.285 1.495 . . . . 0.0 109.416 170.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -56.26 -48.19 77.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 115' ' ' ASN . 0.7 OUTLIER -89.3 -14.35 0.2 Allowed Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -167.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 113' ' ' PRO . 96.7 Cg_exo -51.62 -17.45 4.77 Favored 'Trans proline' 0 C--N 1.353 0.809 0 CA-C-N 121.249 1.482 . . . . 0.0 110.333 157.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.409 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 7.2 m-20 72.99 21.77 3.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.513 171.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -102.67 121.28 42.11 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.627 -174.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -138.73 125.06 20.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.735 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.33 140.5 50.63 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.975 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 50.2 t -99.14 113.07 32.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.214 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 56.4 m -87.34 122.01 30.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.386 0.612 . . . . 0.0 110.989 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.787 ' HB ' HG13 ' A' ' 69' ' ' ILE . 14.4 mt -89.12 109.0 19.7 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.593 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -88.94 95.93 10.51 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.461 -177.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.654 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.46 148.86 48.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.156 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -59.51 -41.96 91.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.969 0.414 . . . . 0.0 110.957 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.79 159.92 15.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.536 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 105.49 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.894 0.378 . . . . 0.0 110.874 -176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.14 70.92 1.23 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.597 174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 14.8 m 63.73 73.59 0.44 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 172.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.682 HG23 ' HD3' ' A' ' 132' ' ' PRO . 1.6 tt -54.76 -41.59 90.82 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.682 ' HD3' HG23 ' A' ' 131' ' ' ILE . 20.2 Cg_endo -91.93 126.72 0.92 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 121.808 1.672 . . . . 0.0 111.881 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -18.04 63.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 110.552 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -79.9 4.98 15.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.583 ' HB ' HD23 ' A' ' 95' ' ' LEU . 3.7 m -58.39 -30.15 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.824 0.345 . . . . 0.0 111.498 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.1 pt -87.96 89.91 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.18 0.515 . . . . 0.0 109.961 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' A' ' 96' ' ' ASN . 12.3 pt -70.78 -28.16 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.648 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.473 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -155.06 124.92 6.56 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.001 171.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.405 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -121.97 132.46 54.55 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -141.44 159.37 42.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.185 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tt -100.32 144.39 29.39 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 88' ' ' GLU . 15.0 tt -124.33 135.66 63.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.007 0.432 . . . . 0.0 110.489 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 144' ' ' ILE . 6.4 tp10 -115.39 47.23 1.34 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.822 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 145' ' ' ASN . 1.2 tt 69.29 176.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.106 0.562 . . . . 0.0 111.793 173.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 144' ' ' ILE . 3.7 t-20 -75.8 57.27 1.01 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.558 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.95 -57.48 2.06 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -80.57 61.16 4.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.126 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -132.4 61.07 1.67 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.1 t60 40.23 57.73 2.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.298 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -73.32 124.33 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 21.5 t-80 -141.27 26.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.432 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 3.8 m170 72.2 155.57 0.16 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.239 -174.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.319 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.32 -152.26 50.71 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.23 -0.509 . . . . 0.0 112.191 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.606 ' H ' ' HD2' ' A' ' 97' ' ' ARG . 8.7 t-20 -134.56 154.91 51.24 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.765 0.317 . . . . 0.0 110.405 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -121.43 120.98 36.55 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 5' ' ' LEU . 2.3 mm? -106.21 144.91 32.24 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.8 0.333 . . . . 0.0 110.251 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' HE1' HG22 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -132.61 138.35 47.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.461 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.67 HH11 HD12 ' A' ' 21' ' ' LEU . 44.9 ttt180 -139.21 111.1 7.25 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -107.15 157.85 15.36 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.643 HG12 ' H ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -148.73 136.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 16.19 14.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.065 0.459 . . . . 0.0 110.959 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -116.7 58.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.176 0.512 . . . . 0.0 109.804 -178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 91' ' ' TYR . 2.0 mp0 -58.02 -21.56 45.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -68.98 -47.62 65.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.78 -42.58 99.76 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.891 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -55.06 -53.12 59.96 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.554 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.473 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -66.83 -24.95 66.21 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.638 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -93.88 -15.41 25.04 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.479 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.48 -9.81 75.68 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.448 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.567 ' HB2' ' HG3' ' A' ' 23' ' ' PRO . 1.6 mm-40 -174.71 -169.59 0.43 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.67 HD12 HH11 ' A' ' 7' ' ' ARG . 0.5 OUTLIER -77.2 61.29 2.07 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.054 0.454 . . . . 0.0 111.003 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 52.67 69.07 2.56 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.231 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.567 ' HG3' ' HB2' ' A' ' 20' ' ' GLN . 86.0 Cg_endo -83.14 82.57 2.1 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.787 2.325 . . . . 0.0 112.077 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -115.85 -152.3 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 131' ' ' ILE . . . 74.7 173.95 31.98 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.31 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 153.94 33.63 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.817 0.447 . . . . 0.0 109.856 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.825 ' HG3' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -115.45 138.59 50.85 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 43' ' ' LYS . . . -85.99 49.49 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.982 0.42 . . . . 0.0 111.145 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 64.45 -74.05 0.05 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.329 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 59.2 t -84.9 -85.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 30' ' ' VAL . . . 168.6 179.02 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.111 0.564 . . . . 0.0 110.404 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -107.97 44.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.439 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -44.13 103.27 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.207 -174.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HD1' ' H ' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -64.36 -24.65 67.72 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.58 -178.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.455 ' H ' ' HD1' ' A' ' 34' ' ' TYR . 2.4 t70 59.92 -77.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.585 0.553 . . . . 0.0 110.602 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' TYR . . . -157.49 177.74 34.16 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 37' ' ' LYS . 3.6 mppt? 59.59 13.97 3.68 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.23 0.515 . . . . 0.0 110.473 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 48.27 39.99 13.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.118 -174.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -87.51 95.05 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.707 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -79.65 45.09 0.66 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.68 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.21 31.89 2.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.137 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.46 -150.6 7.8 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.127 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 28' ' ' ALA . 14.6 tttt -77.38 94.05 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.0 110.277 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -170.55 84.64 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.744 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -61.52 -66.78 0.48 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.473 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -142.54 152.76 42.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.064 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.64 127.51 0.89 Allowed Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.3 -24.25 27.42 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.629 2.219 . . . . 0.0 111.177 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.583 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 46.9 m -126.36 85.56 2.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.466 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 49' ' ' SER . 4.8 p 165.21 168.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.062 0.945 . . . . 0.0 109.206 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.601 ' HA ' HD13 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 50.09 -159.7 0.07 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 172.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -48.52 -31.54 6.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.452 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.468 ' H ' ' HG3' ' A' ' 51' ' ' LYS . . . -55.62 -65.5 0.58 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.675 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.401 ' HB ' ' H ' ' A' ' 50' ' ' VAL . 3.4 p -66.05 -32.31 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.768 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -66.04 -61.03 2.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.92 84.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -62.68 -44.54 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.131 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -49.65 66.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 110.686 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 82.0 mt -62.65 -36.12 73.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.621 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -69.95 -52.34 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.217 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.7 p -64.39 -76.63 0.07 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.463 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.21 7.22 11.7 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.361 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.621 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 43.6 tp 64.24 -79.11 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.58 0.352 . . . . 0.0 110.334 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -107.22 64.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.98 -38.46 88.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.881 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.21 -1.58 0.55 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.129 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.3 m -78.04 -15.74 58.66 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.827 0.313 . . . . 0.0 111.275 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -121.29 157.12 31.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.224 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 31.0 mt -98.03 100.81 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.936 -176.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m -77.21 114.32 15.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.548 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.32 168.9 16.17 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.77 0.319 . . . . 0.0 110.715 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -112.31 152.2 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -25.67 68.06 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.77 133.25 34.0 Favored 'General case' 0 N--CA 1.461 0.112 0 O-C-N 122.127 -0.358 . . . . 0.0 110.497 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -59.62 -25.79 64.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.679 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.53 -6.82 58.78 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.418 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -23.88 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.006 0.432 . . . . 0.0 110.52 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.48 98.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.736 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -71.36 -44.07 65.72 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -57.99 -51.58 69.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.782 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -61.27 -48.02 83.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.212 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -55.83 -44.86 78.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.552 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -70.62 -43.03 70.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.001 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.5 m -63.51 -28.52 70.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.328 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.1 p -86.84 -5.52 59.08 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 110.6 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.34 35.17 89.85 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 92' ' ' ILE . 3.1 tp -69.1 -8.92 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 142' ' ' ILE . 43.9 mt-10 -28.52 -49.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.558 0.743 . . . . 0.0 112.741 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -121.14 91.11 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.49 -143.93 5.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.091 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.502 ' HB2' ' NE2' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -122.85 150.16 43.24 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.038 0.535 . . . . 0.0 110.352 -174.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.611 HG13 ' HG3' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -142.86 137.8 27.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 110.198 176.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -118.34 145.77 44.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.571 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 2.1 t -106.63 128.78 61.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.525 172.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 142.01 51.37 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.951 0.782 . . . . 0.0 109.119 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.547 ' HB2' HD13 ' A' ' 137' ' ' ILE . 7.3 t-20 -113.24 144.56 42.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.908 0.385 . . . . 0.0 111.557 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.606 ' HD2' ' H ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -64.1 -39.54 94.27 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.269 -175.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -69.53 -26.33 64.46 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.193 0.52 . . . . 0.0 109.915 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.74 HD22 HG23 ' A' ' 137' ' ' ILE . 12.4 tp -66.51 -39.19 88.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.399 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.556 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 48.1 m-85 -61.72 -42.8 99.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.441 174.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -38.99 90.45 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.907 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -62.05 -44.07 97.48 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.199 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.498 ' OH ' ' HB2' ' A' ' 134' ' ' GLU . 17.6 m-85 -76.99 -12.0 59.88 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.891 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m 70.66 27.62 3.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.457 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.548 HD11 ' HG3' ' A' ' 132' ' ' PRO . 18.4 mt -72.24 148.09 9.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.545 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 69.4 m-85 -89.81 122.77 33.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.565 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.79 138.62 31.33 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.15 112.06 5.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.28 119.28 39.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.131 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -87.29 129.65 38.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 174.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -121.55 128.75 52.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.466 0.651 . . . . 0.0 110.847 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.678 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 50.5 m80 -80.33 -174.81 0.52 Allowed Pre-proline 0 C--N 1.318 -0.766 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 80.6 Cg_exo -46.19 149.37 2.52 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 121.211 1.274 . . . . 0.0 111.232 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.434 ' HG3' ' H ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -52.0 -51.42 57.44 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -166.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.405 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -99.84 -13.45 0.17 Allowed Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 116.371 1.989 . . . . 0.0 116.371 -167.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.541 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 92.2 Cg_exo -50.15 -16.25 1.75 Allowed 'Trans proline' 0 C--N 1.356 0.943 0 CA-C-N 121.767 1.667 . . . . 0.0 110.903 163.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 t-20 69.37 28.59 4.72 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.778 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HB3' ' HB2' ' A' ' 112' ' ' HIS . 20.3 tp10 -103.09 98.4 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.364 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -131.14 108.75 9.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.779 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.556 ' HB3' HG22 ' A' ' 110' ' ' VAL . 6.7 tm-20 -99.7 115.1 28.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.99 -178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t -96.49 101.1 11.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.092 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.553 ' HB ' ' HE ' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -93.79 127.92 39.76 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.073 0.463 . . . . 0.0 110.869 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 28.2 mm -88.43 102.9 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.283 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.553 ' HE ' ' HB ' ' A' ' 122' ' ' THR . 6.9 mmt180 -86.0 101.72 13.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.841 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.422 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -69.71 156.71 38.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.146 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.503 ' HG3' HD11 ' A' ' 32' ' ' ILE . 9.4 tt0 -65.18 -29.51 70.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.261 178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -147.34 161.17 41.53 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 49.8 t -79.84 150.58 30.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.719 -176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.94 47.13 4.57 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.542 173.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.53 ' SG ' ' NH2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 48.68 63.82 1.95 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 177.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.923 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -50.73 -45.77 86.28 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.923 ' HD3' HG23 ' A' ' 131' ' ' ILE . 92.8 Cg_endo -93.14 109.5 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.669 1.579 . . . . 0.0 112.295 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -61.93 -27.74 69.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.965 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.498 ' HB2' ' OH ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -88.01 11.96 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.886 -178.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.615 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 13.1 p -59.77 -24.44 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.837 0.351 . . . . 0.0 111.556 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -88.34 104.36 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.873 0.844 . . . . 0.0 109.782 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.74 HG23 HD22 ' A' ' 99' ' ' LEU . 1.6 pt -63.12 -26.61 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . . . -145.82 146.0 30.99 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.326 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -128.26 123.14 33.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.611 ' HG3' HG13 ' A' ' 92' ' ' ILE . 1.9 pt-20 -140.49 160.29 40.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.159 0.504 . . . . 0.0 111.122 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -111.26 151.76 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.612 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 88' ' ' GLU . 9.8 tt -128.45 132.06 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.769 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.629 ' HG3' ' HB3' ' A' ' 145' ' ' ASN . 8.1 pt-20 -128.02 29.78 5.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -173.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 10.2 tp 37.91 44.97 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 122.341 1.067 . . . . 0.0 111.195 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.629 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.5 t30 -148.15 170.47 17.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.396 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.14 168.07 10.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.519 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.64 89.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.474 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -83.4 70.43 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -63.83 128.48 35.99 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.407 -174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 80.32 0.22 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.485 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -152.27 131.4 12.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.219 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 70.47 1.61 3.71 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.454 0.471 . . . . 0.0 110.632 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.896 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.859 0.362 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.13 97.21 0.27 Allowed Glycine 0 C--N 1.333 0.378 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.615 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 97' ' ' ARG . 12.5 p-10 -159.91 158.6 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -114.83 161.25 18.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 111.182 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -100.53 154.93 18.15 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 171.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.89 141.25 38.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.374 0.607 . . . . 0.0 111.267 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.581 ' HB2' HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -144.07 156.07 44.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.703 176.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -137.74 157.65 24.25 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.453 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.591 HG23 ' H ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -147.27 140.31 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.447 -178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 6.26 14.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.488 0.661 . . . . 0.0 109.296 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.591 ' H ' HG23 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -101.36 49.08 0.88 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.603 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -59.91 -26.73 66.15 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -61.09 -46.57 90.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.753 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.8 -47.16 86.35 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.96 -50.03 69.91 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.448 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -72.0 -24.24 61.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.41 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -74.46 -42.41 59.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.1 0.476 . . . . 0.0 110.718 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -94.1 -16.1 24.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.32 2.51 89.32 Favored Glycine 0 C--N 1.331 0.273 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.0 159.2 36.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.621 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -81.18 130.92 35.24 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.473 ' HE2' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER 50.98 151.91 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.266 0 C-N-CA 125.075 1.35 . . . . 0.0 113.835 177.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.52 -164.39 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 111.663 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.22 129.68 4.44 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.65 12.2 8.33 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.885 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.466 ' HB3' HD12 ' A' ' 131' ' ' ILE . 30.9 t-20 -93.92 131.0 39.79 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 122.797 -0.237 . . . . 0.0 110.497 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -155.66 70.69 0.72 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.449 0.642 . . . . 0.0 110.09 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.545 ' HB1' ' HG3' ' A' ' 43' ' ' LYS . . . -138.73 31.14 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.839 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 57.34 -79.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.27 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -144.72 100.99 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.694 ' HA ' ' HG2' ' A' ' 43' ' ' LYS . . . -74.47 -32.37 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.725 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.48 HG13 HG12 ' A' ' 50' ' ' VAL . 7.9 mt -94.86 99.01 8.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.063 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -98.25 3.82 48.84 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.634 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 66.73 -65.27 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.904 -175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 t70 66.82 16.33 10.35 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 122.955 0.502 . . . . 0.0 111.246 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 77.43 -59.62 3.67 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.059 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.21 -1.41 17.62 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -173.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.5 t80 71.85 -5.79 1.61 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.546 0.338 . . . . 0.0 111.708 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -83.51 -18.67 37.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.834 0.349 . . . . 0.0 110.448 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CE1' HG23 ' A' ' 32' ' ' ILE . 10.5 m-85 65.03 176.08 0.2 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -88.0 -176.15 5.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.95 -77.23 0.19 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.893 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.694 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 58.24 -90.59 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.943 0.497 . . . . 0.0 111.012 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.09 66.16 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 110.589 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.54 -51.5 69.61 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -106.54 44.21 1.08 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.899 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.99 138.18 9.59 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.133 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -90.38 -177.89 1.36 Allowed 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.092 2.528 . . . . 0.0 112.119 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.9 m 69.42 -176.39 0.2 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.264 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.756 HG12 ' H ' ' A' ' 51' ' ' LYS . 1.3 t 55.23 -168.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.283 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.756 ' H ' HG12 ' A' ' 50' ' ' VAL . 70.9 mttt 59.57 -170.94 0.13 Allowed 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.426 0.631 . . . . 0.0 112.565 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -60.81 -22.46 64.17 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.657 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -65.84 0.57 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.444 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -68.68 -27.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.661 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -63.17 1.36 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.416 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.97 87.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.437 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -55.92 -52.48 63.96 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.174 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 26.9 tp60 -66.39 -54.87 19.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.244 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -63.58 -37.14 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.464 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -80.29 -58.47 3.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.51 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 m -69.27 -19.84 63.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.633 0.254 . . . . 0.0 111.57 -175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.63 -111.71 0.77 Allowed Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 13.5 tp -162.07 -92.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' H ' ' HB3' ' A' ' 63' ' ' LEU . 15.4 m-85 -105.36 -38.05 6.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.267 0.556 . . . . 0.0 109.523 175.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.65 -155.24 0.22 Allowed 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.074 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.01 -14.61 76.85 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.487 174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.52 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 97.6 m -61.5 -50.55 72.28 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.429 0.292 . . . . 0.0 111.212 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -104.33 160.2 15.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.262 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.2 mp -110.53 99.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 110.59 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.81 115.41 21.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.421 HG21 ' HA ' ' A' ' 5' ' ' LEU . 96.7 m -140.89 129.41 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.148 0.499 . . . . 0.0 111.441 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -82.22 151.14 26.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.003 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.07 10.73 1.1 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.895 0.378 . . . . 0.0 111.823 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -106.43 123.46 48.11 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -49.2 -28.47 4.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -64.81 -19.97 66.13 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.69 0.281 . . . . 0.0 111.07 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -28.72 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.557 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -51.64 68.16 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.273 0.558 . . . . 0.0 110.651 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.94 -43.62 67.81 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.616 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.05 -47.87 77.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.099 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -64.35 -54.22 36.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -54.35 -43.89 71.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.544 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 m -73.76 -48.31 32.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 m -68.84 -18.22 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB2' HG13 ' A' ' 87' ' ' ILE . 18.0 m -92.78 -3.38 54.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.835 0.35 . . . . 0.0 110.528 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.44 38.77 96.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.251 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 82' ' ' ALA . 15.8 mt -79.61 -8.44 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 121.957 0.103 . . . . 0.0 111.041 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 142' ' ' ILE . 10.8 mt-10 -33.28 -39.1 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -119.85 100.87 7.49 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.6 -148.77 16.74 Favored Glycine 0 C--O 1.238 0.347 0 C-N-CA 120.371 -0.918 . . . . 0.0 113.445 178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -109.5 128.18 54.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 -175.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.4 mt -105.03 133.36 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.17 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 7' ' ' ARG . 21.5 m-85 -116.38 146.1 42.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.724 0.297 . . . . 0.0 110.8 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -134.38 122.53 40.37 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.958 176.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.733 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.58 140.86 48.78 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.071 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.43 ' HB2' HG21 ' A' ' 137' ' ' ILE . 24.5 t-20 -80.5 138.43 36.55 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -68.61 -40.64 80.3 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -172.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -82.25 -10.36 59.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.575 0.226 . . . . 0.0 111.19 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.96 -42.58 76.44 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 174.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.604 ' HB3' HD12 ' A' ' 105' ' ' ILE . 3.3 m-85 -68.34 -43.48 77.41 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.683 174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -38.1 86.84 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.993 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -70.63 -41.68 71.89 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -64.8 -19.52 65.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.3 m 72.9 38.23 0.74 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.001 172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -75.89 166.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.732 ' HB3' ' HB3' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -75.51 109.32 8.97 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.341 -175.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.39 99.82 12.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -110.85 114.13 27.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.902 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.32 113.97 25.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.415 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -87.54 115.12 27.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -103.19 137.11 41.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.329 0.585 . . . . 0.0 111.264 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -87.95 174.37 5.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.572 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 52.7 Cg_exo -49.44 159.6 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.924 1.749 . . . . 0.0 112.575 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.474 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -44.34 -65.07 0.56 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.1 t-20 -92.76 -18.44 0.23 Allowed Pre-proline 0 CA--C 1.541 0.635 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.572 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 44.5 Cg_exo -44.46 -18.82 0.21 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 121.551 1.59 . . . . 0.0 112.051 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.409 ' N ' ' C ' ' A' ' 115' ' ' ASN . 2.2 t-20 73.64 12.01 4.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.607 167.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -103.46 122.11 44.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 111.014 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -142.9 109.4 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.283 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.571 ' HB3' HG13 ' A' ' 110' ' ' VAL . 14.3 tt0 -100.52 132.61 45.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 -175.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.4 t -97.96 104.37 15.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.925 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.2 m -84.59 114.59 22.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.172 0.51 . . . . 0.0 110.166 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 46.0 mm -88.01 100.62 10.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.663 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.732 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -86.32 93.16 9.02 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.008 179.331 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.17 151.76 46.5 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.435 178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.589 ' HA ' HH21 ' A' ' 124' ' ' ARG . 3.3 mm-40 -65.37 -11.04 38.35 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -170.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.688 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 32.2 t0 -145.26 156.19 43.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.27 132.54 47.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 111.468 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 91.29 33.05 8.32 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.127 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 60.95 70.88 0.59 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.983 0.42 . . . . 0.0 110.356 178.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.899 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -37.83 -54.82 2.3 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.899 ' HD3' HG23 ' A' ' 131' ' ' ILE . 20.1 Cg_endo -93.11 128.64 0.72 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.306 2.004 . . . . 0.0 112.493 -174.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -81.36 -7.17 59.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.111 0.481 . . . . 0.0 110.554 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -83.71 -4.78 58.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.456 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 132' ' ' PRO . 28.2 m -81.84 -9.41 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.043 0.449 . . . . 0.0 110.247 175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.08 89.73 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.43 HG21 ' HB2' ' A' ' 96' ' ' ASN . 5.5 pt -63.79 -35.07 71.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.702 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 94' ' ' VAL . . . -155.32 167.96 28.65 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 111.772 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 160.54 43.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.368 173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -141.34 160.58 39.83 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.015 -175.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 tt -105.37 149.43 26.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.4 tt -139.38 130.88 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.934 0.397 . . . . 0.0 110.461 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -122.93 35.95 4.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.774 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt 61.34 -83.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.82 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.99 142.67 27.78 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.326 0.584 . . . . 0.0 111.717 -171.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -131.53 156.74 45.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.02 174.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.537 ' HB2' HD22 ' A' ' 146' ' ' LEU . 0.0 OUTLIER 67.59 116.37 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.422 0.451 . . . . 0.0 110.037 -175.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -66.98 -25.52 66.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.598 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -70.3 -22.56 62.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.98 125.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.063 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.33 134.5 49.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.254 -173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -97.13 -10.6 25.65 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.053 178.325 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.55 -154.92 52.74 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.73 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' H ' ' HB3' ' A' ' 97' ' ' ARG . 47.4 t30 -150.73 159.52 44.47 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.6 128.87 35.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.195 0.521 . . . . 0.0 111.176 -175.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.648 HD21 HD13 ' A' ' 123' ' ' ILE . 7.0 mp -100.7 135.94 41.36 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.508 ' HD2' HD11 ' A' ' 92' ' ' ILE . 1.4 m-85 -121.57 124.59 44.72 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.174 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.81 150.2 43.02 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.538 ' HA3' HG13 ' A' ' 87' ' ' ILE . . . -129.95 158.26 22.23 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.326 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.562 HG13 HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.46 140.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 122.774 0.43 . . . . 0.0 110.468 -175.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.49 ' N ' HG12 ' A' ' 9' ' ' ILE . 2.5 p -89.24 -39.36 13.57 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 122.202 -0.311 . . . . 0.0 110.346 174.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 10' ' ' SER . 7.8 t 174.88 -150.26 0.01 OUTLIER 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.059 0.544 . . . . 0.0 109.79 178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -56.77 -40.49 75.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.419 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 14.1 pm0 -56.42 -32.55 64.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.972 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -84.98 -31.93 23.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.52 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.803 ' HG2' ' HB3' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -52.56 -51.01 61.79 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 170.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -73.33 -40.17 64.66 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.14 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' A' ' 14' ' ' ASP . 23.7 t30 -57.55 -48.16 80.09 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.62 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -82.87 -35.49 26.18 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' NZ ' ' A' ' 24' ' ' LYS . . . 68.8 16.02 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.895 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -132.52 4.09 3.93 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.803 ' HB3' ' HG2' ' A' ' 15' ' ' GLU . 33.3 tp -71.0 -54.17 12.19 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.558 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -88.44 132.92 37.63 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.271 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 130' ' ' CYS . 32.1 Cg_exo -59.23 112.54 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.783 2.322 . . . . 0.0 111.962 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' HA3' ' A' ' 129' ' ' GLY . 7.0 pttt -112.08 -12.66 13.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.005 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.45 154.54 33.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.164 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 7.0 t-20 -98.87 -75.58 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.826 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' HB3' HG13 ' A' ' 131' ' ' ILE . 6.2 ptpp? 152.74 161.64 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.681 1.193 . . . . 0.0 109.768 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.587 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . . . -177.36 -95.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.206 0.316 . . . . 0.0 111.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' H ' HG21 ' A' ' 50' ' ' VAL . 2.2 tm-20 65.45 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.959 0.504 . . . . 0.0 110.453 -172.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -175.5 136.09 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.899 0.381 . . . . 0.0 111.531 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 61.35 23.3 13.56 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.73 169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' CD1' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -78.99 74.65 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.215 0.531 . . . . 0.0 110.439 -176.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -59.46 95.13 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.285 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.78 92.19 2.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.09 104.63 0.32 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.924 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 -91.88 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.759 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.12 178.99 4.08 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.525 0.202 . . . . 0.0 111.326 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' HZ ' ' HB2' ' A' ' 108' ' ' TYR . 25.2 m-85 72.31 158.88 0.21 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.209 0.943 . . . . 0.0 111.827 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -113.16 92.37 3.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.777 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.472 ' CD1' ' HB ' ' A' ' 32' ' ' ILE . 27.4 m-85 -80.65 83.5 6.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.353 0.596 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -88.74 -23.75 22.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.75 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.87 56.99 2.1 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -50.81 -40.8 56.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.015 0.526 . . . . 0.0 112.289 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . . . -143.64 -166.74 2.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 110.849 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 46' ' ' HIS . 1.6 m -147.36 174.93 11.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.486 ' H ' HG22 ' A' ' 45' ' ' THR . 0.2 OUTLIER 83.02 -47.47 0.14 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.515 0.726 . . . . 0.0 111.457 173.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.587 ' HA3' ' HB2' ' A' ' 28' ' ' ALA . . . -49.48 115.04 2.59 Favored Glycine 0 CA--C 1.524 0.595 0 O-C-N 123.264 0.353 . . . . 0.0 112.867 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -81.28 -34.43 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.89 2.393 . . . . 0.0 112.616 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.25 62.92 4.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.812 -174.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 51' ' ' LYS . 6.7 p -162.51 -148.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.353 -176.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.775 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 71.01 177.59 0.27 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.576 0.703 . . . . 0.0 111.948 172.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -53.87 -29.7 42.64 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.95 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 57' ' ' HIS . . . -54.6 -66.6 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.935 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.73 -37.64 80.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.518 0.199 . . . . 0.0 110.994 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -64.15 1.04 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-O 120.981 0.42 . . . . 0.0 110.662 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.03 -46.53 90.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.172 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 53' ' ' ALA . 6.1 m-70 -58.65 -46.88 86.18 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.839 -177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.428 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -60.05 -51.72 68.45 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.572 HD11 HH22 ' A' ' 124' ' ' ARG . 84.5 mt -58.62 -46.28 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.548 -176.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -77.0 -39.77 49.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.3 m -80.35 -42.8 22.25 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -173.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.16 11.38 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.155 -1.022 . . . . 0.0 113.569 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 37.7 tp 63.32 -75.67 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.89 0.476 . . . . 0.0 110.885 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 122' ' ' THR . 17.8 m-85 -131.02 68.15 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.558 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.428 ' HB3' ' NE2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -58.91 -43.72 91.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.191 -178.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 164.13 -11.93 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.453 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.89 -29.89 69.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 117.289 0.545 . . . . 0.0 110.849 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -114.61 160.06 19.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.673 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.6 HG13 HD23 ' A' ' 5' ' ' LEU . 3.0 tp -115.05 123.68 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.872 0.368 . . . . 0.0 110.369 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -105.59 147.69 28.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.809 -174.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.705 HG22 HG13 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -137.78 148.78 45.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.283 171.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.538 ' H ' HD12 ' A' ' 77' ' ' ILE . 2.9 m -81.49 155.85 25.6 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.217 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -25.9 65.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -85.88 129.01 34.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.705 0.288 . . . . 0.0 110.739 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.83 -18.39 64.08 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -67.5 -9.69 44.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.497 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.538 HD12 ' H ' ' A' ' 72' ' ' THR . 2.2 tt -46.71 -31.83 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.56 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.6 -62.81 1.48 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.357 0.598 . . . . 0.0 111.289 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -70.16 -41.49 73.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.825 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.61 -45.27 92.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.306 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 5.8 t80 -68.58 -53.81 20.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.175 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.81 75.44 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.498 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m -74.82 -52.58 11.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.665 0.269 . . . . 0.0 111.259 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.8 m -70.72 -10.4 59.34 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -105.07 3.78 30.81 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.297 -0.252 . . . . 0.0 110.865 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 57.47 36.25 76.34 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.182 -0.532 . . . . 0.0 111.945 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.538 HG13 ' HA3' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -89.76 -9.21 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.741 -176.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -45.18 -28.25 0.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.174 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -107.39 109.08 20.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.94 -126.44 3.55 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.921 -0.656 . . . . 0.0 113.145 175.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.43 150.86 51.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.508 HD11 ' HD2' ' A' ' 6' ' ' TYR . 16.9 tt -145.18 133.87 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.846 0.355 . . . . 0.0 110.067 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -128.8 154.98 45.88 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.162 0.506 . . . . 0.0 111.099 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' CG2' ' HB3' ' A' ' 138' ' ' ALA . 21.6 m -122.84 145.31 29.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 121.596 0.713 . . . . 0.0 111.494 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.799 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -120.15 141.2 50.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.198 -1.365 . . . . 0.0 108.327 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.465 ' HB2' HD13 ' A' ' 137' ' ' ILE . 61.0 t-20 -105.81 128.74 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 122.084 -0.385 . . . . 0.0 111.427 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.452 ' HB3' ' H ' ' A' ' 3' ' ' ASN . 19.2 ttp180 -67.35 -34.19 76.81 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.021 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.18 -36.38 72.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.209 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.17 -38.92 89.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.668 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -71.56 -34.27 69.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.84 -39.04 96.96 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -65.94 -43.13 88.92 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 173.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -65.45 -18.58 65.42 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.648 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.7 m 71.89 30.43 2.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.677 0.751 . . . . 0.0 110.423 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.3 mt -72.38 156.77 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.473 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 15.2 m-85 -78.5 138.27 38.34 Favored 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -118.61 104.72 10.9 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.497 ' HB2' ' HZ ' ' A' ' 38' ' ' PHE . 15.3 t80 -109.62 112.25 24.22 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.0 OUTLIER -99.46 111.6 23.93 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -83.76 107.02 14.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.9 129.73 44.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.043 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 48.6 m170 -83.09 178.21 2.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.458 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 112' ' ' HIS . 81.7 Cg_exo -48.15 168.67 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.011 1.807 . . . . 0.0 112.511 175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.46 -70.11 0.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -172.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.479 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 2.0 t-20 -77.42 -21.42 0.37 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -167.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 18.2 Cg_exo -39.13 -22.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 121.832 1.688 . . . . 0.0 112.244 166.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 73.09 6.25 5.25 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.919 164.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.24 140.07 52.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.223 0.535 . . . . 0.0 112.058 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.64 98.31 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 172.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.602 ' HB3' HG13 ' A' ' 110' ' ' VAL . 0.8 OUTLIER -70.39 105.42 3.03 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -173.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.705 HG13 HG22 ' A' ' 71' ' ' THR . 2.2 p -82.66 104.33 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.574 0.702 . . . . 0.0 109.63 -177.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 3.2 m -97.39 130.4 44.53 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.528 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.648 HD13 HD21 ' A' ' 5' ' ' LEU . 2.0 mp -87.64 107.08 16.89 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.003 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.622 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 6.7 mmm180 -87.0 91.7 8.79 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.227 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -72.92 148.97 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.78 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' O ' HG23 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -61.25 -60.28 3.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.11 0.481 . . . . 0.0 110.468 -178.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -85.61 141.29 29.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.112 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.66 114.91 7.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.393 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.512 ' HA3' ' HE2' ' A' ' 24' ' ' LYS . . . 91.43 70.71 1.19 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.194 -0.527 . . . . 0.0 114.088 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.418 ' HB2' ' HA ' ' A' ' 23' ' ' PRO . 72.0 m 59.45 72.71 0.51 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 170.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.648 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.59 -43.43 83.95 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.792 174.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.648 ' HD3' HG23 ' A' ' 131' ' ' ILE . 2.1 Cg_endo -81.28 135.66 9.66 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.873 1.715 . . . . 0.0 112.246 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -71.65 -26.64 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.288 0.566 . . . . 0.0 110.095 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.23 10.88 13.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.006 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.799 HG22 HD23 ' A' ' 95' ' ' LEU . 8.0 p -52.54 -35.79 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 110.779 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.541 HG13 HG13 ' A' ' 135' ' ' VAL . 66.6 mt -93.37 95.36 5.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.485 HG13 ' N ' ' A' ' 138' ' ' ALA . 1.2 pt -76.04 -35.99 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.326 -174.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 137' ' ' ILE . . . -146.18 157.97 43.85 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.592 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -133.61 148.47 51.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.739 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.55 154.8 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.747 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 tt -112.14 147.62 35.72 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 tt -141.6 140.65 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.866 0.365 . . . . 0.0 111.404 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -138.08 53.29 1.82 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.881 0.372 . . . . 0.0 110.194 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.491 HG13 ' HB2' ' A' ' 146' ' ' LEU . 5.2 tp 36.16 99.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.052 1.341 . . . . 0.0 113.884 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -72.17 73.43 0.93 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.787 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.491 ' HB2' HG13 ' A' ' 144' ' ' ILE . 20.2 tp -94.83 -62.22 1.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.879 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.63 61.07 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.151 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -108.51 12.5 26.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.907 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -113.34 129.83 56.43 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.887 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -67.2 -31.98 72.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.014 0.435 . . . . 0.0 110.433 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -82.56 71.54 9.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -57.46 132.58 53.58 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.552 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.546 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.938 0.399 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.82 71.74 2.12 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.44 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -85.82 122.83 30.45 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.81 149.58 37.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.288 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.409 HD11 ' HD2' ' A' ' 97' ' ' ARG . 0.8 OUTLIER -100.09 131.65 45.92 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' HA ' HG12 ' A' ' 94' ' ' VAL . 3.1 t80 -96.82 112.42 24.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.479 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -130.59 155.87 45.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.0 158.33 22.27 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.693 HG23 ' HB3' ' A' ' 91' ' ' TYR . 4.7 tt -143.99 152.78 15.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -175.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.01 14.14 3.54 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.234 0.54 . . . . 0.0 111.041 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 9' ' ' ILE . 1.8 t 58.9 -97.15 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -66.17 -46.7 76.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.943 -167.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -60.98 -57.03 14.33 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.24 -43.38 98.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.802 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -51.1 71.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -59.9 -44.8 94.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.735 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -63.29 -51.04 67.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.046 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m-80 -78.76 -27.67 44.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.905 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 20' ' ' GLN . . . 90.34 47.17 3.87 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -172.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 41.6 mm-40 103.91 -144.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.858 1.663 . . . . 0.0 108.434 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.36 52.93 2.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 118.411 0.551 . . . . 0.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' ASN . 22.9 mtpp 68.52 131.4 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.857 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.7 142.66 9.25 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.716 2.277 . . . . 0.0 112.11 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.61 136.49 57.05 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.48 -89.26 0.09 OUTLIER Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.171 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 26' ' ' ASN . 0.0 OUTLIER -165.07 139.22 4.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.966 0.412 . . . . 0.0 110.741 179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -80.28 168.49 18.98 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.431 -177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -113.33 -143.3 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.323 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -139.28 -169.32 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.3 t -78.92 60.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.846 0.832 . . . . 0.0 110.56 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -143.28 26.23 1.66 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.148 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.54 HG22 ' CE2' ' A' ' 106' ' ' PHE . 45.1 mm -113.81 97.26 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.287 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -103.79 165.53 10.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.363 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -142.35 137.2 30.35 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.61 -62.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.044 0.449 . . . . 0.0 109.994 -175.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.92 -45.47 0.29 Allowed Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -115.91 45.46 1.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -73.89 142.88 45.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.956 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -81.95 136.65 35.28 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.208 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -120.67 124.97 46.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.429 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 1.3 t70 -145.98 -150.4 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.58 -66.64 3.84 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -90.04 65.29 6.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.04 0.448 . . . . 0.0 109.837 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.47 72.65 0.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.308 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 m -151.54 154.77 37.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.393 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -75.62 116.51 16.41 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.23 155.28 21.17 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.991 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.4 -28.12 12.56 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.885 2.39 . . . . 0.0 112.239 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.66 144.04 47.9 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.317 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER 50.64 -175.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.101 0.96 . . . . 0.0 112.856 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.576 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER 72.79 175.52 0.28 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.609 0.719 . . . . 0.0 111.561 178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 22.3 p-10 -58.43 -21.81 52.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.547 174.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.66 -55.71 31.37 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.563 173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.14 -35.01 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.774 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.423 ' HB2' ' HA ' ' A' ' 52' ' ' ASN . 6.5 m-85 -63.21 -40.77 98.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.219 0.533 . . . . 0.0 109.959 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.52 97.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.826 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -61.95 -38.35 88.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.133 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 63' ' ' LEU . 38.9 tt0 -58.55 -57.9 10.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.65 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -75.07 -45.72 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.42 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.46 -54.73 6.31 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.935 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 m -82.84 -18.64 39.68 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.67 0.272 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . 91.41 30.53 10.67 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 121.074 -0.584 . . . . 0.0 111.808 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 62' ' ' GLY . 0.6 OUTLIER 44.53 22.05 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.059 0.944 . . . . 0.0 113.083 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 54.84 17.15 1.67 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.977 0.511 . . . . 0.0 111.354 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 36.47 47.02 0.47 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.944 0.898 . . . . 0.0 111.869 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -35.68 0.02 OUTLIER Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.718 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -37.61 84.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 110.425 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.443 ' HB2' HD13 ' A' ' 63' ' ' LEU . 19.9 m-85 -130.19 162.17 29.51 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.446 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.8 mp -93.42 99.06 9.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.591 -176.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.425 ' OG ' HD11 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -86.3 124.13 32.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.027 177.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.403 ' O ' ' N ' ' A' ' 121' ' ' VAL . 14.6 t -140.03 161.37 37.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.899 178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.539 ' H ' HG13 ' A' ' 77' ' ' ILE . 2.1 m -90.17 154.83 19.46 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.4 m -61.58 -28.31 69.25 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.246 0.546 . . . . 0.0 110.456 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -87.17 135.49 33.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -59.23 -19.87 49.28 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.163 177.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -6.09 18.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.199 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -51.73 -30.85 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 110.194 173.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.68 -51.06 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -72.06 -43.74 64.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.592 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.441 ' HG2' ' N ' ' A' ' 81' ' ' PHE . 8.5 tttt -61.05 -53.34 58.41 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.441 ' N ' ' HG2' ' A' ' 80' ' ' LYS . 58.8 t80 -67.51 -50.37 59.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.759 -175.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB1' ' CD1' ' A' ' 87' ' ' ILE . . . -56.72 -52.01 66.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.54 -175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.6 m -69.75 -37.98 76.65 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.606 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.3 m -68.95 -24.83 64.31 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.684 0.278 . . . . 0.0 111.029 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.3 m -89.3 1.76 55.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.78 178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.58 42.88 99.84 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.661 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' CD1' ' HB1' ' A' ' 82' ' ' ALA . 2.8 pt -61.4 -9.41 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.635 0.218 . . . . 0.0 111.49 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -33.84 -45.33 0.19 Allowed 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.238 0.336 . . . . 0.0 110.791 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -132.21 123.8 27.74 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.652 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.79 -153.48 24.89 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.71 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.693 ' HB3' HG23 ' A' ' 9' ' ' ILE . 7.1 t80 -122.33 149.85 43.19 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.477 HD13 ' OH ' ' A' ' 6' ' ' TYR . 62.1 mt -130.98 133.02 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.514 -177.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 32.6 p90 -132.37 129.67 39.7 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.326 0.584 . . . . 0.0 111.233 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.611 HG23 ' HB3' ' A' ' 138' ' ' ALA . 2.6 m -112.59 130.99 65.35 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.182 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -110.37 141.24 43.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.28 -175.033 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.46 ' HB2' HG21 ' A' ' 137' ' ' ILE . 10.3 t-20 -83.11 149.76 26.69 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 110.677 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.427 HH21 ' CD ' ' A' ' 107' ' ' GLU . 9.0 ttt180 -99.99 -20.2 16.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -35.28 78.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.128 0.49 . . . . 0.0 110.132 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp -64.05 -38.12 89.9 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.036 176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 5.9 m-30 -64.86 -39.23 93.23 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.781 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.17 -52.72 51.64 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.824 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.435 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -64.1 -29.94 71.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 110.868 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.435 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 4.5 m-30 -82.85 -16.97 45.59 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.715 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.7 m 64.96 47.36 2.6 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.621 0.724 . . . . 0.0 110.275 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 125' ' ' ALA . 24.9 mm -77.06 150.1 6.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.92 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' CE2' HG22 ' A' ' 32' ' ' ILE . 16.0 m-30 -96.4 103.56 15.47 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.951 0.405 . . . . 0.0 111.402 -168.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 123' ' ' ILE . 2.1 pt-20 -93.3 108.17 19.86 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.111 0.481 . . . . 0.0 110.103 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -99.86 114.26 27.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.337 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 11.6 pt-20 -85.82 120.03 26.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.822 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -92.5 107.76 19.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 170.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -114.21 161.04 18.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.132 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -129.19 172.32 7.32 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.557 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -45.2 168.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.37 2.047 . . . . 0.0 112.682 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 1.5 pm0 -55.97 -51.22 68.47 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -170.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.511 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.3 t-20 -83.64 -28.42 0.42 Allowed Pre-proline 0 N--CA 1.471 0.609 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -169.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 22.1 Cg_exo -37.17 -21.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.485 2.123 . . . . 0.0 113.378 170.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.401 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.4 t-20 83.65 -3.94 1.16 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.35 0.66 . . . . 0.0 112.005 163.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -122.48 145.5 48.25 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.239 0.542 . . . . 0.0 111.846 -172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.756 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 16.8 tttm -150.05 95.48 2.29 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -100.13 117.01 33.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 0.0 111.175 -169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 22.8 t -89.22 107.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.456 HG21 HD22 ' A' ' 63' ' ' LEU . 5.2 m -91.28 113.65 25.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.926 0.393 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 107' ' ' GLU . 4.5 mt -88.31 103.53 13.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.184 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.98 115.16 27.78 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.267 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -74.44 163.44 27.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.728 174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -39.44 -39.85 0.74 Allowed 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.497 0.498 . . . . 0.0 111.439 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -157.45 161.67 38.92 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.06 174.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 63.5 m -62.24 160.9 12.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.044 0.45 . . . . 0.0 112.01 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.39 31.13 9.87 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.221 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 2.4 m 48.97 69.33 0.59 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.661 0.384 . . . . 0.0 111.876 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.749 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -53.77 -46.35 98.44 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.723 179.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.749 ' HD3' HG23 ' A' ' 131' ' ' ILE . 91.0 Cg_endo -92.73 108.74 0.21 Allowed 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 121.854 1.703 . . . . 0.0 112.038 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.41 -5.84 55.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.026 0.441 . . . . 0.0 110.622 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -88.63 -3.42 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 95' ' ' LEU . 9.5 p -76.3 -21.11 15.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.9 pt -86.59 89.74 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.726 0.774 . . . . 0.0 109.341 -176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.46 HG21 ' HB2' ' A' ' 96' ' ' ASN . 14.2 pt -74.94 -37.07 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.046 -174.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.611 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -136.76 127.84 27.82 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.812 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -123.07 136.52 54.85 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.431 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -141.26 159.46 42.16 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.239 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.2 tt -112.72 152.18 29.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.8 tt -140.84 125.89 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.357 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.43 ' HG3' HD21 ' A' ' 141' ' ' LEU . 6.3 mt-10 -133.92 93.87 3.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 174.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 14.8 mt 70.73 107.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.936 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -86.18 60.77 6.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.451 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.67 -33.5 66.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.284 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.22 154.99 17.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.113 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.35 39.59 0.83 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.4 t60 72.01 -12.82 0.64 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -170.31 109.12 0.36 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 111.099 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 152' ' ' HIS . 15.3 t-80 -109.45 -13.44 14.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.164 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 151' ' ' HIS . 16.3 t-80 77.11 -49.06 0.54 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.628 0.771 . . . . 0.0 110.86 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 C--O 1.246 0.914 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.421 ' C ' ' HB3' ' A' ' 97' ' ' ARG . . . -143.67 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.13 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 90.45 -106.61 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 110.16 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.51 153.94 24.01 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 121.997 -0.44 . . . . 0.0 111.243 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 144.82 51.12 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.107 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.416 ' HD1' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -111.7 132.68 54.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.428 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 0.9 OUTLIER -141.14 105.93 4.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.996 0.427 . . . . 0.0 110.345 177.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.657 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -92.73 155.37 22.55 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.698 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 58.2 mt -131.34 129.59 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.412 . . . . 0.0 110.607 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.21 -24.45 23.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.214 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.02 48.88 1.67 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.146 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.494 ' NE2' ' HA2' ' A' ' 90' ' ' GLY . 27.5 mt-30 -56.76 -32.24 65.41 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -68.87 -49.36 58.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.933 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.11 -44.1 91.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.569 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.68 -48.17 82.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.341 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -67.76 -32.76 73.58 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.221 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -72.1 -38.39 69.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -83.05 -22.55 33.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.033 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 76.79 5.52 84.01 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.813 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 1.4 mt-30 -156.01 165.28 36.91 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.249 0.62 . . . . 0.0 109.441 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.61 56.47 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.65 137.11 0.05 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.063 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.11 73.28 4.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.801 2.334 . . . . 0.0 112.489 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -108.82 146.77 33.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.302 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -155.24 73.9 0.24 Allowed Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -81.86 69.65 8.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 27' ' ' LYS . 16.3 mmmt -110.17 109.0 19.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . 178.81 -31.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.269 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.43 ' HB2' ' HG3' ' A' ' 43' ' ' LYS . 1.4 mp0 71.61 -64.53 0.38 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.032 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 45' ' ' THR . 99.3 t 69.75 147.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 122.948 0.499 . . . . 0.0 111.732 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 143.9 41.84 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.433 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.595 HG22 ' HB3' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -134.45 136.15 53.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.989 -175.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -144.49 91.75 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.119 0.485 . . . . 0.0 110.985 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -144.11 135.73 25.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.195 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -67.62 157.64 34.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 128.39 -178.25 17.26 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.442 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -85.83 23.65 1.41 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.21 0.529 . . . . 0.0 110.502 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -76.63 106.95 8.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -72.74 71.03 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 109.908 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.528 ' HB3' HG13 ' A' ' 32' ' ' ILE . 11.5 m-85 -64.62 146.76 54.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.636 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.94 -98.36 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.11 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.31 99.04 1.75 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.739 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG3' ' HB2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -152.62 162.51 41.14 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 66.7 -77.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.366 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.576 HG23 HG13 ' A' ' 30' ' ' VAL . 3.4 m 57.81 67.56 0.95 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.279 0.561 . . . . 0.0 110.922 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -103.26 4.41 36.59 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.87 177.82 46.83 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -87.38 -163.96 0.18 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.122 2.548 . . . . 0.0 112.358 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 m 61.18 73.43 0.48 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.483 0.658 . . . . 0.0 111.153 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.597 HG22 ' H ' ' A' ' 51' ' ' LYS . 5.7 p -103.57 172.84 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.93 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.597 ' H ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -44.2 -61.07 1.62 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.065 174.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.595 ' HB3' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -67.46 -14.66 63.13 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -175.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.79 -52.84 8.81 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' OH ' ' A' ' 68' ' ' TYR . 13.8 p -63.24 -35.05 70.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.08 0.467 . . . . 0.0 109.827 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 124' ' ' ARG . 14.9 m-30 -61.39 -50.3 73.42 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.29 72.53 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.769 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -61.59 -52.78 62.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.064 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.686 ' HB2' HD12 ' A' ' 63' ' ' LEU . 18.6 tm0? -59.52 -40.22 86.43 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.399 0.618 . . . . 0.0 110.723 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.7 mt -73.55 -38.49 52.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.31 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -84.5 -69.92 0.61 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.99 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 -24.97 18.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.764 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.84 162.35 26.83 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 58' ' ' GLN . 13.7 mt -155.57 152.65 29.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.359 0.599 . . . . 0.0 110.151 -175.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -62.51 83.91 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.048 172.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -57.71 82.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.737 0.78 . . . . 0.0 111.417 -176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' TYR . . . -145.86 -32.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.9 m -55.17 -28.07 50.3 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.4 0.619 . . . . 0.0 110.006 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.527 ' CD1' ' HA ' ' A' ' 124' ' ' ARG . 30.3 m-85 -103.59 161.2 14.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.825 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.2 mp -101.29 100.56 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.014 0.435 . . . . 0.0 110.288 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -78.84 123.1 26.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.931 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.83 152.69 50.56 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.495 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 6.0 m -105.24 159.9 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -28.42 66.68 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.013 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -100.34 134.23 43.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -58.72 -19.55 41.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.375 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.557 ' HB3' ' HE2' ' A' ' 80' ' ' LYS . 12.4 mm-40 -52.91 -24.85 10.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -49.81 -35.7 10.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.069 178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.14 -50.05 74.76 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.408 0.623 . . . . 0.0 110.609 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -69.41 -47.07 65.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.761 -176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 53.2 mttm -63.29 -48.51 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.334 -176.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.657 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -63.1 -47.42 82.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.883 -177.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.636 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -57.07 -57.47 12.43 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.195 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 m -60.65 -45.05 95.55 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.832 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 m -60.61 -29.88 69.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 111.151 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -83.8 -6.7 59.49 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.26 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 75.23 45.82 18.11 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.636 HG21 ' HB1' ' A' ' 82' ' ' ALA . 7.2 tp -68.49 -18.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -32.43 -44.36 0.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.015 0.822 . . . . 0.0 112.468 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -130.95 101.74 5.75 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.494 ' HA2' ' NE2' ' A' ' 12' ' ' GLN . . . 170.83 -166.82 40.01 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.321 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.45 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -93.05 142.99 26.68 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.013 0.525 . . . . 0.0 109.825 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -134.86 112.79 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.125 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 2.7 m-85 -95.05 129.66 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.223 0.535 . . . . 0.0 110.144 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.83 113.61 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.932 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 95' ' ' LEU . 3.6 mp -112.43 140.96 46.73 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.466 0.479 . . . . 0.0 109.839 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -91.61 129.43 37.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.421 ' HB3' ' C ' ' A' ' 2' ' ' GLY . 6.1 ttp85 -80.76 -28.38 36.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.914 -175.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -59.18 -33.6 71.13 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.44 ' HB3' HG23 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -61.07 -38.54 86.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.012 175.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 4.9 m-85 -66.49 -44.05 83.69 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.202 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.76 -45.24 96.83 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.901 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -61.84 -43.67 98.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.231 0.539 . . . . 0.0 110.016 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -69.41 -21.64 63.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.516 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.2 m 68.59 37.83 2.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.041 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.545 HG23 ' HA ' ' A' ' 125' ' ' ALA . 17.5 mm -67.65 153.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.245 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -84.67 104.14 14.39 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 121.038 0.447 . . . . 0.0 110.859 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -88.04 110.72 20.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.731 -177.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.406 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 0.2 OUTLIER -100.48 113.22 25.83 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -105.86 130.03 53.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.116 0.484 . . . . 0.0 110.66 -178.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.8 m -117.22 131.66 69.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.557 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.8 pm0 -87.78 131.34 34.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.031 0.443 . . . . 0.0 110.311 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 113' ' ' PRO . 2.2 m170 -83.37 175.69 4.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.518 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 82.3 Cg_exo -45.95 164.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.44 2.093 . . . . 0.0 113.138 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' HG2' ' N ' ' A' ' 115' ' ' ASN . 0.3 OUTLIER -51.09 -55.84 15.65 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -168.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.479 ' N ' ' HG2' ' A' ' 114' ' ' GLU . 2.1 t-20 -103.28 -9.32 0.12 Allowed Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 116.115 1.895 . . . . 0.0 116.115 -170.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 42.7 Cg_exo -43.07 -27.34 0.96 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 CA-C-N 121.708 1.646 . . . . 0.0 110.867 162.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 t30 67.64 31.57 5.98 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.605 167.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.89 145.89 29.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 110.834 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 111' ' ' GLU . 5.5 mptt -123.09 130.4 52.73 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.266 177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -82.8 108.4 16.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.148 0.499 . . . . 0.0 110.23 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.08 96.6 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.461 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.27 117.05 29.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.3 mm -87.3 106.36 16.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.026 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 68' ' ' TYR . 26.0 mmt180 -85.19 100.23 11.62 Favored 'General case' 0 C--O 1.246 0.903 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.138 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.545 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -85.57 161.04 19.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.572 ' HB2' HD13 ' A' ' 131' ' ' ILE . 33.2 mt-10 -65.21 -21.05 66.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.073 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -137.52 161.18 37.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 110.56 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 2.1 m -71.85 99.61 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.256 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.35 71.55 1.21 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.91 -0.662 . . . . 0.0 114.1 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.9 71.84 0.48 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.718 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -58.95 -44.21 98.61 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.694 ' HD3' HG23 ' A' ' 131' ' ' ILE . 65.6 Cg_endo -74.51 109.69 2.95 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.444 1.429 . . . . 0.0 112.23 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -63.15 -21.57 66.29 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -77.46 -15.43 59.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.442 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.562 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.4 p -70.47 -22.12 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.55 97.03 6.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.431 0.634 . . . . 0.0 109.554 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 pt -69.04 -28.26 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.46 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.73 141.9 18.36 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.505 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 95.26 5.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 108.956 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -95.08 157.75 15.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.283 0.564 . . . . 0.0 111.493 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 tt -137.0 147.9 46.55 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.642 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.7 tt -140.73 138.34 35.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.937 0.399 . . . . 0.0 110.624 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -129.21 53.83 1.86 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.786 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.2 mt 60.01 87.82 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.628 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -57.4 145.04 34.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.203 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.471 HD13 ' N ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -66.71 -22.33 66.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.657 0.265 . . . . 0.0 111.625 -176.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.471 ' N ' HD13 ' A' ' 146' ' ' LEU . 2.1 mm-40 -74.7 158.19 34.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.276 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -139.28 100.23 3.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.749 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 66.2 -84.88 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.257 -177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -169.24 21.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.431 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 20.5 m80 47.96 -139.85 0.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.48 -177.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.431 ' H ' ' HB3' ' A' ' 151' ' ' HIS . 45.1 t60 -155.59 118.91 4.37 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.743 0.306 . . . . 0.0 110.347 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.793 -0.622 . . . . 0.0 109.605 179.108 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.531 ' O ' ' HB2' ' A' ' 97' ' ' ARG . 10.5 tpt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.722 0.296 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.41 -147.63 18.69 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.295 -176.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -168.69 -97.7 0.01 OUTLIER 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -125.49 119.32 27.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.721 HD21 HD13 ' A' ' 123' ' ' ILE . 29.4 mt -99.22 124.52 44.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.291 -175.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.23 114.62 18.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.904 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -139.77 144.38 37.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -114.19 158.51 14.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.504 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.609 HG12 ' H ' ' A' ' 11' ' ' CYS . 4.3 tt -151.45 168.21 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.82 0.448 . . . . 0.0 110.294 -171.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -87.98 -14.55 38.85 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.226 0.536 . . . . 0.0 109.999 172.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' H ' HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER 60.16 -86.27 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.597 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -37.77 -57.13 1.02 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -169.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -61.85 -56.18 22.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.361 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.85 -41.54 97.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.31 0.576 . . . . 0.0 111.006 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -65.78 -52.5 50.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.271 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -63.51 -36.73 84.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.898 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -68.84 -55.47 11.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.209 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -88.41 -8.7 54.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.725 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.57 1.26 89.24 Favored Glycine 0 C--N 1.329 0.175 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 179.65 -175.91 0.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.32 67.31 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.811 0.339 . . . . 0.0 111.113 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt 54.21 64.47 6.32 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.103 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.46 62.71 7.99 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.573 2.182 . . . . 0.0 112.202 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -85.76 61.33 6.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 26' ' ' ASN . . . -124.86 -171.46 13.32 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.411 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 25' ' ' GLY . 5.5 t-20 78.93 117.09 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.982 0.913 . . . . 0.0 111.027 178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 45' ' ' THR . 8.7 tttt -137.33 -80.43 0.37 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.005 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -173.0 -85.82 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.008 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.61 -156.49 0.71 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.136 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.49 ' H ' ' HB2' ' A' ' 29' ' ' GLU . 39.0 t -48.99 144.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 123.774 0.671 . . . . 0.0 112.294 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.496 ' HB3' ' H ' ' A' ' 44' ' ' ALA . . . -159.66 -157.33 0.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.312 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 48.2 mt 68.14 -93.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.094 0.558 . . . . 0.0 111.209 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 66.4 155.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 110.272 -170.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.465 ' HB3' ' CD1' ' A' ' 38' ' ' PHE . 15.4 t80 -168.45 148.26 4.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.33 -45.87 14.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.515 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.75 85.52 0.16 Allowed Glycine 0 CA--C 1.52 0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 113.077 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? 64.7 -74.26 0.05 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.348 0.659 . . . . 0.0 111.012 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 34' ' ' TYR . 16.5 t80 61.64 68.28 0.71 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.526 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.08 44.54 1.02 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.16 0.505 . . . . 0.0 109.984 175.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -136.93 168.75 18.98 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.072 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.28 132.82 3.58 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.8 -173.69 46.41 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.31 -0.948 . . . . 0.0 113.054 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.51 127.88 56.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.103 0.561 . . . . 0.0 110.364 -176.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' H ' ' HB3' ' A' ' 31' ' ' ALA . . . -117.98 147.94 42.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.195 176.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -45.17 -59.56 2.57 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.581 0.753 . . . . 0.0 112.852 -176.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 4.5 m-70 -95.95 95.72 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.79 0.329 . . . . 0.0 110.723 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -55.7 -51.9 51.92 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.471 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 47' ' ' GLY . 56.0 Cg_endo -70.07 -3.74 12.82 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.438 2.092 . . . . 0.0 112.926 179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 46' ' ' HIS . 12.9 t -126.28 -146.35 0.34 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.43 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 35.5 t 60.87 -111.09 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 35.5 pttt 30.91 -134.79 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -59.54 -25.92 64.93 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.333 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 50' ' ' VAL . . . -61.05 -54.59 42.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.747 0.308 . . . . 0.0 110.524 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.49 -36.42 54.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.41 -55.4 21.19 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.048 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.39 90.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.543 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -57.14 -54.4 47.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.056 0.455 . . . . 0.0 110.188 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.564 ' HG3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -59.91 -32.58 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -176.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 58' ' ' GLN . 59.6 mt -88.77 -70.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -60.82 -45.67 93.54 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.138 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 m -81.65 -19.29 42.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.876 0.37 . . . . 0.0 110.982 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 51.21 4.2 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.333 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' GLN . 40.7 mt 64.05 79.83 0.25 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.828 0.451 . . . . 0.0 110.868 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -53.87 -27.26 29.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.646 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -163.77 150.82 12.13 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.673 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.58 69.13 2.38 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.768 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -16.38 27.9 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -119.41 152.43 36.85 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.156 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.525 ' HB ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -107.88 110.17 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.492 -176.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 3.2 m -99.93 136.04 40.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.838 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.683 ' HB ' HD23 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -141.06 155.41 46.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.274 175.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 m -86.67 162.33 17.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 110.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -44.48 96.76 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 6.8 t70 -83.68 136.92 34.02 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 -174.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -56.92 -21.94 33.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.845 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' A' ' 74' ' ' ASP . 10.0 pt-20 -61.18 -16.85 49.18 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.789 0.328 . . . . 0.0 110.937 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.95 -29.29 11.13 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.133 177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.84 -66.36 0.42 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.0 0.429 . . . . 0.0 111.956 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -71.15 -35.67 71.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.37 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -62.13 -44.45 96.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.009 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -67.16 -51.24 56.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.918 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.668 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -54.77 -46.21 74.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.327 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -69.43 -44.1 72.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.664 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.1 m -73.52 -18.78 61.05 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.4 ' HB2' HG13 ' A' ' 87' ' ' ILE . 19.0 m -101.5 10.68 40.13 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.537 0.208 . . . . 0.0 111.267 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.79 21.18 69.09 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.169 -0.468 . . . . 0.0 113.029 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 82' ' ' ALA . 18.1 mt -72.8 -8.35 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.523 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -39.45 -34.41 0.21 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.545 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -130.45 89.54 2.79 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.42 -144.98 6.64 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.228 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -127.18 150.72 49.39 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.567 HG23 HG21 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -133.25 143.19 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 178.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 43.1 p90 -129.65 139.3 51.44 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.271 0.557 . . . . 0.0 110.843 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.4 m -126.16 139.92 50.18 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.866 -176.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.801 HD23 HG13 ' A' ' 135' ' ' VAL . 0.4 OUTLIER -126.05 141.04 52.12 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.024 -174.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.657 ' HB2' HD13 ' A' ' 137' ' ' ILE . 38.4 t-20 -96.97 139.84 32.39 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.86 0.362 . . . . 0.0 110.769 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -66.25 -25.92 67.12 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.78 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.88 -35.26 70.74 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.238 0.542 . . . . 0.0 109.892 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 96' ' ' ASN . 4.4 mm? -75.94 -50.81 13.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.482 -174.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.85 -30.21 68.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.05 -47.57 87.52 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -60.06 -40.01 87.99 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 105' ' ' ILE . 1.8 m-85 -68.96 -22.0 64.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.944 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m 66.75 38.43 3.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.66 0.743 . . . . 0.0 109.803 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -71.69 163.88 3.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.642 -178.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 5.2 m-30 -75.53 161.61 29.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.957 0.408 . . . . 0.0 110.544 -171.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -141.23 155.9 45.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.297 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.465 ' HB2' HH11 ' A' ' 124' ' ' ARG . 0.3 OUTLIER -155.28 110.84 3.07 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 174.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -108.71 120.03 41.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.774 0.321 . . . . 0.0 110.343 -177.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 m -108.6 149.21 12.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.991 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -105.25 142.57 34.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.018 177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -174.41 0.48 Allowed Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 172.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 116' ' ' PRO . 99.3 Cg_exo -45.79 163.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 121.414 1.409 . . . . 0.0 111.811 171.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.67 -51.83 64.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -103.69 -9.26 0.12 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 -168.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 40.8 Cg_exo -42.13 -23.22 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 CA-C-N 121.683 1.637 . . . . 0.0 112.161 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 70.55 30.07 3.23 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.567 169.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -138.69 150.82 46.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 111.087 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -129.77 129.79 44.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.616 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -94.65 103.13 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.942 0.401 . . . . 0.0 109.986 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 4.4 p -92.54 110.11 22.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.482 0.658 . . . . 0.0 110.442 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 87.6 m -91.68 114.74 27.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.519 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.721 HD13 HD21 ' A' ' 5' ' ' LEU . 2.1 mp -87.82 129.47 39.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.623 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -111.8 119.34 38.26 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.456 -173.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.1 149.45 49.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.67 -57.23 13.84 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.57 158.88 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.056 169.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.28 160.36 31.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.993 0.425 . . . . 0.0 110.767 -177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 73.29 32.13 60.5 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.043 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 11.6 m 57.49 71.31 0.59 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.155 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.85 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -35.52 -49.64 1.35 Allowed Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.85 ' HD3' HG23 ' A' ' 131' ' ' ILE . 84.7 Cg_endo -99.87 109.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.336 2.024 . . . . 0.0 112.019 174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 3.87 15.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.873 0.368 . . . . 0.0 110.606 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.85 -9.58 39.79 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 175.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.801 HG13 HD23 ' A' ' 95' ' ' LEU . 6.8 p -71.42 -9.26 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.585 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.6 pt -86.1 91.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 96' ' ' ASN . 11.6 pt -63.41 -29.92 48.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.446 -173.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.609 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -148.74 148.83 30.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.215 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -150.45 135.37 17.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -142.63 153.14 43.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.032 -171.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -95.44 150.79 19.9 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.508 HG13 ' OD1' ' A' ' 145' ' ' ASN . 7.4 tt -139.37 120.23 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.443 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -121.56 70.29 0.94 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.186 0.517 . . . . 0.0 110.227 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.1 mt 56.33 30.14 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.355 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.508 ' OD1' HG13 ' A' ' 142' ' ' ILE . 18.5 p-10 -94.18 -24.17 17.62 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.0 mp 64.49 -88.9 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.139 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 149' ' ' HIS . 33.6 tt0 -97.45 143.21 28.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -65.56 -29.71 70.35 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.432 ' H ' ' HG2' ' A' ' 147' ' ' GLU . 2.5 t-80 61.72 83.35 0.15 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.203 173.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -78.88 87.67 4.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.643 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.407 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 32.6 m170 68.07 -147.02 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.455 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.407 ' H ' ' HB3' ' A' ' 151' ' ' HIS . 71.0 t60 -65.66 134.33 53.0 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 111.587 -175.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 C--O 1.246 0.901 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.012 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mtm . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.78 -80.22 0.68 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.277 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -155.99 174.67 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.738 0.304 . . . . 0.0 110.473 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -109.2 133.95 52.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.695 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 60.3 mt -113.69 147.18 38.64 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 176.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -140.1 135.1 32.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.493 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 93' ' ' TYR . 1.4 tpt180 -148.37 155.96 41.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -137.49 157.52 24.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.758 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.695 HG23 ' HB3' ' A' ' 91' ' ' TYR . 5.9 tt -138.43 133.14 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.027 0.442 . . . . 0.0 110.47 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -31.31 27.38 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.536 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 53.22 2.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.802 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 91' ' ' TYR . 13.3 tm0? -56.58 -27.32 57.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.09 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -74.96 -39.34 61.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.948 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.87 -48.1 75.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.319 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -66.16 -35.28 80.06 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.411 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 tt0 -63.57 -43.35 97.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.127 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.02 -40.58 98.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.341 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.97 -31.95 71.18 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.364 177.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.48 7.69 71.9 Favored Glycine 0 C--O 1.234 0.129 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.652 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.486 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 4.6 mm-40 -170.93 -178.05 2.4 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.2 mt -82.06 38.42 0.53 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 111.219 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm 53.3 60.74 11.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.23 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 55.4 Cg_endo -69.09 149.95 71.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.321 2.014 . . . . 0.0 110.97 178.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 -138.5 0.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 121.195 -0.202 . . . . 0.0 111.505 -173.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.31 57.58 0.17 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -74.44 80.57 1.92 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.893 0.377 . . . . 0.0 111.031 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB3' ' H ' ' A' ' 28' ' ' ALA . 1.4 mppt? 65.55 -160.97 0.27 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.505 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.746 ' HA ' ' HG3' ' A' ' 43' ' ' LYS . . . 64.19 21.18 12.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.139 0.495 . . . . 0.0 110.289 -178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -40.22 105.98 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.264 -1.334 . . . . 0.0 112.729 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t 45.78 38.9 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 O-C-N 124.166 0.916 . . . . 0.0 112.078 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.67 ' HB1' ' HA3' ' A' ' 42' ' ' GLY . . . -149.75 -50.77 0.14 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.729 HD11 ' HG3' ' A' ' 126' ' ' GLU . 1.2 mm 52.41 -134.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.77 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 12.9 ttm-85 -177.9 102.32 0.04 OUTLIER 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HD2' ' HB2' ' A' ' 38' ' ' PHE . 4.3 t80 -145.8 146.03 31.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.759 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -133.26 27.03 4.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.881 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.58 -119.4 2.65 Favored Glycine 0 C--N 1.331 0.259 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 177.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -89.11 25.95 1.72 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.572 0.701 . . . . 0.0 109.759 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.553 ' HB2' ' HD2' ' A' ' 34' ' ' TYR . 26.3 m-85 -151.75 111.31 3.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.149 178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -86.47 70.54 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.301 0.572 . . . . 0.0 110.501 -176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 18.1 m-85 -89.42 85.71 6.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.989 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -93.98 54.12 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.392 0.615 . . . . 0.0 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.67 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . -89.89 -102.64 1.12 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.057 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.746 ' HG3' ' HA ' ' A' ' 28' ' ' ALA . 21.6 mmtt -84.14 173.69 10.86 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.383 0.273 . . . . 0.0 110.552 -174.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -119.82 -106.05 0.38 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.611 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m 58.52 78.34 0.26 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.272 0.558 . . . . 0.0 111.225 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -76.56 76.49 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.202 0.525 . . . . 0.0 110.65 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.22 -105.6 0.19 Allowed Glycine 0 CA--C 1.519 0.343 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.907 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HB2' ' H ' ' A' ' 49' ' ' SER . 31.1 Cg_endo -82.91 -133.92 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.152 2.568 . . . . 0.0 112.028 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.482 ' H ' ' HB2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 54.34 -161.81 0.14 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.468 0.707 . . . . 0.0 111.495 176.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -93.81 -105.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.426 -0.171 . . . . 0.0 111.107 -177.095 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HA ' HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER 60.67 -169.42 0.16 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.464 0.65 . . . . 0.0 112.698 174.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -48.26 -31.89 6.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.131 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.75 -60.42 3.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 50' ' ' VAL . 2.2 p -62.91 -32.71 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -62.64 -53.15 58.94 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.166 0.508 . . . . 0.0 110.418 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.06 99.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.666 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -64.8 -48.96 72.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -70.6 -22.13 62.58 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.836 -175.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.549 HD11 ' NH2' ' A' ' 124' ' ' ARG . 17.0 mm -92.35 -54.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.853 0.359 . . . . 0.0 111.047 178.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -76.91 -50.29 13.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.512 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -80.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.605 0.241 . . . . 0.0 111.412 -173.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.15 79.13 1.62 Allowed Glycine 0 C--N 1.332 0.335 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 58' ' ' GLN . 19.8 tp -57.33 86.06 0.01 OUTLIER 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 111.535 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' CE1' HG21 ' A' ' 122' ' ' THR . 20.9 m-85 61.55 60.27 1.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.0 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.33 -34.19 68.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.372 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.33 -13.95 0.45 Allowed Glycine 0 C--N 1.33 0.238 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.353 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.437 ' HB2' ' OE1' ' A' ' 58' ' ' GLN . 13.9 m -61.3 -33.0 72.87 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 58' ' ' GLN . 19.8 m-30 -106.71 153.51 22.32 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.05 177.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.3 mt -93.1 99.6 9.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 120.833 0.349 . . . . 0.0 110.53 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.78 112.86 24.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.567 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -122.16 170.39 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.919 0.39 . . . . 0.0 111.005 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -98.78 158.29 15.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.966 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.52 -16.97 64.06 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 111.655 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.53 134.08 45.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.156 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.7 -19.09 63.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.794 -177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -61.17 -16.51 45.42 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.666 0.27 . . . . 0.0 110.655 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.57 -30.62 14.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.902 177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.76 -60.37 3.55 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.155 0.502 . . . . 0.0 111.352 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -73.65 -35.44 65.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.185 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -60.63 -47.67 85.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.808 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -64.38 -51.73 61.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.664 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.46 -59.21 5.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.229 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -66.87 -35.54 80.26 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.861 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.0 m -73.49 -17.85 61.18 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.444 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 m -99.78 -2.85 34.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.6 0.238 . . . . 0.0 110.682 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.87 31.59 78.9 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 -9.75 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.206 -0.497 . . . . 0.0 111.031 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -47.48 -27.36 1.71 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.694 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.487 HD21 HD11 ' A' ' 144' ' ' ILE . 6.3 m-20 -110.11 88.48 2.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.99 -138.74 5.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.364 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.695 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.7 t80 -123.49 148.48 46.19 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.743 0.417 . . . . 0.0 110.022 -174.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.449 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 pt -140.09 139.15 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 7' ' ' ARG . 10.6 p90 -132.13 132.21 43.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.933 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.1 m -109.98 139.69 32.17 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 CA-C-O 121.333 0.587 . . . . 0.0 110.729 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.3 mp -121.09 142.75 49.55 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.005 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -85.46 125.81 33.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.891 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.495 HH21 ' CD ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -69.49 -53.61 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -171.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.64 -20.37 65.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.061 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 135' ' ' VAL . 15.0 tp -64.61 -34.77 79.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.183 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.534 ' CE1' HG11 ' A' ' 135' ' ' VAL . 0.2 OUTLIER -67.01 -43.89 81.71 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.618 176.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.87 -38.96 94.84 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.638 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -59.78 -50.38 74.06 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -64.98 -20.81 66.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.603 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.1 m 68.88 37.85 2.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.499 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.3 mp -71.97 158.86 6.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 171.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.836 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.6 m-85 -77.08 102.49 6.54 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.301 -166.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.495 ' CD ' HH21 ' A' ' 97' ' ' ARG . 41.4 mt-10 -91.63 126.51 36.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.264 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.632 ' HB2' ' HD3' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -134.32 111.01 9.86 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.513 ' HB3' HG13 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -117.0 118.03 31.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.126 0.489 . . . . 0.0 109.706 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 32.0 m -99.81 135.66 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.344 -176.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -92.77 142.37 27.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.342 0.592 . . . . 0.0 110.557 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.23 175.84 2.25 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.28 160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.906 1.737 . . . . 0.0 111.844 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.85 -41.23 97.85 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -167.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.484 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -86.26 -25.39 0.34 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -172.151 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 26.0 Cg_exo -39.37 -23.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.928 1.752 . . . . 0.0 112.091 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.413 ' N ' ' C ' ' A' ' 115' ' ' ASN . 1.8 m-20 76.15 6.22 3.68 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.223 164.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -150.11 160.72 43.44 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.142 0.496 . . . . 0.0 111.951 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.42 148.55 48.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.775 174.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -96.02 105.25 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.024 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 109' ' ' GLU . 33.7 t -89.25 102.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 -177.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.451 HG21 ' CE1' ' A' ' 64' ' ' TYR . 5.3 m -104.63 109.59 21.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.189 0.518 . . . . 0.0 111.248 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.408 HG21 ' CD2' ' A' ' 100' ' ' PHE . 5.1 mp -89.85 116.81 31.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.709 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.836 ' HG2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -103.04 118.68 37.35 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 121.833 0.825 . . . . 0.0 110.076 179.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.77 163.35 20.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.958 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.729 ' HG3' HD11 ' A' ' 32' ' ' ILE . 18.3 tt0 -51.55 -29.18 16.05 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.616 0.573 . . . . 0.0 111.719 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.415 ' H ' ' CG2' ' A' ' 131' ' ' ILE . 36.3 t0 -140.3 160.43 40.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.471 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 1.5 t -67.42 128.27 35.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.578 -176.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.93 59.69 1.85 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.578 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 10.3 m 47.46 70.4 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 172.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.896 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.2 OUTLIER -54.71 -44.87 99.58 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.896 ' HD3' HG23 ' A' ' 131' ' ' ILE . 91.1 Cg_endo -94.0 124.59 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.112 1.875 . . . . 0.0 112.32 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.432 ' H ' ' HG3' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -84.3 -14.9 48.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.306 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -61.4 -29.89 70.21 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.903 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.64 ' HA ' HD23 ' A' ' 99' ' ' LEU . 22.3 m -72.93 -12.51 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.48 93.63 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 pt -71.9 -26.45 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.923 -174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -144.45 139.79 28.55 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.409 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -132.48 126.92 34.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.278 177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.76 160.25 40.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.592 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.479 HD21 ' HG3' ' A' ' 143' ' ' GLU . 3.1 tt -102.55 153.47 20.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.5 tt -137.26 133.84 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.133 0.492 . . . . 0.0 111.329 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.479 ' HG3' HD21 ' A' ' 141' ' ' LEU . 31.4 mt-10 -134.0 74.68 1.56 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.954 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.487 HD11 HD21 ' A' ' 89' ' ' ASN . 7.2 mt 52.43 50.26 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.514 0.673 . . . . 0.0 110.677 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -64.91 -54.96 22.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.869 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.5 ' H ' HD22 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -95.34 43.38 1.09 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -171.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -139.18 156.1 47.36 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.92 0.391 . . . . 0.0 111.1 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -120.91 -6.47 9.56 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.101 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -79.95 68.61 6.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.961 0.41 . . . . 0.0 110.164 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -96.94 -19.44 18.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.449 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -77.22 126.61 31.22 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.408 -176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 62.37 107.33 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.461 0.705 . . . . 0.0 112.586 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.177 177.613 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.32 179.97 22.88 Favored Glycine 0 C--O 1.236 0.234 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.663 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 84.72 171.17 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.114 0.966 . . . . 0.0 109.907 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.52 141.44 48.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.049 0.452 . . . . 0.0 110.594 -176.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.611 HD22 HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -99.97 135.14 41.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HD2' HD11 ' A' ' 92' ' ' ILE . 1.6 m-85 -96.15 141.18 29.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 0.0 110.664 -175.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.13 123.01 9.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.397 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.551 ' H ' ' HZ ' ' A' ' 81' ' ' PHE . . . -119.8 157.33 15.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.225 -0.512 . . . . 0.0 111.863 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.545 HG22 ' HD1' ' A' ' 91' ' ' TYR . 8.3 tt -149.71 159.09 5.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.113 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 25.59 5.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.125 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.58 64.83 1.09 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.417 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.63 -23.84 67.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.558 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -61.7 -44.83 96.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.455 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.55 -41.65 88.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.234 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -59.66 -42.16 92.22 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.383 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -71.73 -33.55 68.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.13 -48.4 35.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -87.75 -27.71 22.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.967 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.2 6.61 75.2 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.993 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -153.02 17.57 0.57 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.89 0.345 . . . . 0.0 111.578 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.88 98.35 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.21 0.319 . . . . 0.0 110.686 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 10.2 mmmm 68.4 137.69 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 123.175 0.59 . . . . 0.0 110.879 -175.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' HE2' ' A' ' 22' ' ' LYS . 93.9 Cg_endo -79.7 149.56 20.94 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.396 2.064 . . . . 0.0 111.987 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -81.02 -174.67 4.98 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.798 179.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 49' ' ' SER . . . -82.29 -145.49 5.41 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.384 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -163.43 -64.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.747 0.273 . . . . 0.0 111.021 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -129.98 142.12 50.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.932 -174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 29' ' ' GLU . . . -78.69 -56.35 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.459 178.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 26.8 tt0 72.63 -61.86 0.49 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.402 -176.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.9 m -111.29 170.41 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.777 0.323 . . . . 0.0 110.675 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.612 ' HA ' ' HA3' ' A' ' 42' ' ' GLY . . . -77.7 163.28 26.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.396 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 7.7 mm -72.78 -44.23 59.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.601 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 33' ' ' ARG . 4.3 mmt180 54.54 55.89 7.46 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.652 174.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.608 ' HD2' ' HB2' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -85.95 113.4 22.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 170.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.65 115.62 10.02 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -169.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.34 -72.04 2.39 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.911 170.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -53.83 -39.39 65.53 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.658 0.383 . . . . 0.0 112.003 -172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.608 ' HB2' ' HD2' ' A' ' 34' ' ' TYR . 15.3 m-85 -139.69 92.48 2.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.789 0.328 . . . . 0.0 110.716 -175.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -70.05 78.13 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.141 0.496 . . . . 0.0 110.53 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . 22.1 m-85 -82.16 164.44 21.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.456 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -93.8 -108.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . 175.2 -67.96 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -81.24 54.17 2.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.357 0.598 . . . . 0.0 109.523 176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.66 -15.16 59.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.389 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 m 72.94 -57.18 0.64 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.18 0.592 . . . . 0.0 111.498 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -67.44 -36.09 80.54 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.777 0.322 . . . . 0.0 110.663 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.62 71.69 0.46 Allowed Glycine 0 C--N 1.333 0.369 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -90.25 -50.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.996 2.464 . . . . 0.0 114.408 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.412 ' HB2' ' HA3' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -89.35 42.69 1.1 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.54 HG23 HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -103.44 -74.33 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.03 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 32' ' ' ILE . 39.0 mtmt 58.26 179.13 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.885 0.85 . . . . 0.0 113.083 171.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.45 -24.31 54.9 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.809 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.43 -68.44 0.17 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.096 178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG21 ' SG ' ' A' ' 67' ' ' CYS . 3.6 p -79.96 -26.27 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.189 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.419 ' O ' HG12 ' A' ' 59' ' ' ILE . 2.8 m-85 -63.36 -53.62 49.69 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.93 0.395 . . . . 0.0 110.039 177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.549 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -56.24 -52.23 65.22 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.043 0.449 . . . . 0.0 109.941 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -62.4 -48.78 78.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.236 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 ' O ' ' A' ' 55' ' ' TYR . 46.7 mm -69.74 -41.2 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -84.71 -54.62 4.58 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.588 0.232 . . . . 0.0 111.401 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.2 m -74.92 -31.62 61.59 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.24 -161.89 12.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.142 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.433 HD11 ' OG ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -79.45 73.22 6.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.612 -176.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -71.58 -14.43 62.08 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.16 -171.52 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.651 171.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.45 -50.7 4.09 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.807 176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.615 ' SG ' HG21 ' A' ' 54' ' ' VAL . 34.6 t -84.87 -46.1 11.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 110.947 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -115.21 143.77 44.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.257 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.91 99.48 8.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.943 0.401 . . . . 0.0 110.229 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.433 ' OG ' HD11 ' A' ' 63' ' ' LEU . 60.0 m -80.49 122.67 27.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.653 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 5' ' ' LEU . 2.2 m -127.21 131.36 50.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.091 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.68 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -80.36 167.87 19.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.618 -179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.1 p -81.82 9.64 7.67 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.064 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 76' ' ' GLU . 0.5 OUTLIER -116.92 133.28 56.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.165 0.507 . . . . 0.0 110.899 -177.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -65.17 -19.75 66.13 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.008 -176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.402 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 27.7 mm-40 -77.57 -5.14 49.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.021 -176.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.68 HD12 ' H ' ' A' ' 72' ' ' THR . 2.7 tt -48.22 -34.51 4.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.547 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.74 -53.57 56.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.184 0.516 . . . . 0.0 110.787 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -70.59 -46.04 64.19 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.769 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -60.03 -48.23 82.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.53 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.551 ' HZ ' ' H ' ' A' ' 8' ' ' GLY . 6.0 t80 -67.35 -53.96 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.109 -176.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -56.61 -42.83 79.45 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.332 -176.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.2 m -70.85 -48.16 55.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.227 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -66.39 -20.55 66.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.691 0.282 . . . . 0.0 111.54 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -93.83 9.62 36.51 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.771 0.32 . . . . 0.0 110.638 178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.87 36.71 67.23 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.785 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.534 HG21 ' HB1' ' A' ' 82' ' ' ALA . 3.3 tp -70.76 -10.2 13.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 144' ' ' ILE . 2.0 tm-20 -38.56 -37.51 0.32 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 123.502 0.501 . . . . 0.0 111.193 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.07 89.18 2.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.85 -152.61 11.96 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.139 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' A' ' 9' ' ' ILE . 48.0 t80 -129.89 135.87 48.86 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.524 ' HB ' HG12 ' A' ' 87' ' ' ILE . 9.9 tt -139.97 138.9 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.981 0.42 . . . . 0.0 111.516 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -131.8 156.75 45.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 138' ' ' ALA . 1.7 m -128.17 137.35 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.074 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.477 HD23 HG13 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -113.82 140.63 48.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.356 -178.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -81.92 146.28 29.88 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.711 0.291 . . . . 0.0 110.702 -178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -94.27 -24.98 17.23 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.36 -43.4 67.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.345 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.64 -39.75 91.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.465 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 3.6 m-85 -67.14 -36.92 82.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.939 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.72 99.6 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -59.19 -53.44 58.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.113 0.482 . . . . 0.0 110.339 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -70.93 -16.75 62.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.043 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.3 m 63.88 47.97 3.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.509 0.671 . . . . 0.0 110.222 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -62.62 163.01 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.523 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 7.3 m-85 -74.6 99.78 3.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.129 0.49 . . . . 0.0 110.491 -170.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -94.94 101.61 13.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.766 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.512 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 54.6 t80 -116.49 125.3 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.1 140.61 47.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.804 0.335 . . . . 0.0 111.264 -173.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 120' ' ' GLU . 2.5 m -123.92 150.13 28.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.291 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.18 142.34 27.98 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.653 -0.419 . . . . 0.0 109.89 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 118' ' ' GLU . 3.0 m170 -84.99 175.09 4.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.535 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.0 Cg_exo -50.4 170.2 0.13 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.025 1.817 . . . . 0.0 112.461 176.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -53.13 -64.68 0.74 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -166.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.452 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.5 t-20 -93.79 -12.47 0.18 Allowed Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.535 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 52.0 Cg_exo -44.87 -24.04 1.1 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 CA-C-N 121.421 1.543 . . . . 0.0 111.174 163.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 72.25 -11.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.541 166.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 3.8 mt-10 -102.67 155.15 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.143 0.497 . . . . 0.0 111.029 -172.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -115.03 133.75 55.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HB3' HG22 ' A' ' 110' ' ' VAL . 1.1 tm-20 -89.04 135.32 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.36 100.4 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.459 ' HB ' ' NE ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -74.23 113.27 11.25 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.299 177.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.611 HG13 HD22 ' A' ' 5' ' ' LEU . 7.0 mm -87.45 100.19 9.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.605 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 48.6 mtt-85 -101.59 110.13 22.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.437 -172.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -68.5 160.34 30.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.365 -177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 131' ' ' ILE . 18.7 mt-10 -54.49 -49.94 68.95 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.934 -176.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.677 ' H ' HG21 ' A' ' 131' ' ' ILE . 30.5 t70 -110.18 160.28 16.63 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.15 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 24' ' ' LYS . 12.3 t -80.39 129.41 34.49 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.852 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.91 69.2 1.19 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.975 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 31.2 m 46.87 70.29 0.41 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.869 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -69.33 -44.44 26.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.093 176.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.869 ' HD3' HG23 ' A' ' 131' ' ' ILE . 83.5 Cg_endo -97.92 109.68 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.451 2.101 . . . . 0.0 111.707 176.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -78.63 -27.46 45.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.976 0.417 . . . . 0.0 110.638 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.18 -9.07 58.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 132' ' ' PRO . 6.4 p -73.13 -15.18 17.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.842 0.353 . . . . 0.0 111.155 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.9 mt -86.94 89.64 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.6 pt -80.23 -28.03 12.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.422 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.682 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -128.17 140.12 52.1 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.04 0.448 . . . . 0.0 111.46 -177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.464 ' HG3' ' OH ' ' A' ' 91' ' ' TYR . 12.1 ttmt -141.62 126.49 18.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.273 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.37 131.41 24.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.775 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' A' ' 143' ' ' GLU . 2.9 tt -92.68 151.89 19.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 171.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -140.52 122.29 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-O 121.177 0.513 . . . . 0.0 112.031 -175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.468 ' HG3' HD21 ' A' ' 141' ' ' LEU . 26.9 mt-10 -126.79 93.16 3.7 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.001 176.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 88' ' ' GLU . 2.1 mt 52.93 44.99 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 123.407 0.683 . . . . 0.0 111.778 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -80.89 65.91 6.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.333 0.587 . . . . 0.0 110.267 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.1 -85.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.267 176.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -95.51 166.48 11.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -162.37 66.58 0.23 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.855 0.359 . . . . 0.0 110.494 -176.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -76.95 -171.67 2.05 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.866 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.09 69.5 0.73 Allowed 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -176.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.5 m170 65.91 -134.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.476 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 73.7 m80 65.2 13.56 8.82 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.233 0.54 . . . . 0.0 110.502 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 15.2 t60 . . . . . 0 C--O 1.244 0.797 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.623 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.708 ' SD ' ' HD3' ' A' ' 97' ' ' ARG . 21.4 ttt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.753 0.311 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.22 45.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.689 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -149.54 153.19 36.79 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -141.93 174.93 10.13 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.554 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -118.97 159.07 24.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.098 178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' HE2' ' HB ' ' A' ' 92' ' ' ILE . 0.3 OUTLIER -112.67 132.39 55.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.554 -177.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.504 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 12.1 ttt180 -131.49 94.77 3.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.656 ' HA3' HD13 ' A' ' 87' ' ' ILE . . . -90.42 157.48 25.74 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.142 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 HD11 HD22 ' A' ' 21' ' ' LEU . 49.7 mt -125.47 128.71 72.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.869 0.366 . . . . 0.0 110.122 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.86 -31.01 11.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.858 178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 2.7 p -94.43 55.32 1.96 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -49.92 -29.44 8.34 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.315 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.526 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -70.85 -38.8 73.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.386 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -72.96 -36.18 67.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.722 -179.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.55 -53.39 28.78 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.454 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -59.81 -36.06 75.98 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.92 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 15.3 t-20 -68.27 -39.88 82.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.183 177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -67.18 -32.47 73.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.293 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.46 2.36 73.36 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.116 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -169.86 177.75 4.28 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 9' ' ' ILE . 7.1 mt -81.38 49.02 1.22 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.479 0.18 . . . . 0.0 111.166 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt 54.7 69.26 2.15 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.415 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 20' ' ' GLN . 67.1 Cg_endo -86.21 148.57 9.13 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.71 2.273 . . . . 0.0 112.233 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -148.79 4.69 0.66 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.767 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.31 96.54 0.49 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -152.97 21.77 0.58 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.405 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -141.28 122.09 14.41 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 110.032 175.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -97.77 -110.71 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.543 -168.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 54.59 63.21 2.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.23 0.538 . . . . 0.0 110.168 -173.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.5 86.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.555 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.501 ' HB3' ' H ' ' A' ' 43' ' ' LYS . . . -131.97 27.43 4.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.962 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.527 HG23 ' HA3' ' A' ' 42' ' ' GLY . 2.3 pt -135.92 145.45 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.76 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -157.79 149.59 21.94 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -69.57 73.63 0.37 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.142 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -50.95 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.081 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.11 -44.96 0.65 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -85.16 119.24 25.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -77.13 30.22 0.14 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -114.68 19.18 16.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 110.386 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 80.18 1.09 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 109.834 176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' HA ' ' HD2' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -68.03 78.75 0.23 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.527 ' HA3' HG23 ' A' ' 32' ' ' ILE . . . -87.22 -179.94 48.35 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.471 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.501 ' H ' ' HB3' ' A' ' 31' ' ' ALA . 45.4 mttm 67.07 179.61 0.22 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.906 0.482 . . . . 0.0 110.908 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.68 -156.67 0.58 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.311 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -15.13 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.725 0.297 . . . . 0.0 111.695 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -34.73 69.2 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 175.84 73.87 0.05 OUTLIER Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.006 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.29 -21.22 23.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.61 2.207 . . . . 0.0 111.67 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.3 p -91.41 15.35 12.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.57 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 p -51.53 -39.53 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.375 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HD3' ' H ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -56.02 -68.85 0.17 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.6 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.69 -53.03 34.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.024 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.56 -61.97 2.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.914 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.595 HG11 HH21 ' A' ' 124' ' ' ARG . 3.5 p -67.9 -37.1 77.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -172.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.489 ' O ' HG12 ' A' ' 59' ' ' ILE . 6.5 m-85 -63.41 -59.49 4.62 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.08 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.98 83.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.081 -177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.41 -29.58 69.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.053 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.782 HE22 ' HB3' ' A' ' 67' ' ' CYS . 8.6 tp-100 -67.62 -45.21 76.09 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 109.834 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 55' ' ' TYR . 18.4 mm -66.02 -31.73 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.437 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -81.58 -74.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.559 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.0 p -95.68 -38.72 10.24 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.39 48.18 Favored Glycine 0 C--O 1.239 0.41 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -171.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 58' ' ' GLN . 2.5 mp 59.97 -88.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.636 0.774 . . . . 0.0 111.37 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -95.72 64.33 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.365 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 63.54 -74.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.675 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -139.45 66.84 0.51 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.782 ' HB3' HE22 ' A' ' 58' ' ' GLN . 8.0 t -56.93 -42.7 80.5 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.753 0.311 . . . . 0.0 110.959 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.622 ' HD2' ' HG2' ' A' ' 58' ' ' GLN . 21.4 m-85 -123.39 159.72 28.33 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.37 104.21 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -170.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 21.3 m -87.39 111.22 20.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 t -123.85 157.22 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 p -87.52 158.49 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -13.16 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.807 0.336 . . . . 0.0 110.9 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -79.79 130.53 35.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.832 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp -58.61 -24.07 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.643 -176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.02 1.03 22.19 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.669 0.271 . . . . 0.0 111.0 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -48.93 -34.06 5.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.651 179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.04 -57.56 12.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 111.372 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -70.42 -43.09 70.67 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.832 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -60.62 -46.46 90.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.282 -178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.409 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 19.3 t80 -68.82 -44.39 73.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.294 -176.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.662 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -57.2 -50.61 72.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.68 -44.4 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -15.64 63.77 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.433 ' HB2' HG13 ' A' ' 87' ' ' ILE . 6.8 m -105.42 2.75 28.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.4 41.22 96.6 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.253 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 82' ' ' ALA . 10.1 mt -91.01 -7.8 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -29.21 -43.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.732 0.813 . . . . 0.0 113.186 -174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -125.17 92.72 3.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.03 -144.73 6.35 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.917 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -105.09 143.37 33.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.72 0.408 . . . . 0.0 110.448 -175.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.522 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 5.4 pt -139.88 113.92 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 110.296 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -101.99 156.31 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.098 179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -129.36 136.92 58.27 Favored 'Isoleucine or valine' 0 C--O 1.247 0.947 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.384 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.559 HD23 HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -128.34 133.9 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.295 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.493 ' HB2' HG21 ' A' ' 137' ' ' ILE . 48.5 t-20 -79.5 134.83 36.52 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.485 0.183 . . . . 0.0 110.701 -175.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.708 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.69 -51.64 13.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.333 -176.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.43 -17.8 64.85 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.782 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp -59.17 -45.61 90.56 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.344 0.592 . . . . 0.0 109.536 174.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.458 ' HE2' HD11 ' A' ' 5' ' ' LEU . 59.9 m-85 -66.48 -35.48 80.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.951 177.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.01 -36.59 93.1 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.952 175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -72.41 -37.2 68.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.136 0.493 . . . . 0.0 110.023 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -75.76 -23.39 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.785 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m 69.71 33.93 2.82 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.788 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.1 mp -65.13 163.92 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.922 174.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' A' ' 124' ' ' ARG . 1.3 m-85 -74.45 99.29 3.51 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 120.346 -0.541 . . . . 0.0 109.593 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -96.8 99.32 10.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.75 112.39 24.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.614 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER -105.02 107.45 18.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.925 0.393 . . . . 0.0 110.177 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.604 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -91.25 107.54 18.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.35 129.04 34.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.528 0.68 . . . . 0.0 109.455 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -80.75 169.35 19.82 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.146 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.82 167.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.217 1.945 . . . . 0.0 112.407 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.81 -55.96 28.19 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -169.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.464 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.0 OUTLIER -87.88 -14.74 0.21 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -168.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 45.6 Cg_exo -43.44 -23.36 0.47 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 121.392 1.533 . . . . 0.0 111.298 162.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 67.84 27.82 7.25 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.584 168.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -160.33 154.51 23.27 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.239 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.81 135.96 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' A' ' 110' ' ' VAL . 19.0 tt0 -98.5 113.56 25.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.0 0.428 . . . . 0.0 111.016 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 t -95.73 103.77 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.981 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 58.3 m -93.19 112.47 24.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 100' ' ' PHE . 4.2 mp -88.68 110.04 20.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.619 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.596 ' O ' HG23 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -100.41 116.82 33.26 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.558 178.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.42 ' HB1' ' CG2' ' A' ' 131' ' ' ILE . . . -69.99 159.55 33.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.052 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' H ' ' HG2' ' A' ' 126' ' ' GLU . 1.2 mm-40 -48.16 -59.55 3.32 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 111.012 -176.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.668 ' H ' HG21 ' A' ' 131' ' ' ILE . 48.4 t0 -104.63 154.98 19.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.622 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 3.7 t -76.41 140.68 41.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.834 0.349 . . . . 0.0 110.864 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.466 ' N ' ' SG ' ' A' ' 67' ' ' CYS . . . 90.9 49.34 3.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.31 -0.471 . . . . 0.0 112.766 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.504 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 32.0 m 52.14 70.88 0.51 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.047 0.451 . . . . 0.0 112.206 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.668 HG21 ' H ' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -69.28 -38.35 10.42 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 178.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.661 ' HD3' HG23 ' A' ' 131' ' ' ILE . 95.4 Cg_endo -82.68 118.88 2.87 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 121.267 1.311 . . . . 0.0 112.005 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.1 -31.27 69.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -83.28 10.07 9.36 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.494 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 4.2 p -63.29 -29.8 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.934 0.397 . . . . 0.0 110.611 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.49 93.38 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.493 HG21 ' HB2' ' A' ' 96' ' ' ASN . 18.0 pt -74.86 -32.71 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.102 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -161.56 166.78 26.48 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.868 0.366 . . . . 0.0 111.371 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -145.42 144.49 30.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.167 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -141.08 160.44 40.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.851 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -103.39 148.39 25.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.4 tt -126.07 137.89 56.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.192 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.46 105.64 6.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.205 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 72.5 mt 66.15 102.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.562 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -77.34 66.26 3.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.51 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.1 tp -92.11 -62.84 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.828 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -152.4 123.52 7.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.64 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -74.99 82.34 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -43.12 118.88 1.39 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.139 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -58.29 125.4 23.08 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.895 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -79.87 101.15 8.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.025 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -90.49 -42.73 10.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.239 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.64 178.059 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.521 ' SD ' HG22 ' A' ' 73' ' ' THR . 1.8 ttt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.53 -161.69 34.68 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.393 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -169.86 -50.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' HZ ' ' HB2' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -157.73 154.65 28.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.097 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.505 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -122.68 151.02 41.94 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.837 0.351 . . . . 0.0 110.597 -174.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.63 136.61 52.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.044 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.471 ' NH1' ' SG ' ' A' ' 130' ' ' CYS . 15.2 tpt180 -142.43 102.39 4.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.77 137.12 13.22 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.46 129.66 75.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.207 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.39 -28.57 20.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 110.313 175.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -90.09 42.29 1.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.808 -178.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.24 -34.59 23.61 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.148 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -68.93 -42.99 76.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.563 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.6 t70 -65.4 -42.55 92.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 21' ' ' LEU . 2.1 tt0 -61.85 -54.83 36.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.718 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -60.65 -32.5 71.68 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.785 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -35.03 74.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.931 0.396 . . . . 0.0 110.189 176.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -73.87 -24.31 59.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.784 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.05 5.41 89.73 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.37 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -169.7 162.16 9.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . 1.5 mt -69.33 73.32 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 66.27 149.47 0.12 Allowed Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.919 -176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 145.53 82.1 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.592 2.195 . . . . 0.0 111.734 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.26 139.42 37.4 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.508 -177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -158.05 99.17 0.18 Allowed Glycine 0 CA--C 1.517 0.179 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -93.0 156.1 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.278 0.561 . . . . 0.0 111.757 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -115.18 52.76 0.85 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.031 172.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -61.0 2.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.85 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 31' ' ' ALA . 2.0 mm-40 55.42 35.29 24.74 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 176.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.6 t 65.01 -3.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.338 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -89.16 47.1 1.45 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.958 -176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG12 ' HE3' ' A' ' 51' ' ' LYS . 11.9 mt -147.38 137.22 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.952 175.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.1 mtp85 -137.35 -29.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.364 -0.134 . . . . 0.0 111.133 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.8 t80 57.8 55.4 5.47 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.525 0.679 . . . . 0.0 110.172 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.58 82.99 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.132 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.04 -65.12 4.2 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.586 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -105.71 -179.57 3.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -74.32 69.09 1.57 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.101 0.476 . . . . 0.0 110.529 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -109.2 126.94 53.81 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.069 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.6 OUTLIER -168.67 167.36 11.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 -176.138 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.834 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 13.1 t70 -88.65 113.47 24.24 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.069 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 131.78 11.93 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.03 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -98.4 106.22 18.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.859 0.33 . . . . 0.0 110.919 -174.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 53.81 -128.74 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.433 0.458 . . . . 0.0 111.534 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -75.66 -4.7 41.66 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.277 0.231 . . . . 0.0 111.276 -179.088 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 45' ' ' THR . 9.2 m80 76.11 -49.47 0.59 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.633 0.773 . . . . 0.0 111.461 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.87 -171.99 24.27 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.981 -0.447 . . . . 0.0 111.981 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -87.64 -3.12 7.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.526 . . . . 0.0 112.238 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 50' ' ' VAL . 60.5 m -128.24 155.4 44.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.941 -173.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 49' ' ' SER . 0.3 OUTLIER 61.25 172.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.799 0.84 . . . . 0.0 112.339 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.478 ' HE3' HG12 ' A' ' 32' ' ' ILE . 1.0 OUTLIER 59.05 -172.18 0.11 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.746 174.014 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -53.3 -27.47 23.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.36 -66.43 0.39 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.733 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -30.82 49.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.664 0.268 . . . . 0.0 110.96 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.675 ' HA ' ' NH1' ' A' ' 124' ' ' ARG . 22.6 m-30 -62.35 -61.54 2.38 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.649 0.262 . . . . 0.0 110.591 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.75 77.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -52.11 -59.33 4.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.522 ' NE2' ' SG ' ' A' ' 128' ' ' CYS . 1.4 tp-100 -65.72 -51.32 60.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.003 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.476 ' HB ' HH22 ' A' ' 124' ' ' ARG . 2.7 tt -76.91 -24.13 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -169.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -93.78 -35.89 12.54 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.571 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.9 m -89.68 -58.8 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.581 0.229 . . . . 0.0 111.321 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.38 -128.1 6.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.198 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -156.18 -157.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 68' ' ' TYR . 5.5 m-85 -98.26 -6.85 30.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.092 -175.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -60.78 91.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.594 0.711 . . . . 0.0 111.288 -172.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.64 -39.03 3.04 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.222 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.609 ' SG ' ' CZ ' ' A' ' 68' ' ' TYR . 51.8 t -78.92 -48.22 14.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.144 -176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.609 ' CZ ' ' SG ' ' A' ' 67' ' ' CYS . 30.3 m-85 -129.17 162.68 27.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.658 0.383 . . . . 0.0 110.467 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.64 ' HB ' ' HB ' ' A' ' 123' ' ' ILE . 4.6 mp -92.15 99.21 9.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 111.019 -174.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 m -75.73 109.96 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.443 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -118.26 129.09 55.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.995 0.426 . . . . 0.0 111.275 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.627 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.1 m -75.91 157.46 33.18 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.611 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.521 HG22 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -86.07 9.86 16.03 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.643 -177.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 76' ' ' GLU . 16.2 t70 -109.33 135.7 49.96 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.494 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HE2' ' HG3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -55.46 -26.15 40.66 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HG3' ' HE2' ' A' ' 75' ' ' LYS . 11.2 mt-10 -82.81 2.03 36.13 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 121.999 0.12 . . . . 0.0 111.075 -177.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.627 HG13 ' H ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -44.61 -38.57 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 123.354 0.409 . . . . 0.0 111.457 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 4' ' ' PHE . . . -60.03 -55.88 28.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.226 0.536 . . . . 0.0 110.988 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.79 -42.09 67.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.275 -175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.299 -178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 22.5 t80 -65.74 -49.48 68.29 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.708 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -53.5 -56.46 16.79 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.303 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.8 m -63.3 -39.85 95.71 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.222 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.6 m -65.58 -25.6 67.48 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.941 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -90.4 0.18 57.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.696 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.87 54.8 30.78 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.708 HG21 ' HB1' ' A' ' 82' ' ' ALA . 4.2 tp -77.12 -9.9 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -174.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' A' ' 144' ' ' ILE . 4.2 tt0 -33.32 -47.72 0.22 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.492 0.495 . . . . 0.0 111.281 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -131.36 118.01 19.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.938 171.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 166.25 -168.44 39.9 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.091 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' HD1' ' HA ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -89.85 137.55 32.24 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.91 0.484 . . . . 0.0 109.744 179.579 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.48 111.31 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.7 0.286 . . . . 0.0 110.287 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 3.6 m-30 -111.68 143.4 42.64 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 176.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -129.97 130.32 66.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.02 178.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -125.04 141.34 52.19 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.497 -177.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' A' ' 99' ' ' LEU . 23.5 t-20 -85.58 132.53 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -62.48 -48.25 80.44 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.269 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.709 -175.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 96' ' ' ASN . 1.3 tp -62.84 -43.33 99.09 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.478 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 33.2 m-85 -62.91 -41.05 99.33 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.592 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -59.62 -36.03 88.04 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.802 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -66.07 -44.94 83.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -69.26 -16.62 63.62 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.3 m 72.13 31.0 2.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.608 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 124' ' ' ARG . 1.7 mt -75.55 157.05 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.391 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.476 ' HZ ' HG21 ' A' ' 32' ' ' ILE . 7.7 m-85 -83.6 101.95 11.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.734 -163.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -94.87 105.74 17.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.663 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.444 ' HE2' ' HE ' ' A' ' 124' ' ' ARG . 10.6 p90 -126.57 145.27 50.6 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.991 0.425 . . . . 0.0 110.032 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -95.45 125.27 39.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.689 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 120' ' ' GLU . 1.6 p -90.75 106.85 17.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 171.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.8 145.98 27.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.415 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -108.36 170.58 5.34 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.7 Cg_exo -47.7 170.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.452 2.101 . . . . 0.0 113.068 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -46.57 -67.28 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -170.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -93.28 -11.81 0.17 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 35.8 Cg_exo -43.88 -20.49 0.27 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 CA-C-N 121.556 1.592 . . . . 0.0 112.683 164.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 72.09 9.39 6.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.407 0.683 . . . . 0.0 111.708 170.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -110.09 115.61 30.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.217 0.532 . . . . 0.0 112.102 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -138.33 95.75 3.06 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.525 ' HB3' HG13 ' A' ' 110' ' ' VAL . 9.7 tt0 -93.96 140.21 29.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.737 -173.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.1 t -93.92 106.26 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.0 m -92.47 121.86 34.34 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.246 0.546 . . . . 0.0 111.349 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.64 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 18.1 mm -88.71 93.42 4.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.153 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.675 ' NH1' ' HA ' ' A' ' 55' ' ' TYR . 6.8 tpp180 -82.1 99.71 9.36 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.192 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.427 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -70.52 160.51 32.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.828 173.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.414 ' HB2' HD13 ' A' ' 131' ' ' ILE . 12.8 mt-10 -58.09 -30.81 66.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -147.44 160.87 42.08 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.184 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.522 ' SG ' ' NE2' ' A' ' 58' ' ' GLN . 76.7 m -61.7 149.94 38.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.983 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.42 26.78 50.43 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.873 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.471 ' SG ' ' NH1' ' A' ' 7' ' ' ARG . 1.8 m 57.21 72.0 0.54 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.708 0.29 . . . . 0.0 110.485 178.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.84 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -38.85 -46.2 3.17 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -176.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.84 ' HD3' HG23 ' A' ' 131' ' ' ILE . 85.2 Cg_endo -85.68 107.67 0.97 Allowed 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 120.651 1.268 . . . . 0.0 111.07 173.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -24.69 64.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.263 0.554 . . . . 0.0 110.528 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.56 3.52 15.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.374 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.499 HG13 HD23 ' A' ' 95' ' ' LEU . 2.4 p -77.9 -8.76 11.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.267 0.556 . . . . 0.0 110.733 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mm -86.2 96.14 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 pt -64.12 -32.99 59.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.137 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -144.68 136.3 25.61 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.024 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 8.1 mtmt -111.42 129.08 56.13 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.328 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -140.98 160.46 40.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.541 -176.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 tt -135.93 150.3 49.25 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 145' ' ' ASN . 21.2 tt -140.84 147.93 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 111.801 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -151.28 103.4 3.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.791 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.45 HD13 ' HG2' ' A' ' 88' ' ' GLU . 20.2 mm 61.56 85.53 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.242 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.698 ' HB2' HD11 ' A' ' 142' ' ' ILE . 25.5 t30 -65.26 -37.71 88.05 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.649 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.2 mt -131.92 172.68 12.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.212 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -71.88 -41.48 67.95 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.325 0.583 . . . . 0.0 110.049 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -132.99 177.23 7.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 51.71 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.395 0.617 . . . . 0.0 109.991 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.11 130.46 3.09 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.11 -19.54 36.52 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.501 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -134.7 151.98 51.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.903 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.838 178.519 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.18 85.1 0.81 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.299 -0.477 . . . . 0.0 113.024 -176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -113.63 3.56 15.71 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' HA ' ' H ' ' A' ' 97' ' ' ARG . 38.0 p90 39.73 -170.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.688 1.195 . . . . 0.0 113.54 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -147.33 160.59 42.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.21 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.488 ' OH ' HD13 ' A' ' 92' ' ' ILE . 7.4 t80 -121.19 129.56 53.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.628 -170.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.53 HH11 HG12 ' A' ' 69' ' ' ILE . 18.0 ttt180 -140.95 155.12 46.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.92 158.07 16.65 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.931 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.826 HG23 ' HB3' ' A' ' 91' ' ' TYR . 1.1 tt -139.07 129.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.122 0.487 . . . . 0.0 110.468 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.14 -2.04 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.55 0.691 . . . . 0.0 109.378 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.15 35.93 1.82 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.659 -176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -56.74 -32.73 65.83 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.444 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -69.56 -38.76 77.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.814 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -61.84 -45.75 92.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.909 177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.03 -52.2 66.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.42 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.49 -27.63 66.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.255 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -71.74 -40.96 69.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.137 0.494 . . . . 0.0 110.481 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -85.13 -28.4 25.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.35 17.87 51.32 Favored Glycine 0 CA--C 1.519 0.29 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -174.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.494 ' HG2' ' N ' ' A' ' 21' ' ' LEU . 4.1 tt0 174.44 158.36 0.16 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.528 0.731 . . . . 0.0 109.498 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' N ' ' HG2' ' A' ' 20' ' ' GLN . 54.0 mt -65.02 97.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.86 154.31 0.14 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.803 0.69 . . . . 0.0 110.645 -178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.97 167.2 26.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.765 2.31 . . . . 0.0 112.483 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -108.98 141.27 41.32 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.074 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.435 ' HA3' HG21 ' A' ' 45' ' ' THR . . . -112.07 -152.31 11.82 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.454 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' THR . 56.3 t30 -128.54 136.29 50.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -62.19 132.47 52.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.519 -177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -168.01 112.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.821 177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' ' H ' ' A' ' 42' ' ' GLY . 2.6 tp10 -114.55 131.87 56.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.891 0.377 . . . . 0.0 110.934 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.89 5.99 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.875 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.07 -147.41 0.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.063 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' A' ' 52' ' ' ASN . 23.0 mt 75.55 104.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 123.658 0.783 . . . . 0.0 111.418 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 mtt180 -137.05 -45.61 0.57 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.508 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER 67.49 124.79 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.277 -176.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.16 -18.52 65.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.568 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.7 4.77 81.23 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.136 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt 52.04 58.35 5.53 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.225 0.61 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.65 -41.36 21.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.422 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.27 88.78 0.09 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.2 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HE1' ' HB2' ' A' ' 34' ' ' TYR . 4.0 p90 -140.16 31.44 1.96 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.557 0.694 . . . . 0.0 109.624 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.49 148.08 25.09 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.805 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' H ' ' HG2' ' A' ' 29' ' ' GLU . . . 151.24 -58.41 0.43 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 113.032 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' NZ ' HD11 ' A' ' 131' ' ' ILE . 58.0 tttt -132.54 116.89 17.29 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.861 -0.199 . . . . 0.0 111.347 -172.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.27 141.75 0.33 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.78 0.675 . . . . 0.0 109.453 175.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.435 HG21 ' HA3' ' A' ' 25' ' ' GLY . 35.6 m -69.26 152.7 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.017 0.437 . . . . 0.0 111.537 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -77.84 67.18 3.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.954 174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.97 -173.11 49.23 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.723 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.05 -22.48 41.41 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.942 2.428 . . . . 0.0 111.669 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 m -149.72 -107.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 51' ' ' LYS . 1.8 t 54.51 -174.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 122.573 0.349 . . . . 0.0 110.53 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.718 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER 57.74 -154.23 0.36 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-O 120.993 0.425 . . . . 0.0 111.832 173.027 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.578 ' HB2' ' HA ' ' A' ' 32' ' ' ILE . 1.2 t30 -59.66 -27.24 66.21 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.845 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.44 -60.23 4.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.528 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 51' ' ' LYS . 4.8 p -63.35 -35.4 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.509 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.1 m-85 -59.88 -63.17 1.39 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.573 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.2 -46.33 79.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.175 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -62.05 -46.28 89.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 0.0 111.007 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 1.3 pt20 -70.05 -30.26 67.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.316 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 ' HG3' ' A' ' 58' ' ' GLN . 1.2 mp -81.21 -47.39 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.661 0.267 . . . . 0.0 110.722 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.79 -57.18 5.4 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.004 -177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.403 ' HB ' HD23 ' A' ' 63' ' ' LEU . 11.7 m -74.67 -26.35 59.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.283 -177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.6 22.03 78.83 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.222 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 65' ' ' ASP . 0.8 OUTLIER -65.68 -33.38 75.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 111.174 -178.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.6 t80 33.74 46.87 0.14 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.795 -174.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.523 ' H ' HD12 ' A' ' 63' ' ' LEU . 37.4 t70 -90.4 -0.27 57.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.483 0.659 . . . . 0.0 109.408 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.07 144.81 46.67 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.417 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 p -71.21 0.77 7.12 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -65.31 158.79 25.47 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.718 0.294 . . . . 0.0 111.142 -177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.53 HG12 HH11 ' A' ' 7' ' ' ARG . 18.1 mt -102.75 138.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.052 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.95 131.0 42.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 172.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 5' ' ' LEU . 96.9 m -140.8 110.1 6.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 111.033 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 77' ' ' ILE . 3.4 m -68.97 152.85 44.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.103 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 10.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -136.96 142.4 42.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.526 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -54.47 -19.81 6.44 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.733 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -50.21 -31.21 13.31 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.862 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -48.07 -31.08 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.447 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.27 -54.72 40.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -45.41 62.93 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.765 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -58.52 -49.18 78.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.352 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 7' ' ' ARG . 27.2 t80 -67.48 -49.22 64.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.475 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -55.57 -47.11 76.96 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.507 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 m -75.91 -39.32 56.51 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.814 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.3 m -72.69 -20.15 61.28 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -96.62 3.66 52.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.848 0.356 . . . . 0.0 110.718 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.5 76.03 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.655 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 82' ' ' ALA . 4.6 mt -72.97 -7.26 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 144' ' ' ILE . 1.8 mt-10 -28.68 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -126.46 99.97 6.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.997 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.49 -139.97 5.34 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.77 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.826 ' HB3' HG23 ' A' ' 9' ' ' ILE . 2.2 t80 -124.47 150.88 45.25 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.505 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.3 pt -136.84 142.54 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.778 0.323 . . . . 0.0 111.103 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -132.63 135.11 45.66 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.178 0.514 . . . . 0.0 111.704 176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 m -113.92 139.3 40.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.564 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -125.97 142.04 51.7 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.124 -173.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.447 ' HB2' HG21 ' A' ' 137' ' ' ILE . 30.4 t30 -79.68 124.59 28.71 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.815 0.341 . . . . 0.0 111.139 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.588 ' HB2' HD23 ' A' ' 5' ' ' LEU . 46.9 ttt180 -75.64 -32.76 60.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.49 79.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.727 HD23 ' HA ' ' A' ' 135' ' ' VAL . 9.6 tp -65.27 -37.73 88.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.793 177.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.535 ' HD2' ' HA ' ' A' ' 97' ' ' ARG . 22.6 m-85 -62.07 -42.71 99.48 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.761 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.13 -36.25 92.07 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.655 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -66.62 -48.3 69.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.133 0.492 . . . . 0.0 109.901 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -66.43 -16.45 64.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.584 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 m 67.69 30.84 6.28 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.37 0.605 . . . . 0.0 110.291 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 124' ' ' ARG . 3.5 mt -68.91 152.2 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.778 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.32 101.42 10.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 111.187 -166.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -106.36 120.65 42.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.954 0.407 . . . . 0.0 110.097 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -115.74 120.08 38.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.712 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 121' ' ' VAL . 2.3 tt0 -91.44 132.81 35.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.306 0.574 . . . . 0.0 111.233 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 m -117.75 149.16 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.774 171.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.62 135.14 54.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 110.631 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -79.44 178.06 2.54 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 73.7 Cg_exo -50.08 158.01 2.55 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 121.229 1.286 . . . . 0.0 111.427 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -47.54 -70.37 0.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.425 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.6 OUTLIER -88.88 -9.7 0.14 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -166.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.536 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 68.0 Cg_exo -47.26 -24.32 3.7 Favored 'Trans proline' 0 C--N 1.359 1.12 0 CA-C-N 121.535 1.584 . . . . 0.0 110.716 161.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.58 32.29 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.032 169.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.72 105.09 13.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.395 -176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -104.56 107.33 18.22 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -101.47 125.7 48.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.681 -171.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 109' ' ' GLU . 19.1 t -116.75 106.46 20.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.37 116.48 22.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.758 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.476 HG13 HD22 ' A' ' 5' ' ' LEU . 9.5 mm -87.77 110.82 21.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.82 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.525 ' O ' HG23 ' A' ' 105' ' ' ILE . 1.4 mtt-85 -111.96 106.77 15.55 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.816 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.91 162.3 28.28 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.64 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.34 -24.83 67.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.332 0.586 . . . . 0.0 110.376 -175.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.24 162.42 33.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.236 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 5.3 t -80.44 144.39 32.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.546 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.47 32.19 14.23 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 113.529 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.7 m 57.48 68.49 0.84 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.256 0.551 . . . . 0.0 110.537 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.851 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -46.56 -49.89 43.71 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.959 -175.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.851 ' HD3' HG23 ' A' ' 131' ' ' ILE . 93.9 Cg_endo -88.44 107.73 0.52 Allowed 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 121.33 1.353 . . . . 0.0 112.118 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -76.83 2.15 15.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.108 0.48 . . . . 0.0 110.763 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -90.36 -15.37 31.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.727 ' HA ' HD23 ' A' ' 99' ' ' LEU . 4.0 p -81.58 -14.05 12.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 139' ' ' LYS . 1.1 tt -87.65 97.54 6.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.447 HG21 ' HB2' ' A' ' 96' ' ' ASN . 40.0 pt -75.45 -29.65 21.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.63 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -151.7 146.17 25.58 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.634 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.64 ' HB3' HD11 ' A' ' 136' ' ' ILE . 45.7 pttt -150.32 130.18 13.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.765 174.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -141.68 160.7 39.63 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.889 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 tt -75.74 145.98 40.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 173.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.453 ' HB ' HG12 ' A' ' 92' ' ' ILE . 20.4 tt -125.3 141.35 45.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.066 0.46 . . . . 0.0 110.214 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -149.17 126.6 11.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.552 -177.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 88' ' ' GLU . 5.1 tt -45.97 93.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 124.183 0.927 . . . . 0.0 108.952 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 179.83 -37.87 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.938 -165.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tt 71.24 107.43 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.01 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 61.16 7.58 1.67 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.834 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 56.63 20.62 5.12 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.633 0.373 . . . . 0.0 110.324 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.8 p80 25.47 56.04 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.423 1.089 . . . . 0.0 112.525 -172.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -177.24 -71.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.043 176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 47.31 62.38 2.44 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.106 0.479 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -68.99 115.26 8.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.823 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.332 178.52 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 mmm . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.99 -173.52 13.36 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.096 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.46 ' HB3' ' HG3' ' A' ' 97' ' ' ARG . 53.0 t30 -61.02 159.04 12.25 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.03 125.71 35.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.272 -175.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 3.9 mp -100.64 152.39 20.5 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.81 133.54 36.02 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.344 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.662 ' HG3' HH11 ' A' ' 7' ' ' ARG . 0.9 OUTLIER -147.69 130.1 15.75 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.503 ' HA3' HG22 ' A' ' 92' ' ' ILE . . . -125.23 157.17 19.35 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.011 -176.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.25 128.93 59.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 122.961 0.504 . . . . 0.0 109.998 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -15.6 18.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.252 0.549 . . . . 0.0 110.214 176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -83.34 60.82 5.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.48 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -27.26 19.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.368 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.17 -49.33 28.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.449 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.6 OUTLIER -56.65 -43.2 80.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.204 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -73.76 -33.01 64.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.438 -177.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -79.46 -16.71 55.63 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.495 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.12 -40.08 24.62 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.692 ' ND2' ' H ' ' A' ' 22' ' ' LYS . 13.0 t30 -89.15 -65.48 1.01 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -176.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.88 41.73 8.03 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.55 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -175.53 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.176 0.512 . . . . 0.0 110.648 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 17.8 mt 53.07 42.62 32.22 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.52 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.692 ' H ' ' ND2' ' A' ' 18' ' ' ASN . 17.3 ttpp 44.6 74.84 0.73 Allowed Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 123.127 0.571 . . . . 0.0 112.178 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.477 ' HD3' HD21 ' A' ' 18' ' ' ASN . 71.0 Cg_endo -84.37 161.78 13.0 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 122.796 2.331 . . . . 0.0 112.947 -176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.656 ' HG2' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -165.48 149.79 8.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.736 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.96 166.99 23.24 Favored Glycine 0 C--O 1.236 0.265 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.383 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -174.57 179.61 1.71 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.543 0.337 . . . . 0.0 110.337 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 27' ' ' LYS . 9.0 mptt -74.22 145.96 43.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.072 0.463 . . . . 0.0 111.389 -173.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.96 -69.68 0.66 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.752 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 171.66 -157.44 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.193 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.1 75.28 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.206 0.527 . . . . 0.0 109.836 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.21 6.36 49.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.83 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mt -134.75 117.93 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.757 0.313 . . . . 0.0 110.546 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -145.79 76.26 1.46 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 38' ' ' PHE . 21.2 m-30 -85.27 -106.72 0.05 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -170.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -156.19 -141.78 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.455 -0.153 . . . . 0.0 110.921 -168.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.39 142.56 42.8 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.724 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt 59.55 23.64 12.33 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.938 0.495 . . . . 0.0 110.833 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 20.0 m-85 -129.17 40.63 3.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.957 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 77.53 0.11 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.566 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' OH ' ' HA ' ' A' ' 126' ' ' GLU . 21.0 t80 -155.27 111.78 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.441 -174.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -19.28 57.49 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.222 0.534 . . . . 0.0 111.012 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.85 -71.28 0.27 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.129 -0.558 . . . . 0.0 111.793 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt 66.11 -71.82 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.551 . . . . 0.0 110.322 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 127' ' ' ASP . . . -94.15 129.8 40.6 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -158.48 36.45 0.23 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.219 0.533 . . . . 0.0 110.281 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -118.2 3.58 11.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.526 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.64 -166.38 4.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.679 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.656 ' HD3' ' HG2' ' A' ' 24' ' ' LYS . 42.3 Cg_endo -65.72 -48.36 3.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.569 2.179 . . . . 0.0 112.036 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.6 m -144.08 134.69 24.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.637 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -135.76 -163.57 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.512 ' H ' HG12 ' A' ' 50' ' ' VAL . 33.9 mttm 55.39 -157.04 0.24 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.642 0.377 . . . . 0.0 111.764 175.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.444 ' H ' ' HB3' ' A' ' 51' ' ' LYS . 4.3 m-20 -61.33 -23.81 65.99 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.452 -176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.85 -61.02 2.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.353 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 p -69.94 -30.63 44.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.032 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -61.88 -50.43 72.27 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.87 88.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.331 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -56.12 -46.62 79.1 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.262 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.506 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 2.0 tt0 -59.88 -56.08 26.18 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.427 -176.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.0 mt -74.46 -33.67 33.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.667 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -83.47 -63.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.395 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 m -84.28 -45.33 12.95 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.066 0.46 . . . . 0.0 111.451 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.02 108.78 2.74 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.068 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.506 ' HG ' ' HA ' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -123.06 52.06 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 109.761 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -91.07 38.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.174 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -77.83 -24.09 48.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.272 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.99 -14.74 0.14 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.017 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.502 ' HA ' ' H ' ' A' ' 129' ' ' GLY . 0.1 OUTLIER -55.64 -55.73 28.63 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.499 0.19 . . . . 0.0 110.827 177.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.423 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 16.5 m-85 -127.81 154.45 45.42 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.21 102.89 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.867 0.365 . . . . 0.0 111.017 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.14 132.42 42.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.394 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -135.54 108.53 7.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.19 177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.16 164.23 25.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.23 -176.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -35.88 48.8 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -100.4 132.9 45.52 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 -175.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -60.87 -19.65 60.52 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.864 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 16.6 tp10 -54.05 -18.06 3.26 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.06 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -44.52 -33.61 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.836 177.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.43 -66.89 0.34 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.154 0.502 . . . . 0.0 112.035 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -69.17 -37.51 78.22 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.334 -174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HG2' ' HG3' ' A' ' 76' ' ' GLU . 46.5 mmtm -63.86 -41.74 97.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.113 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.73 -46.46 72.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.972 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HA ' HD12 ' A' ' 87' ' ' ILE . . . -57.25 -52.61 64.64 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.289 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.0 m -68.74 -50.63 49.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.862 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 m -68.06 -14.82 63.27 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB2' HG13 ' A' ' 87' ' ' ILE . 16.1 m -103.23 4.84 37.15 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.143 -0.348 . . . . 0.0 111.003 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.56 24.53 73.89 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.066 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 82' ' ' ALA . 6.9 mt -81.12 -8.09 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.509 0.195 . . . . 0.0 110.772 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.494 ' O ' HG12 ' A' ' 142' ' ' ILE . 16.9 mt-10 -37.58 -39.04 0.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.637 0.775 . . . . 0.0 112.866 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -109.86 87.64 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.74 -141.2 5.33 Favored Glycine 0 C--O 1.238 0.378 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.901 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -134.87 125.86 27.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.503 HG22 ' HA3' ' A' ' 8' ' ' GLY . 2.0 pt -119.89 147.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 7' ' ' ARG . 2.8 p90 -130.44 148.58 52.27 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.278 0.561 . . . . 0.0 110.608 177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.0 m -113.35 140.22 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.264 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.811 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 1.2 mp -119.59 143.16 47.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.473 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.597 ' HB3' HG21 ' A' ' 137' ' ' ILE . 6.7 t30 -102.55 133.74 47.03 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.936 0.398 . . . . 0.0 111.083 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.683 ' HG2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -64.82 -42.82 94.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.045 -178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.09 -34.02 65.6 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.213 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.09 -50.76 64.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.368 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.409 ' HD1' HG13 ' A' ' 105' ' ' ILE . 49.6 m-85 -68.4 -29.95 68.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.98 -47.24 91.35 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.475 177.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -37.92 79.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.062 0.458 . . . . 0.0 110.236 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -70.92 -20.16 62.51 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.001 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 8.4 m 66.24 46.67 1.99 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.507 0.67 . . . . 0.0 110.569 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 125' ' ' ALA . 9.0 mm -79.31 152.15 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.078 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.498 ' HB3' ' HG2' ' A' ' 124' ' ' ARG . 4.2 t80 -75.44 122.61 24.07 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.988 0.423 . . . . 0.0 110.939 -168.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -104.84 106.52 17.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.512 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -103.44 113.42 26.91 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.979 0.418 . . . . 0.0 109.875 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.27 109.25 20.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.016 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -88.2 115.69 28.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 173.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 137.4 40.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.551 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -91.01 170.37 9.94 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.512 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 78.1 Cg_exo -50.21 157.1 3.24 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.377 1.384 . . . . 0.0 111.063 173.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.64 -57.73 5.8 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -168.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.463 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.8 OUTLIER -91.51 -17.55 0.22 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -168.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.512 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 38.2 Cg_exo -42.23 -22.8 0.24 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.37 1.525 . . . . 0.0 111.808 164.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.4 ' N ' ' C ' ' A' ' 115' ' ' ASN . 16.9 m-20 68.74 8.51 6.8 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.102 166.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -111.58 138.04 48.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.737 0.303 . . . . 0.0 110.965 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -141.6 145.88 35.58 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 110' ' ' VAL . 1.7 tm-20 -122.12 125.08 45.39 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.98 95.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.5 m -87.08 113.88 23.21 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.572 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.637 HG13 HD21 ' A' ' 5' ' ' LEU . 48.6 mm -88.25 97.25 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.436 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HG2' ' HB3' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.534 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.566 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -69.46 159.65 32.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.581 ' HB2' HD13 ' A' ' 131' ' ' ILE . 7.1 mp0 -50.81 -48.24 59.72 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.907 0.384 . . . . 0.0 111.506 -175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.451 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 3.6 t0 -119.18 160.43 22.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 0.0 110.074 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.01 128.56 34.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.178 -174.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.502 ' H ' ' HA ' ' A' ' 67' ' ' CYS . . . 93.17 65.16 1.07 Allowed Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.244 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.03 70.43 0.47 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 126' ' ' GLU . 7.4 tt -68.18 -37.24 10.57 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.649 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.564 ' HD3' ' CG2' ' A' ' 131' ' ' ILE . 59.3 Cg_endo -98.52 118.91 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.385 2.057 . . . . 0.0 111.808 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.21 -7.31 53.5 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.276 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.21 6.91 23.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.193 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.552 ' HB ' HD23 ' A' ' 95' ' ' LEU . 6.0 m -60.31 -22.8 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.554 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.7 mt -87.63 88.22 2.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 120.988 0.423 . . . . 0.0 109.866 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.597 HG21 ' HB3' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -79.91 -29.77 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.551 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -153.81 166.98 31.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.302 172.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -147.57 159.09 44.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.074 0.464 . . . . 0.0 110.879 179.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -141.14 140.75 34.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.019 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -95.09 149.63 21.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 171.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 88' ' ' GLU . 16.5 tt -140.99 141.64 31.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.518 . . . . 0.0 111.68 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.577 ' O ' ' HB ' ' A' ' 144' ' ' ILE . 4.8 tt0 -139.01 22.45 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.747 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 143' ' ' GLU . 10.3 tp 147.29 141.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.513 1.525 . . . . 0.0 109.096 -177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -100.18 88.53 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.5 tp -141.37 75.44 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.446 ' HB3' ' H ' ' A' ' 148' ' ' HIS . 2.4 mm-40 55.2 -105.78 0.29 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.812 174.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.446 ' H ' ' HB3' ' A' ' 147' ' ' GLU . 70.5 m-70 -112.13 142.16 44.93 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -83.25 95.16 8.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.804 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -65.99 91.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.438 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -74.26 73.18 1.8 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.835 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -168.25 175.11 6.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.693 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.203 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.92 -90.22 0.47 Allowed Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.418 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -151.6 169.24 22.59 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -109.49 156.47 20.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.718 0.294 . . . . 0.0 110.826 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.814 HD12 HG21 ' A' ' 71' ' ' THR . 0.2 OUTLIER -99.55 139.9 34.53 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -106.61 128.29 54.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.676 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 135.66 20.8 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -110.87 158.3 14.46 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.321 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.555 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 2.3 mt -113.89 129.32 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 122.762 0.425 . . . . 0.0 110.161 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.34 25.39 11.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.338 0.589 . . . . 0.0 109.899 177.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.795 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -152.89 58.98 0.79 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.916 -173.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 5.7 mp0 -51.15 -42.4 60.75 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.36 -32.79 73.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.051 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.795 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 1.4 m-20 -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.961 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -60.38 -45.35 93.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 109.666 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -62.71 -42.72 99.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.981 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.51 -43.36 97.43 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.934 0.397 . . . . 0.0 110.499 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -71.94 -24.85 61.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.444 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.09 -10.84 72.74 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.262 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -172.6 172.73 4.18 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 mt -65.03 91.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.32 0.387 . . . . 0.0 110.602 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HE3' ' SG ' ' A' ' 128' ' ' CYS . 15.2 tptp 74.7 132.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.473 0 O-C-N 123.891 0.744 . . . . 0.0 110.746 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.01 132.64 18.53 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.298 1.998 . . . . 0.0 111.046 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 2.2 mmmm -84.16 142.16 30.53 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.662 0.267 . . . . 0.0 110.293 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.01 59.39 4.91 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.273 -0.489 . . . . 0.0 114.035 -172.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.416 ' ND2' ' HG2' ' A' ' 27' ' ' LYS . 56.0 t30 45.92 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.293 0.637 . . . . 0.0 112.571 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.9 pttp -172.02 -172.74 1.02 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.732 0.413 . . . . 0.0 109.952 -178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.472 ' HB1' HG22 ' A' ' 30' ' ' VAL . . . -179.19 -46.67 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.662 0.267 . . . . 0.0 110.918 -177.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 71.7 -18.27 0.31 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.377 0.671 . . . . 0.0 112.746 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.472 HG22 ' HB1' ' A' ' 28' ' ' ALA . 3.5 m -57.82 132.54 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 111.008 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.39 176.49 4.6 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.514 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.723 HG23 ' HA ' ' A' ' 51' ' ' LYS . 1.1 mm -111.94 91.72 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.94 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -76.08 69.68 2.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -67.7 122.17 17.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.372 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.87 76.11 0.89 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.302 0.572 . . . . 0.0 110.193 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . 175.45 41.0 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.783 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 21.2 mtpp 74.47 -58.81 0.57 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.653 0.781 . . . . 0.0 111.918 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -70.44 81.75 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 111.484 -175.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -103.85 83.01 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.911 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CZ ' HG13 ' A' ' 32' ' ' ILE . 31.4 p90 -74.89 138.43 42.42 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.173 0.511 . . . . 0.0 110.943 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -107.0 157.5 17.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.714 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.12 169.63 30.73 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.363 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' HZ2' ' HA ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -150.42 133.68 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.12 -55.52 13.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 111.01 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.33 -78.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.769 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -100.21 174.59 6.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.301 -178.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.14 70.39 0.07 OUTLIER Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.543 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.436 ' HG2' ' H ' ' A' ' 49' ' ' SER . 78.1 Cg_endo -84.51 -56.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.702 2.268 . . . . 0.0 112.314 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.436 ' H ' ' HG2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -89.27 53.44 2.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.355 -176.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.637 HG22 ' H ' ' A' ' 51' ' ' LYS . 14.8 p -114.63 -127.94 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.908 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.723 ' HA ' HG23 ' A' ' 32' ' ' ILE . 20.4 mtpp 59.59 -167.37 0.17 Allowed 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.296 0.57 . . . . 0.0 112.059 174.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -56.83 -23.53 44.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.021 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.2 -60.68 3.23 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.872 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.85 -32.77 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.647 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -60.41 -51.4 69.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.59 -49.37 78.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.79 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -58.19 -50.55 73.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.687 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.562 ' HG3' ' CD2' ' A' ' 68' ' ' TYR . 9.4 mm100 -55.39 -49.01 73.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 -177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 mt -74.53 -46.08 43.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.493 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -61.96 -48.24 81.28 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.074 -176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.426 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 3.6 m -77.59 -32.38 53.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.641 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.66 53.96 9.18 Favored Glycine 0 C--N 1.332 0.32 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.174 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' H ' HD12 ' A' ' 63' ' ' LEU . 2.7 mp -81.05 -75.87 0.26 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.497 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 52.28 39.4 27.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.431 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -90.73 -57.29 2.87 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.713 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -125.32 -60.4 0.17 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.24 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 74.1 m -51.76 -52.96 44.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.562 ' CD2' ' HG3' ' A' ' 58' ' ' GLN . 18.1 m-30 -120.51 145.05 47.68 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.85 128.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 -174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 122' ' ' THR . 2.3 m -87.6 130.82 34.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.814 HG21 HD12 ' A' ' 5' ' ' LEU . 13.4 m -127.74 137.77 52.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.461 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.2 OUTLIER -88.14 148.01 24.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.453 178.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.77 10.47 3.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.93 0.395 . . . . 0.0 111.377 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.75 121.99 28.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -63.0 -19.63 64.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 80' ' ' LYS . 6.9 pt-20 -90.13 0.34 57.21 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.66 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 72' ' ' THR . 5.0 tt -49.64 -29.83 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.775 -177.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.66 -68.9 0.15 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.886 0.374 . . . . 0.0 111.908 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -28.45 47.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HB2' ' HG3' ' A' ' 76' ' ' GLU . 9.7 tttp -56.23 -49.79 73.13 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.496 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.18 -49.47 50.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.741 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.9 68.22 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.485 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -73.74 -48.91 28.36 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.596 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 m -65.59 -21.37 66.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.676 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.2 m -95.47 0.38 53.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.05 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.31 31.01 72.43 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.831 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.65 -8.8 11.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.639 -173.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.426 ' O ' HG12 ' A' ' 142' ' ' ILE . 31.1 mm-40 -40.27 -34.29 0.31 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.916 0.487 . . . . 0.0 112.101 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -112.26 96.76 6.2 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.45 -135.52 3.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.022 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.555 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -123.94 150.31 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.082 0.553 . . . . 0.0 109.609 -175.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.551 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 1.5 pt -142.97 133.08 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -131.72 154.97 48.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.1 0.476 . . . . 0.0 111.379 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 138' ' ' ALA . 32.9 m -129.84 136.63 58.55 Favored 'Isoleucine or valine' 0 C--O 1.25 1.1 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.459 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -113.64 141.95 46.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.809 -177.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.455 ' HB3' HG21 ' A' ' 137' ' ' ILE . 3.3 p30 -83.8 143.4 29.98 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.56 -27.98 21.04 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.689 0.28 . . . . 0.0 111.073 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.0 -33.51 62.65 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.743 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -61.44 -41.57 97.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.064 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 135' ' ' VAL . 22.6 m-85 -71.11 -41.23 70.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.043 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.96 -35.22 91.08 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.05 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -74.73 -43.45 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.0 109.576 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.06 -25.22 66.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.569 -177.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 m 67.21 28.63 8.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.226 0.536 . . . . 0.0 110.046 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 124' ' ' ARG . 0.7 OUTLIER -66.43 164.79 2.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.294 176.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.78 ' HB3' ' HB2' ' A' ' 124' ' ' ARG . 4.0 t80 -73.45 99.35 2.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.293 0.568 . . . . 0.0 110.381 -167.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -95.3 100.02 11.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.012 175.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.54 ' HB3' ' NE ' ' A' ' 124' ' ' ARG . 4.1 t80 -124.73 113.47 18.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -97.64 142.14 29.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.652 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.81 132.07 49.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.491 ' HB3' ' HE3' ' A' ' 119' ' ' LYS . 6.5 pt-20 -129.57 136.13 49.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.084 0.468 . . . . 0.0 110.541 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 178.06 2.63 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.736 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.76 171.02 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.028 1.819 . . . . 0.0 112.28 171.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.9 -67.87 0.23 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.49 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 1.8 t-20 -86.15 -11.08 0.17 Allowed Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -166.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 43.7 Cg_exo -42.35 -25.48 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 CA-C-N 121.439 1.55 . . . . 0.0 111.271 162.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 69.9 3.8 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.656 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -122.74 130.72 53.26 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.329 0.585 . . . . 0.0 111.646 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 111' ' ' GLU . 17.6 ptmt -150.97 141.62 22.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.763 174.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -122.62 132.91 54.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.947 0.403 . . . . 0.0 111.073 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -90.91 112.42 25.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.924 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 70' ' ' SER . 2.7 m -88.78 114.9 25.9 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.779 0.324 . . . . 0.0 110.383 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pt -87.45 113.4 24.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.78 ' HB2' ' HB3' ' A' ' 106' ' ' PHE . 23.1 mtt-85 -114.91 88.51 2.88 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.744 -172.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.664 ' HB1' HG22 ' A' ' 131' ' ' ILE . . . -69.87 123.23 20.96 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.583 172.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -51.77 -46.43 64.12 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.386 0.429 . . . . 0.0 111.637 -168.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.704 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 2.0 t70 -80.21 122.66 27.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.567 ' SG ' ' HE3' ' A' ' 22' ' ' LYS . 7.4 t -54.02 119.56 5.22 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.459 -173.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.94 56.89 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.936 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 8.8 m 63.26 74.82 0.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.704 ' HB ' ' HB3' ' A' ' 127' ' ' ASP . 19.3 tt -45.44 -35.27 3.08 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.623 ' HG2' ' HB ' ' A' ' 135' ' ' VAL . 91.9 Cg_endo -96.42 109.1 0.11 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 121.595 1.53 . . . . 0.0 111.592 169.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -63.8 -22.78 67.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.392 0.615 . . . . 0.0 109.842 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -70.21 -7.68 43.94 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.556 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.623 ' HB ' ' HG2' ' A' ' 132' ' ' PRO . 2.3 p -77.26 -15.25 14.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.078 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.86 89.96 3.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.455 HG21 ' HB3' ' A' ' 96' ' ' ASN . 14.5 pt -74.74 -30.62 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.275 -173.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -150.0 148.14 28.69 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.41 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -143.94 127.74 17.26 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.323 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -131.11 152.23 50.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.273 -176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.57 150.07 23.78 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 88' ' ' GLU . 20.7 tt -140.19 135.41 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.114 0.483 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -120.84 42.82 2.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.241 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.8 mt 70.34 94.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.483 -173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -30.01 70.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.621 -176.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 129.0 38.59 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.915 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 140.55 58.77 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.537 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -129.88 66.66 1.47 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.41 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.99 57.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.036 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -166.28 42.11 0.06 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.387 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.6 m170 53.49 -97.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.932 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -152.17 15.45 0.62 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 110.289 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.82 -0.61 . . . . 0.0 110.129 -177.479 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.849 0.357 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.91 43.86 32.8 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.357 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.54 65.49 9.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -60.03 155.47 16.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.261 -173.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.545 ' H ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -100.29 146.09 27.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.537 ' HE1' ' HB ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -113.57 130.96 56.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.744 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HG3' HG22 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -138.25 126.78 23.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.653 178.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -109.6 157.84 14.86 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 HG12 ' SG ' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -129.94 132.66 65.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.205 0.526 . . . . 0.0 110.488 -177.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -22.22 19.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.401 173.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -84.8 49.03 1.64 Allowed 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.499 -177.004 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.53 ' HG3' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -57.78 -26.11 61.46 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 14' ' ' ASP . 2.2 pt20 -63.43 -41.48 98.68 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.848 176.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -69.65 -41.46 75.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.677 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.93 -55.86 29.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.48 178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -63.24 -39.51 94.83 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.072 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -64.59 -37.33 87.21 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 110.448 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.32 -23.98 37.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.55 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . 65.78 14.5 60.79 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -174.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 13.2 mt-30 -156.38 172.87 17.76 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -85.11 42.29 0.93 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.822 0.344 . . . . 0.0 110.751 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt 45.61 59.23 15.03 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.16 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.91 171.71 9.21 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.95 2.433 . . . . 0.0 113.177 -171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -135.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.087 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 127' ' ' ASP . . . 94.05 99.0 1.58 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.136 -179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -92.43 -9.82 40.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.73 0.3 . . . . 0.0 110.407 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 71.83 115.0 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.577 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.627 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . . . -139.5 5.91 2.26 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.646 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.421 ' CD ' HH22 ' A' ' 33' ' ' ARG . 0.3 OUTLIER -64.11 128.9 37.82 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.35 0.595 . . . . 0.0 110.968 -178.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -164.59 -39.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.297 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.2 17.68 4.51 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.2 mm -76.84 76.76 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.408 0.623 . . . . 0.0 110.565 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.421 HH22 ' CD ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -111.12 -11.45 14.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.779 -177.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.5 t80 75.77 -42.36 0.46 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.705 0.802 . . . . 0.0 112.307 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -62.3 -13.99 34.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.796 0.331 . . . . 0.0 111.348 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.93 31.39 5.63 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.5 tptm 69.48 -79.16 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.318 0.647 . . . . 0.0 110.384 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.44 ' HB3' ' OD1' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -168.76 -99.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -177.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? 57.78 22.82 8.9 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.023 0.439 . . . . 0.0 111.71 174.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -83.28 60.95 5.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.272 0.558 . . . . 0.0 109.733 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.02 77.65 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.899 -176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 47' ' ' GLY . . . 64.17 -159.38 40.68 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.299 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HG2' ' HB2' ' A' ' 28' ' ' ALA . 20.3 mttt -93.3 52.27 1.75 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 70.07 -68.75 0.19 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.821 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -70.51 -50.23 39.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.717 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -131.55 149.8 52.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.335 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.34 61.1 0.3 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.519 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -85.73 -8.37 8.21 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.699 2.266 . . . . 0.0 111.964 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.3 p -144.86 163.2 34.83 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 51' ' ' LYS . 1.4 t 51.95 -160.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.176 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.744 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER 52.9 -146.2 0.54 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.02 0.528 . . . . 0.0 111.605 172.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 38' ' ' PHE . 1.8 t30 -53.79 -34.87 60.48 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.6 -57.04 12.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.897 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.6 -34.37 69.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.507 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -58.4 -64.22 1.0 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.906 0.384 . . . . 0.0 110.109 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.86 83.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.23 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.692 ' HB3' HD22 ' A' ' 63' ' ' LEU . 1.1 t-80 -64.92 -49.65 69.57 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.355 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HA ' ' HA2' ' A' ' 62' ' ' GLY . 35.9 tt0 -66.1 -38.1 87.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.258 0.551 . . . . 0.0 110.851 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mt -71.1 -34.4 54.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.7 -74.22 0.42 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.836 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -64.41 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.484 0.659 . . . . 0.0 111.441 -178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 58' ' ' GLN . . . 133.75 158.99 8.82 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.692 HD22 ' HB3' ' A' ' 57' ' ' HIS . 2.6 pt? -175.96 -44.49 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.066 0.433 . . . . 0.0 111.233 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.435 ' CE2' ' SG ' ' A' ' 128' ' ' CYS . 0.0 OUTLIER -114.35 89.26 3.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 110.752 -174.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.56 134.86 33.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.725 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.4 -7.56 81.72 Favored Glycine 0 C--O 1.229 -0.196 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.369 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.6 t -73.45 -35.63 65.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.19 0.519 . . . . 0.0 110.58 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -127.53 160.75 30.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.783 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.731 HG12 ' HB ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -105.06 100.69 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -175.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' HG23 ' A' ' 122' ' ' THR . 0.0 OUTLIER -85.95 125.23 33.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.611 176.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.644 HG23 HD12 ' A' ' 77' ' ' ILE . 97.3 m -137.44 148.56 46.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.572 0.225 . . . . 0.0 110.541 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.38 170.55 9.53 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.725 -177.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.21 4.74 9.79 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -176.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -106.53 135.92 47.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.806 0.336 . . . . 0.0 110.332 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -66.35 -23.35 66.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -70.84 -16.13 62.69 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.74 -175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.644 HD12 HG23 ' A' ' 71' ' ' THR . 0.0 OUTLIER -48.39 -34.27 5.07 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 O-C-N 123.387 0.43 . . . . 0.0 110.977 176.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.46 -53.99 51.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.885 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 79' ' ' LYS . 24.1 ttpt -75.11 -40.35 59.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.888 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -59.5 -52.3 66.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.04 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' A' ' 77' ' ' ILE . 1.4 t80 -64.74 -45.84 84.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.469 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -52.36 -59.15 4.76 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.272 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -64.5 -39.13 93.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.4 m -66.71 -26.66 67.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.685 0.279 . . . . 0.0 111.429 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 m -90.09 2.05 55.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.84 0.352 . . . . 0.0 110.478 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.34 33.36 84.26 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.538 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.63 HD12 HG21 ' A' ' 142' ' ' ILE . 1.8 pp -65.44 -9.96 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -29.22 -50.41 0.09 Allowed 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.181 0.925 . . . . 0.0 112.323 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -118.36 89.66 3.17 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.48 -149.58 10.25 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.989 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.53 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 6.7 t80 -115.92 145.44 42.9 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.733 0.413 . . . . 0.0 110.524 -175.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.537 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 1.9 pt -143.54 129.46 16.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.42 ' HE1' ' HB ' ' A' ' 9' ' ' ILE . 15.5 p90 -130.71 144.36 51.38 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.102 0.477 . . . . 0.0 111.232 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.787 HG23 ' HB3' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -108.95 135.94 46.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.164 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -118.15 130.34 56.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.131 177.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.618 ' HB3' HD12 ' A' ' 99' ' ' LEU . 59.3 t30 -79.8 141.68 36.02 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.576 0.227 . . . . 0.0 111.011 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 100' ' ' PHE . 16.2 ttt180 -80.07 -50.95 9.63 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.63 -22.46 65.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 111.088 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 96' ' ' ASN . 18.8 mt -64.15 -37.43 87.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.65 175.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.446 ' CE1' HG11 ' A' ' 135' ' ' VAL . 49.8 m-85 -63.28 -44.27 95.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.698 176.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.73 -37.47 83.84 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 175.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -66.61 -36.64 83.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.101 0.477 . . . . 0.0 110.499 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -83.94 -7.87 59.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.173 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.0 m 69.56 34.67 2.7 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.27 0.557 . . . . 0.0 110.791 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.589 HG13 ' HA ' ' A' ' 125' ' ' ALA . 1.2 mp -74.22 157.18 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.919 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -77.12 101.22 6.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.198 0.523 . . . . 0.0 111.114 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.81 99.96 12.87 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.217 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.401 ' HE2' ' HZ ' ' A' ' 38' ' ' PHE . 1.2 t80 -104.65 113.36 26.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.06 126.21 54.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 120' ' ' GLU . 3.7 m -108.26 132.01 57.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -111.65 133.77 53.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.232 0.539 . . . . 0.0 110.577 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.83 174.55 5.76 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.208 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 84.5 Cg_exo -48.37 170.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.447 2.098 . . . . 0.0 113.25 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -40.79 -71.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -170.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 1.1 t-20 -100.13 -9.17 0.13 Allowed Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -169.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HG2' ' HB2' ' A' ' 113' ' ' PRO . 47.4 Cg_exo -42.34 -26.98 0.63 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 CA-C-N 121.846 1.695 . . . . 0.0 111.09 165.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.65 26.45 9.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.386 168.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 116' ' ' PRO . 89.8 mt-10 -114.39 118.09 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.24 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -124.83 112.59 16.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.507 ' HB3' HG22 ' A' ' 110' ' ' VAL . 8.5 tt0 -96.26 106.16 18.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 109.991 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.56 95.86 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.618 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 70' ' ' SER . 0.2 OUTLIER -81.07 107.11 13.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.175 177.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.731 ' HB ' HG12 ' A' ' 69' ' ' ILE . 23.0 mm -87.85 106.68 16.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 105' ' ' ILE . 37.7 mtt85 -104.46 119.12 38.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.241 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.589 ' HA ' HG13 ' A' ' 105' ' ' ILE . . . -68.9 155.31 40.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.934 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.79 -49.4 62.78 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.313 0.578 . . . . 0.0 110.098 -176.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.575 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.2 t0 -122.35 156.09 34.65 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.416 -0.811 . . . . 0.0 108.991 175.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.435 ' SG ' ' CE2' ' A' ' 64' ' ' TYR . 20.5 t -73.07 150.28 42.46 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.79 0.328 . . . . 0.0 111.236 -175.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.61 51.87 2.97 Favored Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.807 -0.633 . . . . 0.0 113.098 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 41.62 70.34 0.28 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.865 0.466 . . . . 0.0 112.243 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.842 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -56.17 -48.5 96.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.755 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.842 ' HD3' HG23 ' A' ' 131' ' ' ILE . 87.1 Cg_endo -100.31 109.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.591 2.194 . . . . 0.0 112.395 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -77.37 -0.48 25.87 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.665 0.269 . . . . 0.0 111.301 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -87.81 -5.33 58.67 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.291 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.462 HG23 HD23 ' A' ' 95' ' ' LEU . 30.9 m -76.21 -17.25 15.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.84 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.3 pt -86.11 89.89 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.738 0.78 . . . . 0.0 109.378 -176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 7.8 pt -64.61 -31.06 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.305 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -142.18 146.21 35.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.415 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -151.66 114.92 4.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.856 177.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -140.61 160.5 39.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.878 0.37 . . . . 0.0 110.848 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -97.65 156.63 16.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.034 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.63 HG21 HD12 ' A' ' 87' ' ' ILE . 13.8 tt -134.16 137.76 51.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 146' ' ' LEU . 4.4 tm-20 -119.83 90.43 3.33 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.028 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.7 pt 37.7 -133.09 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.528 0.731 . . . . 0.0 111.49 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -88.73 56.59 3.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.048 0.451 . . . . 0.0 110.04 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 143' ' ' GLU . 0.0 OUTLIER -58.9 150.84 23.12 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.94 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -3.93 1.0 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.272 172.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 71.89 47.66 0.31 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.845 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -161.39 -38.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.506 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 51.49 -163.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.091 0.556 . . . . 0.0 111.932 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -121.96 150.03 42.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -98.56 118.77 36.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.219 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.501 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.83 0.348 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.74 138.43 3.16 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -161.91 163.59 29.05 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -116.07 150.46 37.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.212 0.53 . . . . 0.0 111.577 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 71' ' ' THR . 0.1 OUTLIER -100.53 151.35 21.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.97 132.57 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.779 0.323 . . . . 0.0 111.161 -173.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 7' ' ' ARG . 27.6 ttt-85 -140.15 99.39 3.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.406 0.622 . . . . 0.0 109.41 171.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.611 ' H ' ' HE2' ' A' ' 81' ' ' PHE . . . -89.13 154.74 24.67 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 91' ' ' TYR . 39.0 mt -121.16 133.24 68.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.938 0.399 . . . . 0.0 110.823 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -122.37 17.68 10.59 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.47 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.61 ' H ' HG22 ' A' ' 9' ' ' ILE . 0.5 OUTLIER -123.5 46.68 2.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.646 -179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -54.02 -29.79 45.01 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.752 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -63.99 -42.29 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.073 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -69.13 -45.29 70.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.068 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -38.6 83.44 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.205 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -69.74 -41.98 74.54 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.9 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -69.97 -41.25 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.456 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -80.41 -27.21 38.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.766 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.77 6.79 85.64 Favored Glycine 0 C--N 1.33 0.207 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -164.49 178.37 7.46 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 136' ' ' ILE . 12.6 mt -80.11 61.08 3.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.079 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 32.76 71.91 0.65 Allowed Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.397 1.079 . . . . 0.0 113.047 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.54 169.85 8.02 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.002 2.468 . . . . 0.0 112.258 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -126.26 -54.3 1.48 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.811 177.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.49 48.27 5.09 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.386 -0.435 . . . . 0.0 112.883 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -93.42 119.03 32.05 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.07 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' H ' ' A' ' 43' ' ' LYS . . . -171.09 -138.06 0.02 OUTLIER 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.681 -175.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.0 144.28 30.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.347 -0.388 . . . . 0.0 109.995 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.78 124.48 9.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.194 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -160.54 34.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 110.212 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.68 HG23 ' HE2' ' A' ' 51' ' ' LYS . 41.0 mt -128.57 138.74 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.549 -176.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 10.6 mmp_? -111.3 149.26 31.34 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.789 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.581 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -164.55 -166.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.246 175.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.51 71.02 3.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.033 0.444 . . . . 0.0 111.607 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 65.25 -80.19 0.07 OUTLIER Glycine 0 CA--C 1.523 0.555 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.618 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -56.27 -29.08 60.67 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -170.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 34' ' ' TYR . 3.4 m-85 -72.0 85.3 0.99 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.779 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.764 ' HE2' ' HB2' ' A' ' 104' ' ' SER . 0.2 OUTLIER -84.93 88.98 7.48 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.179 0.514 . . . . 0.0 111.331 -179.472 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 38' ' ' PHE . 67.4 m-85 -78.57 109.58 12.9 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -84.17 -20.43 32.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.573 0.225 . . . . 0.0 111.24 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.46 174.66 20.59 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.868 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' H ' ' HB3' ' A' ' 28' ' ' ALA . 11.4 pttp -157.78 -170.51 3.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.643 ' HB3' ' HA ' ' A' ' 49' ' ' SER . . . -135.93 -173.68 3.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 176.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.5 m -49.29 134.22 18.62 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.443 0.465 . . . . 0.0 111.656 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -63.59 132.24 50.56 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.6 -82.33 0.34 Allowed Glycine 0 C--N 1.331 0.25 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 52' ' ' ASN . 74.2 Cg_endo -70.21 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.904 2.402 . . . . 0.0 110.551 173.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.643 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 0.2 OUTLIER 67.62 162.17 0.18 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.225 0.535 . . . . 0.0 111.85 171.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 p -67.86 -55.27 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.55 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.68 ' HE2' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -53.44 -60.33 3.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.712 0.292 . . . . 0.0 111.17 -175.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 48' ' ' PRO . 5.2 m-20 -50.99 -59.57 4.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.151 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -58.29 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.265 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 50' ' ' VAL . 2.8 p -64.25 -37.35 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.516 -171.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 29.7 m-85 -77.58 -42.4 35.29 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.538 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.36 -47.66 75.44 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 109.976 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -66.16 -48.72 69.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.36 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 62' ' ' GLY . 1.4 tt0 -57.98 -29.79 65.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.954 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.7 mt -93.56 -52.78 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.709 0.29 . . . . 0.0 111.337 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -77.13 -49.56 14.96 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.828 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.98 -32.88 24.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.104 0.478 . . . . 0.0 111.244 -175.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 58' ' ' GLN . . . 134.59 172.11 12.71 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 70' ' ' SER . 84.3 mt -58.83 -15.3 11.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.413 0.607 . . . . 0.0 111.507 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 74.31 -28.0 0.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 164.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.79 101.25 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.999 0.428 . . . . 0.0 111.664 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -175.49 -112.8 0.31 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.776 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.4 p -76.99 -34.88 57.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.765 -177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -83.15 145.61 29.11 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.731 HD12 HD11 ' A' ' 123' ' ' ILE . 21.4 mt -117.94 128.06 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.39 -173.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.638 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.3 p -95.22 113.95 25.68 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 175.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.541 HG21 ' HB2' ' A' ' 5' ' ' LEU . 7.8 p -122.77 144.43 49.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.622 0.249 . . . . 0.0 110.801 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.0 m -87.81 150.2 23.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.831 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -16.06 62.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -79.35 135.52 36.74 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.858 0.361 . . . . 0.0 110.519 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -62.41 -20.9 64.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.804 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -72.63 -4.19 29.44 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.787 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.4 tt -51.29 -34.35 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.326 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.5 -58.91 6.52 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.151 0.5 . . . . 0.0 111.068 -176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -70.31 -43.52 70.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.058 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -59.95 -44.54 94.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.225 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.611 ' HE2' ' H ' ' A' ' 8' ' ' GLY . 87.5 t80 -65.98 -55.37 17.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.003 -178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -54.61 -46.43 73.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.671 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 m -72.73 -45.91 56.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.604 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.1 m -70.7 -17.15 62.83 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.6 m -92.9 -4.2 53.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.555 0.217 . . . . 0.0 111.001 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.99 37.6 95.23 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' HA ' HD13 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -90.88 -8.8 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.365 -0.417 . . . . 0.0 111.653 -171.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -42.37 -32.75 0.55 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -119.13 90.79 3.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.49 -145.97 8.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.253 -0.498 . . . . 0.0 112.375 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -107.68 146.79 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 122.252 0.221 . . . . 0.0 110.458 -178.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 16.3 mt -138.68 118.44 14.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.406 ' OH ' ' HD3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -131.89 143.4 50.13 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.75 173.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' A' ' 138' ' ' ALA . 2.4 m -120.75 149.38 23.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.044 0 CA-C-O 121.275 0.56 . . . . 0.0 111.123 -176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.662 HD23 HG22 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -122.92 134.91 54.34 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.523 -174.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.565 ' HB2' HD13 ' A' ' 137' ' ' ILE . 31.0 t30 -87.22 115.75 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.714 0.292 . . . . 0.0 110.944 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.44 -30.08 70.84 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.505 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -63.21 -36.37 83.43 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.515 HD21 ' HB3' ' A' ' 134' ' ' GLU . 32.2 tp -69.14 -40.41 78.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.361 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -62.5 -34.74 77.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.388 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.74 -39.94 98.0 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.519 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.481 ' HG3' ' N ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -63.55 -42.1 98.39 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.085 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.481 ' N ' ' HG3' ' A' ' 102' ' ' GLN . 19.4 m-85 -74.07 -16.94 61.02 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.964 0.412 . . . . 0.0 110.339 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.764 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 2.5 m 65.42 33.8 8.6 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.101 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 125' ' ' ALA . 75.3 mt -63.23 147.79 11.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.234 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.63 ' HB2' ' HB2' ' A' ' 124' ' ' ARG . 1.6 m-85 -75.21 150.13 38.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.808 0.337 . . . . 0.0 110.642 -167.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.25 118.05 8.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.585 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.509 ' HB2' ' HZ ' ' A' ' 38' ' ' PHE . 72.6 t80 -127.52 117.58 22.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.619 ' HG2' HG22 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -92.5 133.24 36.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.84 -177.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -97.91 134.11 37.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 168.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -96.71 133.06 41.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.362 0.601 . . . . 0.0 111.209 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -78.87 171.81 11.55 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 168.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 86.5 Cg_exo -46.63 164.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.824 1.682 . . . . 0.0 112.136 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -47.56 -67.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -170.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER -87.18 -13.69 0.2 Allowed Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -167.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 115' ' ' ASN . 31.5 Cg_exo -42.59 -23.63 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 CA-C-N 121.454 1.555 . . . . 0.0 111.774 163.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.41 23.67 9.07 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.895 170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -117.11 134.87 54.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.991 0.424 . . . . 0.0 111.88 -172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -125.39 106.57 9.92 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.065 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.582 ' HB3' HG22 ' A' ' 110' ' ' VAL . 2.7 tp10 -79.29 91.92 5.08 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.106 0.479 . . . . 0.0 110.201 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.619 HG22 ' HG2' ' A' ' 109' ' ' GLU . 17.5 t -73.43 98.82 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.175 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.565 HG21 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -84.16 114.84 22.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.731 HD11 HD12 ' A' ' 69' ' ' ILE . 1.6 pp -86.45 129.66 37.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 109.463 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.63 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -119.32 108.08 14.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.731 -173.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.575 ' HA ' HG23 ' A' ' 105' ' ' ILE . . . -78.45 161.11 27.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.405 178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.4 -6.27 42.3 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.865 0.364 . . . . 0.0 110.455 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 131' ' ' ILE . 3.9 t70 -153.48 159.71 42.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 6.7 m -85.85 133.51 33.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.899 0.381 . . . . 0.0 111.235 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.38 49.68 2.96 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.447 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.444 ' HB3' HG11 ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.76 70.3 0.66 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.816 0.341 . . . . 0.0 111.672 173.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.816 HG23 ' HD3' ' A' ' 132' ' ' PRO . 0.3 OUTLIER -61.61 -45.7 93.62 Favored Pre-proline 0 CA--C 1.55 0.948 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.816 ' HD3' HG23 ' A' ' 131' ' ' ILE . 59.1 Cg_endo -70.91 129.95 17.18 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 121.436 1.424 . . . . 0.0 112.096 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -64.14 -24.92 67.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.046 0.45 . . . . 0.0 110.881 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.515 ' HB3' HD21 ' A' ' 99' ' ' LEU . 3.7 mp0 -88.74 10.63 20.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.835 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.662 HG22 HD23 ' A' ' 95' ' ' LEU . 10.0 p -59.31 -31.61 46.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.937 0.399 . . . . 0.0 111.646 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.418 HG12 HD11 ' A' ' 21' ' ' LEU . 10.8 mt -89.17 88.2 2.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.565 HD13 ' HB2' ' A' ' 96' ' ' ASN . 1.1 pt -79.36 -28.4 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.958 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -146.98 141.55 26.57 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.633 171.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.09 124.92 19.7 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.773 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.8 157.14 45.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 -173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.74 146.47 36.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.3 tt -134.19 135.45 54.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 0.0 111.492 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -129.94 51.64 2.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.503 -0.771 . . . . 0.0 108.947 177.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.1 mt 70.56 -66.78 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.327 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.1 t30 54.2 77.84 0.18 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.328 0.585 . . . . 0.0 110.815 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.67 -50.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.2 -176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.65 150.18 43.22 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.61 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -106.6 11.41 30.53 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.485 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 65.14 53.4 1.35 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.835 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -48.64 -43.57 36.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.578 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.69 143.12 49.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.972 177.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -77.77 -37.44 48.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.077 0.465 . . . . 0.0 110.203 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.0 p-80 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.348 177.52 . . . . . . . . 0 0 . 1 stop_ save_